Free Orals: Biliary  by unknown
© 2012 The Authors
HPB 2012, 14 (Suppl. 2), 107–287 HPB © 2012 Americas Hepato-Pancreato-Biliary Association
FREE ORALS: BILIARY
FOS001
PORT SITE RESECTION DOES NOT 
IMPROVE SURVIVAL IN INCIDENTAL 
GALLBLADDER CANCER BY THE 
AFC-GBC-2009 STUDY GROUP
D. Fuks1, J.-M. Regimbeau1, P. Pessaux2, M. Adham3, 
J. Hardwigsen4, AFC-GBC-2009 Study Group1 and 
O. Farges5
1Department of Digestive Surgery, Amiens University 
Hospital, Amiens, France; 2Department of Hepatobiliary 
Surgery and Liver Transplantation, Hautepierre Hospital, 
Strasbourg, France; 3Department of Hepatobiliary Surgery 
and Liver Transplantation, Herriot Hospital, Lyon, France; 
4Department of Hepatobiliary Surgery and Liver 
Transplantation, Conception Hospital, Marseille, France; 
5Department of Hepatobiliary Surgery and Liver 
Transplantation, Beaujon Hospital, Clichy, France
Introduction: Incidental gallbladder cancer (IGBC) is fre-
quently discovered on the specimen when laparoscopic cho-
lecystectomy (LC) for a benign disease is performed. The 
objective of the present study was to assess the role of port 
site excision IGBC patients in a French registry.
Methods: Data on patients with IGBC identifi ed after LC 
between 1998 and 2008 were retrospectively collated in a 
French, multicenter database. Those subjected to port site 
resection were compared with patients who underwent resec-
tion without port site removal and analyzed for differences 
in recurrence patterns and survival. Among 218 patients with 
IGBC after LC, 148 underwent re-resection with curative-
intent; 54 patients had port site resection and 94 did not.
Results: Both groups were comparable according to 
demographic data (gender p = 0.54, age > 70 p = 0.85, co-
morbidities), surgical procedures (major resection p = 0.08, 
lymphadenectomy p = 0.09, common bile duct resection p = 
0.75) and postoperative morbidity (p = 0.29). In the resected 
port site group, depth of tumor invasion was T1b = 6, T2 = 
24, T3 = 22, T4 = 2, no signifi cantly different from patients 
with no port site excision (p = 0.69). Port site metastasis was 
observed in only 1 (2%) patient with T3 tumor who died with 
peritoneal metastases 15 months after resection. Port site 
excision did not improve the overall survival (77%, 58%, 
21% at 1, 3, 5-year respectively) compared to patient with 
no port site excision (78%, 55%, 33% at 1, 3, 5-year respec-
tively, p = 0.37).
Conclusion: In patients with IGBC, port site excision was 
not associated with improved survival and should not be 
considered mandatory during defi nitive surgical treatment.
FOS002
BILIRUBIN LEVEL IN THE DRAINAGE 
FLUID IS AN EARLY AND INDEPENDENT 
PREDICTOR OF BILE LEAKAGE AFTER 
HEPATIC RESECTION
J. Kirchberg, N. N. Rahbari, H. Elbers, M. Koch, 
M. Dutlu, A. Mehrabi, M. W. Büchler and J. Weitz
Department of General, Visceral, and Transplant Surgery, 
University of Heidelberg, Germany
Introduction: Variations in the defi nition of bile leakage 
after hepatic resection have prevented identifi cation of risk 
factors for early diagnosis and effi cient management. The 
ISGLS defi nition standardizes reporting of this complication. 
It was the aim of the present study to prospectively validate 
the ISGLS defi nition of bile leakage after hepatic resection. 
Furthermore, we sought to identify early predictors of clini-
cally relevant bile leakage.
Methods: A total of 265 patients who underwent elective 
hepatic resection were enrolled prospectively. Bilirubin con-
centrations were determined in the serum and drainage fl uid 
until postoperative day (POD) fi ve. Risk factors of Grade 
B/C bile leakage were assessed using univariate and multi-
variate analyses.
Results: Bile leakage was diagnosed in 72 (27.2%) patients 
and classifi ed into Grade A, B and C leakage in 23 (8.7%), 
38 (14.3%) and 11 (4.1%) patients. Perioperative mortality 
was 0% for Grade A, 5.2% for Grade B and 45.4% for Grade 
C leakage (p < 0.0001). On univariate analysis, anatomic 
resection (p = 0.03), intraoperative blood loss >1 l (p = 0.01), 
operating time >240 minutes (p = 0.0003) and bilirubin con-
centration in the drainage fl uid >2.4 mg/dl on postoperative 
day 2 (p < 0.0001) were associated with Grade B/C bile 
leakage. Multivariate analysis confi rmed bilirubin concentra-
tion in the drainage fl uid >2.4 mg/dl on postoperative day 2 
(p < 0.0001) and anatomic resection (p = 0.04) as indepen-
dent predictors of bile leakage.
Conclusion: The ISGLS defi nition and severity grading of 
bile leakage after hepatic resection is clinically meaningful. 
Bilirubin concentration in the drainage fl uid on postoperative 
day two is a strong predictor of clinically relevant bile 
leakage.
FOS003
DEFINITION OF T3/4 AND REGIONAL 
LYMPH NODES IN GALLBLADDER 
CANCER: WHICH IS MORE VALID, 
THE UICC OR THE JAPANESE 
STAGING SYSTEM?
Y. Kishi, K. Shimada, S. Hata, S. Oguro, Y. Sakamoto, 
S. Nara, M. Esaki and T. Kosuge
Hepatobiliary and Pancreatic Surgery Division, National 
Cancer Center Hospital, Tokyo, Japan
Introduction: The staging of gallbladder cancer differ 
between the Union Internationale Contre Le Cancer (UICC) 
and the Japanese Society of Biliary Surgery (JSBS) staging 
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systems especially in that hepatic invasion with or without 
invasion of another organ is defi ned as T3 by the UICC, but 
as either T3 or T4 by the JSBS, and that posterosuperior 
pancreatic lymph node (PSPLN) metastasis is defi ned as M1 
by the UICC, but as N2 by the JSBS.
Methods: The survival of 224 patients who underwent mac-
roscopically curative resection for gallbladder cancer was 
evaluated. The infl uence of the differences between the two 
staging systems on the postoperative survival was assessed.
Results: For stage III or IV, the survival curves could be 
stratifi ed better by the JSBS staging. Fifty seven patients 
were classifi ed as UICC-T3 but JSBS-T4. These patients 
showed better survival than 43 patients with UICC-T4/
JSBS-T4 and comparable survival with 17 patients with 
UICC-T3/JSBS-T3. UICC-stage IIIB composed of two sub-
groups: U-T2N1, 18 patients; U-T3N1, 21 patients. Five-
year survival of the two subgroups was 85% and 41%, 
respectively (P = 0.01). The latter was comparable with that 
of 28 patients with T3N0 (35%, P = 0.93). The survival of 
the UICC-M1 restricted to PSPLNs was signifi cantly better 
than that of the UICC-M1 beyond PSPLNs (5-year survival, 
35% vs. 17%; P = 0.04).
Conclusion: Although T category is more accurately defi ned 
by UICC, the prognosis of patients with gallbladder cancer 
is better stratifi ed by JSBS staging mainly because UICC-
stage IIIB includes T1/2N1M0 that shows signifi cantly better 
survival than T3N0M0. PSPLN may well be classifi ed as 
regional lymph node.
FOS004
IS T-TUBE PLACEMENT STILL 
NECESSARY AFTER A COMMON BILE 
DUCT EXPLORATION?
M. N. A. Tan, I. G. Shridhar, T. W. V. Lee, 
K. Madhavan and K. Y. S. Chang
Division of Hepatobiliary and Pancreatic Surgery, National 
University Health System, Singapore
Introduction: T-tube insertion after common bile duct 
exploration (CBDE) used to be common practice, but there 
are other alternatives that can be used. This study aims to 
compare the post-operative outcomes of patients who under-
went T-tube insertion or other methods of closure (biliary 
stenting, ERCP stent left in-situ, primary closure without 
stenting) after CBDE.
Methods: A retrospective study on results of common bile 
duct explorations (CBDE) with different forms of bile duct 
drainage (or no drainage) performed between January 2006 
and April 2009 in our institution.
Results: Among 49 CBDE performed, 23 (47%) were lapa-
roscopic, and 26 (53%) were open explorations. T-tubes were 
inserted in 15 patients (30.6%); 6 (12.2%) had biliary stent-
ing; 10 (20.4%) had previously inserted ERCP stents left 
in-situ, and 18 (36.7%) had primary closure without any 
stenting. These were transcystic (25, 51%) or transductal (24, 
49%). There were no mortalities. All explorations were suc-
cessful and there were no retained stones. Comparing T-tube 
(Group I, n = 15) against the others (Group II, n = 34), Group 
I had a statistically longer length of hospital stay (p = 0.002), 
and longer time to regain independent ambulation (p = 
0.007). Group I and II had a complication rate of 33.3% 
(5/15) and 20.6% (7/34) respectively (p = 0.339).
Conclusion: T-tube insertion after CBDE is associated with 
longer hospital stays and longer recovery of independent 
ambulation, as compared to other methods of closure. T-tube 
insertion should not be routinely done after CBDE.
FOS005
THE ROLE OF 99MTECHNETIUM-
LABELLED HEPATO IMINO DIACETIC 
ACID (HIDA) SCAN IN THE 
MANAGEMENT OF BILIARY PAIN
R. Dave, A. Cockbain and G. Toogood
Department of HPB and Transplant Surgery, St James 
University Hospital, Leeds, UK
Introduction: Biliary pain is a common presentation in 
the acute surgical take and the surgical clinic. In patients 
with normal ultrasound fi ndings, symptoms can sometimes 
be disregarded as being non-specifi c. We propose that in 
this cohort, a HIDA scan is a useful investigation, and 
patients with a positive test have good results following 
cholecystectomy.
Methods: We obtained reports of all HIDA scans with an 
abnormal ejection fraction (EF < 40%) performed in our 
centre from 15/05/2007 to 28/12/2010. This database was 
cross-linked with a prospectively-maintained database and 
electronic records of patients undergoing cholecystectomy in 
the same period. All patients with a positive HIDA who went 
on to have laparoscopic cholecystectomy (LC) were fol-
lowed up by a review of the electronic records, and a tele-
phone interview to assess symptom improvement.
Results: 50 patients were investigated. Mean age was 48, 
and majority were female. Ultrasound fi ndings revealed 
normal gall bladder (no stones) in 96%. 92% of patients were 
happy with the decision to proceed with LC, and 87.5% felt 
that their symptoms were improved (62.5% ‘Very Much 
Improved’). Post-operatively, 56.3% had no residual pain 
whatsoever and 31.3% had only occasional mild discomfort. 
The histology was pathological in 83%; 29% had stones in 
the gall bladder. During the HIDA scan, injection of a CCK-
analogue caused pain in 56%. Symptoms were ‘Very Much 
Improved’ after LC in 74% and 44% respectively in the 
responders and non-responders to CCK-analogue injection. 
The sensitivity of CCK-analogue injection was 68% and 
specifi city was 50%.
Conclusion: HIDA scan is a useful clinical tool in the diag-
nosis and management of patients with typical biliary pain 
and normal ultrasound fi ndings. Outcomes following LC in 
this cohort of patients are favourable, with high patient sat-
isfaction. The injection of a CCK analogue is a sensitive 
adjunct to the test, but non-response does not rule out benefi t 
from LC.
 Free Orals Abstracts 109
© 2012 The Authors
HPB 2012, 14 (Suppl. 2), 107–287 HPB © 2012 Americas Hepato-Pancreato-Biliary Association
FOS006
HEPATIC RESECTION FOR 
BILATERAL HEPATOLITHIASIS: 
LONG-TERM RESULTS
Y.-S. Cheng1, C.-C. Lin1, P.-Y. Lin2, C.-J. Ko1, 
Y.-L. Chen1,3, S.-T. Chen1 and S.-J. Kuo1
1Division of General Surgery, Department of Surgery, 
Changhua Christian Hospital, Changhua, Taiwan; 
2Transplantation Medicine Laboratory, Changhua 
Christian Hospital, Changhua, Taiwan; 3School of 
Medicine, Chung Shan Medical University, Taichung, 
Taiwan
Introduction: There are increased evidence showing that 
hepatic resection is probably the best defi nitive treatment for 
unilateral hepatolithiasis. However, the role of hepatic resec-
tion for bilateral hepatolithiasis is rarely mentioned in the 
literature. This study aims to evaluate and compare the out-
comes between unilateral and bilateral hepatolithiasis after 
undergoing hepatic resection.
Methods: From Dec 1987 to Dec 2007, a total of 156 
patients with unilateral hepatolithiasis were defi ned in the 
group UNI and 41 patients with bilateral hepatolithiasis were 
defi ned in the group BI. All patients underwent hepatic resec-
tion for their hepatolithiasis. The short-term and long-term 
outcomes in terms of blood loss, operating time, stones clear-
ance rate, perioperative morbidities, stones recurrence rate, 
incidence of subsequent cholangiocarcinoma and the long-
term mortality rates were evaluated.
Results: The group BI had longer operating time (200 
minutes vs 173 minutes, p = 0.006), lower immediate stones 
clearance rate (56.1% vs 91.7%, p < 0.001), lower fi nal 
stones clearance rate (75.6% vs 94.9%, p = 0.001), higher 
rate of stones recurrence (22.6% vs 6.1%, p = 0.009) and 
disease related mortality (19.5% vs 5.1%, p = 0.006).
Conclusion: Bilateral hepatolithiasis has worse outcomes 
than unilateral hepatolithiasis after being treated with hepatic 
resection. It deserves to be considered as a distinct disease.
FOS007




M. T. de Boer1, J. M. Klaase2, C. Verhoef3, 
R. M. van Dam4, T. M. van Gulik5, I. Q. Molenaar6, 
K. Bosscha7 and R. J. Porte1
1Department of HPB and Liver Transplantation, University 
Medical Center Groningen, Oosterparkwijk, The 
Netherlands; 2Department of Surgery, Medisch Spectrum 
Twente, Oldenzaal, The Netherlands; 3Department of 
Surgery, Daniel den Hoed, Erasmus Medical Center, 
Rotterdam, The Netherlands; 4Department of Surgery, 
Maastricht University Medical Center, Maastricht, The 
Netherlands; 5Department of Surgery, Academic Medical 
Center, Amsterdam, The Netherlands; 6Department of 
Surgery, University Medical Center Utrecht, The 
Netherlands; 7Department of Surgery, Jeroen Bosch 
Hospital, The Netherlands
Introduction: Bile leakage, bleeding and abscess formation 
are major resection surface-related complications after liver 
resection. It is unclear whether application of fi brin sealant 
to the resection surface is effective in reducing these com-
plications. Objective of this study is to evaluate effi cacy of 
fi brin sealant in reducing resection surface-related complica-
tions in liver surgery.
Methods: In a multicenter, randomized trial in 310 non-
cirrhotic patients undergoing liver resection, we compared 
prophylactic application of fi brin sealant to the resection 
surface (156 patients) with no application of fi brin sealant 
(154 patients). In addition to clinical assessments, patients 
underwent protocolized CT-scan one week postoperatively. 
Primary endpoint was a composite of postoperative resection 
surface-related complications (bile leakage, bleeding or 
abscess), as adjudicated by a clinical-events committee that 
was unaware of the study-groups assignments.
Results: Overall rate of resection surface-related complica-
tions was not different between the two groups: 24% (38/156 
patients) in the fi brin sealant group and 24% (37/154 patients) 
in the control group. Bile leakage was detected in 14% of 
patients in the fi brin sealant group and in 14% of controls. 
CT-scans showed a fl uid collection at the resection surface 
larger than 100 L in 28% of patients in the fi brin sealant 
group and in 26% of controls (P = 0.800). The rate of rein-
terventions for resection surface-related complications (12% 
vs. 10%; P = 0.492) and severity of complications did also 
not differ between the two groups.
Conclusion: This randomized multicenter trial shows that 
prophylactic application of fi brin sealant at the resection 
surface after liver resections does not lead to a reduction in 
the incidence or severity of postoperative bile leakage or 
other resection surface-related complications.
FOS008
ROLE OF PROLYL HYDROXYLASE 1 IN 
LIVER CIRRHOSIS
J. Kirchberg, J. Kiss, M. Mollenhauer, M. Stauch, 
M. Neumann, T. Hank, J. Weitz and M. Schneider
Department of General and Transplantation Surgery, 
University of Heidelberg, Germany
Introduction: Various liver diseases end up in irreversible 
liver cirrhosis (LC). Pro-fi brotic cascades are promoted by 
oxidative stress, caused by decreased antioxidative enzyme 
activity and presence of reactive oxygen species (ROS). Loss 
or inhibition of the molecular oxygen sensor, prolyl hydroxy-
lase domain enzyme 1 (PHD1), induces hypoxia tolerance of 
liver tissue via molecular adaption of hepatocyte metabo-
lism. We therefore hypothesized that PHD1 defi ciency or 
pan-inhibition of PHD1-3 reduces LC in mice.
Methods: Two distinct models of LC were applied in 
PHD1 and PHD3 knock out (KO) or corresponding wild 
type (WT) mice: (i) To induce acute cholestatic LC, common 
bile duct (CBD) ligation was performed along with chole-
cystectomy. Control animals underwent sham OP and chole-
cystectomy. Laboratory values and liver histology were 
subsequently assessed to screen for fi brotic liver damage. (ii) 
To mimic chronic toxic LC, mice were gavaged with 
5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) or vehicle 
control for 4 or 6 weeks. In a translational approach, WT 
mice were subjected to i.p. injection of pharmacologic PHD 
enzyme inhibitors (EDHB, ICA) or vehicle control prior to 
induction of LC via CBD ligation.
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Results: Histologic analyses revealed comparable paren-
chymal liver damage in PHD1 KO and WT mice 5 days after 
induction of acute cholestatic LC. Impairment of liver protein 
synthesis was however signifi cantly attenuated in PHD1 
KO mice compared to their WT littermates or to PHD3 KO 
mice.
6 weeks after induction of chronic LC, liver body weight 
ratio (LBWR) was signifi cantly lower in PHD1 KO com-
pared to WT mice, indicating attenuated parenchymal 
damage. Consistently, histological analyses revealed signifi -
cantly reduced cirrhotic damage of PHD1 KO livers.
Pharmacological inhibition of PHD-enzymes signifi cantly 
attenuated the impairment of liver function in mice subjected 
to acute cholestatic LC as indicated by attenuated levels of 
serum bilirubin.
Conclusion: Loss of PHD1 in mice improves liver func-
tion in acute cholestatic LC, and minimizes the extent of 
liver parenchymal damage in chronic LC. Pharmacological 
PHD-inhibition is likewise protective against liver cirrhosis 
in mice, and might therefore represent a promising 
approach for organ protection in cholestatic and cirrhotic 
liver disease.
FOS009
IMPACT OF 3D-CT ANALYSIS IN 
PREOPERATIVE PLANNING FOR 
HILAR CHOLANGIOCARCINOMA
R. Matsuyama1, K. Taniguchi1, R. Mori1, K. Takeda1, 
K. Tanaka1, A. Schenk2, H.-O. Pitgen2 and I. Endo1
1Department of Gastroenterological Surgery, Yokohama 
City University, Graduate School of Medicine, Yokohama, 
Japan; 2Fraunhofer MEVIS, Bremen, Germany
Introduction: Hepatic hilum has complicated and variable 
anatomy of the bile duct, portal vein and hepatic artery. 
Preoperative precise anatomical understanding for hepatic 
hilum is necessary for curative and safe resection of hilar 
cholangiocarcinoma. Recently, due to advancement of 3D 
imaging technology, surgeons can obtain 3D images easily. 
The aim of this study is to clarify the usefulness of 3D-CT 
image of the hepatic hilum for preoperative simulation of 
hepatectomy for hilar cholangiocarcinoma.
Methods: 118 patients with hilar cholangiocarcinoma who 
underwent resection between 1992 and 2011 were enrolled 
in this study. The patients was divided into two groups of 2D 
group (n = 63) which did preoperative diagnosis by 2D-CT, 
angiography and cholangiography and 3D group (n = 55) 
who added a 3D-CT images. 3D group underwent preopera-
tive multidetector row computed tomography (MDCT) 
cholangiography; 3D images of the portal vein, hepatic 
artery and bile ducts were created and viewed simultaneously 
using software (Liver Explorer, MeVis, Bremen, Germany). 
Several perioperative factors and survival rates were com-
pared between two groups.
Results: Combined vascular resection was performed more 
frequently in 3D group than 2D group (36/55 (65.0%) vs 
22/63 (34.9%), p = 0.001). Blood loss in 3D group was fewer 
than 2D group (1300 ml vs 2750 ml, p < 0.001). Blood 
transfusion rate of RCC in 3D group was lower than 2D 
group (47% vs 78%, p = 0.001). Morbidity rate of 3D group 
was lower than 2D group (49% vs 73%, p = 0.008), espe-
cially bile leakage was fewer in 3D group than 2D group 
(9/55 vs 21/63, p = 0.055). The mortality rates were 1.8% 
(1/55) in 3D group and 9.5% (6/63). Potentially curative 
resection rate was improved from 63.4% in 2D group to 
85.4% in 3D group (p = 0.011) and 5-year overall survival 
rate of 3D group was better than 2D group (58.0% vs 33.3%, 
p = 0.029).
Conclusion: 3D-CT was useful and allows preoperative 
simulation based on accurate information about the relation-
ship between hilar tumor and adjacent vessels, and the 
branching pattern of hepatic veins. Therefore, blood loss and 
postoperative morbidity rate can be reduced and might be 
lead to better long-term survival.
FOS010
USEFULNESS OF MULTI-THREE 
DIMENSIONAL COMPUTED 
TOMOGRAMS FUSED WITH MULTI-
PLANAR PRECONSTRUCTION IMAGES 
AND PERORAL CHOLANGIOSCOPIC 
FINDINGS IN CHOLANGIOCARCINOMA
Y. Nagakawa, K. Kasuya, B. Kyo, T. Matsudo, 
S. Kikuchi, Y. Suzuki and A. Tsuchida
Tokyo Medical University, Tokyo, Japan
Introduction: Multi-planar reconstruction (MPR) images 
are useful for assessing the degrees of horizontal and vertical 
extension of cholangiocarcinoma; however, it is diffi cult to 
ascertain the range of extensive superfi cial ductal spread. On 
the other hands, peroral cholangioscopy (POCS) is used for 
diagnosing superfi cial ductal spread and mapping biopsy. 
With this background, we have developed a novel technique 
to fuse conventional 3D-CT images with MPR images and 
peroral cholangioscopy (POCS) fi ndings.
Methods: MPR images were created using the Synapse 
Vincent volume analyzer (Fujifi lm). The range of cancer 
extension was assessed on MPR images, plotted, and fused 
onto cholangiographic CT images to create multi-3DCT 
images. The results of biopsy performed under POCS for 
assessment of the range of superfi cial extension of cancer 
were compared with virtual endoscopic fi ndings and the 
obtained fi ndings were marked on the multi-3DCT images. 
A bile duct resection line was designed based on these 
images. Multi-3DCT images were created for 16 patients 
with cholangiocarcinoma (hilar cholangiocarcinoma; 7 
cases, middle and distal cholangiocarcinoma; 9 cases), and 
the diagnostic accuracy of longitudinal ductal spread was 
assessed with pathological fi ndings.
Results: In 11 cases who were performed POCS, extensive 
superfi cial ductal spread was found in 4 cases. The location 
of the tumor was correctly diagnosed in all cases using Multi-
3DCT images. In only one of these cases, the cut end of the 
intrahepatic bile duct was positive, resulting in 87.5% diag-
nostic accuracy for longitudinal spread, which was signifi -
cant higher compare with cases diagnosed by only MPR 
images (accuracy; 68.7%). R0 resection was achieved in 14 
cases (87.5%).
Conclusion: The bile duct resection line for cholangiocar-
cinoma should be designed based on the degree of cancer 
extension and an understanding of the branching pattern of 
the bile duct and three-dimensional relationship between 
the portal vein and arteries. This novel technique using 
multi-3DCT images was useful for not only understanding 
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CONTROLLED TRIAL OF 
GASTRIC EMPTYING AFTER 
PYLORUS-PRESERVING 
PANCREATICODUODENECTOMY: 
COMPARISON BETWEEN ANTECOLIC 
AND VERTICAL RETROCOLIC 
DUODENOJEJUNOSTOMY
Prof. Chijiiwa
FACS, AGAF, Miyazaki, Japan 
Background: Delayed gastric emptying (DGE) is a worri-
some complication after pylorus-preserving pancreaticoduo-
denectomy (PPPD). The aim of this prospective randomized 
controlled study was to compare DGE and gastric emptying 
after PPPD with an antecolic (AC) route and modifi ed retro-
colic route, namely vertical retrocolic (VRC) route and to 
examine the factors affecting DGE.
Methods: Of 165 patients who underwent pancreaticoduo-
denectomy between 2005 and 2010, 116 patients who were 
planned to receive PPPD and agreed to the informed consent 
were randomly divided into the two groups, either the AC (n 
= 58) or the VRC (n = 58) group. Surgical procedures includ-
ing the area resected and the extent of lymph node dissection, 
the length of the duodenum transected from the pylorus ring, 
pancreaticojejunostomy and hepaticojejunostomy through 
the right side of the transverse mesocolon were similar 
between the two groups. Only the fi nal step of duodenojeju-
nostomy was randomized to either the AC or VRC route. 
DGE was defi ned as grade A, B and C based on the defi nition 
proposed by the ISGPS. Gastric emptying was evaluated by 
13C-acetate breath test before and on postoperative day 
(POD) 14 and 30. The factors infl uencing DGE were evalu-
ated by the univariate and multivariate analyses.
Results: Clinicopathological and operative factors were 
similarly distributed between the two groups. DGE was 
found in 7 (12%) in the AC and 14 (24%) in the VRC group. 
Clinical DGE (Grade B, C) were observed in 5% in the AC 
and 10% in the VRC group. No signifi cant difference was 
observed between the two reconstruction groups. Gastric 
emptying evaluated by T1/2 (half-emptying time) on POD 
14 and 30 was prolonged in both groups in comparison to 
preoperative levels, but no signifi cant difference was found 
between the two groups. The factors signifi cantly affected 
DGE by univariate analysis were body-mass index and pan-
creatic fi stula, but not the reconstruction route. Multivariate 
analysis revealed that the pancreatic fi stula (p < 0.0005) was 
the only factor infl uencing DGE.
Conclusions: The reconstruction route, AC or VRC, has no 
signifi cant effect on DGE after PPPD. Postoperative pancre-
atic fi stula is only the factor affecting DGE.
FOS012
TREATMENT STRATEGY OF PT2 
GALLBLADDER CARCINOMA: 
BENEFIT OF HEPATECTOMY BASED 
ON LONG-TERM OUTCOME
C. Seunghui1, Y. B. Moo2, K. J. Hong2, K. M. Wook1, 
K. J. Hun1 and K. W. Hwan1
1Departments of Surgery, School of Medicine, Ajou 
University, Suwon, Korea; 2Departments of 
Gastroenterology, School of Medicine, Ajou University, 
Suwon, Korea
Introduction: The pT2 gallbladder cancer (GBC) which is 
the most critical state of GBC in the progression of the 
disease and the optimal surgical treatment has not yet been 
analyzed in detail. While most surgeons perform standard 
regional lymphadenectomy in gallbladder cancer, the clinical 
indications for hepatectomy in patients with pT2 gallbladder 
carcinoma remains controversial. The aim of this study is to 
identify the therapeutic effect of hepatectomy for the surgical 
treatment of pT2 GBC.
Methods: In the 21 years between January 1995 and 
November 2009, 163 patients with GBC was diagnosed and 
underwent a surgical exploration in AJOU university hospital 
and 73 patients with pT2 GBC who underwent a potentially 
curative resection were retrospectively analyzed regarding 
their recurrence rate, recurrence site according to extents of 
resection. And the patient wad analyzed regarding their 
pathological fi nding, surgical procedure, and survival. We 
investigated clinical features, preoperative diagnoses, preop-
erative tumor sizes, CA 19-9 level, tumor differentiations, 
complications, adjuvant therapy.
Results: pT2 GBC was divided hepatectomy group (N = 27) 
and non-hepatectomy (N = 46) group. On the database the 
pathological fi nding of one-stage hepatectomy group have 
no malignancy in liver specimen. Pathologic fi nding of eight 
patients underwent re-resection after incidental GBC was 
observed no malignant cell even once. There was no signifi -
cant difference in recurrence site in both group (P = 0.610). 
Hepatic metastasis of pT2 GBC was multiple on both lobe 
and Gallbladder bed recurrence (S4b, S5) was not noticed so 
far. The survival rates at 5 years of non-Hepatectomy group 
were 63% and recurrence occurred in 15 patients (32.61%). 
The survival rates at 5 years of hepatectomy group were 
62.96% and recurrence occurred in 9 patients (29.63%).
Conclusion: Based on above mentioned fi ndings, it is sug-
gested that Hepatectomy (including segmentectomy) showed 
no benefi t for pT2 GBC if negative surgical margin are 
secured. If it is not confi dent in R0 resection, wedge resection 
of gallbladder bed is suffi cient for pT2 GBC.
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FOS013
IMPROVED SURVIVAL IN 
AFRICAN AMERICAN MALES 
WITH INTRAHEPATIC 
CHOLANGIOCARCINOMA LARGELY 
DUE TO INCREASED OPERATIVE 
TREATMENT
K. Simo, J. Martinie, D. Iannitti and D. Sindram
Section of Hepatobiliary and Pancreas Surgery, 
Department of General Surgery, Carolinas Medical Center, 
Charlotte, NC, USA
Introduction: Historically, in the US racial inequality has 
been a major determinant in outcomes secondary to its resul-
tant distrust of the healthcare system and disparages in 
medical care access. More specifi cally, African Americans 
(AA) with intrahepatic cholangiocarcinoma (ICCA) have 
been reported to have worse survival than other racial groups. 
Evaluation of the impact of race on treatment and survival 
in ICCA in the US over the past 20 years was undertaken.
Methods: Mortality and survival rates for Whites, AA 
(Blacks), and Hispanics with histologically proven ICCA 
were obtained from the surveillance, epidemiology and end 
results survey (SEER) database. Comparative subgroup 
examination of White vs. Black males was also 
performed.
Results: 2297 patients (White = 2003, Black = 148, Hispanic 
= 146) had histologically proven ICCA (1989–1998 = 1206, 
1999–2008 = 1091). The % of Black males with ICCA 
remained stable over time (3.2% vs. 3.5%). From 89–98, the 
only signifi cant difference in Kaplan-Meier survival was 
found between White and Black males (p < 0.005). From 
99–08, survival of Black males matched that of White males. 
No statistically signifi cant differences in survival for any 
other race or gender from 99–208 were found. In Blacks, the 
% undergoing surgery is now similar to Whites (18.4% vs. 
16%) in contrast to the fi rst time period (5% vs. 11.6%). 
Substantial decreases for Blacks were seen in: not recom-
mending (72% to 41%), contraindications to (15.4% to 0%), 
and refusal of surgery (1.4% to 1%).
Conclusion: The survival of Black males with histologi-
cally proven ICCA, appears to now be equivalent to White 
males in the US and due mainly to increased operative treat-
ment. Further, racial inequality seems to be moving toward 
extinction in regard to the treatment of this disease.
FOS014
NON INVASIVE PATHWAY TO REDUCE 
NEGATIVE ERCP IN PATIENTS 
PRESENTED BY OBSTRUCTIVE 
JAUNDICE WITH GALLSTONES
A. ElFateh1 and B. O. Al-Jiffry2
1Department of Surgery, Al-Hada Armed Forces Hospital, 
Taif, Saudi Arabia; 2Department of Surgery, Taif 
University, Taif, Saudi Arabia
Introduction: Common bile duct stones (CBDs) are the 
most common cause of obstructive jaundice and cholangitis 
and occurs in about 10%. This study aimed to fi nd non-
invasive preoperative tests for predicting CBDs to select 
patients for preoperative endoscopic retrograde cholangio-
pancreatography (ERCP) before lap chole (LC). We 
conducted a prospective preoperative study on 896 patients 
with symptomatic gall stones who underwent LC at Al Hada 
military Hospital, Taif, Saudi Arabia from April 2006 to April 
2010.
Methods: All patients were subjected to clinical, laboratory 
(LFT) and ultrasound (US) examination. Patients with 
normal LFTs and US were referred to LC. Patients with 
jaundice and US proven CBD abnormality (stones, dilatation 
>7 mm or both) were referred for ERCP for diagnosis con-
fi rmation and stone removal, followed by LC. Patients with 
jaundice and normal US were referred to magnetic resonance 
cholangiopancreatography (MRCP). When MRCP detected 
CBDs, the patients were referred for ERCP for confi rmation 
and stone extraction followed by LC. MRCP and ERCP 
negative cases were subjected to LC with Intraoperative 
cholangiography (IOC).
Results: 193/896 (21.5%) were diagnosed to have obstruc-
tive jaundice. 102 (52.8%) had normal CBD, the other 91 
(47.2%) had CBD abnormalities on US. CBDs were found 
in 23 (25.3%), dilatated CBD in 28 (30.8%), and 40 (40.3%) 
had dilated CBD with stones. These 91 patients were referred 
to ERCP and stones were extracted in 82 (90%). The 102 
patients with normal CBD on US were referred to MRCP, 70 
(68.6%) were normal by MRCP and were subjected to LC 
with IOC. CBDs were detected in 2 (2.9%). 32 (31.4%) had 
stones by MRCP and referred to ERCP which detected CBDs 
in 25 (78.2%). When CBD was abnormal on US, ERCP 
detected stones in 90% and when normal it was only 26.5%. 
MRCP helped avoid un-necessary ERCP in 66.7% with false 
negative of 1.96% and false positive of 6.7%.
Conclusion: We have documented a considerably higher 
incidence of obstructive jaundice in our area, one that makes 
this simple disease a community health issue. Also, with the 
small number of MRCP machines most hospitals have a long 
waiting time facility. Therefore, patients with obstructive 
jaundice and abnormal CBD on US are considered of high 
risk for CBDs and the use of MRCP is not justifi ed. However, 
if any of the tests were normal MRCP is indicated to decrease 
the incidence of negative ERCP.
FOS015
TREATMENT STRATEGY FOR 
ADVANCED BILIARY CARCINOMAS: A 
SPECIAL REFERENCE TO ADJUVANT 
CHEMOTHERAPY AND REPEATED 
HEPATECTOMY FOR INTRAHEPATIC 
RECURRENCE
Y. Morine, M. Shimada, T. Utsunomiya, S. Imura, 
T. Ikemoto, J. Hanaoka, Y. S. amd and H. Miyake
Department of Surgery, the University of Tokushima, Japan
Introduction: The aim of the present study was to clarify 
the effectiveness of GEM combined with CDDP and 5FU 
(GFP) therapy as a adjuvant chemotherapy for advanced 
biliary carcinomas (BCs), and repeated hepatectomy for 
intrahepatic reccurence after surgical treatment.
Methods: 1. Adjuvant GFP therapy: The prognostic factors 
were investigated by multivariate analysis in one hundred 
patients with BCs before induction of GFP chemotherapy, 
including intrahepatic cholangiocarcinoma (IHC: n = 33), 
hilar cholangiocarcinoma (HC: n = 28), and gallbladder 
cancer (GBC: n = 39). In one hundred thirty-fi ve patients 
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with BCs (IHC: n = 40, HC: n = 43, GBC: n = 52), patients 
with poor prognostic factors were received postoperative 
adjuvant GFP therapy.
2. Validation of repeated hepatectomy: Our indications of 
repeated hepatectomy as follows; 1) other organ metastasis 
was not detected and 2) recurrence site was curatively resect-
able. Five patients with intrahepatic recurrence, who under-
went repeated hepatectomy, were included.
Results: 1. R2 resection, LN meta. and intrahepatic meta. 
were identifi ed as independent prognostic factors. Seventy-
nine patients (58.5%) had poor prognostic factors. Of these, 
22 patients received adjuvant GFP therapy. Prognosis of 
patients with poor prognostic factors, who were received 
adjuvant GFP therapy, was signifi cantly better than those not 
having adjuvant therapy (3 y: 59.6% vs. 18.9%).
2. Primary sites of these patients were 2 intrahepatic, 2 
extrahepatic and 1 gallbladder. Median recurrence free 
period after fi rst surgery was 2.3 years (0.25–5.96). Repeated 
hepatectomies were consisted of 1 lobectomy, 3 subsegmen-
tectomies and 1 partial resection. Median overall survival 
period was 6.2 years (4.1–14.3), and all patients survived.
Conclusion: Postoperative adjuvant GFP therapy for 
patients with poor prognostic factors and repeated hepatec-





MARKED ENHANCEMENT ON 
ARTERIAL-PHASE COMPUTED 
TOMOGRAPHY REFLECTS FAVORABLE 
SURGICAL OUTCOMES
S.-ichi Ariizumi, Y. Kotera, Y. Takahashi, S. Katagiri, 
I-P. Chen, T. Ota, H. Egawa and M. Yamamoto
Department of Surgery, Institute of Gastroenterology, 
Tokyo Women’s Medical University, Tokyo, Japan
Introduction: Outcomes after hepatectomy in patients with 
mass-forming (MF) type intrahepatic cholangiocarcinoma 
(ICC) with marked enhancement within the tumor on arte-
rial-phase computed tomography (CT) scans have not been 
clarifi ed in detail.
Methods: We retrospectively studied 140 patients with MF 
type ICC who underwent hepatectomy from 1989 through 
2008. Surgical outcomes were compared between 25 patients 
with MF type ICC with marked enhancement within the 
tumor (hypervascular ICC) and 109 patients without enhance-
ment within the tumor (hypovascular ICC) on arterial-phase 
CT scans.
Results: Portal invasion and intrahepatic metastasis were 
signifi cantly lower in patients with hypervascular ICC than 
in those with hypovascular ICC. The 5-year survival rate was 
signifi cantly higher in patients with hypervascular ICC 
(86%) than in patients with hypovascular ICC (27%, p < 
0.0001). Multivariate analysis showed hypervascular ICC on 
arterial-phase CT scans, normal level of cancer-associated 
carbohydrate antigen 19-9, absence of portal invasion, and 
absence of intrahepatic metastasis of ICC to be signifi cant 
independent prognostic factors for overall survival in patients 
with MF type ICC.
Conclusion: MF type ICC with marked enhancement within 
the tumor on arterial CT scans showed a favorable surgical 
outcome due to its less invasive histopathologic characteris-
tics in patients with MF type ICC.
FOS017
SURGICAL RESULTS OF INTRAHEPATIC 
BILIARY CYSTIC NEOPLASMS: A 
SINGLE CENTER EXPERIENCE
C.-W. Lee1, T.-C. Chen2, M.-C. Yu1, W.-L. Kuo1, Y.-Y. Jan1 
and M.-F. Chen1
1Department of Surgery, Chang Gung Memorial Hospital, 
Linkou, Taiwan; 2Department of Pathology, Chang Gung 
Memorial Hospital, Linkou, Taiwan
Introduction: Intrahepatic biliary cystic neoplasms, such as 
biliary cystadenomas and biliary cystadenocarcinomas, are 
rare hepatic tumors and account for less than 5% of intrahe-
patic cystic lesions. Accurate preoperative diagnosis is dif-
fi cult and the outcome differs among various treatment 
modalities. The aim of this study is to investigate the clini-
copathological characteristics of intrahepatic biliary cystic 
neoplasms and to establish eligible diagnostic and treatment 
suggestions.
Methods: From December 1986 to November 2011, patients 
with intrahepatic biliary cystic neoplasms who underwent 
surgery at Chang Gung Memorial Hospital, Linkou, were 
retrospectively reviewed. Of them, 19 patients had biliary 
cystadenoma and one patient had biliary cystadenocarci-
noma. Their clinicopathological variables and survival 
outcome were examined.
Results: Serum and cystic fl uid CA 19-9 levels were ele-
vated and the cystic fl uid CA 19-9 level was higher than that 
of serum. Loculation (84.2%) and septation (63.2%) were the 
most common radiologic fi ndings. 6 (31.58%) patients 
received preoperative percutaneous biopsy, but the interpre-
tation was inconclusive for diagnosis. 11 (57.9%) patients 
received complete tumor excision by either enucleation or 
hepatic resection, while the remaining 8 (42.1%) patients 
underwent only fenestration of liver cysts. Among patients 
who had fenestration, 4 (50%) patients had recurrence post-
operatively and 3 received additional operations. All patients 
who received complete tumor excision recovered well after 
operation and no recurrence was reported at follow-up.
Conclusion: High serum and cystic fl uid CA 19-9 levels, 
together with loculated and septated cystic lesions found on 
radiologic exams, should raise clinical suspicion of biliary 
cystadenoma. Preoperative tissue diagnosis by percutaneous 
biopsy is inconclusive and is not recommended. Surgical 
fenestration is inadequate and invariably results in persis-
tence or recurrence of disease. The standard treatment is 
complete tumor excision. The patients can achieve satisfying 
long-term results once tumor is resected.
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FOS018
PATHOLOGIC CHARACTERISTICS OF 
INTRAHEPATIC, PERI-HILAR AND 
DISTAL CHOLANGIOCARCINOMA: A 
RETROSPECTIVE ANALYSIS OF A 
MULTICENTRIC DATABASE ON 481 
RESECTED PATIENTS
G. Ercolani1, A. Dazzi, F. Giovinazzo2, A. Ruzzenente2, 
M. Cescon1, P. Guglielmi2, C. Bassi2 and A. D. Pinna1
1Department of Surgery and Transplantation, University of 
Bologna, Bologna, Italy; 2Department of Surgery, 
University of Verona, Verona, Italy
Introduction: To analyze pathologic characteristics among 
resected patients for cholangiocarcinoma depending on the 
site of origin (intrahepatic, peri-hilar, and distal).
Methods: A database of 481 resected patients collected 
from 3 referral Centres (located in Bologna and Verona) was 
retrospectively reviewed. There were 171 hepatic resections 
for intrahepatic, 243 for peri-hilar and 67 pancreato-
duodenectomy for distal cholangiocarcinoma. Pathological 
fi ndings such as TNM classifi cation (AJCC 7th edition), 
R1-R0 resection, lymph node involvement, and tumor dif-
ferentiation were evaluated.
Results: TNM staging and grade of differentiation were sig-
nifi cantly different in the 3 groups. Distal tumors showed a 
signifi cant higher T stage than others; similarly this group 
showed a signifi cant higher incidence of lymphnode metas-
tases. G3 grade of differentiation was signifi cantly more 
frequent in intrahepatic and hilar tumor. Curative resections 
(R0, 339 patients, 70%) were signifi cantly higher in intrahe-
patic type (81%), without difference between hilar and distal 
types. TNM stage, LNs, differentiation and R status were 
signifi cantly prognostic factors in each group. However, 
within each category (T1-T2 and T3-T4, N0 and N1, G1-2 
and G3, R0 and R1) the survival rates were similar among 
the 3 groups.
Conclusion: Intrahepatic colangiocarcinoma was usually 
resected at an earlier stage compared to hilar and distal type 
which both showed a signifi cant higher rate of R1 resection. 
Survival rates for corresponding TNM stage, grade of dif-
ferentiation and radicality among intrahepatic, hilar and 
distal colangiocarcinoma were similar.
FOS019
OUTCOME OF SURGICAL RESECTION 
FOR ADVANCED DISTAL BILE 
DUCT CARCINOMA
Y. Iso, T. Sawada and K. Kubota
Department of Gastroenterological Surgery, Dokkyo 
Medical University, Tochigi, Japan
Introduction: The distal bile duct carcinomas (DBCs) are 
usually in the advanced stage at the time of diagnosis. 
Although pancreatoduodenectomy (PD) is a golden standard 
of the treatment, the recurrence rate is still high with a poor 
prognosis. In this study, we retrospectively reviewed our 
experiences of resected cases of advanced-DBCs, in terms 
of clinocopathological features and the outcome.
Methods: PD with D2 lymphadenectomy (dissection of the 
lymph nodes of the hepatoduodenal ligament) is the standard 
operative procedure in our department. Between April 2000 
and November 2011, a total of 227 PDs for biliary-pancreatic 
carcinomas (included 75 DBCs) were carried out in our 
department. Here we focused on the 49 cases of UICC-stage 
II over advanced-DBCs.
Results: There were 23 males and 26 females with a mean 
age of 68.7 years of advanced-DBCs. Median operation time 
was 563.0 min and median operative blood loss was 706.0 ml. 
Post-operative hospital stay was 42.5 days. There were 
no operation-related deaths. Clinicopathological fi ndings 
revealed no signifi cant differences between survival periods 
for those positive or negative for serosal invasion, hilar infi l-
tration, and pancreatic invasion. Lymph node (LN) metasta-
sis was observed in 19 patients. Median survival periods of 
patients with positive and negative for LN metastasis were 
13.0 and 57.6 months (P = 0.01), respectively. However, the 
number or localization of LN metastases was not a signifi -
cant factor. Recurrence rates were: 40.0% (local recurrence), 
26.7% (hepatic metastases), 20% (distant metastases), and 
13.3% (recurrences in LNs), respectively.
Conclusion: The present study demonstrated that, in 
advanced-DBCs, there were no signifi cant differences in the 
median survival periods according to UICC cancer-stages. 
Surgical resection is crucial matter in cases of advanced-
DBCs. Furthermore, since the only adverse prognostic factor 
in patients who undergo surgical resection is positive of 
LN metastasis, lymphadenectomies should be performed 
completely.
FOS020
A NOVEL CLASSIFICATION OF 
HEPATOLITHIASIS BASED ON THE 
PATHOLOGICAL CHARACTERISTICS
J. Dong1, L. V. Wenping1, S. Wang2 and Z. Huang1
1Hospital & Institute of Hepatobiliary Surgery, Chinese 
PLA General Hospital, Beijing, China; 2Hospitals 
&Institute of Hepatobiliary Surgery, Southwest Hospital, 
Chongqing 400038, China
Introduction: An optimal classifi cation of hepatolithiasis 
can not only be helpful in determining treatment strategies 
but also be simple and easy to apply. However, there is no 
optimal classifi cation of hepatolithiasis up to now. A novel 
classifi cation of hepatolithiasis based on clinical and patho-
logical characteristics was introduced in this study.
Methods: Between Jan1976 and Dec 2008, 1951 patients 
with hepatolithiasis who underwent operation (Hepatectomy 
or Stones Remove only) were admitted to our institute, of 
which, 21 (1.1%) patients with a pathologic diagnosis of 
cholangiocarcinoma associated with intrahepatic stones were 
excluded, 1930 cases were studied. In the novel classifi ca-
tion, hepatolithiasis was divided into two types: Type I and 
Type II. Type I is a localized stone disease with stones locat-
ing in some segments; Type II is a diffuse stone disease, 
which is divided into three subtypes: Type IIa (without any 
atrophy or fi brosis of hepatic parenchyma); Type IIb (with 
segmental atrophy or fi brosis of hepatic parenchyma) and 
Type IIc (with biliary cirrhosis and portal hypertension).
Results: According to the novel classifi cation, there were 
1551 Type I patients (80.4%) and 379 Type II patients 
(19.6%). There were more patient with cholangitis in Type 
II than Type I (32.2% vs 47.0%, P < 0.001), and more cases 
with biliary strictures in Type II than Type I (68.6% vs 
58.9%, P = 0.001); 960 cases (61.9%) with Type I had been 
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underwent hepatectomy, 215 cases (56.7% of Type II) with 
Type IIb had been underwent hepatectomy (P = 0.065). There 
were higher immediate stone clearance rates in Type I 
patients than type II (75.3% vs 54.4%, P < 0.001). Moreover, 
operative morbidity was lower in type I than type II (12.1% 
vs 15.8%, P = 0.031).
Conclusion: Hepatectomy is a curative treatment for Type 
I patients; Type II is a high risk of stone recurrence type, and 
Type IIb should be performed with hepatectomy combining 
with Roux-en-Y hepaticojejunostomy or hepaticocutaneous 
jejunostomy for repairment of biliary strictures.
FOS021
MONOLOBAR CAROLI’S DISEASE IN 
ADULTS: A SINGLE CENTRE 
EXPERIENCE OF 14 CASES
A. Cristaudi, E. Uldry, N. Demartines and N. Halkic
Digestive Surgery Department, Centre Hospitalier 
Universitaire Vaudois, Lausanne, Switzerland
Introduction: Congenital bile ducts dilatation is a rare dis-
order fi rst described by Caroli et al. in 1958. Common clini-
cal features include lithiasis formation, cholangitis, jaundice, 
and predisposition to cholangiocarcinoma. Surgical partial 
hepatic resection can be a defi nitive treatment option for 
unilobar forms. We report our single-centre experience of 14 
clinical cases, successfully treated by surgical resection.
Methods: A retrospective analysis of 14 patients, operated 
in our hospital centre between 1991 and 2011, was per-
formed. Demographic features, clinical presentation, bio-
logical abnormalities and radiological investigations were 
analyzed for each patient. Todani’s classifi cation was applied 
on the basis of radiological images, with 12 patients with an 
intra-hepatic (IH) disease classifi ed as type V, 1 patient as 
type IVa and 1 patient as type I, having a dilatation of the 
common bile duct (CBD). Surgical intervention was classi-
fi ed according to the Brisbane 2000 terminology. Post-
operatives complications were classifi ed according to 
Clavien’s classifi cation between type I and IIIa. A minimal 
follow-up of fi ve months up to 10 years was performed.
Results: We treated only monolobar disease with 0% of 
mortality. Left side involvement was found in 76% of cases. 
Eight patients presented with cholangitis; the average delay 
between symptoms and operation was 21 months (range 
2–84). Eleven patients had previous treatments by ERCP 
and/or cholecystectomy. Left hemihepatectomy was the most 
performed operation, followed by 3 segmentectomies, 3 
bisegmentectomies and one CBD resection. Eleven patients 
had another surgical procedure associated (8 cholecystec-
tomy, 3 CBD explorations, 4 biliodigestive reconstructions 
(BDR), 3 controlateral biopsies and one kystic marsupialisa-
tion). Ten of the 12 patients did not present any recourrence. 
Only 1 case of cholangiocarcinoma was found, 10 years after 
BDR.
Conclusion: Liver resection is the treatment of choice for 
monolobar Caroli’s disease. Although a rare disease, it 




HEPATIC TRANSECTION DURING LEFT 
HEPATECTOMY AND CAUDATE LOBE 
RESECTION FOR HILAR BILE 
DUCT CANCER
C.-S. Park, S. Hwang, J.-M. Namgoong, Y.-H. Park, 
H.-W. Park, T.-Y. Ha, G.-W. Song and S.-G. Lee
Department of Surgery, Asan Medical Center, University of 
Ulsan College of Medicine, Seoul, Korea
Introduction: The liver hanging maneuver (LHM) is a 
useful technique enabling a safe anterior approach, but it has 
several technical limitations for resection of the hepatic para-
caval portion. We had presented a modifi ed LHM that facili-
tates concurrent resection of the paracaval portion, a 
technique applicable to left liver resection for hilar bile duct 
(HBD) cancers. However, after accumulation of experience, 
straightforward anterior resection appeared more feasible 
without using any type of LHM.
Methods: During 2010 and 2011, 10 HBD cancer patients 
underwent left liver resection, with intentional omission of 
LHM. This method included straightforward anterior tran-
section to the caudal paracaval portion. The parenchyma 
transection plane was tailored to remove most of the paraca-
val portion.
Results: In this revised technique, liver transection was 
totally approached from the right side, with no touch to the 
left side. After parenchymal transection, the left liver was 
mobilized and removed. This modifi cation resulted in short-
ening of operation time by 30 minutes and omission of pains-
taking retrohepatic tunneling. The fi nal parenchymal 
transection plane was the same as that following conven-
tional surgical technique for HBD cancers.
Conclusion: In conclusion, we think that this straightfor-
ward anterior transection method is as effective as using 
modifi ed LHM and technically simpler procedure for resec-
tion of the left liver and caudate lobe in HBD patients.
FOS023
FACTORS AFFECTING SURGICAL 
OUTCOME OF BENIGN BILE 
DUCT STRICTURE – SINGLE 
CENTE EXPERIENCE
P. Joseph, F. Vyas, R. S. Raju, A. Bharathan, 
A. Eapen and S. V. Ramani
Christian Medical College Hospital, Vellore, Tamil Nadu 
State, India
Introduction: Bile duct strictures have a varied etiology. 
Those arising as a result of iatrogenic injury at the time of 
cholecystectomy are of special interest to surgeons. The 
option for surgical repair of these bile duct stricture consists 
of lowering of the hilar plate followed by roux-en-y hepati-
cojejunostomy. The ability to predict both, outcome of these 
repairs and prevention of those factors that lead to poorer 
outcome are important strategies in their long term 
management.
Methods: Records of patients who underwent repair 
of benign biliary stricture from 2003 to 2011 were 
retrospectively reviewed with reference to etiology, level of 
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involvement, hospital course and outcome. Only strictures 
arising secondary to a cholecystectomy done for benign 
disease were included. Follow-up was documented by review 
of outpatient records and mail/phone interviews. The stric-
ture was classifi ed based on operative fi ndings using the 
Bismuth classifi cation. Preoperative diagnosis was done by 
Magnetic resonance imaging. Most patients underwent a 
repair using a roux-en-y hepaticojeunostomy. Nearly all had 
a radiological access loop created with the distal loop of 
jejunum. Outcome was analysed depending on need for 
further intervention.
Results: 183 patients were diagnosed with benign bile duct 
strictures. Of which 125 were a result of iatrogenic injury 
during cholecystectomy (60 open and 65 laparoscopic cho-
lecystectomy). Majority (53%) presented one year after 
injury. 12/125 patients (9.6%) had type IV and 5/125 (4%) 
had type V stricture. 9 patients had secondary biliary 
cirrhosis.
Following repair, 10/122 required additional procedures 
including re-operation and access loop dilatation (9 of 
these10 had type III and IV stricture). Perioperative mortality 
was (3/125) 2.4%, all had secondary biliary cirrhosis at the 
time of repair (2 with type IV and 1 with Type III stricture). 
One additional death occurred at 3 year followup, due to 
decompensation from secondary biliary cirrhosis.
Conclusion: A surgical repair of the stricture produced good 
results for majority of patients without the need for ongoing 
intervention. Outcome depended mainly on the level of bile 
duct injury and secondary biliary cirrhosis. Redo of hepati-
cojejunostomy and avoiding delay in treatment beyond the 
duration for control of local sepsis will prevent parenchymal 
injury. Radiological jejunal access loop is a relatively safe 
method for surveillance of these anastomosis and dilatation, 
when required.
FOS024
THERAPEUTIC EFFECT OF 
LAPAROSCOPIC CHOLECYSTECTOMY 
PERFORMED AT DIFFERENT TIME 
AFTER PERCUTANEOUS 
TRANSHEPATIC GALLBLADDER 
DRAINAGE FOR PATIENTS WITH 
SEVERE ACUTE CHOLECYSTITIS
H. Q. Yang1, L. Chen2, X. Y. Peng3, S. J. Zhang4, 
Z. Y. Huang5 and X. P. Chen6
Hepatic Surgery Center of Tongji Hospital, Wuhan, China 
Introduction: Percutaneous transhepatic gallbladder drain-
age (PTGD) is an effective technique for severe acute cho-
lecystitis, which can decompress the swollen gallbladder and 
lead to patients’ early recovery. It may decrease the technical 
diffi culty of laparoscopic cholecystectomy (LC) and facili-
tate successful surgery when the patients’ condition improves. 
However, the optimal time of LC after PTGD remains 
controversial.
Methods: From 2004 to 2011, LC after PTGD was per-
formed in 107 patients with severe acute cholecystitis. All 
patients were divided into two Groups. Group I members 
underwent LC within 2 weeks after PTGD (n = 42), whereas 
Group II members underwent LC at more than 3 weeks 
after PTGD (n = 65). The therapeutic effect, frequency of 
postoperative complications, rate of conversion to open lapa-
rotomy and length of postoperative hospital stay.
Results: PTGD were successfully performed on all patients 
in two groups. Mean time intervals to LC after PTGD were 
8.79 ± 2.25 d and 29.34 ± 6.29 d respectively. No operative 
death happened during LC in two groups. The conservation 
rate of LC in Group I was higher than in Group II with sig-
nifi cant difference (19.0% vs. 4.6%, p < 0.05). Mean opera-
tive time in group I was greater than in group II (76.07 ± 
29.17 min vs. 57.05 ± 14.28 min; p < 0.05). Postoperative 
complication rate of LC in Group I was more than in Group 
II with signifi cant difference (11.9% vs. 1.5%; p < 0.05). The 
acute/chronic ratio of those two groups determined by patho-
logic diagnosis were 35/7 (Group I) and 3/62 (Group II). 
Hospital stay was not signifi cant difference between two 
groups (p > 0.05).
Conclusion: LC performed at least more than 3 weeks after 
PTGD for patients with severe acute cholecystitis is more 
safe than within 2 weeks after PTGD because of its lower 
diffi culty, lower conversion rate and lower complication rate.
FOS025
LAPAROSCOPIC ‘RADICAL’ 
CHOLECYSTECTOMY: A SAFE 
STRATEGY FOR POTENTIALLY 
MALIGNANT GALLBLADDER LESIONS
M. A. Hilal1, M. Hamdan2, F. D. Fabio1, T. Armstrong1, 
J. Primrose1 and N. Pearce1
1Hepatobiliary-Pancreatic and Laparoscopic Surgical Unit, 
Southampton University Hospitals NHS Foundation Trust, 
Southampton, UK; 2Department of General Surgery, Royal 
Devon and Exeter NHS Foundation Trust, Exeter, UK
Introduction: Potentially malignant gallbladder (GB) 
lesions are frequently diagnosed. Laparoscopic cholecystec-
tomy (LC) is recommended for polyps >10 mm in diameter, 
fast-growing, sessile or arise from the GB neck or abnormal 
GB wall ultrasound fi ndings. GB cancer is found in >10% 
of the cases when LC is performed for these indications, 
where a simple LC may not be oncologically adequate. With 
the expansion of laparoscopic liver surgery a minimally inva-
sive strategy to avoid R1/R2 resections can be proposed.
Methods: A retrospective review of all patients who had 
laparoscopic radical cholecystectomy (LRC) for potentially 
malignant GB lesions; on radiological imaging, in a univer-
sity teaching hospital between August 2006 and February 
2011. LRC was defi ned as laparoscopic en bloc GB and liver 
bed resection (5–30 mm layer of surrounding liver paren-
chyma in segments IVb and V) with the cystic node and the 
cystic duct; divided fl ush to the common bile duct (CBD). 
The specimen was sent then to frozen section (FS) and the 
results determined whether further liver, CBD resection or 
total lymphadenectomy were performed.
Results: Thirty patients had LRC. Median operating time 
was 117.5 (60–390) ins. Median blood loss was 50 (0–500) L. 
Median hospital stay was 2 (1–14) days. Three conversions 
were recorded; one patient was found to have high grade 
dysplasia with possible cancer and a positive node on FS and 
therefore had open completion lymphadenectomy and 
two due to technical diffi culties in patients with benign his-
tology. Histology revealed chronic cholecystitis (n = 16), 
xanthogranulomatous pseudo-tumor (n = 3), adenomyoma-
 Free Orals Abstracts 117
© 2012 The Authors
HPB 2012, 14 (Suppl. 2), 107–287 HPB © 2012 Americas Hepato-Pancreato-Biliary Association
tosis (n = 3), adenocarcimoa (n = 3), benign porcelain GB (n 
= 1), normal features (n = 1), villous adenoma (n = 1), meta-
static renal cell carcinoma (n = 1) and low-grade dysplasia 
(n = 1). All resections were R0. 4 complications were 
observed with no mortality.
Conclusion: LRC is a safe and valid minimally invasive 
strategy for the management of patients with potentially 
malignant GB pathology. It offers an initial minimally inva-
sive approach as opposed to starting with an open procedure 
which can also be unnecessary. It permits full staging and 
complete resection in one setting removing the need for a 
second open operation. In case of malignancy; it prevents 
the risk of incomplete resection, seeding and port site 
metastasis.
FOS026
USE OF CT ANGIOGRAPHY TO 
DIAGNOSE ASSOCIATED VASCULAR 
INJURIES IN PATIENTS WITH COMMON 
BILE DUCT INJURIES FOLLOWING 
CHOLECYSTECTOMY
A. Demirjian1, L. Findeiss2, C. Lall2 and D. Imagawa1
1Division of Hepato-Pancreato-Biliary Surgery, 
Department of Surgery, University of California-Irvine, 
Orange, CA, USA; 2Department of Radiology, University of 
California-Irvine, Orange, CA, USA
Introduction: Laparoscopic cholecystectomy has become 
an exceedingly common procedure with a low incidence of 
morbidity and mortality. Injury to the common bile duct has 
long been recognized as the most debilitating of these com-
plications. Previously poorly appreciated, there is an emerg-
ing literature regarding the alarming frequency of concomitant 
vascular injury.
Methods: This is a retrospective analysis of 42 patients 
from our institution, a high-volume, multidisciplinary hep-
ato-pancreato-biliary center. All patients were referred from 
other hospitals in southern California for a higher level of 
care. Patients were evaluated using percutaneous cholangi-
ography and/or endoscopic retrograde cholangiopancreatog-
raphy (ERCP), as well as a dual-phase CT scan of the 
abdomen plus/minus selective angiography. The imaging 
studies were reviewed in a blinded fashion by two senior 
radiologists at our institution.
Results: 42 patients suffered biliary complications after 
cholecystectomy. 14 were identifi ed with vascular injuries. 
The affected vessels included the right hepatic artery (RHA), 
the portal vein, and mixed injuries. We began using CT 
angiography 2.5 years ago due to concern for vascular injury. 
9 of 42 patients had both a dual-phase CT scan and selective 
angiography, and 4 of 9 were found to have vascular injuries. 
3 of 4 were identifi ed by CT using criteria of perfusion 
differences between the right and left liver and non-
visualization of a vessel. In the 4th patient, the injury was 
not initially identifi ed, but perfusion disparity and non-
visualization of the RHA were identifi ed during re-review. 
All injuries were confi rmed by angiography.
Conclusion: There should be a high index of suspicion for 
vascular injury in patients who suffer biliary injury as after 
cholecystectomy. Patients should undergo CT angiography 
of the abdomen as part of the initial/pre-operative evaluation. 
Key fi ndings include perfusion abnormalities and differences 
in enhancement of the liver, and non-visualization or abrupt 
cut-offs of the hepatic artery and/or portal vein. Selective 
angiography should be used in cases where the fi ndings are 
uncertain or equivocal.
FOS027
ANALYSIS OF ENDOSCOPIC 
RETROGRADE PANCREATOGRAPHIC 
(ERCP) MANAGEMENT OF COMMON 




Background: Common bile duct stones (CBDS) occur 
commonly in gallstone disease. In the UK, management 
trends are to perform laparoscopic cholecystectomy and 
endoscopic retrograde cholangiopancreatography (ERCP) 
separately, necessitating co-operation of surgical and gastro-
enterological specialists. The 2008 British Society of 
Gastroenterology (BSG) guidelines state that 90% of CBDS 
can be successfully treated endoscopically. We investigated 
whether these targets were commonly attained in routine 
practice.
Methods: The records of ERCPs performed in our regional 
hospitals between January 2006 and April 2011 were retro-
spectively interrogated in the NHS Unisoft database system. 
All patients who underwent ERCP regardless of concomitant 
surgical intervention were included. Those patients who pre-
sented with CBDS were specifi cally identifi ed, together with 
an analysis of the number of procedures they underwent to 
achieve duct clearance, and whether common bile duct stents 
were placed. CBDS was classifi ed at ERCP as either directly 
visualised stones, features identifi ed suggestive of stone 
passage, the presence of biliary sludge or pre-procedural 
imaging confi rming CBDS (MRCP, CT, AUSS) with no 
stones seen on ERCP.
Results: 1229 patients were identifi ed, of whom 736 under-
went ERCP for CBDS. In those, stones were directly visu-
alised on ERCP in 539 cases with the remaining 197 showing 
the presence of biliary sludge or evidence of passed stones. 
Of the 539 patients, 390 patients had successful stone 
removal on fi rst ERCP (72.2%), whereas 149 patients 
(27.6%) required repeated ERCPs and placement of CBD 
stents. Of these 149 patients, 124 eventually had successful 
CBDS clearance (median of 2 ERCPs: range 1–12). However, 
25/149 patients proceeded to surgical exploration of the CBD 
following unsuccessful fi rst ERCP. Overall, endoscopic 
CBDS clearance was achieved in 95.4% (514/539), though 
23% (124/514) of the cases required two or more ERCPs.
Conclusions: The rate of eventual CBDS clearance of our 
practice is consistent with the BSG guidelines. The propor-
tion of patients requiring repeated ERCP remains signifi cant. 
Therapeutic ERCP is gaining in popularity but carries spe-
cifi c complication hazards which are not inconsiderable. 
With improving laparoscopic techniques, it may be appropri-
ate to consider early referral for laparoscopic bile duct explo-
ration following inability to clear the CBD following ERCP.
(*Equal contributors)
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FOS028
FLUORESCENT CHOLANGIOGRAPHY. A 
SAFE AND EASY METHOD TO DIMINISH 
THE RISK OF BILIARY INJURIES
P. Ferraina1, F. Dip2, L. Alle2, M. Nahmod2, L. Sarotto2, 
F. S. Anzorena2
1MAAC, FACS, Buenos Aires, Argentina; 2MAAC, Buenos 
Aires, Argentina
Introduction: The surgical lession of the bile duct reach the 
0.4%. It can be serious and in cases hepatic transplant is 
necessary. The accurate anatomic identifi cation of the bile 
duct can prevent the lession or its identifi cation during the 
intra-operative. The traditional intra-operative radioscopic 
cholangiography is frequently used and may prevent the 
severity of the lesion when it is interpreted correctly.
However, it would be very useful to have an imaging 
method that show in real time.
Methods: The study was approved by the ethics committees 
of the Anchorena Hospital and the Medical University of 
Buenos Aires. Informed consent was obtained from all 
patients undergoing Laparoscopic cholecistectomy for symp-
tomatic gallbladder lythiasis between June 2011 and 
November 2011.
Administration Of The Fluorescent Dye: Considering that 
the ICG is excreted into the bile within minutes after intra-
venous injection, reaching a maximum within 2 hours, we 
administrated the dye one our before surgery in a dose of 
0.05 mg/kg.
During the cholecistectomy we alternate the exposure of 
the biliary structures to xenon and infrared light and evaluate 
the identifi cation of the biliary structures before dissection. 
Results: Fluorescent cholangiography delineated common 
bile duct and the cyst duct in all 65 patients. In 47 we identi-
fi ed the gallbladder with fl uorescence before dissection. 
In 60 patients the hepatic ducts were visualized. Three 
accesory bile ducts were found in three patients with the 
fl uorescence vision. There was no complication related to the 
technique.
Conclusion: The fl uoroscopic cholangiography with indo-
cyanine green proved to be a sensible and reliable method 
for the real-time detection of the anatomic structures of the 
extra hepatic bile duct without requiring the catheterization 
of the bile duct. This facilitated the laparoscopic cholecys-
techtomy performance providing greater accuracy in the 
interpretation of the common bile duct and cystic duct.
FOS029
EVALUATION OF CLINICAL VALUE OF 
CONCOMITANT PORTAL VEIN 
RESECTION FOR ADVANCED 
GALLBLADDER CARCINOMA
T. Igami, T. Ebata, Y. Yokoyama, G. Sugawara, 
Y. Takahashi and M. Nagino
Division of Surgical Oncology, Department of Surgery, 
Nagoya University Graduate School of Medicine, Nagoya, 
Japan
Introduction: Recently, we reported clinical value of surgi-
cal resection for advanced gallbladder carcinoma involving 
the extrahepatic bile duct. For locally advanced gallbladder 
carcinoma which required concomitant portal vein resection 
(PVR), we have aggressively performed surgical resection. 
The aim of this study is to evaluate clinical value of PVR for 
advanced gallbladder carcinoma.
Methods: From 2000 to 2010, 127 consecutive patients 
with gallbladder carcinoma underwent surgical resection. Of 
them, 30 (24%) underwent PVR to obtain complete resec-
tion. Two patients who had synchronous biliary malignant 
disease were excluded from this study. The remaining 28 
patients formed the cohort of the present study. Their medical 
records were retrospectively reviewed.
Results: Pancreatoduodenectomy (PD), gallbladder bed 
resection (GB) plus extrahepatic bile duct resection (EBD), 
GB plus PD, major hepatectomy (MH) plus EBD, and MH 
plus PD (HPD) were performed in 1, 1, 4, 14, and 8 patients, 
respectively. Histologically, 19 patients had regional lymph 
node metastasis (N), 4 had periaortic lymph node metastasis 
(PA-N), and 3 had distant metastasis other than PA-N (M). 
R0 resection was achieved in 20 (71%) patients. Five patients 
died of postoperative complications, and 3 of the 5 patients 
underwent HPD. The 5-year survival for the 23 patients who 
tolerated surgery was 33%; actually, 3 patients survived more 
than 5 years. There were no 5-year survivors in the patients 
who underwent HPD.
Conclusion: There were only a few long-term survivors in 
patients with locally advanced gallbladder carcinoma who 
underwent combined PVR. Surgical indication of HPD with 
PVR should be carefully considered.
FOS030
ROLE OF RESECTION FOR BISMUTH 
TYPE IV KLATSKIN TUMOR AND 
ANALYSIS OF DETERMINING FACTORS 
FOR CURATIVE RESECTION
I. W. Han, J.-Y. Jang, M. J. Kang, J. W. Park, 
W. Kwon and S.-W. Kim
Department of Surgery & Cancer Research Institute, Seoul 
National University College of Medicine, Seoul, South 
Korea
Introduction: Surgical resection has been the mainstay of 
curative treatment for extrahepatic bile duct cancers. In the 
past, Bismuth type IV hilar cholangiocarcinomas had been 
considered unresectable. However, extended liver resection 
provides long-term survival in selected patients with Bismuth 
type IV hilar cholangiocarcinomas. This study was intended 
to evaluate the role of resection for Bismuth type IV Klatskin 
tumors and to explore the determining factors for curative 
resection.
Methods: Forty of 159 patients with Bismuth type IV hilar 
cholangiocarcinoma underwent surgical resection between 
2000 and 2010 at Seoul National University Hospital. Among 
them, 33 patients (82.5%) had curative-intended major 
hepatic resection (CIR). Mean age of the patients with CIR 
was 60.1 years. Male to female ratio was 1.75 to 1. 
Preoperative portal vein embolization was conducted in 10 
patients. The type of operation included right-sided hepatec-
tomy (n = 16, 48.5%) and left-sided hepatectomy (n = 17, 
51.5%). R0 resection rate was 63.6%. Clinicopatholgical 
features and survival were investigated and disease extent 
and anatomical variations were analyzed to explore the 
factors which enable curative resection in Bismuth type IV 
Klatskin tumor.
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Results: The rate of CIR with hilar trifurcation bile duct 
variation (BDV) was signifi cant higher than that with other 
type of BDV (39.4% vs. 14.4%; p < 0.001). The length of 
left 2nd confl uence and the tumor infi ltration into left bile 
duct of right-sided CIR was shorter than that of left-sided 
CIR (10.8 ± 4.9, 2.7 ± 0.8 vs. 16.5 ± 8.4, 7.0 ± 5.3 mm, p = 
0.029). Patients undergoing left-sided CIR had higher pro-
portion of tumors invading less than 5 mm over the right 2nd 
confl uence than those undergoing right-sided CIR (76.9% vs. 
40%; p = 0.067). The survival rates after CIR was signifi -
cantly higher than those after non-CIR (3YSR 28 vs. 0%, p 
= 0.006). Adjuvant radiotherapy was single signifi cant prog-
nostic factor (median survival 23 vs. 12 months, p = 0.042).
Conclusion: Hilar trifurcation BDV, the length of contralat-
eral 2nd confl uence and the tumor infi ltration over 2nd con-
fl uence of right-or left-dominant Bismuth type IV Klatskin 
tumor were important for CIR. Carefully selected patients 
with Bismuth type IV Klatskin tumor can be candidate for 
CIR with expected prolonged survival.
FOS031
INCIDENCE AND CLINICAL IMPACT OF 
OCCULT PANCREATICOBILIARY 
REFLUX IN HEALTHY ADULT
H.-I. Seo and S.-P. Yun
Department of Surgery, Postgraduate School of Medicine, 
Pusan National University, Busan, Korea
Introduction: The refl ux of pancreatic enzymes into the 
biliary tract has been associated with infl ammation and 
increased cellular proliferation of the biliary epithelium, 
leading to biliary carcinoma. The refl ux of pancreatic enzyme 
into the biliary tract can be caused by pancreaticobiliary 
maljunction or sphincter of Oddi dysfunction, but this kind 
of study is limited. The aim of this study is for detecting the 
incidence of occult pancreaticobiliary refl ux in patients who 
underwent laparoscopic cholecystectomy.
Methods: From December 2010 to March 2011, 47 patients 
with symptomatic gallstone who underwent laparoscopic 
cholecystectomy and gallbladder bile samples were obtained 
from the specimen of were recruited for this study. Patients 
with preoperative ERCP and PTGBD were excluded. The 
amylase level in the bile was measured. Patients were catego-
rized into Group A, as those who had higher level of amylase 
in bile acid than in blood serum, and Group B, as those who 
did not. The immunohistochemistry of p53, SMAD4 and 
Ki-67 were performed for detecting metaplasia and 
dysplasia.
Results: Biliary amylase was measured higher than blood 
serum amylase in 10 patients (Group A: 127.5~109444 U/
mL, Group B: 0–54.4 U/mL). Mean age was 67.2 in group 
A and 51.2 in group B (p < 0.01). The ratio of gender was 
3 : 7 in group A and 17 : 20 in group B (p = 0.297). Three 
cases of metaplasia were found in group A and 17 cases in 
group B (p = 0.474). Eight patients had infl ammation in 
group A, and 13 patients in group B (p = 0.014). There were 
6 patients with positivity in p53 in group A, and 12 patients 
with positivity in group B (p = 0.111). The numbers of 
patients with loss of SMAD4 were 6 in group A and 5 in 
group B (p = 0.333), and the numbers of patients with 
positive Ki-67 test were 5 in group A and 5 in group B 
(p = 0.024).
Conclusion: The incidence of pancreaticobiliary refl ux of 
pancreatic enzymes from occult pancreaticobiliary refl ux 
was increased with ages, and so did the incidence of infl am-
mation. And it might be suggested that the refl ux can cause 
the process to dysplasia due to the high positive ratio in Ki65 
test. The clinical consideration of pancreaticobilicary refl ux 
from the malfunction of the sphincter of Oddi might be 
needed. Therefore, in patients with suspected OPBR, close 
follow up will be required.
FOS032
ODDI SPHINCTER PRESERVING HILAR 
CHOLANGIOPLASTY, A NEW 
PROCEDURE TO TREAT 
HEPATOLITHIASIS
X. S. Zhou, Z. Xu, X. F. Ling, L. X. Wang, C. S. Hou
Peking University Third Hospital, Beijing, China
Introduction: Hepatolithiasis (HL) is common in China. If 
the intrahepatic foci (stones and bile duct strictures) were 
limited to a few segments, the foci can be eliminated by 
Simple Segmental Hepatectomy (SSH). The Cholangitis 
Recurrence Rate (CRR) of SSH is 25 ± %. However, about 
40% of HL patients, the foci are too widely spread to be 
eliminated by SSH. Such cases are traditionally managed 
with CholedochoEnterostomy (CE). The CRR of CE is 
50%~70%. In order to improve the outcome, we designed 
this procedure.
Methods: Oddi Sphincter Preserving Hilar CholangioPlasty 
(SPHCP): Extend the incision on the choledochus upward to 
the right and left secondary or tertiary hepatic ducts. Incise 
all strictures and retrieve all stones encountered. Prepare 
a jejunum loop (12 cm~15 cm) with a vasal pedicel. 
Anastomose its rectal end to the biliary stoma to correct the 
stenosis. Close its oral end; embed it subcutaneously to form 
a permanent tunnel from abdominal wall to biliary tract. If 
the gallbladder remains in situ, use it instead of jejunum.
Patient Assignment: SSH: for limited foci; CE: for widely 
spread foci and Oddi sphincter already narrowed or bypassed; 
SPHCP: for widely spread foci and intact Oddi sphincter 
allowing a F-16# sound to pass through.
Results: From February of 1993 to December of 2006, 23 
patients were treated with SSH, 24 with CE, and 82 with 
SPHCP; in total 129. Out of them, 115 (89.1%) were fol-
lowed up for 1 to 174 months (median = 71 months): 17 
(73.9%) in SSH; 18 (75.0%) in CE; 80 (97.6%) in SPHCP.
The Cumulative Probability of Postoperative Cholangitis 
(CuPPC) was estimated and compared using survival analy-
sis. By 50 months postoperatively, the CuPPC of SSH, CE 
and SPHCP were 16%, 49%, and 19% respectively. By 100 
months postoperatively, the CuPPC were 16%, 74%, and 
22% respectively. The CuPPC was lower in group SPHCP 
than in CE. Log-rank χ2 test between SPHCP and CE shows 
χ2 = 7.288, P = 0.007; between SPCP and SSH, χ2 = 0.277, 
P = 0.599; between CE and SSH, χ2 = 4.484, P = 0.034.
Conclusion: The CuPPC after SPHCP is much lower than 
after CE. This is due to the preserved function of Oddi 
sphincter and the tunnel established between abdominal wall 
and biliary tract. The former prevents entero-biliary refl ux, 
the most important trigger of cholangitis. The latter provides 
a permanent access allowing easy retrieval of residual/recur-
rent stones, a predisposing factor of recurrent cholangitis. 
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When intrahepatic foci cannot be eliminated, SPHCP is supe-
rior to CE after SSH or lithotomy.
FOS033
CLINICOPATHOLOGICAL FEATURES 
AND PROGNOSIS OF MUCIN-
PRODUCING BILE DUCT TUMOR AND 
MUCINOUS CYSTIC TUMOR OF THE 
LIVER: A MULTI-INSTITUTIONAL 
STUDY OF THE JAPAN BILIARY 
ASSOCIATION
K. Kubota, Y. Nakanuma, F. Kondo, M. Miyazaki, 
M. Nagino, M. Yamamoto, H. Kinoshita and K. Inui
Scientifi c Committee on IPNB and MCN, Japan Biliary 
Association, Hokkaido, Japan
Introduction: Mucinous cystic neoplasm of the liver 
(MCN) is a controversial entity regarding differentiation 
from mucin-producing intraductal papillary neoplasm of the 
intrahepatic bile duct (IPNB). The WHO classifi cation 
defi ned MCN as a cyst-forming epithelial neoplasm com-
posed of mucin-producing epithelium and associated with 
ovarian-like stroma. In order to clarify the clinicopathologi-
cal features of MCN and IPNB, multi-institutional study was 
performed by Japan Biliary Association (JBA).
Methods: We performed a multi-institutional, retrospective 
study on patients with MCN or IPNB. Final diagnosis of 
MCN was made on the basis of the presence of ovarian-like 
stroma. Clinicopathological features and prognosis were 
investigated.
Results: A total of 194 cases (IPNB; 146, MCN; 48) were 
collected from 35 institutes. Pathological examination was 
done in 128 cases (IPNB; 97, MCN; 31). Ovarian-like stroma 
was confi rmed in 7 females of 31 cases with an institutional 
diagnosis of MCN and a total of 121 cases (74 males and 47 
females) were diagnosed as IPNB. IPNB vs MCN: mean age; 
65 vs 61 years, cancer; 75 vs 1 cases, non-cancer lesion; 46 
vs 6 cases, symptoms; abdominal pain, liver dysfunction, 
jaundice, mucobilia vs abdominal pain, size of lesion; 38 × 
22 vs 45 × 35 mm, size of protruding lesion; 22 × 16 vs 23 
× 17 mm, ALT; 57 vs 20 U/l (p < 0.05 -GTP; 212 vs 98 U/l 
(p < 0.05), 5-year survival rate; IPNB cancer 82% vs 100%. 
IPNB and MCN were predominantly found in the left lobe.
Conclusion: MCN with ovarian-like stroma is a rare tumor 
only found in females, while IPNB develops more frequently 
in males. The main symptoms of IPNB included abdominal 
pain, liver dysfunction and mucobilia with signifi cant 
increases of ALT and -GTP, while that of MCN was abdomi-
nal pain. The cystic lesion tended to be bigger in MCN than 
in IPNB. Both tumors showed good prognosis when resected 
completely.
FOS034
SURGICAL TREATMENT FOR 
RECURRENT BILIARY TRACT CANCER
Y. Takahashi, T. Ebata, Y. Yokoyama, T. Igami, 
G. Sugawara and M. Nagino
Division of Surgical Oncology, Department of Surgery, 
Nagoya University Graduate School of Medicine, Nagoya, 
Japan
Introduction: The complete surgical removal of biliary 
tract cancer including cholangiocarcinoma (perihilar, distal, 
intrahepatic) and gallbladder carcinoma, offers the only 
chance of cure. Long-term survival, however, is very limited 
because of frequent recurrence, and surgical indication for 
recurrence is still debatable. The aim of this study was to 
assess the effi cacy of resection in selected patients with 
recurrent biliary tract cancer.
Methods: Between 1975 and 2010, 1139 consecutive 
patients with biliary tract cancer underwent resection with 
curative intent. Of these, 75 patients underwent resection of 
recurrent disease.
Results: A total of 94 resections for recurrence were per-
formed in 75 patients and various types of resection were 
applied, including from tumor resection to major hepatec-
tomy. The mean time between initial surgery and resection 
for recurrence was 22.6 months (range, 1.4–119.5 months). 
The site of recurrence presented chest or abdominal wall 
including seeding of percutaneous transhepatic biliary drain-
age tract in 29 patients (39%), liver in 16 patients (22%), 
locoregional recurrence in 10 patients (13%), lymph nodes 
in 10 patients (13%), and others in 10 patients (13%). The 
overall 3-year survival rates after recurrence was 26.4%, and 
15 patients survived for more than 3 years after recurrence.
Conclusion: Our results demonstrate that repeated resection 
for recurrence is feasible and can offer prolonged survival in 
selected patients with biliary tract cancer recurrence.
FOS035
CHOLANGIOCARCINOMA: ARE 
NORTH AMERICAN SURGICAL 
OUTCOMES OPTIMAL?
A. Loehrer, H. Pitt, M. House, M. Kilbane and A. Nakeeb
Department of Surgery, Indiana University, Indianapolis, 
IN, USA
Introduction: Cholangiocarcinomas are deadly, and their 
surgical management requires complex decisions. Some 
referral centers have reported good results, but no robust, 
risk-adjusted operative outcome data are available. Therefore, 
the aims of this study were to analyze the surgical outcomes 
of a very large North American cohort of patients under-
going operations for intrahepatic, perihilar and distal 
cholangiocarcinoma.
Methods: The American College of Surgeons – National 
Surgical Quality Improvement Program Participant Use File 
was queried for patients with bile duct cancers. Patients (N 
= 844) were classifi ed as having intrahepatic (36%), perihi-
lar (35%) or distal (29%) cholangiocarcinomas by the type 
of procedure performed. Operations were grouped into four 
categories: hepatectomy, bile duct resection (BDR), hepatec-
tomy plus BDR or pancreatoduodenectomy. Observed (O) 
and expected (E) mortality and O/E ratios were determined.
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Results: The mean age was 64.4 years; 59% were men; and 
72% were ASA Class 3 or 4.
Surgical outcomes were:
Intrahepatic/Hepatectomy (N = 305): mortality = 5.2%, mor-
tality O/E = 2.36, morbidity = 29.2%.
Perihilar/BDR (N = 150): mortality = 6.1%, mortality O/E = 
1.36, morbidity = 42.2%.
Perihilar/BDR + Hepatectomy (N = 146): mortality = 11.9%, 
mortality O/E = 2.90, morbidity = 57.3%.
Distal/Pancreatoduodenectomy (N = 243): mortality = 1.2%, 
mortality O/E = 0.35, morbidity = 46.5%.
All Patients (N = 844): mortality = 5.5%, mortality O/E = 
1.67, morbidity = 41.1%.
Mortality and O/E ratios were highest for perihilar tumors 
that were managed with BDR and hepatectomy. Frequent 
major complications included sepsis (13.9%) organ space 
infection (13.5%), and reoperation (8.6%).
Conclusion: This analysis suggests that a) outcomes are 
best for distal and worst for perihilar cholangiocarcinomas, 
b) hepatectomy for bile duct cancers is associated with a 2–3 
fold mortality risk and c) less than half of perihilar tumors 
are managed with a hepatectomy. We conclude that in North 
America outcomes for patients with proximal cholangiocar-
cinomas can be improved. We suggest that further regional-
ization into higher volume centers will be required to 
optimize outcomes.
FOS036
THE PROGNOSTIC FACTORS AFTER 
CURATIVE RESECTION IN DISTAL 
COMMON BILE DUCT CANCER; 
FOCUSING ON THE SIGNIFICANCE OF 
PERINEURAL INVASION AND 
LYMPHOVASCULAR INVASION
C. K. Cho, H. J. Kim, B. G. Choi, S. H. Cho, C. Y. Kim, 
Y. H. Hur, J. C. Kim and H. J. Kim
Chonnam National University Medical School, Gwangju, 
Korea
Introduction: Recently perineural invasion (PNI) and lym-
phovascular invasion (LVI) have been known to be important 
prognostic factors in peripheral cholangiocarcinoma and 
hilar cholangiocarcinoma, but, in distal common bile duct 
cancer (distal CBD Ca) it is not clear until now. The purpose 
of this study was to evaluate the factors that infl uence recur-
rence and long-term survival and especially the signifi cance 
of PNI and LVI as the prognostic factor after curative resec-
tion (R0) of distal CBD Ca.
Methods: We examined the patients with distal CBD Ca 
who underwent radical surgery at Chonnam National 
University Hospital between March 2006 and June 2010. 
Retrospective analysis was performed for 64 patients of 
distal CBD Ca with R0 resection confi rmed by pathologic 
results. We examined clinicopathologic features, recurrence 
and survival rate, and evaluated the prognostic factors affect-
ing survival. Survival curves were analyzed using the 
Kaplan-Meier method, and for the evaluation of prognostic 
factors, log-rank test was used for univariate analysis and 
Cox proportional hazards model was used for multivariate 
analysis. A p-value <0.05 was considered to be statistically 
signifi cant.
Results: Overall survival rates for 1, 3, and 5 years were 
78%, 43%, and 35% respectively. In the univariate analysis, 
the prognostic factors infl uencing survival were histologic 
differentiation, lymph node metastasis, and TNM stage. 
Among them, lymph node metastasis was identifi ed to be 
only independent prognostic factor for overall survival in 
multivariate analysis. As for the PNI, the 5-year survival rate 
is higher in PNI-negative group than in PNI-positive group, 
but there was no statistical signifi cace. And also the LVI was 
not signifi cantly associated with long-term survival.
Conclusion: Lymph node metastasis was only signifi cant 
prognostic factor affecting survival after curative resection 
of distal CBD Ca. As for the PNI and LVI those are recently 
thought to be signifi cant prognositic factors in cholangiocar-
cinoma, our study did not show any signifi cant relationship 
with long-term survival after curative (R0) resection of distal 
CBD Ca. We think that further larger scaled studies should 
be necessary to identify the prognostic signifi cance of PNI 
and LVI in distal CBD Ca.
FOS037
INCIDENCE OF CONCOMITANT 
HEPATIC ARTERY INJURY IN PATIENTS 
WITH IATROGENIC BILE DUCT 
INJURIES RECONSTRUCTED WITH 
HEPATICO-JEJUNOSTOMY: 
A NATIONWIDE STUDY
N. M. Stilling1, C. Fristrup1, J. Nygaard2, M. Sall3, 
A. Wettergren4, L. Bardram4, K. Holte4 and 
M. B. Mortensen1
1Department of Surgery, Odense University Hospital, 5000, 
Odense C, Denmark; 2Department of Surgical 
Gastroenterology L, Aarhus University Hospital, 8000, 
Aarhus, Denmark; 3Department of Surgical 
Gastroenterology A1, Aalborg Hospital, Aarhus University 
Hospital, 9100, Aalborg, Denmark; 4Department of 
Surgical Gastroenterology C, Rigshospitalet, 2100, 
Copenhagen Ø, Denmark
Introduction: Iatrogenic bile duct injuries (BDI) sustained 
during cholecystectomy are associated with severe short and 
long term morbidity and even mortality. The impact of con-
comitant hepatic artery injury (HAI) on morbidity and the 
long term reconstruction result has been debated. Likewise 
there is a large variation (12–47%) in the reported incidence 
of concomitant HAI in selected series. This study was con-
ducted to elucidate the incidence of concomitant HAI in a 
nationwide population of BDIs.
Methods: All patients undergoing hepatico-jejunostomy 
(HJ) reconstruction after iatrogenic BDI sustained during 
cholecystectomy between January 1995 and January 2010 
were retrospectively identifi ed in local and national registers 
associated with the fi ve hepatopancreaticobiliary (HPB) 
centers in Denmark. Patient charts were reviewed for evi-
dence of concomitant HAI. No specifi c investigations were 
performed to reveal concomitant vascular injury in addition 
to the surgeons’ observations during the reconstructive 
surgery.
Results: 139 patients with BDI reconstructed with HJ were 
identifi ed. A concomitant HAI was reported in 26 cases 
(19%). Twenty-four of these were injuries to the right hepatic 
artery (RHA) and 2 suffered a complete transection of the 
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common hepatic artery. No cases of damage to the portal 
vein were observed. The incidence of observed concomitant 
vascular injury ranged from 0% to 37%. The incidences of 
HAI described in the 5 centers were 0, 6, 37, 25 and 19%, 
respectively. This difference of described incidence between 
the fi ve HPB centers was signifi cant (p = 0.03).
Conclusion: In this nationwide retrospective study covering 
15 years BDI, concomitant HAI was described in 19% of the 
patients reconstructed with HJ after BDI. RHA injury 
accounted for the majority of cases. This incidence is most 
likely underestimated. To obtain the true incidence of HAI 
would require a prospective and CT angiography and intra-
operative Doppler ultrasound controlled study.
FOS038
IS THE PREOPERATIVE LEVEL OF 
TOTAL BILIRUBIN IN THE BILE FROM A 
PREDICTED REMNANT LIVER USEFUL 
FOR THE PREDICTION OF 
POSTOPERATIVE LIVER FAILURE IN 
MAJOR HEPATECTOMY IN PATIENTS 
WITH OBSTRUCTIVE JAUNDICE?
R. Higuchi1, T. Ota1, H. Kajiyama1, T. Yazawa1, 
S.-ichi Ariizumi1, T. Araida2, T. Otsubo3 and 
M. Yamamoto1
1Department of Surgery, Institute of Gastroenterology, 
Tokyo Women’s Medical University, Tokyo, Japan; 
2Department of Gastroenterology, Tokyo Women’s Medical 
University, Yachiyo Medical Center, Chiba, Japan; 
3Department of Gastrointestinal and General Surgery, St. 
Marianna University School of Medicine, Kanagawa, 
Japan
Introduction: In recent years, hepatectomy has been safely 
performed because of a progression in surgical procedures 
and the establishment of liver function assessment. However, 
the correct evaluation of a functional liver reserve is some-
times diffi cult in patients with obstructive jaundice. This 
study examined whether the preoperative level of total bili-
rubin in the bile from a predicted remnant liver (LTB) can 
be used as a predictor for postoperative liver failure (PLF) 
in these patients.
Methods: Forty patients with obstructive jaundice who 
underwent right or more extended hepatectomy were enrolled 
in the study. All of the bile from the future remnant liver was 
collected for analysis. The LTB was calculated by multiply-
ing the volume (dl) and the density (mg/dl) of the bile from 
the future remnant liver. PLF was defi ned as the total bile 
(T-Bil) increasing postoperatively to over 10 mg/dl.
Results: The surgical procedure was right hepatectomy with 
caudate lobectomy in 35 (85%) patients, right trisegmentec-
tomy with caudate lobectomy in 5 (15%), reconstruction of 
the portal vein in 14, and reconstruction of the hepatic artery 
in 2. According to a univariate analysis, the LTB (P = 0.0015), 
operative time (P = 0.0088), intraoperative bleeding (P = 
0.0069), and blood transfusion (P = 0.0040) were signifi cant. 
Multivariate analysis showed LTB is only a predictive factor 
of PLF (P = 0.0459). Hospital death occurred in 3 of 5 PLF. 
Two of the 3 hospital deaths occurred in patients who under-
went surgery in 1990. The LTB was an apparently low value. 
The third death occurred from liver failure because of 
impeded blood fl ow in the liver.
Conclusion: LTB may be a good indicator for postoperative 
liver failure in major hepatectomy in patients with obstruc-
tive jaundice.
FOS039
PROGNOSTIC SIGNIFICANCE OF 
LYMPH-NODE METASTASES IN 
CHOLANGIOCARCINOMA, RESULTS 
OF MULTI-INSTITUTIONAL STUDY 
ON 481 PATIENTS
A. Ruzzenente1, T. Campagnaro1, G. Ercolani2, 
F. Giovinazzo3, A. Dazzi2, C. Bassi3, A. D. Pinna2 and 
A. Guglielmi1
1General Surgery A, Department of Surgery, University of 
Verona, Verona, Italy; 2Liver and Multiorgan Transplant 
Unit, Department of General Surgery, University of 
Bologna, Bologna, Italy; 3General Surgery B, Department 
of Surgery, University of Verona, Verona, Italy
Introduction: The prognosis of patients with cholangiocar-
cinoma (CCC) is poor, only curative surgery can allow long 
term survival. Lymph-node (LN) metastases is one of the 
most signifi cant independent prognostic factors in patients 
with CCC. The aims of this study are to identify factors 
associated with outcome after surgical management of CCC 
(intrahepatic, perihilar and distal) and examine the impact of 
LN assessment on survival.
Methods: From a multi-institutional database (3 referral 
Centre), 481 patients who underwent surgery for CCC (171 
intrahepatic, 243 per-hilar and 67 distal) between 1990 and 
2010 were identifi ed. 339 (70.4%) patients submitted to 
surgery with curative intent were the subject for this study. 
Clinical and pathologic data were evaluated using uni- and 
multivariate analyses.
Results: Median survival was 34.9 months, and 5-year sur-
vival was 31.3%. Factors associated with adverse prognosis 
included macrovascular invasion (HR, 1.86; P < 0.001), peri-
neural invasion (HR, 1.55; P = 0.015), and T stage (AJCC 
seventh edition) (HR, 1.20; P = 0.042). Lymphadenectomy 
was performed in 229 patients (67.6%); 97 of these (42.4%) 
had LN metastasis. Median survival for N0 was 42.4 months 
vs 26.0 months fro N1; HR 1.48, P = 0.029). The number of 
positive LN and the ratio of positive LN (cut off value of 
0.25) were signifi cantly related with survival with HR 
of 1.48 (P < 0.01) and of 1.87 (P < 0.01). Multivariate analy-
sis identifi ed that prognostic factors were macrovascular 
invasion and LN ratio with HR of 1.65 (P = 0.01) and 1.59 
(P = 0.03).
Conclusion: Macrovascular invasion, perineural invasion, 
T stage and LN metastasis were associated with survival. N1 
status adversely affected overall survival. Lymphadenectomy 
should be strongly considered for CCC, because more than 
40% of patients will have LN metastasis and the presence of 
positive LN metastases strongly affects the long term 
outcome of surgical resection.
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FOS040
VALIDATION OF THE INTERNATIONAL 
STUDY GROUP OF LIVER SURGERY 
(ISGLS) DEFINITION AND GRADING OF 
BILE LEAKAGE AFTER HEPATOBILIARY 
AND PANCREATIC SURGERY
P. Deka, D. Jindal, S. Singh, V. Pamecha and S. S. Negi
Institute of Liver and Biliary Sciences, New Delhi, India
Introduction: Despite postoperative bile leak being a 
common complication in patients undergoing hepatobiliary 
and pancreatic head surgery, defi nitions of postoperative bile 
leak vary widely, precluding accurate comparisons of surgi-
cal techniques and experiences. The ISGLS has proposed a 
classifi cation scheme for bile leakage after hepatobiliary and 
pancreatic surgery. However, this defi nition and classifi ca-
tion scheme has not been rigorously tested or validated.
Methods: Between August 2009 and December 2011, 181 
consecutive patients underwent surgery of the liver, biliary 
tract or pancreas with potential for bile leakage from the cut 
surface of the liver, from injury of the bile ducts, or from 
anastomotic leakage after bilioenteric anastomosis. In all 
these patients, at least one abdominal drain was placed at 
surgery. Bile leak was defi ned by ISGLS criteria. Cases were 
divided into four categories: no bile leak; biochemical bile 
leak without clinical sequelae (grade A), bile leak requiring 
endoscopic or radiologic therapeutic intervention (grade B), 
and bile leak requiring relaparotomy (grade C). Clinical out-
comes were analyzed across all grades including patients 
with no bile leak.
Results: 14 patients had a bile leak for an overall incidence 
of 7.7%. Grade A fi stulas occurred in 7 patients, grade B in 
6 patients, and grade C in 1 patient. Among the 6 patients 
with Grade B bile leak, 1 patient was classifi ed as Grade B 
as hospital stay was prolonged by 10 days due to persistently 
high drain output which however resolved without interven-
tion. In addition to the 6 patients with Grade B bile leak, 2 
more patients subsequently developed bile leak which would 
have been graded as Grade B. Hence, applying the ISGLS 
defi nition could correctly identify only 75% patients with 
Grade B bile leak. Duration of stay, ICU duration, and addi-
tional diagnostic and therapeutic interventions progressively 
increased from grade A to C.
Conclusion: Biochemical evidence of bile leak alone has no 
clinical consequence. Increasing bile leak grades have nega-
tive clinical impact on patients. However, the ISGLS defi ni-
tion of bile leak does not always correctly identify patients 
with Grade B bile leaks. These fi ndings partially validate the 
ISGLS classifi cation scheme for bile leak.
FOS041
CHOLEDOCHAL CYST WITH 
MALIGNANCY: A SINGLE 
CENTRE EXPERIENCE
A. K Agarwal
GB Pant Hospital & MAM College, Department of GI 
Surgery, New Delhi, India
Background and aim: Malignancy is a recognised compli-
cation of long standing choledochal cyst (CDC). Although it 
commonly occurs in the cyst wall itself, the entire hepato-
pancreatic-biliary region is at risk. We herein report our 
experience of the spectrum o f malignancies associated with 
CDC.
Methods: Of the 436 patients admitted with the diagnosis 
of CDC during January 2001 to May 2011, there were 34 
cases (7.79%) of malignancy. Clinical presentation, type of 
cysts (as per Todani’s modifi cation of Alonso Lej classifi ca-
tion), site of the tumour, management and follow up of these 
patients were analysed.
Result: A total of 34 patients of CDC with malignancy were 
diagnosed during the period form a prospective database. 
Twenty patients (58.8%) were found to have gall bladder 
cancer (GBC) and 14 patients (41.1%) had cholangiocarci-
noma arising from the cyst wall. The majority of the patients 
were females (n = 25) and the mean age was 47 years (range 
20–74). Twenty three had Type I, 9 had type IVa CDC and 
2 had Type V cysts. There were no cases of malignancy in 
the patients between 0–15 years, 19 (55.8%) cases between 
16–49 years and 15 (44.1%) in >50 years. Six of the 20 
patients with GBC had metastatic disease on preoperative 
workup and 2 were found unresectable (metastasis-1, locally 
advanced-1) on surgical exploration. Radical cholecystec-
tomy with excision of choledochal cyst was performed in 9 
and additional resection of adjacent organs was required in 
3 patients. Of the 14 patients with malignancy in the cyst 
wall, 7 had metastatic disease on preoperative workup and 
another 2 at the time of surgical exploration. One patient 
underwent Whipple’s pancreato duodenectomy with cyst 
excision. Four others underwent excision of the extrahepatic 
biliary tree with the tumor. GBC had a respectability rate of 
60% while cholangiocarcinoma had 35.7%. Overall resect-
ability rate was 50%.
Conclusion: Choledochal cyst has a defi nite risk of malig-
nancy in the cyst wall and the gall bladder, which was 7.79% 
in the current series. All CDC should thus be excised upon 
diagnosis.
FOS042
EVALUATION OF MODIFIED 
ESTIMATION OF PHYSIOLOGIC 
ABILITY AND SURGICAL STRESS IN 
PATIENTS UNDERGOING SURGERY FOR 
CHOLEDOCHOCYSTOLITHIASIS
Y. Haga1, Y. Wada2, H. Takeuchi3 and T. Furuya4
1National Hospital Organization Kumamoto Medical 
Center, Kumamoto, Japan; 2National Hospital 
Organization Himeji Medical Center, Hyogo, Japan; 
3National Hospital Organization Iwakuni Clinical Center, 
Yamaguchi, Japan; 4National Hospital Organization 
Kanmon Medical Center, Yamaguchi, Japan
Introduction: The incidence of complicated choledocho-
cystolithiasis is increasing with an aging society. Surgeons 
often wonder whether they should perform operations on 
their elderly patients. We recently constructed a model to 
predict postoperative morbidity and mortality in general 
surgery, termed modifi ed Estimation of Physiologic Ability 
and Surgical Stress (mE-PASS) (Ann Surg 2011;253:194–
201). This study was undertaken to evaluate the utility of this 
model in patients with choledochocystolithiasis.
Methods: A subset of 4329 patients from previous multi-
center cohort studies was reanalyzed in the current study. The 
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patients had undergone surgery for choledochocystolithiasis 
in 44 Japanese referral hospitals between April 11, 1987 and 
April 6, 2007. The patients were analyzed for the predicted 
in-hospital mortality rates (R) of mE-PASS along with infor-
mation on postoperative morbidity and mortality. The dis-
crimination power of R to detect in-hospital mortality was 
assessed by calculating the area under the receiver operating 
characteristic curve (AUC). Categorical variables were com-
pared between the groups using a chi-squared test with Yates 
correction for continuity.
Results: Postoperative mortality and morbidity rates were 
0% and 3.0%, respectively, for laparoscopic cholecystec-
tomy (n = 3442), 0.19% and 14.2% for open cholecystec-
tomy (n = 521), 1.6% and 23.8% for laparoscopic 
choledochotomy (n = 63), 1.1% and 23.9% for open choledo-
chotomy (n = 264) and 5.1% and 35.9% for plasty or resec-
tion of the common bile duct (n = 39). Overall, mE-PASS 
demonstrated a high discrimination power to predict in-hos-
pital mortality in patients (AUC, 95% confi dence intervals: 
0.96, 0.94–0.99). When R increased, postoperative morbidity 
rates also increased signifi cantly: 4.4% when R is less than 
0.01 (n = 3967), 24.0% when R is 0.01 or greater but less 
than 0.05 (n = 312), and 42.0% when R is 0.05 or greater 
(n = 50); P < 0.0001.
Conclusion: Recent advances in endoscopic treatment for 
choledochocystolithiasis have enabled multiple therapeutic 
options for elderly patients. The current study suggests that 
mE-PASS may accurately predict postsurgical risk in patients 
with choledochocystolithiasis. mE-PASS will be useful for 
making medical decisions and obtaining informed consent 
from high-risk patients. Because mE-PASS requires only 
seven preoperative variables, the data entry will not signifi -
cantly increase the workload of doctors.
FOS043
PORTAL VEIN INVASION IN PERIHILAR 
CHOLANGIOCARCINOMA: WHICH IS 
MORE PREDICTIVE, GROSS 
INSPECTION OR HISTOLOGY?
T. Ito, T. Ebata, Y. Yokoyama, G. Sugawra, T. Igami, 
Y. Takahashi and M. Nagino
Division of Surgical Oncology, Department of Surgery, 
Nagoya University Graduate School of Medicine, Nagoya, 
Japan
Introduction: Combined portal vein (PV) resection has 
been universally applied in locally advanced perihilar chol-
angiocarcinoma. According to UICC system for perihilar 
cholangiocarcinoma, PV invasion is classifi ed into three: no 
invasion (Category A), invasion of the ipsilateral portal vein 
treated as T3 (Category B), and that of the contralateral 
portal vein as T4 (Category C). This categorization is 
straightforward but lacks clinical validation.
Methods: Between 2001 and 2010, 386 patients with peri-
hilar cholangiocarcinoma underwent surgical resection. 
Excluding 8 patients who died in hospital, 49 with pM1 
disease, and 5 with insuffi cient information, the remaining 
324 patients formed the cohort. PV resection was performed 
in 117 patients when the portal bifurcation was grossly 
involved. In this study, PV invasion was histologically 
defi ned as presence of cancer cell infi ltration into the PV 
adventitia or deeper, and its extent was anatomically classi-
fi ed into three types: Category A to C. These pathologic 
factors were analyzed in terms of survival.
Results: Survival rate for patients without PV resection was 
63.0% at 3 years and 55.6% at 5 years with a median survival 
time (MST) of 84.3 months; whereas that for patients with 
PV resection 43.1%, 29.5%, and 28.2 months, respectively 
(p < 0.001). In patients without PV resection, survival for 
Category A was comparable to that for Category B: MST of 
92.1 versus 72.3 months, respectively (p = 0.714). In patients 
with PV resection, Category A, B and C had MST of 25.3, 
36.8, and 27.7 months, respectively: the survival for Category 
B was comparable to that for Category A (p = 0.772) or 
Category C (p = 0.721).
Conclusion: PV resection (ie, gross PV invasion) has a 
great impact on survival. Stratifi ed according to presence or 
absence of PV resection, anatomic extent of PV invasion has 
no prognostic impact. With or without gross PV invasion is 
more predictive variable than microscopic PV invasion.
FOS044
REPEAT REPAIR FOR BILE DUCT 
INJURY AFTER CHOLECYSTECTOMY
P. Addeo, E. Oussoultzoglou, E. Rosso, C. Nobili and 
P. Bachellier
Hepato-Bilio-Pancreatic Surgery and Liver Transplantation 
Center, University of Strasbourg, France
Introduction: Iterative repair for bile duct injuries (BDI) 
after cholecystectomy remains technically challenging and 
with debated outcomes. We evaluated short and long-term 
outcomes of repeat repair for BDI at a single institution.
Methods: Data from 46 consecutive BDI referred to our 
institution between January 1991 and May 2011 were retro-
spectively reviewed. Patients were stratifi ed into two groups 
according to the presence of a previous repair and statisti-
cally compared.
Results: There were twenty-four primary (52.1%) and 
twenty-two (47.8%) repeat repair. Patients in the repeat repair 
group were statistically younger (P = 0.0001), had BDI more 
often diagnosed intraoperatively (P = 0.0007), were statisti-
cally signifi cantly referred later from BDI occurrence (P = 
0.044) and with ongoing cholangitis (P = 0.0071). Patients in 
the repeat repair group underwent surgery at a later interval 
(P = 0.001) with no signifi cant differences in term of postop-
erative mortality, morbidity, hospital stay and long-term stric-
ture rate (P > 0.05). Patients with associated vascular injuries 
showed a signifi cantly higher postoperative mortality (P = 
0.001), higher morbidity (P = 0.05) and a statistically signifi -
cant higher need for liver resection (P = 0.0385).
Conclusion: Repeat repairs for BDI show short and long 
term outcomes comparable to primary repairs when per-
formed in tertiary centers. The presence of an associated 
vascular injury increases postoperative mortality, morbidity 
and the need for liver resection.
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FOS045
DOES LIVER RESECTION CURE 
INCIDENTAL GALLBLADDER CANCER? 
A CRITICAL VIEW
J. Lendoire, L. Gil, G. Raffi n, F. Duek, C. Quarin, 
V. Garay, M. Rivaldi and O. Imventarza
Hospital Cosme Argerich, Buenos Aires, Argentina
Introduction: Surgical management of gallbladder cancer 
(GC) is still controversial. Therapeutic effi cacy and the 
appropriate extent of the liver resection still remains 
unclear.
Methods: A retrospective analysis of patients referred to the 
Hospital Argerich with diagnosis of incidental GC between 
June 1999 and June 2010 was performed. Patients were iden-
tifi ed from the Liver Transplantation and Surgical Division 
prospective computerized database. Incidental (I) tumors 
were included. Data covering demographic features, clinical 
characteristics, local pathological stage, surgical procedure, 
morbidity, histological features and factors for long term 
survival were analyzed. Survival curves were estimated with 
the Kaplan-Meier method and compared using the log-rank 
test.
Results: 24 patients with IGC were resected: 20 females 
(83.3%). Median age 57.4 years (range 38–78). Local patho-
logical stage was T1 (1), T2 (12), T3 (11). Laparoscopic 
cholecystectomy was performed in 4 patients (16.6%). All 
were treated by resection of segments 4b-5 and lymphade-
nectomy, port site excision was used in all laparoscopic 
resected patients. No peri-operative mortality, 20.8% mor-
bidity (60% type I), R0 in 23 /24 (96%). Histological exami-
nation revealed microscopic tumor involvement in 29%, 
positive nodes in 12.5% and peritoneal invasion in 4.1% (T2 
16%/T3 72% p 0.01), all presented recurrence between 3 and 
12 month. Overall 5-year survival was 53% (stage 
AJCC 7thed. II 90%, IIIA 28%, IIIB and VI 0%) and in the 
univariate analyses was signifi cantly associated with T stage 
(p < 0.001), TNM stage (p < 0.001), and residual tumor in 
histophatological examination of resected liver (p < 0.001).
Conclusion: Preoperative T stage is an important factor in 
determining survival as confi rmed by our study. As T stage 
of the disease increase, the chance of fi nding residual disease 
and positive nodes increased and survival decrease dramati-
cally. Patients with residual disease present recurrence and 
died into 15th month of follow-up.
FOS046
COMPARATIVE ANALYSIS OF LEFT 
VERSUS RIGHT SIDED RESECTION IN 
PATIENTS UNDERGOING LIVER 
SURGERY FOR KLATSKIN TUMOR: 
RIGHT SIDED RESECTIONS HAVE 
BETTER LONG TERM OUTCOME?
F. Ratti, F. Ferla, F. Cipriani, G. Ferla and L. Aldrighetti
Department of General Surgery, Hepatobiliary Surgery 
Unit, IRCCS H San Raffaele, Vita-Salute San Raffaele 
University, Milan, Italy
Introduction: Achievement of negative margins in Klatskin 
tumor surgery has-been advocated as a main goal of curative 
intent treatment: a more aggressive treatment, including hilar 
and left or right sided liver parenchyma resection, allows to 
obtain a better long term outcome. Considering the anatomi-
cal relationships between the vascular hilar structures and 
bile duct, this study aims to compare short and long term 
outcome of left and right sided resections.
Methods: From January 2004 to December 2011, 94 
patients with preoperative diagnosis of Klatskin tumor were 
candidated to surgery at the Hepatobiliary Surgery Unit of 
the Hospital San Raffaele in Milan: of these, 75 underwent 
major liver resection. The data of all patients were prospec-
tively collected and are retrospectively reviewed. 46 patients 
underwent right sided resections (Right Group), while the 
remaining 29 left sided resections (Left Group). The two 
groups were compared in terms of perioperative morbidity 
and mortality and overall and disease free survival.
Results: The two groups were comparable in terms of 
patient and disease characteristics. Patients in Right Group 
needed more frequently preoperative PVE. The postopera-
tive morbidity and mortality was greater in Right Group 
(56.6% and 8.7% respectively) than in the Left Group (34.5% 
and 3.4% respectively) (p < 0.005). The most frequent cause 
of death was postoperative liver failure (more frequent in the 
Right Group). R1 resections were 26.1% in the Right Group 
and 31.5% in the Left Group (p not signifi cant). 5-years 
survival rate was 32% in the Right Group and 25% in the 
Left Group, with no signifi cant differences. Recurrent disease 
was found in 70.6% of patients, without statistically signifi -
cant differences between the two groups.
Conclusion: Right sided resections for Klatskin tumors are 
associated with a signifi cantly higher postoperative morbid-
ity compared with left sided, probably related to a greater 
parenchymal sacrifi ce. Despite this, they seem to be associ-
ated with better long-term survival (data require a validation 
on a larger scale), since resection of the right hepatic pedicle, 
which anatomically lies behind the biliary carrefour, may 
allow a full radicality in right sided lesions.
FOS047
PREDICTORS OF SURVIVAL IN 
GALLBLADDER CANCER: A REVIEW OF 
90 PATIENTS SUBMITTED TO SURGERY 
WITH CURATIVE INTENT
D. Cavallucci, S. Cleary, A. Fox and K. Leung
University Health Network, Toronto General Hospital, 
Ontario, Canada
Introduction: Long-term survival from gallbladder cancer 
remains poor. One diffi culty remains identifying patients 
who despite presenting with early disease, have an increased 
risk of recurrence and may benefi t from more aggressive 
adjuvant treatment.
Methods: Retrospective review of all (n = 90) patients with 
gallbladder cancer submitted to surgery with curative intent 
in the past 10 years.
Results: 51 had previous surgery with 47 cholecystecto-
mies. Those patients who had undergone previous surgery 
had superior survival (median 30 vs 18 m, p = 0.0002) which 
was maintained across all stages of disease. A positive cystic 
duct margin predicted residual disease and inferior survival 
on univariate analysis (HR 1.86, p = 0.048). Presenting with 
jaundice is confi rmed as a strong predictor of unresectability 
and inferior survival (HR 2.68, p = 0.003) with all patients 
having recurrent disease. If residual disease was present at 
re-resection following cholecystectomy, the survival is no 
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better than patients not diagnosed incidentally. The extent of 
liver resection or resection of adjacent directly involved 
organs did not signifi cantly impact survival.
Conclusion: Patients whose gallbladder cancer is diagnosed 
incidentally at cholecystectomy have improved survival even 
when stage is taken into account. The presence of residual 
disease at re-resection however, removes this survival 
advantage.
FOS048
K-RAS MUTATION IS STRONGLY 
ASSOCIATED WITH PERINEURAL 
INVASION AND REPRESENTS AN 
INDEPENDENT PROGNOSTIC 
FACTOR OF INTRAHEPATIC 
CHOLANGIOCARCINOMA 
AFTER HEPATECTOMY
H.-Y. Ho1, T.-C. Chen2, Y.-Y. Jan1 and T.-S. Yeh1
1Department of Surgery, Chang Gung Memorial Hospital 
Chang Gung University, Taoyuan, Taiwan; 2Department of 
Pathology, Chang Gung Memorial Hospital Chang Gung 
University, Taoyuan, Taiwan
Introduction: Unsatisfying long-term survival of intrahe-
patic cholangiocarcinoma (ICC) triggers the clinicians 
searching for molecular markers, such as K-ras mutation, to 
tailor management strategy. Additionally, emergence of tyro-
sine kinase inhibitors (TKIs) brings the new hope to palliate 
advanced ICC; whereas whether the effi cacy of TKIs is infl u-
enced by k-ras mutation is largely unknown. The aims of this 
study were to determine the prevalence of k-ras mutation and 
its clinical signifi cance in ICC.
Methods: A total of 86 patients with ICC undergone hepa-
tectomy were retrospectively recruited. K-ras mutation was 
determined using laser capture microdissection and direct 
sequencing method. Association among clinicopathological 
variables and K-ras mutation was analyzed. Prognostic 
factors of ICC after hepatectomy were also determined.
Results: There were 19 (22.0%) patients exhibiting K-ras 
mutations. Of them, 17 had their K-ras mutations occurring 
at codon 12, while the remaining two occurring at codon 13 
and codon 61 in one each. Perineural invasion was exclu-
sively the variable associated with K-ras mutation (Odds 
ratio, 6.9) using logistic regression analysis. Multivariate 
analysis demonstrated that resection margin, T-status, nodal 
metastasis and K-ras mutation were independent prognostic 
factors. The median survival of ICC patients with K-ras 
mutation was 5.7 months compared to 19.0 months in those 
without K-ras mutation (p = 0.002).
Conclusion: The prevalence of K-ras mutations in a consid-
erably large cohort of ICC was 22%. K-ras mutation is 
strongly associated with perineural invasion phenotypically. 
K-ras mutation is an independent prognostic factor of ICC 
after hepatectomy.
FOS049
PROGNOSTIC FACTORS FOR 
GALLBLADDER CANCER IN THE 
LAPAROSCOPY ERA: IATROGENIC BILE 
SPILLAGE WORSENS THE PROGNOSIS
Y. H. Kim and Y. H. Roh
Department of Surgery, Dong-A University, College of 
Medicine, Busan, South Korea
Introduction: Hepatobiliary surgery has changed dramati-
cally in the recent decades with the advent of laparoscopic 
techniques. The aim of this retrospective study was to 
compare survival rates according to stages, adjusting for 
important prognostic factors.
Methods: A retrospective study of a 17-year period from 
January 1994 to April 2011 was carried out. The cases 
studied were divided into 2 time period cohorts, those treated 
in the fi rst 9 years (N = 109) and those treated in the last 7 
years (N = 109).
Results: An operation with curative intent was performed 
on 218 patients. The 5-year survival rates according to the 
depth of invasion were as follows: 86% with T1, 56% with 
T2, 45% with T3, 5% with T4. The number of cases of inci-
dental gallbladder cancer (GBC) found during 3919 laparo-
scopic cholecystectomies (LC) was 96 (2.4%). Incidental 
GBC revealed a better survival rate (p = 0.003). Iatrogenic 
bile spillage was found in 20 perforations of the gallbladder 
during LC, 16 preoperative percutaneous transhepatic gall-
bladder drainages (PTGBD) and 16 percutaneous transhe-
patic biliary drainages (PTBD). These patients showed a 
signifi cantly lower survival rate than patients without iatro-
genic bile spillage (p < 0.01).
Conclusion: This study found that the prognosis of GBC is 
still determined by the stage at presentation due to the 
aggressive biology of this tumor. Iatrogenic bile spillage and 
tumor violation is a risk factor that infl uences the prognosis 
of GBC. Early diagnosis, radical resection and appropriate 
adjuvant therapy can increase overall survival.
FOS050
PORTAL VEIN RESECTION FOR 
PERIHILAR CHOLANGIOCARCINOMA: 
UPDATED SURGICAL OUTCOME 
SINCE 2001
T. Ebata, Y. Yukihiro, I. Tsuyoshi, S. Gen, T. Yu and 
N. Masato
Division of Surgical Oncology, Nagoya Graduate School of 
Medicine, Nagoya, Japan
Introduction: Resection of the portal vein (PV) has been 
frequently employed in surgery for advanced perihilar chol-
angiocarcinoma. Previously we reported surgical outcome of 
52 patients who underwent PV resection before 2000, where 
mortality and 5-year survival was 10% and 10%, respec-
tively (Ann Surg 2003). The aim of this study was to reap-
praise the current role of PV resection in patients with 
perihilar cholangiocarcinoma.
Methods: Between 2001 and 2010, a total of 513 patients 
with perihilar cholangiocarcinoma was treated in our service, 
386 (75%) of whom underwent resection. PV resection was 
performed in 142 (37%) of the 386 patients when the bifurca-
tion, contralateral PV, or the main PV was macroscopically 
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involved during the dissection of the hepatic hilus. Short- and 
long-term outcome of the 142 patients with PV resection 
(Group A) was compared to those of the 244 patients without 
(Group B) or the 127 unresected patients (Group C).
Results: Sixteen (11%) patients underwent wedge resection, 
followed by direct closure (n = 11) or patchy graft recon-
struction (n = 5); the remaining 126 (89%) underwent 
segmental resection, followed by direct end-to-end anasto-
mosis (n = 113) or interposition of the iliac vein graft 
(n = 13).
Complications of Clavien grade III or more occurred in 78 
(55%) patients of Group A and 120 (50%) of Group B (p = 
0.397); Re-operation was done in 8 (6%) and 7 (3%) patients, 
respectively (p = 0.275); and mortality was 4% (n = 6) and 
1% (n = 2), respectively (p = 0.275). Overall survival rate 
for Group A was 23% at 5 years; that for Group B was 43%, 
respectively (p < 0.001). Survival for Group A was signifi -
cantly better than that for Group C (4% at 3 years, p < 0.001).
Conclusion: Survival has improved (from 10% to 23% at 5 
years) and mortality has reduced (from 10% to 4%), as com-
pared to our previous report. Therefore, PV resection should 
be applied aggressively to selected patients with advanced 
perihilar cholangiocarcinoma.
FOS051
PROGNOSTIC IMPLICATION OF THE 
EXTENT OF RESECTION FOR 
ADVANCED GALLBLADDER CANCER
T. Tsirlis1, F. Ausania1, B. Haugk2, S. White1, J. French1, 
B. Jaques1, R. Charnley1 and D. Manas1
1Hepatobiliary and Transplant Surgery Unit, Freeman 
Hospital, NUTH NHS Trust, Newcastle upon Tyne, UK; 
2Histopathology Department, Royal Victoria Infi rmary, 
NUTH NHS Trust, Newcastle upon Tyne, UK
Introduction: The extent of potentially curative resection in 
advanced (T2-4) gallbladder cancer is still a matter of debate. 
The aim of this study was to investigate the impact of extra-
hepatic biliary tree resection and extended (>segment 
IVB+V) resections on the patient survival.
Methods: From July 2003 to July 2011 161 patients with 
gallbladder cancer were referred to our centre and all details 
recorded in a prospectively maintained database. Of the 161 
patients, 68 had potentially operable gallbladder cancer. 
36/68 patients underwent a radical resection and were 
included in this study. 24/36 patients had a re-resection after 
cholecystectomy whereas 12/36 patients had a primary 
resection. Final histology was graded according to the 6th 
edition of the AJCC TNM staging system.
Results: There were 17 men and 19 women with a mean 
age of 63.3 years (range 41–85). Final histology was pT2 (n 
= 23), pT3 (n = 10), pT4 (n = 3). Of the 36 radical resections, 
28 patients had non-anatomical segment IVB+V resection 
and 8 patients a more major resection including 3 extended 
right hepatectomy ± PV resection. 25/36 patients also had 
extra-hepatic biliary tree resection. Overall median survival 
was 27.8 months (range 3.2–106.4). In univariate analysis 
neither extra-hepatic biliary tree resection (p = 0.271) nor 
extended resection (p = 0.120) infl uenced survival. Adverse 
prognostic factors included R1 resection (p < 0.001), gall-
bladder bed invasion (p = 0.002), high lymph node ratio (p 
= 0.015), pT4 (p = 0.004). On multivariate analysis only R0 
resection.
Conclusion: In this study, an R0 resection is the single most 
important variable associated with survival after radical 
resection for gallbladder cancer. Therefore extrahepatic 
biliary tree resection and extended resections are only indi-
cated when a clear resection margin can be achieved.
FOS052
SURGICAL AMPULLECTOMY: A SAFE 
AND COMPLETE TREATMENT OF 
PRESUMED BENIGN AMPULLOMAS
A. Sauvanet1, C. Hubert2, S. Gaujoux1, S. Dokmak, 
P. Ponsot3, A. Couvelard4, P. Levy3 and J. Belghiti1
1Department of HBP Surgery, Hopital Beaujon, University 
Paris VII, Clichy, France; 2Department of Abdominal 
Surgery and Transplantation, Universite Catholique de 
Louvain, Brussels, Belgium; 3Department of 
Gastroenterology-Pancreatology, Hopital Beaujon, 
University Paris VII, Clichy, France; 4Department of 
Pathology, Hopital Beaujon, University Paris VII, Clichy, 
France
Introduction: Presumed benign ampullomas (PBA) can be 
treated by either pancreaticoduodenectomy (PD), endoscopic 
ampullectomy or surgical ampullectomy. Safe indication of 
SA needs to exclude preoperatively invasive carcinoma (Ca.) 
and should lead to a tumor-free margins to avoid the risks of 
subsequent PD or tumor recurrence. The aim of this study 
was to evaluate both feasibility and results of surgical ampul-
lectomy (SA).
Methods: From 1995 to 2011, 49 pts (38–79 yrs) underwent 
SA for PBA revealed by pain/cholangitis (n = 14), pancreati-
tis (n = 7), incidentally (n = 22) or during follow-up after 
previous ampullectomy (n = 6, including 3 SA). Work-up 
included endoscopic ultrasound (EUS) and side-viewing 
duodenoscopy + biopsies (including 15 after sphincterot-
omy). EUS staging was uT1N0 in all pts. No ampullary 
lesion was ulcerated. Preoperative biopsies revealed 
either low-grade (n = 35) or high-grade dysplasia (n = 7), or 
infl ammatory/normal mucosa (n = 7). Intraoperative frozen 
section (FS) was done routinely on resection margins. 
Patients were informed of the need for PD in case of positive 
margin proven intraoperatively or invasive Ca. on defi nitive 
pathologic examination.
Results: There was 1 (2%) immediate conversion to PD due 
to gross aspect suggestive of invasive Ca. confi rmed histo-
logically. At FS, 11 biliary + 5 pancreatic ductal margins 
were tumor-positive, needing 9 additional ductal resections 
(with tumor-free margins). Mean PBA size was 20 mm 
(range: 5–65). There was no postoperative death and no 
complications in 33 pts (67%) but 3 reoperations for com-
plications (6%). Resection was R0 in all 48 pts with 8 non-
adenomatous benign lesions, 32 adenomas (18 LGD, 14 
HGD), 6 T1D0 Ca., and 2 invasive T1D1 Ca. (with one 
secondary PD due to pathological fi ndings; the other one pt 
was unfi t for PD). With a median 45 mo. follow-up (3–120), 
5 (10%) pts had symptoms and 6 (12%) developed tumor 
recurrence with one reoperation.
Conclusion: SA with routine FS can treat PBA with no 
mortality and less morbidity than PD. SA can also obtain 
tumor-free margins, particularly along the common bile duct. 
SA can be performed after a previous ampullectomy, what-
ever surgical or endoscopic. After adequate preoperative 
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endoscopic work-up, the probability of invasive malignancy 
and the need for subsequent PD are less than 10%.
FOS053
SURGICAL TREATMENT OF TUMOR 




D. Ribero1, A. D. Pinna2, G. Nuzzo3, A. Guglielmi4, 
L. Aldrighetti5, S. M. Giulini6, G. E. Gerunda7 and 
L. Capussotti1
1Department of Surgery, Ospedale Mauriziano “Umberto 
I”, Torino, Italy; 2Department of Surgery and Organ 
Transplantation, Ospedale Sant’Orsola-Malpighi, 
University of Bologna, Bologna, Italy; 3Hepatobiliary 
Surgery Unit, Department of Surgery, Catholic University 
of the Sacred Heart School of Medicine, Roma, Italy; 
4Division of General Surgery A, Department of Surgery, 
University of Verona Medical School, Verona, Italy; 
5Department of Surgery-Liver Unit, Scientifi c Institute San 
Raffaele, Milano, Italy; 6Department of Medical and 
Surgical Sciences, Surgical Clinic, Brescia University, 
Brescia, Italy; 7Liver and Multivisceral Transplant Centre, 
University of Modena and Reggio Emilia, Modena, Italy
Introduction: Long-term outcomes after hepatectomy for 
intrahepatic cholangiocarcinoma (IHC) are still ill-defi ned. 
In particular, scarce data exist on rates and pattern of recur-
rence following a curative intent resection as well as on the 
effi cacy of a re-resection in the treatment of recurrent disease. 
Aim of this study was to examine frequency and type of 
treatment failure and the results of repeat surgery for tumor 
recurrences.
Methods: 575 consecutive patients treated with curative 
intent hepatectomy for IHC between 1995 and 2011 at 12 
tertiary referral centers were identifi ed from a multi-
institutional registry created and prospectively maintained 
under the aegis of the Italian Chapter of the IHPBA. Survival 
data were updated at 10/2011 (median follow-up 42 months). 
Data on recurrence and surgical treatment were analysed.
Results: 52% of patients recurred after a median of 10 
months (range 3–158), irrespective of the site of recurrence 
(p > 0.05). First site of recurrence was hepatic only 
(57%), extra-hepatic only (19.6%), intra- and extrahepatic 
(17.8%), and unknown (5.6%). 43 patients (15%) were 
treated with repeat surgery (36 liver, 3 pulmonary, 3 tho-
racic lymph node and 1 partial duodenal resections) with 
or without perioperative CTx for either single (27) or mul-
tiple (16) lesions. Postoperative mortality was nil. Rate and 
pattern of recurrence remained similar after repeat surgery 
with 25% of patients undergoing a 3rd resection. 5-yrs sur-
vival of patients whose recurrence was surgically treated 
was 43.6% from the 2nd resection and 64.0% from the 1st 
resection.
Conclusion: Over one-half of patients resected for IHC 
develop tumor recurrence. Although repeat surgery can be 
offered only to a subset of patients, an aggressive surgical 
approach signifi cantly prolongs survival.
FOS054
THE IMPACT OF DELAY IN TREATMENT 
OF HILAR CHOLANGIOCARCINOMA ON 
RESECTABILITY AND SURVIVAL
A. Ruys, S. Heuts, E. Rauws, O. Busch, D. Gouma and 
T. van Gulik
Department of Surgery, Academic Medical Center, 
Amsterdam, The Netherlands
Introduction: Substantial time elapses before patients with 
hilar cholangiocarcinoma (HCCA) receive operative treat-
ment, due to extensive preoperative staging and preoperative 
interventions, such as biliary drainage and portal vein 
embolisation. Long delays potentially lead to unresectability 
and formation of metastases, yet this has never been inves-
tigated before. Therefore we aimed to investigate the impact 
of treatment delay on resectability, metastases, tumour stage, 
and survival.
Methods: Treatment delays of consecutive patients with 
HCCA presenting in our center from January 2003 through 
August 2010 were evaluated by contacting GPs, and by 
evaluating local hospital fi les. Presenting symptoms as well 
as time and cause of delay were retrieved and correlated with 
resectability, metastases, tumour stage, and survival by logis-
tic and Cox regression analysis.
Results: Treatment delays in 210 consecutive HCCA 
patients were evaluated. Median delay from fi rst visit to GP 
until presentation in our (tertiary) center was 36 days. Delay 
was longer (days) when initial symptoms did not include 
jaundice (aspecifi c symptoms, p < 0.001). Duration of pre-
operative work-up and optimization of preoperative biliary 
drainage in our center to fi nal surgical treatment resulted in 
an additional median delay of 74 days. No correlation was 
found between delay in weeks and resectability [odds ratio 
(OR): 0.986 (0.962–1.009)], metastasis 0.947 (0.898–0.998), 
tumour stage [OR: 1.003 (0.979–10.28)], and survival in 
resected patients [hazard ratio: 0.996 (0.953–1.041)].
Conclusion: The delay between presenting symptoms and 
fi nal treatment in patients with HCCA is substantial, espe-
cially in patients with aspecifi c symptoms. This delay 
however does not affect resectability, metastasis, tumour 
stage, or survival, suggesting that preoperative optimization 
should not be omitted because of potential resulting delays.
FOS055
MODULATION OF GUT BARRIER 
FUNCTION IN PATIENTS WITH 
OBSTRUCTIVE JAUNDICE 
USING LP299V
C. Jones1, S. A. Badger1, M. Regan1, B. Clements1, 
T. Diamond1, R. W. Parks2 and M. A Taylor1
1Department of Surgery, Institute of Clinical Sciences, 
Queens University, Belfast, Northern Ireland; 2Department 
of HPB Surgery, Edinburgh Royal Infi rmary, Edinburgh, UK
Introduction: The barrier function of the gastrointestinal 
tract is defective in patients with obstructive jaundice, and 
may be improved with the probiotic LP299v. Previous 
studies have shown LP299v prevented an increase in intes-
tinal permeability in rats, however this response has not been 
assessed in humans. This study aimed to determine the effect 
of LP229v on intestinal permeability and TNF p55 receptor 
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concentrations in patients with obstructive jaundice pre and 
post biliary drainage.
Methods: This prospective trial involved patients undergo-
ing endoscopic or surgical biliary drainage over a 1 year 
period. Patients were randomised to three groups to receive 
LP299v, inactivated LP299v (placebo) or water daily; given 
at noon for 7 consecutive days. Inclusion criteria included 
visible presence of jaundice, a history of pale stools and dark 
urine (in keeping with symptoms of extrahepatic biliary 
obstruction) and a serum bilirubin greater than 80 μmol/l. 
Lactulose/mannitol was given to measure intestinal perme-
ability on admission, the day before biliary drainage, and on 
days 1 and 7 following biliary drainage. Urine was collected 
for laculose/mannitol (L/M) ratio and serum TNF p55 recep-
tor concentration was measured at each time point.
Results: 25 patients were recruited; 12 had choledocholi-
thiasis and 9 had a periampullary tumour. 9 patients had open 
biliary drainage, 12 ERCP and 5 PTC. After exclusions, 5 
received LP299v, 5 placebo and 7 water. Median L/M ratio 
was 0.035 (0.018–0.065) at baseline. There was no signifi -
cant difference between the groups on admission, pre-drain-
age and day 7 drainage (p = 0.59, 0.175 and 0.61 respectively). 
However, the L/M ratio was signifi cantly lower in the 
LP299v group on day 1 post-drainage (0.01 [0.01] vs. 0.18 
[0.03–0.3] and 0.11 [0.07–0.14]; p = 0.37). Although, TNF 
p55 receptor was lower on day 1 post-drainage in LP299V 
group (15.3 ng/ml vs. 30.9 and 82.7; p = 0.43), there was no 
signifi cant difference in concentration at any of the four time 
points.
Conclusion: Pre-treatment with probiotic LP299v improves 
intestinal permeablility immediately following biliary drain-
age and may attenuate a subsequent infl ammatory response 
in patients following biliary intervention for obstructive 
jaundice. However, a much larger mutli-centre trial is 
required to determine the effects on clinical outcome.
FOS056
SURGICAL STRATEGY OF T2 
GALLBLADDER CANCER: A 
MULTICENTER SURVEY
S. E. Lee1, J.-Y. Jang2 and S.-W. Kim2
1Department of Surgery, Chung-Ang University School of 
Medicine, Seoul, Korea; 2Department of Surgery, Seoul 
National University College of Medicine, Seoul, Korea
Introduction: Although all the guidelines suggest that T2 
gallbladder (GB) cancer should be treated by extended cho-
lecystectomy and almost every surgeon would agree with 
that, the high level scientifi c evidence is lack because there 
has been no randomized controlled trial on gallbladder 
cancer till now. The aim of this study is to investigate clinical 
feature and clinical outcome of T2 GB cancer and to deter-
mine surgical strategy for T2 GB cancer through a multi-
center survey.
Methods: A nationwide multicenter study was performed in 
which 14 university hospitals in Korea participated from 
1995 to 2004. A total 431 patients with T2 were enrolled. 
The clinicopathologic fi ndings & long-term follow-up results 
were analyzed after the consensus meeting of the Korean 
Pancreas Surgery Club.
Results: Mean age was 63-years-old and male to female 
ratio was 1 : 1.3. Simple cholecystectomy (SC) was 
performed in 214 patients (49.4%) and extended cholecys-
tectomy (EC) in 206 patients (47.8%). Curative resection 
was performed in 82% of the patients. Lymph node metas-
tasis was observed in 108 patients (108/292, 37.0%). The 
overall 5 year survival rate was 45%. Lymph node dissection 
and EC was associated with an improvement in overall sur-
vival. However, if curative resection was performed, there 
was no signifi cant difference in survival between EC and SC. 
Recurrence occurred in 86 patients (24.3%) and among 
them 35 patients (40.7%) after SC and 51 (59.3%) after EC 
(p = 0.11).
Conclusion: If curative resection could be performed, 
simple cholecystectomy and lymph node dissection would 
be recommended for T2 gallbladder cancer patients.
FOS057
AGGRESSIVE SURGICAL RESECTION 
FOR ADVANCED HILAR 
CHOLANGIOCARCINOMA: 
EXAMINATION OF TUMOR EPICENTER 
AND PATTERNS OF RECURRENCE
T. Reichman1, P. Ryan2, A. Fox1, P. Greig1, C.-A. Moulton1, 
A. Wei1, S. Gallinger1 and S. Cleary1
1Department of Surgery, Toronto General Hospital, 
University of Toronto, Toronto, Ontario, Canada; 
2Department of Pathology, Toronto General Hospital, 
University of Toronto, Toronto, Ontario, Canada
Introduction: Over the last few decades, more aggressive 
surgical management has been used for patients with hilar 
cholangiocarcinoma. Few large single center series are avail-
able given its low incidence and high rate of unresectability. 
Long term outcomes and patterns of recurrence are still 
poorly understood.
Methods: The objective of this study was to analyze out-
comes following resection of patients with hilar cholangio-
carcinoma at a high volume HPB center. A retrospective 
review was performed of patients who underwent resection 
from 1982–2009. 108 patients were evaluated and divided 
into 2 time periods: Era 1 (1982–1999) and Era 2 (2000–
2009). Demographic, operative, clinical and pathologic data 
was collected. A detailed pathologic review was performed 
on cases where original gross pathologic specimens were 
available for analysis. Disease-free and overall survival was 
examined. Predictors and patterns of recurrence were 
identifi ed.
Results: No differences in patient demographics were 
noted. There were more R0 resections in era 2 (77.3% vs. 
60.3%, p = 0.042). However, overall 5-year survival rates 
were similar (40% vs. 37%, p = 0.402). Patients in Era 2 had 
more advanced disease (Stage IIIb or greater, 51.2% vs. 
15.9%) (p < 0.001). Recurrence with distant metastases was 
more frequent in patients in Era 2 (12/44 patients vs. 5/57 
patients, p = 0.014); however, local recurrence rates were 
statistically similar. Tumor epicenter was examined in 35 
patients. Patients in which tumors derived from 1st order 
branches had a trend towards improved 5-year survival 
as compared to patients whose tumor epicenter was 
identifi ed at the bifurcation or the main duct (78% vs. 18%, 
p = 0.069).
Conclusion: Aggressive surgical resection of more advanced 
hilar cholangiocarcinoma results in higher rates of R0 
resections, excellent local recurrence rates, and good long-
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term survival. Despite this, patients with advanced disease 
still recur with distant disease. Tumor epicenter may repre-
sent a new pathologic prognostic feature that requires further 
study. Better adjuvant treatments need to be developed to 
obtain better long term survival.
FOS058
DELAYED VERSUS EARLY 
LAPAROSCOPIC CHOLECYSTECTOMY 
FOR ACUTE CHOLECYSTITIS: A 
PROSPECTIVE RANDOMIZED STUDY
L. D. Mare, A. Saadi, D. Roulin, N. Demartines and 
N. Halkic
Service de CHIRURGIE Viscérale, CHUV-Lausanne, Vaud, 
Switzerland
Introduction: The optimal timing to operate acute biliary 
cholecystitis remains debated. Immediate surgery is pro-
posed usually within 72 hours, and for longer evolution, 
delayed operation is recommended. However, the results in 
the literature are still confusing. Some randomized con-
trolled-trials found no differences in term of complications 
between early and delayed operation, but the exact onset of 
symptoms was not clearly defi ned. The aim of our present 
study is to compare the clinical outcomes of early versus 
delayed laparoscopic cholecystectomies in patients with 
more than 72 hours of acute cholecystitis symptoms.
Methods: This a monocentric non-blinded prospective ran-
domized study. All patients older than 16 years admitted with 
acute biliary cholecystitis radiologically proven and with 
more than 72 hours symptoms were proposed the study. 
Exclusion criteria were pregnancy, acute pancreatitis, chol-
angitis, generalized peritonitis, perforated gallbladder, 
immunosuppression and severe sepsis. In the early group, 
laparoscopic cholecystectomy with 3 trocarts was performed 
immediately following diagnosis. In the delayed group, a 
standardized conservative treatment with antibiotics was ini-
tiated and an elective cholecystectomy scheduled at least 6 
weeks after the initial diagnosis.
Primary outcome was the overall morbidity following 
initial diagnosis. Secondary outcomes were postoperative 
complications, operative time, and total length of hospital 
stay. According to power calculation with alpha of 0.025 and 
a power of 80%, 466 patients were required to show the 
absence of difference in terms of complications between both 
groups. An intermediary analysis after the 50 fi rst patients 
was planned. Both groups were compared by intention-to-
treat analysis and using 2 or Mann-Whitney U tests where 
appropriate.
Results: In the present intermediate analysis, 54 patients 
were randomized. In the early group, 1 patient out 27 could 
not be immediately operated and was postponed. In the 
delayed group, 2 patients had to be operated following their 
primary admission due to clinical aggravation under antibi-
otic treatment. Both groups were comparable for age, gender, 
BMI, ASA, and duration of symptoms prior to admission. In 
terms of overall morbidity following primary diagnosis, there 
was a signifi cant difference favoring early cholecystectomy 
(p = 0.044). In the early group, 6 patients had complications: 
two acute pulmonary oedema, one surgical site infection, two 
postoperative choledocholithiasis requiring ERCP, and one 
presented with postoperative pain necessitating readmission. 
In the delayed group, there were 13 patients with complica-
tions: two had aggravating sepsis despite antibiotics, one 
parietal hematoma during primary stay, six patients needed 
readmission before elective operation (two symptomatic cho-
lecystolithiasis, one choledocholithiasis, one pancreatitis, and 
two recurring cholecystitis), and four patients developed post-
operative complications (one biliary leak, one surgical site 
infection, one urinary retention, and one umbilical pain). Of 
note, between immediate and delayed operation, we observed 
no signifi cant difference in operative time and postoperative 
complication rate. Regarding total length of stay, a signifi cant 
difference in favor of early (median 4 days, range 2–21) vs. 
delayed (median 7 days, range 3–16) was found.
Conclusion: Our intermediate analysis suggest that laparo-
scopic cholecystectomy even after 72 hours of symptoms is 
safe and may be recommended, as delayed approach seems 
to be associated with an increased complication rate and 
length of stay. This results need to be confi rmed by the fi nal 
analysis.
FOS059
QUALITY OF LIFE IN INOPERABLE 
HEPATOPANCREATOBILIARY 
MALIGNANCIES – A PILOT STUDY TO 
ASSESS THE EFFECTS OF PALLIATIVE 
INTERVENTIONS AGAINST 
CONSERVATIVE END OF LIFE CARE
S. Lahiri1, D. Chatterjee1, D. P. Ghosal1 and S. Ghosh2
1Surgery, R G Kar Medical College, Kolkata, West Bengal, 
India; 2Surgery, Medical College Kolkata, West Bengal, 
India
Introduction: Hepatobiliary and pancreatic cancers are 
very common in India. Most of our patients here present at 
a very advanced stage beyond curative surgery. They have 
very poor quality of life owing to disease related symptoms 
like jaundice, itching, ascites, anorexia etc. Some of these 
patients opt for palliative interventions but several others 
refuse palliation on personal choice or for prohibitive 
expenses. We carried out a pilot study to assess the difference 
in quality of life (QOL) and survival.
Methods: Twenty patients with inoperable hepatopancreati-
cobiliary malignancies admitted at our center between 
January to December 2010 were placed under two groups 
– as those who opted palliative interventions (Group A) and 
those who refused (Group B). The FACT-Hep (Functional 
assessment of cancer therapy-hepatobiliary) questionnaire 
was used to record the QOL indicators in these patients at 
the time of presentation and subsequently at monthly inter-
vals till they last consented. The data was analyzed for 
median survival time and standard multiple regression was 
performed to assess any relation with QOL parameters with 
survival time. Logistic regression was performed to predict 
survival from QOL parameters.
Results: Twenty patients enrolled for the study in one year 
and were distributed as twelve (Group A) and 8 (Group B). 
Median survival in group A was signifi cantly higher than in 
group B (3.6 months vs. 2.6 months P < 0.05) Multiple 
Regression analysis of survival time in both groups as a 
dependant variable of QOL FACT subscale scores revealed 
clinically insignifi cant variance of survival time (Adjusted R 
square min. 5.8%, max 18%, regression coeffi cient beta; 
0.217–0.542, P < 0.05) with QOL parameters. Logistic 
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Regression of predicting survival as dependant variable with 
multiple covariate FACT subscale scores also revealed insig-
nifi cant variance in survival (Cox and Snell R square 6.04%–
12.24%, regression coeffi cient beta 0.324–0.262, P < 0.05).
Conclusion: We conclude that although palliative interven-
tions signifi cantly increases median survival times in patients 
with inoperable hepatopancreaticobiliary cancers, QOL is 
not a signifi cant predictor of survival and there is no signifi -
cant relation between QOL and survival times.
FOS060
CLINIC AND MORPHOLOGIC GROUND 
OF PARENCHYMA PRESERVING 
(NONRESECTIONAL) TECHNIQUES IN 
CHRONIC PANCREATITIS PATIENTS
A. Klymenko, V. Klymenko, A. Steshenko and 
V. Tumanskiy
Zaporozhye State Medical University, Ukraine
Introduction: Resectional nature of Beger and Frey tech-
niques in chronic pancreatitis (CP) surgery is established by 
severe morphologic changes in pancreatic head but the com-
parison with pancreatic body and tail morphology is missing.
Methods: 44 CP patients have undergone parenchyma pre-
serving operation – longitudinal total pancreatowirsungo-
duodenopapillotomy with longitudinal Roux-en-Y 
pancreaticojejunoduodenostomy. Intraoperatively tissue 
samples were taken from pancreatic head, body and tail in 
all the patients. The samples were examined by histologic 
and immunohystochemical methods determining fi brosis 
prevalence, IV type collagen, a-SMA-positive stellate cells 
– excessive collagen producers. Also immune infi ltration was 
examined. 41 (93.2%) patients had alcohol CP. Patients 
workup included: US, CT, ERSP, intraoperative US, 
C-peptide, endogenic insulin, parathormone, CA-19-9, IgG, 
fecal elastase-1.
Results: The morphology revealed absolute homogeneous 
changes in head, body and tail of the pancreas: considerable 
area of periductal fi brosis with immune infi ltration zones, 
formation of thick peculiar connective tissue inclosure. 
There was a big number of activated a-SMA-positive stellate 
cells in the fi brotic zone, substantial expression of IV type 
collagen and intussusception of a-SMA-positive stellate cells 
from periductal fi brosis zone into interlobular pancreatic 
stroma with formation of interlobular fi brotic septa of differ-
ent degree. In the remote period all patients were pain-free. 
CP patients without exocrine (23/44; 52.3%) and endocrine 
(34/44; 77.3%) insuffi ciency did not gain malnutrition and 
pancreatogenic diabetes postoperatively.
Conclusion: Revealed absolutely homogeneous morpho-
logic changes in CP patient’s pancreatic head, body and tail 
are the consequences of the long-lasting untreated pancreatic 
ductal hypertension and prove to be a ground of giving-up 
resectional techniques in CP surgery. CP patients require 
parenchyma preserving type of surgery.
FOS061
DEVELOPMENT OF A SURGICAL 
TEMPLATE SYSTEM FOR APPLICATION 
IN IMAGE GUIDED LIVER SURGERY
D. Wallach1, M. Peterhans1, B. Brun1, V. Banz2, 
D. Candinas2 and S. Weber1
1Artorg Center for Computer Aided Surgery, University of 
Bern, Switzerland; 2Department for Visceral Surgery and 
Medicine, Inselspital, University Hospital and University 
of Bern, Switzerland
Introduction: Surgical instrument guidance systems can 
increase the spatial accuracy during liver tumor resections 
and ablations. A main challenge of their application is the 
transfer of the preoperative planning data (based on CT or 
MRI) to the intraoperative setting, especially owing to liver 
deformation and movement during surgery. We propose a 
patient-specifi c 3D mesh placed around the liver to exactly 
reproduce its shape (known at the time of imaging) enabling 
the tracking of its position during surgery.
Methods: A fi rst biocompatible, sterilisable, polymer-based 
plastic mesh was produced using a rapid-prototyping process 
for a patient scheduled for surgical resection of liver metas-
tases. The liver surface was segmented in the preoperative 
CT and then meshed, resulting in a 3D grid reproducing the 
shape of the liver. The mesh was reduced to the parts relevant 
for maintaining the organ shape and separated into 3 sub 
parts to be mounted around the liver. In addition, retro-
refl ective spheres were added to enable tracking in a surgical 
instrument guidance system (CAScination, Bern, CH). 
During surgery, the mesh could be tracked by the system.
Results: The mesh was successfully placed around the liver 
and mounted during surgery, successfully constraining the 
liver to its preoperative shape and size, even after complete 
mobilisation. The liver was co-registered to its image data 
(MeVis, Bremen, Germany) by identifying corresponding 
landmarks both on the liver and on the mesh. A fi ducial 
registration error of 1.8 mm was obtained, compared to a 
median error of 6.3 mm when the registration was carried 
out using standard anatomical landmark registration. We 
have tested the feasibility of this approach in a fi rst patient.
Conclusion: Navigated surgery in soft tissues is compli-
cated by organ deformation. Here we successfully show that 
constraining templates are relatively simple to design, manu-
facture and apply in a patient-specifi c clinical setting. 
Preliminary tests indicate that the accuracy of patient-to-
image registration and thus instrument guidance is improved. 
Future work will show whether this method meets the 
requirements of standard clinical routine, improving patient 
outcome in the long term.
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FOS062
IMPROVED OUTCOMES OF RADICAL 
SURGERY FOR CENTRAL HYDATID 
CYSTSS OF THE LIVER: IS AN 
AGGRESSIVE APPROACH JUSTIFIED?
A. Recordare1, F. Shala2, N. Loxha2, B. Vrella2, H. Kingji3, 
B. Kastrati3, R. Nikqi4 and I. Ahmetgjekaj5
1IV Division of Surgery, Treviso Hospital, Italy; 2Division 
of Surgery, Peja Hospital, Kosovo; 3Division of Anesthesia 
and Intensive Care, Peja Hospital, Kosovo; 4Department of 
Radiology, Peja Hospital, Kosovo; 5Department of 
Radiology University Clinical Center of Prishtina, Kosovo
Introduction: Radical surgery is considered the treatment 
of choice for liver hydatidosis, but it’s more technically 
demanding. This is why the percentage of radical procedures 
vary in different series, especially for central or complicated 
cysts. Within a training project in HBP surgery at Peja 
Hospital, Kosovo (an endemic area) a prospective study was 
carried out to assess what kind of improvements in radical 
surgery can be obtained applying the surgical techniques 
used in developed countries.
Methods: From Jun 2007 to Sept 2009, 11 consecutive 
patients (pts) (F = 5, M = 6, mean age 30.5 ± 13.08 yrs (range 
8–54) with 18 cysts (mean diameter 7.9 ± 3.07 cm) were 
treated for liver hydatidosis in the Surgical Division of Peja 
Hospital, Kosovo. Five pts had multiple cysts. One pts had 
recurrent hydatidosis. All patients received Mebendazol in 
the perioperative period. Medical therapy was discontinued 
the day after operation if the cysts were not opened (all but 
2 cysts). Pts were classifi ed to have peripherical (n = 1) or 
centrally (n = 10) located cysts when at least one of them 
was in close relationship with the main vascular and biliary 
structures. Preoperative evaluation included a CT scan in all 
pts and in all of them was planned a radical operation.
Results: Eleven pts with 18 cysts not suitable for PAIR 
underwent radical surgery and 17/18 cysts (94%) were 
totally removed (1 right hepatectomy, 2 left lobectomy, 10 
total pericistectomy with closed and 1 with opened cyst). 
One pt with cyst fi stulized in the right posterior bile duct 
underwent a subtotal perycistectomy;. Mean operative time 
was 206 ± 81 min. Intermittent Pringle manouver was used 
in 2 cases; in the other cases selective infl ow control on 
demand was performed. Inferior vena cava was prepared for 
clamping in 2 cases, but never used. Mean postoperative stay 
was 4.9 days (range 3–10). One pt had a low output biliary 
fi stula that healed in 9 days. No recurrences were observed 
during follow-up (mean 24 months, range 2–52 months).
Conclusion: Central cysts need to be considered for radical 
surgery and referred to centers in which this surgery can be 
carried out with acceptable risk. In this setting: 1) Careful 
preoperative planning and meticulous dissections of cysts is 
required to minimize the complication rate. 2) Impeachment 
of the caval and the main hepatic veins was not considered 
an absolute contraindication to radical surgery, and the only 
limit was to avoid unwanted ligation of a main branch of the 
bile ducts or portal vein.
FOS063
THE SURGICAL IMPACT OF THE 
INFERIOR RIGHT HEPATIC VEIN IN 
RIGHT ANTERIOR OR POSTERIOR 
SECTIONECTOMY
J. woong Hwang, J. H. Lee, D. K. Song, K.-M. Park and 
Y.-J. Lee
Division of Hepatobiliary and Pancreatic Surgery, 
Department of Surgery, Asan Medical Center, Seoul, Korea
Introduction: Glissonean pedicle transection method 
(GPTM) in right anterior sectionectomy (RAS) or right pos-
terior sectionectomy (RPS) can enable the precise anatomi-
cal hepatectomy, and in consequence right hepatic vein 
(RHV) has to be exposed. However, the existence of inferior 
right hepatic vein (IRHV) may affect the course of RHV, so 
RHV couldn’t aid anatomical hepatectomy. The aim of this 
study is for the evaluation of the affect of IRHV to the expo-
sure of RHV.
Methods: From January 2009 to October 2011, 147 patients, 
102 men and 45 women, have underwent RAS or RPS. Every 
patient underwent hepatectomy using GPTM and was tried 
to expose RHV as possible for a precise anatomical hepatec-
tomy. We reviewed operative records for the extent of expo-
sure of RHV and the existence of IRHV retrospectively, and 
measured the size of RHV and IRHV by referring preopera-
tive CT scan.
Results: Of the patients, 90 (61.2%) patients underwent 
RAS, 57 (38.8%) patients underwent RPS. The size of RHV 
ranged from 2.2 cm to 15.0 cm with an average of 7.6 cm. 
The size of IRHV ranged from 1.9 cm to 9.5 cm with an 
average of 5.0 cm. The extent of exposure of RHV is graded 
3 stages, the stage of no exposure was 24 (16.3%) (with 
IRHV, 18 cases; without IRHV, 6 cases), the stage of half 
exposure was 33 (22.4%) (with IRHV, 17 cases; without 
IRHV, 16 cases), the stage of full exposure was 90 (61.2%) 
(with IRHV, 25 cases; without IRHV, 25 cases). And there 
was linear correlation between the extent of RHV and the 
existence of IRHV (p < 0.001).
Conclusion: In RAS or RPS, RHV play a role in an accurate 
parenchymal dissection as an anatomical border. The exis-
tence of IRHV affects the course of RHV and in consequence 
affects the extent of exposure of RHV, because IRHV drains 
mainly segment 6. Therefore, when we plan RAS or RPS, 
we must evaluate the existence of IRHV, and then for a 
precise anatomical resection, more careful parenchymal dis-
section following the demarcation of liver after GPTM is 
recommended.
FOS064
RESOURCE UTILIZATION IN HEPATIC 
SURGERY: CAN WE PREDICT (AND 
POSSIBLY REDUCE) THE NEED FOR 
REOPERATION AND HOSPITAL 
READMISSION?
A. Barbas1, R. Turley1, M. Lidsky1, S. Reddy2 and 
B. Clary1
1Duke University Medical Center, Durham, NC; 2University 
of Pittsburgh Medical Center, Pittsburgh, PA
Introduction: Although the mortality rate following partial 
hepatectomy has profoundly improved over time, this proce-
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dure is still associated with signifi cant morbidity and resource 
utilization. The goal of this investigation was to characterize 
the prevalence and pattern of early re-operation (ReOp) and 
re-admission (ReAd) following partial hepatectomy as well 
as to identify risk factors for both.
Methods: Peri-operative outcomes of 1281 patients under-
going hepatic resection at a single academic hospital from 
1996–2009 were analyzed. The indications for early (within 
90 days) ReOp and ReAd were reviewed. Standard multi-
variate logistic regression analyses were performed assessing 
the predictive value of standard perioperative variables on 
the need for ReOp and ReAd.
Results: 91 patients (7.1%) required ReOp. The most fre-
quent procedure was exploration for hemorrhage (26.4%). 
The peri-operative mortality in patients requiring ReOp was 
signifi cantly higher than for those not requiring ReOp (22% 
vs. 3.5%, p < 0.001). Factors predicting ReOp included con-
comitant non-hepatic procedures, greater blood loss, and the 
presence of COPD.
184 patients (14.4%) required ReAd. The most frequent indi-
cation was intra-abdominal fl uid collection (27.2%). 
Combined length of stay for patients requiring ReAd was 
signifi cantly longer than for those not requiring ReAd (21.9 
vs. 9.0 days, p < 0.001). Factors predicting ReAd included 
major hepatectomy, concomitant non-hepatic procedures, 
and development of major complications.
Conclusion: In the current era of hepatic surgery, early reop-
eration and hospital readmission remain relatively frequent. 
As we look to decrease our initial lengths of stay in patients 
who are increasingly receiving regionalized care far from 
home, we must be mindful of the need for frequent rehospi-
talizations. In an effort to better serve our patients, and because 
these events represent important determinants of overall 
resource utilization, strategies to minimize them are critical.
FOS065
FIBROCAPS™, A NOVEL FIBRIN 
SEALANT, FOR BLEEDING DURING 
HEPATIC RESECTION: RESULTS OF 
A PHASE 2, RANDOMIZED, 
CONTROLLED STUDY
R. J. Porte1, C. Verhoef2, J. H. W. de Wilt3, A. M. Rijken4, 
J. M. Klaase5, N. Ayez2, M. van Rij6 and P. A. Frohna7
1University Medical Center Groningen, Oosterparkwijk, 
The Netherlands; 2Daniel den Hoed Cancer Center, 
Erasmus Medical Center, Rotterdam, The Netherlands; 
3Radboud University Nijmegen Medical Center, Nijmegen, 
The Netherlands; 4Amphia Hospital, Breda, The 
Netherlands; 5Medisch Spectrum Twente, Enschede, The 
Netherlands; 6ProFibrix BV, Leiden, The Netherlands; 
7ProFibrix, Inc., Leiden, The Netherlands
Introduction: Fibrin sealants mimic the fi nal stage of the 
clotting cascade and are used when control of bleeding by 
surgical technique is diffi cult. Diffuse bleeding of the hepatic 
resection surface can be a problem due to the vascularity of 
the liver, for which fi brin sealants have been used. Fibrocaps™ 
(ProFibrix, Leiden, The Netherlands) is a ready-to-use, pre-
mixed powder blend of human plasma-derived fi brinogen 
and thrombin. We conducted a study of the effi cacy and 
safety of Fibrocaps in liver surgery.
Methods: Study FC-002 NL was a Phase 2, randomized, 
single-blind, controlled, comparative effi cacy and safety 
study of Fibrocaps in subjects with diffuse bleeding during 
hepatic resection at 5 centers in The Netherlands. 56 subjects 
were randomized (2 : 1) during surgery to Fibrocaps (n = 39) 
or gelatin sponge (n = 17). Treatment was followed by a 
10-min observation period where hemostasis was evaluated 
every minute, with failure defi ned as lack of hemostasis by 
10 min. The primary effi cacy endpoint was the mean time to 
hemostasis (TTH), and the secondary was the incidence of 
hemostasis at 10, 5 and 3 min. Overall safety was determined 
by treatment-emergent adverse events, clinical labs and anti-
thrombin antibodies monitored for 4 weeks after treatment.
Results: Subject demographics were similar across both 
treatment groups (64% male, mean age of 61 yrs). The mean 
± SD dose of Fibrocaps was 1.4 ± 0.5 g used for a mean ± 
SD bleeding surface area of 58 ± 29 cm2. There was a statisti-
cally signifi cant reduction on the intent-to-treat analysis of 
the mean TTH of Fibrocaps 2.2 ± 1.2 min vs. gelatin sponge 
4.4 ± 3.1 (p = 0.004). There were no treatment failures in the 
Fibrocaps arm and 3 in the control arm (p = 0.025). The 
incidence of hemostasis at 5 min was also statistically sig-
nifi cant for Fibrocaps (p = 0.022). The safety was compa-
rable across both treatments, with most AEs gastrointestinal, 
and classifi ed mild or moderate and unrelated to treatment. 
No neutralizing anti-thrombin antibodies were detected.
Conclusion: These effi cacy results with Fibrocaps in liver 
surgery demonstrate a signifi cant reduction in mean bleeding 
time across patients and in the incidence of treatment failure. 
The safety profi le of Fibrocaps in this study was very good 
and consistent with events expected in subjects with multiple 
diseases undergoing major hepatic resection under general 
anesthesia. The observed benefi t: risk profi le strongly sup-
ports the conduct of a Phase 3 study in surgical hemostasis.
FOS066
TOWARDS HIGHER PRECISION IN 
INSTRUMENT GUIDED LIVER 
SURGERY: AUTOMATIC ALIGNMENT 
OF 3D ULTRASOUND WITH 
PRE-OPERATIVE MEVIS-CT
D. Ribes1, M. Peterhans1, S. Anderegg2, V. Banz3, 
D. Candinas3 and S. Weber1
1ARTORG Center for Computer Aided Surgery, Univversity 
of Bern, Bern, Switzerland; 2CAScination AG, Switzerland; 
3Department of Visceral Surgery and Medicine, Clinic for 
Visceral and Transplantation Surgery, Inselspital, Bern 
University Hospital and University of Bern, Switzerland
Introduction: Progress in computer sciences enables the 
use of instrument guidance systems for open liver surgery by 
providing improved orientation and guidance support during 
planning and intraoperative realization. Precise alignment 
between preoperative image data and the intraoperative situ-
ation remains challenging as the liver deforms during the 
surgery. We present a framework to allow for such alignment 
using intraoperative ultrasound imaging (US) and preopera-
tive computed tomography (MeVis-CT) data.
Methods: A total of 14 corresponding CT and US datasets 
(both in 3D) were collected during open liver surgery of 9 
patients (58 ± 28 yrs, 3 males, 6 females) using the CAS-One 
liver navigation system (CAScination AG, Switzerland). The 
following protocol was performed: 1) Pre-alignment of the 
MeVis-CT model with the real patient using manually 
selected landmarks. 2) Acquisition of 3D volumes of B-mode 
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navigated US images on a desired site of interest (SOI) (e.g. 
around tumours). 3) Segmentation of available vessel in the 
US images. 4) Generation of 3D US vessel model. 5) 
Implementation of an algorithm aligning the 3D vessel 
models of the US with that of the pre-operative MeVis-CT 
data. 6) Measurement of success of the alignment process.
Results: Manual pre-alignment was achieved with a mean 
accuracy of 11 mm. Large vessels (e.g. cross of the portal 
vein) were visually identifi able on the 3D US generated 
model. In 8/14 (57%) datasets, alignment between the CT 
and US was improved according to visual inspection. 
Alignment did not improve in 34% of the cases, attributed 
to insuffi cient amount of vessel information in the acquired 
SOI (e.g. large tumours) (28%), non-convergence of align-
ment algorithm due to poor US image quality (7%), and an 
unclear technical failure of the algorithm (7%). US acquisi-
tion, vessel segmentation and automatic alignment required 
49 seconds of time on average. A more quantitative 
assessment for alignment accuracy is currently under 
development.
Conclusion: We present fi rst results on the evaluation of an 
automatic US based registration approach. This will allow 
for precise alignment of the intraoperative situation with the 
pre-operative image data. First qualitative results indicate 
that its precision is better than those in existing (manual) 
alignment approaches. Involved clinicians confi rmed the 
general usability of the presented framework in clinical 
routine. More data sets are currently collected to assess the 
precision of the approach.
FOS067
INTRODUCTION OF AN ENHANCED 
RECOVERY PROTOCOL CAN REDUCE 
LENGTH OF STAY FOLLOWING 
LIVER RESECTION
L. Pearce, S. Jamdar, A. Kausar, A. Krige, J. Clarke, 
E. Atkinson and D. Chang
Royal Blackburn Hospital, Haslingden Road, Blackburn, 
Lancashire, UK
Introduction: The principles of enhanced recovery after 
surgery are well established in colorectal surgery. Recent 
data points towards similar benefi ts following liver resection. 
This study aims to assess the impact of the introduction of a 
multi-modal fast-track package of care (Enhanced Recovery 
Protocol, ERP) aimed at improving outcomes and reducing 
length of hospital stay.
Methods: Patients undergoing elective liver resection fol-
lowing introduction of ERP in 2011 constitute the interven-
tion group (N = 42). The control group underwent surgery 
and standard care in 2009 and 2010 (N = 43). The ERP 
included preoperative counselling, avoidance of preoperative 
fasting, carbohydrate loading, epidural anaesthesia, early 
postoperative feeding and early mobilisation. The primary 
outcome measure was length of postoperative stay. Secondary 
outcome measures were complication rates, transfusion 
requirement, 30 day readmission rate and mortality. Data are 
presented as median (range). Analyses were undertaken by 
non-parametric Mann-Whitney U-test accepting signifi cance 
at P < 0.05 level.
Results: In the control group the median length of stay was 
9 (4–19) days. There was a reduction in length of stay in the 
enhanced recovery group at 7 (3–44) days (P = 0.01). There 
were no signifi cant differences in the rate of complications, 
30-day readmission rate or transfusion requirement between 
the two groups. The overall mortality rate was 1.2% with no 
difference between the groups.
Conclusion: The introduction of a multi-modal enhanced 
recovery protocol can improve length of stay following liver 
resection without adverse impact on the overall quality of 
care.
FOS068
FUTURE REMNANT LIVER VOLUME 
AND FUNCTION, THE INFLUENCE OF 
PORTAL VEIN EMBOLIZATION
M. Malinowski1, J. F. Lock1, S. Lehmann1, B. Gebauer2, 
A. Schulz1, P. Neuhaus1 and M. Stockmann1
1Department of General, Visceral, and Transplantation 
Surgery Campus Virchow Klinikum, Charité 
Universitätsmedizin Berlin, Germany; 2Department of 
Radiology Campus Virchow Klinikum, Charité 
Universitätsmedizin Berlin, Germany
Introduction: The only curative therapy by patients with 
Klatskin Tumor is a surgical resection. Extended resection 
of right liver lobe en block with extra hepatic bile duct is the 
standard operating procedure. The postoperative liver insuf-
fi ciency according to the low future remnant liver (FRL) 
worsens the outcome. Selective portal vein embolisation 
(PVE) prior to resection improves the FRL volume. Still 
the infl uence of PVE on the function of the FRL is not 
known.
Methods: Patients undergoing (PVE) and not (non-PVE) 
before extended resection of the right liver lobe were included 
into the study on the prospective manner. Liver function was 
measured using the new LiMAx-test ([µg/kg/min]) and bio-
chemical liver function tests. Volume of the left lateral liver 
lobe (FRL) was measured using Amira Software (contrast 
enhanced CT-scans). Dindo classifi cation was used for 
assessment of the postoperative complications.
Results: 14 and 23 patients were included into PVE and 
non-PVE groups respectively. The FRL volume increased 
from 320 to 445 ml (18 to 25%, p < 0.001) in PVE group. 
FRL volume in non-PVE group was 602 ml (32%, p < 0.05 
vs. PVE). Function of FRL improved from 65 to 103 (18 to 
24% respectively, p = 0.001). FRL function in non-PVE 
group was 121 (32%, p < 0.05 vs. PVE). The postoperative 
liver function course was better in non-PVE group till POD 
10 (p = 0.03), then improved up to 3rd postoperative month. 
30 days mortality was similar: 9 and 14% (PVE vs. non-PVE, 
n.s.), still the PVE group developed more severe complica-
tions (Dindo > II, 68 vs. 43%, n.s.). The increase of FRL 
volume but not FRL function was correlated with time 
(Pearson = 0.757, p < 0.001).
Conclusion: PVE improves as well the FRL volume as FRL 
function. By calculating the FRL function instead of volume 
more precise estimation of postoperative liver function and 
risk of complications is possible. Since FRL function 
improves faster than volume, the shorter time between PVE 
and resection resulting with lower risk of the tumor growth 
will be possible.
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FOS069
RESULTS OF AN INTERNATIONAL 
SURVEY ON LAPAROSCOPIC LIVER 
SURGERY IN THE HPB COMMUNITY
R. Coelen1, T. Lodewick1, J. Stoot2, R. van Dam1 and 
C. Dejong1
1Department of Surgery, Maastricht University Medical 
Centre, Maastricht, The Netherlands; 2Department of 
Surgery, Orbis Medical Centre, Sittard, The Netherlands
Introduction: Liver resection remains one of the few pro-
cedures where the extended use of laparoscopic techniques 
has not found its way to everyday practice yet. Although 
laparoscopic liver resections are gaining popularity world-
wide, the experience in several countries is still limited. The 
objective of this survey was to investigate the differences 
within the worldwide HPB community in the use of a lapa-
roscopic approach for liver resections.
Methods: An international web-based electronic survey 
consisting of 32 questions concerning various aspects of 
laparoscopic liver surgery was sent out to 502 HPB surgeons 
worldwide in February 2011. Two reminders were sent in 
April and May 2011 to non-responders and individuals, who 
had partially completed the survey. Statistical analysis was 
performed in December 2011 using SurveyMonkey and 
SPSS.
Results: A total of 164 surgeons from 38 different countries 
responded (response rate 32.7%) of which 134 (81%) fi n-
ished the survey completely. According to responding sur-
geons, of which 70% were trained in laparoscopic liver 
surgery, the two most important aspects for a laparoscopic 
approach are safety and time to recovery. However, the 
choice for laparoscopy is also infl uenced by surgeon and 
patient preference. Half of participants believe laparoscopy 
has no advantages over open surgery with regard to safety 
and costs. Only 10% of surgeons indicated the availability 
of guidelines for laparoscopic liver surgery in their country. 
Twenty-four percent of participants believe cultural differ-
ences exist between countries in the choice for 
laparoscopy.
Conclusion: Opinions considering safety and cost-effec-
tiveness of laparoscopic liver surgery vary widely between 
liver surgeons. Uncertainties and lack of guidelines make 
certain individuals rely on good evidence before adapting 
new techniques, while other implement new techniques with 
meagre scientifi c support. Therefore, results of randomized 
studies comparing laparoscopic and conventional liver 
surgery are urgently needed.
FOS070
TRANSFUSION OF IRRADIATED 
AUTOLOGOUS BLOOD FOR 
HEPATOBILIARY AND PANCREATIC 
CANCER RESECTIONS
C. Barnett, J. Hankinson, M. Marcaccio, J. Ramsay, 
K. Webert, S. Orr and L. Ruo
McMaster University, Hamilton, ON, Canada
Introduction: Hepatobiliary/pancreas (HBP) cancer resec-
tions can result in signifi cant blood loss and often require 
perioperative blood transfusion. We evaluated the feasibility 
of intraoperative blood salvage and irradiation as one com-
ponent of a blood conservation program. Autologous blood 
transfusion (ABT) eliminates the risk of blood-borne viral 
infections, prevents alloimmunization, conserves blood bank 
resources, and avoids both short and long term consequences 
of homologous blood transfusion (HBT).
Methods: Patients at increased risk for blood transfusion 
(elderly patients with preoperative anemia, hypoalbumin-
emia, and higher ASA classifi cation) scheduled for major 
HBP cancer resections at a single institution between Nov 
2007 and Feb 2011 were targeted for enrolment. Shed blood 
was collected intraoperatively with a cell saver. Processed, 
salvaged blood was then irradiated and washed. Patients 
requiring perioperative blood transfusion preferentially 
received ABT, but also received HBT if indicated. 
Clinicopathologic data, blood processing parameters, and 
transfusion requirements were documented. An aliquot of 
salvaged, irradiated blood was submitted for cytopathology 
with immunohistochemistry to confi rm eradication of malig-
nant cells.
Results: Of 32 patients enrolled in the study, 18 were trans-
fused (10 HBT ± ABT, 8 ABT only). HBT frequency was 
reduced by 45%. Implementation of the study protocol 
yielded 29 units of processed RBC from 20 patients. Mean 
RBC volume was 234 mL and mean processing time 
was 29 minutes. Cytopathology with immunohistochemistry 
revealed no malignant cells in the irradiated salvaged blood. 
Overall postoperative infection rate was 19% (7% for those 
receiving no transfusion, 25% for ABT only, and 30% for 
any HBT). After a median follow up interval of 18.5 months, 
23/32 (72%) patients were alive (13 NED, 10 AWD). Of the 
9 deceased patients, 7 demonstrated disease progression. 
There were no signifi cant differences in clinical outcome 
between patient groups.
Conclusion: Transfusion of irradiated autologous blood for 
major HPB cancer resections appears feasible and reduces 
the need for HBT. In patients at increased risk for transfu-
sion, comprehensive blood conservation strategies, including 
modalities such as ABT, may be of benefi t and should be 
rigorously studied.
FOS071
INTRA AND PERIOPERATIVE CLINICAL 
OUTCOME FOLLOWING REPEAT 
HEPATECTOMY
E. De Raffele, S. Vaccari, M. Mirarchi, S. Palumbo, 
R. Bellusci, A. Cavallari and B. Cola
Dipartimento di Emergenza/Urgenza, Chirurgia Generale e 
dei Trapianti, Policlinico S.Orsola-Malpighi, Università 
degli Studi di Bologna, Bologna, Italy
Introduction: Recurrence after hepatectomy for liver 
tumours is frequent and may be confi ned to the liver. Repeat 
hepatectomy is indicated in selected cases. The aim of this 
study was to clarify the perioperative outcome of repeat 
hepatectomy.
Methods: From January 2000 to December 2011, 515 liver 
resections have been performed with curative intent by at 
least one of the authors and were included in a prospective 
database. 170 hepatectomies were done for primary tumours, 
229 for metastases and 116 for other tumours. The intra and 
postoperative parameters of 400 fi rst hepatectomies (GrFH) 
were compared with those of 107 repeat hepatectomies 
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(GrRH), including 78 second, 25 third and 4 fourth hepatec-
tomies. Values were expressed as mean ± SD. The Chi-
square and the Students t tests were used for statistics; 
signifi cance was defi ned as p < 0.05.
Results: GrFH included 244 males and 156 females aged 
61.69 ± 12.40 (range 18–88) yrs; GrRH included 70 males 
and 37 females aged 64.10 ± 9.39 (range 37–85) yrs (p = 
NS). Intraoperative blood transfusions were 205.48 ± 416.53 
(range 0–3300) ml and 196.70 ± 368.41 (range 0–2100) ml 
in GrFH and GrRH, respectively (p = NS). Duration of surgi-
cal procedure was 290 ± 120 (range 70–765) min and 323 ± 
124 (range 60–785) min in GrFH and GrRH, respectively (p 
= 0.0124). Postoperative complications were 16.00% and 
14.95% in the two groups, respectively (p = NS). There were 
two postoperative deaths. Postoperative hospital-stay was 
11.07 ± 7.28 (range 3–72) days and 9.90 ± 4.16 (range 4–33) 
days in GrFH and GrRH, respectively (p = NS).
Conclusion: Repeat hepatectomy had similar perioperative 
results than fi rst hepatectomy in our experience, but should 
be reserved to experienced liver surgeons because is usually 
more challenging. Surgery should remain the treatment of 
choice for selected patients with recurrent liver cancer.
FOS072
DOES OBESITY AND LIVER STEATOSIS 
IMPAIR LIVER REGENERATION AFTER 
PORTAL VEIN EMBOLISATION?
A. F. Bouras1, G. Petrovai1, E. Boleslawski1, G. Liddo1, 
S. Truant1, G. Sergent2 and F.-R. Pruvot1
1Chirurgie Digestive et Transplantations, Hopital Claude 
Huriez, Lille, France; 2Radiologie Diagnostique et 
Interventionnelle, Hopital Claude Huriez, Lille, France
Introduction: The number of overweight patients undergo-
ing liver resection is dramatically increasing. Although the 
indications for preoperative portal vein embolization (PVE) 
are currently the same in these patients as in normal weighted 
patients, it is not known whether the expected liver hyper-
trophy (LH) following PVE could be impaired by obesity or 
steatosis.
Methods: From 2001 to 2010, 66 patients underwent PVE 
prior to liver resection. After exclusion of incomplete PVE, 
previous hepatectomy, metastasis in the future remnant liver 
(FRL) and embolization of segment IV, the study population 
included 42 patients and was divided into 3 groups according 
to patients’ body mass index (BMI): 18 patients without 
overweight (BMI ≤ 25, group N); 9 patients with overweight 
(25 < BMI < 30, group S); and 15 obese patients (BMI ≥ 30, 
group O). The three groups were comparable in terms of time 
from PVE to volume assessment (p = 0.42) and number of 
patients receiving chemotherapy prior to PVE (p = 0.61). LH 
was expressed as the increase in FRL volume ratio to total 
liver volume before and after PVE.
Results: The median LH was 4.9% [-1.4–18.1%] for 
group N (median FRL before/ after PVE = 17.1/21.3%), 
5.9% [1.5–12.6%] for group S (median FRL before/ after 
PVE = 18.2/28, 6%) and 5.8% [-5.2–18%] for group O 
(median FRL median before/after PVE = 18.8/25.5%), with 
no signifi cant differences between groups N and S (p = 0.1) 
and groups N and O (p = 0.58). Six patients had hepatic 
steatosis greater than or equal to 30%. Comparison of this 
group with 36 patients without steatosis (<30%) showed no 
difference in terms of LH (4.7% vs. 6.1% respectively, 
p = 0.57).
Conclusion: Obesity and steatosis do not seem to impair 
liver regeneration after PVE. These results, however, require 
confi rmation on a larger population.
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FOS073
LIVER RESECTION WITH 
PREOPERATIVE CHEMOTHERAPY FOR 
ADVANCED OR AGGRESSIVE 
COLORECTAL CANCER METASTASES
K. Tanaka, K. Nojiri, T. Kumamoto, K. Taniguchi, 
K. Takeda, M. Sugita and I. Endo
Department of Gastroenterological Surgery, Yokohama City 
University Graduate School of Medicine, Yokohama, Japan
Introduction: Surgery in isolation may be approaching 
technical limits for metastatic colorectal cancer patients, but 
now is likely to help more patients because of success of 
preoperative chemotherapy (CTx) and advances in proce-
dural technique. Here we review our treatment results of liver 
resection (Hx) for advanced or aggressive colorectal liver 
metastases using effective prehepatectomy CTx.
Methods: Data from 411 patients who underwent Hx 
were retrospectively analyzed. Metastases were resectable at 
initial diagnosis in 237 patients. Among the other 174 
patients with unresectable (n = 53) or marginally resectable 
metastases (n = 121), 110 received prehepatectomy CTx 
(unresectable in 53, marginally resectable in 57). Forty-four 
of the 110 patients received their fi nal prehepatectomy che-
motherapy via the hepatic artery, 26 via the systemic infu-
sion, and the other 40 both via the hepatic arterial infusion 
and the systemic infusion. Hx with portal vein embolization 
was performed in 65 patients and 2-stage Hx was performed 
in 38 patients.
Results: As for liver resection margin status, superior 
impact of R0 resection compared to R1 on survival was not 
confi rmed in patients with unresectable or marginally resect-
able metastases, especially those with a favorable response 
to prehepatectomy CTx.
As for complete disappearing metastases during CTx, per-
sistent microscopic residual disease or recurrence in situ 
were observed only in 35%.
Growth factors generally up-regulated early after liver 
resection for liver regeneration considered to be implicated 
in tumor growth and recurrence, however, in patients treated 
with 2-stage Hx with chemotherapy, mRNA expression of 
cyclin and growth factors in metastatic tumors that were 
resected at the fi rst and second Hx were not signifi cantly 
different.
Conclusion: Combining R1 resection and leaving in place 
of disappearing metastases may be a reasonable treatment 
strategy for patients responsive to preoperative chemother-
apy. Two-stage hepatectomy did not induce tumor growth in 
combination with effective preoperative chemotherapy. 
Therefore, more relaxed consideration of the margin and 
disappearing metastases, and applying special technique 
such as a 2-stage strategy may permit extension of surgical 
indications for treating colorectal metastases.
FOS074
IN-SITU-SPLIT PROCEDURE – A 
PROMISING APPROACH TO 
EXPAND RESECTABILITY IN 
LIVER METASTASIS
G. A. Stavrou1, M. Donati1, K. J. Niehaus1, T. Maghsoudi1, 
H.-O. Peitgen2 and K. J. Oldhafer1
1Department of General and Visceral Surgery, Asklepios 
Hospital Barmbek, Hamburg, Germany; 2Fraunhover 
MeVis Insitute for Medical Imaging, University of Bremen, 
Bremen, Germany
Introduction: As only one third of liver metastasis are 
resectable on fi rst presentation, the hypertrophy concept 
using portal vein occlusion has been advocated to achieve 
resectability in cases of a small liver remnant. A new 
approach takes the concept of staged procedures further – the 
in-situ-split procedure is promising in inducing hypertrophy 
in the future remnant liver (FRL) much faster and more 
effective.
Methods: Between March and December 2011 fi ve patients 
with irresectable liver metastasis (4 CRLM and 1 GIST) 
requiring extended resections with a preoperative FRL 
of 19.2% (range 15.5–24.6%) on 3D volumetry (MeVis 
Hepavision) were submitted to a two stage procedure: at fi rst 
portal vein occlusion was combined with an in-situ-split pro-
cedure. Pre- and postoperative 3D volumetry with Fraunhofer 
MeVis HepaVision software allows to safely analyze the 
hypertrophy and go forward with the second stage 
operation.
Results: The mean time to gain a reasonable safe FRL was 
24.2 days (range 10–43 days). The mean volume gain in the 
FRL was 97% (range 54–200%) and patients were safely 
resected without mortality/morbidity.
Conclusion: Our preliminary data show that the proposed 
strategy, though challenging, is safe and very effective in 
expanding resectability. We saw a much more effective and 
quicker gain in volume of the FRL – from our experience it 
is also likely that not only liver volume but also liver function 
in the FRL is enhanced.
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FOS075
USE OF BIORESORBABLE MEMBRANES 
TO REDUCE ABDOMINAL AND PERI-
HEPATIC ADHESIONS IN TWO-STAGE 
HEPATECTOMY (TSH) FOR 
METASTASES FROM COLORECTAL 
CANCER (MCRC): RESULTS OF A 
RANDOMIZED PHASE II TRIAL
M. Rivoire1, A. Dupre1, A. Gandini1, E. Buc2, 
J. R. Delpero3, G. Passot4, S. Evrard5 and S. Chabaud6
1Department of Surgery, Leon Berard Cancer Center, Lyon, 
France, Clermont-Ferrand, France; 2Department of 
Surgery, D’Estaing University Hospital; 3Department of 
Surgery, Paoli Calmette Institute, Marseille, France; 
4Department of Surgery, South Lyon University Hospital, 
Lyon, France; 5Department of Surgery, Bergonie Institute, 
Bordeaux, France; 6Department of Biostatistics, Leon 
Berard Cancer Center, Lyon, France
Introduction: TSH offers the possibility of long-term sur-
vival to selected patients whose liver metastases cannot be 
removed in a single procedure. However, the 2nd operation 
is made more diffi cult by adhesions arising from the 1st. Use 
of a bioresorbable membranes (Seprafi lm®) has been shown 
to reduce adhesions in abdominal surgery but there is no trial 
assessing its use in hepatectomy. We aimed to assess feasibil-
ity and effi cacy of Seprafi lm® to prevent perihepatic adhe-
sions in mCRC patients requiring TSH.
Methods: In this phase II trial patients candidates to TSH 
were enrolled from 8 university hospitals in France and ran-
domly assigned (3 : 1 ratio) after the 1st hepatectomy to 
implantation of 4 sheets of Seprafi lm® or standard manage-
ment. The randomization sequence was computer generated 
and stratifi ed by centre; treatment allocation was concealed 
by use of a web-based application. Investigators and patients 
were unmasked to treatment assignment. The primary end-
point was the time to achieve complete liver mobilization at 
the beginning of the 2nd hepatectomy. Secondary endpoints 
were extent and severity of adhesions and complications 
(CNS) rate after 1st and 2nd hepatectomies. Analysis was by 
intention to treat. This study is registered NCT01262417.
Results: 54 patients were assigned to Seprafi lm® (n = 41) 
or standard management (n = 13). Positioning of the mem-
branes was feasible in all but one patient and did not increase 
the rate of specifi c CNS after 1st hepatectomy. 30 patients 
from the membrane arm and 11 controls (well matched on 
important variables) underwent the 2nd hepatectomy. 
Patients in the membrane arm required 33% less time than 
controls to achieve complete liver mobilization (50 vs 75 
minutes). The proportion of patients with extensive adhe-
sions was reduced in the membrane arm (31% vs 55% con-
trols), as was the rate of severe adhesions (17% vs 46% 
controls). The proportion of patients with one or more CNS 
at 2nd hepatectomy was higher in the control arm (55% vs 
23% Seprafi lm®).
Conclusion: In this phase II, randomized, controlled, mul-
ticenter study, use of Seprafi lm® at the end of 1st hepatec-
tomy reduced the extent and severity of adhesions and 
facilitated the second hepatectomy in patients with liver 
metastases who required a TSH. These results justify the 
organization of a phase III randomized trial assessing the use 
of Seprafi lm in patients having liver surgery with a high 
probability of repeat hepatectomy.
FOS076
SYNCHRONOUS SURGERY FOR 
COLORECTAL CANCER AND LIVER 
METASTASES: LAPAROSCOPIC 
COLORECTAL RESECTION IMPROVES 
SHORT TERM OUTCOME. A 
COMPARATIVE STUDY
F. Ratti1, L. Aldrighetti1, S. D. Palo2, l. Ghirardelli2, 
C. Staudacher2 and G. Ferla1
1Hepatobiliary Surgery Unit, General Surgery Department, 
IRCCS H San Raffaele, Vita-Salute San Raffaele 
University, Via Olgettina 60, Milan, Italy; 2Colorectal 
Surgery Unit, General Surgery Department, IRCCS H San 
Raffaele, Vita-Salute San Raffaele University, Via Olgettina 
60, Milan, Italy
Introduction: 30% of patients with colorectal cancer pres-
ents with liver metastases at diagnosis. Long-term survival 
is infl uenced by obtaining a complete removal (R0) of the 
primary tumor and liver metastases. Aim of this study was 
to assess the short-term outcome of combined resection of 
left colon or rectum cancer and liver metastases, comparing 
the results of the primary tumor resection performed laparo-
scopically or by laparotomy.
Methods: From January 2004 to December 2011, 93 
patients underwent combined resection of colorectal cancer 
and synchronous liver metastases. 57 patients underwent 
laparoscopic colorectal resection (LPS Group), and were 
compared with 29 patients undergoing colorectal resection 
by laparotomy (LPT Group). Right colonic resections were 
excluded from the analysis. A further analysis was per-
formed, including only the colonic resection.
Results: The two groups resulted comparable in terms of 
patients and disease characteristics, extent of liver resection, 
lymphadenectomy and length of surgery. Patients in the LPS 
Group had a signifi catively lower blood loss (400 mL vs 
650 mL, p < 0.001) and rate of intraoperative transfusions 
(19.3% vs 47.2%, p = 0.04) compared to the LPT Group. 
LPS Group was associated with a lower postoperative mor-
bidity (24.6% vs 44.4%, p = 0.039), and a shorter postopera-
tive median hospital stay (9 vs 13 days, p < 0.001). Blood 
loss, morbidity and length of postoperative stay were not 
correlated to liver resection extent. The analysis of the sub-
group of patients undergoing colon resection confi rmed the 
same results.
Conclusion: Laparoscopic resection of colorectal cancer in 
patients undergoing simultaneous resection of liver metasta-
ses by laparotomy is associated with a reduction of blood 
loss, morbidity and postoperative hospital stay, without 
affecting the oncologic radicality.
In simultaneous resections of colorectal cancer and liver 
metastases, postoperative morbidity and hospital stay are 
mainly conditioned by the type of approach to intestinal 
surgery (laparoscopic or open), rather than the extent of liver 
resection.
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FOS077
SYNCHRONOUS COLORECTAL LIVER 
METASTASES DON’T INFLUENCE 
LONG TERM SURVIVAL 
AFTER HEPATECTOMY
M. Martenot, Q. Denost, S. Bekkar, A. David, J. Saric and 
C. Laurent
Department of Digestive Surgery, Saint-Andre Hospital, 
Victor Segalen University of Bordeaux, Bordeaux, France
Introduction: At the time of colorectal cancer diagnosis, 
15 to 20% patients have synchronous liver metastases. 
Synchronous metastases may confer a poorer prognosis than 
metachronous metastases but this is uncertain. The aim of 
this study is to compare survival of synchronous and meta-
chronous colorectal liver metastases following curative 
hepatectomy.
Methods: From 1995 to 2009, patients with colorectal liver 
metastases treated by hepatectomy with curative intent were 
collected and retrospectively analysed. Patients with extra 
hepatic metastases were excluded. A case-control study was 
conducted of patients who had synchronous or metachronous 
colorectal liver metastases. The following criteria were 
matched: sex, age, site and stage of colorectal tumor, number, 
size, and distribution of metastases, operative procedure and 
type of hepatectomy. Complete resection (R0) was defi ned 
by a surgical margin greater than 0 millimeter. Synchronous 
lesions were defi ned as metastases discover with the primary 
lesion or in the six months. Overall survival (OS) and dis-
ease-free survival (DFS) rates were compared.
Results: After matching, 258 patients were included in this 
study, 112 with metachronous liver metastases and 146 with 
synchronous liver metastases with a median follow-up of 36 
months. There was no difference for mortality (2.7 vs 2.8%) 
and for morbidity (8 vs 11%). Complete resections were 
similar in the two groups (96.4 vs 96.6%). Recurrence was 
earlier for synchronous group compared with metachronous 
group (10.9 vs 13.2 months, p = 0.037). Five-year OS was 
60% in metachronous group, compared with 46% in syn-
chronous group (p = 0.116). Five-year DFS was 23% in 
metachronous group, compared with 21% in synchronous 
group (p = 0.135).
Conclusion: After matching according to tumor character-
istics of liver metastases and even if the recurrence is earlier 
in the synchronous group, survivals are comparable between 
the two groups. Patients with synchronous colorectal liver 
metastases must have a curative and optimal treatment.
FOS078
PROGNOSTIC IMPACT OF POSITIVE 
SURGICAL RESECTION MARGINS 
AFTER RESECTION OF COLORECTAL 
CANCER LIVER METASTASES IN THE 
ERA OF MODERN CHEMOTHERAPY 
PROTOCOLS
H. Tranchart1, M. Chirica1, M. Faron1, M. Svrcek2, 
N. Mourra2, P. Balladur1 and F. Paye1
1Department of Digestive Surgery, Saint Antoine Hospital, 
Paris; 2Department of Pathology, Saint Antoine Hospital, 
Paris
Introduction: The prognostic role of a positive resection 
margin (R1) of colorectal cancer liver metastases (CRLM) 
has been recently challenged. This monocentric study aims 
to assess the prognostic impact of a positive surgical margin 
after liver resection (LR) of CRLM in a population of patients 
treated by effective chemotherapy.
Methods: From January 2000 to December 2009, 215 
patients (177 males: 62%, mean age 61 ± 11 years) under-
went LR with curative intent for CRLM. Patients with resid-
ual macroscopic disease (R2 resection) and patients who had 
extrahepatic disease at diagnosis of CRLM were excluded. 
LR was considered as R1 (margin <1 mm) in 49 patients 
(33%) and R0 in 166 patients (77%). Overall, 108 (50%) 
patients received preoperative and 156 (72%) patients 
received postoperative FOLFOX or FOLFIRI chemotherapy. 
Patients in the R1 group had more often bilobar and larger 
LM (p < 0.001). There was no difference between the R0 and 
R1 groups regarding use of pre- (p = 0.3) and postoperative 
(p = 0.4) chemotherapy.
Results: Overall (47% vs. 40%, p = 0.05) and disease free 
(36% vs. 23%, p = 0.006) 5-year survival rates were signifi -
cantly lower in the R1 group. Recurrence occurred in 152 
patients (71%) and was signifi cantly higher (84% vs. 67%, 
p = 0.02) in the R1 group. On multivariate analysis, the N+ 
stage of the primary colorectal tumor (p = 0.008), the pres-
ence on the pathologic specimen of at least one CRLM unde-
tected prior to LR (p = 0.04), and a R1 resection margin (p 
= 0.03) were negative predictors whereas use of postopera-
tive chemotherapy (p = 0.03) was a favorable predictor factor 
of overall survival. Use of postoperative chemotherapy (p = 
0.03) was the only independent predictive factor of disease-
free survival.
Conclusion: In the era of modern chemotherapy a positive 
surgical resection margin, remains a signifi cant poor prog-
nostic factor of survival after LR of CRLM. Postoperative 
chemotherapy reduces recurrence rates after R1 resection of 
CRLM.
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FOS079
PATTERN OF RECURRENCE 
FOLLOWING NON-ANATOMICAL 
RESECTION FOR COLORECTAL 
LIVER METASTASIS
A. Hakeem, G. Marangoni, A. Nair, R. Young, E. Hidalgo, 
G. Toogood, J. P. Lodge and K. R. Prasad
Department of Hepato-Pancreato-Biliary Surgery, St 
James’s University Hospital NHS Trust, Leeds, UK
Introduction: Non-anatomical resection (NAR) for colorec-
tal liver metastasis (CRLM) has become more common in 
an attempt to preserve liver parenchyma. Pattern of recur-
rence (POR) following NAR has been reported previously, 
but there has been no detail on the hepatic recurrences with 
respect to previous NAR. We aim to investigate pattern of 
hepatic recurrence in patients who underwent NAR for 
CRLM, especially looking at the recurrences in the context 
of previous resected segment.
Methods: 1580 CRLM resection were performed in our 
centre between 1993–2010. 591 (37.4%) were NAR and 989 
(62.6%) were AR. Patients who underwent simultaneous 
Anatomical Resection (AR) were excluded (95 out of 591 
patients). All NAR were grouped as either unilobar or bilobar 
metastatectomy and POR studied in relation to previous 
resected segment.
Results: 495 NAR were included. There were 291 recur-
rences (58.7%). 188 were hepatic (37.9%) and 103 extra-
hepatic (20.8%). In 11 patients with hepatic recurrence, data 
was not available for recurrence segment and therefore 
excluded from POR analysis. The POR following unilobar 
metastasectomy (n = 127): same segment (n = 32, 25.2%), 
same sector (n = 9, 7.1%), ipsilateral hemi-liver (n = 48, 
37.8%), contralateral hemi-liver (n = 15, 11.8%) and bilobar 
(n = 23, 18.1%). The POR following bilobar metastatectomy 
(n = 50): same segment (n = 1, 2%), hemi-liver with equal 
number of segments resected previously (n = 15, 30%), 
hemi-liver with lesser involved segments previously (n = 7, 
14%), hemi-liver with more segment involved previously 
(n = 10, 20.0%) and bilobar (n = 17, 34.0%).
Conclusion: This retrospective study shows that following 
unilobar CRLM resections, 70.0% recur in the ipsilateral 
hemi-liver. In bilobar resections, 22.0% recur in the same 
segment or hemi-liver with previous multiple resections. Our 
data supports a more aggressive approach for unilobar 
disease. Further studies need to be done on pattern of recur-
rences in patients undergoing parenchyma preserving surgery 
to develop best surgical strategies.
FOS080
ANATOMIC VERSUS NONANATOMIC 
RESECTION OF COLORECTAL LIVER 
METASTASES: A COMPARISON OF 
SURGICAL AND ONCOLOGICAL 
OUTCOMES
C. Neal, G. Garcea, C. Moreman, A. McGregor, C. Mann, 
V. Cairns, M. Metcalfe and A. Dennison
Leicester General Hospital, Leicester, UK
Introduction: Non-anatomic resections (NAR) for colorec-
tal liver metastases (CRLM) have become increasingly 
common in an attempt to increase resection rates and to 
enable parenchyma-preserving resections. Some investiga-
tors, however, have reported NAR to be associated with 
higher rates of resection margin positivity and poorer long-
term survival than anatomic resections (AR). The aim of this 
study was to compare surgical outcomes, recurrence and 
survival in patients treated with NAR and AR.
Methods: Patients undergoing hepatic resection for CRLM 
between January 2002 and December 2008 were identifi ed 
from a prospectively maintained database. Patients were 
divided into two groups: those who underwent AR and those 
who underwent NAR. Patients who underwent simultaneous 
AR and NAR were excluded from analysis. Clinicopathological 
variables and perioperative outcomes, as well as long-term 
disease-free and overall survival were compared between the 
AR and NAR groups.
Results: Over the study period 91 patients underwent AR 
and 77 patients underwent NAR. Perioperative (90-day) 
morbidity, major morbidity and mortality occurred in 25.0%, 
8.3% and 1.8% of cases respectively. There was no signifi -
cant difference in rates of perioperative morbidity, major 
morbidity or mortality according to resection type (all P > 
0.30). There was also no difference in the incidence of posi-
tive resection margins between resection types (P = 0.413). 
Overall survival was 48.5% and 36.6% at 3 and 5 years 
respectively, with disease-free survival of 31.4% and 25.3% 
at 3 and 5 years respectively. Type of resection was not 
associated with any signifi cant difference in overall (P = 
0.430) or disease-free survival (P = 0.625) following 
metastasectomy.
Conclusion: AR is not superior to NAR in terms of periop-
erative risk, tumour clearance, time to recurrence or long-
term survival following metastasectomy. NAR should 
remain an integral component of the surgical treatment of 
CRLM and may enable increasing rates of operability. 
Furthermore, the preservation of hepatic parenchyma by 
NAR may enable a larger proportion of patients subse-
quently developing recurrent metastatic disease to undergo 
repeat metastasectomy.
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FOS081
THE PROGNOSTIC FACTORS IN 
PATIENTS WHO UNDERWENT HEPATIC 
RESECTION OF COLORECTAL LIVER 
METASTASES IN THE ERA OF 
EFFECTIVE CHEMOTHERAPHY
N.-J. Yi, M.-S. Park, H. Kim, Y.-R. Choi, G. Hong, 
K.-W. Lee and K.-S. Suh
Seoul National University College of Medicine, Surgery 
Department, Seoul, Korea
Introduction: Hepatic resection has only guaranteed long-
term survival in patients with colorectal liver metastasis 
(CRLM) even in the era of effective chemotherapy. The 
defi nite role of neoadjuvant chemotherapy (NCT) is to down-
stage unresectable CRLMs to resectable CRLMs, but it 
has not been elucidated for initially resectable CRLMs 
(IR_CRLMs).
Methods: We reviewed 226 patients for IR_CRLM from 
2003–2008. Of all patients, 10% had more than 4 nodules, 
11% had tumors larger than 5 cm, and 61% noted synchro-
nous CRMLs. Among these patients, 20 patients (Group Y) 
underwent NCT, and 206 (Group N) did not according to the 
physician’s preference. The median follow-up duration was 
34.1 months.
Results: Initial surgical plans were changed after NCT to 
further resection in 20% and to limited resection in 10% of 
20 patients. Complication rates of Groups Y (30%) were 
indifferent from Group N (23%) (p = 0.233), but intraopera-
tive transfusions were more frequent in Group N (15%) than 
in Group Y (5%) (p = 0.006). There was one hospital mortal-
ity. Disease-free survival rates in Groups Y and N were 23% 
and 39%, respectively, and patient survival rates were 42% 
and 66% (p > 0.05). By multivariate analysis, old age (>60), 
differentiation of primary tumor (poorly/mucinous), resection 
margin involvement, and no adjuvant chemotherapy were 
associated with poor patient survival; the number of CRLMs 
(>4) was associated with poor disease-free survival.
Conclusion: NCT had no positive impact on survival but no 
negative impact, even saving intraoperative transfusion, was 
observed on the operative outcome in IR_CRLM. Further 
study is required to elucidate the role of NCT for IR-CRLMs.
FOS082
ADJUVANT CHEMOTHERAPY AFTER 
RESECTION OF COLORECTAL LIVER 
METASTASES IN PATIENTS AT HIGH 
RISK OF HEPATIC RECURRENCE: A 
COMPARATIVE STUDY BETWEEN 
HEPATIC ARTERIAL INFUSION OF 
OXALIPLATIN AND MODERN 
SYSTEMIC CHEMOTHERAPY
D. Goere1, L. Benhaim1, S. Bonnet1, D. Malka2, M. Faron3, 
J. Lefevre1, M. Ducreux2 and D. Elias1
1Surgical Oncology, Institute Gustave Roussy, Villejuif, 
France; 2Medical Oncology, Institute Gustave Roussy, 
Villejuif, France; 3Deparment of Biostatistics, Institut 
Gustave Roussy, Villejuif, France
Introduction: After curatively-intended surgery for colorec-
tal liver metastases (CRLM), liver recurrences occur in more 
than 60% of patients, despite the administration of adjuvant 
systemic chemotherapy. The aim of this study was to assess 
the benefi t of combined adjuvant hepatic arterial infusion 
(HAI) and intravenous (IV) 5-FU compared to standard 
modern adjuvant IV chemotherapy in patients at high risk of 
hepatic recurrence.
Methods: From January 2000 to December 2009, the 98 
patients who had undergone curative resection of at least four 
CRLM, were selected from a prospective database. Among 
them, 44 (45%) had received postoperative HAI combined 
with systemic 5-FU (HAI group) and 54 (55%) ‘modern’ 
systemic chemotherapy (IV group).
Results: The two groups were similar in terms of age, 
gender, the stage of the primary, and preoperative chemo-
therapy. The median number of HAI cycles per patient was 
7 [range, 1 to 12]. Twenty-nine patients (66%) had received 
at least six cycles of oxaliplatin HAI. After a median follow-
up of 60 months [51–81], 3-year disease-free survival (DFS) 
was signifi cantly longer in patients in the HAI group com-
pared to those in the IV group (33% vs. 5%, p < 0.0001), and 
3-year overall survival was slightly higher in the HAI group 
(75% vs. 62%, p = 0.17). In the multivariate analysis, adju-
vant HAI chemotherapy and an R0 resection margin status 
were the only independent predictive factors for prolonged 
DFS.
Conclusion: Postoperative HAI oxaliplatin combined with 
systemic chemotherapy after curatively-intended surgery of 
CRLM is feasible, and may signifi cantly improves DFS of 
patients at high risk of hepatic recurrence compared to adju-
vant modern systemic chemotherapy alone. These results 
should be confi rmed in a randomized study.
FOS083
TREATMENT STRATEGIES FOR 
COLORECTAL LIVER METASTASES – 
SPECIALIST VS. NON-SPECIALIST 
DECISION MAKING
R. Jones1, R. Adam2, J.-N. Vauthey3, M. Rees4, D. Berry5, 
S. Fenwick6, G. Poston6 and H. Malik6
1School of Cancer Studies, Institute of Translational 
Medicine, University of Liverpool, Liverpool, UK; 2AP-HP 
Hôpital Paul Brousse, Centre Hépato-Biliaire, Univ 
Paris-Sud, UMR-S 776, Villejuif F-94800, France; 
3Division of Surgery, MD Anderson Cancer Center, 
Houston, TX, USA; 4Department of Hepatobiliary Surgery, 
Basingstoke and North Hampshire NHS Foundation Trust, 
Basingstoke, UK; 5Department of Hepatobiliary Surgery, 
University Hospital Wales, Heath Park, Cardiff, UK; 
6Department of Hepatobiliary Surgery, Aintree University 
Hospital, Liverpool, UK
Introduction: Improved surgical technique and better 
chemotherapeutic manipulation of metastatic disease has 
increased the number of patients eligible for potentially cura-
tive resection of colorectal liver metastases. The rapid evolu-
tion in this fi eld suggests that non-specialist decision-making 
may lead to inappropriate management. This study aimed to 
assess the management of colorectal liver metastases by non-
liver surgeons.
Methods: All patients treated with palliative intent chemo-
therapy for metastatic colorectal cancer at a regional 
oncology centre between 1st January 2009 and 31st December 
2009 were identifi ed from a prospectively maintained local 
142 Free Orals Abstracts
© 2012 The Authors
HPB © 2012 Americas Hepato-Pancreato-Biliary Association HPB 2012, 14 (Suppl. 2), 107–287
database. One hundred and ten patients were treated with 
palliative chemotherapy, of whom 53 had liver only disease 
and had not been reviewed by a specialist liver surgeon. One 
scan was excluded as all reviewers felt it to be of insuffi cient 
quality to assess. Six resectional liver surgeons blinded to 
patient management and outcome reviewed pre-treatment 
imaging and assigned each scan a score based on their own 
management choice.
Results: 63.9% patients were considered potentially resect-
able, with a high level of inter-observer agreement (k = 
0.577). When individual approach to management was 
considered, inter-observer agreement was less marked 
(k = 0.378).
Conclusion: Non-specialist management of patients with 
colorectal liver metastases can lead to patients being denied 
potentially curative treatments. Management of these patients 
must involve a specialist liver surgeon to ensure appropriate 
management.
FOS084
COMPLETE RESPONSE BY IMAGING TO 
PREHEPATECTOMY CHEMOTHERAPY 
IN TREATING ADVANCED LIVER 
METASTASES FROM COLORECTAL 
CANCER
K. Tanaka, K. Nojiri, T. Kumamoto, K. Taniguchi, 
K. Takeda, M. Sugita and I. Endo
Department of Gastroenterological Surgery, Yokohama City 
University Graduate School of Medicine, Yokohama, Japan
Introduction: Recent advances in procedural technique and 
chemotherapy (CTx) now allow many metastatic colorectal 
cancer patients to have safe, potentially curative surgery. 
Although increasing numbers of patients (pts) with colorec-
tal liver metastases undergo surgical resection with preopera-
tive CTx, much uncertainty still persists, especially whether 
the site of metastases that have disappeared from preopera-
tive images should be included in a resection or can be left 
in place.
Methods: Eighty-six pts with marginally resectable and 
unresectable colorectal liver metastases, who underwent CTx 
and hepatectomy (Hx) between 1998 and 2009 were included. 
Numbers of metastases were 1 in 12 pts, 2 in 5 pts, 3 in 3 pts, 
and 4 or more in 66 pts; the median number of metastases at 
diagnosis was 6 (range, 1 to 29). Forty-four pts received their 
fi nal prehepatectomy CTx via the hepatic artery, 15 via the 
systemic infusion, and the other 27 both via the hepatic arte-
rial infusion and the systemic infusion.
Results: Imaging showed 616 metastases before treatment 
in the 86 pts included in this study. Among these, 91 disap-
peared from images after CTx. Excluding 14 of these treated 
with ablation, microscopically persistent metastases or recur-
rences in situ were observed only in 27 (35%). Recurrence 
occurred at a median of 12 mo after Hx in 8 of the pts with 
14 recurrent metastases in situ where complete response 
(CR) lesions were left in place, however, more than half of 
these pts had a synchronous hepatic recurrence at another 
site.
When outcomes were compared between those in pts with 
some CR lesions left in place and others with all CR metas-
tases being resected, no difference in overall survival was 
confi rmed.
Conclusion: Sites of metastases that have disappeared by 
imaging after prehepatectomy chemotherapy should be left 
in place. Such a treatment approach may permit extension of 
surgical indications and may improve long-term survival in 
treating colorectal cancer liver metastases.
FOS085
IMPACT OF PORTAL VEIN 
EMBOLIZATION ON SURVIVAL AND 
LIVER RECURRENCE AFTER RIGHT 
(±EXTENDED) HEPATECTOMY FOR 
COLORECTAL METASTASES
F. Ardito, G. Grande, F. Giuliante, M. Vellone, 
A. Coppola and G. Nuzzo
Hepatobiliary Surgery Unit, Catholic University of the 
Sacred Heart, Rome, Italy
Introduction: Portal vein embolization (PVE) is a safe and 
effective procedure to increase future remnant liver before 
major hepatectomy and resect patients otherwise unresect-
able. However several studies about the impact of PVE on 
oncologic outcome after liver resection for colorectal liver 
metastases (CRLM) have been published with controversial 
results. Aim of this study was to assess the effect of PVE on 
long-term outcome and on intrahepatic recurrence rate after 
hepatectomy for CRLM.
Methods: Between 1998 and 2010, 100 patients underwent 
right (±extended) hepatectomy for CRLM. Patients who 
underwent two-stage hepatectomy were excluded from this 
analysis. Of these 100 patients, 20 (group A) underwent PVE 
before surgery and 80 underwent liver resection without 
PVE. Among these 80 patients, 20 were selected as the 
control group (group B), by matching with patients of group 
A for clinical features.
Results: The two groups were well matched by number and 
size of tumors and temporal relationship of CRLM (synchro-
nous vs. metachronous). Rate of R0 resection was 80% in 
both groups. After a mean follow-up of 36 months (range 
5–154), the 5-year overall survival rates were 43.9% in group 
A and 40.5% in group B (p = 0.68). The disease-free survival 
rates were 28.1% in group A and 26.2% in group B (p = 
0.64). The intrahepatic recurrence rate was not signifi cantly 
different in the two groups (45% in group A vs. 40% in group 
B; p = 0.74). The 5-year specifi c liver disease-free survival 
was 50.7% in group A and 51.5% in group B (p = 0.71).
Conclusion: This study showed that PVE did not negatively 
impact oncologic outcomes of patients with CRLM undergo-
ing hepatectomy. Moreover, rate of intrahepatic recurrence 
following liver resection was not infl uenced by preoperative 
PVE.
 Free Orals Abstracts 143
© 2012 The Authors
HPB 2012, 14 (Suppl. 2), 107–287 HPB © 2012 Americas Hepato-Pancreato-Biliary Association
FOS086
RIGHT AND EXTENDED RIGHT 
HEPATIC TRISECTIONECTOMY – 
SHORT AND LONG TERM OUTCOMES 
OF 332 RESECTIONS
G. Marangoni, A. Hakeem, R. Storey, Z. Hamady, H. Sethi, 
R. Prasad, G. Toogood and J. P. Lodge
St James’ Hospital, HPB and Transplant Unit, Leeds, UK
Introduction: Despite advances in surgical and anaesthetic 
techniques made over the last 2 decades, right hepatic trisec-
tionectomy (RHT) is still a challenging procedure associated 
with higher rates of morbidity and mortality. Some patients 
may even require further extension of the resection to include 
part of segments II/III to achieve clearance (extended right 
hepatic trisectionectomy, ERHT). Aim of the study was to 
assess and compare the early and long-term outcomes of 
RHT and ERHT in our Unit.
Methods: From January 1993 to December 2010, 252 RHT 
and 80 ERHT were performed (n = 332). Resection for 
colorectal liver metastases (CRLM), hepatocellular carci-
noma, cholangiocarcinoma and other aetiology were 127, 43, 
25 and 57 for RHT and 60, 3, 2, 15 for ERHT respectively. 
Mean age was 58.3 vs 57.9 and 57.1% vs 55% were males 
(RHT vs ERHT, p = NS). There were 61 caudatectomy in 
the RHT group and 15 in the ERHT (p = 0.36, NS); vascular 
resection (Inferior vena cava or portal vein) was performed 
in 61 and 10 cases (p = 0.18, NS), biliary reconstruction was 
performed in 75 and 7 cases (p = 0.01) and total vascular 
exclusion was necessary in 26 and 6 cases respectively (p = 
NS). The amount of functional hepatic remnant was based 
on intra-operative judgement.
Results: There were 23 in-hospital deaths (6.9%, RHT: 19, 
ERHT: 4; p = NS). Overall morbidity was 44% (RHT) and 
47.5% (ERHT). Bile leak (17 vs 3), haemorrhage (14 vs 4), 
sepsis (33 vs 9), cardio-vascular events (12 vs 1) and renal 
failure (12 vs 3) did not differ among the two groups (RHT 
vs ERHT; p = NS). There were 42 (12.6%) post-hepatectomy 
liver failure (according to “50 : 50 criteria”): 23 in the RHT 
group and 19 in the ERHT group respectively (p = 0.001). 
Mean hospital stay was 15.8 vs 17.1 days (RHT vs ERHT, 
p = NS). In the CRLM cohort, 1, 5 and 10 year survival was 
78%, 47% and 39% vs 79%, 47% and 37% (RHT vs ERHT, 
p = 0.93, NS). Median survival was 49 and 43.9 months 
respectively (p = NS) and median follow-up was 59.7 and 
56.5 months (RHT vs ERHT).
Conclusion: RHT and ERHT are a major undertaking with 
signifi cant morbidity and mortality but represent the only 
chance of cure in selected patients. Liver failure is higher in 
the ERHT group but does not translate in increased mortality. 
Long-term survival in CRLM is achievable and does not 
differ among the two groups. Extensive liver resections even 
beyond conventional boundaries should not be considered an 
absolute contraindication to surgery.
FOS087
CAN PET-CT PREDICT OUTCOME IN 
COLORECTAL LIVER METASTASES?
C. Jones1, S. A. Badger1, L. D. McKie1, T. Diamond1, 
M. A. Taylor1, R. H. Wilson2 and T. B. Lynch3
1Department of HPB Surgery, Mater Hospital, Belfast; 
2Department of Oncology, Belfast City Hospital, Belfast; 
3Department of Radiology, Belfast City Hospital, Belfast
Introduction: PET-CT scanning, in the detection of colorec-
tal liver metastases, has been shown to detect extra-hepatic 
disease, and thus reduce the rate of futile laparotomies. 
PET-CT can also assess metabolic activity of tumours by 
standard uptake value (SUV), along with other dimensional 
data. This study aimed to assess the role of PET-CT in pre-
dicting outcome and survival in patients with colorectal liver 
metastases.
Methods: Patients with potentially resectable colorectal 
liver metasatses, from 2007–2009, were identifi ed retrospec-
tively. Survival from PET-CT staging to date was calculated, 
as recorded by the Northern Ireland Cancer Registry. The 
effect on survival from the date of PET-CT, of the number 
of lesions, maximum diameter, standard uptake value – 
SUVpeak, SUVmax and SUVmean, and reconstructed 
volume on PET-CT was calculated. The proportion of 
patients was expressed as a percentage, with continuous vari-
ables expressed as mean (±SD) values. Kaplan-Meier analy-
sis was used, with a p value of 0.05 considered statistically 
signifi cant.
Results: 79 patients were identifi ed, 8 were excluded due to 
incomplete data. The mean age was 64.8 years (±11.1), with 
47 males. There was a strong trend for the reconstructed 
tumour volume on PET-CT to infl uence outcome (p = 0.027). 
The metabolic activity of the tumour as measured by 
SUVmax and SUVmean (p = 0.076, and 0.054 respectively) 
showed a trend towards signifi cance for survival, while 
SUVpeak failed to predict outcome (p = 0.236). Maximum 
tumour diameter was also not shown to infl uence outcome 
(p = 0.119). Biochemical parameters including CEA, fi brino-
gen, platelets and liver function tests, and primary tumour 
pathology were not found to infl uence outcome.
Conclusion: The metabolic activity of colorectal liver 
metastases (SUVmax and SUV mean) as assessed by PET-CT 
along with reconstructed tumour volume were found to infl u-
ence survival. Interestingly SUVpeak did not infl uence 
outcome. Further larger prospective studies are required to 
validate this further.
FOS088
PROGNOSTIC FACTORS INFLUENCING 
SURVIVAL AFTER LIVER RESECTION 
FOR COLORECTAL METASTASIS
S. K. P. John, S. Rehman, A. Vallance, S. Robinson, 
R. C. B. Jaques, D. Manas and S. White
Hepatobiliary Surgery, Freeman Hospital, Newcastle upon 
Tyne, UK
Introduction: A variety of factors have been identifi ed in 
the literature which infl uence survival following resection of 
colorectal liver metastases (CRLM). The aim of this study 
was to identify those factors which infl uence survival in 
patients undergoing resection of CRLM in a UK centre.
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Methods: All patients having liver resection for CRLM 
during an 11 year period up to 2011 were identifi ed from a 
prospectively maintained database and relevant clinical data 
retrieved from case records. Prognostic factors analysed 
included tumour size (>5 cm or <5 cm), lymph node status 
of primary tumour, margin positivity R1 (<1 mm) or R0, 
neo-adjuvant chemotherapy (for liver), tumour differentia-
tion, number of liver metastasis (4 or more), preoperative 
CEA (>200 or <200) and whether metastases were synchro-
nous (i.e. diagnosed <12 months) or metachronous to the 
primary tumour. Overall survival (OS) was compared with 
Kaplan Meier plots, log rank test. Multi-variate analysis was 
performed using Cox regression model (SPSS vs 19). p < 
0.05 considered signifi cant.
Results: 432 patients underwent resection of CRLM during 
this period (67% male; mean age 64.5 years). The overall 5 
year survival in this series was 43%. A pre-op CEA > 200 
was present in 10% of patients and was associated with a 
poorer 5 year OS (24% vs 45%; p < 0.001). A resection 
margin <1 mm was present in 16% of patients and this had 
a negative impact on 5 yr OS (15% vs 47%; p < 0.001). 
Tumor differentiation, number, size, presence of biliary or 
vascular invasion, relationship to primary disease, nodal 
status of primary, or the use of neoadjuvant chemotherapy 
had no impact on OS. Multi-variate analysis identifi ed only 
the presence of a positive resection margin (OR 1.75; p < 
0.05) and a pre-op CEA > 200 (OR1.88; p < 0.01) as inde-
pendent predictors of poorer OS.
Conclusion: Despite the wide variety of prognostic factors 
reported in the literature we were only able to identify a 
pre-op CEA > 200 and the presence of tumour within 1 mm 
of the resection margin as being of value in predicting sur-
vival. These variables are likely to identify patients who may 
benefi t from intensive follow-up to enable early aggressive 
treatment of recurrent disease.
FOS089
RUSSIAN EXPERIENCE IN 
MANAGEMENT OF METASTATIC 
COLORECTAL CANCER PATIENTS IN 
COMPARISON WITH GLOBAL DATA 
ACCORDING TO LIVERMETSURVEY 
DATABASE
O. Skipenko1, M. Sekacheva1, V. Zagaynov2, V. Kukosh2, 
A. Bedzanyan1 and L. Polishuk1
1FSBI Petrovsky National Research Center of Surgery 
RAMS, Moscow, Russia; 2Privolzhsky Federal Medical 
Center, Nizhny Novgorod, Russia
Introduction: The aim of the study was to analyze epide-
miologic and treatment-related data in the surgical and thera-
peutic management of metastatic colorectal cancer (MCC) 
patients (pts) of a academic surgical center and federal 
medical center under conditions of routine clinical care in 
comparison with global data according to LiverMetSurvey 
(LMS) database. By analyzing our data in relation with data 
of LMS we aimed at providing an instrument of internal 
quality control at our institutions.
Methods: We retrospectively analyzed prospectively gath-
ered data of liver metastatic colorectal cancer patients treated 
at Russian academic surgical center (ASC) and at a federal 
medical center (FMC) in comparison with global data 
according to LiverMetSurvey. From 06/2006 to 12/2010, a 
total of 367 liver MCC pts (239 pts in ASC and 128 pts in 
FMC) were treated. To 12/2010 in LMS 14973 pts were 
registered.
Results: In comparison with the LMS cohort there was a 
trend to the younger age at the fi rst operation (median LMS 
60–70 vs 50–70 yrs in Russia). Also there was a higher 
proportion of bilobar disease and disease with ≥5 mts with 
size >50 mm in the FMC (n > 5 30% vs LMS 15%; size > 
5 cm 55% vs LMS 20%). There was no difference in rate of 
extrahepatic disease. In the FMC there were more pts with 
initially resectable disease (98%) and therefore lower pro-
portion of pts treated chemotherapeutically preoperatively 
(1%). It was registered the increasing rate of major hepatec-
tomy in comparison the LMS (53%) to ASC (64%) and to 
FMC (78%). 1-year survival was signifi cantly lower in the 
FMC (LMS 92%; ASC 96%; FMC 82%). Other survival 
end-points are not reached yet.
Conclusion: Data of LiverMetSurvey are useful and effec-
tive tool of internal quality control. The differences in disease 
stage at the time of liver resection and the shortage of pre-
operative chemotherapy may be responsible for the low 
1-year survival rate in the federal medical center. Further 
detailed comparison could be the base for the possibility to 
infl uence on government structures for supporting effective 
but very costly strategy of multidisciplinary treatment.
FOS090
SHOULD PATIENTS WITH PERITONEAL 
CARCINOMATOSIS OF COLORECTAL 
ORIGIN WITH SYNCRONOUS LIVER 
METASTASES BE TREATED 
WITH CURATIVE INTENT? A 
CASE-CONTROL STUDY
L. Maggiori, D. Goere, B. Viana, D. Tzanis, F. Dumont, 
C. Honoré, C. Eveno and D. Elias
Institut Gustave Roussy, Cancer Center, Villejuif, France
Introduction: This aim of this case-control study was to 
assess the prognostic impact of the presence of liver metas-
tases (LM) in patients operated on colorectal peritoneal car-
cinomatosis (PC) who underwent complete cytoreductive 
surgery (CRS) and LM resection followed by intraperitoneal 
chemotherapy.
Methods: From a prospectively maintained database, all 
patients with colorectal PC and synchronous LM who under-
went CRS followed by intraperitoneal chemotherapy, were 
manually matched to all identical patients with isolated PC, 
operated on over the same period, on the following matching 
criteria: age, peritoneal cancer index (PCI), site of the 
primary colorectal cancer (colon or rectum), lymph node 
involvement on the primary colorectal cancer specimen 
(pN), and postoperative chemotherapy.
Results: From 1993 to 2009, 37 patients with PC and LM 
were matched to 61 patients with isolated PC. After a mean 
follow-up of 36 months, 3-year overall (OS) and disease free 
survival rates were signifi cantly lower in patients with PC 
and LM, respectively 40% and 66% (p = 0.04) and 6% and 
27% (p = 0.001). In Cox regression analysis, PCI ≥ 12 
(Odds-ratio (OR): 4.6), pN+ status (OR: 3.3), no adjuvant 
chemotherapy (OR: 3.0) and presence of LM (OR: 2.0) were 
identifi ed as independent factors of poor OS. Thus, 3 groups 
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could be identifi ed: 1) patients with a low PCI (<12) and no 
LM (OS of 76 months); 2) patients with a low PCI (<12) and 
1 or 2 LM (OS of 40 months); and 3) patients with a high 
PCI (≥12) or patients with ≥3 LM (OS of 27 months).
Conclusion: This fi rst case control study confi rms that pro-
longed survival can be achieved in highly selected patients 
operated on limited carcinomatosis and liver metastases less 
than 3. When the peritoneal and the liver involvement are 
greater, the complete surgical treatment followed by intra-
peritoneal chemotherapy should be discussed according to 
criteria of aggressiveness of the tumor disease.
FOS091
LAPAROSCOPIC LIVER SURGERY OF 
SOLID TUMORS. INITIAL EXPIERIENCE
R. J. Maurette, D. Bogetti, M. Bregante, E. Silberman, 
H. Ruiz and E. A. Porto
British Hospital of Buenos Aires, Hepatobilio-Pancreatic 
Surgery and Liver Transplant Sector, General Surgery 
Service, Buenos Aires, Argentina
Introduction: Worldwide there are an increasing number of 
publications in Laparoscopic Liver Surgery (LLS), some of 
them coming from South America. There have been several 
obstacles to the widespread use of LLS, mainly to the diffi -
culty of reproducing maneuvers of open resection, fears 
of uncontrollable hemorrhage, and in the non-developed 
country lack of adequate laparoscopic equipment. The aim 
of the present communication is to describe the initial experi-
ence in laparoscopic liver surgery of solid tumors.
Methods: From a prospective database, it included patients 
who underwent to LLS of solid tumors between Jan 08 and 
Nov 11. It excluded lesions that need major hepatectomy, 
nodules close to main vessels, and unable to achieve R0 in 
malignant tumors. The following variables were taken into 
account: indication of LLS, number, size and location of 
tumors, Pringle maneuver, operative time, conversion rate, 
length of stay, morbidity-mortality and long term outcomes. 
The performed procedures were: laparoscopic ligation 
of portal vein with/without combined treatment (LLPV), 
laparoscopic radiofrequency ablation (LRFA), laparoscopic 
liver resection: pure or hand assisted (LLR or HA-LLR). 
Complications were stage according with the Dindo-Clavien 
classifi cation.
Results: 24 patients were attempted to undergo LLS (appli-
cability 23.5%). There were 2 LLPV, 3 LRFA, 16 LLR, and 
3 HA-LLR. The conversion rate was 21%. Of the LLR, 
6 had benign lesions, 1 HCC, 2 non-colorectal non-
neuroendocrine liver metastases (NCNN), and 10 colorectal 
liver metastases (CLM). The mean operative time was 
150 min (80–240). In 63% portal clamping was performed. 
There were 16 non anatomic and 3 anatomic resections. The 
median length of stay was 8 days (1–49). There were no 
mortality and 7 morbidities (32%). One of the LLVP died of 
progression of disease and 1 is alive with recurrence. One of 
the NCNN died of no cancer related dead. The resected HCC 
are still alive with no recurrence. 2 patients with CLM died 
of progression of diseases.
Conclusion: Laparoscopic approach in liver surgery is start-
ing to gain acceptance.
Ligation of main portal vein lobe plus combined treatment 
in the remaining liver performing by laparoscopy as part of 
the two stage hepatectomy, avoid one laparotomy shortening 
the recovery times.
LRFA allowed a good positioning of the needle with the 
possibility of multiples shut and the overlapping of the 
lesions, reducing the recurrence rate and the incidence of 
bleeding doing the puncture by direct vision.
FOS092
OUTCOME OF LAPAROSCOPIC 
LIVER RESECTION COMPARED TO 
OPEN TECHNIQUE
A. H. Jahromi, H. Shokouh-Amiri, E. Jafarimehr, 
D. Doumite and G. B. Zibari
Department of Surgery, Louisiana State University Health 
Sciences Center-Shreveport, LA, USA
Introduction: To our knowledge no prospective random-
ized controlled trial has ever been reported to compare lapa-
roscopic and open liver resections. Feasibility, safety, pros 
and cons of LLR compared to open surgery remains contro-
versial. In this study, we investigate safety, practicality, and 
feasibility of Laparoscopic liver Resection (LLR) for differ-
ent liver pathologies.
Methods: Retrospective, IRB approved, chart review of 465 
liver resections performed between July 1993 and January 
2011 was conducted. Patients with laparoscopic liver resec-
tion (G-I, N = 73) were compared to a matched cohort 
(demographics, type, size of liver pathology and extent of 
liver resection) (G-II, N = 73) from our total liver resection’s 
pool. Demographic data and pathologic fi ndings were com-
parable in both groups. In each group, 24 patients had malig-
nant pathology. Comparison were made with respect to their 
OR time, estimated blood loss (EBL), blood transfusion (BT) 
requirement, complication rate, achievement of malignancy 
free resection margins (R-0), morbidity, mortality, length of 
stay (LOS), recurrence and survival.
Results: OR time was signifi cantly lower in G-I compared 
to G-II (160 vs. 256 min, P < 0.05). There was only one 
perioperative mortality in G-I. EBL was lower in G-I com-
pared to G-II (185.4 vs. 790.8 mls, P < 0.05). 8 patients in 
G-I vs. 26 patients in G-II required BT (P < 0.05). 15 patients 
in each group had postoperative complications. Average LOS 
was signifi cantly less in G-I than G-II (5.32 vs. 8.57 days, P 
< 0.05). R-0 resection was achieved in 91.7% of the malig-
nant lesions in G-I and 95.8% in G-II. Five year survival in 
the patients with malignant pathology was similar in both 
groups (P = 0.64). Hazard regression analysis showed malig-
nancy, presence and type of complications to be independent 
predictors of mortality within the 5 years post operation.
Conclusion: The goal of any curative excision is to achieve 
R-0. We achieved this goal equally in both groups. Long-
term outcome was equal regardless of the surgical approach. 
In this study, laparoscopic liver resection compared favor-
ably to open resection with regards to OR time, LOS and 
need for BT. Malignant pathology, presence and type of 
complications are independent predictors of mortality within 
the 5 years post operation period.
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FOS093
FAST-TRACK LIVER SURGERY – WHAT 
INFLUENCES LENGTH OF STAY?
P. Swan, D. U. Rodriguez, F. Welsh, K. Chandrakumaran, 
B. Cresswell, T. John and M. Rees
Hepatobiliary Unit, Basingstoke and North Hampshire 
Foundation Trust, Bristol, UK
Introduction: The ‘fast-track’ approach to perioperative 
care in major abdominal surgery is well recognised in elec-
tive bowel surgery, the primary goal being to reduce in-
hospital length of stay. Its role in liver resection is less 
established, in our unit, a multi-factorial fast-track approach 
has evolved. We asked whether length of stay (LOS) follow-
ing liver surgery for colorectal liver metastases (CRLM) has 
reduced in our unit over time and if so, what clinical and 
operative factors have infl uenced this.
Methods: 1609 consecutive hepatic resections for CRLM 
in a single centre from 1987 to 2011 were included in the 
study. Using the SPSS ‘Binning method’, the total number 
of resections were divided in three chronological groups: T1 
(03/1987 to 09/2001), T2 (10/2001 to 07/2006) and T3 
(08/2006 to 10/2011). The LOS for each patient was catego-
rised into one of two groups, depending on whether it was 
below the overall median LOS or not. The clinical and oper-
ative factors that infl uenced LOS were analysed using fi rstly 
a univariate analysis and then multinominal logistic regres-
sion analysis (MLRA), for both adverse and benefi cial 
effects.
Results: There were 537, 536 and 536 resections in T1, T2 
and T3 respectively. The overall median LOS was 8 days. 
There was a signifi cant reduction in LOS over time, with 83 
resections (15%) staying less than 8 days in T1, compared 
with 298 (56%) and 377 (70%) in T2 and T3 respectively (p 
= 0.001). MLRA showed that major resection (Odds ratio 
[OR] = 3.16, p = 0.001), additional surgery (OR = 1.72, p = 
0.001), blood loss (OR = 1.00, p = 0.03) and complications 
(OR = 4.08, p = 0.001) adversely affected LOS, with LOS 
increased by the value of the OR of the variable. In contrast, 
previous liver surgery (OR = 1.36, p = 0.036) and surgery in 
T3 (OR = 2.35, p = 0.001) were associated with a reduced 
LOS (by the OR of the variable). Patient age and ASA did 
not affect LOS.
Conclusion: In our unit, liver surgery within the last fi ve 
years (T3), when a more focused fast-track approach was 
adopted, is associated with a signifi cant reduction in LOS. 
Furthermore, meticulous surgery, with low blood loss and 
morbidity are integral to any enhanced-recovery programme, 
as our data confi rms that factors associated with surgery, 
rather than patient factors, are what matters.
FOS094
COLORECTAL LIVER METASTASES 
IMAGING STUDY (CLIMAX)
L. Bonanni1, N. de’Liguori Carino1, R. Deshpande1, 
D. Sherlock1, B. Ammori1, F. Carlei2 and D. O’Reilly1
1HPB Unit, North Manchester General Hospital, 
Manchester, UK; 2Surgical Department, S.Salvatore 
Hospital, L’Aquila, Italy
Introduction: The role of imaging in colorectal cancer liver 
metastases management is crucial to offer the best treatment, 
and the longer survival rates.
Intraoperative ultrasound has been the standard in surgical 
decision making in oncologic liver surgery, but since preop-
erative imaging techniques have improved in recent years the 
importance of IOUS might be changed.
At the same time there is no yet consensus on which is the 
most accurate whole-body imaging technique for metastatic 
colorectal cancer.
Methods: A single-centre prospective study was performed 
on 51 patients undergoing preoperative imaging with FDG 
PET/CT, CT scan, MR liver, intra-operative ultrasound 
(IOUS) and surgical treatment for colorectal cancer liver 
metastases.
Pre-operative and intra-operative metastatic disease detec-
tion was compared with histological fi ndings. We analyzed 
and compared number of liver metastases, number and local-
ization of extrahepatic metastatic deposits, AJCC/UICC 
stage, number of new lesions identifi ed intraoperatively and 
interval time among preoperative imaging modalities and 
surgery.
Cohen’s Kappa test was used as measure of agreement 
among preoperative imaging, intraoperative fi ndings and 
histology.
Results: Concordance between the number of liver metas-
tases identifi ed with imaging and histology showed moderate 
concordance for CT scan: K: 0.490 (95% CI: 0.28–0.69), 
moderate concordance for MR scan K: 0.546 (95% CI: 0.34–
0.74), good concordance for FDG PET/CT K: 0.680 (95% 
CI: 0.48–0.87), very good concordance for IOUS K: 0.882 
(95% CI: 0.77–0.99).
Despite the use of a complete preoperative imaging, new 
metastatic liver lesions were identifi ed intraoperatively in 
5/51 (9.8%) patients with IOUS.
Presence of extrahepatic metastatic colorectal cancer 
disease was identifi ed in 23.52% of the patients. FDG PET/
CT identifi ed intrabdominal lymph nodal metastatic disease 
in 15.68% of patients, none of these lesions was diagnosed 
with CT scan.
Conclusion: Our study compares for the fi rst time the agree-
ment of all the main preoperative (CT, MRI, PET/CT) and 
intraoperative imaging modalities with histology results, 
showing that IOUS remains the most sensitive scan for the 
detection of CRCLM.
According to our results PET/CT showed higher sensitiv-
ity in detection of colorectal cancer extrahepatic metastatic 
disease than CT scan and should be considered the modality 
of choice for the best preoperative staging, as previously 
described in literature.
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FOS095
COMBINED USE OF INTRAOPERATIVE 
ULTRASOUND AND INDOCYANINE 
GREEN FLUORESCENCE TO DETECT 
LIVER METASTASES FROM 
COLORECTAL CANCER
A. Peloso1, M. Canepa1, L. Briani1, L. Barbieri1, 
E. Franchi1, P. Quaretti2, P. Dionigi1 and M. Maestri1
1IRCCS Policlinico San Matteo Department of Surgical 
Sciences, Pavia, Italy; 2IRCCS Policlinico San Matteo 
Interventional Radiology, Pavia, Italy
Introduction: Surgical excision is currently the method of 
choice for managing liver metastases from colorectal carci-
noma. Achievement of R0 resection margins is a major deter-
minant of disease-free survival rate in these patients, but the 
imaging techniques have limits of resolution.
In this study we evaluated a new approach for intraopera-
tive detection of colorectal liver metastatic tissue based on 
the emission of indocyanine green fl uorescence.
Methods: In our study we enrolled 20 consecutive 
patients with advanced, multinodal liver metastases from 
primary colorectal cancer who were eligible for liver 
resection. Twenty-four hours before surgery, each patient 
received an intravenous bolus of indocyanine green (ICG) 
(0.5 mg pro kg of body weight). During surgery proce-
dures, ICG fl uorescence, which accumulates around 
neoplastic lesions as a result of defected biliary clearance, 
was detected with a specifi cally near-infrared camera 
system (PDE-PhotoDynamicEye).
We recorded total number of lesions detected by PDE-
ICG, intraoperative ultrasound (IOUS) and preoperative 
computed tomography (CT).
Results: PDE-ICG revealed a total number of 54 metastatic 
liver nodules confi rmed by histological analysis, approxi-
mately half of which were missed on preoperative CT and/
or IOUS. 32 (59%) of these nodules were seen on preopera-
tive CT, and 38 (70%) were observed on IOUS. IOUS dem-
onstrated quite similar to CT when dealing with nodules 
more than 3 mm of diameter and allowed to discover several 
nodules below 3 mm. However the use of PDE-IOUS 
increased the detection of liver tumors in a signifi cant way, 
particularly discovering small nests below 3 mm.
The resected specimens were sent for pathological exami-
nation and were confi rmed as metastases from primary color-
ectal cancer.
Conclusion: While ultrasounds are gold standard for intra-
operative guidance during liver resection, it has limitations 
too: just a two-dimensional cross section, and the need of a 
considerable training and experience for a correct interpreta-
tion of the fi ndings.
This study suggests that PDE-ICG combined with intra-
operative ultrasound, could be a safe and effective tool for 
ensuring complete surgical eradication of liver metastases 
from colorectal cancer.
FOS096
DOES GADOXETIC ACID-ENHANCED 
MRI REDUCE THE INCIDENCE OF 
INTRAOPERATIVE DETECTION OF 
METASTATIC NEW TUMOR NODULES 
AND POSTOPERATIVE EARLY HEPATIC 
RECURRENCE IN COLORECTAL LIVER 
METASTASIS SURGERY?
T. Mizuno, K. Hideyuki, S. Teiichi, Y. Okamura and 
K. Uesaka
Department of Hepato-Biliary-Pancreatic Surgery, 
Shizuoka Cancer Center Hospital, Shizuoka, Japan
Introduction: Despite the improvement of preoperative 
imaging studies for colorectal liver metastases (CRLMs), we 
sometimes identify new metastatic liver nodules intraopera-
tively. These nodules frequently make us change operative 
procedures and can be a risk of early hepatic recurrence if 
they were not identifi ed. Though there are several reports 
indicating the better detectability with Gadoxetic acid-
enhanced MRI for CRLM patients, their impact on surgery 
is rarely evaluated.
Methods: Between 2002 and 2010, a total of 168 consecu-
tive hepatic resections (HRs) without any preoperative treat-
ment for target CRLMs were performed and 411 nodules 
were resected. We divided them into two groups, the groups 
S; patients preoperatively examined by superparamagnetic 
iron oxide (SPIO) enhanced MRI ((n = 118, 299 nodules); 
performed in 2002–2008), the group G; patients examined 
by Gadoxetic acid-enhanced MRI ((n = 50, 112 nodules); 
performed in 2008–2010) for preoperative imaging study. 
We compared the preoperative detectability, the number of 
NMLNs and early hepatic recurrence of each groups.
Results: Eighty-four (1–10 per one HR) NMLNs were 
detected in 33 (19.6%) HRs. (group S: 69 nodules in 28 HRs 
(23.7%), group G: 15 nodules in 5 HRs (10.0%) (P = 0.04)). 
Preoperative detectability was 76.9% in group S and 86.6% 
in group G, respectively (P = 0.03). The average of maximum 
diameter of NMLNs was 6.0 mm (group S; 6.2 mm, group 
E; 4.0 mm (P = 0.037)). In analysis of 114 nodules less than 
10 mm in diameter, 70 nodules (51.8%) were NMLNs, pre-
operative sensitivity were 38.6% in group S and 62.2% in 
group G, respectively (P = 0.0001). Gadoxetic acid-enhanced 
MRI for preoperative examination was not the signifi cant 
factor reducing early hepatic recurrence (P = 0.3, 95%CI; 
0.120–2.053).
Conclusion: Gadoxetic acid-enhanced MRI could detect 
smaller nodules, reduce the risk of NLMNs than SPIO MRI, 
but could not contribute to reduce postoperative early hepatic 
recurrence.
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FOS097
COMPARATIVE ANALYSIS OF 
“REVERSE” VERSUS “CONVENTIONAL” 
STRATEGY FOR THE SURGICAL 
MANAGEMENT OF SYNCHRONOUS 
COLORECTAL LIVER METASTASES
M. Auguste1, E. Vibert1, D. Castaing3, D. Azoulay1, 
C. Salloum1 and R. Adam2
1AP-HP Hopital Paul Brousse, Centre Hepato-Biliaire, 
F-94800 Villejuif, France; 2Univ Paris-Sud, Faculte de 
Médecine, Le Kremlin-Bicêtre, F-94270 Le Kremlin-
Bicêtre, France; 3Inserm, Unite 785, F-94800 Villejuif, 
France
Introduction: Resection of colorectal liver metastases 
(CRLM) prior to that of colorectal tumor (reverse strategy) 
has been proposed as an alternative to the conventional strat-
egy (primary resection then CRLM). The objective of this 
study was to compare the results of both strategies.
Methods: From 2006 to 2008, all patients resected from 
synchronous CRLM were included in a prospective database. 
Reversed strategy was mainly considered for advanced 
hepatic tumor disease with asymptomatic primary and con-
ventional one for the other patients. Groups were compared 
for pre- and perioperative fi ndings then outcome after 
surgery. Among 111 consecutive patients surgically treated 
for synchronous CRLM in the 2-year period, 93 patients 
(72%) had a Conventional strategy and 18 patients (28%) 
had a Reverse strategy. A higher maximal tumor diameter 
was demonstrated in the Reverse group (62 ± 66 vs 32 ± 
25 mm – p = 0.0034) as well as a higher rate of severe mor-
bidity: 33% vs 12% (p = 0.003).
Results: Postoperative mortality was nil. A R0 resection 
was achieved in 12/18 (66%) patients of the Reverse group. 
After a similar follow up in the 2 groups (RS vs Conv: 24 ± 
13 vs 25 ± 13 months; p = 0.76), one and 3-year overall 
survival were 82% and 67% in the Reverse group vs 94% 
and 75% in the Conventional one (p = 0.10). After R0 resec-
tion, one and 3-year recurrence-free survival were 78% and 
57% vs 86% and 73% (p = 0.18), respectively. One and 
3-year recurrence rate was 26% and 55% vs 34% and 61% 
respectively (p = 0.58).
Conclusion: The «reverse strategy» provides a similar 
outcome compared to conventional strategy, despite a more 
advanced metastatic disease.
FOS098
LAPAROSCOPIC RESECTION OF 
COLORECTAL CANCER FACILITATES 
SIMULTANEOUS SURGERY OF 
SYNCHRONOUS LIVER METASTASES
C. Hatwell1, F. Bretagnol1, O. Farges2, J. Belghiti2 and 
Y. Panis2
1Colorectal Department, Beaujon Hospital (APHP), 
University Paris VII, Clichy, France; 2Hepatobiliary 
Department, Beaujon Hospital (APHP), University Paris 
VII, Clichy, France
Introduction: Combined resection of colorectal cancer and 
synchronous liver metastases (LM) still remains controver-
sial because of the higher risk of morbidity, the oncologic 
results and the necessity of adequate abdominal approach for 
both liver and colorectal resection. Laparoscopy may be ben-
efi cial in terms of operative results and could facilitate surgi-
cally this combined procedure. To date, only very few studies 
have been reported, with small number of patients on the 
possible benefi t of laparoscopy.
Methods: From 2006 to 2011, all patients with colorectal 
cancer and resectable synchronous LM for which total length 
of the procedure was less than 8 hours, underwent a colorec-
tal laparoscopic resection with combined liver open and/or 
laparoscopic resection.
Results: Fifty-one patients (29 men) with a median age of 
61 years (range, 29–77) underwent combined surgery includ-
ing for the primary colorectal tumor procedure a laparo-
scopic left colectomy (n = 28), rectal resection (n = 20), right 
colectomy (n = 2) and total colectomy (n = 1). Synchronous 
liver resections included major surgery (3 or more segments 
removed) (n = 10, 20%) and minor surgery (n = 41). 
Extraction of the colorectal specimen was performed through 
an incision used for open liver resection, i.e. a right subcostal 
(n = 21), a bi-subcostal (n = 14), an upper midline (n = 9) 
incisions, except in 7 patients (14%) where a totally one-step 
laparoscopic procedure was performed. The overall conver-
sion rate was 8% (n = 4). The 30-day mortality rate was 0%. 
The overall morbidity rate was 55% (n = 28), including 
colorectal related complications in 11 patients and liver 
related in 17 patients. Clinical anastomotic leakage was 12% 
(n = 6). Major morbidity (i.e. Dindo III-IV) rates was 25% 
(n = 13) related to colorectal surgery in 3 cases (anastomotic 
leakage) and to liver surgery in 10 cases (bile leakage with 
hepatic abscess). The median hospital stay was 16 days 
(range, 6–40).
Conclusion: This study showed that laparoscopic colorectal 
resection combined with open or laparoscopic liver resection 
for synchronous LM was feasible and safe. Moreover, lapa-




DOES NOT IMPROVE PATIENT 
OUTCOME FOLLOWING 
LIVER RESECTION
S. Robinson1, R. Saif2, G. Sen2, J. French2, J. Bryon2, 
R. Charnley2, D. Manas2 and S. White2
1Institute of Cellular Medicine, Newcastle University, 
Framlington Place, Newcastle upon Tyne NE2 4HH, UK; 
2Department of HPB and Transplant Surgery, Freeman 
Hospital, High Heaton, Newcastle upon Tyne NE7 7DN, 
UK
Introduction: Post-operative hepatic dysfunction is a major 
cause of concern when undertaking liver resection. The gen-
eration of reactive oxygen species (ROS) as a result of 
hepatic ischaemia/reperfusion injury can result in hepatocel-
lular injury. Experimental evidence suggests that 
N-acetylcysteine may ameliorate ROS mediated liver injury 
and reduce the risk of post hepatectomy liver failure (PHLF) 
although a benefi cial clinical effect has not been conclusively 
demonstrated.
Methods: A cohort of 44 patients who had undergone liver 
resection and receiving peri-operative NAC (10 g/24 hrs) 
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were compared to a further cohort of 44 patients (matched 
for the extent of liver resection, gender, age and chemo-
therapy use) who did not.
Liver function tests (ALT, Alk Phos, Bilirubin and 
Prothrombin time) were compared on post-operative days 1, 
3 and 5. Peri-operative outcome data was retrieved from a 
prospectively maintained database within our unit and com-
plications graded as per the Dindo-Clavien classifi cation. 
PHLF was graded according to the International Study 
Group of Liver Surgery guidelines.
Results: Administration of NAC was associated with a pro-
longed prothrombin time on the third post-operative day 
(18.4 s vs 16.4 s; p = 0.002) as a consequence of which there 
was a higher incidence of grade A PHLF (32% vs 9%; p < 
0.01) in this group. The incidence of grades B and C PHLF 
was lower in the NAC group although this difference did not 
reach statistical signifi cance (6.9% vs 14%; p = 0.287). The 
overall complication rate in the NAC group was lower (30% 
vs 43%; p < 0.05). There was one peri-operative death in the 
NAC group and none in the control group.
Conclusion: Despite promising experimental evidence this 
study was not able to demonstrate any advantage in the 
routine administration of peri-operative NAC in patients 
undergoing liver resection of 3 or more segments.
FOS100
EARLY LIVER RECURRENCE AFTER 
HEPATIC RESECTION FOR 
COLORECTAL METASTASES HAD NO 
IMPACT ON LONG TERM SURVIVAL
Q. Denost, M. Martenot, L. Quintane, J. Saric and 
C. Laurent
Department of Digestive Surgery, Saint-Andre Hospital, 
Victor Segalen University of Bordeaux, Bordeaux, France
Introduction: Despite improvements in treatment of 
colorectal liver metastases (CLM) with the association of 
surgery and chemotherapy, most patients develop early liver 
recurrence after hepatic resection. However, data are lacking 
on the effect of short time recurrence pattern on oncological 
outcomes. This study aimed to assess predictive factors and 
oncological prognosis of early liver recurrence after hepatic 
resection for colorectal metastases.
Methods: From 1999 to 2009, 429 patients had a liver 
resection for CLM. Patients with no curative liver resection 
or with another site of colorectal metastases were excluded. 
Curative resection was defi ned by a surgical margin greater 
than 0 millimetres. Recurrences occurring within 12 months 
after liver resection were defi ned as early recurrences. 
Oncological outcomes were analyzed according to timing of 
liver recurrence. Recurrence and survival were assessed by 
Kaplan Meier method. Univariate and multivariate analyses 
of factors associated with short time to liver recurrence after 
hepatic resection for CLM were carried out.
Results: Two hundred seventy two patients were included 
with a median follow up of 33 months. Patients had bilobar 
CLM in 42% of cases. Liver recurrence rate was 39% and 
two third occurred within 12 months after liver resection. 
Predictive factors of early recurrence were surgical margin 
less than 6 mm (OR = 1.65; 95%CI 1.03–2.63; p = 0.038) 
and radiofrequency (OR = 2.64; 95%CI 1.44–4.82; p = 
0.002). Patients with early liver recurrences had less often 
other sites of metastatic disease compared to those with late 
liver recurrence. Patients with liver recurrences had a cura-
tive treatment in 41% of cases. Five years global survival 
was not altered by early liver recurrence compared to late 
liver recurrences (50% vs. 55%, p = 0.277).
Conclusion: Our results suggest that a safe surgical margin 
is necessary to avoid early liver recurrence after liver resec-
tion for CLM. Moreover, early liver recurrence did not affect 
long term survival because the recurrence was essentially in 
the liver allowing an iterative hepatectomy. Patients with 
short time to recurrence after liver resection for CLM should 
benefi t of a curative treatment.
FOS101
TIMING OF RESECTION FOR 
SYNCHRONOUS LIVER METASTASES 
FROM COLORECTAL CANCER
K. Nojiri, K. Tanaka, T. Kazuhisa, R. Matsuyama, 
T. Kumamoto, M. Ota, Y. Ichikawa and I. Endo
Department of Gastroenterological Surgery, Yokohama City 
University, Graduate School of Medicine, Yokohama, 
Japan
Introduction: The optimal timing of hepatic resection for 
synchronous liver metastases to colorectal primary is still 
controversial. This study aimed to determine the patient 
selection criteria for simultaneous resection of the colorectal 
primary and the liver metastases.
Methods: Among 182 patients with synchronous colorectal 
liver metastases (SCRLM), 71 patients were performed 
hepatic resection simultaneously with primary resection 
(simultaneous group) and 111 patients were performed 
hepatic resection after primary resection (metachronous 
group). Clinical characteristics and surgical outcomes were 
compared between the groups.
Results: Patients background and operative data: The pro-
portion of patients with multiple hepatic metastases (p = 
0.02) and bilobar distribution (p = 0.02), proportion of 
major hepatectomy (p < 0.01), preoperative chemotherapy 
(p < 0.01) and ablative therapy adjunct to hepatectomy (p = 
0.04) was signifi cantly greater in the metachronous resec-
tion group than in the simultaneous resection group. These 
two groups were comparable among the primary status of 
the neoplasm, duration of operation, intraoperative blood 
loss.
Short-term outcomes: No postoperative mortality was 
observed. The morbidity in the simultaneous group (34%) 
was higher than in the metachronous group (18%) (p = 0.02). 
Long-term outcomes: No signifi cant difference in 5-year 
overall and disease-free survival was observed between the 
synchronous group (49.5% and 19.9%) and the metachronous 
group (42.6% and 19.2%; p = 0.96, 0.32).
In the simultaneous resection group, the volume of 
resected liver (more than 300 g) was selected as a risk factor 
for postoperative morbidity (relative risk, 1.626 [95% confi -
dence interval, 1.030–25.091]; p = 0.046). With respect to 
the oncological results, multivariate analysis retained patients 
age (65 years or older), histologic differentiation of colorec-
tal primary and the number of hepatic metastases (4 or more 
lesions) as an independent worse prognostic factors.
Among 182 patients with SCRLM, 83 patients (45.6%) 
were bilobar tumor distribution with 4 or more liver metas-
tases. Of these 83 patients, 21 patients were performed hepatic 
resection simultaneously with primary resection (without 
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neoadjuvant group) and 44 patients were performed hepatic 
resection after primary resection with neoadjuvant prehepa-
tectomy chemotherapy (neoadjuvant group). The proportion 
of patients with disease-free interval less than 6 months was 
signifi cantly higher in the without neoadjuvant group (47.6%) 
than in the neoadjuvant group (22.7%) (p = 0.042).
Conclusion: A one-stage procedure appears not to be desir-
able for synchronous colorectal hepatic metastases for 
patients with 4 or more hepatic lesions and requiring resec-
tion of more than 300 g. Patients with bilobar multiple liver 
metastases should receive neoadjuvant chemotherapy during 
the interval between the colorectal primary and the liver 
resection.
FOS102
A PROSPECTIVE STUDY OF 
PRE-OPERATIVE RADIOLOGICAL 
INVESTIGATIONS FOR THE DETECTION 
OF COLORECTAL LIVER METASTASES
C. Jones1, S. A. Badger1, S. Gillespie2, B. Kelly2, 
J. C. Clarke2, L. D. McKie1, T. Diamond1 and 
P. T. Kennedy2
1Department of HPB Surgery, Mater Hospital, Belfast, 
Northern Ireland; 2Department of Radiology, Royal 
Victoria Hospital, Belfast, Northern Ireland
Introduction: Accurate detection of colorectal liver metas-
tases (CRLM) is paramount to aid prompt treatment. 
Controversy remains regarding the most reliable imaging 
modality, and poses a diagnostic dilemma for surgeons, 
oncologists and radiologists alike. This prospective study 
aimed to compare the fi ndings of 3 modalities of liver spe-
cifi c imaging in the detection of CRLM; and assess associ-
ated long-term survival.
Methods: Consecutive patients with CRLM underwent 
computerised tomographic arterial portography (CTAP), 
magnetic resonance imaging (MRI), and positron emission 
tomographic scan (PET-CT). Two blinded radiologists for 
each modality reviewed the scans by consensus. Group 1 
included those suitable for surgical resection, and radiologi-
cal fi ndings were compared with histopathology. Sensitivity, 
specifi city, and overall accuracy for each investigation were 
calculated. Group 2 included patients deemed unresectable, 
and correlation of results between modalities were deter-
mined. Long-term survival was calculated. Ethical approval 
and written consent was obtained.
Results: 55 patients from September 2002 to May 2004 
were included. In group 1, a yield of 87 possible abnormali-
ties was noted. 40 were reported as metastatic by at least one 
modality, 28 were subsequently confi rmed as metastatic by 
pathology. 15 were correctly characterised by all 4 modali-
ties. MRI was the most accurate (90.6%), followed by CTAP 
(86.0%) and PET-CT (82.6%). MRI was also most specifi c 
(96.5%) while CTAP most sensitive (82.1%). 5-year survival 
was 43.7%. In group 2, 51 lesions were described as meta-
static by all 3 imaging modalities, with PET-CT detecting 
extra-hepatic disease. Correlation of results between MRI 
and PET-CT was (62.1%), followed by MRI/CTAP (51.4%), 
then CTAP/PET-CT (35.0%). 5-year survival was 15.6%.
Conclusion: MRI provided the most accurate pre-operative 
assessment of colorectal liver metastases, for which there is 
a favourable 5-year survival. PET-CT demonstrated the 
ability to detect extra-hepatic disease, while CTAP overesti-
mated the extent of hepatic disease. The combination of MRI 
and PET-CT appears to be the best staging strategy for 
colorectal metastatic patients.
FOS103
IS LIVER RESECTION JUSTIFIED FOR 
PATIENTS WITH LIVER METASTASIS 
FROM BREAST CANCER?
J. Y. Kim, J. K. Kim, H. J. Lee, J. S. Park, D. S. Yoon, 
H. S. Chi and B. R. Kim
Department of Surgery, Gangnam Severance Hospital, 
Yonsei University Health System, Seoul, Korea
Introduction: Metastatic breast cancer has become an 
important issue in breast cancer treatment.
Breast cancer patients developing liver metastases have 
traditionally been considered to show poor prognosis. The 
issue of choosing the appropriate treatment method is still 
debatable. The purpose of this study is to examine our expe-
rience with liver resection in patients.
Methods: We conducted our research targeting 2,176 
patients who underwent surgery due to breast cancer in the 
breast cancer center in Gangnam Severance Hospital from 
January, 1991 through December, 2006. 100 patients had 
multiple-organ metastasis including the liver metastasis and 
13 patients had only liver metastasis. Finally, 13 patients 
were retrospectively reviewed.
Results: The average age of the 13 patients was 51.1 years 
(±9.4 years), and all patients were female. The histological 
classifi cation of the breast cancer was infi ltrating breast 
cancer for 11 patients (84.6%), and they received an adjuvant 
therapy after surgery for breast cancer depending on their 
hormone receptor status and the stage. Synchronous detec-
tion was observed in 2 patients, and metachronous lesion 
detection was seen in 11 patients. The mean time interval 
between detection of liver metastasis and initial breast cancer 
treatment was 62.5 months. All patients was underwent liver 
resection. The medial survival time after liver resection from 
breast cancer was 57.9 months and 1 year and 3 year survival 
rates were 84.6%, 50.1%, respectively.
Conclusion: Liver resection for breast cancer liver metasta-
ses has an important role in the oncological treatment of 
metastatic breast cancer with excellent prognosis.
FOS104
LAPAROSCOPIC RESECTION OF 
COLORECTAL LIVER METASTASES 
DOESN’T INFLUENCE INFLAMMATORY 
MEDIATORS: PROSPECTIVE OPEN VS 
LAPAROSCOPIC TRIAL
R. Montalti, N. V. Damme, K. Geboes, S. Laurent and 
R. I. Troisi
Department of General & Hepato-Biliary Surgery, Liver 
Transplantation Service, Ghent University Hospital and 
Medical School, De Pintelaan 185, 9000 Ghent, Belgium
Introduction: Laparoscopic surgery is thought to reduce the 
postoperative immunologic effects of surgical trauma. The 
aim of the present study was to evaluate the infl uence of 
surgical trauma on infl ammatory mediators.
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Methods: Forty patients with resectable liver metastases of 
colorectal origin were assigned to laparoscopic liver resec-
tion (LLR; n = 22) or conventional open liver resection 
(OLV; n = 18). Blood samples were drawn preoperatively 
and 24 hours after resection. Commercially available ELISA 
methods were used for the determination of IL-6 and IL-8. 
From 25 patients (LLR n = 10 and OLR n = 15), the mRNA 
of infl ammation related factors (COX-2 and MMP-9), angio-
genesis related factor VEGF and HIF-1alpha in tumor tissue 
and normal liver parenchyma were detected by real-time 
RT-PCR.
Results: There were no differences in IL-6 and IL-8 levels 
before resection between the open and laparoscopic tech-
nique; IL-6 levels were signifi cantly elevated in both groups 
at 24 hours compared to preoperative levels (p = 0.028 and 
p = 0.012, respectively). IL-8 levels were also increased at 
24 hours in both groups, although not signifi cantly. The 
expression of COX-2, MMP-9, VEGF and HIF-1alpha 
mRNA was not different between LLR and OLR as well as 
for tumor tissue as for normal liver parenchyma.
Conclusion: Immunological effects assessed by IL 6, IL 8, 
Cox 2, MMP-9, VEGF and HIF-1alpha are similar between 
open and laparoscopic procedures. Laparoscopic approach 
does not reduce the surgical stress in patients suffering from 
colorectal liver metastases.
FOS105
FACTORS INFLUENCING THE IMPACT 
OF CONTRAST-ENHANCED 
INTRAOPERATIVE ULTRASOUND 
DURING LIVER SURGERY FOR 
COLORECTAL CANCER LIVER 
METASTASES
F. Botea, F. Procopio, V. M. Correa, M. Donadon, 
M. Cimino, D. D. Fabbro, M. Montorsi and G. Torzilli
Liver Surgery Unit, 3rd Department of Surgery, University 
of Milan School of Medicine, IRCCS Istituto Clinico 
Humanitas, Rozzano, Milan, Italy
Introduction: Contrast-enhanced intraoperative ultrasound 
(CE-IOUS) during surgery for colorectal liver metastases 
(CLM) is entered in clinical practice. However, its impact 
seems to decrease with the improvement of preoperative 
imaging. Therefore, if CE-IOUS should be selectively or 
routinely applied remains unclear: a profi le of patients who 
may benefi t of CE-IOUS application has to be disclosed. The 
aim of this study is to defi ne reliable criteria for a selective 
use of CE-IOUS during surgery for CLM.
Methods: One hundred and twenty-seven consecutive 
patients underwent liver resection using IOUS and CE-IOUS 
for CLM. All patients underwent preoperative CT and/or 
MRI within 3 weeks prior to surgery. CE-IOUS was per-
formed by injecting intravenously 2.4 mL of sulphur-
hexafl uoride microbubbles (SonoVue, Bracco, Italy). 
Reference standards were histology and imaging at 6 months 
after surgery. Univariate and multivariate analyses were per-
formed. Statistical signifi cance was set at P = 0.05.
Results: IOUS discovered 172 additional lesions in 51 
patients. CE-IOUS found 14 additional lesions not seen at 
IOUS in 6 patients, and confi rmed all the IOUS fi ndings. 
Seventy-fi ve CLM in 36 patients appeared within 6 months 
after surgery. Sensitivity, specifi city, positive predictive 
value, and negative predictive value were: 63%, 98%, 100% 
and 27% for preoperative imaging, 87%, 100%, 100% 
and 52% for IOUS, and 89%, 100%, 100% and 56% 
for IOUS+CE-IOUS, respectively. In 15 patients (12%) 
CE-IOUS allowed better defi nition of tumor margins thus 
helping in resection guidance. At multivariate analysis only 
the presence of multiple CLM (P = 0.014) and their isoechoic 
pattern at IOUS (P = 0.05) independently correlated with 
new fi ndings at CEIOUS.
Conclusion: CE-IOUS may improve IOUS fi ndings both 
for detection and for resection guidance. Furthermore, these 
results show that multiple presentation and isoechoic CLM 
at IOUS are reliable factors requiring the use of CE-IOUS.
FOS106
RADIOFREQUENCY ABLATION FOR 
LIVER COLORECTAL METASTASES
V. Vishnevsky, D. Ionkin, M. Efanov, O. Zhavoronkova, 
O. Melechina, A. Shurakova and A. Zhao
A.V.Vishnevsky Institute of Surgery, Moscow, Russia
Introduction: Aim – patients with liver colorectal metasta-
ses treatment improvement.
Methods: A total of 97 patients with liver colorectal metas-
tases including 41 males and 56 females; age – 51.6 years 
(varying from 27 to 83 years) since 2002 underwent ultra-
sound-guided radiofrequency Ablation (RFA). All patients 
but three undergone primary tumor removal as the fi rst stage 
and they had adjuvant therapy. Radionics Cool-Tip® Ablation 
System and water-cooling probe system was used for RFA. 
189 RFA was performed in total, among them 165 percutane-
ous RFA (PcRFA) and 24 RFA with laparotomy. Mean 
session time (PcRFA) was 2.2 + 1.7 (from 1 to 8). Effi ciency 
control was performed with US, MRI from fi rst 24 hours 
after procedure, from 3, 5 days (US) and then from 1, 3, 6 
(MRI), 12 (MRI), 18, 24 (MRI) months.
Results: An overall complication rate was 10.9% (18/165) 
after PcRFA and 16.6% (4/24) after RFA by open approach. 
Pleural effusion was the most frequent complication (42.5%). 
2 patients died (2.07%) within the fi rst two months after the 
procedure. In spite of chemotherapy and repeated RFA ses-
sions 61% developed new foci during fi rst 6 months, among 
them 26% intrahepatic, 34% extrahepatic and 45.8% intra- 
and extrahepatic. Post-RFA 1-, 2-, 3-, 4- and 5-years survival 
rates were 84.2%; 62.7%; 51.7%; 32.7% and 26.3% rela-
tively. Mediana survival – 30 months.
Conclusion: Patients with liver colorectal metastases 
treated with RFA, as well as operatively develop different 
results, depending on the following prognostic factors: 
metastases identifi cation period, localization, tumor nodes 
number and size. US and CT are less informative in RFA 
effi ciency control comparing with MRI. Partial destruction 
is more frequent than progressive tumor growth. PcRFA can 
be performed whenever necessary. RFA, especially PcRFA, 
as a minimally invasive local treatment, has become an effec-
tive and relatively safe alternative for the patients with liver 
colorectal metastases.
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FOS107
DETERMINATION OF SAFE FUTURE 
LIVER REMNANT RATIO PRIOR TO 
MAJOR HEPATECTOMY IN PATIENTS 
WITH COLORECTAL LIVER 
METASTASES
M. Narita1, E. Oussoultzoglou2, P. Fuchshuber3, I. Ikai1, 
P. Pessaux2, E. Rosso2, D. Jaeck2 and P. Bachellier2
1Department of Hepato-Pancreato Biliary Surgery, Kyoto 
Medical Center, Kyoto, Japan; 2Centre de Chirurgie 
Viscérale et de Transplantation, Hôpitaux Universitaires de 
Strasbourg, Hôpital de Hautepierre, Strasbourg, France; 
3Department of Surgical Oncology, The Permanente 
Medical Group, California, USA
Introduction: A multidisciplinary approach involving pre-
operative chemotherapy has become common practice in 
patients presenting with colorectal liver metastases (CLM). 
Data on clinically based determination of safe future liver 
remnant (FLR) volume in these patients is lacking. The aim 
of study was to identify predictors of postoperative morbidi-
ties in patients undergoing major hepatectomy after intensive 
preoperative chemotherapy for CLM.
Methods: Between January 2000 and August 2010, 101 
consecutive patients presenting with CLM underwent major 
hepatectomy after preoperative chemotherapy (≥6 cycles of 
oxaliplatin or irinotecan regimen with or without targeted 
therapies) in Hôpital de Hautepierre, Strasbourg, France. 
Predictors of postoperative overall morbidities, sepsis, and 
liver failure were identifi ed using uni- and multivariate 
analysis.
Results: Postoperative mortality rate was 1.0%. Fifty-eight 
patients had 95 postoperative complications. Sepsis and post-
operative liver failure occurred in 23 (22.8%) and 16 patients 
(15.8%), respectively. On univariate analysis small future 
liver remnant (FLR) ratio (defi ned as FLR volume [mL]/total 
liver volume [mL] × 100%) was signifi cantly associated with 
overall morbidity, sepsis, and liver failure. Using Receiver 
Operator Characteristic analysis, the cut-off for FLR ratio in 
predicting overall morbidity, sepsis, and liver failure was 
44.8%, 43.1%, and 37.7%, respectively. On multivariate 
analysis each FLR ratio cut-off was an independent predictor 
of overall morbidity (OR; 4.85), sepsis (OR; 9.36), and liver 
failure (OR; 130.90).
Conclusion: This study provides the optimal FLR ratio for 
safe postoperative outcome after major hepatectomy in CLM 
patients and receiving 6 or more cycles of preoperative 
chemotherapy.
FOS108
TREATMENT STRATEGY FOR 
SYNCHRONOUS BILOBAR 
COLORECTAL LIVER METASTASES
H. Yoshidome, H. Shimizu, M. Ohtsuka, A. Kato, 
H. Yoshitomi, K. Furukawa, F. Kimura and M. Miyazaki
Department of General Surgery, Chiba University 
Graduate School of Medicine, Chiba, Japan
Introduction: Synchronous bilobar colorectal liver metas-
tases (CRLM) are often recurred even after curative hepatec-
tomy. We previously reported benefi ts of delayed resection 
for synchronous CRLM because it may reduce early recur-
rence caused, at least in part, by existence of micrometasta-
ses. The objective of this study is to investigate the benefi ts 
and limits of sequential resection of primary and synchro-
nous bilobar CRLM and to also demonstrate effects of con-
version chemotherapy.
Methods: We identifi ed 362 patients who underwent initial 
hepatic resection (Hx) for CRLM. Among these patients, 84 
patients had synchronous bilobar CRLM. Fifty two patients 
underwent simultaneous resection and 32 patients underwent 
delayed Hx. The tumor progression during interval between 
primary resection and Hx was determined by an identical 
abdominal enhanced CT. We also identifi ed 34 patients with 
initially unresectable synchronous CRLM. The effect of con-
version therapy using cytotoxic agents and biologics was 
determined. Medical records of these patients were retro-
spectively reviewed. Overall survival rates were evaluated 
by the Kaplan-Meier method. The univariate or multivariate 
analyses were estimated by the Cox proportional hazards 
models.
Results: Median/mean interval between the evaluations 
prior to the resection for primary tumor and Hx was 2/2.2 
months. Twenty-two of the 32 (68%) patients had new 
detectable lesions after reevaluation. The median/mean 
number of metastases was not signifi cantly different between 
the simultaneous and delayed Hx group. Hepatic disease-free 
survival after Hx was signifi cantly different between the two 
groups. Multivariate analysis showed that delayed Hx, pN2, 
5 or more liver mets were signifi cant prognostic factors for 
survival. Among 34 patients with initially unresectable 
CRLM, 22 patients were converted to Hx. The overall sur-
vival was better in patients who had 20% or more tumor 
shrinkage at 8 weeks after conversion therapy and underwent 
Hx.
Conclusion: Tumor progression was recognized and occult 
metastases were detected after the interval reevaluation. 
Delayed hepatectomy may be a useful approach to reduce 
rapid remnant liver recurrence in synchronous bilobar 
CRLM. Neoadjuvant chemotherapy may be required in 
patients who have primary nodal metastases (pN2) or 5 or 
more synchronous resectable CRLM. Tumor shrinkage of 
20% or more at 8 weeks after conversion chemotherapy may 
be a useful indicator for survival in initially unresectable 
CRLM.
FOS109
A POTENTIAL ROLE FOR 
PHARMACOGENOMICS IN 
DETERMINING OXALIPLATIN INDUCED 
TISSUE INJURY AFTER DOWN STAGING 
COLORECTAL LIVER METASTASIS
S. Robinson1, J. Mann1, A. Burt, D. Manas2, D. Mann1 
and S. White1
1Institute of Cellular Medicine, Newcastle University, 
Framlington Place, Newcastle upon Tyne NE2 4HH; 
2Department of HPB and Transplant Surgery, Freeman 
Hospital, High Heaton, Newcastle upon Tyne NE7 7DN
Introduction: Oxaliplatin based chemotherapy has been 
linked to the development of sinusoidal obstruction syn-
drome (SOS) which can have a negative impact on outcome 
following resection of colorectal liver metastases.
The aim of this study was to determine what effect expres-
sion of genes involved in the transport of platinum based 
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drugs may have on tissue injury following exposure to 
Oxaliplatin based chemotherapy in a murine model of color-
ectal liver metastases.
Methods: Experimental colorectal liver metastases were 
established in C57/Bl 6 mice using the syngeneic MCA38 
colorectal cancer cell line via a midline laparotomy. After 3 
weeks animals were culled and RNA extracted from liver, 
spleen and tumour tissue. RT-PCR was then performed to 
determine expression of transporters associated with the 
uptake of platinum based drugs (CTR1 & 2) and its export 
from cells (ATPase 7A & 7B).
Tumour bearing or sham operated animals (n = 6 per 
group) were treated with either intraperitoneal FOLFOX or 
vehicle control weekly for 3 weeks and culled 1 day after the 
fi nal dose. Drug induced tissue injury was assessed by H & 
E staining and chemotherapy induced DNA damage by 
immunohistochemistry for H2AX.
Results: Both spleen and tumour tissue demonstrated evi-
dence of injury following treatment with FOLFOX whereas 
there was no evidence of liver injury. In keeping with this 
FOLFOX treatment was associated with an increase in the 
number of H2AX positive cells in both the spleen (38 vs 9 
cells per HPF; p < 0.01) and tumour tissue (51 vs 38 cells 
per HPF; p < 0.01) but not in the liver.
All tissues demonstrated relatively high expression of 
CTR1 and lower expression of CTR2, a pattern that is 
accepted as indicating sensitivity to Platinum drugs. In con-
trast the liver was found to express very high levels of the 
ATPase 7B whereas low levels were expressed in the 
FOLFOX sensitive spleen and tumour tissue suggesting they 
are less able to remove the drug.
Conclusion: High levels of expression of ATPase 7B seem 
to be associated with resistance to tissue injury following 
FOLFOX chemotherapy.
Numerous polymorphisms have been linked to this gene 
potentially resulting in accumulation of both copper and 
platinum in certain tissues. These genetic polymorphisms 
could explain the variability of SOS seen in patients having 
liver resection for colorectal liver metastasis.
FOS110
PLANNED LAPAROSCOPIC TWO-STAGE 
STRATEGY FOR PATIENTS WITH 
MULTIPLE BILOBAR COLORECTAL 
LIVER METASTASES (CRLM)
M. Gelli, C. Gronnier, N. Shivathirthan and B. Gayet
Institut Mutualiste Montsouris, Paris, France
Introduction: Two-stage hepatectomy (TSH) represents a 
valuable option for CRLM otherwise not amenable to cura-
tive resection. Laparoscopic liver surgery has been demon-
strated as a safe and effective approach respecting oncological 
principles and results. The purpose of this study was to assess 
feasibility, risks and patient outcomes of planned laparo-
scopic two-stage strategy for CRLM through a retrospective 
analysis of the entire cohort of TSH in a tertiary hepato-
biliary laparoscopic center.
Methods: Between 2000 and 2011, 16 of 41 patients 
referred to our institution for multiple bilobar CRLM were 
enrolled for a TSH. Median number of CRLM was 6 with 
median diameter of 40 mm. During fi rst hepatectomy (FH), 
future liver remnant clearance was achieved by major hepa-
tectomy (MH) and minor hepatectomy/ablative procedure 
respectively in 1 and 15 patients. Two concomitant portal 
vein ligations and 7 interval portal vein embolizations were 
performed. After a median interval of 4 months, 14 (88%) 
patients were proposed for the second hepatectomy (SH) and 
12 (75%) of them completed TSH by a MH (5 right hepa-
tectomy, 3 extended right hepatectomy, 1 extended left hepa-
tectomy and 1 segmentectomy 2, 3, 4b and 7) or by multiple 
metastasectomy in 2 cases.
Results: FH and SH were achieved by laparoscopy in 81 
and 75% of patients, respectively. A concomitant colorectal 
resection was performed in 43% of cases. One conversion 
and 3 open resections were necessary during SH. Median of 
intraoperative blood loss of the SH was 273 ml. During FH 
and SH, severe complications (grade III/IV Clavien-Dindo 
classifi cation) were 12 and 25% with no postoperative mor-
tality. Microscopic negative margin resection rate was 75%. 
Hepatic progression occurred in 2 patients before planned 
SH, but one of them underwent a delayed second hepatic 
resection. 3 and 5-year overall survival rate were 55 and 23% 
respectively. Median overall and disease free survival in 
patients who completed TSH were 36.4 and 10.9 months 
respectively.
Conclusion: A planned laparoscopic TSH strategy repre-
sents an effi cient alternative to the open procedure for mul-
tiple bilobar CRLM in an experienced tertiary center. Main 
advantages of its extended application are to offer the con-
ventional laparoscopic benefi ts and to facilitate iterative 
hepatic dissection minimizing surgical impact in case of con-
traindications for curative resection. In our initial experience, 
TSH can be performed safely by laparoscopy with limited 
technical restrictions.
FOS111
EXPRESSION PATTERN OF CXCR4/
CXCL12 IS A PROMISING PREDICTIVE 
MARKER FOR SURVIVAL AFTER 
HEPATIC RESECTION FOR 
COLORECTAL LIVER METASTASES
H. Yoshidome, N. Sakai, T. Shida, D. Takeuchi, 
H. Shimizu, M. Ohtsuka, F. Kimura and M. Miyazaki
Department of General Surgery, Chiba University 
Graduate School of Medicine, Chiba, Japan
Introduction: Liver metastases develop in a signifi cant 
number of patients with colorectal cancer. The chemokine 
network such as interaction between CXCR4 and CXCL12 
plays a role in the induction of organ-specifi c metastases. 
The present study examined CXCR4/CXCL12 axis in 
colorectal liver metastases (CRLM) and determined whether 
the expression patterns affect tumor microenvironment, and 
whether they could serve as a marker for survival and a 
personalized therapy.
Methods: We identifi ed 92 CRLM patients whose tumors 
were evaluated by CXCR4 and CXCL12 immunohistochem-
istry. Immunoreactivity for CXCR4 was semi-quantifi ed by 
assessing staining intensity. CXCL12/CD133 immunoreac-
tivity was semi-quantifi ed by assessing the staining intensity 
and ratios (%) of positively stained cells. The median follow-
up time of these patients was 38 months. Clinicopathological 
data of these patients were examined. Overall survival rates 
were evaluated by the Kaplan-Meier method. The univariate 
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or multivariate analyses were estimated by the Cox propor-
tional hazards models. The expression profi le of CXCR4 in 
the colorectal cancer cell line was determined by fl uores-
cence microscopy.
Results: The cytoplasmic CXCR4 expression was higher in 
36 patients than that indicated by CXCR4 staining intensity 
of hepatocytes. CXCL12 was also expressed in hepatocytes 
surrounding the tumors at high and low levels in 68 (74%) 
and 24 (26%), respectively. High levels of nuclear CXCR4 
expression were seen in 23 patients which signifi cantly cor-
related with CXCL12 expression in hepatocytes. The nuclear 
CXCR4 expression in the cancer cell line increased after 
exposure to CXCL12. The univariate and multivariate analy-
ses demonstrated that high levels of nuclear CXCR4 and the 
increased CXCL12 expression in hepatocytes were signifi -
cantly better prognostic factors for overall and hepatic dis-
ease-free survival in patients with CRLM.
Conclusion: The CXCR4 expression in CRLM together 
with the upregulation of CXCL12 in hepatocytes may help 
to predict the clinical outcomes of patients with CRLM after 
hepatic resection. Curative hepatic resection could be per-
formed in patients with high nuclear CXCR4 expression and 
CXCL12 in hepatocytes. Otherwise, adjuvant chemotherapy 
may be required for other patients which may establish a 
personalized therapy.
FOS112
IS RESECTION OF COLORECTAL LIVER 
METASTASES AFTER CHEMOTHERAPY 
WITH BEVACIZUMAB AN EFFICIENT 
STRATEGY?
R. Audollent1, M. Chirica1, M. Faron1, H. Tranchard1, 
M. Svrcek2, P. Balladur1, A. de Gramont3 and F. Paye1
1Service de Chirurgie Digestive, Hôpital Saint Antoine, 
Paris, France; 2Service d’Anatomopathologie, Hôpital 
Saint Antoine, Paris, France; 3Service d’Oncologie, 
Hôpital Saint Antoine, Paris, France
Introduction: Resection of colorectal liver metastasis 
(CLM) can be performed after tumor downstaging by sys-
temic chemotherapy enhanced with bevacizumab because of 
tumor progression, but long term outcome in this setting is 
poorly studied. This study assesses postoperative oucome 
and long-term survival of patients who underwent resection 
of CLM after a downstaging chemotherapy including beva-
cizumab by comparison with initially resectable patients 
treated with fi rst line FOLFOX neoadjuvant chemotherapy.
Methods: Between 2000 and 2010, 347 consecutive patients 
underwent surgical resection for CLM in our institution and 
were recorded retrospectively. All 121 patients who under-
went CLM resection following neoadjuvant chemotherapy 
were included. Among them, 26 received bevacizumab asso-
ciated to chemotherapy in order to control tumor progression 
under initial chemotherapy regimen (group A) and 95 patients 
received FOLFOX without tumoral progression for two 
months before hepatic resection (group C).
Results: Groups A and C did not differ for % of synchro-
nous CLM, postoperative mortality (0% vs 1%) and morbid-
ity rates (8% vs 21%) and use of postoperative chemotherapy. 
In group A, CLM were more numerous (3 [2–7] vs 2 [1–3], 
p < 0.01), larger (40 ± 37 mm vs 30 ± 22 mm, p = 0.03) and 
more often bilobar (69% vs 29%, p < 0.01). 1-year, 3-year 
and 5-year overall survival (OS) rates were 88%, 41% and 
41% in group A and 95%, 60%, 38% in group C (p = 0.32). 
Disease free survival rates were respectively 41%, 24%, and 
16% and 48%, 25%, 20% (p = 0.37). In group A, absence of 
extra hepatic disease (p < 0.01) and complete pathologic 
response of at least one CLM (p < 0.01) were associated with 
better OS, the latter being the single signifi cant factor on 
multivariate analysis.
Conclusion: This study confi rms the favourable postopera-
tive outcome of hepatectomies for CLM in patients preopera-
tively treated with bevacizumab. It validates the resection of 
CLM which progression under standard chemotherapy is 
controlled by adjunction of bevacizumab, by reporting for 
the fi rst time, the good long-term oncological outcome of this 
strategy. Resectable CLM treated with neoadjuvant FOLFOX 
and CLM becoming resectable with adjunction of bevaci-
zumab share the same prognosis after resection.
FOS113
A NEW DEVICE FOR DESTRUCTION OF 
LIVER METASTASES (LM) USING HIGH 
INTENSITY FOCUSED ULTRASOUND 
(HIFU): FIRST CLINICAL RESULTS
A. Dupré1, A. Gandini1, Y. Chen1, D. Melodelima2, 
J.-Y. Scoazec3, J.-Y. Chapelon2 and M. Rivoire1
1Département de Chirurgie, Centre Léon Bérard, Lyon, 
France; 2UMR INSERM U1032 LABTAU, France; 
3Laboratoire d’Anatomie et de Cytologie Pathologiques, 
Hospices Civils de Lyon, Lyon, France
Introduction: HIFU has demonstrated effi cacy for prostate 
cancer treatment. It holds great promise in liver tumor treat-
ment due to echographic targeting and no need of puncture. 
We developed a new powerful toroidal transducer with an 
integrated ultrasound imaging probe (IUSP) allowing real-
time targeting and monitoring. In preclinical studies*, it gen-
erated a 7 cm3 ablation (i.e. 2 cm in diameter) in 40 seconds. 
This phase I-II study was designed to assess its effectiveness 
in patients operated on for LM.
Methods: Patients with LM having right hepatectomy were 
included after informed consent. 2 HIFU ablations (1 super-
fi cial, 1 deep) were performed on normal liver to be resected. 
Phase I was designed to confi rm preclinical results and dem-
onstrate effectiveness of HIFU to ablate quickly and safely 
a large volume of liver. Secondary endpoints concerned 
real-time monitoring of the lesion with the IUSP. Phase II 
was designed to assess the ability of the IUSP to precisely 
guide HIFU ablations. An echogenic marker located within 
the liver represented a target to be destroyed or to be 
spared by the HIFU ablation (part 1 or 2 of the phase II). 
IUSP and pathology measurements were compared after 
hepatectomy.
Results: 15 patients with LM having right hepatectomy 
were included from 02/10 to 10/11. For Phase I, 12 40-seconds 
HIFU ablations were performed in 6 patients. There were no 
hemodynamic and respiratory changes. No HIFU-related 
complications occurred. IUSP allowed precise real-time 
monitoring of all HIFU ablations. IUSP and pathological 
measurements correlated well (r = 0.91). HIFU ablation 
diameter and depth were 18.7 ± 2.0 and 27.5 ± 6.3 mm (mean 
± SD). For Phase II, 18 40-seconds HIFU ablations were 
performed in 9 patients. Phase I results were confi rmed. The 
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marker was centered in the HIFU ablation with a precision 
of 1–2 mm. In the second part of the phase II the HIFU abla-
tion was precisely located at 7 ± 2.3 mm from the marker 
(expected distance 7.5 mm).
Conclusion: This study confi rms our preclinical results*. 
This new HIFU device achieved fast, safe and accurate large 
volume liver ablation, without puncture. The accuracy, 
coupled with real-time guidance and monitoring provided by 
IUSP, allows juxtaposition of elementary ablations and 
destruction of large LM with per treatment precise evaluation 
of margins. Depending on the results of an ongoing phase II, 
HIFU ablation may become a reference tool to treat LM.
Reference
*Parmentier H et al Ann Surg 2009;249:129–36
FOS114
A PREHABILITATION PROGRAM FOR 
LIVER SURGERY
D. Dunne1, R. Jones1, G. Poston1, H. Malik1, D. Palmer2, 
S. Jack3 and S. Fenwick1
1Northwestern Hepatobiliary Centre, Aintree University 
Hospital, Liverpool, UK; 2Department of Oncology, 
University of Liverpool, Liverpool, UK; 3Department 
of Respiratory Medicine, Aintree University Hospital, 
Liverpool, UK
Introduction: Rehabilitation exercise programs improve 
recovery from surgery and quality of life. Prehabilitation 
improves fi tness prior to surgery. This is challenging before 
liver resection as patients tend to be sedentary and time is 
limited. Our aim was to design a 4 week program, suitable 
for sedentary individuals, which would yield a 1.5 ml/kg/min 
increase (10%) in the relative VO2 uptake at the anaerobic 
threshold (AT), as measured by a cardiopulmonary exercise 
test (CPET).
Methods: Interval based exercise program of 12 sessions on 
a stationary bike. Each session 40 min long consisting of 6 
intervals, warm up and cool down. The interval intensities 
were calculated using anaerobic threshold detected by initial 
CPET. AT is independent of volition and can be detected with 
reliability in most patients. This represents a measure for 
designing exercise programs for patients. Eleven healthy 
volunteers completed the exercise program.
Results: The 11 volunteers had a mean age of 46 years 
(range 38–60). They consisted of 2 men 9 women. Mean 
BMI 30.7 (range 25.5–39.2), 2 smokers, 9 non-smokers, no 
signifi cant comorbidities. 96% attendance with 9/11 volun-
teers achieving 100% attendance. Mean relative VO2 at AT 
was 12.4 ml/kg/min pre exercise program and 14.0 ml/kg/
min post exercise program, a 12% improvement (p < 0.001). 
Mean resting O2 uptake decreased by 28% (p – 0.014). There 
was a trend to lower resting O2 pulse rate. At AT signifi cant 
differences were achieved in mean O2 pulse (+11.6), and 
power (25.7%) p < 0.001. Peak values also improved with 
mean peak O2 pulse climbing by 10.7% (p – 0.001), mean 
peak power by 14.7% (p – 0.006).
Conclusion: This is the fi rst 4 week exercise program 
designed for patients prior to liver resection and the only 4 
week exercise program based round AT. It is feasible in 
sedentary healthy volunteers and achieves a >10% fi tness 
improvement. An RCT is underway assessing this program’s 
feasibility in patients prior to liver resection. Using our 
CPET risk stratifi cation protocol a 10% fi tness improvement 
in these patients would move 30% of our patients from high 
to low operative risk.
FOS115
PLASMA BILE SALT, TRIGLYCERIDES 
AND APOA-V LEVELS IN THE 
PREDICTION OF LIVER VOLUME AND 
FUNCTION AFTER PORTAL VEIN 
EMBOLIZATION
L. Hoekstra1, K. van Lienden2, J. van den Esschert1, 
F. Schaap3 and T. van Gulik1
1Department of Surgery, Academic Medical Center, 
University of Amsterdam, Amsterdam, The Netherlands; 
2Department of Radiology, Academic Medical Center, 
University of Amsterdam, Amsterdam, The Netherlands; 
3Tytgat Institute for Liver and Intestinal Research, 
Academic Medical Center, University of Amsterdam, 
Amsterdam, The Netherlands
Introduction: Preoperative portal vein embolization (PVE) 
is a technique to increase the future remnant liver (FRL). The 
hypertrophy response after PVE has been shown to correlate 
with outcome after resection. The commonly employed 
method to assess liver hypertrophy in the non-embolized 
lobe following PVE is CT volumetry, performed 3–6 weeks 
after PVE. Early parameters to predict effective hypertrophy 
are therefore desirable.
Methods: The aim of this study was to assess plasma bile 
salt levels, triglycerides and apoA-V in the prediction of the 
hypertrophy response after PVE. Serum bile salt, triglycer-
ides and apoA-V levels were determined in 20 patients with 
colorectal metastases before PVE, and 5 hours, 1 day, and 
21 days after PVE. These parameters were correlated with 
liver volume as measured by CT volumetry, and liver func-
tion determined by Tc-labled mebrofenin hepatobiliary scin-
tigraphy using SPECT.
Results: In patients undergoing PVE, both bile salt and tri-
glyceride levels at 5 hours after PVE positively correlated 
with the increase in FRL volume (r = 0.672, p = 0.024; r = 
0.620, p = 0.042 resp.) as well as with liver function after 22 
days (for bile salts r = 0.640, p = 0.046). Serum apoA-V was 
not altered by PVE but increased shortly after subsequent 
liver resection.
Conclusion: Bile salt and triglycerides levels at 5 hours 
after PVE are signifi cant, early predictors of post-PVE liver 
volume and function increase after 3 weeks. Thus, these 
parameters can be used in timing of resection after PVE.
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FOS116
IS SURGERY JUSTIFIED IN PATIENTS 
WITH MORE THAN 10 LIVER 
METASTASES FROM COLORECTAL 
CANCER?
R. Adam1, D. Elias2, V. Zagainov3, L. Capussotti4, 
S. Lopez-Ben4, E. Barroso5, A. Guglielmi6 and G. Mentha7
1AP-HP Hôpital Paul Brousse, Centre Hépato-Biliaire, 
Villejuif, France; 2Institut Gustave Roussy, Villejuif, 
France; 3Nizhny Novgorod State Medical Academy, Nizhny 
Novgorod, Russia; 4Ospedale Mauriziano Umberto I, 
Torino, Italy; 5Curry Cabral Hospital, Lisbon, Portugal; 
6GB Rossi University Hospital, Verona, Italy; 7Hôpitaux 
Universitaires de Genève, Genève, Switzerland
Introduction: Liver resection is the sole curative treatment 
of colorectal liver metastases (CRLM). However patients 
with more than 3 metastases are known to have less chance 
of long term survival. With 10 metastases or more, surgery 
is usually assumed to be merely palliative. The aim of the 
study was to assess the long term outcome of patients 
resected for ≥10 metastases.
Methods: From January 1995 to June 2011, within a total 
cohort of 11 509 patients resected from CRLM and prospec-
tively included in LiverMetSurvey, an international registry, 
445 patients (3.9%) had ≥10 CRLM. Both groups with <10 
and ≥10 CRLM were compared. Prognostic factors were 
identifi ed by uni- and multivariate analysis for overall and 
disease-free survival (OS, DFS).
Results: In the group with ≥10 CRLM, patients were 
younger (p < 0.001) with similar sex ratio but lower propor-
tion of rectal primary (28.8 vs 35.8%, p = 0.004) and higher 
lymph node invasion (74.2 vs 63.2%, p < 0.0001). Metastases 
were more often synchronous (p < 0.0001), with higher value 
of CEA at diagnosis (p = 0.0005). Mean number of CRLM 
was 13.9 vs 2.3 (p < 0.0001) with a mean size of 45 vs 
38.6 mm, respectively (p = 0.001). Metastases were also 
more bilateral (92.6 vs 33.1%, p < 0.001) and initially non 
resectable (67.8 vs 15.1%, p < 0.03) needing a major hepa-
tectomy (70 vs 54.2%, p < 0.01), more often combined to an 
adjuvant technique (Portal embolisation, Radiofrequency, 
Two-stage) but however less frequently curative (57.7 vs 
92.4%). A preoperative chemotherapy was more frequently 
delivered in pre- as well as in postoperative setting (both p 
< 0.001), and included more often a targeted therapy 
(Cetuximab or Bevacizumab: 38.4 vs 23.2%, p < 0.0001) 
with a higher response rate to chemotherapy (77.9 vs 64.3%, 
p < 0.0001). OS was 42 vs 62% at 3 yrs and 21 vs 44% at 
5 yrs with a DFS of 28 vs 38% at 3 yrs and 13 vs 27% at 
5 yrs (all p < 0.01). At multivariate analysis, independent 
predictive.
Conclusion: factors of OS were: age >70 (p = 0.02), 
maximum size >30 mm (p = 0.03), incomplete liver resection 
(p = 0.04) and absence of preoperative targeted therapy 
(p = 0.004).
Liver resection for ≥10 CRLM is likely to offer a 21% 
5-year survival, although being potentially curative in only 
60% of the cases. A good response to preoperative chemo-
therapy combined to a targeted therapy in a patient <70 years 
submitted to a complete resection are the best predictors of 
a prolonged survival.
FOS117
GLASS MICROSPHERE (YTTRIUM-90) 
RADIOEMBOLIZATION FOR HEPATIC 
NEUROENDOCRINE METASTASES
R. Groeschl, W. Rilling, R. Hieb, K. Christians, S. Tsai, 
E. Quebbeman, T. Gamblin and S. Pappas
Medical College of Wisconsin, Milwaukee, WI, USA
Introduction: Yttrium-90 radioembolization (RE) is a 
treatment option for management of unresectable hepatic 
malignancies. Most reports regarding RE for metastatic neu-
roendocrine tumors (mNET) focus on the use of a resin 
microsphere delivery system. We sought to examine the tox-
icity, effi cacy, and prognostic factors associated with glass 
microsphere RE treatment for unresectable mNET.
Methods: A retrospective review of unresectable mNET 
patients treated with RE was performed. Demographic and 
clinical data were collected, including Eastern Cooperative 
Oncology Group (ECOG) status. Tumor response was mea-
sured by RECIST criteria and degree of necrosis. Kaplan-
Meier curves were used to examine overall survival (OS) 
from the time of initial RE treatment. Cox proportional 
hazards models generated hazard ratios (HR) and 95% con-
fi dence intervals (CI) to assess independent signifi cance of 
potential prognostic factors.
Results: Forty-two RE treatments were performed in 27 
patients, 20 of which had carcinoid tumors. Indications were 
symptom control and/or radiographic disease progression. 
Mean time from diagnosis to RE was 3.8 yrs (range: 
1.1–6.2 yrs). Mean number of previous regional therapies 
was 2.5 and 4 patients had undergone previous liver resec-
tion. There were no 30-day mortalities. 6-month surveillance 
imaging showed no complete responses, 14 partial responses, 
stable disease in 27, and 1 patient had progressive disease. 
Median OS was 19.4 months. Higher ECOG status indepen-
dently predicted poorer survival (HR: 3.3, CI: 1.6–7.4, 
p = 0.002).
Conclusion: To our knowledge, this is the largest reported 
series of patients treated with glass microsphere RE for 
mNET. The control of disease progression in advanced 
disease highlights RE as a useful tool in the treatment algo-
rithm for mNET. Our results demonstrate comparable out-
comes to resin microspheres, however larger comparative 
studies are needed to validate this fi nding.
FOS118
TEN YEARS OF FOLLOW UP AFTER 
RESECTION OF COLORECTAL LIVER 
METASTASES
K. Roberts1, A. Cockbain1, J. Hodson2, R. Prasad1, 
G. Toogood1 and P. Lodge1
1Department of Liver Surgery, St James Hospital, Leeds, 
UK; 2Medical Statistician, University Hospitals 
Birmingham, UK
Introduction: There are few series of 10 year follow up 
after resection of colorectal liver metastases (CLRM). 
Previous studies have suffered from a high proportion of 
patients lost to follow up, small numbers or combining data-
bases between units. The aim of this study was to review a 
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cohort of patients with 10 years of actual follow up following 
resection of CRLM from a single European institution.
Methods: Consecutive patients between 1992 and 2001 
were identifi ed from a departmental database. Post operative 
deaths (n = 18) were excluded. Hospital records, general 
practitioners, patients and cancer registries were reviewed to 
minimise loss to follow up and accurately record causes of 
death.
Results: The 1, 5 and 10 year actual survival was 86, 39 and 
23% of 270 subjects respectively. 3 patients cause of death 
could not be verifi ed and 2 were lost to follow up (2%). 
Seventy patients underwent 105 further resections for recur-
rent disease of which 86% were within 5 years of follow up. 
5% of those alive at 5 years developed their fi rst episode of 
recurrence after this point. Advanced age, 6 or more hepatic 
segments resected, extrahepatic resection, major vascular 
reconstruction, margin status, node positive primary were 
associated with worse survival whilst resection of recurrent 
disease increased median survival.
Conclusion: Providing surveillance beyond 5 years of 
follow up is advantageous. Nearly one quarter of all patients 
undergoing resection of CRLM will be alive 10 years fol-
lowing initial liver resection.
FOS119
IMPACT OF PATHOLOGICAL ANALYSIS 
FROM THE FIRST STAGE 
HEPATECTOMY ON FEASIBILITY AND 
RESULTS OF TWO-STAGE 
HEPATECTOMY
F. Faitot1, O. Scatton1, P. Balladur2, D. Wendum3, 
J. Sandrini3 and O. Soubrane1
1Department of Hepatobiliary Surgery and Liver 
Transplantation, Hôpital Saint-Antoine, Paris, France; 
2Department of Digestive Surgery, Hôpital Saint-Antoine, 
Paris, France; 3Department of Pathology, Hôpital 
Saint-Antoine, Paris, France
Introduction: Patients with multiple bilobar colorectal liver 
metastases (CRLM) can be proposed a two-stage hepatec-
tomy strategy in a curative intent. However, considering its 
morbidity and mortality and the risk of drop out after the fi rst 
stage, engaging a patient in this technically demanding strat-
egy must be discussed. We sought to identify if histological 
factors obtained from the resected specimen at the fi rst stage 
increased predictability of feasibility and long-term results 
of the strategy.
Methods: From 2004 to 2010, 50 patients who underwent 
a fi rst stage hepatectomy for bilobar CRLM were included. 
The specimen resected at the fi rst stage of 38 of these patients 
were retrospectively analyzed for number, size, differentia-
tion, vascular, lymphatic and biliary invasion, margins and 
histological response according to Blazer’s score, Rubbia-
Brandt’s Tumor Response Grade (TRG) and growth pattern 
of the lesion in a systematic way. Usual perioperative param-
eters were studied as well. A statistical analysis was con-
ducted in order to identify clinical and histological factors 
predictive of (i) feasibility of the second stage and (ii) overall 
and disease-free survival.
Results: The feasibility of the two stages was 76%. The 
clinical predictive factors of non feasibility of the second 
stage were male gender (p = 0.003), segment 1 metastasis 
(p = 0.037) and necessity to resect or radiofrequence more 
than 3 lesions (p = 0.003). Vascular invasion in the primary 
(p = 0.02) and microscopic biliary invasion (p = 0.02) 
better discriminated feasibility of the second stage. A clini-
copathological score based on these criteria predicted feasi-
bility of the two stages and disease-free survival in patients 
achieving the 2 stages. Pathological response evaluated by 
Blazer’s score, TRG or the growth pattern was predictive of 
overall survival and growth pattern was predictive of recur-
rence-free survival in patients achieving the two-stages.
Conclusion: Pathological analysis from the resected speci-
men of the fi rst stage hepatectomy presents an additional 
value in predicting feasibility of the second stage, overall 
survival and disease-free survival in patients who achieve the 
two stages. Combined to clinical parameters it enables better 
prediction of short and long-term outcomes.
FOS120
PROTECTION OF PHARMACOLOGICAL 
POST-CONDITIONING IN PATIENTS 
UNDERGOING LIVER SURGERY. 
RESULTS OF A PROSPECTIVE 
RANDOMIZED CONTROLLED TRIAL
S. Breitenstein1, B. Beck-Schimmer2, J. Bonvini2, 
M. Lesurtel1, M. Ganter2, A. Weber3, M. Puhan4 and 
P.-A. Clavien1
1Department of Visceral and Transplantation Surgery, 
University Hospital Zurich, Switzerland; 2Institute of 
Anesthesiology, University Hospital Zurich, Switzerland; 
3Institute of Surgical Pathology, University Hospital 
Zurich, Switzerland; 4Department of Epidemiology, Johns 
Hopkins Bloomberg School of Public Health, Baltimore, 
USA
Introduction: Targeted organ protection has gained increas-
ing interest to improve perioperative clinical outcomes. 
Infl ow occlusion is an established procedure to reduce blood 
loss during liver transection in selective patients, which is, 
however, potentially harmful due to the associated ischemia-
reperfusion injury. Preventive strategies include the use of 
repetitive short periods of ischemia interrupted by a reperfu-
sion phase (intermittent clamping), and the application of 
short period of ischemia prior to transection (ischemic pre-
conditioning) or some drugs prior to transection (pharmaco-
logical preconditioning). However, whether interventions 
after resection (post-conditioning) may confer protection is 
unknown.
Methods: A 3 arm-prospective randomized trial was 
designed in patients undergoing liver resection with infl ow 
occlusion comparing the effects of pharmacological post-
conditioning with the volatile anesthetic sevofl urane (n = 
48), intermittent clamping (n = 50) and no protective inter-
vention (continuous infl ow occlusion, n = 17) based on 
proper sample size calculation. Endpoints included serum 
transaminase levels (AST), postoperative complications and 
hospital stay. All patients were intravenously anesthetized 
with propofol. In patients with post-conditioning, propofol 
infusion was stopped upon reperfusion and replaced by sevo-
fl urane for 10 min.
Results: Compared to the control group, both post-
conditioning (p = 0.044) and intermittent clamping (p = 
0.015) signifi cantly reduced AST levels. The risk of major 
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complications was signifi cantly decreased by post-condition-
ing (odds ratio 0.10 [0.03 to 0.37, p = 0.001]) and intermittent 
clamping (odds ratio 0.51 [0.27 to 0.96, p = 0.036]) com-
pared to controls. Both interventions reduced length of hos-
pital stay (post-conditioning −4 days [−6 to −1, p = 0.009], 
and intermittent clamping  2 days, [−4 to 0, p = 0.019]).
Conclusion: This is the fi rst trial demonstrating that phar-
macological post-conditioning reduces organ injury and 
importantly postoperative complications. This easily appli-
cable strategy with clinically relevant benefi ts should be 
used selectively in higher risk patients requiring infl ow 
occlusion.
FOS121
CHANGES IN THE PRACTICE OF LIVER 
RESECTION FOR COLORECTAL LIVER 
METASTASES OVER A FIFTEEN-YEAR 
PERIOD IN A HIGH-VOLUME UK 
HEPATOBILIARY UNIT
C. Macutkiewicz, C. Briggs, E. Hidalgo, G. Toogood, 
J. P. Lodge and K. R. Prasad
Department of HPB and Transplant Surgery, St James’s 
University Hospital, Leeds, UK
Introduction: Colorectal cancer remains the second most 
common cause of cancer-related death in Europe and North 
America. More than 50% of patients develop liver metasta-
ses within their lifetime and liver resection remains their only 
chance of cure. Recent trends in liver surgery have favoured 
parenchyma-preserving liver surgery over traditional major 
hepatectomies. The aim of this study was to investigate the 
trend in approach to liver surgery over a fi fteen-year period 
at a high-volume hepatobiliary unit.
Methods: A prospectively maintained database containing 
data for the resection of colorectal liver metastases was ana-
lysed from 1995 to 2010. Demographic data was extracted 
together with data on types of liver resection, morbidity and 
mortality rates, and major versus minor hepatectomies. 
Minor hepatectomy was defi ned as any resection up to three 
segments and major hepatectomy was more than three seg-
ments resected. Data displayed compare the three fi ve-year 
periods from: 1995–1999, 2000–2004 and 2005–2009.
Results: A total of 1414 hepatectomies were undertaken 
from 1995 up to 2010. 172 resections were performed in 
1995–1999, 570 in 2000–2004 and 672 in 2005–2009. 
Median age and range were as follows: 61 years (36–80 
years) in 1995–1999, 65 years (32–87 years) in 2000–2004, 
and 65 years (23–91 years) in 2005–2009. Major versus 
minor hepatectomy ratio were as follows: 55 : 45 in 1995–
1999, 45 : 55 in 2000–2004, and 33 : 67 in 2005–2009. 
Complication rates were as follows: 29.1% in 1995–1999, 
23.5% in 2000–2004, and 15.9% in 2005–2009. Mortality 
rates were signifi cantly reduced from 9.3% in 1995–1999, 
and 3.3% in 2000–2004, to 1.9% in 2005–2009 (P < 0.05).
Conclusion: The trend in liver resection has been towards 
more segmentectomies and metastasectomies rather than the 
more traditional major anatomical resections. This has been 
associated with a decreased complication rate and a signifi -
cantly reduced mortality rate. This may refl ect not only 
improvements in technique and critical care management but 
also in the paradigm shift towards parenchyma-preserving 
liver surgery. Local recurrence and survival rates will dictate 
whether this is the optimal treatment.
FOS122
FACTORS PREDICTIVE OF SURVIVAL 
FOLLOWING RESECTION OF EITHER 
RECTAL OR COLONIC LIVER 
METASTASES
S. Rehman, S. M. Robinson, S. K. P. John, 
R. M. Charnley, B. C. Jaques, J. J. French, 
D. M. Manas and S. A. White
Department of HepatoPancreaticoBiliary & Transplant 
Surgery, Freeman Hospital, Newcastle Upon Tyne, UK
Introduction: Whilst colonic and rectal carcinomas are 
often considered a single disease entity there is a growing 
body of evidence that this is not the case. Whilst a variety of 
factors have been shown to predict outcome following resec-
tion of metastatic disease from colorectal tumours it is not 
known if colonic liver metastases (CLM) behave differently 
to those of rectal origin (RLM). The aim of this study was 
to identify those factors which predict long-term survival 
following resection of CLM or RLM.
Methods: We analysed a prospectively maintained 
Hepatobiliary database of 418 patients (with complete follow 
up) who underwent liver resection for CRM between January 
2000 and December 2010. The cohort was stratifi ed accord-
ing to the site of the primary tumour with rectal tumours 
being defi ned as those within 15 cm of the anal verge.
Continuous variables were compared with the Mann-
Whitney U-Test whereas categorical variables were com-
pared with chi-squared test. Survival analysis was performed 
with Kaplan Meier plots and signifi cance assessed with log 
rank test. Multivariate analysis was performed using a Cox-
Regression model. A p-value of <0.05 was considered 
signifi cant.
Results: 55% of patients had CLM whereas 45% had RLM 
(p = 0.258). Patients with CLM were less likely to have node 
positive primary disease (52% vs 62%; p < 0.05). Overall 5 
year survival was similar for both CLM and RLM (42% vs 
45%; p = 0.62).
Following resection of CLM multi-variate analysis identi-
fi ed a CEA > 200 (OR 2.39; p < 0.01) and the presence of 
4 or more tumours (OR 2.4; p < 0.05) as independent predic-
tors of survival. Whilst there was a strong trend towards 
poorer 5 year overall survival in those with a resection 
margin <1 mm this did not reach statistical signifi cance (p = 
0.383) on univariate analysis. Following resection of RLM 
the presence of a resection margin <1 mm was the only 
independent predictor of survival (OR 2.86; p < 0.001).
Conclusion: Overall 5 year survival following resection of 
both CLM and RLM is similar. However prognostic factors 
which predict long-term survival following liver resection 
differ and this may have implications for selecting those 
patients for intensive follow-up and perhaps patients who 
may benefi t from other adjuvant treatments.
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RESULTS FROM THE TREATMENT OF 
SYNCHRONOUS COLORECTAL LIVER 
METASTASES AND ANALYSIS OF 
PROGNOSTIC FACTORS
I. Vasilevski, I. Takorov and N. Vladov
HPB and Transplant Surgery, Military Medical Academy, 
Sofi a, Bulgaria
Introduction: There is no single opinion on behavior, espe-
cially concerning criteria for simultaneous resection of the 
primary colorectal carcinoma (CRC) and liver metastases 
(LM), on the long-term survival. The aim of this study is to 
optimize our approach in the treatment of patients with syn-
chronous colorectal liver metastases based on analyzing 
prognostic factors.
Methods: This study included 79 curative resection on the 
occasion of synchronous LM from CRC performed in the 
period January 2004–December 2010. 43 patients underwent 
simultaneous resection of primary CRC and LM (S-group) 
and 36 patients – staged liver resection (LR) (St-group).
Results: The 1-, 3-, 5-year survival rates were 74, 42, 29% 
in S-group and 74, 29, 13% in St-group, with median sur-
vival – 29 vs 23 months, respectively. Univariate analysis for 
S-group showed favorable impact of: male gender (p < 
0.006), smaller and atypical LR (p < 0.001), but negative 
impact of: number of LM > 3 (p < 0.008), size >5 cm (p < 
0.013), major LR (p < 0.001), bilobar distribution (p < 0.011) 
and blood loss >300 ml (p < 0.056). For St-group positive 
were 2 factors: negative LN (p < 0.026) and T2-3 of primary 
tumor (p < 0.039). Multivariate analysis for S-group showed 
that the volume of LR was the only signifi cant factor on 
survival (p < 0.005). For St-group negative impact had: 
number of LM > 3 (p < 0.014), distribution of LM (p < 
0.003), metastatic LN (p < 0.014).
Conclusion: Determination of an individual therapeutic 
approach in each patient with synchronous LM from CRC 
allows achieving the most favorable outcome.
FOS124
CHEMOTHERAPY ASSOCIATED LIVER 
INJURY AND ITS INFLUENCE ON 
OUTCOME AFTER RESECTION OF 
COLORECTAL LIVER METASTASES
C. Reissfelder1, K. Brand2, M. Koch1, J. Sobiegalla1, 
P. Schirmacher2, M. Buchler1 and J. Weitz1
1Department of General, Visceral and Transplantation 
Surgery, University of Heidelberg, Germany; 2Department 
of Pathology, University of Heidelberg, Germany
Introduction: Advances in neoadjuvant therapy have pro-
vided novel strategies for treating resectable and initially 
unresectable colorectal cancer liver metastases. While it is 
known in principle that chemotherapeutic agents cause 
certain types of liver parenchymal injury, the actual contribu-
tion of chemotherapy-associated hepatotoxicity to postopera-
tive morbidity remains poorly defi ned.
Methods: Between 2002 and 2010, 119 patients with neo-
adjuvant chemotherapy were included. Eleven histologically 
defi ned alterations of nontumoral liver tissue were 
examined.
Results: The localization of the infl ammation had a high 
infl uence on morbidity, as patients with a combined portal 
and parenchymal infl ammation had a signifi cantly higher 
complication rate (81%; p = 0.005). Steatosis did not infl u-
ence the postoperative outcome (p = 0.5), whereas steato-
hepatitis (as assessed by the NAS score) was highly related 
with morbidity (p = 0.0001). In multivariate analysis portal 
and parenchymal infl ammation (CI 1.6–51, OR 9.2; p = 0.01) 
and steatohepatitis (CI 1.8–14.9, OR 5.2; p = 0.002) were 
signifi cantly related with postoperative morbidity.
Conclusion: In this study for the fi rst time, the effect of 
conventional chemotherapy on infl ammation and its rele-
vance for the development of clinical complications could be 
shown. Steatohepatitis seems to be a matter of particular 
interest because of its correlation with postoperative morbid-
ity. In contrast, targeted types of therapy neither affect paren-
chymal structure of the liver nor perioperative outcome after 
hepatic resection.
FOS125
SURGICAL MANAGEMENT OF LIVER 
METASTASIS FROM METASTATIC 
MELANOMA
S. W. Ryu1, R. Saw2, R. Scolyer1, J. Gallagher3, 
M. Crawford3, D. Joseph3, J. Thompson2 and 
C. Sandroussi4
1Royal Prince Alfred Hospital, Sydney, Australia; 
2Melanoma Institute of Australia, Sydney, Australia; 
3Upper Gastrointestinal Unit, Royal Prince Alfred 
Hospital, Sydney, Australia; 4Surgical Outcomes Resource 
Centre, Solomons Research Group, Sydney, Australia
Introduction: There is limited evidence in the published 
literature about the role for surgical resection of hepatic 
metastasis from melanoma. Our aim was to determine the 
outcomes for patients who underwent resection of hepatic 
metastasis, the survival rate and the factors which were pre-
dictive of both survival and recurrence.
Methods: Data for all patients who underwent liver resec-
tion for melanoma metastasis were collected in a prospective 
database. These data were supplemented with a review of the 
patient’s charts. Thirty one patients who underwent resection 
for melanoma were identifi ed between 1980 to 2010. All data 
were analysed using SPSS version 17. Univariate and mul-
tivariate analysis were undertaken to determine the factors 
which were predictive of survival and recurrence following 
liver resection for melanoma metastasis.
Results: The median time to development of liver metasta-
sis from initial diagnosis of melanoma was 46 months (range 
0–357). Twenty (65%) patients underwent major resection 
(hemihepatectomy, extended hepatectomy) and 11 (35%) 
had minor resection (sectionectomy, wedge resection). 
Twenty-three (74%) of thirty-one patients had histologically 
complete resection margins (R0) and 7 (23%) had histologi-
cally incomplete resection (R1/2). The median survival was 
29 months (range 2–139). The actuarial 5-year survival rate 
was 36%. Improved survival was observed in patients who 
underwent major resection (major resection, 44 months; 
minor resection, 12 months; P = 0.02) and those with clear 
histological margins (R0, 35 months; R1/2, 12 months; 
P = 0.068).
160 Free Orals Abstracts
© 2012 The Authors
HPB © 2012 Americas Hepato-Pancreato-Biliary Association HPB 2012, 14 (Suppl. 2), 107–287
Conclusion: Resection of metastatic melanoma of the liver 
can improve the overall survival. Thus, complete surgical 
resection of hepatic melanoma metastasis should be consid-
ered in selected patients.
FOS126
BEYOND THE LIMIT OF AGE FOR 
LIVER RESECTION FOR COLORECTAL 
METASTASES
F. Di Benedetto, N. De Ruvo, G. D’Amico, G. Tarantino, 
N. Cautero, R. Montalti, R. Ballarin and G. E. Gerunda
Liver and Multivisceral Transplant Center, University of 
Modena and Reggio Emilia, Modena, Italy
Introduction: Older adults with colorectal liver metastases 
(CLMs) are increasingly undergoing treatments similar to 
those used in younger individuals, including chemotherapy 
and surgery. Before considering a surgical approach for 
CLMs in older adults, it is imperative to analyze risks and 
costs of such surgery against the potential improvement in 
life expectancy. The aim of this study was to use a case-
control protocol to assess the safety and long-term results of 
hepatic resection of CLMs in older adults.
Methods: Thirty-two patients with CLMs aged 70 and older 
(older group) and 32 patients younger than 70 (younger 
group) were matched in a 1 : 1 ratio according to sex, 
primary tumor site, liver metastases at diagnosis, number of 
metastases, maximum tumor size, infi ltration of cut margin, 
type of hepatic resection, and hepatic resection timing.
Results: There was no signifi cant difference in preoperative 
clinical fi ndings between the two study groups. The inci-
dence of cumulative postoperative complications was similar 
in the older (28.1%) and younger (34.4%) groups (P = 0.10). 
One-, 3-, and 5-year disease-free survival rates were 57.6%, 
32.9%, and 16.4%, respectively, in the younger group and 
67.9%, 29.2%, and 19.5%, respectively, in the older group 
(P = 0.72). One-, 3-, and 5-year participant survival rates 
were 84.1%, 51.9%, and 33.3%, respectively, in the older 
group and 93.6%, 63%, and 28%, respectively, in the younger 
group (P = 0.50).
Conclusion: Resection of colorectal liver metastases in 
older adults can be performed with low mortality and mor-
bidity and offers a long-time survival advantage to many of 
these individuals. Based on the results of this case-control 




RESECTION OF COLORECTAL 
PRIMARY TUMOR AND LIVER 
METASTASES: PRELIMINARY 
RESULTS OF A MULTICENTRE 
INTERNATIONAL STUDY
S. Ferretti1, J.-W. Huh2, J. Buell3, G. Belli4, B. Gayet5, 
H. H. Seong6, G. Ettore7 and I. Dagher1
1Department Minimally Invasive Abdominal Surgery, 
Antoine Beclere Hospital, AP-HP, Clamart, F-92140, 
France; 2Department of Surgery, Chonnam National 
University Hwasun Hospital and Medical School, 
Gwangju, Korea; 3Department of Surgery, Division of 
Transplant Surgery, Tulane Medical Center, New Orleans, 
USA; 4Department of General and Hepato-Pancreato-
Biliary Surgery, S.M. Loreto Nuovo Hospital, Naples, Italy; 
5Department of Digestive Diseases, Institut Mutualiste 
Montsouris, University of Paris V, Paris, France; 6Director 
of Comprehensive Cancer Center, Seoul University, Korea; 
7Liver Unit, Azienda Ospedaliera San Camillo, Forlanini, 
Rome, Italy
Introduction: The arguments for a synchronous resection 
of colorectal primary tumors and liver metastases by an open 
technique have been widely discussed in the literature with 
encouraging results. Laparoscopic liver resection and colo-
rectal surgery have been reported safe, feasible and improved 
postoperative course. Our aim was to analyze the feasibility, 
the immediate and long-term outcomes and the advantages 
of laparoscopy for simultaneous resection of colorectal 
primary tumour and liver metastases.
Methods: A retrospective review of 12 International centres 
on laparoscopic simultaneous resection of colorectal primary 
tumor and liver metastases was undertaken. All types of 
colorectal resection as well as all types of liver resection 
were included in the study.
Results: One hundred and twelve patients were analysed. 
Laparoscopy enabled liver and colonic resection with the 
addition of one or two extra trocars. The feasibility, conver-
sion rate, the use of hand assistance and postoperative results 
are reported. The advantages of this laparoscopic combined 
technique are discussed.
Conclusion: Laparoscopic colorectal resection with simul-
taneous resection of liver metastases is technically feasible 
and safe with some short-term advantages.
FOS128
REPEAT LIVER RESECTION 
FOLLOWING HEPATIC 
TRISECTIONECTOMY AND EXTENDED 
TRISECTIONECTOMY FOR 
COLORECTAL LIVER METASTASIS
I. Rajput, O. Ziff, K R. Prasad, G. Toogood, R. Adair and 
P. Lodge
St. James’s Hospital, Leeds, UK
Introduction: Right and left hepatic trisectionectomy and 
extended trisectionectomy are the largest liver resections 
performed for malignancy. We report a series of 23 patients 
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who had at least one repeat resection following hepatic tri-
sectionectomy for colorectal liver metastasis (CRLM).
Methods: A retrospective analysis of a single center pro-
spective liver resection database from May 1996 to April 
2009 was used for patient identifi cation. Full notes, radiology 
and patient reviews were analysed for a variety of factors 
with respect to survival.
Results: Twenty three patients underwent up to 3 repeat 
hepatic resections following 20 right and 3 left hepatic tri-
sectionectomies. In 18 cases the initial surgery was an 
extended trisectionectomy. Overall 1-, 3- and 5-year survival 
rates after repeat resection 100%, 46%, and 32%. No factors 
predictive for survival were identifi ed.
Conclusion: Repeat resection following hepatic trisectio-
nectomy for CRLM can offer extended survival and should 
be considered where appropriate.
FOS129
SIMULTANEOUS COLORECTAL AND 
HEPATIC PROCEDURES FOR 
COLORECTAL CANCER: INCREASED 
MORBIDITY BUT EQUIVALENT 
MORTALITY TO COLORECTAL OR 
HEPATIC PROCEDURES ALONE – 
OUTCOMES FROM THE NATIONAL 
SURGICAL QUALITY IMPROVEMENT 
PROJECT (NSQIP)
O. Hamed, J. Kaifi , E. Kimchi, K. Staveley-O’Carroll and 
N. Gusani
Division of Surgical Oncology, Department of Surgery, 
Penn State College of Medicine, Hershey, PA
Introduction: Simultaneous colorectal and hepatic proce-
dures for colorectal cancer (CRC) are increasingly being 
performed as CRC surgery becomes safer, less invasive, and 
better tolerated. NSQIP provides validated, risk-adjusted 
30-day perioperative outcome data from over 250 hospitals 
nationwide, allowing large-scale examination of these 
procedures.
Methods: Data from NSQIP 2005–2008 were used to 
compare 22534 patients (19925 colorectal procedures for 
primary malignancy [CR]; 2295 hepatic procedures for sec-
ondary malignancy [H]; 314 simultaneous procedures 
[SIM]).
Results: Patients undergoing SIM procedures had higher 
rates of the following co-morbid conditions compared 
to CR patients: Dyspnea, Coronary Intervention/Surgery, 
Hypertension, Peripheral Vascular Disease, Disseminated 
Cancer, Weight Loss, Chemotherapy, and Radiation (p < 
0.05). Fewer complex colorectal and hepatic procedures 
were performed in the SIM group (LAR/Total Colectomy 
21.5% vs 26% (p = 0.014), Hemihepatectomy or greater 
19.1% vs 33.5% (p < 0.001)). Operative time (min) varied 
across groups: CR 148, H 216, SIM 265 (p < 0.001), as did 
post-operative stay (days): CR 6, H 5, SIM 7 (p < 0.001). 
Compared to CR and H procedures alone, SIM surgery 
resulted in a higher rate of the following complications: 
wound infection (p < 0.001), organ space infection (p < 
0.001), and septic shock (p = 0.014). 30-day mortality did 
not differ among the groups (CR 2.4%, H 1.2%, SIM 1.6%, 
p = 0.35).
Conclusion: Patients undergoing simultaneous colorectal 
and hepatic procedures have a higher comorbidity profi le, 
and these procedures are associated with an increased opera-
tive time, length of stay, and rate of perioperative complica-
tions. Simultaneous procedures do not, however, increase 
perioperative mortality.
FOS130
LAPAROSCOPIC MAJOR LIVER 
RESECTIONS: 50 FIRST CASES
A. Laurent1, C. Tayar1, C. Salloum1, J. Calderaro2, 
A. Luciani3, D. Cherqui1 and D. Azoulay1
1Hepato-Biliary and Liver Transplant Unit, Henri Mondor 
Hospital, Créteil, France; 2Department of Pathology, Henri 
Mondor Hospital, Créteil, France; 3Department of 
Radiology, Henri Mondor Hospital, Créteil, France
Introduction: The place of laparoscopic major liver resec-
tions for liver tumors remains debated. The aim of the present 
study was to evaluate the feasibility and safety of laparo-
scopic major liver resection in a large series from a single 
center.
Methods: From 2000 to August 2011, 578 patients under-
went major liver resection (≥3 segments according to 
Couniaud). Among them, 50 (8.7%) were performed under 
laparoscopy and represent the present study population. The 
laparoscopic approach was considered for tumors without 
contact with the main vascular structures.
Tumors were benign in 20 (40%) cases. Malignant tumors 
(30 cases, 60%) included colorectal metastases (n = 12), 
HCC on chronic liver disease (n = 9), and breast cancer 
metastases (n = 5). Tumor size was <15 cm. Five-port CO2 
laparoscopy was used and the specimen was extracted in a 
bag through a separate lower abdominal incision.
Results: Resections were: 35 right hepatectomies and 15 
left hepatectomies. According to the Louisville’s interna-
tional position statement in 2008, 38 procedures were purely 
laparoscopic and 12 were hand-assisted. The mean operative 
time was 300 ± 90 min. 28 (56%) procedures were per-
formed without clamping and 22 (44%) under intermittent 
clamping with a mean duration of 38 ± 13 min. Mean blood 
loos was 500 ± 480 ml. Conversions to laparotomy occurred 
in 10 cases (20%) for hemorrhage in 6 cases (one major > 
1500 ml) and insuffi cient exposure 4. Four cancer patients 
(13.3%) had R1 resection on the specimen. Operative mortal-
ity was nil. According to Clavien’s classifi cation, complica-
tions were grade 0, I, II, III, IV in 38, 1, 5, 5 and 1 cases 
respectively (morbidity rate = 24%). Duration of ICU stay 
and hospitalization were 2.8 ± 2.5 and 9.3 ± 3.8 days 
respectively.
Conclusion: Our study shows that major LLR in selected 
patients is a safe procedure. Surgical margin for malignant 
tumors needs to be improved.
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FOS131
SAFETY AND EARLY EFFICACY OF 
IRREVERSIBLE ELECTROPORATION 
FOR HEPATIC TUMORS IN PROXIMITY 
TO VITAL STRUCTURES
R. Cannon1, D. Hayes2, K. McFarlin3, G. Narayanan4 and 
R. Martin1
1University of Louisville Division of Surgical Oncology, 
Kentucky, USA; 2Baptist Health Care, USA; 3Henry 
Ford Hospital, Detroit, USA; 4University of Miami, 
Florida, USA
Introduction: Thermal ablation of hepatic tumors is an 
accepted treatment modality when resection is not feasible. 
Current thermal ablation technologies such as RFA, 
Microwave, and Cryo are often limited by tumor location, 
particularly proximity to major vascular and biliary struc-
tures. This study was undertaken to evaluate the safety and 
early effi cacy of irreversible electroporation (IRE) for hepatic 
tumors.
Methods: An IRB approved prospective, multi-institutional, 
treatment registry of 150 patients undergoing 175 treatments 
for primary or secondary cancers in the liver was evaluated 
from 8/2009 to 10/2011. Outcomes were compared and 
stratifi ed by treatment approach and tumor histology. 
Ablation success was defi ned as lack of recurrence at the 
ablation site, and was determined by Kaplan-Meier.
Results: There were 60 patients undergoing 71 IRE proce-
dures, with 52 (88%) pts lesions in proximity to major vas-
culature, bile duct, or other organ. IRE was performed via an 
open (19.6%), lapaparoscopic (3.9%), or percutaneous 
(76.5%) approach. The median number of tumors treated per 
procedure was 1, with a maximum of three. The most 
common diagnosis was colorectal metastasis (43.1%), fol-
lowed by HCC (33.3%). There were 9 adverse events. 
Overall, successful ablation was maintained in 35.2% at 12 
months. This rate was lowest in the percutaneous group 
(25.7%), and highest in the open treatment group (62.5%; 
p = 0.765).
Conclusion: IRE is safe for palliation of nonresectable 
hepatic tumors, although it may be limited by early recur-
rence, particularly for metastatic CRC and when performed 
percutaneously. Further prospective study is needed to deter-
mine its ideal role in the therapeutic armamentarium.
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FOS132
MULTICENTRE STUDY OF LIVER 
CELL ADENOMAS
J. M. Ramia1, B. Carmen2, A. Valdivieso3, C. Dopazo4, 
J. M. Jover5, J. Figueras6, F. Pardo7 and 
J. L. Fernandez-Aguilar8
1HPB Unit, Department of Surgery, Hospital de 
Guadalajara, Guadalajara, Spain; 2Department of Surgery, 
Hospital Central de Asturias, Spain; 3Department of 
Surgery, Hospital de Cruces, Spain; 4Department of 
Surgery, Hospital Vall d´Hebron, Barcelona, Spain; 
5Department of Surgery, Hospital de Getafe, Getafe, Spain; 
6Department of Surgery, Hospital Josep Trueta, Girona, 
Spain; 7Department of Surgery, Clinica Universitaria de 
Navarra, Pamplona, Spain; 8Department of Surgery, 
Hospital Carlos Haya, Malaga, Spain
Introduction: Liver cell adenoma (LCA) is a benign tumour 
that could present several complications. Classical surgical 
strategy was to resect every LCA diagnosed. Some recent 
papers have demonstrated that LCA smaller than 3 cm and 
without expression of ßcathenin should not be resected 
because they usually did not complicate. So, non-surgical 
therapy and close follow up has been postulated for some 
LCA. HPB Section of the Spanish College of Surgeons has 
performed a retrospective multicentre study of resected LCA 
as fi rst step of a prospective study of every LCA evaluated 
in Spanish HPB Units.
Methods: Retrospective multicentre study made by 14 HPB 
Units. Inclusion criteria: LCA patients operated on with man-
datory histological confi rmation. Study period: 1995–2011. 
Data collection was made by a database including epidemio-
logical, clinical, surgical and follow up parameters.
Results: We have operated on 81 patients with proven 
LCA. Median age: 39.5 years (range: 14–75). Sex: 61 
women (75%). Body mass index: 27 kg/m2 (range: 21–41) 
Previous estrogen intake: 26%. LCA median size was 
8.8 cm (range: 1–20 cm). Only 6 LCA were smaller than 
3 cm (7.4%) Median number of LCA was 1 (range: 1–12). 
Nine patients had adenomatosis. 51% of the patients (41) 
were symptomatic. Most frequent symptom was abdominal 
pain. Haemorrhage or rupture occurs in 9 patients. 
Preoperative diagnosis was correct in 60% of the cases. 
Only one preoperative embolization was done. 90% of sur-
gical procedures were planned (73/81). The procedures 
were: major hepatectomies (18) (22%), minor (62) (77%) 
and liver transplantation (1). 20% were made by laparo-
scopic approach. Morbidity rate was 28% (23/81) (Clavien 
I-II: 19 (82%); Clavien: III-IV: 4 (18%)). Mortality was 
nil. Two patients had malignant transformation and one 
case showed severe dysplasia. Median follow up was 43 
months (range: 1–192). 2 relapses were diagnosed in 
follow up. Comparing ruptured and/or bleeding cases with 
non-complicated cases: patients with complicated cases 
present bigger LCA, more frequently adenomatosis and a 
higher morbidity (p < 0.05).
Conclusion: In our retrospective study, patients are usually 
women (75%), with huge lesions (8.8 cm), a low estrogen 
intake (30%), only symptomatic in 50% of the cases and 10% 
of the cases are complicated (bleeding/rupture).
– Major hepatectomy was performed in 22% of the patients. 
20% of the procedures were performed laparoscopically. 
Morbidity was low and no mortality was observed.
– Complicated cases occur in bigger LCA and in patients 
with adenomatosis. Postoperative morbidity is much 
higher in these cases comparing with non-complicated 
cases.
FOS133
HEPATIC RESECTION FOR 
HEPATOCELLULAR CARCINOMA 
USING A RADIOFREQUENCY 
ABLATION DEVICE
N. Vlad1, E. Tarcoveanu1, C. Gouillat2, C. Lupascu1, 
S. Georgescu1 and R. Moldovanu1
11st Surgical Clinic, St. Spiridon Hospital Iasi, University 
of Medicine and Pharmacy “Gr.T.Popa” Iasi, Romania; 
2Digestive and General Surgery and Liver Transplant Unit, 
Croix-Rousse Hospital, Lyon, France
Introduction: The hepatocarcinoma (HCC) is the most fre-
quent primary liver malignant tumor. The surgical resection 
remains the gold standard for this malignancy. In the last 
decades different techniques have been developed to allow 
safer liver resection; radiofrequency assisted liver resection 
is one pf these methods. The aim of this study is to evaluate 
this procedure.
Methods: We enrolled into the study 35 consecutive patients 
with resectable HCC. The patients were assigned in two 
groups: 45.7% (N = 16) in group A – operated using a radio-
frequency ablation device (RFAD) and respectively, 54.3% 
(N = 19) in group B – liver resection performed classicaly 
without RFAD. The men/women ratio was 25/10 and the 
mean age 62.57 ± 1.96 years old (range: 26–88). We found 
no difference between the two groups from point of view of 
demographic data. All the data were encoded and introduced 
into a MS Access database and statistically analyzed using 
SPSS software.
Results: Cirrhosis and esophageal varices were more fre-
quent in group A (p = 0.013 and respectively 0.021). In most 
cases the tumor was unique 77.1%; however 14.3% patients 
have 2 tumors, 5.7% 3 tumors, and in one case (2.9%), 4 
tumors have been encountered. The mean overall tumor 
volume was 161.79 ± 35.5 mL, with no difference between 
the two groups (p = 0.938). The postoperative time was lower 
in group A (132.5 ± 15.37 vs 167.89 ± 10.61 min) but without 
statistical signifi cance (p = 0.061). The blood loss was also 
reduced in group A (459.37 ± 85.41 vs 716.31 ± 148.69 mL). 
Even no difference between the two groups has been noted 
for operative accidents (p = 0.508), postoperative morbidity 
(p = 0.782). The overall postoperative mortality was 2.2% 
(N = 1, in group B).
Conclusion: The use of RFAD allows performing liver 
resection with low rates of postoperative mortality and mor-
bidity and decreasing operating time and blood loss. For the 
central segments the technique is less used for to anatomical 
reasons.
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FOS134
SINGLE CENTER EXPERIENCE OF 
LAPAROSCOPIC HEPATECTOMY: THE 
COMPARISON OF PERIOPERATIVE 
OUTCOMES BETWEEN EARLY AND 
LATE PERIOD
H.-J. Kim, S.-H. Son, S.-S. Yun, D.-S. Lee and D.-H. Lee
Department of HBP Surgery and Liver Transplantation, 
Yeungnam University Hospital, South Korea
Introduction: The aim of this study is clarifying the safety 
and feasibility of laparoscopic hepatectomy through compar-
ing early and late period perioperative outcomes.
Methods: We retrospectively analyzed medical records of 
138 patients who underwent laparoscopic liver resections 
from January 2003 to June 2011 at Yeungnam University 
Hospital. We divided the patients to early period (from 
January 2003 to February 2007) and late period (March 2007 
to June 2011) and compared perioperative outcomes includ-
ing mean operation time, intraoperative blood loss, postop-
erative hospital stay, ICU stay hour, and duration of LFT 
normalization.
Results: The mean operation time was 308 minutes (range 
140–510 minutes) in early period group and 193 minutes 
(range 40–350 minutes) in late period group (p < 0.001). 
The mean intraoperative blood loss was 171 ml (range 
50–1200 ml) in early and 44 ml (range 0–400 ml) in late (p 
= 0.005). The postoperative hospital stay was 9.7 days (range 
4–31 days) in early and 6.8 days (range 2–9 days) in late 
period (p < 0.001). The ICU stay was 21.6 hour (range 0–120 
hour) in early and 2.8 hour (range 0–24 hour) in late period 
(p < 0.001). The duration of LFT normalization was 5.7 days 
(range 0–39 days) in early and 2.1 days (range 0–20 days) 
in late period (p = 0.003). The perioperative outcomes were 
signifi cantly better in late period than in early period.
Conclusion: Laparoscopic liver surgery is feasible and can 
be safely performed in selected patients but requires a long 
experience in open liver resection and mastery of laparo-
scopic surgical skills.
FOS135
ADJUVANT LIPIODOL I-131 AFTER 
RESECTION OR RADIOFREQUENCY 
ABLATION FOR HEPATOCELLULAR 
CARCINOMA
L. Schwarz1, E. Huet1, M. Bubenheim2, G. Riachi3, 
E. Clavier4, P. Vera5, O. Goria2 and M. Scotté1
1Digestive Surgery Department and INSERM U1073, 
Rouen University Hospital, Rouen, France; 2Biostatistics 
Department, Rouen University Hospital, Rouen, France; 
3Gastroenterology Department, Rouen University Hospital, 
Rouen, France; 4Radiology Unit, Rouen University 
Hospital, Rouen, France; 5Nuclear Medicine Department, 
Rouen University Hospital, Rouen, France
Introduction: After resection or destruction by radiofre-
quency ablation (RF) of hepatocellular carcinoma (HCC), 
recurrences are frequent. Following the randomized con-
trolled trial in Hong Kong by Lau et al. in 1999, patients 
have been offered adjuvant lipiodol I-131. The aim of this 
study was to determine the effectiveness of adjuvant lipiodol 
I-131, following potentially curative surgery for HCC on 
overall and disease-free survival rates through the experience 
of a single-center hepatobiliary center.
Methods: Cohort comparison study of patients surgically 
treated for HCC. 38 patients were treated with adjuvant 
postoperative intra-arterial injection of 131I-lipiodol and 
compared to 42 patients who did not receive the treatment. 
Surgery was considered curative on the pathological exam-
ination of the specimen (surgical resection) and imaging 
control 1 month after surgery. Risk factors for liver 
disease, tumour criteria and the criteria of quality of treat-
ment were analyzed. Each patient was reviewed every 
three months with a morphological (CT scan) and biologi-
cal (alpha-fetoprotein) assessment. Disease-free survival 
and overall survival were analyzed and compared between 
the two cohorts.
Results: The 2 groups were similar. During a median follow 
up of 24 months, 21 recurrences were observed in the treated 
group vs 32 in the control group. The recurrence was hepatic 
and unique in 62% of cases in the treated group, while the 
recurrence was multiple (hepatic or extra hepatic) in 50% of 
cases in the control group. The 2 years recurrence-free sur-
vival was 43.8% in the treated group vs 29% in the control 
group (p = 0.0139). The median recurrence-free survival 
rates were 23 vs 11 months, respectively.
The overall survival at 2 and 3 years, with or without 
treatment was 100 and 72%, 70 and 59%; respectively. 
Median overall survival was not signifi cantly different 
between 2 groups (45 months vs 40.2 months).
Conclusion: This study suggests that adjuvant iodine-131-
lipiodol improves disease-free survival in patients with HCC 
after hepatic resection or RFA. Overall survival was not 
signifi cantly improved by this treatment in our study, 
although a trend in favour of adjuvant therapy can be 
observed.
FOS136
THE FEASIBILITY AND THERAPIUTIC 
EFFECT OF PURE LAPAROSCOPIC 
HEPATECTOMY
M. Yasunaga, K. Okuda, H. Sakai, T. Ogata, 
H. Kinoshita and K. Shirouzu
Department of Surgery, Kurume University School of 
Medicine, Kurume, Japan
Introduction: Liver resection has dramatically evolved 
over the years. Laparoscopic hepatectomy is especially a 
recognized alternative to open surgery. However, in pure 
laparoscopic hepatectomy (PLT), the safety and the effi cacy 
of the techniques are still unknown. This study explored the 
feasibility and therapeutic effect of PLT.
Methods: Between April 2002 and November 2011, patients 
suitable for liver resection were carefully assessed. Data 
were collected prospectively to assess the outcome includ-
ing, size of tumor, intra-operative blood loss, operation time, 
duration of hospitalization, diseased free survival rate, and 
overall survival rate.
Results: The lateral segmentectomy and partial resection 
was performed under Pure laparoscopic Surgery. The left or 
right lobe was mobilized by laparoscopically, followed by 
applying a small incision, and the left or right Glissonian 
pedicle was handled integrally by the Endo-linear stapler. 
Liver resection was carried out with the SonoSurge (brade 
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type) or CUSA using a hanging maneuver. Twenty-three of 
fi fty-six patients underwent PLH. The mean size of tumor 
was 25.1 ± 11.6 mm, mean operation time and blood loss 
was 348.1 ± 130.4 min and 339.2 ± 496.7 g. The mean dura-
tion of hospitalization was 12.6 ± 5.84 days. One, three, fi ve 
year disease free survival rate: 97.8%, 31.4%, 23.6%. Three, 
fi ve years survival rate: 94.0%, 81.0%.
Conclusion: Pure laparoscopic hepatectomy can be done 
safely and effectively with applying some devices for appro-
priately selected patients.
FOS137
USEFULNESS OF EVALUATING 
SEGMENTAL FUNCTIONAL RESERVE 
OF THE LIVER USING EOB-MRI AND 
INDOCYANIN GREEN FLUORESCENCE 
NAVIGATION DURING OPERATION FOR 
SAFE AND CURATIVE HEPATECTOMY
K. Sugimoto, M. Shimada, T. Utsunomiya, S. Imura, 
Y. Morine, T. Ikemoto, H. Mori and H. Miyake
Departments of Surgery, The University of Tokushima, 
Tokushima, Japan
Introduction: Gadolinium-ethoxybenzyl-diethylenetri-
amine pentaacetic acid (Gd-EOB-DTPA), EOB-MRI, can be 
useful as a novel imaging technique for the estimation 
of regional liver functional reserve. Hypereye medical 
system (Mizuho, Japan) is also a novel imaging system by 
using indocyanine green fl uorescence. In this study, we con-
fi rmed the usefulness of pre-operative estimation with 
EOB-MRI and intraoperative navigation with Hypereye 
medical system.
Methods: 1. EOB signal intensity (SI) and estimation of 
regional liver functional reserve: Non-dilated (58 cases) and 
segmental-dilated (6 cases) intrahepatic duct type were 
examined. We evaluated the correlation between SI and liver 
function.
2. Intraoperative navigation using Hypereye: 19 cases (34 
nodules) of hepatectomy were examined. Indocyanine green 
(ICG, 0.5 mg/kg) were injected via peripheral vein 4–7 days 
before operation. During operation, we confi rmed known 
tumors and search unknown tumors. Under the US, we con-
fi rmed the optimal liver resection area by portal vein injec-
tion (direct method) or vein injection after the interruption 
of the dominant Glisson’s (indirect method). Moreover, we 
checked the bile leakage by bile duct injection.
Results: 1. Standardized SI had strong correlation with LHL 
(r = 0.64) and ICG15 (r = 0.72) and there was not deviation 
in the cases of hyperbilirubinemia and liver damage C. SI in 
segmental dilated intrahepatic duct (2.4 ± 0.4, ICG: 17.0%) 
was lower than that of non-dilated intrahepatic duct (3.1 ± 
1.0, ICG: 1.6%), and we could estimate the remnant liver 
volume and function using volumetry.
2. 31 nodules (91%) were detected from liver surface and 
we found 2 new nodules. Both direct and indirect method 
had the signifi cant demarcation line. Using the stained area 
as intersegmental plane during operation, we could navigate 
the accurate anatomical hepatectomy. We had 3 cases of bile 
leakage, however we prevented the post-operative bile 
leakage by repairing.
Conclusion: We could perform the safe and curative hepa-
tectomy by preoperative estimation with EOB-MRI and 
intraoperative navigation using indocyanine green fl uores-
cence navigation.
FOS138
NOVEL THREE-DIMENSIONAL VIRTUAL 
LIVER SURGERY SYSTEM IS USEFUL 
FOR SIMULATION OF ANATOMICAL 
HEPATECTOMY
S.-ichi Ariizumi, Y. Takahashi, H. Mu, Y. Kotera, T. Kato, 
S. Katagiri, H. Egawa and M. Yamamoto
Department of Surgery, Institute of Gastroenterology, 
Tokyo Women’s Medical University, Tokyo, Japan
Introduction: The relevance of novel 3-dimensional (3-D) 
virtual liver surgery system in patients with liver tumors who 
underwent anatomical hepatectomy has not been evaluated 
in detail.
Methods: Between 2010 and 2011, 80 patients with liver 
tumors underwent virtual anatomical hepatectomy using a 
3-D virtual liver surgery system. Predicted liver volume was 
compared with the actual liver volume among patients who 
underwent anatomical sectionectomy, segmentectomy, and 
hemihepatectomy.
Results: The mean predicted liver volume and actual liver 
volume were 323 ± 176 ml and 303 ± 170 ml in 41 sectio-
nectomy, 146 ± 78 ml and 162 ± 93 ml in 11 patients who 
underwent segmentectomy, and 592 ± 279 ml and 546 ± 
244 ml in 26 hemihepatectomy. The average error between 
predicted liver volume and actual liver volume was 28 ± 
22 ml in sectionectomy, 26 ± 17 ml in segmentectomy, and 
56 ± 67 ml in hemihepatectomy, respectively. The predicted 
liver resection volume showed a signifi cant correlation with 
the actual liver volume in patients who underwent sectionec-
tomy (r = 0.985, n = 41, p < 0.0001), segmentectomy (r = 
0.955, n = 11, p < 0.0001), and hemihepatectomy (r = 0.968, 
n = 26, p < 0.0001).
Conclusion: A novel 3-D virtual liver surgery system is a 
useful tool for simulation of anatomical hepatectomy.
FOS139
INFLUENCE OF THE NON-TUMOUROUS 
PARENCHYMA IN THE SAFETY OF 
LIVER RESECTION FOR METABOLIC 
SYNDROME ASSOCIATED HCC
F. Cauchy1, S. Zalinski1, S. Dokmak1, D. Fuks1, 
L. Castera2, V. Paradis3, O. Farges1 and J. Belghiti1
1HPB Surgery & Liver Transplantation Department, 
Beaujon Hospital, Clichy, France; 2Hepatology 
Department, Beaujon Hospital, Clichy, France; 3Pathology 
Department, Beaujon Hospital, Clichy, France
Introduction: Hepatocellular carcinoma arising in patients 
with insulin resistance/metabolic syndrome (MS-HCC) is 
frequently associated to non-alcoholic fatty liver disease 
(NAFLD). Despite increasing incidence, results regarding 
liver resection in this setting remain poorly described.
Methods: From 2000 to 2011, 62 patients (68.4 ± 7.8 years) 
underwent curative resection for MS-HCC, representing over 
15% of all HCC resections during the latest years. Patients 
were classifi ed according to the degree of underlying paren-
chymal damage: (a) normal liver in patients with NAFLD 
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activity score (NAS) <2 without fi brosis/cirrhosis; (b) dis-
eased parenchyma in patients presenting with a NAS of 2 or 
more and/or associated cirrhosis. This latter group was 
divided according to the fi brosis grade into fatty non-cir-
rhotic livers and cirrhotic livers. Patient’s characteristics and 
outcomes were compared according to pathological features 
of the underlying parenchyma, and predictive factors of mor-
bidity were analyzed.
Results: Tumor size was 7.5 cm (2–25) and 32 (52%) 
patients underwent major resection. Non-tumorous paren-
chyma was normal in 24 patients (39%) and diseased in 38 
(61%) including 18 (29%) with cirrhosis. Preoperative 
biopsy performed in 26 (42%) patients identifi ed a diseased 
parenchyma with 86% sensitivity. Mortality, overall and 
major complications were signifi cantly increased in patients 
with diseased parenchyma even without cirrhosis. Major 
postoperative complications were also associated to portal 
trial clamping, increased blood loss, age of more than 70 
years and major right-sided resection. One, 3 and 5 years-
overall and disease-free survival rates of 83%, 75%, 75% and 
83%, 70%, 56% respectively were not infl uenced by the 
underlying parenchyma.
Conclusion: MS-HCC is increasingly observed. Increased 
operative risk following liver resection in these old patients 
with large tumors in case of diseased underlying parenchyma 
even without cirrhosis emphasizes the role of preoperative 
biopsy in the non-tumourous parenchyma. Favourable long-
term outcome justifi es perioperative refi nements to improve 
postoperative tolerance.
FOS140
SAFETY OF LIVER RESECTION AFTER 
SORAFENIB ADMINISTRATION
L. Barbier1, D. Fuks1, P. Pessaux2, F. Muscari3, 
Y.-P. L. Treut4, S. Faivre5 and J. Belghiti1
1AP-HP, Hôpital Beaujon, HPB Surgery and Liver 
Transplantation, Beaujon University Hospital, Clichy, 
F-92110, France; 2HPB Surgery and Liver Transplantation, 
Hautepierre Hospital, Strasbourg, F-67098, France; 
3Digestive Surgery and Liver Transplanttaion, Rangueil 
Hospital, Toulouse, F-31059, France; 4Department of 
Digestive Surgery and Liver Transplantation, Aix-Marseille 
Univ, Marseille, France, La Conception Hospital, APHM, 
13005, Marseille, France; 5AP-HP, Hôpital Beaujon, 
Oncology, Beaujon University Hospital, Clichy, F-92110, 
France
Introduction: There is currently no knowledge about feasi-
bility and safety of liver surgery after sorafenib which could 
be used as a neoadjuvant treatment in HCC patients.
Methods: Twenty-three HCC patients who underwent liver 
surgery after mean duration treatment of 1 month (0.2–11) 
with sorafenib were compared with 46 patients matched for 
age, underlying hepatopathy and type of resection. Endpoints 
were intra operative data (operative time, transfusions), post-
operative morbidity and liver function.
Results: A major hepatectomy was performed in 44% in 
sorafenib group and 57% in control group (p = ns). Pediclar 
clamping was required in 70% and 74% respectively (p = 
ns). Operative times were similar (280 m (120–330) vs 
240 m (80–460)). Overall morbidity was 44% and 59% (p = 
ns) with ascites in 22% and 35%, haemorrhage in 0 and 4%, 
liver insuffi ciency in 0 and 9% (p = ns). Prothrombin time 
and bilirubinemia levels at postoperative days 1 and 3 were 
not different, showing no impairment in recovery of liver 
function in sorafenib group. In-hospital stay was 9 d (5–19) 
in sorafenib group and 11 d (5–54) in control group.
Conclusion: This unique study assessing the impact of 
sorafenib before liver surgery showed that no complication 
related to this treatment were observed.
FOS141
IMPACT OF CHEMOEMBOLIZATION 
WITH DOXORUBICIN LOADED BEADS 
(DC BEADS) IN PATIENTS AWAITING 
LIVER TRANSPLANTATION FOR 
HEPOCELLULAR CARCINOMA
A. Soualmia1, A. Luciani2, J. T. V. Nhieu3, 
E. Bruguiere2, M. Hurtova1, D. Cherqui4, C. Duvoux1 
and T. Decaens1
1Service Hépatologie Henri Mondor, Créteil, France; 
2Servive Imagerie Médicale Henri Londor, Créteil, France; 
3Service Anatomie Pathologique Henri Mondor, Créteil, 
France; 4Service Hépatologie Henri Mondor, Créteil, 
France
Introduction: Transarterial chemoembolization is fre-
quently used during the waiting time of liver transplantation 
for hepatocellular carcinoma. Theoretical goals: slow the 
tumor progression, decrease the drop-out rate and decrease 
tumor recurrence after liver transplantation.
The aim of this study was to evaluate the benefi t of chem-
oembolization with doxorubicin loaded beads (DC beads) in 
patients awaiting liver transplantation for hepatocellular 
carcinoma (HCC).
Methods: Between December 2006 and March 2010, 15 
patients evaluated for liver transplantation for HCC were 
treated by hyperselective chemoembolization DC beads 
during the waiting period. The evaluation of the effectiveness 
of treatment was performed according to modifi ed RECIST 
criteria by EASL, by a liver MRI at 1 month of each course. 
In case of complete response, monitoring of recurrence was 
done by quarterly MRI. A new cure was achieved in the 
absence of complete response or in case of recurrence. 
Treatment effi cacy was also assessed by analysis of the liver 
explant (tumor necrosis, number of HCC ...). Data are 
expressed as mean ± SD and median (range).
Results: The mean age of patients was 54 years (2 woman 
and 13 men). The median number of HCC at the initial 
assessment was 2 (1–7), with an average diameter of the 
largest tumor of 31 ± 10 mm, and a sum of diameters of 56 
± 38 mm. The Milan criteria were met in 11/15 cases. After 
the 1st treatment, 4 patients could not have radiological 
assessment because they had been transplanted. Of the 11 
remaining patients, complete response was observed in 3 
cases, partial response in 5 cases, stable disease in 1 cases 
and 1 tumor progression in 2 cases.
Twelve patients were transplanted after a median of 1 
course of DC beads (1–3). In the explant liver, necrosis 
>95% was observed in 4 cases (33%), necrosis between 50 
and 85% in 3 cases (25%) and necrosis <50% in 5 cases.
Conclusion: In this series, chemoembolization with doxo-
rubicin loaded beads (DC beads) has an objective response 
in 8 out of 15 cases after the fi rst course. A complete tumor 
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necrosis was observed in 4 cases out of 12. This technique 
could be proposed for tumor control on waiting list. These 
results must be compared to those of hyperselective conven-
tional chemoembolization.
FOS142
SURVIVAL ANALYSIS OF HIGH 
INTENSITY FOCUSED ULTRASOUND 
THERAPY VERSUS RADIOFREQUENCY 
ABLATION IN THE TREATMENT OF 
RECURRENT HEPATOCELLULAR 
CARCINOMA
A. Chan, T. T. Cheung, S. T. Fan, R. Poon, K. Chok, 
S. C. Chan and C. M. Lo
Division of Hepatobiliary and Pancreatic Surgery, Liver 
Transplantation, Department of Surgery, Queen Mary 
Hospital, The University of Hong Kong, Hong Kong
Introduction: High intensity focused ultrasound (HIFU) is 
a non-invasive local ablative therapy that utilizes thermal 
energy produced by an ultrasonic beam targeting at a focal 
point to induce tissue necrosis. Recent studies showed its 
effi cacy in the treatment of hepatocellular carcinoma (HCC). 
This study aims to evaluate our experience of HIFU in com-
parison with that of radiofrequency ablation (RFA) for the 
treatment of recurrent HCC.
Methods: From October 2006 to October 2009, 27 patients 
received HIFU therapy for recurrent HCC in our center. 
Their postoperative and survival outcomes were analyzed 
and compared with 76 patients who received RFA within the 
same period. Survival outcomes between the two groups 
were compared using the log-rank test and P value <0.05 was 
considered to be signifi cant.
Results: The median duration of follow up was 27.9 months. 
The median tumor size in HIFU and RFA group was 1.8 and 
1.7 cm respectively (P = 0.28). Operative morbidity rate in 
the HIFU and RFA group was 7.4% and 22.4% respectively 
(P = 0.06). Skin burn and liver abscess were the two com-
plications associated with HIFU therapy. There was no hos-
pital mortality in the HIFU group while two deaths occurred 
in the RFA group. The 1-, 2- and 3-year disease-free survival 
rates for HIFU group were 37.0%, 25.9% and 18.5%, and 
for RFA group were 48.6%, 32.1% and 26.5% respectively 
(P = 0.61). The 1-, 2- and 3-year overall survival rates 
for the HIFU group were 96.3%, 81.5% and 69.8%, and 
for RFA group were 92.1%, 76.1% and 64.2% respectively 
(P = 0.19).
Conclusion: Our preliminary experience in utilizing HIFU 
therapy for treatment of recurrent HCC is promising. It 
appears to attain similar survival outcomes with that of RFA. 
Further studies are needed to explore its role as a primary 
treatment for HCC.
FOS143
EXPRESSION OF GLYPICAN-3 IN EARLY 
HEPATOCELLULAR CARCINOMA
I-P. Chen1, S. Ariizumi1, M. Nakano2 and M. Yamamoto1
1Department of Surgery, Institute of Gastroenterology, 
Tokyo Womens Medical University, Tokyo, Japan; 
2Department of Pathology, Ofuna Chuo Hospital, Ofuna 
Kamakura, Kanagawa, Japan
Introduction: Glypican-3 is a specifi c biomarker for 
advanced hepatocellular carcinoma (HCC). However, the 
role of glypican-3 expression in early HCC has not been 
clarifi ed yet. Therefore, our aim is to evaluate the role of 
glypican-3 in early HCC.
Methods: Between 1995 and 2010, 49 patients with early 
HCCs had undergone hepatectomies were selected for 
the study and 49 nodules of early HCCs were diagnosed 
pathologically. Early HCC was defi ned as small well-
differentiated HCC of vaguely nodular type according to the 
Japanese Liver cancer classifi cation. The expression of 
glypican-3 (GPC3) was investigated in relation to the clini-
copathological features of patients with early HCC by immu-
nohstochemistry staining.
Results: A total of 22 cases were immunohistochemistry 
stained glypican-3 (GPC3) positive. Female patients in our 
study received higher GPC3 expression than male patients 
(P = 0.042). Patients in HCV positive (P = 0.044) received 
overexpression of GPC3. Patients with multicentric tumor 
expressed higher GPC3 than those with solitary tumor. 
Furthermore, patients with GPC3 positive expression 
received shorter disease-free survival (DFS) than those with 
negative cases (37.4 ± 7.4 months and 62.1 ± 9.0 months, 
respectively) (P = 0.037). Additionally, overall survival (OS) 
in patients with GPC3 positive was shorter than patients with 
negative expression (65.5 ± 7.6 months and 90.4 ± 10.0 
months, respectively) (P = 0.013).
Conclusion: The expression of Glypican-3 participates in 
the early hepatocaracinogenesis and accompany with poor 
outcome in patients with early stage of hepatocellular 
carcinoma.
FOS144
RESULTS OF HEPATIC RESECTION IN 
TRANSPLANTABLE HEPATOCELLULAR 
CARCINOMA (HCC)
I. L-Cayer1, R. Lapointe2, S. Turcotte2, M. Plasse2, 
R. Letourneau2, M. Dagenais2, A. Roy2 and 
F. Vandenbroucke-Menu2
1Hopital Saint Luc, Universite de Montreal, Montreal, 
Canada; 2Hopital Saint Luc, CRCHUM, Universite de 
Montreal, Montreal, Canada
Introduction: The place of resection in transplantable HCC 
is still debated. The aim of this study was to compare the 
outcomes of liver resection (LR) with liver transplantation 
(LT) for HCC in Child A cirrhotic patients inside Milan 
criteria.
Methods: This was a monocentric retrospective study 
included 97 patients from 1989 to 2009. The data cutoff point 
was April 2010. The resection group was matched to trans-
plant group according these matching criteria: child A cir-
rhosis and HCC inside Milan criteria.
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Results: Fifty-two patients underwent transplantation (LT 
group) and 45 resection (LR group). The mean number of 
HCC was 1.09 for the LR group and 1.5 for the LT group. 
The LR and LT morbidity rates were respectively 34.8% and 
26.9%. The overall survival rates (LR vs LT) were respec-
tively at 1, 3 and 5 years: 90.7 vs 88.2%, 79.5 vs 75.2% and 
65.9 vs 72.1% (p = 0.949). Recurrence rates were 40% for 
LR and 4% for LT (p < 0.001). Five-year disease free sur-
vival rates was respectively for LR and LT: 47.7 vs 72.4% 
(p = 0.057). Recurrence in LR group was within Milan cri-
teria for 12 patients (67%), but only 2 of these patients were 
transplanted.
Conclusion: In our hand, for Child A cirrhotic patients 
inside Milan criteria, LR survival rate was not signifi cantly 
different from LT even if there was more recurrence. These 
results suggest that surgical resection still has an important 
place for patients that could also be eligible to transplanta-
tion, especially because we always face a shortage of donors.
FOS145
LIVER RESECTION FOR 
HEPATOCELLULAR CARCINOMA: A 
WESTERN SERIES OF 313 PATIENTS
J. Salceda1, M. Kluger2, A. Laurent1, C. Tayar1, 
J. T. V. Nhieu3, A. Luciani4, D. Azoulay1 
and D. Cherqui2
1Service de Chirurgie Digestive et Hépatobiliaire, Hôpital 
Henri Mondor, Assistance Publique-Hôpitaux de Paris 
Faculté de Médecine, Université Paris-Est, Créteil, 
France; 2Section of Hepatobiliary Surgery and Liver 
Transplantation, Department of Surgery, New York 
Presbyterian Hospital, Weill Cornell Medical Center, New 
York, NY, USA; 3Service de Anatomie et Cytologie 
Pathologiques, Hôpital Henri Mondor, Assistance 
Publique-Hôpitaux de Paris Faculté de Médecine, 
Université Paris-Est, Créteil, France; 4Service de Imagerie 
Medicale, Hôpital Henri Mondor, Assistance Publique-
Hôpitaux de Paris Faculté de Médecine, Université 
Paris-Est, Créteil, France
Introduction: Hepatocellular carcinoma (HCC) is the most 
common primary liver cancer. Resection and liver transplan-
tation remain the gold standard therapies. Liver resection 
(LR) for HCC has been regaining interest because of a short-
age of organs for transplantation and because LR is the only 
option for large tumors. The aim of this study was to deter-
mine the independent effect of tumor size on recurrence and 
survival.
Methods: 313 patients with a median age of 60 (16–86) 
underwent LR for HCC from 3/89–9/10. 251 patients (80%) 
had underlying liver disease (Hepatitis C = 76, Hepatitis B 
= 77, Alcohol = 61, Other = 37). Data were analyzed accord-
ing to tumor size, <50 mm (G1: 111), 50–100 mm (G2: 113) 
and >100 mm (G3: 89) and for two periods, 1989–1999 (n 
= 91) and 2000–2010 (n = 222). 87% of resections were 
anatomical. Major resections were performed in 56% of 
cases (G1 27%, G2 57%, G3 90%). A laparoscopic approach 
was used in 23% of cases, mostly in G1. Kaplan-Meir 
survival estimates, and univariate and multivariate cox-
regression analyses were performed.
Results: Mortality and morbidity rates were 8% and 29%, 
respectively. 5-year overall survival was 50%, 67% (G1), 
46% (G2), 34% (G3). 5-year disease-free survival was 28%, 
32% (G1), 27% (G2), 26% (G3). 5-year disease free survival 
was signifi cantly better in patients without underlying liver 
disease. On multivariate analysis, poor tumor differentiation 
(HR 1.9), vascular invasion (HR 2.1), blood transfusions 
(HR 1.9), and portal hypertension (HR 2.1) were signifi cant 
predictors of recurrence. Poor tumor differentiation (HR 
4.7), AFP > 200 (HR 1.5), vascular invasion (HR 1.8), blood 
transfusions (HR 2.6), and portal hypertension (HR 2.0) had 
a negative impact on survival, while salvage transplantation 
(HR 0.31) had a positive impact.
Conclusion: LR is an effi cient treatment of HCC for every 
disease stage and its safety has improved in recent years. R0 
resection was achieved in 88%. Tumor size alone did not 
signifi cantly impact survival or recurrence. Tumor biology 
impacts recurrence and survival. Although hampered by 
high recurrence rates, resection offers good overall survival 
and may allow better selection of candidates for transplanta-
tion in an era of organ shortage. 35 patients underwent sec-
ondary LT.
FOS146
SURGICAL STRATEGY FOR HCC-
PATIENTS WITH CHILD-PUGH CLASS B
H. Tashiro, S. Kuroda, H. Amano, T. Kobayashi, 
Y. Mikuriya, H. Tazawa, J. Nambu and H. Ohdan
Department of Gastroenterology, Hiroshima University 
Hospital, Hiroshima, Japan
Introduction: Hepatectomy has been considered a reason-
able treatment for patients with good liver function, such 
those of Child-Pugh class A. There are a few studies regard-
ing treatments for HCC patients classifi ed as being of Child-
Pugh class B. The aims of this retrospective analysis were to 
clarify the prognostic factors after hepatectomy in patients 
with HCC classifi ed as Child-Pugh class B and to delineate 
the selection criteria of hepatectomy.
Methods: Nine hundred nineteen patients with HCC under-
went hepatectomy as initial treatment at our institute between 
1986 and 2008. Among these patients, 150 patients with 
HCC classifi ed as Child-Pugh class B who had been fol-
lowed up for 1 or more years were enrolled in this retrospec-
tive study (Hx group). The prognosis was compared with 23 
patients with HCC who underwent living donor liver trans-
plantation (LDLT) for HCC of Child-Pugh class B at our 
institute between 1991 and December 2008 (LT group). 
Univariate and multivariate analyses were performed to 
identify prognostic factors.
Results: The overall survival rate of the Hx group was sig-
nifi cantly worse than that of the LT group (5-year; 36.0% vs. 
78.3%, P = 0.001). In multivariate analyses, diabetes mellitus 
(P = 0.011), preoperative total bilirubin level >1.5 mg/dl (P 
= 0.038), and Child-Pugh score of 8 or 9 (P = 0.038) were 
independent prognostic factors. The overall survival rates of 
32 patients who underwent curative hepatectomy for HCC 
with none of the 3 adverse prognostic factors within Milan 
criteria were tend to be lower than those of patients who 
underwent LT within Milan criteria, but there was no statisti-
cal signifi cant difference between the 2 groups (90.6% and 
70.9%, and 47.2% at 1, 3, and 5 years) (P = 0.213).
Conclusion: Hepatectomy can be indicated as the initial 
treatment for HCC patients of Child-Pugh class B with none 
of the 3 adverse prognostic factors, whereas LT should be 
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considered the initial treatment for patients of Child-Pugh 
class B with one or more adverse prognostic factors.
FOS147
INTRAOPERATIVE ABLATION FOR 
SMALL HCC NOT AMENABLE FOR 
PERCUTANEOUS RADIOFREQUENCY 
ABLATION IN CHILD A 
CIRRHOTIC PATIENTS
A. El-Gendi1, M. El-Shafei2, F. Abdel-Aziz3 and 
E. Bedewy3
1Department of Surgery, Faculty of Medicine, Alexandria 
University, Egypt; 2Department of Radiodiagnosis and 
Interventional Radiology, Faculty of Medicine, Alexandria 
University, Egypt; 3Department of Hepatology and Tropical 
Medicine, Faculty of Medicine, Alexandria University, 
Egypt
Introduction: Radiofrequency ablation (RFA) was initially 
started by radiologists as a percutaneous treatment, but sur-
geons started to use RFA by surgical approach for patients 
with tumors at locations diffi cult for the percutaneous pro-
cedure. The objective of this study was to evaluate the results 
of intraoperative RFA for small HCCs (<3 cm) in locations 
diffi cult for a percutaneous approach in child A cirrhotic 
patients due to hepatitis C infection.
Methods: 247 patients who had small solitary HCC 
(<3 cm) were treated; 196 underwent percutaneous RFA 
while 51 patients presented at sites not amenable for percu-
taneous route. 27/51 patients (53%) had segmentectomy 
or subsegmentectomy, while 24/51 patients underwent 
intraoperative RFA. The locations of the tumors were 
hepatic dome in 17 patients (9 resections, 8 RFA), near gall 
bladder in 8 patients (5 resection, 3 RFA), near hepatic 
fl exure in 6 patients (all resection), subcapsular near 
stomach in 4 patients (all resection), central in 7 patients 
(all RFA), and caudate lobe in 9 (3 resections, 6 RFA). One 
month later, treatment response was assessed by contrast 
material-enhanced computed tomography (CT) then per-
formed every 2–3 month.
Results: The depth of the tumor from the liver capsule was 
the only signifi cant factor in the choice of the surgeon 
between resection and RFA. RFA was successful in all 
tumors (complete ablation rate of 100%). In surgery group, 
all patient achieved R0 resection. Complication rate was 
comparable (P = 0.17). After a median follow-up of 20 
months (range, 8–30 months), no tumors showed neither 
local progression nor local recurrence. During the follow-up 
period, no signifi cant difference was observed between two 
groups as regards early recurrence, number of denovo lesions 
(P = 0.2). One-year and 3-year survival rates were 91% and 
68%, respectively, in the resection group comparable to the 
corresponding rates of 89% and 62% in the RFA group 
(P = 0.1).
Conclusion: For small HCC in locations diffi cult for a per-
cutaneous approach, intraoperative RFA can be an alternative 
option for deep seated tumors necessitating more than one 
segmentectomy achieving similar tumor control, overall and 
disease-free survival.
FOS148
SERUM OSTEOPONTIN LEVEL 
AS A TUMOR MARKER IN 
HEPATOCELLULAR CARCINOMA
E. Ahmed1, P. Salem1, D. Hashad2 and H. Ahmed1
1Faculty of Medicine, Hepatology Department, Alexandria 
University, Egypt; 2Faculty of Medicine, Clinical Pathology 
Department, Alexandria University, Egypt
Introduction: HCC is currently the third leading cause of 
cancer related deaths world wide. In Egypt, HCC epidemic 
is associated with HCV infection; where Egypt has the 
highest prevalence of HCV in the world with 13.8% of the 
population infected. AFP can be used to help defi ne patients 
at risk, but appears to have limited utility as a screening test. 
The aim of the present work is to study the signifi cants of 
serum Osteopontin (OPN) level as a serological marker in 
HCC with and without metastasis.
Methods: This study was conducted on 80 patients divided 
into 4 groups; group I: HCC patients with metastasis, group 
II: HCC patients without metastasis, Group III: Cirrhotic 
patients, Group IV: healthy subjects. All patients were 
subjected to Laboratory investigations including Liver 
Biochemical profi le, Serum AFP, HBs Ag., HCV Ab and 
Serum Osteopontin Level. Severity of Liver disease was 
graded according to Child Pugh Score. Radiological investi-
gations including chest X ray, CT chest, Triphasic CT 
abdomen and Bone scan in suspected cases. HCC staging 
according to Barcelona Clinic Liver Cancer Staging (BCLC).
Results: In HCC patients with metastasis, Serum OPN at 
the best cut-off value (9.6 ng/ml) had sensitivity of 100%, 
specifi city of 95%, positive predictive value (PPV) of 
95.24%, and negative predictive value (NPV) of 100%, area 
under the curve (AUC = 0.993). While, in HCC patients 
without metastasis; OPN at a cut off value (9.6 ng/ml) had a 
sensitivity of 100%, specifi city of 95%, PPV of 95.24%, 
NPV of 100%, AUC = 0.993. Serum OPN levels were not 
affected by age or sex. again, no signifi cant difference in 
serum OPN levels according to Child score neither in HCC 
patients nor in patients wih metastasis. Serum OPN levels 
were not affected by tumor size, presense of portal vein 
thrombosis or lymph nodes involvements or BCLC staging 
or MELD Score.
Conclusion: Osteopontin (OPN) had a 100% sensitivity and 
95% specifi city in HCC patient with or without metastasis at 
a cut-off value of (9.6 ng/ml); this is the value above which 
we can predict HCC, while AFP was less sensitive and less 
specifi c. OPN was signifi cantly higher in HCC patients with 
metastasis than in HCC patients refl ecting the importance of 
metastatic workup.
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SYSTEMATIC SEGMENTECTOMY FOR 
THE HEPATOCELLULAR CARCINOMA 
IN THE POSTERIOR AND 
SUPERIOR SEGMENTS
K. S. Ahn, Y. H. Kim, T. J. Lim, T. J. Park 
and K. J. Kang
Division of HBP Surgery, Department of Surgery, 
Keimyung University School of Medicine, Daegu, South 
Korea
Introduction: Systematic segmentectomy, limited anatomi-
cal resection, is useful in treating small hepatocellular carci-
noma (HCC) in the cirrhotic liver. However, anatomical 
segmentectomy of posterior and superior segment (segment 
VII, VIII) is technically demanding either with Glissonian 
approach or systematic approach due to deep location of 
vascular pedicles, absence of anatomical landmark and vari-
able anatomy of portal branches.
Methods: From January 2001 to May 2011, systematic seg-
mentectomy by dye injection method was performed in 68 
patients. We evaluated effi ciency of systematic segmentec-
tomy with ultrasonogram guided dye injection into the portal 
branches that feed tumor bearing segments including 
posterosuperior segments. The type of tumor-feeding portal 
vein (PV) branch, perioperative outcome and survival rates 
were analysed retrospectively.
Results: For the variation of portal venous branches, of 71 
masses in 68 patients, 38 masses (55.9%) were fed by single 
magistral PV (Type 1) and in 17 masses (25.0%) by a couple 
of PV branches (Type 2), 11 masses (16.2%) were supplied 
partially by only one portal venous branch (Type 3). In 5 
patients (7.4%), masses were supplied by several small dis-
tributed PV. For the type 1 & 2, the tumor bearing segment 
was resected anatomically by stain, for the type 3 was par-
tially stained and the opposite side was demarcated with 
counter stain, and dye injection could not perform. In 32 
patients, masses were located in seg V, VI and in remaining 
36 patients, masses were located in the segment VII & VIII.
Conclusion: Systematic segmentectomy by dye injection 
method is safe and effective for performing anatomical seg-
mentectomy in particularly for the segment 7 or 8. Although 
it is not feasible in a few patients (Type 4), this method 
makes overcome variation of portal venous tributaries of 
segments and can do according to the natural segment instead 
of artifi cial division.
FOS150
TRANSIENT TELOMERE DYSFUNCTION 
INDUCES CHROMOSOMAL INSTABILITY 
AND PROMOTES CARCINOGENESIS IN 
TELOMERASE-PROFICIENT MICE
D. Hartmann1, Y. Begus-Nahrmann2, H. A. Kestler3, 
P. Schirmacher4, H.-W. Lee5, H. Friess1, A. Lechel6 and 
K. L. Rudolph6
1Department of Surgery, Technische Universität München, 
Ismaninger Str. 22, 81675 München, Germany; 2Georg-
August-Universität Göttingen, Justus-von-Liebig-Weg 11, 
37077 Göttingen, Germany; 3Institute of Neural 
Information Processing, University of Ulm, Germany; 
4Institute of Pathology, University Hospital Heidelberg, Im 
Neuenheimer Feld 220/221, 69120 Heidelberg, Germany; 
5Department of Biochemistry, College of Science, Yonsei 
University, Seoul 120-749, Korea; 6Institute of Molecular 
Medicine and Max-Planck-Research Department on Stem 
Cell Aging, University of Ulm, Albert-Einstein-Allee 11, 
89081 Ulm, Germany
Introduction: A current concept indicates that telomere 
dysfunction can increase liver cancer initiation by induction 
of chromosomal instability, but initiated tumor cells need to 
reactivate telomerase for genome stabilization and tumor 
progression. However, this concept has not been proven in 
vivo since appropriate mouse models were lacking.
Methods: Here, we analyzed hepatocarcinogenesis (i) in a 
novel mouse model of inducible telomere dysfunction on a 
telomerase-profi cient background, (ii) in telomerase knock-
out mice with chronic telomere dysfunction (G3 mTerc-/-), 
and (iii) in wild-type mice with functional telomeres and 
telomerase.
Results: Transient or chronic telomere dysfunction enhanced 
the rates of chromosomal aberrations during hepatocarcino-
genesis, but only telomerase-profi cient mice exhibited sig-
nifi cantly increased rates of macroscopic tumor formation 
and cancer cell proliferation in response to telomere dysfunc-
tion. In contrast, telomere dysfunction resulted in pronounced 
accumulation of DNA damage, cell cycle arrest and apopto-
sis in telomerase-defi cient liver tumors.
Conclusion: Together, these data provide the fi rst in vivo 
evidence that telomere dysfunction can promote chromo-
somal instability and carcinogenesis in telomerase-profi cient 
mice in the absence of additional, genetic checkpoint defects 
at germline level. This supports the stepwise role of crisis 
and telomerase reactivation during tumor initiation and pro-
gression in hepatocarcinogenesis.
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HILAR DISSECTION VERSUS 
“GLISSONEAN” APPROACH 
FOR MAJOR HEPATECTOMIES: 
SURGICAL OUTCOME
C. Jigjidsuren1, M. Gillet2, N. Puntsagdulam3, S. Ruvjir1 
and T. Erdenebileg1
1HPBS Department, National Cancer Center, Ulaanbaatar, 
Mongolia; 2CHUV, Lausanne, Switzerland; 3Health 
Sciences University, Ulaanbaatar, Mongolia
Introduction: Effective treatment for HCC includes liver 
resection, and one of the main determinants of surgical 
outcome is remaining liver volume. One of the most promis-
ing techniques which allows easy liver resection is the 
“Glissonean” approach. This technique can increase remain-
ing liver volume and reduce intraoperative hemorrhage. The 
current study has been carried out to assess surgical out-
comes of “Glissonean” approach in patients with HCC 
treated at the National Cancer Center of Mongolia.
Methods: Between 2008 and 2010, 346 patients with hepa-
tocellular carcinoma underwent a liver resection at the 
National Cancer Center of Mongolia. Of these patients, 65 
who underwent major resection involving more than 3 seg-
ments according either to the “Glissonean” (n = 26 pts) or to 
the traditional (n = 39 pts) technique were analyzed retro-
spectively. Surgical and six-month survival outcomes of the 
two groups were compared.
Results: Apart from a higher rate of cirrhotic liver paren-
chyma in the “Glissonean” group (38 vs 21%), there were 
no differences in terms of demographic characteristics, hepa-
titis B and C infection rate, pre-operative laboratory param-
eters, size of tumor and its stage according to the TNM 
classifi cation. As expected, the “Glissonean” approach sig-
nifi cantly shortened the duration of surgery (207 ± 52 vs 265 
± 127 min, X ± SD), (p = 0.03) and decreased the intraopera-
tive blood loss (358 ± 294 vs 747 ± 951 ml) (p = 0.052). Six 
months after surgery, the higher survival rate in the 
“Glissonean” group was not different than that of the other 
group (81 vs 69%).
Conclusion: In our hands, both techniques are effective for 
treating the hilar structures but we have found a shorter 
overall operative time and reduced bleeding when using the 
“Glissonean” approach. This technique is our preference par-
ticularly for resecting tumors located in segments fi ve and 
eight in order to preserve functional liver parenchyma.
FOS152
EARLY PREDICTOR OF MORTALITY 
DUE TO IRREVERSIBLE 
POSTHEPATECTOMY LIVER 
FAILURE IN PATIENTS WITH 
HEPATOCELLULAR CARCINOMA
S. H. Kim1, D. R. Kang2, J. G. Lee1, D. Y. Kim3, 
S. H. Ahn3, K.-H. Han3, C. Y. Chon3 and K. S. Kim1
1Department of Surgery, Yonsei University College of 
Medicine, Seoul, Korea; 2Graduate School of Public 
Health, Yonsei University, Seoul, Korea; 3Department of 
Internal Medicine, Yonsei University College of Medicine, 
Seoul, Korea
Introduction: Although mortality after liver resection has 
declined, posthepatectomy liver failure (PHLF) remains a 
major cause of operative mortality. There was not a consen-
sus of defi nition for PHLF. However, there have been many 
efforts to defi ne PHLF causing operative mortality. We 
sought to identify early predictors of mortality due to irre-
versible PHLF.
Methods: We retrospectively analyzed the medical records 
of 359 patients with hepatocellular carcinoma who under-
went liver resection from March 2000 to December 2010. 
Various biochemical parameters were analyzed on postop-
erative days (PODs) 1, 3, 5, and 7, and compared with 
“50-50” criterion.
Results: Operative mortality was 4.7%. Bilirubin; 2.2 mg/
dl and international normalized ratio 1.35 on POD 5 showed 
only signifi cant difference compared with “50-50” criterion. 
The new combination of bilirubin and international normal-
ized ratio (INR) showed higher sensitivity, area under the 
curve and similar accuracy (sensitivity 78.6% vs. 28.6%, p 
= 0.002; area under the curve 0.8402 vs. 0.6396, p = 0.00176; 
accuracy 88.6% vs. 93.4%, p = 0.090). Multivariate analysis 
revealed the combination of bilirubin; 2.2 mg/dl and INR; 
1.35 on POD 5 as an only independent predictive factor 
(odd ratio, 82.29; 95% confi dence interval 8.69–779.64; 
p < 0.001).
Conclusion: In patients with chronic liver disease who will 
undergo liver resection, the combination of bilirubin; 2.2 mg/
dl and INR; 1.35 on POD 5 may be more sensitive predictor 
for mortality due to PHLF. Though it needs to validate by 
prospective study, it may be applied to select patients receiv-
ing artifi cial liver supports or liver transplantation.
FOS153
LAPAROSCOPIC LIVER RESECTION 
FOR T1 AND T2 HEPATOCELLULAR 
CARCINOMA
C. H. D. Kwon, S. Song, J.-W. Joh, S.-J. Kim, 
J. M. Kim, M. Shin, H. H. Moon and S. Lee
Sungkyungkwan University School of Medicine, Samsung 
Medical Center, Seoul, Korea
Introduction: Laparoscopic liver resection has gained 
much popularity in recent years, but relatively few centers 
have performed laparoscopic hepatectomies in hepatocellu-
lar carcinoma (HCC) patients due to the technical diffi cul-
ties. We now present our early experience with laparoscopic 
liver resection in HCC performed in a single institution.
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Methods: From January 2008 until February 2011, total 761 
patients of hepatectomy was done and we excluded TNM 
stage 3, tumors over 7 cm and location of tumors of segment 
I, VII, VIII. 82 laparoscopic liver resections were performed 
and open conversion was 13 cases (15.8%). To reduce 
selection bias we made a propensity case matching and made 
a control group as twice number. We analyzed 69 laparo-
scopic liver resection cases and 138 open liver resection 
cases.
Results: Edmondson grade, microvascular invasion, tumor 
size, TNM stage, preoperative AFP level and cirrhosis were 
comparable with each group. Also we matched the range of 
operation as resection less than 2 segments more than 2 seg-
ments. We found that the length of hospital stay was shorter 
in laparoscopic resection group than open resection group 
(9.5 days vs 13.2 days, p = 0.018), the postoperative compli-
cation rate was lower in laparoscopic resection group (8.7% 
vs 22.5%, p = 0.015) EBL and margin were not different in 
each group. 3 year disease free survival in laparoscopic 
resection group was 35.3% and open resection group was 
51.6% (p = 0.409). 3 year survival rate in laparoscopic resec-
tion group was 81.3% and open resection group was 90.2% 
(p = 0.590).
Conclusion: Laparoscopic liver resection for HCC can be a 
feasible and safe operative method in early stage HCC. To 
draw a fi nal conclusion, randomized control study and long 
term follow up is needed.
FOS154
IS IT POSSIBLE TO REDUCE THE 
BLEEDING IN HEPATIC RESECTIONS 
WITHOUT CONDUCTING TOTAL OR 
PARTIAL VASCULAR EXCLUSION?: 
RESULTS OF THE USE OF BIPOLAR 
RADIOFREQUENCY WITH 
COLD NEEDLES
F. Waechter, U. Teixeira, P. Fontes, M. Nectoux, 
J. Sampaio, L. Pereira-Lima, T. Passarin and L. César
Universidade Federal de Ciências da Saúde de Porto 
Alegre, RS, Brazil
Introduction: Although the resection is the chosen proce-
dure in the therapeutic treatment of liver malign lesions, the 
bleeding represents a factor of morbidity with a great impact 
in the hepatic surgery. With the means of minimizing this 
complication, several technological options have been uti-
lized, being radiofrequency more recently among them, 
allowing the procedure to be realized with smaller incisions, 
without the need of vascular clamping, with minimum 
hepatic dissection, or bleeding.
Methods: Sixty patients were submitted to hepatic resec-
tion through the use of bipolar radiofrequency. The pre-
operation bleeding was evaluated through the medication 
of the collected volume in the vacuum and by the weight 
difference in the compresses utilized during the procedure. 
All cases were monitored in their hepatocitary function 
through laboratory tests during the fi rst week of the post-
operative period.
Results: Hepatic resections were realized with the mean of 
87 minutes, mean incision size of 14 cm and mean bleeding 
of 58 ml. None of the patients received blood transfusion or 
derivatives. Central venous catheters were not utilized. All 
patients obtained fast anesthetic recuperation, leaving the 
recuperation room to the ward in less than 12 hours. The 
postoperative drainage was noted down until the drain 
removal occurring in all patients. The mean hospitalization 
time was of 3.2 days. After the elevation peak of the hepatic 
function tests in the fi rst three days, all patients presented 
regression of them.
Conclusion: It is possible, feasible and valid to use radio-
frequency needles to perform hepatectomies, even larger 
ones, reducing bleeding.
FOS155
EARLY HCC: SELECTION OF PATIENTS 
WHO SHOULD NOT BE TRANSPLANTED
O. Scatton1, S. Zalinski1, L. Fartoux2, F. Conti2, 
O. Rosmorduc2 and O. Soubrane1
1Department of Hepato-Biliary Surgery and Liver 
Transplantation, Hopital Saint Antoine, APHP, Université 
Pierre et Marie Curie, Paris, France; 2Department of 
Hepatology, Hopital Saint Antoine, APHP, Université 
Pierre et Marie Curie, Paris, France
Introduction: The optimal treatment of early HCC still 
remains to defi ne. Liver transplantation (LT) is challenged 
by resection. The main argument to propose LT is based on 
a better disease free survival. To defi nitively convince that 
LT is the best strategy, survival at 10 yr should be consid-
ered. This long-term survival may be altered by the immu-
nosuppressive regimen and frequent underlying liver disease 
recurrence. Resection of HCC with good histological profi le 
and stable liver disease is an alternative.
Methods: The goal of this study was to compare the long-
term survival of two options.
Within 20 yr, 406 HCC patients underwent a curative 
surgery at our institution. Among them, 227 patients under-
went liver resection (LR) and 179 were transplanted (LT). In 
case of resection, a good prognostic profi le was defi ned as 
follow; single lesion less than 5 cm, no microvascular inva-
sion no satellite nodule, good or moderate differentiation, R0 
surgical margin. This population defi ned the “good prognosis 
group” (GPG). Among 227 patients, 62 belonged to this 
selected group.
Among the 179 LT-patients, 40 had a previous LR and 139 
patients had primary LT. Overall, 138 met Milan criteria.
Long-term results of LR with or without GPG and LT 
group were compared.
Results: Among LR, overall 5 and 10-yr survival rates were 
80% and 61% for GPG versus 58% and 45% for non-GPG 
(p = 0.009).
In LT group, 5 and 10-yr survival rates were 81% and 75% 
in the Milan criteria and 54% and 54% beyond the Milan 
criteria (p = 0.019). Milan criteria were evaluated on the 
explants’ specimen.
Overall 5 and 10-yr survival rates were 80% and 61% in 
GPG LR group and 81% and 75% in Milan criteria LT group, 
respectively (p = 0.7).
Overall 5 and 10-yr survival rates were 80% and 61% for 
GPG as compared to 65% and 45% for LT group regardless 
of the Milan status (p = 0.032).
Conclusion: In case of early HCC with good histological 
profi le and stable underlying liver disease, an oncological 
surgical resection challenges LT and gives excellent 
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long-term results comparable to LT. Resection should be 
proposed as a fi rst line treatment of HCC.
FOS156
THE UTILITY OF POSITRON EMISSION 
TOMOGRAPHY IN HEPATOCELLULAR 
CARCINOMA
E. Simoneau1, S. Wong1, M. Jamal1, M. Aljiffry1, 
P. Chaudhury1, J. Tchervenkov1, P. Metrakos1 and 
M. Hassanain2
1Section Hepatobiliary and Solid Organ Transplant, McGill 
University, Montreal, Canada; 2Department of Surgery, 
King Saud University, Riyadh, Saudi Arabia
Introduction: Positron emission tomography (PET) using 
18F-fl uorodeoxyglucose (FDG) is being increasingly used in 
the fi eld of oncology. For hepatocellular carcinoma (HCC), 
it has been suggested that it may be an important predictor 
of outcomes for patients undergoing resection or transplanta-
tion. The objectives of our study were to evaluate the prog-
nostic value of FDG-PET in patients with hepatocellular 
carcinoma and to evaluate the correlation between the stan-
dardized uptake values (SUV) and survival outcomes.
Methods: From 1991 to 2011, patients with HCC were 
identifi ed, who had PET scans done after diagnosis and prior 
to any treatment. A retrospective chart review was performed 
and complete follow up with dates of death were obtained 
until September 2011 from the Government of Quebec 
registry.
Results: 75 patients were identifi ed. 8 patients had surgical 
resection, 46 had loco-regional therapy (TACE, DC beads, 
RFA and microwave ablation) and 21 were transplanted. All 
resected patients, 3 PET positive (SUV > 4) and 5 PET 
negative (SUV ≤ 4) were alive at follow-up (median 3 
years). For the non-resectable HCC 28 patients were PET 
positive and 18 negative. On survival analysis using log-
rank testing the PET negative patients had higher median 
survival compared to PET positive (median 3.5 years vs <1 
year respectively, p = 0.001). For the transplanted patients, 
9 were PET positive and 12 negative. PET negative patients 
outside Milan had lower survival (median 2.7 years) com-
pared to PET positive patients within Milan criteria (median 
4.4 years).
Conclusion: PET scan use can be of value in early prognos-
tication of patients with HCC. PET negative patients had 
higher survival for the non-resectable HCC. When trans-
planted, patients with a negative PET had higher survival 
even outside Milan criteria. PET scan use can be of value in 
early prognostication of patients with HCC, however its 
potential role requires further validation in a prospective 
study.
FOS157
HEPATIC RESECTION FOR 
HEPATOCELLULAR CARCINOMA WITH 
BILE DUCT TUMOR THROMBUS
D.-B. Moon, S.-G. Lee, S. Hwang, K.-H. Kim, 
C.-S. Ahn and G.-W. Song
Hepato-Biliary Surgery and Liver Transplantation, 
Department of Surgery, Asan Medical Center, University of 
Ulsan College of Medicine, Korea
Introduction: Less than 10% of icteric hepatocellular car-
cinoma was related to obstruction of bile duct by the tumor. 
Some patients could be treated by hepatectomy with provi-
sion of adequate preoperative management. This study was 
to examine the outcome of HCC patients with bile duct tumor 
thrombus who underwent operation.
Methods: From October 1994 to August 2010, 53 HCC 
patients (1.6%) having bile duct tumor thrombus involving 
minimum 2nd order branches were treated surgically. These 
were the fi rst surgical treatment of HCC, and the patients 
were followed up more than 18 months. Clinical data were 
reviewed retrospectively and the primary end point was sur-
vival after surgical treatment.
Results: Child A was77.4% and 12 patients (22.6%) had 
cirrhosis. Mean total bilirubin level on admission was 9.8 mg/
dL. Biliary drainage was performed in 32 patients (60.4%). 
Portal vein invasion was accompanied in 24 patients (45.3%). 
Duration of preoperative management was 44 days and portal 
vein embolization was performed in 6 patients. Hepatic resec-
tion was performed in 49 patients (92.5%). Bile duct resec-
tion combined with hepatectomy was performed in 17 
patients (32.1%). 5-year overall and disease survival rate 
were 30.7% and 17.5%. R0 resection of HCC was a signifi -
cant factor affecting on the overall and disease free survival. 
When R0 resection was performed, bile duct resection was 
not affected on the survival, but R0 resection was very dif-
fi cult in Ueda type III patients without bile duct resection.
Conclusion: Preoperative biliary decompression made us to 
perform hepatectomy in HCC with bile duct tumor thrombus. 
R0 resection is very important for good prognosis and hepa-
tectomy with bile duct resection should be performed actively 
in Ueda type III patient, similar to Klatskin’s tumor.
FOS158
THE CLINICAL STUDY OF PRECISE 
HEMIHEPATECTOMY GUIDED BY 
MIDDLE HEPATIC VEIN
Y. Qiu, X. Zhu, R. Zhu, J. Zhou, T. Zhou, Y. Wang and 
Y. Ding
Department of Hepatobiliary Surgery, the Affi liated 
DrumTower Hospital of Nanjing University Medical 
School, Jiangsu, China
Introduction: To preoperatively analyze the feasibility of 
evaluation for hepatic veins, as well as evaluate the safety 
and therapeutic effi cacy of precise hemihepatectomy guided 
by middle hepatic vein.
Methods: Thirty patients with ongoing hemihepatectomy 
from October 2008 to September 2009 in Nanjing DrumTower 
hospital were subjected to multi-slice helical CT hepatic 
venography preoperatively in order to achieve Nakamura’s 
and Kawasaki’s classifi cation of hepatic veins for individual 
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operative program performed by the guidance of middle 
hepatic vein with intraoperative ultrasound. The clinical data 
of these patients were compared with another 38 hemihepa-
tectomy patients (control group) from October 2007 to 
September 2008 in Nanjing DrumTower hospital. The 
amount of intraoperative bleeding and blood transfusion, 
liver function recovery, postoperative complications and 
1-year follow-up data were compared between two groups.
Results: The ratios of Nakamura’s classifi cation type I, II, 
III of hepatic veins were 56.7% (17/30), 26.7% (8/30), and 
16.7% (5/30), respectively. The amount of intraoperative 
bleeding and blood transfusion, as well as serum alanine 
aminotransferase, total bilirubin, and cholinesterase of the 
third postoperative day between the two groups. However, 
negative resection margin and albumin level were more 
favorable in precise hemihepatectomy group than anatomical 
hemihepatectomy group. In addition, the incidence of post-
operative pleural effusion and seroperitoneum was decreased 
signifi cantly by precise hemihepatectomy. The 1-year tumor-
free survival rate was 79% (15/19) in PH group, which is 
48% in RH group.
Conclusion: Preoperative evaluation of hepatic veins is of 
great value for sound individual operative program via deter-
mination of anatomical type of hepatic veins. Precise hemi-
hepatectomy could reserve functional liver tissue with 
complete venous return to a great extent, so make fewer 
incidences of postoperative pleural effusion and seroperito-
neum. Precise hemihepatectomy also has the potential of 
achieving more adequate tumor-free resection margin, which 
may result in higher tumor-free survival rate.
FOS159
VARIABLES RELATED TO 
COMPLICATIONS AFTER LIVER 
RESECTION FOR HEPATOCELLULAR 
CARCINOMA IN THE ELDERLY
K. Fukushima, A. Kobayashi, T. Yokoyama, A. Shimizu, 
H. Motoyama, N. Furusawa, T. Kitagawa and 
S.-ichi Miyagawa
First Department of Surgery, Shinshu University School of 
Medicine, Nagano, Japan
Introduction: Previous studies have showed that liver 
resection can be safely performed in the well selected elderly 
patients with hepatocellular carcinoma (HCC). However, 
few studies have reported the predictive factors associated 
with postoperative complications. The aim of this study is to 
analyze the risk factors in elderly patients (≥75 yr) using 
multiple logistic regression.
Methods: A total of 105 elderly patients underwent 115 
hepatectomies for HCC, including 94 initial and 21 repeat 
liver resections, at a single medical center from 1990 to 2010. 
Pre, intra-, and postoperative clinico-pathological variables 
were analyzed.
Results: There was no 30-day mortality, but one in-hospital 
death (mortality rate of 0.9%). Postoperative complications 
were observed in 44 patients (38%) with major complication 
rate of 12%, classifi ed as grade III to IV of the Clavien-Dindo 
system. Using multiple logistic regression, a factor associ-
ated with overall complications was presence of two or more 
preoperative comorbidities {odds ratio (OR), 2.92; 95% con-
fi dence interval (CI), 1.27–6.71}. Variables related to major 
complications were: packed red cell transfusion (OR, 6.14; 
95% CI, 1.30–28.9) and albumin level <3.8 g/dL (OR, 5.05; 
95% CI, 1.19–21.3).
Conclusion: Liver resection in the elderly can be performed 
with a very low mortality and an acceptable morbidity. In 
order to prevent major complication, every effort should be 
made to reduce the amount of intraoperative blood loss espe-
cially in patients with impaired liver function.
FOS160
STAGING CIRRHOSIS TO NARROW 
DOWN THE INDICATIONS OF LIVER 
TRANSPLANTATION IN PATIENTS 
WITH SINGLE HEPATOCELLULAR 
CARCINOMA FULFILLING THE 
MILAN CRITERIA
Z.-yong Huang, B.-yong Liang, Z.-yi Zhang and 
X.-ping Chen
Tongji Hospital, Tongji Medical College, Huazhong 
University of Science and Technology, Wuhan, China
Introduction: Both liver transplantation and resection are 
effective treatments for single hepatocellular carcinoma 
(HCC) fulfi lling the Milan criteria, however, their indications 
are still controversial in those patients with Child-Pugh A 
liver disease.
Methods: 276 consecutive patients with single HCC fulfi ll-
ing the Milan criteria underwent either liver transplantation 
(n = 20) or resection (n = 256) from 2001 to 2009. Liver 
cirrhosis was staged as none, mild, moderate and severe 
grade by the Laennec scoring system. The patients with 
Child-Pugh A in the resection group (n = 241) were stratifi ed 
to the subgroups with none or different grades of cirrhosis, 
and the survivals of these subgroups were then analyzed.
Results: The 5-year recurrence-free and overall survival 
rates after resection were 68.5% and 92.5%, respectively, for 
the subgroup of no cirrhosis, 63.4% and 85.9%, respectively, 
for the subgroup of mild cirrhosis, and 28.6% and 50.4%, 
respectively, for the subgroup of moderate/severe cirrhosis. 
There was no signifi cant difference between the subgroups 
of no cirrhosis or mild cirrhosis and the transplantation group 
in recurrence-free survival and overall survival, whereas the 
recurrence-free and overall survival in the subgroup of mod-
erate/severe cirrhosis were signifi cantly poorer than those in 
the transplantation group.
Conclusion: Liver resection achieves similar outcomes as 
transplantation in patients both with single HCC fulfi lling the 
Milan criteria and without cirrhosis or with Child-Pugh A 
mild cirrhosis. The indications for liver transplantation could 
be narrowed down through evaluation on liver cirrhosis. 
Liver biopsy should be recommended before liver transplan-
tation for single HCC fulfi lling Milan criteria.
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FOS161
A NEW HEPATECTOMY BASED ON A 
HYBRID CONCEPT OF PORTAL 
PERFUSION OF ANTERIOR SEGMENT 
AND VENOUS DRAINAGE AREA OF 
SUPERIOR RIGHT HEPATIC VEIN
M. Shimada, T. Utsunomiya, M. Kanamoto, T. Miyatani, 
T. Ikemoto, S. Imura, Y. Morine and H. Miyake
Department of Surgery, The University of Tokushima, 
Japan
Introduction: Detailed 3D-image revealed that portal per-
fusion area in cranial side of anterior segment sometimes 
surrounded superior right hepatic vein (SRHV). In such 
patients with HCC, SRHV should be resected for systematic 
resection. This study aimed to clarify characteristics of 
patients with SRHV surrounded by portal perfusion area of 
anterior segment, and propose a new hepatectomy based on 
a hybrid concept of portal perfusion of anterior segment and 
hepatic venous drainage area of SRHV.
Methods: <SRHV-involvement> 3D-CT images of 66 
patients without having tumors in the right lobe were con-
structed using a software of SYNAPSE VINCENT (Fujifi lm 
Corp, Japan). “SRHV-involvement” was defi ned as involve-
ment of more than 1 cm of proximal site (near the root) of 
SRHV surrounded by portal perfusion area of anterior 
segment.
<Procedures> The procedures are as follows: 1) encircling 
of anterior Glissonian pedicle, SRHV and inferior right 
hepatic vein (IRHV), 2) confi rmation of demarcation line of 
anterior segment by occluding Glissonian pedicle and demar-
cation (congested) line by clamping proper hepatic artery and 
SRHV, and 3) IRHV-preserved complete resection of portal 
perfusion area plus drainage area of SRHV, combined with 
SRHV resection.
Results: <SRHV-invlvement> SRHV-involvement was 
observed in 17 out of 66 patients (26%). The large IRHV 
(more than 5 mm in diameter) was found in 16 out of 66 
patients (24%). In patients with SRHV-involvement, the inci-
dence of a large IRHV (8 of 17: 48%) was signifi cantly 
higher, compared to that in those without SRHV-involvement 
(8 of 49: 16%).
Two patients having a large IRHV and HCC near the root 
of SRHV underwent a IRHV-preserved hepatectomy com-
bined with SRHV resection (S8 + SRHV-drainage area 
in 1 and anterior segment + SRHV-drainage area in 1). 
Postoperative CT scan revealed complete resection of drain-
age area of SRHV and no congestion in the remnant posterior 
segment after hepatectomy due to excellent drainage through 
a large IR.
Conclusion: The incidence of SRHV-involvement was not 
so rare, and half of those with SRHV-inclusion had a large 
IRHV. In such HCC patients having a large IRHV, our new 
hepatectomy based on a hybrid concept of portal perfusion 
of anterior segment and venous drainage area of SRHV, 
combined with SRHV resection, is a promising option from 
the viewpoint of systematic resection (curability) and func-
tional reserve of the future remnant liver.
FOS162
ONE HUNDRED LAPAROSCOPIC LIVER 
RESECTION FOR HEPATOCELLULAR 
CARCINOMA COMPLICATING CHRONIC 
LIVER DISEASE
A. Laurent1, C. Tayar1, T. Decaens2, J. Calderaro3, 
A. Luciani4, C. Duvoux2 and D. Azoulay1
1Hepato-Biliary and Liver Transplant Unit, Henri Mondor 
Hospital, Créteil, France; 2Department of Hepatology, 
Henri Mondor Hospital, Créteil, France; 3Department of 
Pathology, Henri Mondor Hospital, Créteil, France; 
4Department of Radiology, Henri Mondor Hospital, Créteil, 
France
Introduction: Laparoscopic liver resection (LLR) was 
developed by a limited number of teams over the past 10 
years. LR for solitary HCC in Child A patient is still contro-
versial because of high mortality and morbidity.
We report here the fi rst 100 patients.
Methods: From November 1998 to August 2011, 303 
patients underwent liver resection for HCC complicating 
chronic liver disease. Among them 100 (33%) were per-
formed under laparoscopy. Tumors were 10 cm or less in size 
and located in antero-lateral segments. Liver disease was due 
to hepatitis B or C in 58 patients, alcohol in 23, NASH in 7 
and others causes in 12. Five-port CO2 laparoscopy was used 
and the specimen was extracted in a bag through a separate 
lower abdominal incision.
Results: One segment or less was resected in 61 patients 
including anatomical resection in 13. Other resection 
included 30 left lateral sectionectomies, 7 right hepatecto-
mies and 2 left hepatectomies. 14 conversions to laparotomy 
occurred for moderate hemorrhage in 6 cases and insuffi cient 
exposure in 5. 10 conversions occurred in resections of one 
segment or less. One cirrhotic patient died on POD 10 from 
cardiac insuffi ciency after uneventful LLS. According to 
Clavien’s classifi cation, complications were grade I, II, III, 
IV in 7, 6, 2 and 6 cases respectively. After a mean follow-up 
of 37.9 months, 51 patients developed tumor recurrence. 19 
patients underwent orthotopic liver transplantation. Overall 
and disease free 3-year survival rates were 66% and 36% 
respectively.
Conclusion: Our study shows that laparoscopic liver resec-
tion for HCC in selected patients is a safe procedure with 
good mid-term results. This approach could have an impact 
on the therapeutic strategy of HCC complicating chronic 
liver disease especially in the fi eld of liver transplantation.
FOS163
UPFRONT LIVER RESECTION IS NOT 
APPROPRIATE FOR PATIENTS WITH 
HEPATOCELLULAR CARCINOMA AND 
HEPATITIS C ELIGIBLE FOR LIVER 
TRANSPLANTATION
M. Chrica, H. Tranchard, V. Tan, M. Faron, P. Balladur 
and F. Paye
Department of Digestive Surgery Saint-Antoine Hospital, 
Paris, France
Introduction: Recent data support liver resection (LR) as 
fi rst-line approach in patients with preserved liver function 
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who have resectable hepatocellular carcinoma and are also 
eligible (<3 nodules, <5 cm) for liver transplantation (LT). 
This retrospective study assesses the infl uence of hepatitis 
C virus infection (HCV) on the outcome of patients who 
underwent upfront LR for HCC, but who were also eligible 
for LT.
Methods: Between 1995 and 2010, 75 patients (65 men, 
mean age 65 ± 10 years) with HCC who were eligible for LT 
were treated by LR. The underlying hepatic disease was 
related to HCV in 30 (42%) patients, virus B infection 
(HBV) in 15 (21%) patients, alcohol abuse in 26 patients 
(36%) and other in 10 patients (13%). Fifty fi ve (73%) 
patients had cirrhosis (METAVIR F4). All patients were 
Child A. Major liver resection was performed in 9 (12%) 
patients. Intermittent clamping of the hepatic pedicle was 
used in 41 (55%) patients. Treatment of recurrence included 
repeat LR in 10 patients (13%) and salvage LT in 9 (12%) 
patients. Survival curves were calculated according to 
Kaplan-Meier and compared with the Log-Rank test.
Results: Operative morbidity and mortality rates were 37% 
and 5% respectively. At 1, 3 and 5 years, overall (OS) and 
disease free (DFS) survival rates were 81%, 69%, 55% and 
56%, 31%, 21% respectively. On univariate analysis, HCV 
infection (p = 0.012) and preoperative AST over 70 U/l (p = 
0.03) were associated with decreased OS. On multivariate 
analysis, HCV infection was the only independent factor 
associated with decreased OS (p = 0.02). On univariate and 
multivariate analysis, HCV infection (p = 0.05) and hepatic 
pedicle clamping (p = 0.003) were associated to decreased 
DFS. The 1, 3 and 5 years OS and DFS rates in patients with 
HCV related HCC were 69%, 53%, 38% and 50%, 18%, 9% 
respectively.
Conclusion: Overall and disease free survival after liver 
resection in patients with HCV related HCC and preserved 
liver function is poor. Liver transplantation should be con-
sidered as fi rst line treatment in these patients.
FOS164
INCREASED EXPRESSION OF 
HOMEOBOX B9 IS ASSOCIATED WITH 
POOR PROGNOSIS IN PATIENTS WITH 
HEPATOCELLULAR CARCINOMA 
AFTER CURATIVE RESECTION
N. Chiba1, T. Hayashida2, A. Shimada1, T. Nakamura1, 
S. Ishikawa1, Y. Arisawa1, M. Hashimoto1 and 
Y. Kitagawa1
1Department of Surgery, Kawasaki Municipal Ida Hospital, 
Kawasaki, Japan; 2Department of Surgery, Keio University 
School of Medicine, Tokyo, Japan
Introduction: Homeobox B9 (HoxB9) alters tumor cell fate 
and promotes tumor progression and metastasis. And HoxB9 
overexpression in breast tumors, by altering the microenvi-
ronment, induces several tumorgenic phenotypes and pro-
motes disease progression in vitro and in vivo. To evaluate 
the clinical signifi cance of HoxB9, we analyzed the associa-
tion of HoxB9 expression and clinicopathologic characteris-
tics in HCC patients.
Methods: Expression levels of HoxB9 in tumor tissue were 
evaluated by immunohistochemistry. Its correlation with 
clinicopathologic parameters and the prognosis for patients 
with HCC after curative resection were analyzed. Prognostic 
signifi cance was assessed by Kaplan-Meier survival esti-
mates and log-rank tests. Multivariate analyses were per-
formed to evaluate prognosis-related factors.
Results: HoxB9 was highly expressed in 8 of 30 (26.7%) 
patients. The mean proportion of tumor cells positively 
stained with HoxB9 was 78.5% in positive HoxB9 group and 
7.3% in negative group. Only intrahepatic metastasis among 
clinicopathological parameters has correlation with HoxB9 
expression (p = 0.05). Increased HoxB9 expression in 
resected HCC predicted lower 1-year disease free survival 
rates (80.0% v.s. 16.7%, p < 0.05), and multivariate analysis 
revealed HoxB9 overexpression was an independent risk 
factor for recurrence. Patients with increased HoxB9 had 
worse 3-year overall survival rates (66.7% v.s. 0.0%, p < 
0.05), and HoxB9 overexpression was an independent prog-
nostic factor on Cox regression analysis.
Conclusion: This is the fi rst report to show that increased 
HoxB9 expression is associated with subsequent recurrence 
and worse survival rates after curative resection of HCC, as 
well as cancer progression such as intrahapatic metastasis. 
Thus, HoxB9 may be a novel prognostic biomarker and 
therapeutic target in HCC.
FOS165
PRE-OPERATIVE PREDICTORS OF 
MICROVASCULAR INVASION IN 
CIRRHOTIC AND NON-CIRRHOTIC 
HEPATOCELLULAR CARCINOMA
R. Young1, A. Hakeem1, A. Nair1, A. Young1, J. Wyatt2, 
G. Toogood1, P. Lodge1 and R. Prasad1
1Department of Transplant and Hepatobiliary Surgery, St 
James’s University Hospital, Leeds, UK; 2Department of 
Histopathology, St James’s University Hospital, Leeds, UK
Introduction: Microvascular invasion (MVI) is a key 
determinant of outcome following curative resection or 
transplantation for hepatocellular carcinoma (HCC). 
Determination of pre-operative predictors of MVI in patients 
with or without cirrhosis may increase our understanding of 
the underlying tumour biology in these diverse patient 
groups. This will allow optimisation of treatment selection 
criteria and patient outcomes.
Methods: Review of a prospective database of 229 con-
secutive patients undergoing hepatectomy or transplantation 
for HCC at St James’s University Hospital, United Kingdom. 
Diagnosis was based on published guidelines and incidental 
tumours excluded. Patients were divided into age matched 
cohorts based on the presence (115, 50.2%) or absence (114, 
49.8%) of cirrhosis. Clinico-pathological characteristics 
were correlated with survival and MVI. Survival was calcu-
lated using the Kaplan-Meir method with Log-rank and Cox 
stepwise regression for survival comparisons. Univariate 
Chi-squared and multivariate logistic regression were used 
to analyse relationships between clinico-pathological vari-
ables and MVI (P < 0.05 was indicative of statistical 
signifi cance).
Results: There was a higher incidence of MVI in non-cir-
rhotic HCC (59.6% vs. 27.8%, P < 0.001). In cirrhotic 
patients recurrence was an independent predictor of overall 
survival (P < 0.001) whilst largest tumour size >5 cm and 
MVI were independent predictors of disease free survival (P 
= 0.027 & P = 0.002). In non-cirrhotic patients only recur-
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rence independently predicted overall survival (P = 0.001) 
whilst multifocal tumours (P = 0.042) and underlying viral 
aetiology (P = 0.031) predicted disease free survival. 
Univariate analysis of pre-operative variables revealed MVI 
was associated with viral aetiology in cirrhotic patients (P = 
0.047), and with multifocal HCC and poor differentiation in 
non-cirrhotic patients (P = 0.04 & P = 0.019).
Conclusion: MVI was an independent predictor of disease 
free survival only in cirrhotic patients. Viral aetiology was 
the only signifi cant pre-operative factor associated with MVI 
in cirrhotic HCC. In non-cirrhotic patients MVI was associ-
ated with poor differentiation and multifocality but by itself 
was not an independent predictor of outcome. Our data 
refl ect differences in the underlying biology of cirrhotic and 
non-cirrhotic HCC and reinforce the prognostic importance 
and challenges of predicting MVI.
FOS166
IS LIVER VOLUME AFTER PORTAL 
VEIN EMBOLIZATION WORTH MORE? 
A CASE-CONTROL STUDY
R. Meier1, C. Toso1, S. Terraz2, T. Berney1, 
L. Rubbia-Brandt3, P. Morel1, G. Mentha1 
and P. Majno1
1Visceral and Transplantation Surgery, Department of 
Surgery, Geneva University Hospitals and Medical School, 
1211 Geneva, Switzerland; 2Department of Radiology, 
Geneva University Hospitals and Medical School, 
1211 Geneva, Switzerland; 3Division of Clinical Pathology, 
Geneva University Hospitals and Medical School, 1211 
Geneva, Switzerland
Introduction: Portal vein embolization (PVE) is used 
before extensive hepatic resections to increase the volume of 
the future remnant liver within safety margins (>0.6% of the 
patient’s weight). Little is known about the impact of PVE 
on postoperative liver function. The aims of this study were 
to assess the impact of preoperative PVE on immediate post-
operative liver function following major hepatic resection 
and to validate/infi rm the hypothesis that increase in volume 
is equivalent to increased function.
Methods: From a total of 68 patients undergoing PVE and 
right or extended right hepatectomy between 1999 and 2010 
we excluded patients older than 70 years or with cirrhosis, 
and compared the remaining 28 patients (study group: PVE) 
to 17 donors of right liver grafts for adult-to-adult living 
donor transplantation who underwent resection on unpre-
pared parenchyma (controls: LD). We fi rst determined 
whether liver volumes were quivalent between the two 
groups, and then quantifi ed their postoperative liver function. 
Statistical analysis was performed using a Student’s t-test or 
a chi-square test (baseline characteristics) and linear regres-
sion models (factor V) with mixed effect when necessary 
(bilirubin levels).
Results: Groups were similar for gender (p = 0.13), size (p 
= 0.55) and weight (p = 0.06). PVE patients were older than 
LD (58 vs. 41 years, p < 0.001). Among PVE patients 79% 
had had preoperative chemotherapy. At the time of surgery, 
PVE and LD patients had similar total liver volume to body 
weight ratios (2.26% vs. 2.15%, p = 0.34), similar resected 
liver to body weight ratios (1.15% vs. 1.05%, p = 0.30), and 
similar volume of the remnant liver to body weight ratios 
(1.15% vs. 1.10%, p = 0.58). Analysis of the postoperative 
bilirubin levels showed signifi cantly lower values from day 
3 to 5 after surgery in PVE patients compared to LD (p ≤ 
0.01). Factor V levels showed signifi cant higher values in the 
fi rst two days after surgery in PVE patients compared to LD 
(p < 0.001).
Conclusion: Our data show that, despite similar remnant 
liver volumes, the immediate postoperative function was 
better in the previously stimulated than in the unprepared 
remnant liver (in spite of older age and chemotherapy). 
Consequently, current threshold fi gures for safe liver 
volumes in patients having undergone PVE may need to be 
revised.
FOS167
IMPROVING SURGICAL OUTCOMES 
AFTER RESECTION FOR 
HEPATOCELLULAR CARCINOMA 
OVER 10 YEARS
D. H. Han1, G. H. Choi1, J. Y. Park2, S. H. Ahn2, 
K.-H. Han2 and J. S. Choi1
1Department of Surgery, Yonsei University College of 
Medicine, Seoul, Korea; 2Department of Internal Medicine, 
Yonsei University College of Medicine, Seoul, Korea
Introduction: Hepatic resection has been considered the 
treatment of choice for hepatocellular carcinoma (HCC) in 
patient with preserved liver function. Some studies have 
reported that long-term outcomes as well as perioperative 
outcomes have improved over the past two decades. 
Therefore, we attempted to demonstrate whether there has 
been improvement of surgical outcomes of curative resection 
of HCC from single center experience of hepatic resection 
for HCC over a 10-year period.
Methods: From January 1996 to December 2007, 610 
patients underwent curative resection for HCC at Yonsei 
University Health System, Seoul, Korea. First, the long-term 
outcomes after resection were analyzed and the prognostic 
factors for disease and overall survival were investigated. 
Second, the patients were divided according to two time 
periods: before 2003 (group1, n = 233) and after 2003 (group 
2, n = 377). The clinicopathological data and survival results 
were compared between the two groups.
Results: Perioperative transfusion, multiple tumors, micro-
scopic vascular invasion, Edmondson-Steiner grade (III-IV) 
and albumin <3.5 g/dL were the independent adverse prog-
nostic factors for overall survival. Although the disease-free 
survival rates were not signifi cantly different, there tended 
to be improved overall survival rates in the group 2 (p = 
0.098). Although there were no signifi cant differences in 
disease-free and overall survival in patients with tumor size 
<3 cm, the group 2 showed a signifi cantly higher overall 
survival in patients with tumor size >3 cm (p = 0.012). The 
group 2 in patients with tumor size >3 cm had a signifi cantly 
lower proportion of blood transfusion and serum albumin 
<3.5 g/dL.
Conclusion: Long-term outcomes after curative resection of 
HCC were associated with underlying liver function, tumor 
invasiveness and surgical techniques. The improving sur-
vival results in patients with tumor size >3 cm in recent 5 
years may be attributable to the proper selection of surgical 
candidate, reduced perioperative transfusion rate as a result 
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of improved surgical techniques and active multimodality 
treatment of recurrent HCC.
FOS168
IS THE EXTENDED CRITERIA FOR LT 
JUSTIFIED IN THE ERA OF LIVER 
TRANSPLANTATION
S. B. Kim1, Y. T. Koh2, E.-H. Cho1, C.-S. Lim3 and 
D. W. Choi4
1Department of Surgery, Korea Cancer Center Hospital; 
2Department of Surgery, National Police Hospital; 
3Gastrointestinal Cancer Center, Dongnam Institution of 
Radiological & Medical Sciences; 4Department of Surgery, 
Samsung Medical Center, Sungkyunkwan University School 
of Medicine, Seoul
Introduction: In the era of transplantation, the indication of 
LT was expanding. However, there were still some debates 
about the application of liver transplantation (LT) or liver 
resection (LR). One of major issue is about the extending 
criteria of LT beyond Milan criteria. However there was no 
consensus which was the acceptable cut off level for extend-
ing criteria of LT. We investigated the outcome of LRs of 
beyond Milan criteria group.
Methods: From January 1986 to October 2011, total of 541 
curative Hepatectomy for hepatocellular carcinomas were 
performed in department of surgery of Korea Cancer Center 
Hospital, Seoul, Korea. We reviewed the medical records and 
clinical outcome of the patients who underwent hepatectomy 
was analyzed.
Results: Median age was 54 years old and Median follow 
up period was 57 months. Most of them were male (80%) 
and HBsAg positive (82%). Among them, there were the 235 
patients beyond Milan criteria. 5, 10 year OS of total popula-
tion were 59.44% & 40.2%, and 5, 10 year DFS were 44.6% 
& 34.6% respectively. Within Milan criteria group, 5 year 
OS & DFS were 68.4% and 48.3%, and beyond Milan 
Group, 48.8% and 26.7%. The factors affecting the prognosis 
were Child-Pugh classifi cation, Tumor size, gross venous 
invasion and postoperative complication. The 5 OS and DFS 
of the favorable group (beyond Milan criteria and Child A, 
no gross venous invasion, size less than 10 cm, no complica-
tion) were 61.0% and 49.6%.
Conclusion: Nowadays, the indication of LT is tending to 
expand beyond Milan criteria, and there was some debate 
about application of LT or LR. But there was no consensus 
beyond Milan group. In the group: beyond Milan but favor-
able group, the outcomes of LR were comparable to LT 




ABLATION FOR THE TREATMENT OF 
HCC USING NO TOUCH TECHNIQUE
O. Seror1, G. N’Kontchou2, Y. Rebai1, M. Beaugrand2, 
J.-C. Trinchet2 and N. Sellier1
1Service de Radiologie, Hôpital de Jean Verdier, APHP, 
Université Paris XIII, Villetaneuse, France; 2Service 
d’Hépato-Gastroentéroligie, Hôpital de Jean Verdier, 
APHP, Université Paris XIII, Villetaneuse, France
Introduction: To prospectively evaluate the safety and 
effectiveness of of extranodular percutaneous multipolar 
radiofrequency (RF) ablation “no touch multipolar radiofre-
quency ablation technique” for the treatment of hepatocel-
lular carcinomas (HCCs) ≤45 mm of diameter.
Methods: One hundred and seven naïve patients (80 male, 
mean age: 65 years (44–82 years) with cirrhosis (Child-Pugh 
class A; 84 /class B; 23) and one, two or three (84/21/2) 
HCCs (median size: 24 mm (10–45 mm; 40 ≥ 30 mm) were 
treated with no touch multipolar radiofrequency ablation 
technique, consisting of simultaneous insertion and activa-
tion of two to four bipolar coaxial electrodes inserted just 
outside the tumors.
The procedures were performed under ultrasonographic 
guidance. Results were assessed by using computed tomog-
raphy. Primary effectiveness, complications, tumor progres-
sion, and survival rates were recorded.
Results: A complete ablation was obtained in all patients 
after one (n = 100) or 2 (n = 7) sessions. The mean number 
of electrodes used per tumor ablation was 3 (4 electrodes was 
used in 7 patients). More than one application was necessary 
in 5 cases, 20 to 330 kJ were delivered per session (mean: 
106 kJ), during 10 min to 55 min (mean; 27 mm).
One patient died of ascites infection 2 months after the 
procedure; one patient experienced jaundice (1) and another 
hemothorax.
After a median follow-up of 23 months, four local and 44 
distant HCC recurrences were detected. At the end point, 27 
patients died and 6 patients were transplanted. The 3-year 
HCC local, distant tumor progression and survival rates were 
(5) x% and (40) % respectively.
Conclusion: Multipolar radiofrequency ablation of HCC 
using no touch technique seems to be a very effective method 
in term of local tumor control.
FOS170
MINIMALLY INVASIVE LIVER 
RESECTION FOR HEPATOCELLULAR 
CARCINOMA WITH LIVER CIRRHOSIS: 
SINGLE CENTER EXPERIENCE
H. Kim, K.-S. Suh, N.-J. Yi, M.-S. Park, Y. Choi, 
G. Hong, H. W. Lee and K.-W. Lee
Department of Surgery, Seoul National University College 
of Medicine, Seoul, Korea
Introduction: Surgical resection for operable hepatocellu-
lar carcinoma (HCC) combined with liver cirrhosis in Child-
Pugh class A showed excellent outcome. However, there are 
some risks intra-operatively and postoperatively in patients 
with underlying liver cirrhosis. Minimally invasive liver 
resection (MILR) can be another option for this risk. 
However, this is still controversial, especially for HCC. The 
 Free Orals Abstracts 179
© 2012 The Authors
HPB 2012, 14 (Suppl. 2), 107–287 HPB © 2012 Americas Hepato-Pancreato-Biliary Association
aim of this study was to investigate the outcome of MILR 
for HCC with liver cirrhosis in our center.
Methods: We performed a retrospective analysis of patients 
who underwent MILR for HCC. Between 2000 and 2011, 
total 39 patients were tried to undergo MILR. Preoperatively, 
HCC was diagnosed with blood test and ultrasonography, 
computed tomography or magnetic resonance imaging. 
Among 39 patients, 23.1% patients (n = 9) were converted 
to open surgery due to diffi cult approach (n = 5), bleeding 
(n = 2), seeding risk (n = 1), hypotension after carbon dioxide 
gas infl ation (n = 1). Finally, 30 patients underwent MILR 
for HCC (25 males and 5 females; mean age 56.0 years, 
range 32 to 75). All cases had underlying liver cirrhosis in 
Child-Pugh class A (23 hepatitis B virus-related, 76.7%; 3 
hepatitis C virus-related, 10.0%; 3 unknown causes, 10.0%; 
1 alcoholic, 3.3%).
Results: Of the resections, 43.3% were performed totally 
laparoscopic, 36.7% laparoscopy assisted, 16.7% hand-
assisted, and 3.3% thoracoscopic trans-diaphragmatic. Non-
anatomical and anatomical resection was 70 and 30%. Mean 
operative time was 200 minutes and there was no intraopera-
tive transfusion, no operation related death, liver failure or 
severe complication except minor bile leak (n = 1). 
Oncologically, tumor size was mean 3.5 cm (range 1.2–12) 
and all surgical margins were negative. Overall mortality was 
13% due to HCC recurrence and overall HCC recurrence was 
in 41.9% (time interval, mean 10 months). Port site related 
HCC seeding was in one case. The 1-year/3-year overall and 
disease-free survival rates were 78.6/75% and 53.6/50%, 
respectively.
Conclusion: In experienced hands, minimally invasive liver 
resection can be safe and oncologically acceptable as a treat-
ment option for HCC with underlying liver cirrhosis in 
Child-Pugh class A. However, meticulous caution is 
demanded because of the risk for port site related recurrence 
or seeding of HCC.
FOS171
LIVER HANGING MANEUVER, A 
MILESTONE IN THE HISTORY OF LIVER 
SURGERY – THE REPORTS OF 410 
CASES IN CHINA
J. T. Li1, Y. Jin1, F. Tao2, Y. Q. Yu1, R. Ma1, Y. Wu3, 
L. P. Cao1 and S. You Peng1
1Department of Surgery, Second Affi liated Hospital, School 
of Medicine, Zhejiang University, Hangzhou, China, 
310009; 2Department of Surgery, Shaoxing People’s 
Hospital, Zhejiang University, Shaoxing, China, 312000; 
3Department of Surgery, the First Hospital of Huhhot, 
Huhhot, China, 010020
Introduction: In 2001, Liver hanging maneuver (LHM) 
was fi rstly described by Jacques Belghiti. Peng fi rstly intro-
duced this technique into China in 2003. Since then, this 
maneuver has been widely used in China. The aim of this 
study is to investigate the safety and indication of liver 
hanging maneuver for hepatectomy and it’s situation in 
China.
Methods: he following Chinese full text databases which 
commonly used in China were searched, (1) Wan Fang Data 
Resource System (http://www.wanfangdata.com.cn/), (2) 
Wei Pu Chinese Scientifi c Journal Database (http://www.
cqvip.com), (3) Chinese Journal Full Text Database (http://
dlib.cnki.net/kns50/). The MESH search term is liver hanging 
maneuver and/or retro hepatic tunnel. 38 papers were 
retrieved, including 4 basic anatomy studies, 5 reviews, 3 
nursing reports, 21 original papers, 5 clinical control studies. 
From January 2003 to October 2010, total of 410 cases were 
reported, the perioperative data of these cases were 
analyzed.
Results: The cases were from 26 different hospitals, the 
majority is teaching hospital (84.6%, 22/26), and the others 
are regional hospitals (15.4%, 4/26). Liver hanging maneu-
ver was performed successfully in 403 cases (98.29%). LHM 
was given up in 7 cases because of either tumor invasion or 
bleeding. Right or extended right hemihepatectomy was per-
formed in 289 cases (70.49%), left hemihepatectomy in 60 
cases (14.63%), other hepatic resections including caudate 
lobe resection in 61 cases (14.88%). 1 case died of failure of 
liver and kidney function (0.2%, 1/410), and overall morbid-
ity is 21.5% (62/288), including bile leakage, pleural effu-
sion, etc.
Conclusion: Liver hanging maneuver is a safe and conve-
nience modality for a great variety of liver resections. As a 
milestone in the history of liver surgery, this revolutionary 
technique has been widely applied in China.
FOS172
EVALUATION OF INTRAOPERATIVE 
MICROWAVE COAGULO-NECROTIC 
THERAPY (MCN) FOR 
HEPATOCELLULAR CARCINOMA (HCC): 
A SINGLE CENTER EXPERIENCE OF 719 
CONSECUTIVE CASES
Y. Takami, M. Tateishi, T. Ryu, Y. Wada and H. Saitsu
Hepato-Billiary-Pancreatic Surgery & Clinical Research 
Institute, National Hospital Organization Kyushu Medical 
Center, Fukuoka, Japan
Introduction: Background Hepatic resection (HRx) or 
radiofrequency ablation (RFA) may be carried out as fi rst-
line treatment of hepatocellular carcinoma (HCC). However, 
we have used intraoperative microwave ablation, named 
microwave coagulo-necrotic therapy (MCN) as a part of 
treatment strategies of HCCs for longer than 15 years. Now 
we will report to describe the treatment outcomes achieved 
at our institution as a high volume center of microwave 
ablation.
Methods: 719 consecutive patients received MCN as their 
initial therapy for HCC in our institute between July 1994 
and December 2010.
Microwaves were generated at a frequency of 2450 MHz. 
We used two types of needle; a 16 gage 150 mm long needle 
or a 21 gage short needle, to suit the conditions of the tumor.
The necrotic area formed with single irradiation was 
small. Therefore, repeated electrode insertion and irradiation 
was required to obtain a suffi ciently large treated area. MCN 
was not performed percutaneously, and had three routes of 
approach to the tumor.; laparotomy, short thoracotomy and 
under laparoscopy.
Therapeutic survival effect, local tumor progression and 
overall recurrence were prospectively evaluated and statisti-
cally analyzed.
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Results: The 1-, 3-, 5-, and 10-year overall survival rates of 
719 patients (mean tumor size, 26.9 mm; mean number of 
lesions, 2.51) were 97.7%, 79.8%, 62.1%, and 34.1%. The 
5-year survival rate of Child–Pugh class B (n = 216) was 
46.6%. The 5-year survival of patients with ≥4 lesions (n = 
168) was 49.6% and that of patients meeting the Milan cri-
teria (n = 470) was 69.6%. The 1-, 3-, 5-,and 10-year overall 
survival rates for 390 patients treated with MCN who had ≤3 
lesions with diameter ≤3 cm were 97.9%, 85.1%, 70.0%, and 
43.0%. Under the same conditions no signifi cant differences 
were found in overall survival rates after MCN and 34 
patients treated with HRx in the same period in our institute 
(P = 0.3592), and in local recurrence rates (P = 0.5926).
Conclusion: MCN is effective for locoregional control of 
HCC; comparable to HRx. MCN should be considered as 
one of the fi rst-choice treatments for HCC, even for patients 




(STAGE IVA): ROLE FOR 
HEPATECTOMY?
A. Leung1, D. Hari1, C. Chiu1, C. Ye1 and A. Bilchik2,3
1John Wayne Cancer Institute at Saint Johns Health Center, 
Santa Monica, CA; 2John Wayne Cancer Institute at Saint 
Johns Health Center, Santa Monica, CA; 3California 
Oncology Research Institute, Santa Monica, CA
Introduction: The role for hepatic resection in locally 
advanced hepatocellular carcinoma (stage IVA [T4N0-1M0]) 
is controversial. The aim of this study was to evaluate 
whether resection has a role in stage IVA hepatocellular 
carcinoma and what predictive factors can be used to improve 
patient selection in a large series.
Methods: Using data from the Surveillance, Epidemiology 
and End Results (SEER) registries, we identifi ed all patients 
treated with stage IVA hepatocellular carcinoma over a 
4-year period (2004–2008). Patient demographics, tumor-
related features, treatment, and survival were analyzed.
Results: Of 448 patients with stage IVA hepatocellular car-
cinoma, 105 (24%) underwent surgery while 343 (76%) did 
not. Median survival was 16 months in the surgical group 
and 3 months in the nonsurgical group. Race, sex, and tumor 
size were comparable between both groups. Patients were 
older in the nonsurgical group (mean age 63 vs. 57 years; p 
= 0.0002) and had more well differentiated tumors (p < 
0.0001). Multivariate analysis showed that increased sur-
vival was associated with younger age (p = 0.0382; hazard 
ratio 1.009 [95% confi dence interval 1.001 to 1.018]), 
smaller tumor size (p = 0.0004; hazard ratio 1.004 [95% 
confi dence interval 1.002 to 1.006]), and surgical interven-
tion (p < 0.0001; hazard ratio 2.974 [95% confi dence interval 
2.189 to 4.040]).
Conclusion: Hepatic resection should be considered in all 
patients with locally advanced hepatocellular carcinoma 
(stage IVA). Tumor size and age should be considered to 
improve selection of patients for surgery.
FOS174
OUTCOME OF PATIENTS WITH 
RECURRENCE FOLLOWING CURATIVE 
RESECTION OF HEPATOCELLULAR 
CARCINOMA
T. Yoo, S.-J. Park, S. H. Kim, S.-S. Han, Y.-K. Kim, 
S. D. Lee, J.-W. Park and C.-M. Kim
Center for Liver Cancer, National Cancer Center, 
Goyang-Si, Korea
Introduction: To evaluate the clinical outcome of patients 
with recurrence following curative resection of hepatocel-
lular carcinoma (HCC).
Methods: Data were retrospectively collected for 338 con-
secutive patients who had recurrence after curative hepatec-
tomy for 595 HCC patients between April 2001 and July 
2008.
Results: Of the 595 patients, 338 had recurrence. The 1-, 3-, 
5-year SR after recurrence were 74.5, 51.3 and 38.9%, MST 
was 40 months. In univariate analysis, age, HBV infection, 
AFP, transfusion, cell differentiation, size, vascular invasion, 
satellite nodules, extrahepatic recurrence and stage were sig-
nifi cant factors and by multivariate analysis, the extrahepatic 
recurrence, the satellite nodules (+) remained as independent 
risk factors. Of 338 recurred patients, 227 had only intrahe-
patic recurrence, 46 had only extrahepatic and 65 had both. 
The lung was the most common site of extrahepatic recur-
rence. survival rates of the IH recurrence group were signifi -
cantly better than those of EH recurrence group and IEH 
recurrence.
Conclusion: The extrahepatic recurrence and the presence 
of satellite nodules were associated with poor survival after 
a hepatectomy. Even with recurrence following hepatectomy 
for HCC, long-term survival is common and proper and 
timely treatment should be applied.
FOS175
MACROPHAGE INFLAMMATORY 
PROTEIN-1 ALPHA/ CC CHEMOKINE 
LIGAND 3 AND TUMOR-ASSOCIATED 
MACROPHAGES IN HEPATITIS C VIRUS-
RELATED HEPATOCELLULAR 
CARCINOMA: RELATION TO TUMOR 
PROGRESSION AND ANGIOGENESIS
H. El Aggan1, M. Helmy2, N. El Deeb3, A. Zeid1 and 
M. Fawzy1
1Department of Medicine, Hepatobiliary Unit, Faculty of 
Medicine, University of Alexandria, Alexandria, Egypt; 
2Department of Clinical Pathology, Faculty of Medicine, 
University of Alexandria, Alexandria, Egypt; 3Department 
of Pathology, Faculty of Medicine, University of 
Alexandria, Alexandria, Egypt
Introduction: Hepatitis C virus (HCV) is a major risk factor 
for hepatocellular carcinoma (HCC). Chemokines, which 
induce leukocyte migration and activate infl ammatory 
response, have recently been implicated in the regulation of 
tumor growth. Therefore, the aim of the present work was to 
study the role of macrophage infl ammatory protein-1alpha/
CC chemokine ligand 3 (MIP-1alpha/CCL3), a potent mac-
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rophage chemoattractant, in the pathogenesis of HCV-related 
HCC in relation to tumor progression and angiogenesis.
Methods: Thirty patients with HCV-related cirrhosis (15 
patients with HCC and 15 patients without HCC) and 15 
healthy subjects were enrolled in the study. Serum levels of 
MIP-1alpha/CCL3 were measured using enzyme linked 
immunosorbant assay and its sensitivity and specifi city in the 
diagnosis of HCC was determined by plotting receiver-oper-
ating characteristic curve. Histological tumor grading was 
evaluated and the surrounding liver tissue was examined to 
assess histological activity index (HAI) and steatosis grade. 
Expressions of MIP-1alpha/CCL3, CD68 [for tumor-
associated macrophages (TAM)] and endoglin (CD105) 
[for determination of microvessel density (MVD)] were 
studied in HCC and adjacent non-neoplastic liver tissues by 
immunohistochemistry.
Results: Serum MIP-1alpha/CCL3 levels were signifi cantly 
higher in cirrhotic patients with and without HCC than in 
healthy subjects and in HCC patients than in patients without 
HCC (P < 0.001). The sensitivity and specifi city of serum 
MIP-1alpha/CCL3 in the diagnosis of HCC were 100% and 
93.3% respectively at a cut-off value of 17.5 pg/ml. HCV-
related HCCs showed signifi cant increases in MIP-1alpha/
CCL3 expression, TAM count and MVD compared with 
adjacent non-neoplastic liver tissues (P < 0.001). The MIP-
1alpha/CCL3 expression in HCCs showed positive correla-
tions with serum MIP-1alpha/CCL3 levels, tumor size, stage 
and histological grade and intratumoral TAM count and 
MVD. Also, TAM count was directly correlated with MVD 
in HCCs (P < 0.05).
Conclusion: The CC chemokine MIP-1alpha/CCL3 play an 
important role in the development and progression of HCC 
in HCV infection possibly, through migration of macro-
phages to tumor microenvironment and enhancement of 
angiogenesis. MIP-1alpha/CCL3 may also serve as a poten-
tial serum biological marker and a useful therapeutic target 
for HCC.
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THIRD LIVER TRANSPLANTATION IN 
ADULT RECIPIENTS: RESULTS OF A 
25-YEAR EXPERIENCE IN A 
SINGLE CENTRE
A. Mariani, C. Salloum, E. Vibert, R. Adam, F. Saliba, 
P. Ichai, D. Castaing and D. Azoulay
AP-HP Hopital Paul Brousse, Centre Hepato-Biliaire, 
F-94800 Villejuif, France
Introduction: Given the critical organ shortage and worse 
survival of retransplantation, a third transplantation (3rd LT) 
that gives the only chance of survival for patients with failing 
two fi rst organs is highly debatable. This study aimed at 
evaluating results in 34 consecutive patients receiving a 3rd 
LT to identify long-term outcomes and prognostic factors 
available at the time of decision of LT.
Methods: From February 1987 to April 2009, 1837 (88%) 
patients underwent only one LT, 199 (9%) patients under-
went a 2nd LT, and 34 (1.6%) patients underwent a 3rd LT 
(mean age: 36 ± 14 years old). Indications of 3rd LT included 
rejection (n = 13, 38%), arterial thrombosis (n = 10, 29%), 
primary non function (n = 5, 14%) and others (n = 6, 17%). 
Before 3rd LT, 18 (53%) patients were at home, 4 (12%) 
were hospitalized and 12 (35%) were ICU-bound with vaso-
pressive drugs in 4 (12%) patients. Third LT was elective in 
25 (73%) patients and urgent in 9 (27%) patients. Uni- and 
multivariate analysis were done to detect prognostic factors 
of survival available at the time of 3rd LT decision.
Results: Post-operative mortality within 90 days of 3rd LT 
was 5/34 (14%) signifi cantly higher in an urgent procedure 
(p = 0.03). With a mean follow-up of 7 years, 1-, 5-, 8-year 
patient and graft survival were respectively 85%, 74%, 65% 
and 85%, 63% and 53%. More specifi cally, 1-, 5-, 8-year 
overall survival is 96%, 85%, 73% and 55%, 41%, 41% in 
elective and urgent procedures respectively (NS). Urea, 
protide and SGPT were predictive factors of outcome.
Conclusion: Elective 3rd LT is justifi ed in selected patients 
but this life-saving option must be discussed in urgent situ-
ation with caution.
FOS177
ICG-FLUORESCENT IMAGING DURING 
LIVER SURGERY FOR EVALUATION OF 
PORTAL UPTAKE FUNCTION OF 
VENOUS CONGESTED REGIONS
Y. Kawaguchi, T. Ishizawa, J. Kaneko, Y. Sakamoto, 
T. Aoki, K. Hasegawa, Y. Sugawara and N. Kokudo
Hepato-Biliary-Pancreatic Surgery Division, Department 
of Surgery, Graduate School of Medicine, University of 
Tokyo, Tokyo, Japan
Introduction: Recently, preoperative 3D-CT enables accu-
rate estimation of liver volumes with venous congestion 
caused by resection of the major hepatic veins, which can 
affect postoperative liver function. However, it remains 
unclear to what extent hepatic function in venous congested 
regions actually decrease compared with that in non-
congested regions. The aim of this study is to evaluate portal 
uptake function of hepatic regions with and without venous 
congestion by using ICG-fl uorescent imaging technique.
Methods: In 63 patients who underwent liver resection with 
excision of the major hepatic veins (n = 22) or liver trans-
plantation (recipient, n = 23; donor, n = 18), ICG (0.0025 mg 
per 1 mL of the remnant liver volume estimated with preop-
erative 3D-CT) was injected intravenously following resec-
tion, harvesting of the liver graft, or reconstruction of hepatic 
vessels in recipient. Then, fl uorescent intensity on liver 
surfaces was recorded with fl uorescent imaging system up 
to 300 seconds after the injection of ICG, and compared 
between venous congested regions and non-congested 
regions.
Results: The slope of fl uorescent intensity between 0 and 
105 seconds after the injection of ICG, which corresponded 
approximately to the velocity of portal uptake of ICG, was 
signifi cantly lower in venous congested regions (median 
[range]; 0.27 [0.06–0.08]) than in non-congested regions 
(0.74 [0.15–1.82]; P < 0.001). The median value of the ratio 
of this slope in venous congested regions to that in non-
congested regions in each patient was 0.38 (0.15–0.86). 
Fluorescent intensity at 240 seconds, when it reached a 
plateau, was also lower in venous congested regions (99 
[39–173]) than in non-congested regions (182 [71–255], P < 
0.001). The ratio of this plateau intensity in venous con-
gested regions to that in non-congested regions was 0.58 
(0.26–0.84).
Conclusion: Fluorescent imaging technique enables real-
time evaluation of portal uptake function in venous con-
gested regions during liver surgery. In venous congested 
regions, the velocity and the plateau value of portal uptake 
of ICG will be approximately 40% and 60% of those in non-
congested regions, respectively, although it can range from 
20% to 80% probably because of the difference in commu-
nication between hepatic vessels in the remnant liver.
FOS178
HEPATIC ARTERY THROMBOSIS 
AFTER LIVER TRANSPLANTATION: 
EXPERIENCE OF SINGLE CENTER
L. Ducatti, W. Andraus, L. Haddad, L. Nacif, O. Ferro, 
B. Canedo, V. Pugliese and L. A. D’Albuquerque
Liver Transplantation Unit, Gastroenterology Department, 
São Paulo University School of Medicine, Sao Paulo, 
Brazil
Introduction: Hepatic artery thrombosis (HAT) is a feared 
complication in the postoperative period of liver transplanta-
tion. It is one of the most serious vascular complications in 
the postoperative period of liver transplantation (LT) and is 
associated with a signifi cant increase in morbidity, graft loss 
and mortality.
Methods: This study was retrospectively on period of 
November 2009 to December 2011, on the Gastroenterology 
Department of Sao Paulo University School of Medicine.
Results: In this period of the analysis we obtained 18 cases 
of hepatic artery thrombosis that correspond to 7, 4%, of a 
total of 243 liver transplantation in this period. Seven cases 
before 15 days (early arterial thrombosis) and eleven 
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cases of late arterial thrombosis. In the early group, 4 of 7 
cases were women and 3 were men. The MELD score 
(Model for End-Stage Liver Disease) average was 28.14. The 
survival rate of retransplantation of this group was 86% in 
this period. On the other hand, in the late group, among the 
11 cases (5 women and 6 men) was six were transplanted, 
two died and three cases are still waiting transplantation.
Conclusion: Our cases are in agreement with the literature. 
Early indication of re transplantation had good rate of 
treatment.
FOS179
EARLY LIVER REGENERATION OF 
REMNANT LIVER VOLUME AFTER 
RIGHT HEPATECTOMY FOR LIVING 
DONATION: A MULTIPLE REGRESSION 
ANALYSIS
S. Gruttadauria1, V. Parikh2, D. Pagano3, F. Tuzzolino4, 
D. Cintorino1, A. Luca3, M. Spada1 and B. Gridelli3
1Is.Me.T.T. (Istituto Mediterraneo per i Trapianti e Terapie 
ad Alta Specializzazione) - University of Pittsburgh 
Medical Center, Palermo, Italy and Department of Surgery, 
University of Pittsburgh, PA, USA; 2School of Medicine, 
University of Pittsburgh, Pittsburgh, PA, USA; 3Is.Me.T.T. 
(Istituto Mediterraneo per i Trapianti e Terapie ad Alta 
Specializzazione), University of Pittsburgh Medical Center, 
Palermo, Italy;  4Is.Me.T.T. (Istituto Mediterraneo per i 
Trapianti e Terapie ad Alta Specializzazione) - University 
of Pittsburgh Medical Center, Palermo, Italy and 
Dipartimento di Scienze Statistiche e Matematiche S., 
University of Palermo, Palermo, Italy
Introduction: Fifteen years after the fi rst successful right 
lobe living-donor liver transplant, performed by S.T. Fan, 
there is still debate over the risks of this procedure and, 
indeed, over whether it should even be performed. Early liver 
regeneration was studied in a series of 70 patients who under-
went right hepatectomy for living donation from November 
2004 to January 2010.
Methods: Liver regeneration was evaluated by multidetec-
tor computed tomography at a mean time of 61.07 days after 
surgery. Age, weight, height, body mass index, liver function 
tests, creatinine, platelet count, international normalized 
ratio, glucose, and variables detected with preoperative mul-
tidetector computed tomography imaging, including diame-
ter of main portal vein, steatosis, original liver volume and 
spleen volume, were investigated as potential predictors of 
liver regeneration. Future remnant liver volume was preop-
eratively calculated by a virtual surgical cut. Liver function 
tests and creatinine on the 30th postoperative day and com-
plications occurring within 90 days of surgery and codifi ed 
within the Clavien classifi cation were analyzed.
Results: Hepatic regeneration of 100% or more at two 
months occurred in 26 of the 70 patients (37.14%). There 
was no association between the clinical outcome and the 
liver regeneration rate. Stepwise multiple regression analysis 
showed that higher body mass index: (0.035; P < 0.0001), 
preoperative parameters such as smaller future remnant liver 
volume (0.002; P < 0.0001), and greater spleen volume/
future remnant liver volume ratio (1.196; P < 0.0001) were 
predictors of greater liver regeneration.
Conclusion: we found approximately 63% of our patients 
had less than 100% regeneration of FRLV at 60 days: It may 
be that a rigorous and comprehensive selection protocol can 
positively infl uence the regenerative process of the remnant 
liver after right hepatectomy for living donation, though 
descriptive reviews of the literature are needed before any 
association can be made.
FOS180
EARLY RE-OPERATION FOR BLEEDING 
AFTER LIVER TRANSPLANTATION HAS 
A SEVERE PROGNOSTIC IMPACT ON 
PROGNOSIS IN THE MODERN ERA
R. Memeo1, C. Salloum1, A. Laurent1, C. Tayar1, 
J. C. Merle2, C. Duvoux3, A. Mallat3 and D. Azoulay1
1Hepato-Biliary and Liver Transplant Unit, Henri Mondor 
Hospital, Créteil, France; 2Anesthesiology and Liver-ICU, 
Henri Mondor Hospital, Créteil, France; 3Department of 
Hepatology, Henri Mondor Hospital, Créteil, France
Introduction: Bleeding remains a common complication in 
the early period following liver transplantation (LT). The 
objective of the study was to analyse the impact early re-
operation for bleeding after LT on short term course and long 
term patient and graft survival.
Methods: 372 consecutive LT performed at our centre since 
2005 were analysed. Patients who needed re-operation for 
bleeding within 30 days of LT (Reopgroup, n = 25 (7%)) 
where compared to patients without this event (NonReopgroup, 
n = 347). Only complications graded III to V according to 
Clavien classifi cation were considered.
Results: The origin of haemorrhage was a vascular anasto-
mosis (44%), nonspecifi c intrabdominal bleeding (36%), 
rupture of subscapsular liver hematoma (12%) and abdomi-
nal wall bleeding (8%). Postoperative mortality was signifi -
cantly higher in Reopgroup (17% vs 5%, p = 0.02). 
Postoperative morbidity was signifi cantly increased in 
Reopgroup (64% vs 27%, p = 0.0001). Arterial complica-
tions were signifi cantly more frequent in Reopgroup (44% 
vs 15%, p = 0.001). The rate of retransplantation in Reopgroup 
was also signifi cantly increased (28% vs 5%, p = 0.0001).
At 1 year, graft survival rate (41% vs 85% respectively, p 
= 0.0001) and patient survival rate (67% vs 89%, p = 0.02 
respectively) were signifi cantly lower in the Reopgroup 
compared to the NonReopgroup.
Conclusion: Re-operation for bleeding following LT 
impacts negatively on overall morbidity, patient and graft 
survival. The identifi cation of independent predictive factors 
of this event is needed to minimize its incidence.
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FOS181
LIVER TRANSPLANTATION FOR 
HEPATOCELLULAR CARCINOMA: IS 
PERIOPERATIVE BLOOD TRANSFUSION 
A RISK FACTOR?
D. Ntourakis, T. Piardi, E. Marzano, B. Ellero, 
A. C. Saouli, M. Audet, P. Wolf and P. Pessaux
Department of Hepato-Biliary Surgery and Liver 
Transplantation, Strasbourg, France
Introduction: Perioperative blood transfusion was demon-
strated as an adverse factor infl uencing morbidity and mor-
tality following hepatic resection and infl uencing the overall 
survival in cases of malignant disease. The aim of this study 
was to analyze the correlation between blood transfusion and 
outcomes after liver transplantation (LT) for Hepatocellular 
Carcinoma (HCC).
Methods: Between 1997 and 2009, 211 adult patients 
within UCSF criteria who underwent whole orthotopic LT 
from cadaveric heart-beating donors were retrospectively 
analyzed. Independent variables were the donor age, cold 
ischemia time (CIT), receiver age and the transfusion of 
blood products (packed red cells, fresh frozen plasma, and 
platelets). Dependent variables were overall survival, mortal-
ity, morbidity and specifi c complications. The Kaplan-Meyer 
method with the Log-Rank test was used for survival analy-
sis. The Spearman’s test, Mann-Whitney U test and Chi-
square test were also used.
Results: The number of transfused patient was 168 (64.9%): 
137 with Packed Red Cells (PRC), 133 with Fresh frozen 
plasma (FFP), and 98 with platelets. Overall 1, 3 and 5 year 
survival was 84%, 75% and 65% respectively. Blood prod-
ucts transfusion was not signifi cantly correlated with the 
overall survival (5-year survival rate: 65% vs 64%; p = 0.56). 
The number of PRC transfused units was statistically cor-
related with the mortality rate (median 6 vs 2, p = 0.002), 
primary graft non function (median 13.5 vs 3, p = 0.005), 
and hemorrhagic complications (median 5 vs 2.5, p = 0.01). 
A prolonged CIT (>600 min) was correlated with a higher 
number of transfused units of PRC and FFP. Accordingly the 
transfusion of 1 or more units of PRC was correlated with a 
prolonged ICU stay (rs = 0.38; p < 0.001).
Conclusion: Even though a difference in survival in HCC 
patients undergoing LT was not demonstrated regarding 
transfusion with blood products, the transfusion of PRC 
seems to be associated with several adverse effects that 
mostly occur on the early postoperative period.
FOS182
THE CHANGES THAT TOOK PLACE TO 
SEEK SURGICALLY SAFE AND 
FEASIBLE RENOPORTAL ANASTOMOSIS 
IN LDLT
D.-B. Moon, S.-G. Lee, H. Hwang, C.-S. Ahn, 
K.-H. Kim, T.-Y. Ha, K.-W. Song and D.-H. Jung
Hepato-Biliary Surgery and Liver Transplantation, Asan 
Medical Center, University of Ulsan College of Medicine, 
Korea
Introduction: When recipients have obliterated portal vein 
and big splenorenal shunts, renoportal bypass is performed 
for portal infl ow reconstruction. Kato fi rst reported end-to-
end (E-to-E) renoportal anastomosis (RPA) by using left 
renal vein (LRV) and interposition of cadaveric iliac vein. In 
LDLT, Osaka group used E-to-E RPA but interposed autog-
enous internal jugular vein, which might have possibilities 
of cosmetic or neurologic complications. At our institution, 
however, more safe and feasible methods have been sought 
after bitter experience of E-to-E RPA. Based on the largest 
experiences of RPA in LDLTs, we would like to present 
better approaches by introduction of the whole changes that 
took place in RPA.
Methods: RPA has been performed in 8 patients among 
1621 adult LDLTs from October 2005 to October 2011. We 
reported side-to-end (S-to-E) RPA without division of LRV 
was easy and secure method under better operation fi eld. 
Cadaveric fresh vessel grafts were used for interposition. 
However, scarcity of organ donation in Korea hindered 
timely LDLT for recipients requiring RPA. To overcome 
shortage of fresh vessel graft, we fi rst reported ringed 
polytetrafl uoroethylene (PTFE) graft for RPA. Recently we 
found E-to-E RPA is also surgically safe and feasible method 
if we perform additional dissection around inferior vena cava 
(IVC) and use IVC cuff of LRV for E-to-E RPA.
Results: S-to-E RPA was performed in 6 patients and all 
patients except 1 dead patient related to brain hemorrhage 
were alive. E-to-E RPA was performed in 2 patients and 
alive. The fi rst E-to-E RPA were performed during early 
period, but stenosis developed on posttransplant 1 day 
because of thin LRV wall and poor operation fi eld after divi-
sion of LRV. However, the second E-to-E RPA was per-
formed recently without diffi culty because IVC cuff of LRV 
had thick wall and large opening. As an interposition graft, 
cadaveric fresh vessel graft was used for initial 5 patients. 
Thereafter, artifi cial vascular grafts including PTFE and 
Dacron have been used without complication in remaining 3 
patients.
Conclusion: As we describes above, if RPA is performed 
considering the safety and feasibility, the type of RPA or 
interposition graft is no longer issue.
FOS183
PRIMARY RESULTS OF SALVAGE LIVER 
TRANSPLANTATION IN THE PATIENTS 
WITH UNRESECTABLE RECURRENT 
HEPATOCELLULAR CARCINOMA 
AFTER INITIAL LIVER RESECTION
B.-yong Liang1, Z.-yong Huang1, P. Hou1, S.-jun Zhou1, 
B. Jiang2 and X.-ping Chen3,4
1Research Laboratory and Hepatic Surgery Center, 
Department of Surgery, Tongji Hospital, Tongji Medical 
College, Huazhong University of Science and Technology, 
Wuhan, China 430030; 2Department of Surgery, Taihe 
Hospital, Yunyang Medical College, Shiyan, China 
442000; 3Research Laboratory and Hepatic Surgery 
Center, Department of Surgery; 4Research Laboratory and 
Hepatic Surgery Center, Department of Surgery, Tongji 
Hospital, Tongji Medical College, Huazhong University of 
Science and Technology, Wuhan, China
Introduction: Studies have indicated that salvage liver 
transplantation (SLT) is a choice of treatment for recurrent 
HCC fulfi lling the Milan criteria. However, there is no 
consensus on the value of SLT in patients with recurrent 
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HCC beyond the Milan criteria, especially in those with 
unresectable HCC.
Methods: Eleven patients with recurrent HCC underwent 
SLT in Tongji Hospital between January 2003 and July 2010. 
All the 11 patients were with recurrent HCC that was unre-
sectable because of deteriorated liver function in two cases, 
multiple bilobar tumors and/or vascular invasion in nine 
cases. Three of the 11 patients fulfi lled the the Milan criteria, 
and other eight patients were beyond the Milan criteria. The 
outcomes and prognostic factors of these patients were 
analyzed.
Results: The mortality of this cohort was zero. At a median 
follow up of 30 months, six patients were alive, including all 
three patients fulfi lling the Milan Criteria. Four patients died 
from HCC recurrence at 8, 14, 16, and 18 months, respec-
tively, and one died from gastric cancer without HCC recur-
rence. The 1-, 2-, and 3-year recurrence rates after SLT were 
58.4%, 72.3% and 86.1%, respectively. The 1-, 2-, and 3-year 
overall survival rates were 90.9%, 40.6% and 40.6%, respec-
tively. Vascular invasion, recurrent HCC beyond the Milan 
criteria and early recurrence within 18 months after initial 
resection are negative prognostic factors of SLT in patients 
with unresectable recurrent HCC.
Conclusion: SLT can be recommended as an alternative 
treatment for the patients with recurrent HCC fulfi lling the 
Milan criteria. For those recurrent patients beyond the Milan 
criteria and those with vascular invasion or early recurrence 
after initial resection, however, SLT is not benefi cial and 
should not be recommended.
FOS184
FEASIBILITY OF LIVER 
TRANSPLANTATION (LT) WITH 
PRESERVATION OF THE INFERIOR 
VENA CAVA (IVC) AND WITHOUT VENO-
VENOUS BYPASS USE (VVB) IN ADULT 
POLYCYSTIC LIVER DISEASE (PLD)
T. Darius, O. Ciccarelli, Z. Hassoun, C. Dereyck, 
F. Roggen and J. Lerut
Starzl Abdominal Transplant Unit, University Hospitals St. 
Luc, UCL, Université Catholique Louvain, Brussels, 
Belgium
Introduction: Massive handicapping hepatomegaly due to 
PLD is accepted as indication for LT. In the early series, 
outcome was poor because of high morbidity and/or mortal-
ity related to technical diffi culties of the hepatectomy. We 
reviewed our surgical experience performing a hepatectomy 
with IVC preservation and without the use of VVB and long 
term outcome.
Methods: Between 1999 and 2010, 21 patients underwent 
LT for PLD. The median age was 50 years (range, 28–68). 
5 patients with isolated PLD (no renal disease) received LT 
alone. 7 of the 21 patients (33%) had previous extensive 
surgical fenestrations of the liver cysts. Of 16 patients with 
combined PLD and Autosomal Dominant Polycystic 
Kidney Disease, 13 underwent isolated LT and 3 received a 
combined liver and kidney transplantation. Tacrolimus 
monotherapy and triple immunosuppressive regimen (tacro-
limus, mycophenolate mofetil and steroids) were given 
respectively after isolated LT and combined liver and 
kidney transplantation. The median follow up was 61 
months (range, 17–147).
Results: IVC sparing hepatectomy without the use of VVB 
could be realized uncomplicated in all patients. In patients 
with previous liver surgery, hepatectomy was much more 
diffi cult and surgical time was signifi cantly longer (p = 
0.032). However, total blood transfusion and transfusion of 
Stable Solution of Plasma Protein were comparable between 
the 2 groups (p = 0.952 and p = 0.627). The allograft was 
routinely implanted using a large latero-lateral cavoplasty 
during partial IVC clamping. The 1 and 5-year patient and 
graft survival were 100% and 100% and 95% and 90%, 
respectively. Hepatic artery thrombosis and diffuse (ischemic 
type) intrahepatic biliary strictures were the causes of graft 
failure, respectively 3 days and 42 months after LT.
Conclusion: LT for PLD can only be justifi ed if transplant 
surgery can be done without major morbidity and no mortal-
ity and if long-term outcome is excellent. Our experience in 
a small patient cohort confi rms that LT technique based on 
surgical anatomy and anatomical surgery allows to obtain 
excellent results. Previous liver cyst surgery is usually unsuc-
cessful at long term and it also seriously compromises the 
transplant procedure.
FOS185
ABERRANT PORTAL VENOUS ANATOMY 
IN RIGHT LOBE LIVING RELATED 
LIVER TRANSPLANTATION: 
MANAGEMENT STRATEGIES AND 
COMPARING OUTCOMES
A. Yadav, S. Gupta, N. Goyal, M. Wadhawan, 
KR VAsudevan and S. Agarwal
Centre for Liver and Biliary Surgery, Indraprastha Apollo 
Hospitals, New Delhi
Introduction: Scarcity of organ grafts has paved the way 
for accepting liver donors with anatomical anomalies once 
considered a contraindication for living related liver trans-
plantation. Anomalous portal venous anatomy is one such 
technical challenge which has been overcome with develop-
ing expertise. Whether this anatomical anomaly effects the 
results of transplantation is an unanswered question. There 
is no consensus in literature regarding the ideal technique to 
deal with this complex anatomical challenge.
Methods: To analyse our results of right lobe living related 
liver transplantation associated with anomalous portal 
venous anatomy and to propose a algorithm for management 
of this spectrum of anatomical variations. Also to compare 
the results of transplantation in this setting vs. standard portal 
venous anatomy we assessed the outcome of 576 patients 
who underwent right lobe LDLT from January 2007 to 
September 2011 with respect to the reconstruction of double-
graft Portal veins.
Results: In 576 right lobe liver recipients 4.3% (n = 25) 
received a graft with dual portal veins. Portal veins were 
unifi ed prior to implantation either by a venoplasty, or using 
a portal vein “Y” graft from the explanted liver. Unison 
venoplasty was the preferred technique used in 76% (n = 19) 
cases. Portal vein “Y” graft was used for unifi cation in n = 
6 cases. The indications for using a Y graft unifi cation were: 
a – the distance between the sectroral portal veins was 
>6 mm: b – the sectroral veins had a parallel course relative 
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to each other. Portal vein complications occurred in 1 patient 
in the dual PV group vs. 2 in the single portal vein group 
(p = ns) over a follow up of 26 months. Graft survival was 
83.2% in single PV grafts vs. 86.6% with dual PV (p = ns).
Conclusion: Although a technical challenge, dual portal 
vein right lobe grafts can be safely utilized for living related 
liver transplantation. The technique for implantation needs 
to be adapted to the anatomical scenario, the results of trans-
plantation with dual portal vein grafts is comparable to those 
with standard PV anatomy.
FOS186
LEFT LOBES PROVIDE IMPROVED 
DONOR SAFETY IN LDLT WITH 
EXCELLENT OUTCOMES BUT HIGHER 
RISKS IN THE RECIPIENTS
B. Samstein, E. Verna, J. Guarrera, E. U. Sotil, 
D. Cherqui, T. Kato, R. Brown and J. Emond
New York Presbyterian Hospital, Columbia University, 
New York, USA
Introduction: Live donation using a portion of the donor’s 
liver has been limited primarily by concerns about the donor 
risk. Although death and liver failure requiring transplanta-
tion occur in donors, we believe that it is important to under-
stand the risks of hepatectomy shy of these consequences. 
We report the largest North American experience with left 
lobe grafts.
Methods: We restricted our analysis to LDLT in MELD era 
(2002-on). These included 92 RL grafts, 25 full LL grafts 
and 33 LLS grafts. We reviewed recipient demographics 
including age, weight, height, primary diagnosis, MELD, 
portal fl ow modulation. We analyzed donor outcomes with 
regard to peak T Bil, INR, AST, Length of stay, Platelet 
counts and complications. We analyzed recipient graft 
and patient survival, biliary and vascular complications, 
re-admissions and Length of stay.
Graft selection: Volumetric analysis of the donor liver was 
performed starting in 2002. If graft/recipient weight ratio 
was >0.6, left lobe grafts were considered. Left lobe grafts 
were the preferred graft if both right and left lobe grafts were 
thought to be feasible.
Results: RL were 830 grams on average and LL were 507 
grams. GRWR was 1.12 for RL and 0.81 for LL. Donor 
outcomes were markedly different. The short term function 
of the liver remnant was markedly better in the LL donors 
with INR and T bil signifi cantly different from RL donors. 
Incidence of T bil > 5 and INR > 2 was 13 and 17% in RL 
and 0% in LL donors. Donor LOS was signifi cantly shorter 
with left lobe donors. Recipient patient survival was not 
signifi cantly different. Recipients experienced an increased 
length of stay with left lobe grafts 13 for RL vs 18.5 for LL. 
Biliary complications were high in each lobe graft but leaks 
were more common in right lobe grafts (55% of biliary 
complications) versus 25% of left lobe grafts.
Conclusion: Liver transplantation is an excellent therapy 
for patients with end-stage liver disease. Survival after liver 
transplantation is markedly improved for patients with 
decompensated cirrhosis. The introduction of the MELD 
allocation has reduced pre-transplant waitlist mortality. Left 
lobe grafts should be the primary choice in living donor liver 
transplantation. The lower limits of graft size that leads to 
an acceptable outcome in the recipients remains to be 
determined.
FOS187
COMPLICATIONS IN DONORS AFTER 
LIVING DONATION FOR LIVER 
TRANSPLANTATION IN ALGERIA
K. Bentabak1, A. Graba1, K. Boudjema2, N. Debzi3, 
B. Griene4, S.-ahmed Faraoun1, M. Boubnider1 and 
T. Boucekkine5
1Service de Chirurgie, Centre Pierre et Marie Curie, Alger, 
Algerie; 2Service de Chirurgie Digestive, Hopital 
Ponchalliou, Rennes, France; 3Service 
d’Hépatogastroenterologie, CHU Mustapha, Alger, Algerie; 
4Service d’Anesthésie Réanimation, Centre Pierre et Marie 
Curie, Alger, Algerie; 5Service d’Hépatogastroenterologie, 
CHU Mustapha, Alger, Algerie
Introduction: In the absence of cadaveric grafts, an adult 
living donor liver transplant (LTLD) program was started in 
Algeria in 2003. The aim of this study is to evaluate donor’s 
complications after hepatectomy in LDLT.
Methods: We retrospectively analyzed the outcomes of 33 
patients who underwent live donor hepatectomy for adult 
living donor related liver transplantation between February 
2003 and December 2011. Right hepatectomy was performed 
in 31 patients, left hepatectomy in 1 patient and in 1 case the 
procedure was aborted. The complications were stratifi ed 
according to Clavien’s system. In this study, grade I and II 
were considered minor complications and grade III and IV 
major complications.
Results: All donors survived the procedure. They were 18 
females and 15 males, with a mean age of 26 years (18 to 58 
years). The mean hospital stay was 19 days (11 to 33 days) 
and the follow-up ranged from 13 months to 106 months. In 
the immediate postoperative period, 26 complications were 
recognized in 16 donors (49%). Complications were scored 
as grade I in 6 cases (23%), grade II in 13 cases (50%), grade 
IIIa in 3 cases (11.5%), grade IIIb in 3 cases (11.5%) and 
grade IV in 1 case (4%). They were minor in 19 cases (73%) 
and major in 7 cases (27%). These major complications were 
encountered in 5 donors (16%). The 33 donors are alive 
without any late complications.
Conclusion: In our experience, hepatectomy in live donor 
liver transplantation was associated with signifi cant compli-
cations. Although most complications were low-grade sever-
ity, a signifi cant proportion were severe or life threatening. 
It is for what, it is important to develop a cadaveric liver 
transplant program.
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FOS188
CHOLEDOCHODUODENOSTOMY IS AN 
EXCELLENT ALTERNATIVE TO ROUX Y 
CHOLEDOCHOJEJUNOSTOMY
J. Peacock1, J. Heimbach2, S. Nyberg2 and C. Rosen2
1Mayo Medical School, Mayo Clinic College of Medicine; 
200 First St. SW, Rochester, MN, USA; 2Mayo Clinic and 
Mayo Clinic College of Medicine, Division of Transplant 
Surgery; 200 First St. SW, Rochester, MN, USA
Introduction: Choledochoduodenostomy (CDD) is an 
alternative to Roux Y choledochojejunostomy (CDJ) for 
biliary reconstruction during liver transplantation. Potential 
advantages include avoidance of a jejunojejunostomy, 
decreased operative time, and ease of endoscopic interven-
tion after transplantation. We reviewed our experience with 
specifi c aims to compare safety and postoperative course 
with CDD versus CDJ.
Methods: Eighteen CDD biliary reconstructions were per-
formed in patients undergoing whole organ deceased donor 
liver transplantation at our institution between 2005 and 
2011. Forty-fi ve control patients underwent CDJ during the 
same time period. We excluded retransplants and patients 
with cholangiocarcinoma. We reviewed hospitalization 
duration, postoperative complications, and survival data. 
Comparisons were made with the Student t-test for binary/
percentage outcomes and with the Mann-Whitney U test for 
non-parametric/median outcomes.
Results: There were no differences in one year patient 
or graft survival between the two groups. There was also 
no difference in median duration of hospitalization. 
Complications requiring intervention were signifi cantly 
more common after CDJ than CDD. Biliary leaks, biliary 
stenoses, and bowel complications were found in 20.0% of 
CDJ patients, compared with 0.0% for CDD patients (p = 
0.04). Median operative time was signifi cantly longer for 
CDJ than CDD. Absence of complications in the CDD group 
precluded comparison of endoscopic intervention.
Conclusion: CDD is an effective and safe technique for 
biliary reconstruction. Safety compares favorably to that of 
CDJ. CDD is associated with shorter operative time and 
fewer complications than CDJ. With additional experience, 
CDD should also prove to be more amenable to endoscopic 
intervention than CDJ.
FOS189
SYSTEMATIC CT-SCAN ON POST-
OPERATIVE DAY 7 AFTER LIVER 
TRANSPLANTATION DECREASES THE 
RATE OF RETRANSPLANTATION FOR 
ARTERIAL COMPLICATIONS
R. Memeo1, E. Vibert1, O. Ciacio1, M. Lewin2, R. Adam3 
and D. Castaing4
1AP-HP Hopital Paul Brousse, Centre Hepato-Biliaire, 
F-94800 Villejuif, France; 2AP-HP Hopital Paul Brousse, 
Service de Radiologie, F-94800 Villejuif, France; 3Univ 
Paris-Sud, Faculte de Medecine, F-94270 Le Kremlin-
Bicetre, France; 4Inserm, Unite 785, F-94800 Villejuif, 
France
Introduction: Arterial thrombosis is a main cause of graft 
lost after liver transplant (LT). Objective of this study was 
to assess the incidence of systematic CT-scan on post-
operative day (POD) 7 on the rate of retransplantation 
(ReLT).
Methods: 232 consecutives pts transplanted in 1997–1999 
(1st period) were compared to 250 pts transplanted in 2008–
2010 (2nd period) in the same center. A clinical, biological 
and echodoppler control was daily performed from POD1 to 
POD7. An injected CT-Scan was realized only in case of 
abnormalities in 1st period and systematically on POD7 in 
2nd period. Graft and donor features, risk factors of arterial 
thrombosis (AT), incidence of arterial stenosis (AS) or AT, 
their treatments and consequences in the 1st year after LT 
were compared in the two groups. Groups (1st vs 2nd period) 
were different for donors’ ages and body mass index (age: 
41 ± 1 yr vs 52 ± 1 yr; p = 0.0001 – BMI: 23 ± 4 vs 25 ± 5; 
p = 0.0001) and recipients’ ages (46 ± 1 yr vs 50 ± 1 yr; 
p = 0.0004).
Results: In the 2nd period, incidence of AS was signifi -
cantly higher (1/232 (0.4%) vs 11/250 (4%); p = 0.006), 
incidence of AT at 1 year was lower but not signifi cantly 
(11/232 (4.7%) vs 5/250 (2%); p = 0.2). Systematic POD7 
injected CT-scan had signifi cantly increased the radiological 
diagnosis of AS and/or AT (1st vs 2nd period): 7/12 (58%) 
vs 15/16 (94%); p = 0.05 and decreased its diagnosis delay 
(3 ± 2.5 months vs 1.1 ± 0.3 months). In the 1st period, AS 
or AT treatments had been reLT (n = 5), arterial reconstruc-
tion (n = 3), stent (n = 1) or anticoagulation (n = 3). In the 
2nd period, treatments had been reLT (n = 1), arterial recon-
struction (n = 4), stent (n = 3) or anticoagulation (n = 8).
Conclusion: After AS and/or AT, the rate of 1st year reLT 
was 5/12 (42%) in 1st period vs 1/16 (6%) in the 2nd period; 
p = 0.04 and 1st year mortality was 1/12 (8%) vs 0/16 (0%); 
p = 0.5.
A systematic injected CT-scan on post-operative day 7 
after LT decreased the rate of reLT for arterial thrombosis by 
improving early detection and treatment of arterial 
abnormalities.
FOS190
SURGICAL ANATOMY OF HEPATIC 
ARTERIAL SYSTEM: IMPLICATIONS 
IN LIVER TRANSPLANTATION AND 
LIVER SURGERY
H. Kumar1, T. deen Yadav1, S. Garg2, D. Sahni2 and 
R. Singh1
1Department of General Surgery, Postgraduate Institute of 
Medical Education and Research, Chandigarh, India; 
2Department of Anatomy, Postgraduate Institute of Medical 
Education and Research, Chandigarh, India
Introduction: An intact hepatic artery is the gateway to 
successful hepatobiliary surgery. Division or damage with 
subsequent thrombosis produces ischemia of liver or bile 
duct which can have devastating consequences.
Most of the studies have focused on replaced or accessory 
arterial branches but without much information regarding 
segmental branching of right and left hepatic artery, which 
are important for right or left liver harvesting.
Methods: Dissections was performed on 50 liver specimens 
which were removed enbloc with abdominal aorta during 
postmortem examination. Liver were dissected under the 
magnascope with lens magnifi cation of 2.5X in the 
Department of Anatomy, PGIMER, Chandigarh. Hepatic 
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artery was dissected from its origin. The extra and intra 
hepatic arterial anatomy was studied. Anatomic variations 
were recorded & classifi ed for its application to LDLT & 
SLT. The observations were photographed with a digital 
camera (DSC-W 90, Cyber shot 8.1 Megapixel, Sony, Japan) 
and schematic diagrams of the arteries were made.
Results: Hepatic artery was classifi ed according to Michels 
classifi cation. Five types of Michels patterns were observed. 
Variations that could not be included in the Michels classifi -
cation was observed in 17% of livers.
Segmental pattern of right hepatic artery (RHA) was clas-
sifi ed into 4 types as per classifi cation proposed by Arnold 
Rathke.
I – Conventional
II – Linear arrangement
III – Early segmental branch
IV – Crossover transposition
Authors proposed a classifi cation on left hepatic artery 
(LHA) into three types based upon its origin and segmental 
pattern.
A – Conventional origin and segmental pattern
B – Normal origin and variant segmental pattern – 3 
subtypes
C – Variant origin and segmental pattern – 4 subtypes
Conclusion: Hepatic vascular anatomy is essential while 
evaluating donors and recipients during living adult liver 
transplantation programs. But their importance in surgical 
planning of adult LDLT has not been described systemati-
cally. Preoperative evaluation plays a crucial role in surgical 
planning and has been shown to minimize mortality and 
morbidity.
FOS191
EARLY DEVELOPMENT OF POST 
TRANSPLANT METABOLIC SYNDROME: 
TIME FOR BARIATRIC SURGERY?
A. Staccini-Myx1, A. Iannelli1, P. Staccini2 and 
J. Gugenheim1
1Department of Digestive Surgery and Liver 
Transplantation, Hospital Archet, 151 Route De Saint-
Antoine De Ginestière, 06000 Nice, France; 2Department 
of Medical Informatics and Biostatistics, Hospital Cimiez, 
4 Avenue Reine Victoria, 06000 Nice, France
Introduction: Post Transplant Metabolic Syndrome 
(PTMS) includes metabolic manifestations of obesity. Its 
prevalence increases in the liver transplant population, 
impacting post operative course and survival. The objectives 
of this study are to estimate the incidence of PTMS and 
determinate risk factors of PTMS development.
Methods: Between June 2005 and December 2010, 128 
patients underwent liver transplantation. Non inclusion cri-
terion was death within 3 months after Liver Transplantation 
(LT). A cohort of 97 (75.8%) patients was followed for at 
least 2 years (mean age 52 ± 10 years, 77.3% men). Indication 
for LT was hepatitis C virus infection in 43.3%, alcohol in 
42.3%, auto-immune hepatitis in 5.1%, fulminant liver 
failure in 5.1% and other in 11.3%. Metabolic syndrome was 
diagnosed according to the worldwide defi nition of the 
International Diabetes Federation.
Results: There was no impact of PTMS on mortality rates 
(13% vs 18%, p = 0.578). The incidence of PTMS increased 
from 17.5% before LT to 40% at 1 year and 56% at 2 years. 
Recipients with PTMS experienced more post surgical infec-
tions (30% vs 11%, p = 0.028). The cardiovascular events 
were comparable for patients with or without PTMS (22% 
vs 9%, p = 0.100). Creatinine clearance was signifi cantly 
decreased at 1 year in the group of patients with PTMS 
(68 mL/mn vs 80 mL/mn, p = 0.016) and comparable at 2 
years (72.2 mL/mn vs 72 mL/mn, p = 0.965). Severe renal 
insuffi ciency rates (estimation using Modifi cation of the Diet 
in Renal Disease) were not signifi cantly different between 
the two groups (19% vs 7%, p = 0.133).
Conclusion: Signifi cant predictive factors for PTMS on 
logistic regression analysis were age >60 years at transplant 
(Odds Ratio [OR] = 6.14 IC95% [1.37; 27.53]), alcoholic 
cirrhosis (OR = 3.53 IC95% [1.02; 12.24]), pre transplant 
diabetes (OR = 3.94 IC95% [1.19; 13.00]), pre transplant 
hypertension (OR = 6.88 IC95% [1.22; 38.80]). PTMS is 
present in 56% of recipients at 2 years after LT. Predictive 
factors for PTMS could be applied to select candidates for 
bariatric surgery to improve long term outcomes.
FOS192
ACTUAL LONG-TERM RISK OF 
HEPATOCELLULAR CARCINOMA 
RECURRENCE AFTER LIVING DONOR 
LIVER TRANSPLANTATION AND 
LOGISTIC SCREENING PROTOCOL
S. Hwang, D.-B. Moon, C.-S. Ahn, J.-M. Namgoong, 
C.-S. Park, Y.-H. Park, H.-W. Park and S.-G. Lee
Department of Surgery, Asan Medical Center, University of 
Ulsan College of Medicine, Seoul, Korea
Introduction: This study intended to establish an actual 
risk-based long-term screening protocol for hepatocellular 
carcinoma (HCC) recurrence after liver transplantation (LT).
Methods: The study population were 334 HCC patients 
who underwent primary living-donor LT with follow-up 
period for more than 5 years. Their medical records were 
reviewed retrospectively. Overall 10-year survival rate was 
67.5% with 4.8% perioperative mortality. HCC recurred in 
68 (21.4%) of 318 survived patients during a mean follow-up 
period of 77 months. Cumulative HCC recurrence rate was 
20.7% at 5 years and 22.2% at 10 years. Annual recurrence 
rate was 11.4%, 6.6% and 2.0% during fi rst, second and third 
years, respectively.
Results: In within-Milan group, annual incidence of HCC 
recurrence was higher during fi rst 3 years, and thereafter only 
6 cases of sporadic recurrence happened over 11 years; in 
beyond-Milan group, recurrence was very common during 
fi rst 3 years, but no more after 3 years. AFP (alpha-
fetoprotein) rise became an initial clue to perform further 
imaging study to diagnose recurrence in 43 (63.2%), whereas 
recurrence was detected incidentally on routine imaging 
study in other 25 (36.8%) showing no AFP rise. Initial sites 
of HCC recurrence were graft liver in 26, lung in 16, abdomi-
nal cavity in 10, bone in 6, brain in 1, and multiple metastasis 
in 6. Median post-recurrence survival period was 10 months 
with 3-year survival rate of 13.2%.
Conclusion: In conclusion, annual risk of posttransplant 
HCC recurrence was signifi cantly different depending on 
Milan criteria. There was a close correlation between pre-
transplant AFP level and AFP rise after HCC recurrence. 
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Patients beyond Milan criteria is indicated for frequent fol-
low-up with tumor marker tests and imaging studies for fi rst 
3 years, and those within Milan criteria is recommended to 
follow up for 10 years, primarily with tumor marker tests.
FOS193
EVALUATION OF 57 CASES SYNTHETIC 
VASCULAR GRAFTS IN 
RECONSTRUCTION OF MIDDLE 
HEPATIC VEIN BRANCHES IN RT 
LOBE LIVING DONOR LIVER 
TRANSPLANTATION
M. M. El Shobari1, M. A. Wahab1, T. Salah1, 
N. Anwer1, A. M. Sultan1, O. Sheha2, A. Yassen3 and 
M. El sadany4
1Gastroenterology Surgical Center, Mansoura University, 
Surgical Department, Egypt; 2Gastroenterology Surgical 
Center, Mansoura University, radiology department, Egypt; 
3Gastroenterology Surgical Center, Mansoura University, 
anaesthesia department, Egypt; 4Gastroenterology Surgical 
Center, Mansoura University, Internal Medicine 
Department, Egypt
Introduction: Venous outfl ow reconstruction of segment V 
and VIII venous branches using synthetic vascular grafts is 
a controversial issue with various techniques. Optimum 
venous outfl ow is essential for graft survival.
Methods: Between 2004 to 2011, 157 cases of living donor 
liver transplant were done in GEC mansoura, males 146 
females 12. Synthetic grafts were used in 57 cases, Age 49.5 
+ 7.7. Post HCV cirrhosis 25, HCC 22 and other indication 
in 3 cases. Synthetic graft to V alone in 29 cases (single in 
28 and double in one case), VIII alone in 12 cases and com-
bined V and VIII in 12 cases.(one graft conduit in 6 cases, 
double graft in 7 cases and combined natural and synthetic 
in one case) Synthetic vascular grafts are used in the back 
table to segment V or VIII veins or both, then to either MHV 
stump or IVC of recipient after revascularization. Patency is 
judged by intraoperative and postoperative Doppler and 
function of the graft. Ct is done only if there is doubt.
Results: Post operative Doppler shew edema in segment V 
or VIII or both in 17% of single RT hepatic vein anastomosis, 
progress to graft infarction in 2 cases. Intraoperative throm-
bosis of synthetic graft was documented by Doppler in 11 
cases and redo with wash of thrombus was successful in 9 
cases. Excellant fl ow was found in 42 cases. Bad fl ow and 
no fl ow was seen in 2 cases and with bleeding and closure 
of graft was done. Salvage grafts were inserted in 3 cases (V 
in 2 and VIII in one) as intraoperative Doppler show segment 
congestion with wide vein inside the Liver (ligated during 
donor hepatectomy). Warm ischemia time was 45.4 min + 
18.5 min (no difference to single anastomosis). Postoperative 
Doppler show obstructed fl ow in 6. Others patent up to 
2 years.
Conclusion: Synthetic grafts are good alternative to native 
grafts with good patency and avoids long warm ischemia 
time. It is safe and can be done on backtable for any number 
of veins.
FOS194
SWINE MODEL OF LIVER 
AUTOTRANSPLANTATION 
WITHOUT VENOUS BYPASS
W. Andraus, B. Canedo, L. Ducatti, R. Arantes, O. Ferro, 
L. Nacif, L. Haddad and L. Augusto D’Albuquerque
Liver Transplantation Unit, Gastroenterology Department, 
School of Medicine, São Paulo University, Brazil
Introduction: Liver transplantation in swine has improved 
surgical technique education and research development. 
Most surgical techniques are conventional liver transplanta-
tion using 1 donor and 1 recipient swine. Aiming to improve 
the technical training of liver transplantation surgeons, mini-
mizing the number of animals used and the research cost, we 
describe an experimental model of liver auto-transplantation 
in swine without venous bypass.
Methods: The surgery starts with a “J” incision. The dissec-
tion of the hepatic hilar structures obey the steps of human 
conventional liver transplantation. Supraceliac aorta is dis-
sected behind the left diaphragmatic crus. Conventional total 
hepatectomy is performed after supraceliac aorta clamping. 
The clamping sequence is: supraceliac aorta, portal, infrahe-
patic and suprahepatic inferior vena cava (IVC). The auto 
implant is performed by suprahepatic, infrahepatic IVC and 
portal end-to-end running anastomosis, using polypropylene 
4.0, 5.0 and 6.0, respectively. Then, the supraceliac aorta 
clamp is removed and the liver revascularization. Arterial 
anastomosis is performed using polypropylene 7.0 and 
biliary anastomosis using polypropylene 6.0.
Results: Surgery is performed in an average time of 237 
minutes (min). The average time of hepatectomy is 
104.6 min. Suprahepatic inferior vena cava (IVC), infrahe-
patic IVC and portal anastomosis are performed in an 
average time of 20 min, 7.33 min and 14 min, respectively. 
Arterial and biliary anastomosis, are done in an average time 
of 14.66 min and 18 min, respectively. The urine output 
average volume is 2.6 mL/Kg/h. The bleeding average 
volume is 367 mL.
Conclusion: The liver auto-transplantation in swine without 
venous bypass is a feasible procedure for surgeons practice. 
It is also a less expensive model, excellent as an experimental 
model for research.
FOS195
SUM OF HCC NODULES AT EXPLANT: A 
MAIN RISK FACTOR FOR HCC 
RECURRENCE AFTER LIVER 
TRANSPLANTATION
R. Alencar1, A. Chagas2, L. Kikuchi2, R. Surjan2, 
F. Lima2, L. D´Albuquerque2, V. Alves3 and F. Carrilho2
1São Paulo State Cancer Institute, São Paulo, Brazil; 
2Department of Gastroenterology, University of Sao Paulo 
School of Medicine, Sao Paulo; 3Department of Pathology, 
University of Sao Paulo School of Medicine, São Paulo, 
Brazil
Introduction: The aim of this study is to evaluate risk 
factors and rate of HCC recurrence in patients submitted to 
liver transplantation (LT).
Methods: Medical records of transplanted patients between 
2002–2007, at our center, were retrospectively analyzed. 
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During this period, 231 LTs were performed and 33 patients 
(14.2%) had HCC. Preoperative patient and tumor character-
istics, pathologic data and rates of tumor recurrence were 
collected.
Results: Of the 33 HCC transplanted patients, 24 (72%) 
were men and median age was 55 years (26–65). Etiology 
of cirrhosis was HCV in 67%. At HCC diagnosis, 20 patients 
were Child-Pugh A. All but 2 cases had tumors within the 
Milan Criteria on the basis of radiology. Most patients had 
uninodular HCC (75%) and median tumor burden was 
25 mm (13–70). During the waiting list period, PEI/RF, 
TACE and combined therapy were used in 10, 13 and 5 
patients, respectively. At explant analysis, tumor was mod-
erately differentiated in the majority of cases (85%). Number 
of nodules was 1, 2, 3 and multinodular in 11 (33%), 8 
(24%), 6 (18%) and 8 (24%) patients, respectively. Median 
HCC size was 27.5 mm. In 24 patients that survived beyond 
the immediate post-transplant period, mean follow-up was 
33 m (8–51). Recurrence occurred in 5/24 cases (21%), at a 
mean time of 27 m (21–35). Liver (n = 1), bone (n = 2), 
nodes (n = 1) and peritoneal (n = 1) were the sites of recur-
rence. Comparing explant analysis of patients with and 
without recurrence, there was no difference in tumor size (3.9 
versus 3.2, ns) or satellite nodules detection (40% versus 
25%, ns). Number of nodules was higher in patients with 
recurrence (3.8 versus 2.2, p = 0.05). In patients with recur-
rence, microvascular invasion was observed in 60% (versus 
18%, p = 0.07). The sum of largest diameter of all nodules 
at liver explant was higher in patients with recurrence and 
this difference was statistically signifi cant (8.5 cm versus 
4.5 cm, p = 0.01).
Conclusion: HCC recurrence after liver transplantation 
occurred in 21%, at a mean time of 27 m. Sum of largest 
diameter of all nodules at explant analysis was the main risk 
factor for HCC recurrence in our center.
FOS196
OUTCOME OF LIVER 
TRANSPLANTATION PATIENTS 
INFECTED WITH GRAM-NEGATIVE 
BACTERIA: NON ACINETOBACTER 
BAUMANNII AND ACINETOBACTER 
BAUMANNII
P. Wen, C.-en Hsieh and Y. Chen
Department of General Surgery, Changhua Christian 
Hospital, Changhua, Taiwan
Introduction: The incidence of infection after liver trans-
plantation is the highest within the fi rst month, and the Gram-
negative bacteria is the major pathogens. Such infection may 
further progress into severe sepsis and even mortality. The 
purpose of this study is to explore Gram-negative bacterial 
infection in Acinetobacter baumannii and non-Acinetobacter 
baumannii groups, to investigate the risk factors of infection 
and the possible complications, so as to provide a suggestion 
for infection elimination.
Methods: A consecutive 103 patients receiving liver trans-
plantation in our center (orthotopic liver transplantation, n = 
37, and living donor of liver transplantation, n = 66) were 
enrolled into this prospective study. Those who were infected 
with Gram-positive microorganism and fungus were 
excluded. The risk factors are classifi ed into pre-operational 
factors and post-operational ones. The infl uences on the 
infection incidence and mortality rates by these factors were 
analyzed.
Results: A total of 89 liver transplantation patients were 
enrolled into the study, of which 59 patients were free from 
infection and 30 patients had Gram-negative infection. The 
infected patients were subgrouped into non-A. baumannii 
and A. baumannii groups, 15 for each group. The infected 
group had signifi cantly longer ICU stays and total hospital 
stays. The percentage of post-operative hemodialysis and 
secondary operation were also of statistical signifi cance 
between infected and non-infected group (P < 0.001). 
Infection was also found to be correlated with higher hospital 
mortality (P = 0.001), lower overall survival rate (P = 0.027), 
and worse pre-operation MELD score (P = 0.049).
Conclusion: The study showed that hemodialysis after the 
operation and secondary operation may increase the risks of 
postoperative Gram-negative bacteremia, which elongate 
the ICU and hospital stay. It is also correlated to the worse 
mortality rate and overall survival. The one-year survival 
rate of A. baumannii infected group is lesser than that of the 
non-A. baumannii infected group. Therefore, early elimina-




OXYGENATION IN A PORCINE NON-
HEART BEATING LIVER MODEL OF 
ORGAN PRESERVATION – A TOOL FOR 
IMPROVED HEPATOCYTE ISOLATION
M. S. Noormohamed1, A. Kanwar2, C. Ray2, 
D. Cowie3, D. Talbot3, M. Wright2, D. Manas3 and 
S. White2
1RCS England Research Fellow, Newcastle University and 
Freeman Hospital, Newcastle upon Tyne, UK; 2Freeman 
Hospital, Newcastle upon Tyne, UK; 3Newcastle University, 
Newcastle upon Tyne, UK
Introduction: The aim of organ preservation is to maintain 
cellular viability and organ function. Non-heart-beating 
donor (NHBD) livers represent a potential pool of organs that 
could signifi cantly supply and meet the demand for liver 
transplantation. To determine whether ECMO affects the 
viability of hepatocytes, we have used a porcine model of 
human organ donation and compared the viability and culture 
of hepatocytes isolated from pigs which have undergone 
ischaemia typical in NHBD tissue with cold perfusion.
Methods: Female pigs were anaesthetised with propofol 
and alfentanyl and killed by a KCl injection followed by 30 
minutes of warm ischemia. Pigs were then subjected to either 
in situ intra-vascular cooling with HTK buffer and intra-
peritoneal cooling for 2 hours (n = 5) or in situ ECMO at 
37°C for 2 hours (n = 7). Livers were retrieved from both 
groups and were subjected to back table fl ush with HTK and 
then placed on a re-perfusion circuit with normo-thermic 
oxygenation for 2 hours. Hepatocytes were isolated by a two 
step collagenase perfusion/digestion and cultured. Hepatocyte 
viability was assessed by trypan blue dye exclusion, culture 
seeding effi ciency and MTT reduction.
Results: The viability of hepatocytes was signifi cantly 
better in ECMO group compared to the cooling group (mean 
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96.6% vs 90.6%). ECMO isolated hepatocytes had signifi -
cantly better viability (p < 0.05) when evaluated with trypan 
blue. Hepatocytes were then cultured for 14–16 hrs at 37°C 
and tested for viability using the MTT assay. The ECMO 
group had superior mitochondrial function compared to the 
cooling group (p < 0.05 mean 0.65 vs 1.21) in addition to 
better seeding effi ciency (77.8% versus 39%). Glycogen 
content was signifi cantly higher in the cooling group both 
before (p < 0.021) and after p < 0.008) reperfusion when 
compared to ECMO. Similarly GSH was signifi cantly pre-
served in the cooling group.
Conclusion: This pre-clinical study suggests that ECMO is 
a viable technique for liver preservation that leads to an 
excellent yield of hepatocytes when isolated from an uncon-
trolled NHBD. It is also technically easier to institute and 
more effi cient than other methods of oxygenation.
FOS198
ORTHOTOPIC LIVER 
TRANSPLANTATION USING SELECTED 
ADVANCED AGE DONORS SHOULD 
BECOME THE ROUTINE
T. Aoyagi1, F. Dondero1, S. Gaujoux1, D. Sommacale1, 
C. Francoz2, F. Durand2, C. Paugam-Burtz3, J. Belghiti1
1Department of HPB Surgery and Transplantation, Beaujon 
Hospital, Clichy, France; 2Department of Hepatology, 
Beaujon Hospital, Clichy, France; 3Department of 
Anesthesiology and Critical Care, Beaujon Hospital, 
Clichy, France
Introduction: Orthotopic liver transplantation (OLT) from 
advanced age donors have been shown to provide acceptable 
results in short series. However, early synthetic function and 
outcome of these grafts has not been studied in large cohort.
Methods: Since 2004, from a prospectively maintained reg-
istry of 771 OLT, 81 OLTs from selected (no cardiac arrest 
or moderate/severe steatosis) donors older than 75 years (75 
to 91) (ELD; Elderly Donor) were compared to 169 OLTs 
from donors between 40 and 60 years (UD; Usual Donor), 
in recipient with similar MELD (17.8 vs 19.5; p = 0.2), with 
a specifi c attention to early postoperative liver function test, 
vascular complications, and long-term outcome.
Results: With similar cold ischemia time (459 vs 463 
minutes; p = 0.827), ELD liver function test and their kinetic 
were superimposable when compared to UD.
ELD short-term outcome was as good as UD one, without 
signifi cant difference in PNF (2.5% vs 3.6%; p = 0.667), 
EAD (11% vs 20%; p = 0.087), 30-day mortality (2.5% vs 
5.6%; p = 0.238), or arterial thrombosis (1.2% vs 4.7%; 
0.06). Long-term outcome were similar regarding 3-year 
graft (72.4% vs 70.6%; p = 0.645) and patient survival 
(74.8% vs 72.3%; p = 0.645) or retransplant rate (5.1 vs 7.7; 
p = 0.445).
Conclusion: This large single center study confi rms that 
selected advanced age donor had excellent short and long-
term outcome. These results should lead us to widely accept 
these selected grafts, and manage them as usual ones.
FOS199
IMPACT OF SIROLIMUS IN RENAL 
FUNCTION RECOVERY FOLLOWING 
LIVER TRANSPLANTATION
C. Florez-Zorrilla1, M. Charco1, A. Muñoz1 and 
L. L. de Guevara2
1Liver Transplant Surgery, Centro Medico Nacional 20 de 
Noviembre-ISSSTE, Mexico City, Distrito Federal, Mexico; 
2Transplant Hepatology, Centro Medico Nacional 20 de 
Noviembre-ISSSTE, Mexico City, Distrito Federal, Mexico
Introduction: Sirolimus is a well recognized immunosup-
presive agent with antiproliferative and antifi brotic proper-
ties, it’s inhibition of mTOR as well as collagen, mRNA 
procollagen, transglutaminase and its lack of nephrotoxicity 
are the key factors to consider this agent as a fi rst line option 
in liver transplant patients who developed adverse effects of 
anti-calcineurinic drugs such as nephro and neurotoxicity.
Methods: A retrospective analysis was done at Liver Unit 
of Centro Medico Nacional 20 de Noviembre-ISSSTE at 
Mexico City.
Patients: Eight liver transplanted patients between 2003 and 
2007 who were under and developed nephrotoxicity associ-
ated to anti-calcineurinic immunosuppresive treatment.
Pre-transplant diagnosis were Hepatitis C Cirrhosis in 3 
cases, Primary Biliary Cirrhosis in 3 cases, Caroli disease in 
one patient and cryptogenic Cirrhosis in one patient.
We calculated time to progression of renal impairment 
following liver transplantation, degree of renal impairment 
according to KDOQI classifi cation, and recovery of renal 
function after Sirolimus (Rapamune®) treatment was started.
Results: All patients were 46 to 64 years old at the time of 
transplantation, 87.5% are female.
62.5% of patients were under tacrolimus and 37.5% under 
cyclosporine.
The mean time of developing nephrotoxicity was 3 years 
for the tacrolimus group and 6 months for the cyclosporine 
group.
Cyclosporine group had the major degree of renal impair-
ment (two on stage V and one stage IV).
According to KDOQI classifi cation before Sirolimus they 
were; Stage III 25%, Stage IV 50% and Stage V 25%, after 
Sirolimus was started they changed to Stage II 25%, Stage 
III 37.5%, and Stage IV 37.5%.
All the patients except one who remain in the same stage 
improve at least one degree or stage. Renal function improve-
ment ranged between 0% to 194%, mean 60% under 
Sirolimus.
Conclusion: Sirolimus was related to a signifi cant improve-
ment of renal function after nephrotoxicity secondary to anti-
calcineurinic treatment.
Sirolimus effect was no different in tacrolimus or 
cyclosporine group.
There were only minor adverse effects after sirolimus was 
started such as mild dislipidemia in 50%.
Pancitopenia seen in two patients were not only attributed 
to sirolimus but also Hepatitis C Virus re-infection.
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FOS200
EFFECT OF RAPAMYCIN COMBINED 
WITH MMF OR CISPLATIN COMBINED 
WITH RAPAMYCIN AND MMF ON 
TUMOR CELL GROWTH SUPPRESSION 
IN 3 TYPES OF HCC CELL LINES
K.-W. Lee1, G. Hong1, H. Kim1, M.-S. Park1, Y. Choi1, 
H. W. Lee2, N.-J. Yi1 and K.-S. Suh1
1Seoul National University Hospital, Seoul, Korea; 2SNU 
Boramae Medical Center, Seoul, Korea
Introduction: There are reports about anti-tumor effect of 
rapamycin after liver transplantation for patients with HCC. 
However, rapamycin only immunosuppression is sometimes 
not enough in terms of immunosuppression after transplanta-
tion. We investigated the anti-tumoric effi ciency of rapamy-
cin only immunosuppression and rapamycin combined with 
other immunosuppressant and fi nally, rapamycin combined 
with anti-tumor drug including cisplatin or sorafenib or 
5-FU.
Methods: We studied anti-tumoric effects in three HCC cell 
lines (HepG2, Hep3B, Huh7) after treatment with rapamycin 
or rapamycin with other immunosuppressants or rapamycin 
with or without anti-tumor drug such as cisplatin, 5-FU, 
sorafenib. To elucidate the underlying molecular signaling 
pathway, we performed Western blotting for phosphorylated 
p70 S6 kinase protein expression. We used immunosuppres-
sants including rapamycin (5 ng/ml), tacrolimus (5 ng/ml), 
MMF (500 ng/ml) and anti-tumor drugs including cisplatin 
(5 uM/L), 5-FU (200 ng/ml), sorafenib (250 uM/L). We per-
formed MTT assay (24 well) after incubation according pre-
viously reported protocol.
Results: Immunosuppression with rapamycin combined 
with MMF inhibited tumor cell growth at the level of 60% 
comparing to control group in Huh7 cell lines (p = 0.001484) 
and more effective than rapamycin only treatment. Treatment 
with rapamycin combined with MMF and cisplatin also 
inhibited tumor cell growth more effectively than immuno-
suppressant with other anti-tumor drug or anti-tumor drug 
only treatment in Huh7 cell lines. These results were similar 
in other cell lines – HepG2 and Hep3B.
Conclusion: Immunosuppression with rapamycin com-
bined with MMF inhibited tumor cell growth at the level of 
60% comparing to control group in Huh7 cell lines (p = 
0.001484) and more effective than rapamycin only treatment. 
Treatment with rapamycin combined with MMF and cispla-
tin also inhibited tumor cell growth more effectively than 
immunosuppressant with other anti-tumor drug or anti-tumor 
drug only treatment in Huh7 cell lines. These results were 
similar in other cell lines – HepG2 and Hep3B.
FOS201
PERI-HILAR COLLECTIONS AFTER 
LIVER TRANSPLANTATION (LT): 
DIAGNOSTIC, MANAGEMENT 
AND OUTCOMES
A. Herrero1, R. Souche1, B. Gallix2, H. Bouyabrine1, 
F. Panaro1, J. P. Carabalona1 and F. Navarro1
1Department of Digestive Surgery and Liver 
Transplantation, Montpellier, France; 2Department of 
Imaging of Digestive Diseases, Montpellier, France
Introduction: Peri-hilar collections are among the most fre-
quent complications after LT and can be fatal. Three diagno-
ses should be discussed: biloma, hematoma and ascite. 
Imagery doesn’t always allow a defi nitive diagnosis. These 
collections can become infected or promote vascular com-
plications like thrombosis or false aneurysms. Different strat-
egies are performed: surgical, radiologic or endoscopic 
treatments, monitoring. The aim of this study was to defi ne 
criteria for optimal management of these patients.
Methods: Using a prospectively maintained database, we 
identifi ed all patients undergoing LT from 2006 through 2011 
who developed a peri-hilar collection in the fi rst 3 months 
postLT. We reported a cohort study of 89 collections in a 
series of 303 LT performed. Clinical and laboratory features, 
imaging criteria, management strategies were collected. The 
study population was comparable to the population of our 
transplant center. The mean age was 54 years old, the causes 
of cirrhosis were alcohol (42%), HCV (22%), HBV (8%), 
35% presented HCC. The mean Meld Score was 20. Liver 
transplantations were performed using piggyback surgical 
technique. A duct-to-duct biliary anastomosis was con-
structed in 54 LT (60%); a biliary drainage was used in 33 
patients (37%).
Results: The most common presenting features were an 
asymptomatic cholestasis (42%), fever (15%) and abdominal 
pain (11%). The average time to diagnosis was 17 days after 
LT. US and CT-Scan were the initial imaging test for the 
diagnosis. Se and Sp of the CT-Scan to diagnose a biloma 
was 80% and 86%. Monitoring was performed for 42 lesions: 
hematoma, ascite <50 mm or biloma <30 mm without sepsis. 
Surgical revision was realized in 37 cases when signs of 
sepsis, lesion >50 mm and suspicion of biloma. Only 4 
patients underwent an un-necessary laparotomy. Radiologic 
treatment was possible when collections were >70 mm. 
Endoscopic stent was mainly used at the beginning but 2 
arterial thrombosis and a false aneurysm associated with a 
biloma required reLT.
Conclusion: Peri-hilar collections are frequent after LT 
(30%). Imaging doesn’t make always the diagnosis and infl u-
ences the surgical strategy when biloma was suspected. The 
length of hospital stay was signifi cantly increased in this 
population (31 d vs 20 d, p < 0.005). A monitoring is pos-
sible (1 US/week during 3 M) for lesions <30 mm without 
vascular complications. To improve this management, it is 
necessary to refi ne the radiological diagnosis in order to 
eliminate a biloma and randomize different treatments.
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FOS202
EVALUATION OF STEATOSIS 
INFLUENCE OVER TRANSPLANT 
OUTCOME: A QUARTER CENTURY 
EXPERIENCE AT A SINGLE CENTER
L. D. Cezar1, M. M. Linhares2, M. Millan3, 
T. Anunziata3, V. Karan4, V. Delvart5, M. Sebagh6 
and R. Adam7
1Fellow Research, Centre Hépato-Biliaire (CHB), Hôpital 
Paul Brousse, Assistance Publique-Hôpitaux de Paris, 
Faculte de Medicine Paris-Sud, Universites Paris XICentre 
Hépato-Biliaire (CHB), Hôpital Paul Brousse; 2Department 
of Post-Graduation in Surgical Gastroenterology, 
Universidade Federal de São Paulo (UNIFESP), Escola 
Paulista de Medicina (EPM); 3Centre Hépato-Biliaire 
(CHB), Hôpital Paul Brousse, Assistance Publique-
Hôpitaux de Paris, Faculte de Medicine Paris-Sud, 
Universites Paris XICentre Hépato-Biliaire (CHB), Hôpital 
Paul Brousse, France; 4Database manager, Centre 
Hépato-Biliaire (CHB), Hôpital Paul Brousse, Assistance 
Publique-Hôpitaux de Paris, Faculte de Medicine 
Paris-Sud, Universites Paris XICentre Hépato-Biliaire 
(CHB), Hôpital Paul Brousse, France; 5Statistician, Centre 
Hépato-Biliaire (CHB), Hôpital Paul Brousse, Assistance 
Publique-Hôpitaux de Paris, Faculte de Medicine 
Paris-Sud, Universites Paris XICentre Hépato-Biliaire 
(CHB), Hôpital Paul Brousse, France; 6Head of patologie, 
Centre Hépato-Biliaire (CHB), Hôpital Paul Brousse, 
Assistance Publique-Hôpitaux de Paris, Faculte de 
Medicine Paris-Sud, Universites Paris XICentre Hépato-
Biliaire (CHB), Hôpital Paul Brousse, France; 7Head of 
department, Centre Hépato-Biliaire (CHB), Hôpital Paul 
Brousse, Assistance Publique-Hôpitaux de Paris, Faculte 
de Medicine Paris-Sud, Universites Paris XICentre 
Hépato-Biliaire (CHB), Hôpital Paul Brousse, France
Introduction: The rational use of liver grafts is being a 
great concern between transplantation teams. As the steatosis 
is frequently present in grafts, many researches have been 
done to study it. Most of them demonstrated that small grade 
(<30%) of macrosteatosis is safe to transplant and is not 
advisable to use graft with severe (>60%) macrosteatosis The 
aim of this study is to evaluate the steatosis infl uence over 
transplant in the Paul Brousse hepatobiliar center.
Methods: We performed a retrospective analysis of a pro-
spectively maintained database in a single center. Two thou-
sand seven hundred and six patients (2.706) were transplanted 
from December 3, 1984 to December 31, 2010. Graft biop-
sies were available in 98% of the cases. Donor and recipient 
data and surgical factors were analyzed. The end-points were 
primary dysfunction, delayed graft function (aspartate ami-
notransferase level >2.000 and TP < 30%), 3-month, 1-year 
and 5-year survival. A multivariable analysis and logistic 
regression were performed to indentify the risk factors asso-
ciated with the outcome.
Results: The presence of microsteatosis or macrosteatosis 
at any percentage is a risk factor for graft dysfunction or 
primary nonfunction (OR: 1.41 and 1.39; P = 0.01 and 0.02 
respectively). The 3-month and 1-year graft survival is only 
affected by macrosteatosis more than 30% (OR: 1.94, P = 
0.002 and OR: 1.41, p = 0.02 respectively). According to the 
grade of macrosteatosis, the 1 year graft survival was 81% 
for <30% macrosteatosis, 73% for 30–50% macrosteatosis, 
67% for 50–60% macrosteatosis, 58% for >60% macroste-
atosis; the 5 year graft survival was 67% for <30% macros-
teatosis, 66% for 30–50% macrosteatosis, 44% for 50–60% 
macrosteatosis, 38% for >60% macrosteatosis.
Conclusion: The presence of graft steatosis, even in the 
macro or micro steatosis presentation does affect the initial 
graft function and we think would be reasonable to avoid it 
in severe patients that could not tolerate a prolonged dys-
function time. Macrosteatosis more than 30% does affect the 
survival. More than 50% macrosteatosis has a greater rate of 
graft loss and we don’t indicate its use.
FOS203
TRANSCYSTIC DRAINAGE REDUCES 
THE POST-REMOVAL BILIARY 
COMPLICATIONS IN LIVER 
TRANSPLANTATION: A MATCHED 
CASE-CONTROL STUDY
F. Panaro, M. Miggino, A. Glaise, H. Bouyabrine, 
J. P. Carabalona and F. Navarro
Department of General and Liver Transplant Surgery, 
University of Montpellier, Hôpital Saint Eloi, 80 avenue 
Augustin Fliche, 34295, Montpellier-Cedex 5, France
Introduction: Bile duct (BD) complications continue to be 
the “Achilles’ heel” of liver transplantation (LT) and the 
utilization of bile duct drainage is still in debate. We describe 
the results of a less invasive trancystic biliary drainage 
(TBD) compared to a standard T-tube (TT).
Methods: The transplanted patients, over a period of 5-years 
with a TBD (TBD-group), were matched 1 : 2 with control 
patients with a TT (TT-group) according to waiting status 
lists, recipient age, recipient body mass index (BMI), model 
for end-stage liver disease (MELD) score, cold ischemic 
time (CIT), BD diameter and surgical technique. Primary end 
points were the overall incidence of BD complications, and 
graft and patient survival. Secondary end points included the 
complications after the drainage removal.
Results: Of the 248 patients who received transplants 20 
(8%) were performed using a TBD. The trancystic (n = 20) 
and matched control group (n = 40) were comparable con-
sidering the above variables. Although the bile duct leakage 
rates were not signifi cantly different between both groups, 
the TT group had a signifi cantly higher rate of overall 1-yr 
BD stenosis (40 vs 10%) (p = 0.036). Three-year patient/graft 
survival rates were 83.2%/80.1% and 84.4%/84.4% for TT 
and TBD groups, respectively. The postoperative BD com-
plications, after drainage removal (peritonitis and stenosis), 
were signifi cantly reduced (p = 0.011) with the use of a TBD.
Conclusion: The use of TBD in liver transplant recipients 
does not increase the number of BD complications compared 
to the T-tube. Furthermore, less BD anastomotic stenosis and 
post removal complications were observed in the TBD group 
compared to the TT group.
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FOS204
LOW PLATELET COUNT AFTER LIVER 
TRANSPLANTATION PREDICTS POOR 
SHORT- AND LONG-TERM OUTCOMES
M. Lesurtel, D. Raptis, C. Oberkofl er, A. El-Badry, 
E. Melloul, P. Dutkowski and P.-A. Clavien
Swiss HPB Center, Department of Surgery, University 
Hospital Zurich, Switzerland
Introduction: Recent experimental and clinical studies 
have shown that platelets play a critical role in liver isch-
emia/reperfusion injury and regeneration. Thrombocytopenia, 
a frequent and potentially serious condition in liver 
transplantation recipients, was shown to be associated with 
postoperative morbidity and mortality after partial hepatec-
tomy. The aim of this study was to evaluate whether postop-
erative low platelet counts are indicators of short- and 
long-term outcomes after liver transplantation.
Methods: Between January 2004 and December 2007, 201 
consecutive patients who underwent liver transplantation 
were included in a prospective database. Pre- and daily post-
operative platelet counts until postoperative day (POD) 7 
were recorded. Uni- and multivariate analyses were per-
formed to assess whether low postoperative platelet counts 
are risk factors of postoperative complications, graft failure, 
re-transplantation and graft and patient survival. Signifi cant 
variables of current prediction models including recipient 
and donor age, MELD score, previous liver transplantation, 
life support dependence, and cold ischemia time were 
included in the analysis.
Results: The median pre-transplantation platelet count was 
88 (IQR: 61–135) × 109/L. The lowest median platelet count 
after liver transplantation was 61 (IQR: 41–88) × 109/L at 
POD4. Patients with POD5 platelet count <60 × 109/L had 
higher rate of grade III-V complications unrelated to bleed-
ing (61% vs. 39%, p < 0.001), graft primary non function 
(5% vs. 0%, p = 0.025), delayed graft function (18% vs. 5%, 
p = 0.006) and re-transplantation within 3 months (4% vs. 
0%, p = 0.05). POD5 platelet count was identifi ed as an 
independent risk factor of grade III-V complications (OR, 
2.5 (1–4.8), p = 0.004)), graft survival (HR, 2.2 (1.2–4.1), p 
= 0.017)) and patient survival (HR, 2.1 (1–4.1), p = 0.037)).
Conclusion: After liver transplantation, platelet count <60 
× 109/L at postoperative day 5 is an independent factor asso-
ciated with major complications, graft failure and patient 
survival. These fi ndings justify further experimental and 
clinical investigations to better understand the underlying 
mechanisms and develop protective strategies in high risk 
patients.
FOS205
SURGICAL ANATOMY OF LEFT – 
HEMILIVER AS APPLIED TO LIVING 
DONOR LIVER TRANSPLANTATION AND 
SPLIT LIVER TRANSPLANTATION
T. Yadav1, H. Kumar1, S. Garg2, D. Sahni2 and R. Singh1
1Department of General Surgery, Postgraduate Institute of 
Medical Education and Research, Chandigarh, India; 
2Department of Anatomy, Postgraduate Institute of Medical 
Education and Research, Chandigarh, India
Introduction: Living donor liver transplantation (LDLT) 
and split liver transplantation (SLT) are innovative surgical 
techniques that have evolved during the last two decades to 
expand the donor pool. Fundamental to the application of 
these techniques is an understanding of intrahepatic vascular 
and biliary anatomy of liver.
Methods: 50 liver specimens which were removed enbloc 
during postmortem examination were dissected under the 
magnascope with lens magnifi cation of 2.5X in the depart-
ment of anatomy, PGIMER, Chandigarh. The extra and intra 
hepatic arterial and biliary anatomy of left hemi-liver was 
studied. The observations were photographed with the digital 
camera (DSC-W 90, Cyber shot 8.1 megapixel, sony, japan) 
and schematic diagrams of the observations were made.
Results: Authors proposed a modifi ed classifi cation of left 
hepatic artery (LHA) into three types based upon its origin 
and segmental pattern.
Type A – Conventional origin and segmental pattern of LHA 
(27%)
Type B – Normal origin and variant segmental pattern of 
LHA (50%) – 3 subtypes
Type C – Variant origin and segmental pattern of LHA (23%) 
– 4 subtypes
Segmental drainage pattern of left hemiliver was classifi ed 
into 4 types according to union of segment II, III & IV 
ducts in relation to umbilical fi ssure and drainage of 
segment IV.
Type 1 – Conventional (56.6%)
Type 2 – Triple confl uence of segment II, III and IV ducts 
(3.3%)
Type 3 – Segment IV duct draining into segment III duct 
(16.6%) 
Type 4 – Dual drainage of segment IV (23.3%)
Conclusion: We observed a high prevalence of surgically 
important vascular and biliary variants in left hemiliver. 
Close attention needs to be paid to these potential anatomic 
variations during the process of graft splitting.
FOS206
PREDICTIVE VALUE OF MELD SCORE 
FOR SURVIVAL AFTER LIVER 
TRANSPLANTATION IS POOR IN LIVING 
DONOR LIVER TRANSPLANTATION
M. S. Kim, D. J. Joo, K. H. Huh, M. K. Ju, G. H. Choi, 
J. S. Choi and S. I. Kim
Department of Surgery and Research Institute for 
Transplantation, Yonsei University, Seoul, Korea
Introduction: Model for End-Stage Liver Disease (MELD) 
score as a prognostic factor is a still controversial issue in 
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liver transplant recipients. The objective of this study was to 
evaluate the predictive ability of the MELD score for out-
comes after living donor liver transplantation (LDLT) to 
exclude various donor factors of deceased donor.
Methods: Among the 238 consecutive liver transplantation 
in Yonsei University Health System between Sep, 2005 and 
Dec, 2010, 13 pediatric, 80 (33.7%) deceased donor liver 
transplantations and 6 (4.1%) liver transplantation due to 
acute fulminant hepatic failure were excluded. Total 139 
LDLT recipients were divided into a high (≥25), moderate 
(15~24) and low (<15) MELD score group. All living donors 
were strictly evaluated their liver function about steatosis, 
anatomy and volume by biopsy, MRI and CT. We retrospec-
tively analyzed the data concerning clinical characteristics 
such as ascites, hepatic encephalopathy and hepatorenal syn-
drome, and patients’ survival rate.
Results: Mean follow up periods was 34.2 ± 19.8 months. 
Mean age was 51.1 ± 8.0 years. There were 110 male and 29 
female patients. The mean MELD score was 14.5 ± 8.0. 
Twenty one recipients in high MELD score group, 27 recipi-
ents in moderate score group, and 91 recipients in low score 
group were included. Clinical manifestations except pre-
transplant recipient status did not signifi cantly different by 
the pre-transplant MELD score group. High MELD score 
group showed high prevalence of decompensate liver failure 
such as intractable ascites, hepatic encephalopathy, and hepa-
torenal syndrome. However, there was no signifi cant differ-
ences in operative mortality, survival rate, and cause of graft 
failure after LDLT by the MELD score.
Conclusion: MELD score showed good relation with clini-
cal symptoms such as ascites, encephalopathy and hepatore-
nal syndrome. However, in the setting of LDLT with 
homogenous donor condition, MELD score did not provide 
accurate prognostic information.
FOS207
LIVER TRANSPLANTATION FOR 
HEPATOCELLULAR CARCINOMA; 
20 YEARS OF GREEK EXPERIENCE
A. Giakoustidis, D. Giakoustidis, A. Sklavos, 
I. Gerogiannis, N. Antoniadis, I. Fouzas, G. Imvrios 
and V. Papanikolaou
Division of Trasnplantation, Department of Surgery, 
Medical School, Aristotle University and Hippokration 
General Hospital, Thessaloniki, Greece
Introduction: Liver transplantation is indicated in selected 
patients with hepatocellular carcinoma (HCC) and cirrhosis. 
We present our experience as treatment approach and high-
light the importance of selection criteria for patients with 
HCC waiting for liver transplantation.
Methods: We performed a retrospective analysis for all 
patients that underwent OLTx in our unit for HCC between 
1992 – October 2010. The diagnosis preoperatively was 
mainly based on radiologic imaging, and alpha-fetoprotein 
levels, and less frequently on liver biopsy. In total 333 ortho-
topic liver transplantations were performed, with 65 of them 
receiving OLTx for cirrhosis and HCC, 54 males and 11 
females.
Results: Average age was 47.9 ± 13.3 (33–72). From the 65 
patients that received OLTx for HCC, 53 were within Milan 
Criteria. Underline cirrhosis due to HBV in 49 (7 HBV + 
HDV, 3 HBV + ALD and 1 HBV + HCV), HCV in 6, ALD 
in 6, and other causes in 4 patients respectively. Average 
Meld score was 13.4 ± 4.7 and Child-Pugh score in 14 (21%), 
25 (38%), and 26 (40%) were A, B and C respectively. 
Maintenance immunosuppression scheme: 33 patients, 
received MMF with CNi, 28 patients mammalian mTORi 
with CNi and, MMF/mTORi in 4 patients. aFP at the time 
of transplantation was more than 400 ng/ml (588 ± 846) in 
14 and less than 400 ng/ml (12 ± 29) in 41 patients respec-
tively. Median survival was 51.3 months ± 44.7 (3–184), and 
5-year Kaplan-Meier survival was 83%.
Conclusion: in selected patients with HCC and cirrhosis 
remains the best available treatment with satisfactory 
survival and reduced incidence of recurrence and 
metastasis.
FOS208
DEFINING AN OPTIMAL TREATMENT 
STRATEGY FOR RECURRENT 
HEPATOCELLULAR CARCINOMA: 
SALVAGE LIVER TRANSPLANTATION, 
REPEATED HEPATIC RESECTION OR 
RADIOFREQUENCY ABLATION?
A. Chan, S. C. Chan, K. Chok, T. T. Cheung and 
C. M. Lo
Division of Hepatobiliary and Pancreatic Surgery, Liver 
Transplantation, Department of Surgery, Queen Mary 
Hospital, The University of Hong Kong, Hong Kong
Introduction: The most optimal treatment strategy for 
patients with recurrent hepatocellular carcinoma (rHCC) 
remains poorly defi ned. The purpose of this study is to 
compare the effi cacy of salvage liver transplantation (SLT), 
repeated hepatic resection (RHR) and radiofrequency abla-
tion (RFA) in patients who had intrahepatic recurrence after 
treatment of primary HCC within Milan criteria, so as to 
defi ne an effi cacious treatment algorithm for this disease 
entity.
Methods: From June 1997 and June 2010, 504 patients 
received either hepatic resections or RFA for primary HCC 
within Milan criteria in our center. In all, 186 patients 
(37.4%) developed intrahepatic recurrences and 92 of them 
underwent SLT (n = 19), RHR (n = 25) or RFA (n = 48). The 
median MELD score at tumor recurrence in SLT, RHR and 
RFA group was 10.7, 7.5 and 8.2 respectively (p = 0.001). 
Their clinicopathological data and survival outcomes were 
reviewed. Survival outcomes were estimated by Kaplan 
Meier method and were compared between each group 
by log-rank test. P-value <0.05 was considered to be 
signifi cant.
Results: 78 out of 92 patients (84.8%) developed rHCC 
within Milan criteria. SLT was performed using living donor 
grafts in 16 patients and deceased donor grafts in 3 patients. 
The 1-, 3- and 5-year tumor-free survival rates for SLT were 
68.4%, 57.9% and 57.9%; for RHR were 71.0%, 51.6% and 
45.2%; and for RFA were 43.0%, 22.5% and 9.0% respec-
tively (p = 0.001). For rHCC within Milan criteria, the 1-, 
3- and 5-year tumor-free survival rates for SLT were all 
60.0%; for RR were 70.2%, 48.0% and 48.0%; and for RFA 
were 43.9%, 23.0% and 9.2% respectively (p = 0.004). 
Subgroup analysis showed that SLT and RR attained 
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comparable survival outcomes, and both treatments attained 
signifi cantly better survival outcomes than patients receiving 
RFA (P < 0.05).
Conclusion: SLT is an effi cacious treatment for patients 
who had post-resection or post-RFA tumor recurrence. It 
should be recommended to patients when RHR becomes 
unfeasible. Nonetheless, future study is needed to justify its 
application to rHCC beyond Milan criteria.
FOS209
LIVING DONOR LIVER 
TRANSPLANTATION FOR 
HEPATOCELLULAR CARCINOMA: 
VALIDITY OF OUR EXPANDED 
CRITERIA
T. Kaido, K. Ogawa, Y. Ogura, K. Hata and S. Uemoto
Division of Hepato-Biliary-Pancreatic and Transplant 
Surgery, Department of Surgery, Graduate School of 
Medicine, Kyoto University, Japan
Introduction: Expanded selection criteria for liver trans-
plantation (LT) for hepatocellular carcinoma (HCC) can be 
justifi ed when the criteria show acceptably low recurrence 
rate. We recently proposed new selection criteria for patients 
with HCC in living donor LT (LDLT) using the combination 
of tumor number, tumor size, and tumor marker considering 
tumor biological behavior. In the present study, we analyzed 
validity of the new criteria.
Methods: We retrospectively analyzed 196 patients who 
underwent LDLT for HCC at our institute between February 
1999 and October 2011. The median observation period was 
89 months (range, 3–155 months). Until 2006, we performed 
LDLT for HCC under the inclusion criteria that HCC unsuit-
able for other treatment modalities, without extrahepatic 
metastasis or macroscopic venous invasion on preoperative 
imaging, and no restrictions on the number or size of tumors. 
Since 2007, we have implemented new extended criteria 
(Kyoto criteria), combination of 3 independent risk factors 
for recurrence: tumor number 10 or less, all tumors 5 cm or 
less in diameter, and des-gamma-carboxy prothrombin level 
400 mAU/ml or less.
Results: The 5-year recurrence rate for patients who met the 
new criteria was signifi cantly lower than for patients who 
exceeded them (4% vs. 52%, p < 0.001). Similarly, patients 
who met the new criteria showed a signifi cantly better 5-year 
survival rate (82% vs. 41%, p < 0.001). One hundred and 
forty patients (71%) received pretreatment for HCC. Among 
these, 19 recipients underwent liver resection before LDLT. 
The survival rate and recurrence rate did not differ between 
patients with or without pretreatments. In patients who 
underwent LDLT following hepatectomy, patients meeting 
the Kyoto criteria (n = 15) showed a signifi cantly higher 
survival rate and lower recurrence rate than patients beyond 
the Kyoto criteria (n = 4) (p = 0.005, p = 0.011, 
respectively).
Conclusion: The Kyoto criteria are simple and useful 
expanded selection criteria for LDLT for HCC.
FOS210
DEVELOPMENT OF EARLY 
ANASTOMOTIC BILIARY STRICTURE 
AFTER LIVER TRANSPLANTATION: 
WHEN BILIARY STENTING IS 
REQUIRED?
C. Pulitanó, C. Michael, D. Joseph, D. Verran and 
C. Sandroussi
Australian National Liver Transplantation Unit, Royal 
Prince Alfred Hospital, NSW, Australia
Introduction: Despite improved surgical and medical care, 
biliary complications are still a major source of morbidity 
after liver transplant. Of the biliary complications, leaks and 
strictures are the most common. Early Strictures at the site 
of the bile duct anastomosis stricture (AS) are thought to 
result from surgical technique and/or local ischemia. 
However, early AS is often not well defi ned and the true 
incidence remain to be defi ned.
Methods: The prevalence, presentation, results of treat-
ment, and patient survival of grafts developing an early AS 
within 90 days from liver transplantation were evaluated. 
Data of 563 adult liver transplantations performed between 
January 2000 and May 2011 were analysed. Clinical and 
laboratory information were obtained from a prospective 
maintained database, and radiological studies were re-
evaluated. In particular, effi cacy of early stenting was 
evaluated.
A successful biliary stenting was defi ned as a reduction of 
serum level of bilirubin of at least 40% within two days from 
the procedure in the absence of other complications.
Results: Twenty-eight grafts (4.9%) showed an early AS: 26 
in duct-to duct anastomoses, and 2 in hepaticojejunal Roux-
en-Y anastomoses. All patients were successfully treated by 
1 or more treatment modalities. ERCP was successful in 10 
of 26 (38%) cases. In 6 of 16 patients who did not benefi t 
from stenting, liver biopsy showed evidence of rejection or 
HCV recurrence. The remaining 10 patients improved spon-
taneously within 10 days.
An ALT serum level of more than 150 U/L, older age of 
donor, HCV status, were all associated with a reduced likeli-
hood of improving from stenting. The only Independent risk 
factor for early AS was bile leak. Graft and patient survival 
were not impaired by early AS.
Conclusion: Signifi cant early AS is a relatively uncommon 
complication after liver transplantation. The fi nding of AS at 
ERCP not always indicated a signifi cant stenosis requiring 
stenting.
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THYMOGLOBULINE PRE-TREATMENT 
AND MINIMIZATION OF 
IMMUNOSUPPRESSION WITH 
ADVAGRAF IN LIVER 
TRANSPLANTATION ALLOWS 
INCREASE OF T-REG FOXP3+ CELLS 
AND GUIDANCE OF TOLEROGENESIS. 
RESULTS OF A PROSPECTIVE 
RANDOMIZED TRIAL
N. De Ruvo1, G. Riva2, F. Di Benedetto1, G. Tarantino1, 
L. Potenza2, R. Ballarin1, M. Luppi2 and G. E. Gerunda1
1Liver and Multivisceral Transplantation Center, University 
of Modena, Modena, Italy; 2Department of Haemathology 
and Immunology, University of Modena, Modena, Italy
Introduction: The role of FOXP3+ Treg cells has strongly 
emerged in the mechanisms of tolerogenesis and maybe 
crucial for determining an effective therapeutic intervention. 
We designed a tolerogenic regimen of recipient pretreatment 
with Thymoglobuline and gradual minimization of immuno-
suppression (IS) in a Advagraf-based prospective trial to 
investigate whether this approach in liver transplantation 
could actively induce expansion of Tregs and effectively 
guide progressive reduction of immunosuppression.
Methods: Thymoglobuline pre-treatment (3 mg/kg once-
only i.o. dose) followed by low-dose Advagraf monotherapy 
(group A) or Advagraf + Certican (group B); IS levels were 
reduced by half at 6 and 12 months in clinically stable 
patients. Venous blood samples were prospectively collected 
at time of LTx and then every 3 months, before any reduction 
of IS, together with clinical data and levels of IS. PBMC 
were collected, and the absolute number (c/µL) and percent-
age (%) of different T-cell subsets (CD8, CD4, CD25, and 
FOXP3+ Treg) were measured by means of standard fl ow 
cytometry. Liver biopsies were also serially obtained to 
search for subtle histological signs of immune activation.
Results: 15 patients have been enrolled so far; from the 
baseline values Thymoglobuline caused a mild decrease of 
CD4 and CD8 at T3 (CD4: 320 c/µL, 38%; CD8: 266 c/µL, 
32%), although a steady increase was noticed up to T12 in 
CD4 (CD4: 334 c/µL, 44%) but not in CD8 (CD8: 171 c/µL, 
23%). % of CD4+CD25+ constantly increased from baseline 
(20.3%) to T12 (64.3%), and, similarly, Treg showed increase 
from 9.57% to 12.48% (max 15.48% at T6), and from 31 c/
µL to 44.7 c/µL (max 47.3 c/µL at T3). Freedom from rejec-
tion was complete in all 15 patients despite very low levels 
of IS (mean ADV/CERT levels fi rst 6 months: 5.0/4.1 ng/ml; 
months 6–12: ADV/CERT 2.5/1.87 ng/ml). No histological 
signs of immune activation was found in all histological 
serial samples.
Conclusion: Induction with Thymoglobuline and minimi-
zation of IS in an Advagraf-based protocol is safe, allows 
full control of rejection and permits a remarkable expansion 
of Treg, which may be usefully applied as a “tolerogenic” 
monitoring tool for guidance in IS reduction.
FOS212
RISK FACTORS OF BILIARY 
COMPLICATIONS AFTER LIVING 
DONOR LIVER TRANSPLANTATION, 
MANSOURA EXPERIENCE
T. Salah1, M. El Shobari1, M. AbdelWahab1, 
A. Soultan1, O. Fathy1, A. Yassen2, M. Elmorshedi2 
and M. El-Saadany3
1Surgical Department, Mansoura University, Egypt; 
2Anaesthesia Department, Mansoura University, Egypt; 
3Hepatology, Mansoura University, Egypt
Introduction: Biliary complications remain a major 
problem despite all surgical and immunological advances in 
the fi eld of liver transplantation. Reports in recent literature 
indicate that biliary complications in adult living donor liver 
recipients ranges from 14% to 46%. Biliary leaks are more 
common than strictures in living donor. In this retrospective 
study we present our experience in adult LDLT and incidence 
of biliary complications in both recipients and donors and 
their management.
Methods: From May 2004 to October 2011. We have 150 
patients underwent LDLT; 139 males and 11 females. We 
have 64 right lobe graft with single bile duct, 78 grafts with 
two bile ducts and 8 grafts with triple orifi ces. We have done 
78 single biliary anastomosis, 67 double anastomosis and 4 
triple anastomosis and one Hepatico. Extrahepatic dissection 
and division of the right hepatic duct was done in fi rst 109 
donors while intrahepatic dissection after parenchymal 
resection was done in last 41 cases.
Results: Biliary complications occurred in 35 recipients 
(23.3%) in the form of 28 cases of biliary stricture and 7 
cases of only bile leak. The incidence of complication was 
signifi cantly affected with the number of bile ducts and extra-
hepatic versus intrahepatic resection of bile ducts. Twenty 
three cases needed intervention in the form of endoscopic 
balloon dilatation and stenting in 14 cases and bilioenteric 
anastomosis in 9 cases. Biliary leak occurred in 17 donors 
from whom 4 donors only underwent treatment in the form 
of endoscopic stent in 3 and surgical exploration in one. Four 
cases of our recipient mortality resulted from uncontrolled 
biliary sepsis.
Conclusion: Biliary complications are the most common 
and important surgical problems after LDLT. The incidence 
of biliary complication is related to the number of lumens on 
the graft surface and technique of resection. Endoscopic 
treatment of biliary stricture is useful and should be attempted 
fi rst. Surgical reconstruction in the form of hepaticojejunos-
tomy is done when endoscopic treatment failed.
198 Free Orals Abstracts
© 2012 The Authors
HPB © 2012 Americas Hepato-Pancreato-Biliary Association HPB 2012, 14 (Suppl. 2), 107–287
FOS213
THE PLACE OF SPLIT AND LIVING 
DONOR GRAFTS IN LIVER 
TRANSPLANTATION FOR 
HEPATOCELLULAR CARCINOMA – A 
WESTERN EXPERIENCE ABOUT 
743 CASES
A. Laurent1, E. Vibert2, S. Irtan3, O. Scatton4, 
O. Soubrane4, O. Boileau5, J. Belghiti3 and D. Azoulay1
1Departement of HBP and Liver Transplantation Surgery, 
Henri Mondor Hospital, Creteil, France; 2Department of 
HBP and Liver Transplantation Surgery, Paul Brousse 
Hospital, Villejuif, France; 3Department of HBP and Liver 
Transplantation Surgery, Beaujon Hospital, Clichy, 
France; 4Department of HBP and Liver Transplantation 
Surgery, Saint Antoine Hospital, Paris, France; 
5Department of HBP and Liver Transplantation Surgery, 
Edouard Herriot Hospital, Lyon, France
Introduction: Graft shortage is a major problem in liver 
transplantation (LT). In the fi eld of hepatocellular carcinoma 
(HCC), it leads to drop-out in case of tumor progression. 
Therefore, all source of grafts have to be considered, as 
partial ones. Comparing to whole grafts (WG group), partial 
grafts (PG group) are associated with several drawbacks, as 
liver regeneration, which can theoretically impair fi nal 
results. The aim of the study was to compare PG to WG in 
LT for HCC.
Methods: From January 1999 to December 2009, 743 
patients underwent LT for HCC in 5 French centers. 593 
received a WG, 150 received a PG (79 living donors and 71 
split LT for cadaveric donors). 535 (72%) patients were in 
Milan criteria’s at the time of inscription. Liver disease was 
due to hepatitis C (n = 251), alcohol (n = 219), hepatitis B 
(n = 99), mixed C-B-OH (n = 82) and other (n = 92).
All variables, known to impact recurrence, were compared 
in univariate analysis by a log-Rank test and in multivariate 
analysis by cox model analysis.
Results: Waiting time was similar in WG and PG (5.9 ± 6.7 
vs 5.1 ± 7.3 months respectively). After a mean follow-up 
of 49.7 ± 34.5 months, 63 patients developed tumor 
recurrence.
Overall and disease free 5-year survival rates were 89% 
and 80.0% respectively. Disease 5-year free survival rates 
was similar in WG and PG (88.1 vs 89.8 months respec-
tively; p = 0.355). In univariate analysis, disease 5-year free 
survival rates was signifi cantly correlated with Milan crite-
ria’s (in Milan: 92% vs out Milan: 76%; p < 0.0001), AFP 
(AFP > 100: 78.5% vs AFP < 100: 98.6; p < 0.006), bilobar 
involvement (yes: 78.5% vs no: 89.5; p = 0.001), presence 
of satellite nodules (yes: 79.4% vs no: 93.2; p = 0.001), and 
macrovascular invasion (yes: 69.1% vs no: 91.5; p = 0.001). 
In multivariate analysis, 5-year disease free survival rates 
was signifi cantly correlated with Milan criteria’s (p = 
0.0001), and macrovascular invasion (p = 0.001).
Conclusion: In a French Population-Based multicentric 
study, with 72% of the patients within Milan criteria’s at the 
time of listing and waiting time was similar in WG and PG 
groups, 5-year overall and disease free survival rates were 
similar. 5-year disease free survival rates was signifi cantly 
correlated with Milan criteria’s and macrovascular 
invasion.
FOS214
DETERMINATION OF THE OPTIMAL 
SURVIVAL MODEL FOR PREDICTING 
MORTALITY IN PATIENTS AWAITING 
LIVER TRANSPLANTATION
A. Krishnan, V. Velayutham, S. Rajagopal and 
J. Venkataraman
Stanley Medical College, Department of Gastroenterology 
and Liver Transplantation Unit, Chennai, India 
Introduction: Decompensated cirrhosis is associated with a 
poor prognosis and liver transplantation provides the only 
curative treatment option with excellent long-term results. 
The Model for End-Stage Liver Disease (MELD) score is 
now used for allocation in liver transplantation (LT) waiting 
lists, replacing the Child-Turcotte-Pugh (CTP) score. 
However, The optimal strategy based on scoring systems is 
still under debate. Aim of the study to compare the CTP 
scores and MELD score for 3, 6 months.
Methods: We investigated 216 consecutive patients listed 
for single-organ liver transplantation for nonfulminant liver 
disease between April 2010 and June 2011. To assess the 
ability of MELD and CTP score predicting the risk of death, 
the study was performed by range by using c-statistic for area 
under the receiver operating characteristic curve.
Results: 56 patients died during the observation period. The 
mean CTP score at baseline, 3, 6 months was 7.4, 7.8 and 
8.1 respectively for patients in the waiting list 7.6, 8.9 and 
9.5 respectively for patients who died on waiting. The Mean 
MELD at 3, 6 months was 12.2, 13.5 and 17 for patients in 
the waiting list and 14.8, 19.6 and 21.8 respectively for 
patients who died on waiting. The sensitivity and specifi city 
to identify mortality or severe deterioration for CTP was 
83.9% and 89.5%, respectively; for MELD 88.6%, 91%, 
respectively. In stratifi ed analysis there were signifi cant 
(<0.001) differences between MELD and CTP for the c-sta-
tistic in patients with low and intermediate range MELD 
scores at 3 and no signifi cant differences in 6 months.
Conclusion: MELD has a better performance over the CTP 
score in determination of priorities for organ allocation. The 
outcome with lower range MELD cannot be reliably pre-
dicted only with their MELD scores, and alternative prog-
nostic markers should be used in conjunction to enhance the 
predictive accuracy. Because in patients with a longer time 
on waiting list CTP may serve as an additional factor for 
assessment of patient prognosis. So, prognostic markers like 
ascites and hyponatremia should be added with MELD to 
enhance the predictive accuracy.
FOS215
EARLY AND LATE BILIARY 
COMPLICATIONS OF LIVING-RELATED 
LIVER TRANSPLANTS IN CHILDREN
P. Colombani1, K. Kling2, M. Felix1 and H. Lau1
1Johns Hopkins University School of Medicine, Baltimore, 
MD, USA; 2University of California, San Diego, San 
Diego, CA, USA
Introduction: Living-related liver transplants (LRT) remain 
an important option for pediatric patients with end-stage liver 
disease. Over a 13 year period we performed 51 LRT in 50 
patients. Follow up was from 6 to 18 years (mean = 13.8 
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years). We reviewed early and late biliary complications in 
this cohort of patients.
Methods: After IRB approval, a retrospective review was 
made of all pediatric LRT cases performed between 
November 1992 and May 2005. Patient demographics, graft 
type, number of bile ducts, donor characteristics, complica-
tions and outcomes were assessed. Early and late biliary 
complications were examined. Follow up was 100%.
Results: Fifty pediatric patients received 51 LRT grafts. 
Seventeen had biliary complications (34%). Majority (71%) 
occurred in the fi rst 3 months post transplant. Early compli-
cations were bile collections or leaks (57%), hepatic 
abscess with biliary communications (9.5%) and an 
obstructed Roux-en-Y (4.7%). Late complications after 3 
months were strictures at the Roux-en-Y anastomosis (24%) 
or multiple strictures (4.7%). Late strictures occurred 
between 6 months and 12 years post transplant. The major-
ity (73%) of early complications were treated by operative 
drainage or revision of Roux-en-Y. All late complications 
were managed non-operatively with percutaneous stenting. 
Graft and patient survival was not infl uenced by biliary 
complications.
Conclusion: Biliary complications are a frequent complica-
tion of LRT occurring in up to one-third of patients. Early 
complications of bile leak or biloma, most often require 
operative repair. Overall, biliary complications did not con-
tribute to patient mortality or graft loss.
FOS216
TEN YEARS OF LIVING DONOR LIVER 
TRANSPLANTATION: OUTCOME DATA 
FROM EGYPTIAN LIVER 
TRANSPLANTATION REGISTRY
I. Marwan1, M. Elmeteni2, A. Fayez2, A. Hosny3, K. Amer4, 
M. Ameen5, M. Abd Elwahab6 and K. Tanaka7
1National Liver Institute, Menoufeya University; 2Faculty 
of Medicine, Ain Shams University, Cairo, Egypt; 3Faculty 
of Medicine, Cairo University, Egypt; 4International 
Medical Center, Military Hospital, Jeddah, Saudi Arabia; 
5Maady Hospital, Military Hospital, Egypt; 6Faculty of 
Medicine, Mansoura University, Egypt; 7Foundation for 
Kobe International Medical Alliance, Kobe, Japan
Introduction: Living donor liver transplantation (LDLT) is 
known to be an established acceptable therapeutic modality 
for end stage liver diseases, especially when cadaveric liver 
transplantation is not available like in Egypt. We present the 
outcome of 1385 LDLT cases performed in the last ten years 
in Egypt.
Methods: Between August 2001 to August 2011, 1385 
LDLT cases were performed in ten centers, adults repre-
sented 1275 (92%, mean age 54 years) while 110 (8%) were 
pediatric cases (mean age 8 years). The main indication for 
LDLT in adults was HCV cirrhosis (95%, with or without 
HCC) with mean MELD score 18. While the main indication 
in the pediatric age group was biliary atresia (52%). Three 
hundred sixty adult patients were diagnosed to have hepato-
cellular carcnioma (HCC). Out of those, 310 recipients 
(86%) were within Milan criteria. Down staging was per-
formed in 42 cases (12%) by liver resection, radiofrequency 
ablation and/or trans-arterial chemo-embolization (TACE). A 
single pediatric case of central hepatoblastoma received 
LDLT and chemotherapy.
Results: The operative mortality was 19 recipients. Donor 
mortality was three (0.2%); the fi rst one 3 months post dona-
tion due to biliary leak, septicemia and multi organ failure, 
the second case died 12 days after donation due to portal vein 
thrombosis and the third was due to sub-clavian artery injury. 
In the adult group, recipient mortality was 31.4% versus 
22.7% for the pediatrics. Biliary complications was24.7% 
and clinical HCV recurrence was 9% requiring anti-viral 
treatment. In adult recipients with HCC, fi rst year recurrence 
occurred in 24 recipients (10%), the 3 years recurrence was 
15%, the 5 year survival was 58% and the mortality rate due 
to tumor recurrence was 13.6%. The hepatoblastoma case is 
doing well for 7 years with no recurrence.
Conclusion: Living donor liver transplantation is a poten-
tially safe procedure especially when cadaveric liver trans-
plantation is not available in some countries like Egypt. The 
long term survival and disease free survival rate in patients 
with HCC transplanted by LDLT is comparable with those 
using diseased donors. Although LDLT had reasonable out-
comes; yet, it carries considerable risks to healthy donors, it 
lacks cadaveric back up, and is not feasible for all patients.
FOS217
SURGICAL ANATOMY OF ARTERIAL 
SUPPLY OF SEGMENT IV OF THE LIVER 
AND ITS RELEVANCE TO LIVING 
DONOR LIVER TRANSPLANTATION AND 
SPLIT LIVER TRANSPLANTATION
H. Kumar1, T. deen Yadav1, S. Garg2, D. Sahni2 and 
R. Singh1
1Department of General Surgery, Postgraduate Institute of 
Medical Education and Research, Chandigarh, India; 
2Department of Anatomy, Postgraduate Institute of Medical 
Education and Research, Chandigarh, India
Introduction: Preoperative evaluation of arteries supplying 
segment IV is critical and may impact the surgical planning 
during split liver transplantations & living donor liver 
transplantations.
Methods: Dissections was performed on 50 liver specimens 
which were removed enbloc with abdominal aorta during 
postmortem examination. Liver were dissected under the 
magnascope with lens magnifi cation of 2.5X in the 
Department of Anatomy, PGIMER, Chandigarh. Hepatic 
artery was dissected from its origin. Arterial supply of 
segment IV was carefully identifi ed and recorded. The obser-
vations were photographed with a digital camera (DSC-W 
90, Cyber shot 8.1 Megapixel, Sony, Japan) and schematic 
diagrams of the arteries were made subsequently.
Results: The variant patterns of artery to segment IV were 
classifi ed into fi ve types according to its source of origin, its 
extra and intrahepatic course and arterial confi guration of 
liver – normal or aberrant.
Artery to segment IV
• Extrahepatic branch was labeled as Middle hepatic 
artery (MHA, 80%)
• Intrahepatic branch that originated inside the umbilical 
fi ssure from left hepatic artery (LHA) or from one of its 
segmental branches was labeled as Segment IV artery 
(A4, 20%)
Classifi cation of origin of artery to segment IV
Type 1 – left hepatic artery, LHA (27%)
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Type 2 – right hepatic artery, RHA (17%)
Type 3 – common/ proper hepatic artery, CHA/PHA (23%)
Type 4 – Dual (13%)
Type 5 – A4 (20%)
Conclusion: The patterns observed in the present study 
refl ect the embryological pattern of arteries & the classifi ca-
tion formed may favorably infl uence the outcome of living 
donor liver transplantations. In the livers with normal hepatic 
arterial confi guration, MHA arose either from LHA or RHA 
whereas in livers where arterial anatomy was aberrant, MHA 
arose from CHA. There was no case in which MHA was 
arising from replaced/accessory vessel. A4 was seen to be 
arising from one of the segmental branches of LHA and all 
the livers had normal hepatic arterial anatomy.
FOS218
USE OF HEPATIC INTRA-ARTERIAL 
INFUSION OF YTTRIUM-90 
MICROSPHERE AS DOWNSTAGING AND 
BRIDGE TO LIVER TRANSPLANTATION 
IN PATIENTS WITH HEPATOCELLULAR 
CARCINOMA
G. Vennarecci, R. Santoro, P. Lepiane, A. Laurenzi, 
L. Colace, E. Moroni, M. Colasanti and G. M. Ettorre
General Surgery and Transplantation Unit, S. Camillo 
Hospital, Rome, Italy
Introduction: Yttrium-90 microspheres radioembolization 
(Y90-RE) is an effective modality of treatment in patients 
with advanced hepatocellular carcinoma (HCC) who are not 
otherwise candidates for local ablation, surgical resection, or 
liver transplantation (OLT). Its use in downstaging HCC or 
as a bridge for OLT is however still unclear. Here, we present 
our experience with Y90-RE in patients with advanced HCC 
who were intentionally treated in order to meet the Milan 
criteria for OLT.
Methods: Among 127 Y90-RE for HCC performed with the 
collaboration of the National Cancer Institute Regina Elena, 
13 patients with HCC were treated with the intention of 
downsizing the tumor within the criteria in 9 cases and as 
bridge in 2 cases in order to pursue OLT.
Results: Eight (61%) patients were treated before listing 
and 5 (39%) were treated on the waiting list because of tumor 
progression. Of those treated before listing, 6 (75%) patients 
were downstaged within the criteria (4 were transplanted and 
2 are waiting for OLT) but two (25%) died on waiting list. 
On the waiting list, 1 (20%) patient was transplanted, 3 
(60%) died on the list and 1 (20%) is alive with disease 
control 2 years after Y90-RE. Two patients who had neoplas-
tic infi ltration of a portal vein branch. After treatment with 
Y90-RE in both patients was noted disappearance of the 
thrombus. The extrahepatic spread was ruled out and later 
they were transplanted. Now they are both alive at 25 and 
14 months without signs of HCC recurrence.
Conclusion: Y90-RE is currently used in our centre as an 
effective modality of treatment in patients with HCC as 
downstaging method or as a bridge to liver transplantation.
FOS219
BACTERIAL TRANSLOCATION AND 
LIVER TRANSPLANTATION: 
A PROSPECTIVE STUDY
T. Piardi, E. Marzano, D. Ntourakis, 
M. L. Woehl-Jaegle, F. Gheza, M. Audet, 
P. Wolf and P. Pessaux
Department of Hepato-Biliary Surgery and Liver 
Transplantation, University of Strasbourg France, 
Strasbourg, France
Introduction: Cirrhosis and portal hypertension are corre-
lated with a high prevalence of bacterial translocation (BT) 
that is associated with severe episodes of sepsis especially in 
patients underwent liver transplantation (LT).
Methods: Between October 2007 and September 2009, 86 
patients underwent LT without temporally portal shunt. A 
routinely peripheral venous sampling was performed at 
induction of anaesthesia, at the end of vacular clamping, in 
Intensive care unit, and in cases of post-transplantation 
Systemic Infl ammatory Response Syndrome. A routinely 
portal vein blood culture was performed at the end of the 
vascular clamping. Portal blood cultures were compared with 
the systemic blood cultures. Risk factors of BT were 
analyzed.
Results: There were 65 men and 21 women. The mean 
clamping time was 122 min (range: 60–250). Portal blood 
culture was positive in 23 patients among 11 had systemic 
blood positive culture. The blood culture was positive for 
gram+ bacteria. The overall and infectious morbidity rate 
were 36% (n = 31) and 14% (n = 12) respectively. The mor-
tality rate was 6.9% (n = 6). There was not difference between 
the 2 groups BT and no BT in term of overall morbidity (52% 
vs 30%, p = 0.06) and infectious complications (21.7% vs 
11.1%, p = 0.21). There was no statistically correlation 
between BT and the duration of portal clamping and the 
mean MELD score.
Conclusion: Despite the absence of statistically differences, 
it appears a trend of increased complication rate with BT. A 
study comparing the achievement of a temporary portal shunt 
on the occurrence of BT and infectious complications should 
be performed.
FOS220
ASSESSMENT OF LATE CHRONIC 
REJECTION IN LIVER GRAFT 
RECIPIENTS RECEIVING LOW-DOSE 
IMMUNOSUPPRESSION
L. Barbier1, S. Garcia2, P. Borentain3, D. Botta-Fridlund3, 
Y.-P. Le Treut1 and J. Hardwigsen1
1Department of Digestive Surgery and Liver 
Transplantation, Aix-Marseille Univ, Marseille, France, La 
Conception Hospital, APHM, 13005, Marseille, France; 
2Department of Histopathology, Aix-Marseille Univ, 
Marseille, France, North Hospital, APHM, 13020, 
Marseille, France; 3Department of Hepato-Gastro-
Enterology, Aix-Marseille Univ, Marseille, France, La 
Conception Hospital, APHM, 13005, Marseille, France
Introduction: Calcineurin Inhibitors (CNI) represent the 
cornerstone immunosuppressants (IS) after liver transplanta-
tion (LT) despite their side effects. As the liver is a 
particularly well-tolerated organ, low or nil doses of CNI 
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could have been proposed in the long-term. The aim of this 
study was to assess prevalence of asymptomatic chronic 
rejection (CR) in low-doses (LD) patients group and to 
compare their characteristics with standard-doses (SD) group 
patients.
Methods: All living patients without recurrence of cirrhosis 
transplanted between 1997 and 2004 (excluding combined 
transplantation or retransplantation) were included and 
divided into 2 groups according to their CNI blood levels 
(BL). Patients in LD group (n = 57, 59%) had tacrolimus 
baseline BL < 5 ng/mL or ciclosporin BL < 50 ng/mL at t0 
or <100 ng/mL at t + 2 h. Thirty-six of 57 patients had a liver 
biopsy (LB) searching for CR according to Banff criteria. 
Other patients were included in SD group (n = 40, 41%).
Results: Among patients with LB (performed 90 m (64–
157) after LT), 56% had CNI alone, 36% CNI + other IS and 
8% had only other IS. CNI were below therapeutic levels for 
41 m (11–115) and liver tests were normal in 72%. No 
chronic rejection was found.
Comparison between LD and SD groups: in LD group, 
decrease of CNI occurred 48 m (12–134) after LT. Patients 
were included 46 m (15–115) after decrease. Patients in LD 
group had more hepatitis B (23% vs 8%, p = 0.045), a better 
renal function (86% of initial clearance vs 70%, p = 0.040) 
and less acute rejection episodes (1.2 vs 1.7, p = 0.028). 
Decrease of CNI without liver tests elevation was favored by 
prescription of other IS and failed in 6% of patients without 
impacting on graft function.
Conclusion: It is possible to decrease, even stop, CNI in the 
long term after LT for most of the patients, without chronic 
rejection.
FOS221
DONOR WASHOUT EFFICACY IS 
INDEPENDENT OF WASHOUT 
PRESSURE, TEMPERATURE, 
AND SOLUTION
I. C. J. H. Post1, M. C. Dirkes1, M. Heger1, de Bruin Kora2, 
R. J. Bennink2 and T. M. van Gulik1
1Department of Surgery, Surgical Laboratory, Academic 
Medical Center, University of Amsterdam, Amsterdam, The 
Netherlands; 2Department of Nuclear Medicine, Academic 
Medical Center, University of Amsterdam, Amsterdam, The 
Netherlands
Introduction: Erythrocyte retention after donor organ 
washout leads to impaired graft viability. Low viscosity 
washout solutions (histidine-tryptophan-ketogluterate, HTK) 
are believed to show less erythrocyte retention than high 
viscosity solutions (University of Wisconsin, UW and 
Polysol, PS). This colloid induced difference in viscosity and 
the agglutinative effect of colloids (HES and PEG) upon 
erythrocytes potentially impairs organ washout.
Methods: To quantify the erythrocyte retention after organ 
washout using different preservation solutions and at differ-
ent temperatures and perfusion pressures, we washed out rat 
livers (n = 5 per group) using 50 mL HTK, UW, PS or Ringer 
lactate (RL) via the portal vein at 4°C or 37°C and at 
15 mmHg or 100 mmHg. The control group was not fl ushed 
and ligated in situ. At start of the experiments, erythrocytes 
were labeled in vivo using 99mTc pertechnate. After washout, 
livers were removed, weighed, and placed in a scintillation 
analyzer. Erythrocyte retention was expressed as radiation 
per gram of liver relative to radiation per gram of blood 
(weight percentage), and corrected for weight and 99mTc 
uptake. Statistics were performed using a one-way ANOVA.
Results: No signifi cant differences were seen in erythrocyte 
retention for any of the solutions after washout at 4°C or 
37°C nor at 15 mmHg or 100 mmHg. Washout time was 
shorter at 100 mmHg and at 4°C for PS and UW (P < 0.001), 
and at 37°C, for PS, UW, and HTK (P < 0.001). Washout 
times were twice as long for PS and UW compared to HTK 
and RL at 4°C (P < 0.001), being an average of 95.97 ± 14.51 
seconds and 33.37 ± 10.41 seconds, respectively. At 37°C 
this difference was not signifi cant.
Conclusion: In conclusion, the addition of a colloid to a 
washout solution does not increase erythrocyte retention. 
Non-colloidal solutions and high washout pressure, however, 
shorten the duration of washout.
FOS222
BILIARY ANASTOMOTIC STRICTURE 
AFTER ORTOTOPIC LIVER 
TRANSPLANTATION: THE UNIVERSITY 
OF SAO PAULO EXPERIENCE
V. Rocha-Santos, J. Bohorquez, R. de Martino, 
R. A. Pécora, W. Andraus, V. Pugliese and 
L. A. Dalbuquerque
Abdominal Transplantation Unit, Gastroenterology 
Department, Hospital das Clínicas, University of São 
Paulo Medical School, São Paulo, Brazil
Introduction: Biliary stricture continues to be one of 
the most important life-threatening complications after 
orthotopic liver transplantation (OLT). The aim of the present 
study was to evaluate the patients’ characteristics, the modal-
ity of diagnosis and the treatment approach of the non-isch-
emic biliary stenosis following OLT in the Clinicas` Hospital 
of the University of Sao Paulo.
Methods: From 2002 to 2010, we performed 567 OLT and 
49 of them (8.6%) had anastomotic biliary structure after 
cadaveric OLT. Patients with concomitant arterial thrombosis 
and living donor transplantation were excluded of the present 
study. In 47 cases (96%), we performed an end-to-end 
hepatic duct anastomosis without T-tube with a 6-0 running 
suture and in 2 cases (4%) we did a Roux en Y biliary recon-
struction. We analyzed the preoperative pathology, preopera-
tive MELD and child-pugh scores, age, gender, cadaveric 
donor characteristics, diagnosis modality and the treatment 
approach.
Results: There were 36 males, the mean age was 46.6 years 
old (range 9–69) and the mean child-pugh score was 9.7 
(range 7–14). Six patients (12.2%) had HCV cirrhosis and 
six patients (12.2%) had fulminant hepatitis. The mean pre-
operative MELD score was 29.1 (range 10–42). Cold isch-
emia time range 2.4 hours to 14 hours (average 6.7 hours) 
and the mean warm ischemia time was 44.7 minutes (range 
33–80). The mean donor age was 46.6 years old (range 
13–74). The mean time of the biliary stricture diagnosis 
was 9.3 months (rage 3 days–51 month). In 14 cases 
(28.5%) abdominal ultrasound showed intra or extra hepatic 
dilatation and in 35 patients the ultrasound examination did 
not show any sign of biliary stricture.
Conclusion: Anastomotic biliary stricture presented a 
high incidence of morbidity but a very low prevalence of 
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mortality. The MRI was the non-invasive gold-standard 
method for biliary stricture diagnosis. The endoscopic 
approach was the fi rst choice of treatment following by the 
percutaneous method with an overall technical success rate 
of 57%.
FOS223
LIVING DONOR LIVER 
TRANSPLANTATION FOR 
HEPATOCELLULAR CARCINOMA
L. Ying and D. Jia Hong
Hospital & Institute of Hepatobiliary Surgery, Chinese 
PLA General Hospital, Beijing, China
Introduction: The aim of this study was to evaluate the 
outcome of living donor liver transplantation (LDLT) for 
hepatocellular carcinoma (HCC).
Methods: We retrospectively analyzed the clinical data of 
180 patients, who had received LDLT (n = 34) or deceased 
donor liver transplantation (DDLT, n = 146) for HCC, com-
pared overall and tumor-recurrence survival between LDLT 
and DDLT, and identifi ed the risk factors of tumor recurrence 
and prognosis by univariate and multivariate analysis.
Results: The 5-year overall survival and tumor-recurrence 
survival rates were 53% and 58% in DDLT group, and 60% 
and 60% in LDLT group, respectively. There was no signifi -
cant difference in overall (P = 0.85) and tumor-recurrence (P 
= 0.89) survival between these two groups. The tumor recur-
rence rates were 26.5% in DDLT group and 17.8% in LDLT 
group, respectively (P = 0.25). Multivariate COX regression 
model analysis identifi ed vascular invasion (relative risk 
2.118, 95% confi dential interval 1.201, 4.353, P = 0.032) and 
tumor beyond UCSF criteria (relative risk 3.490, 95% con-
fi dential interval 1.862–8.207, P = 0.015) as independent risk 
factors of tumor recurrence, and tumor beyond UCSF criteria 
as independent predictors of prognosis.
Conclusion: LDLT is a safe and effective procedure for 
patients with HCC, but further studies are required for selec-
tion criteria of recipients and higher HCC recurrence rate 
after LDLT.
FOS224
REDO LIVER TRANSPLANTATION: 
LESSONS LEARNT FROM A 25-YEARS 
EXPERIENCE IN ADULT RECIPIENTS
A. Schielke1, O. Scatton1, F. Perdigao1, P. Y. Boelle2, 
S. Zalinski1, D. Bernard3, F. Conti1 and O. Soubrane1
1Department of Hepatobiliary Surgery and Liver 
Transplantation, Saint-Antoine Hospital, Assistance 
Publique, Hôpitaux de Paris, Paris, France; 2Department 
of Public Health, Saint-Antoine Hospital, Assistance 
Publique, Hôpitaux de Paris, Paris, France; 3Department 
of Anesthesia and Intensive Care, Saint-Antoine Hospital, 
Assistance Publique, Hôpitaux de Paris, Paris, France
Introduction: Redo liver transplantation (RLT) may be 
indicated in highly selected patients experiencing severe 
complications following LT. Because of a dramatically high 
postoperative mortality, indications for RLT are cautiously 
weighted. This study aimed at evaluating the outcomes and 
risk factors of failure to improve the patients’ selection 
process.
Methods: 1600 LT were performed at our institution 
between 1987 and 2011, which included RLT in 143 cases 
(9%). A retrospective analysis of these 143 cases was 
performed.
Results: In 14 cases, primary LT had been performed during 
childhood (child-adult group). Indications for RLT were vas-
cular (23%), cholangitis (23%), chronic rejection (17%), 
non- or dysfunction (20%) and disease recurrence (8%). 
Postoperative morbidity was mainly due to biliary (25%) and 
arterial (13%) complications. One-, 5- and 10-yrs overall 
and graft survival were 60%, 52% and 39% and 55%, 
46% and 32%, respectively. Better survival (90% and 85% 
at 1- and 5-yrs, p = 0.02) was noted in the group of patients 
retransplanted for cholangitis and in the child-adult group 
(86% and 74% at 1- and 5-yrs, p = 0.12). Multivariate analy-
sis showed renal failure (p < 0.02) and transfusion greater 
than 7 units (p = 0.005) to be associated with an impaired 
survival.
Conclusion: The graft shortage and the dramatic postopera-
tive outcomes call for a stringent selection of the patients 
before RLT. Yet, the subgroups of adult patients initially 
transplanted during childhood and those retransplanted for 
cholangitis experience good postoperative outcomes and 
seem to be the best candidates.
FOS225
EVOLUTION OF THE INDICATIONS TO 
VENO-VENOUS BYPASS AND LONG 
TERM RESULTS OF ITS APPLICATION 
IN LIVER TRANSPLANT RECIPIENTS – 
SINGLE CENTRE EXPERIENCE
P. Smoter, K. Zieniewicz, P. Nyckowski, W. Patkowski 
and M. Krawczyk
Department of General, Transplant and Liver Surgery, 
Medical University of Warsaw, Poland
Introduction: Veno-venous (VVB) had been introduced to 
liver transplantation (OLT) to minimize hemodynamic 
changes following inferior vena cava (IVC) clamping. 
Progress of transplant medicine changed the use of VVB 
from routine to selective, in certain clinical situations. 
Nowadays there are still no generally accepted indications 
for VVB use. The aim of the study was to analyze the indica-
tions for VVB and the results of routine and selective bypass 
use during OLT.
Methods: Two groups of patients operated on with VVB 
use in years 1999–2003, who had complete hemodynamic 
monitoring, were retrospectively analyzed: group A con-
sisted of 50 cases from years 1999–2001 – the period of 
routine VVB use, and group B consisted of 35 cases from 
years 2002–2003, when VVB was used selectively. The 
analysis of indications for VVB, a number of hemodynamic 
parameters (HR, MAP, CPV, CI, SVRI), the temperature 
and the need for vasopressor agents in the three phases of 
the procedure were analyzed. Complications and long-term 
results were compared. Statistical analysis was performed 
with the use of U Mann-Whitney test in Statistica version 8 
program.
Results: The majority of indications for VVB use resulted 
from intraoperative diffi culties. There were: huge collateral 
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circulation (22%), signifi cant hepatomegalia (17%), large-
for-size graft (14%) and large tumor of the recipient’s liver 
(11%). Hemodynamic parameters did not differ between the 
groups. Patients from group B needed signifi cantly higher 
doses of vasopressor agents. The rate of complications asso-
ciated with VVB use was 30% and 31% in group A and B 
respectively. The great majority of complications were mild. 
Serious fatal complication, pulmonary embolism, was 
observed in one case in each of the groups. Long term results 
of OLT were similar except for 5-year survivals, that were 
lower in group B compared to group A (72 vs 85%, p = 0.01).
Conclusion: Bypass enables to decrease the rate of contra-
indications for OLT and a number of high risk patients are 
given the chance for successful transplantation. Hemodynamic 
parameters of high risk patients are similar to those of all 
recipients. VVB is a relatively safe method, however 
every decision of VVB use should be based on important 
indications due to the risk of rare, but potentially fatal 
complications.
FOS226
SURVIVAL IN REDO LIVER 
TRANSPLANT COMPARABLE WITH 
PRIMARY LIVER TRANSPLANTATION 
WHEN RECURRENT HEPATITIS C 
EXCLUDED
M. B. Doyle1, M. MacConmara2, E. Maynard1, 
N. Vachharajani1, S. Shenoy1, J. Wellen1, J. Lowell1 
and W. Chapman1
1Department of Abdominal Transplantation, Washington 
University, St. Louis, USA; 2Department of General 
Surgery, Washington University, St. Louis, USA
Introduction: Retransplantation (re-OLT) is the only treat-
ment option for allograft failure, however it remains contro-
versial given the scarcity of organs and decreased survival 
compared with primary transplantation. Survival also differs 
according to the etiology of allograft failure. We examined 
outcome after re-OLT at this institution.
Methods: Sixty four (7.6%) patients with a previous liver 
transplant (re-OLT) were identifi ed retrospectively from the 
845 adult liver transplants done at this institution between 
1/1/2000 and 12/31/2011. Mean time between primary and 
re-OLT was 4.4 years (±6.0). 27 re-OLT patients (42%) were 
originally transplanted for hepatitis C, 11 (17%) had primary 
sclerosing cholangitis and the others (41%) were miscella-
neous. Eight (29.6%) of the 27 hepatitis C patients were 
retransplanted for recurrence with an interval of 5.9 years 
(±5.1). Demographics, preoperative morbidity, and outcomes 
were examined. Statistical analysis used Student-T, Chi-
Square test as appropriate and Log-Rank test for Kaplan-
Meier curves.
Results: Re-OLT patients were younger (p = 0.005), with 
lower BMI, (p = 0.0008) than primary OLT but had higher 
MELD scores (21.4 vs 26.6, p = 0.0001). Operative times 
were longer for re-OLT (p = 0.001) and blood transfusion 
were greater (p = 0.0001). ICU (5 vs 11 days p = 0.0001) 
and hospital stays (12 vs 22.6, p = 0.001) were signifi cantly 
longer in the re-OLT group. Overall survival at 1, 3 and 5 
years for retransplantation was 77.7, 70.0 and 64.2% which 
was lower than survival for fi rst time transplants (90.0, 85.3 
and 79.6% p = 0.0085). However this signifi cance was lost 
when the 8 recipients undergoing re-OLT for recurrence of 
hepatitis C were removed from the analysis and no difference 
in survival between re-OLT and primary OLT was then seen 
(81.7, 73.1 and 70.4, p = 0.1).
Conclusion: Liver re-OLT had equivalent outcomes to 
primary transplants for indications other than hepatitis C 
recurrence. Furthermore, patients originally transplanted for 
hepatitis C who received a second graft for reasons other than 
recurrence had good survival and should be considered for 
repeat transplantation.
FOS227
LIVER TRANSPLANT OUTCOMES USING 
GRAFTS FROM DONATION AFTER 
CARDIAC DEATH (DCD) DONORS
M. B. Doyle, E. Maynard, Y. Lin, N. Vachharajani, 
S. Shenoy, C. Anderson, J. Lowell and W. Chapman
Department of Abdominal Transplantation, Washington 
University, St. Louis, USA
Introduction: Previous reports suggest that DCD liver 
grafts have increased primary non-function (PNF) and biliary 
cholangiopathy. Warm ischemia prior to cold fl ushing, not 
encountered in standard brain-death donation, is presumed 
to increase these complications.
Methods: Between January 2005 and June 2011 574 adult 
liver transplants were performed at our institution. Thirty-
one (5.4%) patients received DCD donor grafts. A prospec-
tively maintained database was utilized for the current 
analysis. Warm ischemia time (WIT) and cold ischemia time 
(CIT) were obtained from hospital records. Median followup 
was 3.8 years.
Results: DCD donors were younger (29 years, 10–60) than 
non-DCD (46 years, 9–80) (p < 0.0001), with similar recipi-
ent age (55 and 53.9 years, p = 0.56). MELD was lower in 
DCD recipients (18.4 vs 21.9, p = 0.05). Mean CIT and WIT 
was similar between groups (6.3 vs 5.9 hrs, p = 0.36 and 36 
vs 34 mins., p = 0.20). Mean ICU and hospital stay was 2 
days (p = 0.31) and 7 days (p = 0.37). DCD graft WIT was 
23 mins (±8). 1-, and 5-year patient survival was 93%, and 
93% in DCD vs 89%, and 77% in non-DCD (p = 0.1). Graft 
survival was 93%, and 85% vs 87%, and 75% (p = 0.28). 3 
recipients developed ischemic cholangiopathy and were 
associated with increased donor WIT (p = 0.004). Two were 
retransplanted. Bile leak was more common in DCD recipi-
ents (19.4% vs 7.9% p = 0.04).
Conclusion: Careful selection of DCD donors can provide 
suitable donors with results of liver transplantation compa-
rable to standard brain dead donors.
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MORPHOMETRIC ANALYSIS OF 
FIBROSIS AND INFLAMMATORY 
ACTIVITY IN RECURRENT HCV 
INFECTION. CORRELATION BETWEEN 
ISHAK SCORE, SIRIUS RED, AND 
STELLATE CELL ACTIVATION
S. Noory, R. Hajhosseiny, G. Noory, D. Joshi 
and A. Quaglia
King’s College Hospital, UK
Introduction: Histological assessment of recurrent HCV 
infection usually includes semiquantitative scoring systems 
for the grading and staging of infl ammatory activity and 
fi brosis. We have investigated how morphometric analysis of 
fi brosis and infl ammatory activity can contribute to this 
assessment.
Methods: 78 liver biopsies taken between 6–3722 days 
post-transplant (median 688) were reviewed. Sections from 
formalin-fi xed and paraffi n embedded post-transplant liver 
biopsy specimens were stained with Sirius Red (SR), for 
Smooth Muscle Actin (SMA) and CD3 (T lymphocytes). The 
Sirius Red and SMA stained section were digitalised using 
the scanning function of a Leica DM6000. We used ImageJ 
(Version 1.42q) software and Photoshop CS5 software 
package for specimen analysis. The staining proportionate 
area was calculated as described by Calvaruso et al 
Hepatology. 2009 Apr;49(4):1236–44. A cell count of lobular 
CD3+ve lymphocytes was carried out using a microscope 
grid. Semi quantitative scoring was also carried out using the 
Ishak scoring system.
Results: SR CPA, SMA CPA and CD3 count ranged from 
0.26–29.63% (mean = 6.28%), 0.00018–35.62% (mean = 
4.89%) and 1–63 (median = 13) respectively. Mean SMA 
CPA and mean SR CPA for each Ishak score category were 
as follows: 0 = 2.34% (0.25–5.37%), 1 = 3.29% (0–13.33%), 
2 = 4.44% (0–11.56%), 3 = 6.64% (1.49–13.93%), 4 = 6.37% 
(6.02–6.83%), 5 = 7.92% (3.21–14.16%), 6 = 28.96% 
(22.30–35.62%) and 0 = 3.68% (0.59–5.83%), 1 = 4.67% 
(1.35–19.46%), 2 = 4.43% (0.61–10.00%), 3 = 8.65% (1.20–
17.85%), 4 = 6.77% (5.10–8.43%), 5 = 9.79% (0.26–29.63%), 
6 = 11.91% (1.60–22.22%) respectively. On univariate anal-
ysis, Ishak score correlated with SMA CPA (r = 0.62, p < 
0.0001) but not SR CPA (r = 0.226, p = 0.104). There was a 
correlation between CD3 count and AST levels (r = 0.437, 
p = 0.004).
Conclusion: Digitalisation, image analysis and immunohis-
tochemistry for CD3+ve lymphocytes contribute to the 
assessment of infl ammatory activity and fi brosis in post-liver 
transplant recurrent HCV infection.
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FULMINANT HEPATIC FAILURE: 
FACTORS PREDICTING IN-HOSPITAL 
MORTALITY OF ONE-HUNDRED 
PATIENTS PRIORITIZED FOR LIVER 
TRANSPLANTATION IN A SINGLE 
CENTER AT SAO PAULO
E. R. R. Figueira1, J. A. R. Filho2, 
A. R. Assalin3, R. C. T. Surjan1, 
R. S. A. Neto4, E. Chaib1, T. Bacchella1 
and L. A. C. D’Albuquerque1
1Discipline of Digestive Organ Transplantation, 
Department of Gastroenterology, Hospital das Clinicas, 
University of Sao Paulo School of Medicine, Sao Paulo, 
Brazil; 2Discipline of Anesthesiology, Department of 
Surgery, Hospital das Clinicas, University of Sao Paulo 
School of Medicine, Sao Paulo, Brazil; 3Discipline of 
Scientifi c Research in Medicine, University of Sao Paulo 
School of Medicine, Sao Paulo, Brazil; 4Department of 
Pathology, Hospital das Clinicas, University of Sao Paulo 
School of Medicine, Sao Paulo, Brazil
Introduction: Despite the improvements in intensive care 
and in liver transplantation (LT) surgery, fulminant hepatic 
failure (FHF) still carries high mortality rates. The search for 
more accurate prognostic factors could help to optimize the 
patient while waiting for the urgent LT. We aimed to evaluate 
prognostic factors for in-hospital mortality of FHF patients 
referred to LT.
Methods: We retrospectively studied 100 adult patients (78 
female, mean age 35.5 ± 14.7 years) with FHF referred to 
urgent transplantation at our institution from February 2002 
to June 2011. The etiologies were virus in 17% of cases, 
drug-induced in 29%, autoimmune in 13%, cryptogenic in 
34% and other in 7%. Candidacy for LT was determined 
according to the O’Grady criteria. We analyzed age, sex, 
etiology, jaundice-to-encephalopathy time interval, grade of 
encephalopathy, length of stay, INR, Factor V, bilirubin, cre-
atinine, AST, ALT, lactate and the Model for End-Stage Liver 
Disease (MELD). All data were collected at the time of 
prioritization to LT. Outcome end points were LT and in-
hospital mortality with or without LT.
Results: The prioritization-to-LT time interval was 1.5 days 
(0 to 9) and length of stay 18 ± 27 days. The in-hospital 
mortality rate was 69%; 45% of non-survivors died waiting 
for LT. All survivors (31%) were submitted to LT. At priori-
tization, non-survivors showed a higher grade of encepha-
lopathy [3 (1 to 4) vs. 2 (1 to 4)], MELD (41 ± 9 vs. 38 ± 7) 
and lactate (62.2 ± 45.2 vs. 33.9 ± 16.0 mg/dL) compared to 
survivors (p < 0.05). Of the 100 patients, 69% were submit-
ted to LT and 31% died before LT. The non-LT patients 
showed a higher grade of encephalopathy [4 (1 to 4) vs. 3 (1 
to 4)], MELD (44 ± 8 vs. 38 ± 8), lactate (78.4 ± 48.3 vs. 
41.8 ± 30.6 mg/dL) and creatinine (2.60 ± 2.34 vs. 1.55 ± 
1.54 mg/dL) compared to LT patients (p < 0.05).
Conclusion: At the time of prioritization to LT, FHF patients 
with a poor systemic condition, i.e., patients with encepha-
lopathy grades 3 or 4, renal impairment, raised MELD scores 
and high serum lactate levels, have a higher in-hospital mor-
tality rate even when submitted to LT, indicating poor 
prognosis.
 Free Orals Abstracts 205
© 2012 The Authors
HPB 2012, 14 (Suppl. 2), 107–287 HPB © 2012 Americas Hepato-Pancreato-Biliary Association
FOS230
SAFETY OF GRAFT-TO-RECIPIENT 
WEIGHT RATIO <0.7% IN ADULT-TO-
ADULT LIVING DONOR LIVER 
TRANSPLANTATION USING 
RIGHT-LOBE
S. D. Lee, S. H. Kim, S.-J. Park, S.-S. Han and Y. K. Kim
Center For Liver Cancer, National Cancer Center, Korea
Introduction: In living donor liver transplantation (LDLT), 
graft-to-recipient weight ratio (GRWR) is one of the major 
factors for selecting donors.
Methods: From Jan 2005 to July 2011, patients who under-
went adult-to-adult LDLT using right-lobe in National 
Cancer Center, Korea were evaluated. These patients were 
divided into three group; GRWR < 0.7% (A), 0.7% ≤ GRWR 
< 0.8% (B), GRWR ≥0.8% (C). The features of donor, recipi-
ent, operation, laboratory fi nding up to 1 year and small for 
size syndrome (SFSS) among groups were analyzed retro-
spectively. Overall graft survival rate was compared among 
groups using Kaplan-Meier method.
Results: Of 304 patients who underwent LDLT, Group A, 
B, and C included 21, 25, and 258 patients, respectively. 
Mean GRWR among groups were 0.63% ± 0.05%, 0.76% ± 
0.03%, and 1.17% ± 0.25%, respectively. The minimum 
GRWR was 0.53% and the mean graft weight in Group A 
was 478.4 g ± 63.7 g. Group A showed signifi cantly higher 
BMI (mean 27.03), female donor (81.0%), and SFSS (14.3%) 
than other groups. However, there was no difference includ-
ing MELD score, Child classifi cation, donor age, operative 
factors, and complications except vascular stenosis. Graft 
survival rate at 1, 3, and 5 years were not different among 
groups (100%, 90.9%, and 90.9% vs. 96.0%, 81.0%, and 
81.0% vs. 94.6%, 89.1%, and 81.6%; P = 0.750). In Group 
A, there was no death because of SFSS.
Conclusion: GRWR <0.7% graft can be considered safely 
in adult-to-adult LDLT using right-lobe.
FOS231
PORTAL VENOUS GAS AFTER LIVING 
DONOR LIVER TRANSPLANTATION: 
RISK FACTORS AND CLINICAL 
SIGNIFICANCE
D. Ito, S. Ogata, T. Hashimoto, K. Inoue, Y. Maruyama, 
T. Takamoto, T. Miyazaki and M. Makuuchi
Department of HBP Surgery, Japanese Red Cross Medical 
Center, Tokyo, Japan
Introduction: Portal venous gas (PVG), an ominous radio-
logic sign, is associated with a life-threatening underlying 
abdominal disease requiring urgent surgical intervention. 
Although PVG is occasionally detected on Dopplersonography 
in the early postoperative period after cadaveric liver trans-
plantation, few reports are available on PVG after living 
donor liver transplantation (LDLT). The aim of this study 
was to clarify the risk factors and the clinical signifi cance of 
PVG after LDLT.
Methods: Between March 2009 and November 2011, 26 
consecutive adult patients underwent LDLT (mean age 51.9 
range 24–65) at our institution. Serial Doppler sonographic 
examinations were performed twice a day in the fi rst 2 weeks 
and once a week in the 3rd and 4th week after LDLT. 26 
patients were divided into two groups: those with PVG 
(group A, n = 5) and those without PVG (group B, n = 21). 
Risk factors for PVG after LDLT were analyzed. The post-
transplant liver function, morbidity and mortality were com-
pared between the two groups. The post-transplant kinetics 
for transaminase (AST), total bilirubin level and prothrombin 
time (PT) was assessed on post-operative days 1, 3, 5, 10 
and 14.
Results: PVG was detected in 5 patients (20%) on postop-
erative day 7.2 (range 5–10), and continued for 1.9 days 
(range 1–4). Surgical interventions were not required to treat 
PVG. Graft volume/standard liver volume <40% was the 
only signifi cant predictors for post-transplant PVG (p = 
0.007). MELD score, graft type, cold and warm ischemic 
time, a hepatic period, the type of biliary anastomosis did not 
infl uence on the incidence of PVG. Post-transplant liver 
function, mortality (group A vs. group B: 0% vs. 5%), dura-
tion of ICU stay (15.2 days vs. 16.4 days), and morbidity 
grade III (20% vs. 33%), grade IV (20% vs. 19%) were not 
signifi cantly different between the two groups.
Conclusion: PVG is a transient fi nding that has been 
detected in the fi rst 2 weeks after LDLT. Although small-for-
size graft was strongly associated with PVG, there was no 
correlation between the fi nding of PVG and post-transplant 
liver function, the cause of hepatic failure, or subsequent 
death.
206 Free Orals Abstracts
© 2012 The Authors
HPB © 2012 Americas Hepato-Pancreato-Biliary Association HPB 2012, 14 (Suppl. 2), 107–287
FREE ORALS:  PANCREAS
FOS232
BILIARY COMPLICATIONS (BC) IN 
PATIENTS WITH ACUTE LITHIASIC 
PANCREATITIS (ALP)
M. Secchi1, L. Rossi2, L. Quadrelli1, F. Serra3 and J. Forte4
1Medical School, University Institute “IUNIR” and 
Surgical Division, Italian Hospital of Rosario, Argentina; 
2Surgical Division, Modelo Clinic Rufi no; 3Surgical 
Division, Hospital Provincial, Rosario; 4Surgical Division, 
Hospital Clemente Alvarez, Rosario, Argentina
Introduction: Migration of gallstones causing Acute 
Lithiasic Pancreatitis (ALP), but the association between 
Biliary Complications (BC) from Acute Cholecystitis (ACh) 
and Persistent Papillary Obstruction (PPO) with or without 
Cholangitis and ALP modifi es the therapeutic course of both 
diseases: BC and systemic or local complications of ALP. 
The aim of this study was to detect BC and their management 
in a prospective series of 1154 patients with ALP in 4 surgical 
centers in Rosario and Rufi no – Argentina.
Methods: We have prospectively studied a group of 1461 
patients with AP diagnosed by clinical, serologic and mor-
phologic methods, from 1987 to 2011. ACh was confi rmed 
by clinical description, ultrasound patterns and laboratory 
tests, and PPO were diagnosed by high level of bilirubin 
persisted. 79% were ALP: n = 1154. After initial treatment 
of ALP, antibiotic treatment was initiated in mild and severe 
cases, and standard treatment for BC was added once diag-
nosed. When fever, pain or a high level of bilirubin persisted, 
early surgical (endoscopic, laparoscopic or conventional) 
treatment was required (48 to 72 hs) due to the risk of chol-
angitis, sepsis and/or gallbladder perforation, increase pan-
creatic damage and worsening the clinical condition.
Results: Group 1: AC was diagnosed in 109 patients with 
ALP (9.44%). G-2: PPO was found in 52 (4.5%), and G-3: 
cholangitis was found in 24 (2.07%). In a total of 185 cases 
(16.03%), 153 patients had mild ALP and 32 had severe ALP.
G-1: 39 patients with AC received only antibiotics and 
cholecystectomy was performed later; early surgery was per-
formed in 70 cases. G-2: For PPO, expectant behavior was 
applied in 28 cases and 24 patients underwent endoscopic 
papilotomy (EP) after 48 or 72 hs. In G-3: 10 cases of 
cholangitis were controlled with antibiotics, EP was per-
formed in 12 patients, and 2 patients underwent surgery. 
Mortality was 1.3% (2 of 153) and 12% (4 of 32) from both 
biliary complications and mild ALP and severe ALP, respec-
tively (p < 0.01).
Conclusion: The association between Biliary Complications 
(B.C) and ALP is not exceptional (185 of 1154: 16.03% of 
our cases). B.C may worsen the course of ALP with septic 
and/or perforating complications. In such cases, early antibi-
otic treatment (77 of 1154: 6.67%) and/or biliary surgery 
(108 of 1154: 9.36%) may be required to decrease mortality 
from these complications in patients with mild or severe ALP 
(only 6 of 1154: 1.3%, in this cases with the association 
between BC and ALP).
FOS233
PRIMARY HYPERPARATHYROIDISM 
AS A CAUSATIVE FACTOR 
FOR PANCREATITIS
D. Dahiya, A. Behera, R. Kalra, S. Bhadada, S. Rana, 
A. Bhansali and D. K. Bhasin
Postgraduate Institute of Medical Education and Research 
(PGIMER), Chandigarh, India
Introduction: Pancreatitis is commonly caused by gall 
stone disease or by alcohol abuse while hypercalcemia is 
considered to be one of the rarest cause (<1%). Association 
between pancreatitis and primary hyperparathyroidism 
(PHPT) ranged from 3.2 to 5.6%. Pancreatitis can be a diag-
nostic clue to hyperparathyroidism.
Methods: This is a retrospective study of patients who pre-
sented with pancreatic disease and were diagnosed to have 
PHPT (group A) between January 2000 to August 2008 at 
Postgraduate Institute of Medical Education and Research 
(PGIMER), Chandigarh, India. Demographic details, clinical 
profi le, and biochemical parameters were compared to 
patients who had PHPT but without any evidence of pancre-
atic disease (group B) during the same period.
Results: There were 18 patients in group A and 20 in group 
B. Common presentations were of acute pancreatitis in 
38.9%, recurrent in 33.3% while chronic in 27.8% cases. 
Diagnosis of pancreatitis was made after a mean of 3 attacks. 
Median delay in diagnosis of PHPT was 26 and 42 months 
in group A & B respectively (p = 0.3). Extrapancreatic mani-
festation as nephrolithiasis was present in 66.7% in group A 
& 52.4% in group B (p = 0.3). There was no statistically 
signifi cant difference in the location and weight of adenoma, 
occurrence and severity of pancreatitis. Mean serum calcium 
level was signifi cantly higher in group A as compared to 
group B (p = 0.01). iPTH, serum phosphate, serum alkaline 
phosphatase were not different signifi cantly between the two 
groups.
Conclusion: There is an association between PHPT and 
pancreatitis. Higher value of serum calcium level in patients 
with PHPT with pancreatic disease suggests that hypercalce-
mia plays an important role in the development of pancreati-
tis in these patients.
FOS234
ROBOTIC SPLEEN-PRESERVING DISTAL 
PANCREATECTOMY
S. H. Choi, C. M. Kang and W. J. Lee
Division of Hepatobiliary and Pancreas, Department of 
Surgery, Yonsei University College of Medicine, Seoul, 
Korea, Maryland, USA
Introduction: The advanced and delicate laparoscopic tech-
niques are usually required for safe and successful laparo-
scopic spleen-preserving distal pancreatectomy. Unique 
characteristics of robotic surgical system are thought to be 
useful for this minimally invasive procedure.
Methods: From September 2007 to May 2011, patients who 
underwent robotic spleen-preserving distal pancreatectomy 
for benign and borderline malignant tumor of the pancreas 
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were retrospectively reviewed. Perioperative clinicopatho-
logic surgical outcomes were evaluated.
Results: Twenty-three patients were attempted for robotic 
spleen-preserving distal pancreatectomy, and 22 patients 
(95.7%) could intentionally save the spleen either by splenic 
vessels-conservation (SVC; 17, 73.9%), or by splenic ves-
sels-sacrifi ce (SVS; 5, 21.7%). Seven patients were male and 
16 were female with age of 43.2 ± 15.2 years. The body mass 
index was checked as 23.1 ± 3.1 Kg/m2. Pathologic diagnosis 
of the resected pancreatic tumor included mucinous cystic 
tumor (MCT) in 6 patients, serous cystic tumor (SCT) in 5, 
solid pseudopapillary tumor (SPT) in 4, intraductal papillary 
mucinous tumor (IPMT) in 3, neuroendocrine tumor (NET) 
in 3, and other benign conditions (intrapancreatic accessory 
spleen and chronic pancreatitis) in 2.
Conclusion: Robotic surgical system is thought to be ben-
efi cial for improving spleen-preserving rate in laparoscopic 
distal pancreatectomy. However, its expensive cost is a great 




EMISSION TOMOGRAPHY (FLT-PET) 
AND FDG-PET/CT FOR THE DETECTION 
AND CHARACTERIZATION OF 
PANCREATIC TUMORS
M. Erkan1, K. Herrmann2, M. Dobritz3, R. M. Schmid4, 
H. Friess1, M. Schwaiger2, J. Kleeff1 and A. K. Buck2
1Department of General Surgery, Technische Universität 
München, Munich, Germany; 2Department of Nuclear 
Medicine, Technische Universität München, Munich, 
Germany; 3Institute of Radiology, Technische Universität 
München, Munich, Germany; 4Department of Internal 
Medicine, Technische Universität München, Munich, 
Germany
Introduction: Despite recent advancements in clinical 
imaging modalities, differentiation of pancreatic masses 
remains diffi cult. Here, we tested the diagnostic accuracy of 
molecular based imaging using two different traces specifi c 
for cellular metabolism (FDG, radioactive glucose) and cel-
lular division (FLT, radioactive thymidine) in patients with 
suspected pancreatic masses scheduled to undergo surgery.
Methods: 46 patients with pancreatic tumors suspicious 
for malignancy and scheduled for resective surgery have 
been recruited prospectively. In 41 patients, FLT-PET and 
FDG-PET/CT scans were performed. A diagnostic CT per-
formed on a routine basis was available in 31 patients. 
FLT-PET and FDG-PET/CT emission images were acquired 
according to standard protocols. Tracer uptake in the tumor 
(FDG- and FLT-SUV) was quantifi ed by region of interest 
(ROI) technique. For FDG-PET/CT analysis, correct ROI 
placement was ensured via side-by-side reading of corre-
sponding CT images.
Results: 33 of 41 patients had malignancy, whereas 8 patients 
had benign disease. Visual analysis of FDG- and FLT-PET 
resulted in sensitivity values of 91% (30/33) and 70% (23/33), 
respectively. Corresponding specifi cities were 50% (4/8) for 
FDG-PET and 75% (6/8) for FLT-PET. In the subgroup of 
patients with contrast enhanced CT (n = 31), sensitivities were 
96% (PET/CT), 88% (CT alone), 92% (FDG-PET) and 72% 
(FLT-PET) respectively. Mean FLT-uptake in all malignant 
tumors was 3.0 (range SUVmax, 1.1–6.5; mean FDG-
SUVmax: 7.9, range, 3.3–17.8; p < 0.001).
Conclusion: For differentiation of pancreatic tumors, 
FDG-PET and FDG-PET/CT showed a higher sensitivity but 
lower specifi city than FLT-PET.
FOS236
AUTOIMMUNE PANCREATITIS, A 
SINGLE CENTRE EXPERIENCE WITHIN 
THE UNITED KINGDOM
R. Storey, R. Dave, K. Menon, A. Aldoori and A. Smith
Division of Hepatobilary & Pancreatic Surgery, 
Department of Surgery, St. James’s University Hospital, 
Leeds, UK
Introduction: Autoimmune pancreatitis (AIP) was fi rst 
reported in 1961, however was not described as a clinical 
entity until 1995. AIP is considered to have a favourable 
prognosis as patients usually respond well to corticosteroid 
therapy (CST). The natural history of AIP along with which 
patients require CST and for how long is only just beginning 
to be understood. We describe our experience of AIP and the 
potential role for steroid sparing agents.
Methods: Through a clinical database search, all patients 
who were treated at our institution for AIP between Jan 2005 
and Dec 2011 were identifi ed. 17 patients were identifi ed, 
with 65% (n = 11) diagnosed and treated since September 
2009. The diagnostic criteria, incidence of spontaneous reso-
lution, AIP relapse and modality of treatment was assessed.
Results: 17 AIP patients, 82% (n = 14) male and 18% (n = 
3) female. Median age 61 years. 88% (n = 15) jaundiced at 
presentation. 71% (n = 12) features of AIP on imaging and 
59% (n = 10) raised IgG4. Extra-pancreatic manifestations 
in 65% (n = 11). AIP in 23% (n = 4) spontaneously resolved 
within six months. 65% (n = 11) were treated with CST, of 
these 64% (n = 7) presented with raised IgG4. Of those 
treated with CST, 36% (n = 4) subsequently relapsed, two 
while on low maintenance dose CST. All responded to a 
further course of CST and 75% (n = 3) were later converted 
onto steroid sparing agents. Of those initially treated with 
CST 54% (n = 6) have been converted onto steroid sparing 
agents and remain in remission with a median follow up of 
12 months.
Conclusion: Spontaneous remission of AIP may be associ-
ated with a low future relapse rate. There is a potential role 
for steroid sparing agents in patients requiring longer term 
immunomodulation.
FOS237
RETROSPECTIVE COMPARISON OF 
MINIMALLY INVASIVE VERSUS OPEN 
PANCREATICODUODENECTOMY FOR 
PERIAMPULLARY NEOPLASMS
P. Bao, P. Mazirka and K. Watkins
Stony Brook University Medical Center, Stony Brook, NY, 
USA
Introduction: Surgical units are refi ning minimally inva-
sive approaches to pancreaticoduodenectomy (MIPD) for 
periampullary neoplasms. Its complications, benefi ts, and 
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outcomes compared to open pancreaticoduodenectomy 
(OPD) have not been well-studied.
Methods: Outcomes were compared between patients with 
a preoperative diagnosis of periampullary neoplasm under-
going elective minimally invasive pancreaticoduodenectomy 
or open resection from November 2009 to July 2011 at a 
single institution. During this period, 28 MIPD and 28 OPD 
procedures were performed. There were 4 conversions to 
open which were included with the open group for analysis. 
Age, gender, and BMI between groups were similar. 
Pancreatic adenocarcinoma and non-invasive IPMN were the 
most frequent malignant and benign neoplasms, respectively, 
though there were more malignant pathologies in the open 
group (91% vs 67%, p = 0.04).
Results: Comparing MIPD to OPD, median procedure time 
was greater [444 minutes (range 340–628) vs 399 (190–621), 
p = 0.02]. Median lymph node harvest was less [15 (range 
8–32) vs 19.5 (11–32), p = 0.002] while R0 resection rate 
was similar (75% vs 79%, p = 0.73). Complications were 
similar with respect to median length of stay [7.8 days (range 
2–30) vs 8.1 (5–100), p = 0.45], pancreatic fi stula rate of any 
grade (29% vs 34%, p = 0.68), delayed gastric emptying 
(16% vs 12%, p = 0.71), and 30-day readmission rates (25% 
vs 25%). There tended to be fewer surgical site infections 
(17% vs 41%, p = 0.05) and lower average daily oral mor-
phine equivalents given during the fi rst postoperative week 
(31.6 ± 27.1 vs 50.7 ± 49.1, p = 0.23).
Conclusion: MIPD and OPD offer comparable approaches 
to resecting periampullary tumors. Smaller though adequate 
lymph node yields with MIPD will need to be further studied 
for clinical signifi cance. In line with other surgical proce-
dures, the minimally invasive approach appears to be associ-
ated with fewer wound complications and less pain.
FOS238
PANCREATIC RESECTION AS A PART OF 
ENBLOC MULTIORGAN OPERATIONS 
FOR MALIGNANCIES
L. Lipska, V. Visokai and M. Levy
Surgical Department, Thomayer Hospital, First Faculty of 
Medicine, Charles University
Introduction: About 10% of all patients with colorectal 
cancer, up to 30% patients with gastric cancer and not rarely 
in other malignant tumors, the primary invention already 
discloses adhesions or infi ltration of adjacent organs. En bloc 
resection of the primary cancer with adjacent organs is done 
to give patients a chance for curation, since intraoperative 
differentiation isn’t possible. A review of patients with 
advanced abdominal malignancy, managed by multiorgan 
resection including pancreas is reported.
Methods: Inclusion criteria for the cohort of 16 reported 
patients were:
Multivisceral resection including pancreas. R0 en bloc 
resection. Malignant primary tumor or locally recurrent or 
metastatic cancer. Pancreatic involvement proved by 
histology.
Primary site of tumor was colorectal cancer in 6 cases, 
gastric cancer in 4 cases, liposarcoma in 3 cases, pancreatic 
cancer 1 patient, GIST in 1 patient and metastatic pulmonary 
cancer in 1 patient.
Results: In all patients multiorgan resections including pan-
creas were performed. Resections included en bloc proximal 
or distal resection of pancreas and/or with transverse colon, 
gastrectomy, resection of diafragm or kidney. Postoperative 
morbidity was 44% and mortality 6.2%.
Conclusion: In highly selected patients multivisceral opera-
tion including pancreatic resection for malignancy can be 
performed with acceptable morbidity and mortality.
Surgical resection may be an option for a curative 
approach, but in some cases it is only salvage operation.
FOS239
VASCULAR RESECTIONS – A FEASIBLE 
OPTION IN SURGICAL TREATMENT OF 
PANCREATIC CANCER
N. Vladov1, I. Takorov1, V. Mihaylov1, S. Sergeev1, 
V. Mutafchiyski1, T. Lukanova1, E. Odisseeva2 and 
K. Katzarov3
1HPB and Transplant Surgery, Military Medical Academy, 
Sofi a, Bulgaria; 2Department of Anesthesia and Intensive 
Care, Military Medical Academy, Sofi a, Bulgaria; 
3Department of Gastroenterology and Hepatology, Military 
Medical Academy, Sofi a, Bulgaria
Introduction: The incidence of pancreatic cancer is rising 
in all developed countries. It is the 7th leading cause for 
cancer related dead in Bulgaria. Surgery is the only poten-
tially curative treatment for patients with pancreatic carci-
noma, and multimodality therapy results in median survival 
of up to 34 months. Nowadays patients thought previously 
to be unresectable are undergoing R0 resections with satis-
factory survival rates. This study aims to evaluate the effect 
of radical vascular resections.
Methods: Two hundred and nine consecutive patients with 
pancreatic cancer, radically operated in our department for a 
period of 6 years, were evaluated prospectively. Among them 
169 underwent pancreaticoduodenectomies (48 classical 
Whipple’s procedures and 121 PPPD) and the rest 40 – distal 
pancreatic resections (n = 29) or papillectomies (n = 11). 
Forty-three of the presented patients underwent pancreatic 
resection with simultaneous vascular resection – venous in 
41 cases, arterial in 2, and combined in 3 cases. Twenty-three 
segmental and 18 partial wedge venous resections were 
done. Nineteen extended resections were made.
Results: The rate of postoperative morbidity was 33.9% 
(71 pts). A higher frequency of postoperative bleeding was 
observed in cases with vascular resection, especially in 
those who underwent reconstruction with artifi cial graft. 
Signifi cantly improved long-term outcome was registered in 
patients who have overcome postoperative complications (p 
= 0.03). The 3-year survival rate of the radically operated 
patients was 22.5% versus 0 in these with palliative proce-
dures. The data analysis revealed no statistically signifi cant 
difference in the overall survival rate in patients who under-
went resection of the portal vein (median survival 14.5 
months) compared to that in patients with a standard pancre-
atoduodenal resection (17.1 months) – p = 0.5.
Conclusion: Resection should be as radical as possible, 
including portal vein or even arterial resections in selected 
cases. Radical surgery ensures better long-term results, 
anyway. Standardizing of the preoperative staging and the 
surgical approach and technique are the most important 
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details of the complex treatment of pancreatic cancer. We 
recommend this type of surgery to be concentrated in highly 





K. Cheng1, B. Han1, L. Na2, D. Cheng1, B. Shen1, 
X. Deng1, J. Ye1 and C. Peng1
1Department of General Surgery, Rui Jin Hospital, 
Shanghai Jiao Tong University School of Medicine, 
Shanghai, China; 2Department of Endocrinology, The First 
Teaching Hospital, Xinjiang Medical University, Wulumuqi, 
Xinjiang, China
Introduction: Parenchyma-sparing pancreatectomy has 
gained increasing attention. Middle-preserving pancreatec-
tomy (MPP) is a recently reported parenchyma-sparing 
procedure when the body of the pancreas is spared from 
pancreatic multicentric lesions. Due to its rarity, however, 
the role of this surgical procedure is not clearly defi ned. The 
aims of this study were to identify the indications to perform 
MPP and to evaluate the outcomes and quality of life of the 
patients who underwent this operation.
Methods: Firstly, authors reviewed their own experience 
with 2 cases of one-stage MPP; furthermore, a systematic 
review concerning MPP was carried on in English language 
medical literatures with a result of 17 cases of one-stage MPP 
and 3 cases of two-stage MPP have been gained. Patient 
characteristics, surgical techniques, histopathological fi nd-
ings, postoperative complications and prognosis of the 22 
cases including ours were retrospectively analyzed.
Results: In 22 cases underwent MPP, 4 involved the whole 
gland and 18 spared the pancreatic body; 7 involved malig-
nant lesions and 15 were benign or low malignant. The most 
common procedure of MPP consisted of pylorus preserving 
pancreatoduodenectomy and distal pancreatectomy (36.4%). 
Postoperative mortality was nil and postoperative morbidity 
was 9 (40.9%) including 5 pancreatic fi stula, 2 intraperito-
neal bleeding, 1 pseudocyst formation and 1 delayed gastric 
empty. At a median follow-up of 28 months, all are alive and 
disease-free except one died of malignant lymphoma; 4 
(18.2%) developed insulin-dependent diabetes mellitus as 
well as exocrine insuffi ciency; 1 (4.5%) developed only 
diabetes mellitus; 1 (4.5%) developed only exocrine 
insuffi ciency.
Conclusion: MPP is a feasible parenchyma-sparing proce-
dure that is indicated for selected patients and should always 
under the consideration of HPB surgeons. In treating multi-
centric pancreatic lesions that spare even a part of the pan-
creatic body, MPP may serves as an alternative since with it 
total pancreatectomy can be avoided and the risky of endo-
crine and exocrine insuffi ciency might be reduced.
FOS241
GASTROINTESTINAL BLEEDING RISK 
AFTER SPLEEN-PRESERVING DISTAL 
PANCREATECTOMY WITH EXCISION 
OF THE SPLENIC VESSELS: 
LONG-TERM FOLLOW-UP
D. Louis1, M. C. du Rieu1, A. Ponsot2, C.-H. Julio1, 
T. Chaubard1, E. Bloom1, B. Pradere1 and N. Carrere1
1Digestive Surgery Department, Purpan University 
Hospital, Toulouse, France; 2Radiology Department, 
Purpan University Hospital, Toulouse, France
Introduction: Spleen-preserving distal pancreatectomy 
(SPDP) with excision of the splenic vessels (Warshaw opera-
tion) is a fast and effective procedure widely adopted on the 
basis of short-term studies. Splenic blood supply relies on 
the collateral vasculature via the short gastric and left 
gastroepiploic vessels. However, hemodynamic changes of 
splenogastric circulation may lead to the development of 
gastric varices with a risk of gastrointestinal bleeding.
Methods: The aim of this retrospective study was to assess 
the long-term postoperative clinical follow-up of these 
patients and to review the late postoperative imaging and 
results of those who underwent abdominal computed tomog-
raphy (CT) or endoscopic examination during follow-up. 
From 1988 to 2010, 48 consecutive patients with benign or 
low-grade malignant disease underwent a Warshaw opera-
tion in our institution. Late postoperative follow-up was per-
formed using a prospective database and was updated to 
December 2011. The imaging CT studies were reviewed by 
a single GI radiologist and the development of gastric varices 
(defi ned as tortuous veins larger than 5 mm) was systemati-
cally assessed.
Results: Median follow-up was 55 months (mean 70 
months, range 2–286 months). Two patients were lost to 
follow-up. Gastrointestinal bleeding from gastric varices 
occurred in 1 patient only. Bleeding recurrence required sub-
sequent splenectomy in this patient, more than 10 years after 
distal pancreatectomy. Endoscopy and abdominal CT showed 
submucosal gastric varices in this patient only. For the other 
35 patients in whom postoperative abdominal CT were avail-
able, 15 patients had perigastric varices (43%) but none of 
them developed clinical complications from their varices.
All the perigastric varices occurred within 6 months 
after distal pancreatectomy and remained stable during 
follow-up.
Conclusion: This study confi rmed that asymptomatic peri-
gastric varices frequently occurred in patients who under-
went spleen-preserving distal pancreatectomy with excision 
of the splenic vessels, but their bleeding risk seems to be 
very low. Abdominal CT can identify these perigastric 
venous pathways and may distinguish them from rare sub-
mucosal varices at higher risk of gastric bleeding.
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FOS242
MYOCARDIAL ALTERATION IN 
EXPERIMENTAL ACUTE PANCREATITIS
A. Meyer1, J. Jukemura1, M. Kubrusly1, R. Patzina2, 
V. Salemi3, M. Machado1, J. Eduardo Monteiro Cunha1 
and L. A. C. D´Albuquerque1
1Department of Gastroenterology, University of São Paulo, 
São Paulo, Brazil; 2Department of Pathology, University of 
São Paulo, São Paulo, Brazil; 3Heart Institute (InCor), 
University of São Paulo, São Paulo, Brazil
Introduction: Evidences suggest that proinfl ammatory 
cytokines (IL-1, TNF-α, IL-6 and IL-8) act as mediators of 
local and systemic manifestations in acute pancreatitis (AP) 
and correlate with the severity of the disease. The production 
in situ into the myocardium of pro-infl ammatory cytokines 
may lead to acute myocardial damage with functional 
changes and, eventually, chronic sequelae. Evaluate the his-
tological and functional changes of the heart in experimental 
acute pancreatits.
Methods: Adult Wistar rats were subjected to experimental 
acute pancreatitis induced by pancreatic duct infusion of 
Na-taurocholate. Myocardial function was evaluated by 
using echocardiography. Rats were sacrifi ced for biochemi-
cal and histological analysis and TGF-β, IL-6 and TNF-α 
gene expression study at 2, 12 and 24 hours and 15 days.
Echocardiography variables, cytokines, amylase and RNA 
expression were described with the use of summary meas-
ures (median, minimum and maximum) and compared using 
Kruskal-Wallis test followed by nonparametric multiple 
comparisons when there was a statistically signifi cant 
correlation.
The histological measures were described using absolute 
and relative frequencies and compared using Kruskal-Wallis 
test.
Results: We observed decreasing in diastolic and systolic 
function and ventricular compliance in group 2 hours after 
acute pancreatitis. Induction of acute pancreatitis caused an 
increase in amylase and appearance of infl ammatory media-
tors (TNF-α, IL-6 and IL-10). Twelve hours after induction 
of acute pancreatitis was not observed level of TNF-α in 
serum, however there was an increase in levels of IL-6 and 
decreased levels of IL-10 compared to 2 hours. Increased 
myocardial production of cytokines (TNF-α, IL-6, TGF-β) 
and myocardial histological lesions (vacuolar degeneration, 
pyknosis and loss of nuclei and lymphocytes) were associ-
ated with acute pancreatits.
Conclusion: We concluded that in acute pancreatitis there 
is myocardial damage probably related to in situ production 
of myocardial pro-infl ammatory cytokines followed by the 
increasing TGF-β gene expression related to the occurrence 
of fi brosis and cellular repair.
FOS243
OUTCOMES OF MIDDLE 
PANCREATECTOMY: DOES ROBOTIC 
SURGERY HAVE ADVANTAGES OVER 
OPEN SURGERY?
K. Cheng, B. Shen, C. Peng, X. Deng, Q. Liu, 
B. Han and D. Cheng
Department of General Surgery, Rui Jin Hospital, 
Shanghai Jiao Tong University School of Medicine, 
Shanghai, China
Introduction: Middle Pancreatectomy (MP) is a rational 
procedure in treating benign and low-grade malignant neo-
plasms in the neck and body of the pancreas. Laparoscopic 
MP has not been applied widely owing to the technical limita-
tions. Robot was invented to overcome those defi ciencies of 
traditional laparoscopic equipment. But information regard-
ing the advantages of using the robotic system over open 
surgery for MP is rare. Therefore, a comparison of the out-
comes between robotic MP and open MP was conducted.
Methods: Firstly, the authors retrospectively evaluated their 
initial experience with 7 consecutive cases underwent robotic 
MP (Group A). Furthermore, they compared the periopera-
tive outcomes with open MP in 36 cases (Group B) per-
formed in their institution.
Results: 5 females and 2 males were in Group A with a 
median age of 48.1 years (30~62 years), including 1 IPMNs 
and 6 serous cystadenoma. Median tumor size was 2.9 cm 
(0.5~5.0 cm). Pancreaticogastrostomy was performed in all 
cases. Median operation time was 216 min (150~330 min); 
median estimated intraoperative blood loss was 193 ml 
(50~400 ml). No transfusion was given during operations. 5 
experienced postoperative pancreatic fi stula (grade B), 1 
experienced postpancreatectomy hemorrhage (grade B). No 
operative morality was noted. Compared to Group B, Group 
A demonstrated less intraoperative bleeding (p < 0.05), 
quicker recovery of gastrointestinal function (p < 0.05), 
higher postoperative pancreatic fi stula and high postopera-
tive complications (p < 0.05).
Conclusion: Robotic MP appears to be feasible and effec-
tive although it carries higher postoperative complications 
which were mainly due to limited experiences. Further expe-
rience beyond the learning curve phase may improve com-
plication rate and more researches are needed to address the 
role of robotic MP in the advanced laparoscopic era. Robotic 
and open MP should be investigated in a randomized manner 
and long term outcomes should also be evaluated.
FOS244
INDICATORS FOR RESECTION OF 
INTRADUCTAL PAPILLARY MUCINOUS 
NEOPLASMS OF THE PANCREAS: DOES 
SIZE MATTER?
N. Rezaee, S. Reddy, B. Edil, S. Huftless, R. Hruban, 
F. Elliot, A. M. Lennon and C. Wolfgang
Johns Hopkins, Maryland, USA
Introduction:
Objective: To test the validity of the international consensus 
guidelines for management of Intraductal Papillary Mucinous 
Neoplasms (IPMN).
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Summary Background Data: In 2006, consensus guide-
lines proposed resection of all main duct and mixed type 
IPMN, as well as branch duct IPMN associated with a mural 
nodule, symptoms, or size ≥3 cm.
Methods: From 1995 to 2011, 514 pancreatectomies for 
IPMN were identifi ed through a prospective, single-
institution database. Lesions were classifi ed, based on pre-
operative imaging, as main duct if diffuse or segmental main 
pancreatic duct (MPD) dilatation ≥5 mm was present without 
associated dominant cystic lesion; branch duct if a cystic 
lesion was present without MPD dilatation; and mixed if a 
cystic lesion coexisted with MPD dilatation ≥5 mm.
Results: The incidence of invasive carcinoma and high-
grade dysplasia was 67% and 13% in main-duct, and 42% 
and 22% in mixed type IPMN, supporting the recommenda-
tion for resection of such lesions. Branch duct IPMN har-
bored invasive carcinoma in 14% and high-grade dysplasia 
in 22% of cases. Specifi cally, branch duct IPMN with inva-
sive carcinoma were larger more often symptomatic (P < 
0.001), and more associated with a solid component on 
imaging (P < 0.0001) than those without invasive carcinoma. 
However, on multivariate analysis, the presence of a solid 
component (P < 0.0001) or symptoms (P = 0.001), but not 
size ≥3 cm (P = 0.22), were statistically signifi cant indepen-
dent predictors of invasive carcinoma.
Conclusion: In accordance with the consensus guidelines, 
IPMN involving the main pancreatic duct (main duct or 
mixed type), as well as branch duct IPMN with a solid com-
ponent or symptoms have a strong association with malig-
nancy and warrant surgical resection. In the absence of the 
above criteria, size ≥3 cm alone was not independently asso-
ciated with malignancy in branch duct IPMN.
FOS245
PANCREATIC METASTASIS 
FROM RENAL CANCER CELL 
CARCINOMA – RESULTS OF 
SURGICAL MANAGEMENT
L. Schwarz1, E. Oussoultzoglou2, A. Sauvanet3, 
N. Regenet4, B. Gayet5, J.-F. Gigot6, J.-Y. Mabrut7 and 
J.-J. Tuech1
1Department of Digestive Surgery, Rouen University 
Hospital “Charles Nicolle”, Rouen, France; 2Department 
of Digestive Surgery and Liver Transplantation, Hôpital de 
Hautepierre, Strasbourg, France; 3Department of Digestive 
Surgery, Hôpital Beaujon, Clichy, France; 4Clinique de 
Chirurgie Digestive et Endocrinienne, IMAD, University 
Hospital Centre, Hotel Dieu, Nantes, France; 5Department 
of Digestive Diseases, Institut Mutualiste Montsouris, 
Paris, France; 6Department of Digestive Surgery, Saint-
Luc University Hospital, Louvain Medical School, 
Brussels, Belgium; 7Department of Digestive Surgery and 
Liver Transplantation, Hopital de la Croix-Rousse, Lyon, 
France
Introduction: Metastatic tumors to the pancreas from renal 
cell carcinoma are uncommon.
Surgical resection seems to allow prolonged survivals. 
This was suggested through series of clinical cases in 
the surgical literature. Here we retrospectively analysed sur-
gical and oncological data of a French clinical multicentric 
series.
Methods: A French multicentric register was performed by 
retrospective analysis of 60 patients undergoing pancreatic 
resection for renal cell carcinomas metastatic to the pancreas 
between May 1987 and June 2003. Interval from nephrec-
tomy, clinical presentation, other metastatic sites, surgical 
resection, recurrences and survival were evaluated.
Results: All patients underwent radical nephrectomy. The 
median interval from nephrectomy to detection of pancreatic 
metastasis was 10 months (range 0 to 25) with 3 patients who 
presented synchronous metastasis. The pancreas was the fi rst 
metastatic site in 82% of cases. In case of unique tumor 
(67%), the mean tumor size was 44 mm (range 10 to 250). 
Associated resection of extrapancreatic lesions was per-
formed for 9 patients, including liver (n = 3), colon (n = 3) 
and adrenal gland (n = 3). During a median follow up of 46 
months, 26 recurrences were observed 15 recurrences were 
identifi ed in the liver (n = 13), pancreas (n = 7), kidney (n = 
4) and lung (n = 7). The median overall survival and median 
recurrence free survival were respectively 46 and 23 months.
Conclusion: Renal cell carcinoma may be complicated by 
very late pancreatic metastasis. Extended clinical follow-up 
of patients with a medical history of RCC is recommended. 
An aggressive surgical management of single or multiple 
pancreatic metastasis, even in case of extrapancreatic disease, 
should be considered, and would provide a chance for long-
term survival.
FOS246




M. Koizumi, N. Sata, M. Taguchi, Y. Kaneda, A. Miki, 
K. Endo, A. Lefor and Y. Yasuda
Department of Surgery, Jichi Medical University School of 
Medicine, Tochigi, Japan
Introduction: Intraoperative contrast-enhanced ultrasonog-
raphy (ICEUS) has been shown to be useful mainly for liver 
surgery. Computed tomography (CT), magnetic resonance 
imaging and other imaging modalities may not be accurate 
to clearly demonstrate tumor invasion. It is sometimes dif-
fi cult to plan the optimal line of resection in pancreatic 
surgery. In this study, ICEUS for pancreatic tumors is 
evaluated.
Methods: We performed ICEUS in 20 patients with pancre-
atic surgery (11 carcinomas: n = 5-head, 6-body and tail), 4 
intraductal papillary mucinous neoplasm (IPMN: n = 3-head, 
1-head and body), 2 metastatic carcinomas (1-renal cell car-
cinoma, 1-lung cancer), 1 solid pseudo papillary neoplasm, 
and 1 neuroendocrine tumor (insulinoma). In 2 of 11 carci-
nomas (18%), 5 mm liver metastases were identifi ed by 
ICEUS, and resection was avoided. In the remaining 9 car-
cinomas, the resection margin of the tumor was clearly con-
fi rmed by ICEUS.
Results: In one case of carcinoma in the head, the pancreas 
was divided 2 cm from the tumor and the surgical margin 
was negative. In another case of carcinoma in the body, the 
pancreas was divided 1 cm from the tumor and the surgical 
margin was pathologically positive. An additional 5 mm 
resection was necessary to obtain a negative surgical margin. 
In the remaining 7 cases, the surgical margin was negative 
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dividing the pancreas more than 2 cm from the tumor. In 4 
IPMNs, papillary projections in the cystic lesion were 
enhanced by contrast-medium, but carcinoma could not be 
distinguished from an adenoma. One IPMN case was diag-
nosed as carcinoma in the fi nal pathological report.
Conclusion: Although an insulinoma was shown as a poorly 
enhanced tumor on preoperative CT, it was well-enhanced 
by ICEUS as a typical insulinoma fi nding. ICEUS provided 
valuable information for pancreatic surgery, evaluation of the 
tumor, surgical margin and detection for small liver metas-
tases not identifi ed preoperatively. More than a 1.5 cm surgi-
cal margin from a pancreatic carcinoma is necessary to 
obtain a microscopically negative margin.
FOS247
PRESENCE OF PANCREATIC 
INTRAEPITHELIAL NEOPLASIA IN THE 
PANCREATIC TRANSECTION MARGIN 
DOES NOT INFLUENCE OUTCOME IN 
PATIENTS WITH R0 RESECTED 
PANCREATIC CANCER
H. Matthaei1, S.-M. Hong2, M. Dal Molin2, 
C. L. Wolfgang2, J. L. Cameron2, R. D. Schulick2, 
A. Maitra2 and R. Hruban2
1University of Bonn, Bonn, Germany; 2Johns Hopkins 
University, Maryland, USA
Introduction: Margin status is one of the strongest prognos-
ticators after resection of pancreatic ductal adenocarcinoma 
(PDAC). The clinical signifi cance of pancreatic intraepithe-
lial neoplasia (PanIN) at a surgical margin has not been 
established.
Methods: A total of 208 patients who underwent R0 resec-
tion for PDAC between 2004 and 2008 were selected. 
Intraoperative frozen section slides containing the fi nal pan-
creatic parenchymal transection margin were evaluated for 
presence or absence, number, and grade of PanINs. Data 
were compared to clinicopathologic factors, including patient 
survival.
Results: PanIN lesions were present in margins in 107 of 
208 patients (51.4%). A total of 72 patients had PanIN-1 
(34.6%), 44 had PanIN-2 (21.1%), and 16 had PanIN-3 
(7.2%) at their margin. Overall median survival was 17.9 
(95% confi dence interval, 14–21.9) months. Neither the pres-
ence nor absence of PanIN nor histological grade had any 
signifi cant correlation with important clinicopathologic char-
acteristics. There were no signifi cant survival differences 
between patients with or without PanIN lesions at the resec-
tion margin or among patients with PanIN-3 (carcinoma in 
situ) versus lower PanIN grades. However, patients with R1 
resection had a signifi cantly worse outcome compared with 
patients without invasive cancer at a margin.
Conclusion: The presence of PanINs at a resection margin 
does not affect survival in patients who undergo R0 resection 
for PDAC. These results have signifi cant clinical implica-
tions for surgeons, because no additional resection seems to 




IMPROVES ANTITUMOR EFFECT OF 
GEMCITABINE ON PANCREATIC 
TUMOR BY AUTOPHAGY
N. Koshkina, K. Briggs, F. Palalon and S. Curley
Uiversity of Texas M.D. Anderson Cancer Center, Houston, 
TX 77030, USA
Introduction: Chemotherapy based on the use of gem-
citabine (GCB) for patients with pancreatic tumor has limited 
activity and needs further improvement. In this study we 
determined the feasibility of its combination with novel non-
invasive and non-ionizing radiofrequency (RF) treatment in 
a mouse model of orthotopic pancreatic adenocarcinoma and 
evaluated the mechanism of action of this combination 
therapy.
Methods: In vitro, Panc-1 cells were treated with different 
doses of GCB with or without RF exposure and examined 
for cytotoxicity using an apoptosis kit for fl ow cytometry. In 
vivo, mice with established Panc-1 orthotopic pancreatic 
tumors were treated weekly with 70 mg/kg GCB i.p. with or 
without RF. Tumors were measured at the end of experiment. 
Vital organs were collected for histopathological analysis. 
The mechanism of the treatment was studied using immuno-
histochemical staining of tumor cells and tissues with 
antibodies against Ki-67, cleaved caspase 3, LC3B, and 
CD31 with VEGF for proliferation, apoptosis, autophagy and 
angiogenesis, respectively. Electron microscopy was used 
to determine morphological changes in tumor cells after 
treatment.
Results: Addition of RF treatment to GCB inhibited the 
growth of orthotopic Panc-1 tumor in mice, whereas single 
treatments showed no antitumor effect. Immunohistochemical 
analysis confi rmed the decline of proliferating tumor cells in 
GCB + RF treated group versus groups receiving single 
treatment. No difference was noticed between treated groups 
after staining tumors for apoptosis and angiogenesis. Staining 
for autophagy revealed autophagosome formation in tumors 
receiving RF with the highest level in GCB + RF group. In 
vitro studies confi rmed autophagosomes present in Panc-1 
cells immediately after RF exposure, which was reversed 
after 48 h. Addition of subtoxic dose of GCB to RF pre-
vented recovery of tumor cells from autophagy leading to 
their death.
Conclusion: Our study for the fi rst time demonstrates the 
feasibility of adding new non-invasive RF treatment to the 
standard GCB-based chemotherapy for treating pancreatic 
cancer in situ. The treatment was well tolerated. The mecha-
nism of action suggests autophagy induction in tumor cells 
after RF exposure. Without additional treatment tumor cells 
recover from RF-induced autophagy, however addition of 
GCB prevents this recovery, eventually leading to the death 
of tumor cells.
 Free Orals Abstracts 213
© 2012 The Authors
HPB 2012, 14 (Suppl. 2), 107–287 HPB © 2012 Americas Hepato-Pancreato-Biliary Association
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INTERVENTIONAL RADIOLOGICAL 
MANAGEMENT OF PSEUDOANEURYSMS 
COMPLICATING PANCREATITIS
A. De Rosa1, D. Gomez1, G. Pollock2, P. Bungay2, 
M. De Nunzio2, R. Hall1 and P. Thurley2
1Department of Hepatobiliary Surgery and Pancreatic 
Surgery, Royal Derby Hospital, Derby Hospitals NHS 
Foundation Trust, Derby, UK; 2Department of Radiology, 
Royal Derby Hospital, Derby Hospitals NHS Foundation 
Trust, Derby, UK
Introduction: Pseudoaneurysms associated with pancreati-
tis are rare, and bleeding pseudoaneurysms have high associ-
ated mortality rates. The aim of this study was to evaluate 
the utilisation of endovascular embolisation and/or percuta-
neous thrombin injection in the management of pseudoaneu-
rysms complicating pancreatitis.
Methods: Patients with pseudoaneurysms secondary to pan-
creatitis who underwent angiography between April 2005 
and August 2011 were included. The medical notes were 
retrospectively reviewed. Twenty pseudoaneurysms measur-
ing a median of 15 (7–80) mm in 13 patients were identifi ed. 
The initial diagnosis was achieved on contrast computer 
tomography (CT, n = 4), CT angiogram (CTA, n = 7), duplex 
ultrasound (US, n = 1) and mesenteric angiogram (n = 1). 
The pseudoaneurysm was initially missed on the contrast CT 
of 3 patients and not visible for another 3 patients, one day 
before the correct diagnosis was made. All patients who had 
dedicated CTA had the correct diagnosis made.
Results: All 13 patients underwent mesenteric angiography. 
Coil embolisation was successful at fi rst attempt for 7 
patients (58%). The pseudoaneurysm had thrombosed spon-
taneously in one case and was technically inaccessible in 
another who subsequently underwent successful embolisa-
tion with percutaneous thrombin injection. Initial coil 
embolisation failed in 3 cases (25%); 2 patients had subse-
quent successful embolisation, and the third patient under-
went percutaneous thrombin injection which also failed. 
There were no episodes of re-bleeding or cases of surgical 
intervention. The post procedure morbidity rate was 25% (n 
= 3) and mortality rate was 8% (n = 1, pulmonary embolus), 
after a median follow-up of 20 (2–31) months.
Conclusion: CTA is an accurate investigation for the diag-
nosis of pseudoaneurysms. Endovascular embolisation is a 
suitable fi rst-line management strategy, and is associated 
with low re-bleeding rates.
FOS250
INDUCTION CHEMOTHERAPY 
FOLLOWED BY RADIATION THERAPY 
IS ASSOCIATED WITH BETTER 
SURVIVAL FOR PATIENTS WITH 
LOCALLY ADVANCED 
PANCREATIC CANCER
F. Faisal1, K. Olino2, A. De Jesus-Acosta1, 
B. Edil2, R. Schulick2, J. Herman3, C. Wolfgang2 
and L. Zheng1
1Department of Oncology, Johns Hopkins University 
School of Medicine, Baltimore, MD, USA; 2Department of 
Surgery, Johns Hopkins University School of Medicine, 
Baltimore, MD, USA; 3Department of Radiation Oncology, 
Johns Hopkins University School of Medicine, Baltimore, 
MD, USA
Introduction: Advanced pancreatic cancer has a poor prog-
nosis. At diagnosis, 80% of patients are unresectable; and 
among those unresectable, 40% of those are locally advanced. 
Currently, the standard treatment for locally advanced pan-
creatic cancer is not defi ned. We performed a retrospective 
analysis of patients treated at the Johns Hopkins Hospital 
(JHH) to assess the role of chemotherapy and radiation 
therapy for locally advanced pancreatic cancer.
Methods: A total of 1433 pancreatic cancer patients were 
seen at JHH between June 2006 and June 2010 and their 
medical records were reviewed. After excluding borderline 
resectable patients and patients who only had consultations 
at JHH, we identifi ed 67 patients who met the Society of 
Surgical Oncology diagnostic criteria for locally advanced 
pancreatic cancer and who were treated primarily at JHH. 
Clinical information from diagnostic CT scans, chemother-
apy and radiation therapy was collected. Overall survival 
(OS) and progression-free survival (PFS) were compared 
among different subgroups by Kaplan-Meier analysis. For 
the 67 patients (37% female, median age 62 y), median OS 
was 15.7 mo, median PFS 7.9 mo.
Results: Patients who received sequential treatment of full-
dose chemotherapy and radiation had a longer PFS than 
those who received radiation alone (12.0 vs. 4.5 mo, p < 
0.01) or those who received chemotherapy alone (12.0 vs. 
6.8 mo, p = 0.08), but there was no difference in their 
OS. Among patients receiving both therapies sequentially, 
patients who received chemotherapy fi rst had a signifi cantly 
longer OS and a trend toward better PFS than patients who 
received radiation fi rst (OS 18.1 vs. 11 mo, p = 0.03; PFS 
12.6 vs. 8.3 mo, p = 0.15). Patients who received 3 or more 
cycles of chemotherapy prior to radiation had a trend for 
better OS than patients receiving less than three cycles of 
chemotherapy (17.6 vs. 14.6 mo, p = 0.06).
Conclusion: Although treatment course including both che-
motherapy and radiation therapy is still favored, this study 
suggests that chemotherapy may play a more important role 
in the treatment of locally advanced pancreatic cancer. Our 
results support treating patients with induction chemotherapy 
for at least 3 cycles followed by consolidation with radiation 
therapy. These results need to be further validated in prospec-
tive clinical studies.
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FREY PROCEDURE IN PATIENTS WITH 
CHRONIC PANCREATITIS: SHORT AND 
LONG-TERM OUTCOME FROM A 
PROSPECTIVE STUDY
A. Roch1, E. Lermite1, P. Pessaux2 and J.-P. Arnaud1
1CHU Angers, 4 rue Larrey, 49933 Angers, France; 
2Hôpital de Hautepierre, 1 avenue Molière, 67098 
Strasbourg, France
Introduction: The aim of this prospective study was to 
analyze the short and long-term outcome of the Frey proce-
dure in the treatment of chronic pancreatitis and to determine 
if the results endured after 5 years.
Methods: From September 2000 to November 2009, 44 
consecutive patients underwent the Frey procedure. Patients 
were included in the study before surgery and followed 
prospectively at preset intervals with assessment of pain 
relief, weight gain and exocrine/endocrine insuffi ciency. 
Twenty-one patients (47.7%) were followed for longer than 
5 years. This study included 40 men (91%) and 4 women 
(9%) (mean age of 49 ± 6.8 years) with a mean follow-up 
time of 51.5 months. The primary etiology of chronic pan-
creatitis was chronic alcohol abuse in 38 patients (86.4%). 
The major indication for surgery was disabling pain 
(95.5%).
Results: There was no postoperative mortality. Postoperative 
morbidity occurred in 15 patients (34.1%), with specifi c sur-
gical complications in 11 patients (25%). The percentage of 
pain-free patients after surgery was 68.3%. Eight patients 
(18.1%) and 7 patients (16%) developed diabetes de novo 
and exocrine insuffi ciency, respectively. The Body Mass 
Index showed statistically signifi cant improvement during 
follow-up (p < 0.01). Similar benefi cial results concerning 
pain relief and weight gain persisted after the initial 5-year 
follow-up. A comparative subanalysis showed that endo-
scopic therapy was a predisposing factor for global, espe-
cially septic, complications (p = 0.035).
Conclusion: The Frey procedure is an appropriate, safe and 
effective technique for management of patients with chronic 
pancreatitis in the absence of neoplasia, based on short and 
long-term follow-up.
FOS252
EARLY NASOGASTRIC TUBE FEEDING 
VERSUS NIL-BY-MOUTH IN PATIENTS 
WITH MILD OR MODERATE ACUTE 
PANCREATITIS: A RANDOMIZED 
CONTROLLED TRIAL
M. Petrov, A. Phillips and J. Windsor
Department of Surgery, University of Auckland, New 
Zealand
Introduction: Early enteral tube feeding reduces morbidity 
and mortality in patients with severe acute pancreatitis (AP) 
and is a standard of care. It is hypothesized that early enteral 
feeding in patients with mild and moderate AP would 
improve tolerance of subsequent oral refeeding, promote 
intestinal motility and reduce the incidence of ileus. The 
study aim was to compare the safety, tolerance and effi cacy 
of early nasogastric tube feeding (NGF) versus NBM regimen 
in patients with mild and moderate AP.
Methods: A pilot randomized controlled trial in patients 
with mild and moderate AP was conducted between February 
2010 and March 2011. The severity of AP was defi ned on 
the basis of determinants-based classifi cation of severity [2]. 
The patients in the intervention group were NBM until NGF 
was commenced within 24 h of hospital admission and con-
tinued until the treating team decided to introduce oral food. 
The patients in the control group were kept NBM until the 
treating team decided to introduce oral food.
Results: There were 17 patients randomly allocated to NGF 
group and 18 to the NBM group. At baseline, the two groups 
did not have any signifi cant differences in terms of demo-
graphic, anthropometric, and laboratory data. The visual 
analogue pain score decreased to a signifi cantly greater 
extent in the NGF group (from median 9 (range 7–9) at 
baseline to 1 (0–3) at 72 h after randomization) compared 
with the NBM group (from 7 (5–9) to 3 (1–4) (p = 0.036). 
The number of patients not requiring opiates at 48 hours was 
signifi cantly different (p = 0.024) between NGF (9/17) and 
NBM (3/18). Oral feeding intolerance was observed in 1/17 
patient in the ETF group and 9/18 patients in the NBM group 
(p = 0.004).
Conclusion: NGF commenced within 24 h of hospital 
admission is safe and well tolerated in patients with mild and 
moderate acute pancreatitis. Further, when compared with 
NBM, it signifi cantly reduces the intensity and duration of 
initial abdominal pain, need for opiates, and risk of oral 
refeeding intolerance.
FOS253
EVALUATION OF CT ACCURACY TO 
DETERMINE RESECTABILITY 




J. Cortade1, C. Cassinotto1, G. Belleannée2, C. Laurent3 and 
A. Sa-Cunha4
1Department of Radiology, Hôpital Haut-Lévêque, 
Bordeaux Universitary Hospital Center, Bordeaux, France; 
2Department of Pathology, Hôpital Haut-Lévêque, 
Bordeaux Universitary Hospital Center, Bordeaux, France; 
3Department of Surgery, Hôpital Saint-André, Bordeaux 
Universitary Hospital Center, Bordeaux, France; 
4Department of Surgery, Hôpital Haut-Lévêque, Bordeaux 
Universitary Hospital Center, Bordeaux, France
Introduction: To evaluate the accuracy of CT scan for 
determination of resectability R0 after neoadjuvant therapy 
in patients with pancreatic head adenocarcinoma locally 
advanced.
Methods: From January 2005 to December 2010, 80 
patients with pancreatic head adenocarcinoma underwent 
multidetector CT before surgery. Of these, 38 patients 
received neoadjuvant therapy because tumor was considered 
locally advanced on baseline CT scan. We retrospectively 
correlated imaging interpretations with operative and histo-
logical data and compared results in patients without (control 
group) or with (neoadjuvant group) preoperative treatment.
Results: 41/42 patients in control group and 31/38 patients 
in neoadjuvant group fi nally had curative resection. While 
resection R0 is similar in both groups (83% and 81%), CT 
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accuracy in determining resectability R0 was signifi cantly 
decreased in neoadjuvant group (58% versus 83%). CT scan 
specifi city was signifi cantly lower after neoadjuvant therapy 
(52% versus 88% in control group) due to an overestimation 
of vascular invasion: 12/31 patients with complete resection 
in neoadjuvant group were evaluated at high risk of incom-
plete resection on CT scan. Tumor size tends to be underes-
timated in control group (−2 mm) and overestimated in 
neoadjuvant group (+10 mm). T-staging accuracy was 
decreased in neoadjuvant group (39% versus 78% in control 
group).
Conclusion: Neoadjuvant therapy signifi cantly decreases 
the accuracy of CT scan in determining T-staging and resect-
ability R0 of pancreatic head carcinoma. Overestimation of 
tumor size and vascular invasion signifi cantly reduces CT 
scan specifi city after preoperative treatment.
FOS254
SUPERIOR MESENTERIC VEIN (SMV) 
MARGIN POSITIVITY IN RESECTABLE 
PANCREATIC CANCER CORRELATES 
WITH HIGH SUPERIOR MESENTERIC 
ARTERY (SMA) MARGIN POSITIVITY; IS 
VEIN RESECTION ADVISABLE?
V. Siripurapu, E. Liu, A. Khithani, T. Winston and 
D. Jeyarajah
Methodist Dallas Medical Center, Dallas, TX, USA
Introduction: The purpose of this study was to examine the 
hypothesis that patients undergoing pancreaticoduodenec-
tomy (PD) for resectable pancreatic adenocarcinoma with 
positive SMV margin have a high rate of SMA positivity. If 
true, this would question the rationale for clearing the SMV 
margin with vein resection if the SMA margin will remain 
affected.
Methods: A pancreatic cancer database was reviewed to 
identify a single surgeon’s pancreaticoduodenctomies (PD) 
for pancreatic adenocarcinoma that are deemed resectable by 
NCCN guidelines. All patients had pancreatic protocol CT 
scans, Ca 19-9 levels and endoscopic ultrasound as possible. 
The patient’s characteristics, operative parameters and mor-
bidity/mortality were analyzed. Pathologic inking of PD 
specimen was performed with 4 colors to identify and spe-
cifi cally study the SMV and SMA margins.
Results: 97 patients underwent PD for resectable adenocar-
cinoma. Of the 97 patients, 20 patients had SMV positive 
margins (20.6%). Of these, 9 patients had positive SMA 
margins (45%). Comparing the SMA positive versus SMA 
negative margin groups who had SMV positivity, there was 
signifi cance in operative time suggestive of a more complex 
operation; 4.24 ± 0.70 hours for SMA positive and 3.6 ± 0.68 
hours for SMA negative (p < 0.05).
Conclusion: In resectable pancreatic cancer, there is still a 
high rate of SMV positivity. In our series this is nearly 20%, 
with 45% of these patients having additional SMA positivity. 
This suggests that vein resection is futile in these cases and 
that preoperative therapy may be necessary for this disease 






R. Cherif1, S. Gaujoux1, A. Couvelard2, M.-P. Vuillerme3, 
P. Ruzniewski4, J. Belghiti1 and A. Sauvanet1
1Department of Hepato-Pancreato-Biliary Surgery, Pôle 
des Maladies de l’Appareil Digestif (PMAD), AP-HP, 
Beaujon Hospital, Clichy, France; 2Department of 
Pathology, Pôle des Maladies de l’Appareil Digestif 
(PMAD), AP-HP, Beaujon Hospital, Clichy, France; 
3Department of Radiology, Pôle des Maladies de l’Appareil 
Digestif (PMAD), AP-HP, Beaujon Hospital, Clichy, 
France; 4Department of Gastroenterology, Pôle des 
Maladies de l’Appareil Digestif (PMAD), AP-HP, Beaujon 
Hospital, Clichy, France
Introduction: Pancreas-sparing pancreatectomy (PSP), 
including enucleation and central pancreatectomy, has been 
investigated as an alternative to standard resection (SR) for 
pancreatic endocrine neoplasm, but the benefi t-risk of these 
procedures remain little-known.
Methods: From 1998 to 2010, among 197 patients operated 
for well-differentiated pancreatic endocrine tumors, 67 
underwent PSP (22 central pancreatectomies and 45 enucle-
ations) and 66 SR (35 pancreaticoduodenectomies and 31 
distal pancreatectomies) for tumor below 4 cm in size, 
without synchronous distant metastasis. Groups were com-
pared regarding postoperative morbidity, mortality, long-
term pancreatic function, and survival calculated by the 
Kaplan Meier method.
Results: Tumors resected by PSP had a median size of 
15 mm, were mainly incidentally diagnosed (n = 46, 69%), 
and non-functioning (n = 55, 82%). Overall morbidity rate 
was higher after PSP than SR (76% vs 58%, p = 0.003), 
including more frequent pancreatic fi stulas (69% vs 42%, p 
= 0.003). Postoperative diabetes was less frequent following 
PSP than pancreaticoduodenectomy (5% vs 21%; p = 0.02) 
without any difference compared to distal pancreatectomy 
(p = 0.58). Exocrine insuffi ciency was signifi cantly less fre-
quent after PSP than SR (2% vs 32%; p < 0.0001). The 
overall and recurrence-free 5-year survival for patient with 
non-functioning tumors resected by PSP were 96% and 98% 
respectively.
Conclusion: In selected patients, with small and low-grade 
tumors, PSP is associated with an excellent postoperative 
pancreatic function, overall and recurrence-free survival, 
despite an increased postoperative morbidity. PSP should be 
considered as a valid option for treatment of selected well-
differentiated pancreatic endocrine tumors.
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NUTRITIONAL SUPPORT AFTER 
PANCREATICODUODENECTOMY: 
NASOJEJUNAL, JEJUNOSTOMY OR 
PARENTERAL FEEDING?
A. Gerritsen1, M. Besselink1, K. Cieslak1, M. Vriens1, 
E. Steenhagen2, R. van Hillegersberg1, I. B. Rinkes1 
and Q. Molenaar1
1Department of Surgery, University Medical Center 
Utrecht, The Netherlands; 2Department of Dietetics, Julius 
Center for Health Sciences and Primary Care, University 
Medical Center Utrecht, The Netherlands
Introduction: European nutritional guidelines recommend 
routine use of enteral feeding after pancreaticoduodenec-
tomy (PD) whereas American guidelines do not. Data on the 
effi cacy and, especially, complications of the various feeding 
strategies after PD are scarce. The aim of this study was to 
compare the effi cacy and complications of routine feeding 
after PD by nasojejunal tube (NJT), jejunostomy tube (JT) 
or total parenteral nutrition (TPN).
Methods: We performed a retrospective monocenter cohort 
study in 144 consecutive patients who underwent PD during 
a period wherein the routine post-PD feeding strategy 
changed twice. Patients not receiving nutritional support (n 
= 15) were excluded. Complications were graded according 
to the Clavien-Dindo classifi cation and the International 
Study Group of Pancreatic Surgery (ISGPS) defi nitions. 
Analysis was by intention-to-treat. Primary endpoint was the 
time to resumption of normal oral intake (TRNI).
Results: 129 patients undergoing PD were included (NJT = 
44, JT = 48, TPN = 37). Groups were comparable with 
respect to baseline characteristics, Clavien > I complications, 
in-hospital stay and mortality. There were no differences in 
TRNI (NJT/JT/TPN: median 13, 16 and 14 days, P = 0.15) 
and incidence of delayed gastric emptying (P = 0.30). Tube 
related complications occurred mainly in the NJT-group 
(34% dislodgement). In the JT-group, relaparotomy was per-
formed in three patients because of JT-leakage or strangula-
tion leading to death in one patient. Wound infections were 
most common in the TPN group (NJT/JT/TPN: 16%, 6% and 
30%, P = 0.02). A multivariable logistic regression analysis 
showed no difference between the strategies in morbidity or 
mortality.
Conclusion: None of the analysed feeding strategies was 
found superior with respect to TRNI, morbidity and mortal-
ity. Each strategy was associated with specifi c complications. 
Nasojejunal tubes dislodged in a third of patients, jejunos-
tomy tubes caused few but potentially life-threatening bowel 
strangulation and TPN doubled the risk of infections. Future 
studies should address the value of a postoperative oral diet 




COLONY STIMULATING FACTOR (GM-
CSF) PANCREAS TUMOR VACCINE IN 
COMBINATION WITH BLOCKADE OF 
PD-1 IN A PRECLINICAL MODEL OF 
PANCREATIC CANCER
K. Soares1, K. Olino1, B. Edil1, A. Leubner1, B. Salman1, 
E. Jaffee2, L. Zheng2 and R. Schulick1
1Department of Surgery, Johns Hopkins Hospital, 
Baltimore, MD; 2Department of Oncology, Johns Hopkins 
Hospital, Baltimore, MD
Introduction: Our phase I/II human clinical trials utilizing 
a GM-CSF secreting allogeneic pancreas tumor vaccine 
(GVAX) have been shown to be safe and effective in induc-
ing anti-tumor immune response in pancreatic adenocarci-
noma patients. GVAX treated patients have demonstrated 
infi ltration of PD-1+ T cells which is a major immunosup-
pressive mechanism in the tumor microenvironment. We 
hypothesized that the use of a PD-1 blocking antibody and 
GVAX will improve vaccine therapy and pancreatic cancer 
survival.
Methods: Mice were orthotopically transplanted with 2 × 
106 Panc02 pancreatic tumor cells to form liver metastases 
by a hemisplenectomy technique on day 0. Following tumor 
transplantation, wild-type or PD-1 knockout mice were 
treated subcutaneously with a mouse GM-CSF secreting 
pancreatic tumor vaccine (mouse GVAX) in combination 
with anti-PD-1 antibodies or IgG isotype control. GVAX was 
given subcutaneously to mice on days 4, 7, 14, and 21 fol-
lowing tumor transplantation, together with a single low-
dose of Cytoxan on day 3. Anti-PD-1 antibodies or IgG were 
administered twice weekly starting post-operative day 3.
Results: PD-1 knockout mice challenged with pancreatic 
liver metastases had a signifi cant survival advantage over 
wild-type mice (p = 0.0002). Wild-type mice showed 
improved survival both with anti-PD-1 antibody alone (p = 
0.008) or in combination with vaccine (p < 0.0001) versus 
IgG controls. GVAX in combination with anti-PD-1 antibod-
ies versus anti-PD-1 antibodies alone shows a statistically 
signifi cant improved survival (p < 0.05).
Conclusion: PD-1 blockade through monoclonal antibodies 
or genetic knockout in combination with vaccine result in a 
synergistic anti-tumor effect in a preclinical model of pan-
creatic cancer versus treatment with PD1 alone. Anti-PD-1 
blockade antibody is currently being tested in phase II clini-
cal trials for treating chemotherapy-refractory solid tumor 
patients. Our study provides a strong rationale for combining 
PD-1 antibody with GVAX therapy for pancreatic cancer 
treatment.
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FOS258
STUDY OF THE DEGREE OF TUMOR 
REGRESSION IN RESECTED 
ADENOCARCINOMA OF PANCREAS 
FOLLOWING A NEOADJUVANT 
TREATMENT (GEMCITABINE AND 
ABRAXANE). PREDICTIVE VALUE OF 
THE ENDOSONOGRAPHIC 
ELASTOGRAPHY
H. Duran1, B. Ielpo1, E. Diaz1, I. Fabra1, R. Puga1, 
J. C. Plaza2, Y. Quijano1 and E. Vicente1
1General and Digestive Surgery Service, Madrid 
Sanchinarro University Hospital, Madrid, Spain; 2Service 
of Pathology, Madrid Sanchinarro University Hospital, 
Madrid, Spain
Introduction: Mean patient survival after surgery of adeno-
carcinoma of pancreas range from 12 to 20 months. Neo 
adjuvant chemo-radiotherapy has not increased yet this 
overall survival rate; furthermore it is still controversial if 
radiotherapy improves pancreas resecability.
These poor results of neo adjuvant treatment could be due 
to the fact that the tissular area around pancreas cancer 
reduces adsorption of the anti tumoral drug. Endoscopic 
ultrasound can measure the thickness of pancreas tissue. It 
has been proved, on experimental surgical model of pancreas 
cancer, that overall mouse survival using gemcitabine alone 
or in combination with nab-placlitaxel (abraxane) increase 
form 60% to 100% respectively. Nowadays, this protocol has 
been approved for the treatment of metastasic pancreas 
cancer.
This essay provide our preliminary survival results of a 
prospective trial study in which patients with resecable 
cancer pancreas have been treated with a neo adjuvant com-
bination of Gemcitabine and Abraxane. Primary endpoints 
are: to show the tumor regression rate (TRR) after resection 
(Ryan escale) and to fi nd its relation with the tumor tissue 
elastography before and after the neo adjuvant treatment 
(VET).
Methods: We included prospectively 15 patients from 
March 2011 to December 2011. Untill now 7 patients under-
went surgery, one patient had sistemical progression of 
malignancy after treatment and 7 patients are waiting for 
surgery.
Results: The anatomo pathological results of the 7 specimen 
are: 1 well differentiate neuroendocrine tumor; 5 adenocar-
cinoma; 1 pan IN-2.
TRR/ %VET: case 1: TRR: 3 / VET: 70% of decrease; 
Case 2: TRR: 1 / VET: unchanged; Case 3: TRR: 1/ VET: 
62% of increase; Case 4: GRT: 1 / VET: unchanged; Caso 5: 
TRR: 1 / VET: 75% of decrease.
Conclusion: Neo adjuvant treatment combination of 
Gemcitabine and Abraxane showed effi cacy on 80% of the 
resected patients. Elastography measure of the tissue tumor 
during neo adjuvant treatment was not predictive of TRR. It 
has to be defi ne if this good pathological response will be 
ratify by overall survival rate increase.
FOS259
OUTCOME OF A SHORT TERM 
CHEMOTHERAPY IN STAGE III 
PANCREATIC CARCINOMA: 
A SELECTION FOR LOCAL 
ABLATIVE TREATMENT?
I. Frigerio1, A. Giardino1, R. Girelli1, P. Regi1, 
R. Salvia2 and C. Bassi2
1Hpb Surgical Unit, Pederzoli Clinic, Peschiera Del 
Garda; 2Surgical and Oncological Department, University 
of Verona
Introduction: Systemic chemotherapy (CHT) with neoadi-
uvant intent in stage III pancreatic cancer (PC) aims to 
achieve resecability in CHT responders patients. Same stage 
of disease can be treated with a local ablative therapy (RFA). 
In our series of RFA done as fi rst treatment we observed 15% 
of early progression and therefore those patients could not 
take advantage from a local therapy. We aim to evaluate the 
effect of a short CHT in stage III PC to identify those patients 
eligible for RFA.
Methods: All patients with a diagnosis of Stage III ductal 
carcinoma were eligible for the study. In all cases stadiation 
was obtained by CT scan or MRI and CEUS. They were all 
sent to oncologist with a planned re-evaluation after 3 months 
of CHT chosen by the oncologist. Re-staging was performed 
with CT scan and Ca19.9 serum marker. Local or systemic 
progression, stable disease or partial response were the three 
possible event. Depending on re-staging each patient was 
addressed to the most appropriate treatment: surgical explo-
ration for resection or RFA, CHT or palliative medical 
therapy.
Results: 65 patients met the requested criteria. Forty-two 
pts received venous CHT. Three pts died during therapy. 
After 3 months 45% of pts had progression of disease (local 
in 25% and distant in 20%); 31% had stable disease and 18% 
had radiological downstaging. RFA was performed in 65% 
of patients with stable disease and in 30% of patients with 
downstaging whereas resection was conducted in 6% and 
50% of the two groups respectively. All patients who received 
RFA were then treated CHT and external RT. Median sur-
vival of CHT responders undergone to RFA is 19 months 
(IQR 15.75–20.75) and at this time 29% of them are alive 
with controlled disease 19 months after diagnosis. No early 
progressions were observed in this subgroup of patients.
Conclusion: A short term CHT may help to identify those 
patients who can benefi t of a local ablative treatment. In our 
series of patients we observed a high rate of early progression 
within 3 months after RFA due to aggressive biology of 
disease of occulted micrometastasis: these patients could not 
benefi t from local ablation. On the other side, the CHT 
responders who underwent RFA showed a favorable progno-
sis, 19 months survival, signifi cantly higher than data 
reported in literature for same stage of disease.
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MODIFIED DPPHR (DUODENUM-
PRESERVING RESECTION OF THE 
HEAD OF THE PANCREAS) FOR THE 
LOW GRADE MALIGNANT LESION IN 
THE PANCREAS HEAD
T. Tsuchikawa, S. Hirano, E. Tanaka, J. Matsumoto, 
K. Kato, T. Noji and T. Shichinohe
Department of Gasroenterological Surgery II, Hokkaido 
University Graduate School of Medicine, Japan
Introduction: We have been conducting DPPHR for the 
low grade malignant lesion located in the pancreatic head. 
However higher postoperative complications such as pancre-
atic fi stula are concerned. To avoid these complications we 
have recently modifi ed DPPHR, resecting total parenchyma 
of the pancreatic head including groove area. The aim of this 
study was to investigate outcomes in terms of postoperative 
complications and disease control.
Methods: 21 patients underwent DPPHR between 1994 and 
2011. Of them we retrospectively divided patients into two 
groups, conventional DPPHR group (cDPPHR) which 
includes the patients who underwent incomplete pancreatic 
parenchymal resection and modifi ed DPPHR group 
(mDPPHR). We statistically compared these 2 groups regard-
ing for the perioperative factors, especially those related to 
the postoperative complications.
Results: 21 patients consisted of 15 intraductal papillary 
mucinous neoplasms, 2 endocrine tumors, 2 serous cystic 
neoplasms and others. The median age was 61 (23–77) years 
and median follow up period was 51 months. There was 
statistically no signifi cant difference between these 2 groups 
in the operation time. However intra-operative blood loss 
and period of hospital stay was signifi cantly smaller in the 
mDPPHR. The rate of clinically relevant pancreas related 
complications remarkably decreased after technical modifi -
cation compared with that of the previous period (7/8 (88%) 
in cDPPHR and 2/13 (15%) in mDPPHR, P = 0.0022). The 
postoperative mortality rate was 0% in both groups. For the 
neoplastic lesions, surgical margin was negative in all cases.
Conclusion: For the low grade malignant lesion, modifi ed 
DPPHR may provide clinical benefi ts of signifi cant radical-
ity and less invasiveness at the same time.
FOS261
EXPRESSION OF Β-CATENIN AND 
AXIN-1 IN SOLID PSEUDOPAPILLARY 
NEOPLASMS OF THE PANCREAS
C.-H. Liao1, T.-C. Chen2 and T.-S. Yeh3
1Department of Surgery, Chang Gung Memorial Hospital, 
Chang Gung University, Taipei; 2Department of Pathology, 
Chang Gung Memorial Hospital, Chang Gung University, 
Taipei; 3Department of Surgery, Chang Gung Memorial 
Hospital, Chang Gung University, Taipei
Introduction: Solid pseudopapillary neoplasm (SPN) is a 
distinct pancreatic neoplasm and has characteristic, aberrant 
nuclear expression of Beta-catenin in most cases. However, 
alterations in components of the Wnt pathway, other than the 
Bate-catenin (CTNNB1) gene mutation, have not been iden-
tifi ed. In this study, we investigated the status of Axin-1, the 
spectrum of mutations in the CTNNB1 gene, and the clini-
copathological features of SPNs.
Methods: We collected 27 SPNs from 25 patients. A tissue 
microarray was constructed to perform immunohistochemis-
try for Bate-catenin, E-cadherin, and Axin-1. The CTNNB1 
and AXIN1 gene mutations were analyzed by DNA sequenc-
ing. Finally, the clinicopathological features of SPNs were 
analyzed for association with the CTNNB1 mutations and 
the Axin-1 alterations.
Results: All 27 SPNs expressed nuclear immunoreactivity 
of Bate-catenin and exhibited a lack of membranous decora-
tion of E-cadherin. All SPNs harbored CTNNB1 gene muta-
tions. No alterations were present in the AXIN1 gene, and 
the immunohistochemical analysis revealed weak or absent 
reactivity of Axin-1 in the cytosol. All cases with a codon-37 
CTNNB1 mutation had weak Axin-1 immunoreactivity in 
the cytoplasm (P = 0.018).
Conclusion: Nuclear Bate-catenin immunoexpression is 
characteristic for SPNs and corresponds to the CTNNB1 
mutation. The Wnt pathway is involved in the tumorigenesis 
of SPNs, primarily through the alteration of Bate-catenin. 
Despite the absence of any identifi able genetic mutation, a 
low level of Axin-1 in the cytoplasm might contribute to the 
aberrant distribution of Bate-catenin in SPNs.
FOS262
ENHANCED RECOVERY AFTER 
PANCREATIC SURGERY: A SYSTEMATIC 
REVIEW AND META-ANALYSIS
M. Coolsen1, R. van Dam1, A. van der Wilt1, K. Slim2, 
K. Lassen3 and K. Dejong1
1University Hospital Maastricht, Maastricht, The 
Netherlands; 2CHU Estaing, Clermont-Ferrand, France; 
3University Hospital Northern Norway, Norway
Introduction: In the past decade Enhanced Recovery After 
Surgery (ERAS) protocols have been implemented in several 
fi elds of surgery. With these protocols, a faster recovery and 
shorter hospital stay can be accomplished without an increase 
in morbidity or mortality. The aim of this study was to sys-
tematically review the evidence for implementation of an 
ERAS protocol in pancreatic surgery.
Methods: A systematic search was performed in Medline, 
Embase, Pubmed, CINAHL and the Cochrane library for 
papers describing an ERAS programme in adult patients 
undergoing elective pancreatic surgery published between 
January 1966 and December 2010. The primary and second-
ary outcome measures were postoperative length of stay, 
overall post-operative complication rates, re-admissions and 
mortality. Subsequently a meta-analysis of outcome mea-
sures was conducted. This systematic review and meta-
analysis was performed according to the PRISMA 
statement.
Results: Seven out of 152 papers met the predefi ned inclu-
sion criteria. Only two of the studies reported data on dis-
charge criteria and assessed time to recovery and return to 
normal function. Implementation of an ERAS protocol led 
in four out of fi ve comparative studies to a signifi cant 
decrease in length of stay. Meta-analysis showed there was 
a signifi cant difference in complication rates in favour of the 
ERAS group (risk difference 9.8%, 95% CI 3.8–15.9). 
Introduction of an ERAS protocol did not result in an increase 
in mortality. Delayed gastric emptying and incidence of 
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pancreatic fi stula did not differ signifi cantly between groups. 
All studies reporting on hospital costs showed a decrease 
after implementation of ERAS.
Conclusion: This systematic review and meta-analysis 
shows a shorter hospital stay can be achieved by using an 
ERAS protocol in pancreatic surgery without compromising 
morbidity and mortality. Data on discharge criteria and 
recovery to normal function are lacking in most of the 
studies.
FOS263
THE IMPACT OF MFG-E8 IN CHRONIC 
PANCREATITIS: POTENTIAL TARGET 
FOR FUTURE IMMUNOTHERAPY?
J. G. D’Haese1, I. E. Demir1, T. Kehl1, N. A. Giese2, 
T. Giese3, M. W. Büchler2, H. Friess1 and G. O. Ceyhan1
1Department of Surgery, Klinikum Rechts der Isar, 
Technische Universität München, Munich, Germany; 
2Department of General Surgery, University of Heidelberg, 
Heidelberg, Germany; 3Institute for Immunology, 
University of Heidelberg, Heidelberg, Germany
Introduction: The glycoprotein MFG-E8 mediates phago-
cytic clearance of apoptotic cells and infl uences the patho-
genesis and progression of infl ammatory diseases. MFG-E8 
was shown to attenuate the progression of infl ammation and 
improved survival in septic rats. Accumulating evidence sug-
gests an immunomodulatory link between MFG-E8 and the 
pro-infl ammatory chemokine fractalkine, which may deter-
mine the severity of pain, fi brosis, and infl ammation in 
chronic pancreatitis (CP).
Methods: The expression and localization of MFG-E8 was 
investigated in CP (n = 67), and normal pancreas (NP; n = 
34) by QRT-PCR, Western-blot and immunohistochemistry 
analyses. Results were correlated with mRNA expression of 
fractalkine, CX3CR1, and with the degree of pain and fi bro-
sis. Human pancreatic stellate cells (hPSCs) were isolated 
from CP tissues and evaluated for MFG-E8 mRNA expres-
sion after fractalkine stimulation.
Results: MFG-E8-mRNA was signifi cantly overexpressed 
in CP and isolated hPSCs when compared to NP. Western-
blot and immunohistochemistry analysis confi rmed accumu-
lation of MFG-E8 in chronic pancreatitis with noticeably 
increased MFG-E8 immunoreactivity in tubular complexes 
and infl ammatory cells. MFG-E8 expression correlated sig-
nifi cantly with fractalkine expression, the degree of fi brosis, 
and the severity of pain in CP patients. Stimulation of hPSCs 
with fractalkine lead to a signifi cant increase in MFG-E8 
expression.
Conclusion: We demonstrated for the fi rst time that MFG-E8 
is signifi cantly up-regulated in CP patients. Together with 
fractalkine it correlated with the degree of fi brosis and the 
severity of pain. hPSCs overexpress MFG-E8 upon fractal-
kine stimulation, which may be a key mechanism in CP 
fi brogenesis and pain generation. These novel fi ndings dem-
onstrate that MFG-E8 blockade seems to be a promising tool 
for future immunotherapy in CP to attenuate both severity of 
fi brosis and pain.
FOS264
RELATIONSHIP BETWEEN R0 
RESECTION AND TUMOR 
CHARACTERISTICS VERSUS VOLUME 
OF PANCREATICODUODENECTOMY IN 
A NATIONWIDE PATHOLOGY 
DATABASE
V. Onete1, M. Besselink1, C. Van Eijck2, O. Busch3, 
D. Gouma3, R. Porte4, K. Dejong5 and Q. Molenaar1
1Department of Surgery, University Medical Center 
Utrecht, Utrecht, The Netherlands; 2Department of Surgery, 
Erasmus Medical Center, Rotterdam, The Netherlands; 
3Department of Surgery, Academic Medical Center, 
Amsterdam, The Netherlands; 4Department of Surgery, 
University Medical Center Groningen, Groningen, The 
Netherlands; 5Department of Surgery, University Medical 
Center Maastricht, Maastricht, The Netherlands
Introduction: It has been shown that centers with a high 
volume of pancreaticoduodenectomies (PD) have improved 
postoperative outcome and increased survival. The pro-
longed survival may be partially explained by higher R0 
resection rates in high volume centers, but in contrast, these 
centers are supposed to operate more advanced tumors.
Methods: The pathology reports of all PD’s (n = 1877) 
carried out in the period 2004–2009 for malignant and pre-
malignant tumors in the Netherlands were collected from a 
nationwide pathology database (PALGA). The year of 
surgery, histology, radicality, tumor diameter and differentia-
tion were collected. R0 resection was defi ned as tumor nega-
tive resection margins. Centers were classifi ed as high 
volume if they performed at least 20 PD’s per year (2009: n 
= 9 high volume, n = 23 low volume). The primary endpoints 
were the relationship between R0 resection and tumor char-
acteristics versus operation volume. Secondary endpoints 
were trends in time and quality of pathology reports.
Results: In high volume centers, more R0 resections were 
obtained in patients with pancreatic head tumors (55% vs 
48%, P = 0.04) and, in all tumor types, more T3/T4 tumors 
(65% vs 54%, P = 0.001) and more poorly differentiated 
tumors (31% vs 25% P = 0.001) were operated.
In the period 2004–2009, the number of PD’s performed 
for malignant tumors increased by nearly 50% (from 274 to 
409). This trend can be explained partly by an increase in the 
number of T3/T4 tumors operated in high volume centers 
(73% in 2009 vs 60% in 2004, P = 0.03) without an increase 
in low volume centers. Pathology reports of low volume 
centers more often lacked essential data such as tumor stage 
(24% vs 14%, P = 0.001) and tumor diameter (26% vs. 19%, 
P = 0.001).
Conclusion: High volume centers achieved higher rates of 
R0 resections although they resected more advanced tumors. 
Essential data were more often missing in pathology reports 
from low volume centers. Pathology reports should be stan-
dardized to minimize the risk of missing data. The 50% 
increase in PD’s performed in the Netherlands in recent years 
is partly explained by an increase in resections for T3/T4 
tumors in high volume centers.
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PANCREATIC ADENOCARCINOMAS 
ARISING ON THE BACKGROUND OF 
PANCREATIC CYSTIC DISEASE HAVE 
A BETTER OUTCOME THAN 
POOR OUTCOME
G. Morris-Stiff, G. Falk, S. Chalikonda and 
R. M. Walsh
Section of Surgical Oncology/HPB, Cleveland Clinic, 
Cleveland, USA
Introduction: Pancreatic adenocarinoma has a poor prog-
nosis with a reported 5-year survival of <5%, however, this 
general fi gure does not differentiate ductal adenocarcinoma 
from adenocarcinomas arising within a background of pan-
creatic cystic disease. The aim of this study was to report 
long-term survival rates in patients with ductal adenocarci-
noma and compare them to carcinomas arising in cystic 
disease and to those originating from the endocrine 
pancreas.
Methods: Frequency and follow-up data was obtained from 
The National Cancer Institute’s Surveillance, Epidemiology, 
End Results (SEER) database for the period 1973–2006. The 
survival of patients with ductal adenocarcinoma (ICD 
[International classifi cation of disease] codes: 8010, 8140–
8147, 8500) were compared to: adenocarcinoma in IPMN 
(ICD: 8453); mucinous cystadenocarcinoma (ICD: 8470–
8471); endocrine/islet cell carcinoma (8240–8249, 8150–
8157); and mucinous adenocarcinoma 8480–8481). 
Carcinomas classifi ed as malignant neoplasms and those of 
other histopathological subtypes were excluded.
Results: During the period February 1998 to December 
2008, 127,295 patients were identifi ed of which 111,714 
were within the remit of the study. Adequate data to perform 
survival analysis was available for 92,911 cases. 5-yr 
Survival for carcinomas arising in IPMN carcinomas (44%) 
and mucinous cystadenocarcinomas (34.1%) were superior 
to that of standard adenocarcinomas (2.3%) or mucinous 
adenocarcinomas (2.8%) [p<0.001] for each, with survival 
of carcinomas of endocrine origin being similar to that of 
cystic lesion carcinomas (36.7%) [p = 0.38].
Conclusion: It is evident that survival of patients with car-
cinoma arising in this setting is superior and thus all patients 
with a mucinous cystic neoplasm should be referred for a 
surgical opinion.
FOS266
TOTALLY ISOLATED ROUX-EN-Y 
RECONSTRUCTION AFTER 
PANCREATICODUODENECTOMY: FIRST 
RESULTS OF THE SINGLE CENTER 
RANDOMISED TRIAL
I. Shchepotin, A. Lukashenko, O. Kolesnik, 
V. Priymak and D. Rozumiy
National Cancer Institute, Abdominal Oncology, Kiev, 
Ukraine
Introduction: Pancreaticoduodenectomy is associated with 
a high rate of postoperative complications and morbidity. 
Pancreatic anastomotic failure remains among the most 
common and potentially lethal postoperative complications 
of pancreaticoduodenectomy. Use of a Roux-en-Y loop for 
reconstruction of pancreatic drainage is a technique that has 
been suggested to reduce pancreatic anastomotic leakage 
related morbidity and mortality in patients undergoing 
pancreaticoduodenectomy.
Methods: A randomizing trial was started in 2009 and now 
involving 34 patients who underwent pancreatic head resec-
tions. Reconstruction of the pancreatic remnant was done 
using a single loop (SL) in 15 patients and by an original 
technique – totally isolated Roux-en-Y loop`s (TIR) in 19 
patients. Our reconstructive method aims at a complete sepa-
ration of passage of gastric contents, bile and pancreatic 
juice. Thus we prevent any types of possible refl uxes and 
related complications (pancreatic leakage, cholangitis, Â 
gastric ulceration). All pancreatic anastomosis were per-
formed as a duct to mucosa anastomosis, in two layers, 
without pancreatic stent. Pancreatic fi stula was defi ned as 
drainage of greater than 50 ml of amylase fl uid on or after 
day 5.
Results: TIR was associated with a reduction of the inci-
dence of pancreatic anastomotic leak (SL, 31.8%; TIR, 
15.7%; p < 0.05), reduction of the required postoperative 
interventional radiology procedures (SL, 22.7%; TIR, 5.2%; 
p > 0.05). There is no incidents of postoperative cholangitis 
in TIR group (SL, 22.7%). Developed technique was accom-
panied by slight prolongation of the operative time (SL, 4.40 
± 1.20 h; TIR, 4.10 ± 1.11 h).
Conclusion: We found that TIR is associated with a reduc-
tion in morbidity after pancreaticoduodenectomy for pancre-
atic adenocarcinoma compared with SL. Results at the 
beginning of the study are very promising.
FOS267
IMPORTANCE OF HISTOLOGICAL 
SUBTYPING OF PERIAMPULLARY 
CANCER
N. Kumari, R. Singh, K. Prabha and N. Krishnani
Sanjay Gandhi Post Graduate Institute of Medical 
Sciences, Lucknow, India
Introduction: The term periampullary carcinoma is used 
for a heterogeneous group of tumors that are often diffi cult 
to classify with certainty. Another alternative is to classify 
periampullary tumours based on morphologic criteria and 
certain immunohistochemical (IHC) markers on histology 
into intestinal (I) or pancreatobiliary (PB) types. I type 
tumours have been shown to have favorable prognosis com-
pared to PB type. We aimed to study these histologic sub-
types and their clinicopathological correlation.
Methods: All patients (n = 109) with periampullary adeno-
carcinoma who underwent pancreaticoduodenectomy over a 
3 year period were the subjects of the study (ampullary – 
83.4%, pancreas – 8.2%, bile duct – 5.5% and duodenal 
adenocarcinoma – 2.7%). Two experienced pathologists his-
tologically classifi ed into I, PB and other types initially based 
on microscopic morphological criteria only. Then the same 
patients were reclassifi ed based on combination of micro-
scopic morphology and immunohistochemical markers 
(CDX2, MUC2, MUC1 and CK17). These groups were then 
correlated with various clinicopathological factors to ascer-
tain the value of each classifi cation using Chi square and 
Kaplan Meir tests.
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Results: Using microscopic morphologic criteria, 42 & 54 
cases were classifi ed as I & PB type respectively. Upon 
reclassifi cation using a combination of IHC and microscopic 
morphological criteria, 48 cases were classifi ed as I type and 
50 cases as PB type. Using morphologic classifi cation, I type 
were of a lower grade (81%), lesser stage (90% stage I & II), 
had a lower incidence of perineural (19%) and lymphovas-
cular invasion (4.7%) and nodal metastasis (31%). 
Reclassifi cation of cases did not make any difference to the 
correlation to these factors. However, classifi cation without 
using IHC showed a better difference in median survival 
(I and PB type – 30 and 13 months, p = 0.03) than reclas-
sifi cation using IHC (I and PB types – 28 and 16 months, 
p = 0.15).
Conclusion: Periampullary carcinoma can be classifi ed into 
intestinal and pancreatobiliary types using microscopic mor-
phologic criteria. This shows a good correlation with clini-
copathologic factors and survival. Intestinal type cases have 
a better prognosis and survival. In the present study, immu-
nohistochemical staining does not add much to the classifi ca-
tion and its role needs to be studied further.
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NATIONWIDE HOSPITAL MORTALITY 
AFTER PANCREATIC RESECTION
S. Jo1, H.-J. Lee1 and S. Park2
1Department of Surgery, Dankook University College of 
Medicine, South Korea; 2Department of Nursing, Hoseo 
University, Asan, South Korea
Introduction: High-volume hospitals were reported to have 
better outcome after pancreatic resection. This study was 
performed to analyze volume-outcome relationship after 
pancreatic resection for periampullary, pancreatic, and peri-
pancreatic tumors in Korea using the nationwide database.
Methods: We retrospectively analyzed 6,836 patients who 
underwent pancreatic resection including pancreaticoduode-
nectomy (PD) between Jan. 2005 and Dec. 2008 from data-
base of the Health Insurance Review and Assessment Service. 
Total 145 participating hospitals were divided into quintiles: 
very-low, low, medium, high, and very-high. Hospital mor-
tality, which was defi ned as death during the hospital stay 
for pancreatic resection, was used as quality indicator. 
Several risk factors were analyzed for hospital mortality. 
Adjusted hospital mortality was calculated by adjusting con-
founder factors through multivariate logistic regression.
Results: The overall hospital mortality after pancreatic 
resection was 2.2% in Korea. The observed hospital mortal-
ity of each volume category, ranging from 0.7% to 4.6%, 
showed signifi cant volume-outcome relationship after pan-
creatic resection (P < 0.001). This mortality was also higher 
in the medical aid group (P = 0.018) and in the classical PD 
patients (P < 0.001). Average age of mortality group was 
higher than that of the other survived patients (P < 0.001). 
Through multivariate logistic regression, only hospital surgi-
cal volume and age were proved to be independent factors 
for hospital mortality. The adjusted hospital mortality rates 
showed similar difference with the observed mortality rates 
between volume categories.
Conclusion: The higher-volume hospitals were clarifi ed to 
show lower hospital mortality after pancreatic resection for 
periampullary, pancreatic, and peripancreatic tumors through 
nationwide database. The overall hospital mortality was 
2.2% and hospital volume and age were independent risk 
factors for hospital death.
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PATTERN AND CLINICAL PREDICTORS 
OF LYMPH NODE INVOLVEMENT IN 
PANCREATIC NEUROENDOCRINE 
TUMORS (PANNETS)
S. Partelli1, R. Cherif2, L. Bonisegna1, S. Gaujoux2, 
A. Couvelard3, A. Sauvanet2, P. Ruszniewski4 and 
M. Falconi1
1Department of Surgery, University of Verona, Verona, 
Italy; 2Department of HPB Surgery, PMAD, Hopital 
Beaujon, Clichy, AP-HP; 3Department of Pathology, 
Hopital Beaujon, Clichy, AP-HP; 4Department of 
Gastroenterology and Pancreatology, PMAD, Hopital 
Beaujon, Clichy, AP-HP, France
Introduction: Pancreatic neuroendocrine tumors (PanNETs) 
are often indolent neoplasms without pathological lymph 
node (LN) metastasis (pN1). Therefore, in patients with low 
risk of pN1, surgery can be limited and lymphadenectomy 
could be avoided. The aim of the study was to construct a 
model for predicting the risk of pN1 prior to surgical 
resection.
Methods: The combined prospective databases from the 
Surgical Department of the University of Verona and the 
Beaujon Hospital were queried. Clinical and pathological 
data of all patients with resected (R0 or R1), pathologically 
confi rmed nonfunctioning PanNET between 1993 and 2009 
were retrospectively reviewed. Multiple logistic regression 
analysis was performed.
Results: Data were analyzed for 194 patients. Metastases 
were present in the dissected LNs of 58 patients (30%). The 
5-year disease free survival for patients with pN1 was sig-
nifi cantly lower than for those without nodal metastases 
(66% vs 93%, P < 0.0001). Multivariable analysis suggested 
the signifi cant independent factors associated with pN1 were 
radiological nodal status (rN) (odds ratio [OR] 5.01, P < 
0.0001) and the degree of differentiation (G2 vs G1 OR 4.44, 
P = 0.001) (fi rst model). Overall, the 94% of patients with 
rN0 PanNET-G1 were pN0. When the degree of differentia-
tion was excluded, the radiological size >4 cm (OR 2.5, P = 
0.012) was an independent predictor of pN1 (second model).
Conclusion: Patients with PanNET-G1, in the absence of 
radiological node involvement, have a very low risk of pN1. 
When a preoperative cytological diagnosis is not achieved, 
the radiological size of the lesion is a powerful alternative 
predictor of pN1. The analysis demonstrates that the risk of 
pathological nodal involvement in PanNET patients can be 
estimated by a clinical predictive model.
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LONG-TERM OUTCOMES OF 
PANCREATICODUODENECTOMY IN 
PATIENTS WITH PERIAMPULLARY 
ADENOCARCINOMA
S. Hata, K. Shimada, S. Oguro, Y. Kishi, S. Nara, 
M. Esaki and T. Kosuge
Hepatobiliary and Pancreatic Surgery Division, National 
Cancer Center Hospital, Tokyo, Japan
Introduction: Periampullary tumors include carcinomas of 
the pancreatic head, distal bile duct, duodenum and ampulla 
of Vater. All these tumors were treated with pancreticoduo-
denectomy in general. As a prognostic factor of these tumors, 
perineural growth and lymph node ratio have been discussed 
recently. We investigated the long-term outcomes and prog-
nostic factors including perineural growth and lymph node 
ratio in patients with carcinomas of different sites treated 
with the same surgical procedure.
Methods: Between January 1998 and December 2008, a 
total of 406 patients with periampullary adenocarcinoma 
underwent pancreaticoduodenectomy at our institution. Data 
of these patients were retrieved from our prospective data-
base. Their clinicopathological data (age, gender, tumor loca-
tion, preoperative biliary stent, pylorus preservation, tumor 
size, differentiation, lymph node metastases, lymph node 
ratio, pancreas invasion, perineural growth, vascular inva-
sion, lymphatic invasion, residual tumor status) were 
reviewed and analyzed in a multivariate analyses.
Results: There were 258 patients with pancreatic head car-
cinoma, 60 with distal bile duct carcinoma, 28 with duodenal 
carcinoma, and 60 with ampullary carcinoma. Median fol-
low-up time was 26 months. The overall 5-year survival rate 
was 22.3%, 51.7%, 65.9%, and 73.4%, respectively. The 
30-day mortality rate was 0.5% (n = 2). Patients with pan-
creatic head carcinoma had signifi cantly poorer survival 
compared with the other three carcinomas (p < 0.001). In 
multivariate analyses of three carcinomas except for pancre-
atic head carcinoma, lymph node ratio >0.1 (p = 0.0057), 
pancreas invasion (p = 0.0445), and positive surgical margin 
(p = 0.0432) were independent predictors for poor survival. 
Location of the primary site was not a signifi cant factor.
Conclusion: Pancreatic head carcinoma had the worst prog-
nosis among 4 tumors of periampullary lesion. The other 
three tumors such as distal bile duct carcinoma, duodenal 
carcinoma, and ampullary carcinoma had comparatively 
better prognosis. Among these three tumors, not the tumor 
location but lymph node ratio, pancreas invasion, and resid-
ual tumor status would be a useful predictor for survival.
FOS271
ROBOT-ASSISTED PANCREATIC 
SURGERY: A SYSTEMATIC REVIEW OF 
THE LITERATURE
M. Strijker, H. C. van Santvoort, M. G. H. Besselink, 
R. van Hillegersberg and I. Quintus Molenaar
Department of Surgery, University Medical Center Utrecht, 
Utrecht, The Netherlands
Introduction: Pancreatic surgery is technically demanding. 
To potentially improve outcome, robot-assisted pancreatic 
surgery has been introduced. Robot-assisted surgery has 
possible advantages over laparoscopic surgery, such as 
3-dimensional vision and increased freedom of instruments. 
Several centers have now adopted robot-assisted pancreatic 
surgery. We performed the fi rst systematic review to assess 
the safety and feasibility of robot-assisted pancreatic 
surgery.
Methods: We systematically reviewed the literature pub-
lished up to September 30th 2011, according to the PRISMA 
guidelines. Only studies reporting a cohort of at least 5 
patients undergoing robot-assisted pancreatic surgery were 
included. Exclusion criteria were review articles, animal 
studies, and conference abstracts. Data on baseline charac-
teristics, details of the procedures and clinical outcomes were 
extracted and analyzed.
Results: After screening 499 studies, 9 series, reporting on 
260 patients undergoing robot-assisted pancreatic surgery, 
were included. All were retrospective observational cohort 
studies. Types of resection included pancreaticoduodenecto-
mies (PD) (n = 131) and distal pancreatectomies (n = 85). 
Average operation time ranged from 236 to 719 minutes 
(420–719 minutes for PD only) and average blood loss from 
20 to 372 millilitres. 10% of the robotically started opera-
tions were converted to open surgery (17% for PD). Morbidity 
was 30%, mainly pancreatic leaks (21% of all patients). 
Mortality was 1.5%. Average hospital stay ranged from 4 to 
22 days. Five series (n = 127) reported on surgical margin 
status; negative margins were obtained in 93% of the patients.
Conclusion: Robot-assisted pancreatic surgery seems to be 
safe and feasible in selected patients. Future studies should 
report long term oncological outcomes and compare robot-
assisted pancreatic surgery with laparoscopic and open 
resections.
FOS272
NEURAL REMODELLING IN 
PANCREATIC NEUROPATHY IS 
CHARACTERIZED BY INCREASED 
UNMYELINATED NERVE FIBER 
CONTENT AND SELECTIVE 
GLIAL ACTIVATION
I. E. Demir, K. Wang, C. Waldbaur, H. Friess and 
G. Ceyhan
Department of Surgery, Klinikum Rechts der Isar, 
Technische Universitaet Muenchen, Munich, Germany
Introduction: Pancreatic neuropathy in pancreatic adenoar-
cinoma (PCa) and chronic pancreatitis (CP) is associated 
with decreased sympathetic innervation of the pancreas and 
neural remodelling. To complete the characterization of 
pancreatic neuropathy the degree of myelination and glia 
content were investigated in intrapancreatic nerves in PCa 
and CP.
Methods: Intrapancreatic nerves of patients with PCa (n = 
20), CP (n = 20) and normal human pancreas (n = 10) were 
immunolabelled with the neural myelination marker neuro-
fi lament-H (NFH), and the glial activation markers Glial-
Fibrillary-Acidic-Protein (GFAP) und p75 receptor 
(p75NTR). The neural immunoreactivity of each marker was 
correlated to the neuropathic pain sensation, the degree of 
neural invasion (NI) in PCa and to the degree of pancreatic 
neuritis in PCa and CP.
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Results: PCa, and not CP, is associated with decreased 
neural immunoreactivity of GFAP, p75 and NFH. PCa 
patients with pain possess even less GFAP and NFH in their 
intrapancreatic nerves when compared to those without pain. 
Intrapancreatic nerves with increasing degree of pancreatic 
neuritis in PCa and NI harbour higher amounts of NFH and 
p75. Contrastingly, pancreatic neuritis in CP is mostly 
encountered around nerves with small NFH content.
Conclusion: PCa is associated with increased appearance of 
unmyelinated intrapancreatic nerve fi bers and a relative 
decrease of glia cells. However, pancreatic neuritis and NI 
in PCa are directed towards myelinated nerve fi bers which 
are accompanied by activated glia cells. Therefore, pancre-
atic neuropathy in PCa induces a selective, non-global, glial 
activation and the dominance of unmyelinated and thus pain-
transmitting intrapancreatic nerve fi bers.
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GOLD NANOPARTICLES FOR 
APPLICATIONS IN NON-INVASIVE 
RADIOFREQUENCY HYPERTHERMIA 
FOR PANCREATIC AND 
HEPATOCELLULAR CARCINOMA 
TREATMENT
S. Corr1, M. Raoof1, S. Curley1 and L. Wilson2
1University of Texas M.D. Anderson Cancer Center, Texas, 
USA; 2Rice University, Department of Chemistry, Texas, 
USA
Introduction: We are applying full-body penetrating radio-
frequency (RF) electromagnetic waves to liver and pancre-
atic cancer cells that have internalized gold nanoparticles 
(AuNPs), which upon irradiation, heat up and destroy cancer 
by thermal ablation or hyperthermia. Thermal cytotoxicity 
could be enhanced by intracellular pH modulation using 
lysosomotropic agents. AuNP heat production was also 
shown to be dependent on NP size, concentration and surface 
area.
Methods: Antibody-conjugated (C225) AuNPs targeted 
pancreatic (Panc-1) and liver (Hep3B, SNU449) cancer cells 
that express varying amounts of EGFR. Cell viability was 
measured using MTT assays and FACS with Annexin-V and 
PI assays. Intracellular pH was measured using fl uorescence 
ratios of FITC-labeled C225-AuNPs. Intracellular pH was 
modulated using concanamycin A, chloroquine, or NH4Cl. 
Protein denaturation was analyzed using recombinant human 
lentivirus expressing green fl uorescent protein together with 
fi refl y luciferase. Heating was performed using our 600 W 
RF system operating at 13.56 MHz. AuNP-RF dynamics 
were analyzed using complex permittivity measurements 
across the range 10 MHz to 3 GHz.
Results: All cell lines selectively internalized C225-AuNPs 
through receptor-mediated endocytosis, with the NPs pre-
dominantly accumulating and aggregating within cytoplas-
mic endo-lysosomes. After exposure to an external RF fi eld, 
non-aggregated AuNPs absorbed and dissipated energy as 
heat causing thermal damage to the targeted cancer cells. We 
observed that RF absorption and heat dissipation is depen-
dent on solubility of AuNPs in the colloid, which is pH 
dependent. Furthermore, by modulating endo-lysosomal 
pH it is possible to prevent intracellular AuNP aggregation 
and enhance thermal cytotoxicity in pancreatic and 
hepatocellular cancer cells. Heat production was only mea-
sured for NPs of diameters 5 and 10 nm indicating unique 
nanoscale phenomenon.
Conclusion: Contrary to previous publications AuNPs 
heat when exposed to an RF fi eld in a size-, surface-, and 
concentration-dependent manner. By conjugating AuNPs to 
targeting antibodies such as Cetuximab, pancreatic and hepa-
tocellular cancer cells were able to selectively internalize 
these NPs through receptor-mediated endocytosis. Thermal 
cytotoxicity could be greatly enhanced by raising the intra-
cellular pH. This nano-mediated RF technology is a viable 
candidate for alternative cancer therapy.
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INTRAPERITONEAL GEMCITABINE FOR 
RESECTABLE PANCREATIC 
CARCINOMA: EARLY DATA FROM A 
PHASE II STUDY
L. Bijelic1, O. A. Stuart2 and P. Sugarbaker1
1Department of Surgery, Washington Hospital Center, 
Washington, USA; 2Medstar Health Research Institute, 
Maryland, USA
Introduction: Pancreatic cancer patients have a dismal 
prognosis and long term survival is rare even after R0 resec-
tion. Recurrences most commonly involve the local regional 
area, the peritoneal surface and the liver. Intraperitoneal 
chemotherapy provides a pharmacological advantage that 
may reduce the incidence of recurrence following curative 
resection. The aim of this exploratory Phase I/II study is to 
evaluate the safety of intraperitoneal gemcitabine used at the 
time of pancreatic cancer resection.
Methods: This is an ongoing prospective single-institution 
Phase 2 study for patients with resectable adenocarcinoma 
of the pancreas. Patients undergoing standard surgical resec-
tions for pancreatic cancer are treated with 1000 mg/m2 of 
intraperitoneal gemcitabine heated to 42 C for 60 minutes 
immediately following tumor resection and prior to 
creating the anastomoses. Peritoneal fl uid, plasma and urine 
samples are taken every 15 minutes during gemcitabine 
administration and analyzed using HPLC. All morbidity is 
prospectively recorded using the Common Toxicity Criteria 
for the fi rst 30 postoperative days.
Results: Seven patients have been enrolled to date and all 
had a pancreaticoduodenectomy. Intraperitoneal gemcitabine 
was administered in all 7 patients as planned. Minor morbid-
ity was observed in 4 patients: one grade 2 neurologic event, 
one grade 2 neutropenia, one grade 2 urinary tract infection 
and one grade 2 arrythmia. One patient had a grade 3 pan-
creatic fi stula requiring percutaneous drainage. There were 
no returns to the operating room. The mean postoperative 
length of stay was 14 days (range 9–21). Pharmacologic 
analysis showed a favorable peritoneal to plasma AUC ratio 
for gemcitabine ranging from 210 to 368. At the end of 60 
minutes, 43–68% of the drug is systemically absorbed. The 
peak plasma level averages 2.81 mcg/mL.
Conclusion: The preliminary analysis of early data from our 
study shows acceptable morbidity following intraoperative 
intraperitoneal gemcitabine. The pharmacologic analysis 
confi rms a high peritoneal to plasma AUC ratio for gem-
citabine exposing the surfaces at risk for recurrence to high 
levels of gemcitabine. Continued enrollment into the study 
and follow-up with analysis of 2-year survival outcomes will 
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be done. Future studies may include multi-drug intraperito-
neal chemotherapy regimens.
FOS275
THE IMPACT OF MARGINS STATUS ON 
NATURAL COURSE AND RECURRENCE 
RATES FOLLOWING 
PANCREATECTOMY FOR IPMN
M. B. Haim1, N. Lubezky1, G. Lahat1, R. Nakache1, 
E. Santo2, E. Brazowsky3 and J. Klausner1
1Suregery, Tel Aviv Medical Center; 2Gastroenterology, Tel 
Aviv Medical Center, Israel; 3Pathology, Tel Aviv Medical 
Center, Israel
Introduction: Signifi cance of microscopic margins involve-
ment on natural course and recurrence rates following resec-
tion of IPMN are incompletely defi ned.
Methods: Cohort analysis. The extent of resection was 
defi ned by the working diagnosis (IPMN vs. cancer and 
IPMN) and the imaging (CT or MRCP and EUS). Margins 
assessment (frozen section, FS) was not routine. Follow-up 
includes an annual EUS or CT. Outcome measures includes 
rates of R1 resections, IPMN and/or cancer recurrence, need 
for re-pancreatectomy and overall survival.
Results: 91 patients (IPMN only, n = 48; cancer and IPMN, 
43) are included. The rate of margins positivity in the IPMN 
group was 34% (50% when FS was performed vs. 31% when 
not). Recurrences in the remnant pancreas were of IPMN in 
one case (1/35, 3%) and of invasive cancer in 2/35 (6%). 
Mean follow-up is 64 mo. (8–147). There was no correlation 
between margins positivity or the degree of dysplasia and 
late recurrences.
Margins involvement with IPMN was found in 18% and 
with invasive cancer in 26% in the IPMN/cancer group. 
Local recurrence with cancer was 51% and with IPMN, 0%. 
Mean follow-up is 25 mo. (2–124).
Conclusion: Defi ning the extent of resection for IPMN 
according to the pre-operative imaging is practical and safe. 
Intra-operative FS assessment does not ensure R0 resection 
and R1 resection does not directly affect macroscopic recur-
rence. The incidence of cancer in the remnant pancreas fol-
lowing partial pancreatectomy for “benign” IPMN is 6%! 
“Preventive” surgery (total pancreatectomy) for cancer and 
background IPMN is not justifi ed since prognosis is dictated 
by the cancer and IPMN recurrence.
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CLINICAL STUDY OF 60 CASES
X. Wang, Y. Zhu, W. Zhou, D. Huang, Y. Mou, X. Cai 
and S. Peng
Department of General Surgery, Sir Run Run Shaw 
Hospital, School of Medicine, Zhejiang University, 
Zhejiang Province, China
Introduction: To evaluate the effect and safety of 
polypropylene mesh-reinforced pancreaticojejunostomy 
(pancreaticogastrostomy).
Methods: A series of 60 consecutive patients with pancre-
atic or peri-ampullar tumor (pancreatic carcinoma 13 cases, 
pancreatic cystadenoma 6 cases, distal bile duct carcinoma 
29 cases, papillary carcinoma 9 cases, papillary adenoma 2 
cases, duodenal malignant stromal tumor 1 case) underwent 
procedures of pancreticoduodenectomy. The Child’s method 
was used in the present study for alimentary tract reconstruc-
tion. Fifty-four cases underwent polyprolene mesh-
reinforced pancreaticojejunostomy and 6 cases underwent 
polyprolene mesh-reinforced pancreaticogastrostomy.
Results: The mean operative time for polyprolene mesh-
reinforced pancreaticojejunostomy (pancreaticogastrostomy) 
was 25 min (range 22–35 min). Anastomoses of pancreati-
cojejunostomy (pancreaticogastrostomy) were measured for 
tolerance pressure during operation and all cases could toler-
ate a pressure of 25 cm H2O. Post-operative pancreatic fi stula 
was occurred in 7 cases (11.7%) (grade A: 4 cases, grade B: 
3 cases). No massive hemorrhage occurred in the present 
series and there was no postoperative mortality. Mean post-
operative hospital stay was 12 days (range 9–16 days).
Conclusion: Polyprolene mesh-reinforced pancreaticoje-
junostomy (pancreaticogastrostomy) is an appropriate 




TRANSITION IN AMPULLARY CANCER
U. F. Wellner1, N. R. Simanjuntak1, I. Kohler2, 
U. T. Hopt1 and T. Keck1
1Department of General and Visceral Surgery, University 
of Freiburg, Freiburg im Breisgau, Germany; 2Institute of 
Pathology, University of Freiburg, Freiburg im Breisgau, 
Germany
Introduction: Ampullary cancer is a relatively rare disease 
and can frequently be treated by surgical resection. There are 
two main subtypes, intestinal and pancreatobiliary. Invasion 
and metastasis of cancer cells has been shown to be promoted 
by the activation of the ‘epithelial to mesenchymal transition’ 
(EMT) program. ZEB1 (zinc fi nger E-box binding homeobox 
1) is an activator of EMT and cancer stem cell properties.
Methods: We studied the occurrence and mechanisms of 
EMT in ampullary carcinoma using immuno-histochemical 
analysis from human tissue samples and two established 
human ampullary carcinoma cell lines. For in vitro charac-
terization, expression of EMT and tumor subtype markers, 
cell growth and inhibition by chemotherapy, matrigel trans-
migration and tumor sphere formation were employed with 
two pancreatic cancer cell lines serving as controls.
Results: Immunohistochemical (IHC) analysis of human 
ampullary cancer tissue showed lymph node metastasis to be 
associated with tumor budding and loss of CDX2 expression, 
associated with the pancreatobiliary phenotype. Overall, the 
degree of EMT was only moderate. The two ampullary 
cancer cell lines displayed a strong EMT phenotype, evi-
denced by spindle form cell shape, diffuse colony growth 
pattern, high ZEB1 and Vimentin expression, low levels of 
E-Cadherin and micro-RNA 200c and strong matrigel trans-
migration. The intestinal subtype marker CK20 was 
expressed in all cell lines including pancreatic cancer cell 
lines, but CDX2 expression was only found at very low 
levels.
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Conclusion: Invasion and metastasis of ampullary cancer 
are associated with EMT. The pancreatobiliary type of 
ampullary cancer displays more signs of EMT than the intes-
tinal type. High ZEB1 expression levels could not be found 
in human tumor tissue, but in vitro experiments show that 
EMT in ampullary cancer cell lines is regulated by ZEB1.
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A PROSPECTIVE RANDOMIZED 
CONTROLLED TRIAL ON USE OF 
OCTREOTIDE IN PATIENTS WITH 
SOFT PANCREAS UNDERGOING 
PANCREATICODUODENECTOMY: 
INTERIM ANALYSIS
P. Kurumboor, N. P. Kamalesh, K. Pramil, I. S. Vipin, 
A. Shylesh, D. Varma and M. Jacob
PVS Memorial Hospital, Department of GI Surgery, 
Digestive Diseases Centre, Cochin, India
Introduction: Pancreatic fi stula is one of the major reasons 
for morbidity following pancreatoduodenectomy. Benefi cial 
role of octreotide in preventing pancreatic fi stula is not 
clearly proven and it is believed that it may be benefi cial in 
soft glands and normal sized ducts. This prospective random-
ized open label trial aims to assess the role of octreotide in 
decreasing pancreatic fi stulae, postoperative complications, 
morbidity and hospital stay in patients with soft pancreas 
compared with no octreotide.
Methods: Random selection method was used to allocate 
patients with soft pancreas undergoing pancreaticoduodenec-
tomy patients to octreotide group – 100 mcg subcutaneously 
8 hourly for 5 days (Group 1) versus no octreotide group 
(Group 2). Inclusion criteria were elective surgery patients 
undergoing pancreatoduodenectomy for periampullary 
cancer, pancreatic cancer with soft pancreas and non-dilated 
duct. Postoperative outcome was assessed in detail.
Results: At interim analysis, there were 24 patients in 
Group 1 and 21 in Group 2. Demographic features of both 
groups were matching. The pancreatic duct diameter were 
3.75 and 3.38 mms (p = ns) in Groups 1 and 2 respectively. 
The pancreatic fi stulae in Groups 1 & 2 were: Grade A: 14 
(58.3%) & 11 (47.6%), Grade B: 3 (12.5%) & 4 (19.5%) and 
Grade C: 1 (4%) & 1 (4.7%) respectively (p = ns). The drain 
amylase values on 3rd postoperative day (POD3) were 
3615.7 ± 5205.2 and 1558.05 ± 2403.6 U/L (p = ns) in 
Groups 1 & 2. The drain volume on POD3 were 113.3 ± 
181.7 versus 64.84 ± 94.93 ml respectively (p = ns) in 
Groups 1 & 2. Patients in Group 1& 2 were resumed on oral 
liquids on 7 ± 3.8 versus 8.8 ± 4.5 days and semisolid 11.2 
± 3.8 versus 13 ± 5.2 days (p = ns). The 30 day morbidity in 
Groups 1 & 2 were similar, 7 (29.1%) versus 7 (38.1%) (p 
= ns); the hospital stay were also similar 12.7 ± 3.9 versus 
14.8 ± 5.3 days (p = ns) respectively.
Conclusion: Interim analysis of this randomized trial on use 
of octreotide following pancreaticoduodenectomy in those 
patients with soft pancreas shows no signifi cant decrease in 
pancreatic fi stulae, morbidity or hospital stay.
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POSTOPERATIVE INFECTIOUS 
COMPLICATION IS A POOR 




J. Y. Cho, H.-S. Han, Y.-S. Yoon, D. W. Hwang, 
K. Jung, J. H. Kim and Y. Kwon
Department of Surgery, Seoul National University Bundang 
Hospital, Seoul National University College of Medicine, 
Korea
Introduction: The clinical signifi cance of the presence of 
postoperative complication on the prognosis of periampul-
lary cancer after pancreaticoduodenectomy (PD) is unclear.
Methods: Clinical data of consecutive 200 patients with 
periampullary cancer received a PD between October 2003 
and July 2010 were reviewed and survival analysis was per-
formed. Postoperative complications were classifi ed accord-
ing to a modifi cation of Clavien’s classifi cation. Overall 86 
major complications ≥grade II occurred in 71 patients. 
Patients were classifi ed to two groups according to the post-
operative complications ≥grade II: Group C-, absence of 
complication (n = 129); Group C+, presence of complication 
(n = 71).
Results: There was no difference in the sex, mean age, 
TNM stage, biliary drainage, type of resection and radicality 
between two groups (P > 0.05). The 3 year overall and dis-
ease-free survival rates of Group C+ patients (31.0% and 
22.3%) were signifi cantly lower than those of Group C− 
patients (49.0% and 40.0%; P = 0.003 and 0.002, respec-
tively). The multivariate analysis showed postoperative 
complication (P = 0.001), T stage of T3 or T4 (P = 0.001), 
positive node metastasis (P = 0.001), R1 or R2 resection 
(P = 0.023), and angiolymphatic invasion (P = 0.013) were 
independent prognostic factors for disease-free survival. In 
Group C+, systemic recurrence occurred more frequently in 
group Cx+ than those in Group C (P = 0.025).
Conclusion: There was no difference in the sex, mean age, 
TNM stage, biliary drainage, type of resection and radicality 
between two groups (P > 0.05).
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MARKED VENOUS INFILTRATION MAY 
LEAD TO EARLY RELAPSE OF 
ADENOSQUAMOUS CARCINOMA OF 
THE PANCREAS
H. Komatsu1, S. Egawa1, F. Motoi1, N. Sakata1, 
T. Rikiyama1, Y. Katayose1, K. Ishida2 and M. Unno1
1Divisions of Hepato-Biliary Pancreatic Surgery, Tohoku 
University Graduate School of Medicine; 2Department of 
Pathology, Tohoku University Hospital, Miyagi, Japan
Introduction: Adenosquamous carcinoma (ASC) of the 
pancreas is a rare subtype of pancreatic cancer, with a dismal 
prognosis. We describe the clinicopathological features of 
surgically resected ASC of the pancreas in order to elucidate 
the cause of aggressive behavior.
Methods: From 2001 to 2011, 132 patients underwent R0 
resection for stage IIA or IIB pancreatic cancer. Survival rate, 
pathological features and recurrent status were reviewed.
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Results: Out of 132 patients, 121 patients had tubular ade-
nocarcinoma, whereas only 7 patients had adenosquamous 
carcinoma (ASC). The incident rate of ASC increased 
according to the enlargement of tumor size. The overall sur-
vival and disease free survival periods of the patients with 
ASC were signifi cantly shorter (p = 0.0153 and p = 0.0045). 
Histological fi ndings revealed marked venous invasion in 
ASC compared to any other subtypes of tubular adenocarci-
noma (G1, G2 and G3). The proportions of v3, which denotes 
the most severe venous invasion, were 31.3% in G1, 47.3% 
in G2, 60.0% in G3 and 71.4% in ASC, respectively. The 
occurrence of distant metastases was more frequent in ASC 
compared to that in tubular adenocarcinoma (50% versus 
34%).
Conclusion: Adenosquamous carcinoma (ASC) develops as 
a consequence of late diagnosis. Marked venous invasion of 
ASC may lead to early relapse, especially in distant lesions, 
resulting in poor prognosis. To improve the surgical outcome, 




PANCREATECTOMY WITH OR 
WITHOUT SPLEEN VESSELS EXCISION
C. Sperti, V. Beltrame, B. Bellamio and C. Pasquali
Pancreatic and Endocrine Digestive Surgical Unit, Clinica 
Chirurgica IV, University of Padua, Padua, Italy
Introduction: Spleen-preserving during distal pancreatec-
tomy (DP) for benign or border-line neoplasms of the pan-
creas has been proposed to reduce the complications of 
splenectomy. A simplifi ed technique for spleen preservation 
with excision of the splenic artery and vein has been reported 
(Warshaw’s operation). However, the risk of gastric varices 
and subsequent bleeding has been suggested. Aim of this 
study was to evaluate our experience of spleen-preserving 
DP with or without splenic vessels excision.
Methods: From January 1990 to December 2009, 61 con-
secutive patients with benign or low grade malignant pan-
creatic disease underwent spleen-preserving DP: 35 with 
splenic vessels preservation (group A) and 26 with splenic 
vessels excision (group B). Postoperative course and long-
term results were analyzed and compared in both groups of 
patients.
Results: There was 8 cystic neoplasms, 8 IPMN and 19 
endocrine neoplasms in the group A compared to 14 cystic 
tumors, 3 IPMN and 19 endocrine tumors in group B.
There was no operative mortality. Complications (mainly 
grade A and B pancreatic fi stula) occurred in 11 group A 
patients (31%) vs 8 (30%) in group B patients. 1 patients in 
group A and 2 in group B experienced partial splenic infarc-
tion that resolved with conservative treatment. After a 
median follow-up of 72 months (range 24–252) no tumor’s 
recurrence was found. Only one patient (group B) showed 
CT and endoscopic evidence of gastric varices, but episodes 
of gastrointestinal bleeding never occurred.
Conclusion: Splenic preservation during distal pancreatec-
tomy is a feasible and safe procedure. The occurrence of 
perigastric varices and the relative risk of bleeding after 
spleen-preserving distal pancreatectomy with splenic vessels 
excision appear to be overestimated. Excision of splenic 
vessels is a fast and effective method to perform a spleen-
preserving left pancreatectomy.
FOS282
THE CLINICAL IMPACT OF LYMPH 
NODE RATIO AS A PROGNOSTIC 
FACTOR AFTER RESECTION OF 
PANCREATIC CANCER
Y. Yusuke, I. Hisashi, M. Ryo, F. Hitoshi, O. Kazuma, 
O. Toshiya, K. Yukihito and O. Eigo
Division of Digestive Surgery, Department of Surgery, 
Kyoto Prefectural University of Medicine, Kyoto, Japan
Introduction: The ratio between metastatic and dissected 
lymph nodes (LN ratio) has been identifi ed as an independent 
prognostic factor in the treatment of the gastric, breast, and 
colon cancer patients with similar prognosis. The aim of this 
study was to investigate whether the LN ratio is a useful 
predictor of surgical outcomes in patients with pancreatic 
ductal carcinoma.
Methods: The clinical records of 56 patients that underwent 
macroscopic curative pancreatectomy for pancreatic adeno-
carcinoma between January 2001 and December 2009 were 
reviewed retrospectively. Thirty-seven patients were under-
went pancreaticoduodenectomy, 16 underwent distal pancre-
atectomy, and 3 underwent total pancreatectomy, respectively. 
Nineteen clinicopathologic factors, including the number of 
the lymph node metastasis, the number of dissected lymph 
nodes, N category according to the Japanese pancreatic 
society (JPS) classifi cation, and the LN ratio, were analyzed 
using univariate and multivariate analyses in these patients.
Results: The overall 5-year survival rate was 26.9%, and 
median survival time was 23.2 months. Multivariate survival 
analysis showed that positive surgical margin (p = 0.027) and 
LN ratio ≥0.2 (p = 0.025) were independently associated 
with a poorer prognosis. With regard to the subgroup analysis 
among the 33 patients with lymph node metastasis, there 
were signifi cant differences in the survival rates between 
patients with LN ratio ≥0.3 and LN ratio <0.3 (MST 13.0 vs. 
25.1 months, p = 0.01), however, the differences in survival 
between N1 and N2 in JPS classifi cation are not statistically 
signifi cant (MST 25.1 vs. 21.2 months, p = 0.98).
Conclusion: Our results suggested that the LN ratio might 
be more useful than the number of the lymph node metasta-
sis, the number of dissected lymph nodes, and N category 
according to the JPS classifi cation as a predictor for survival 
after pancreatectomy in patients with invasive ductal carci-
noma of the pancreas.
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FOS283
LAPAROSCOPIC DISTAL PANCREATIC 
RESECTIONS: PANCREATIC FISTULA IS 
INVERSELY PROPORTIONAL TO THE 
LENGTH OF THE RESECTED DISTAL 
PANCREAS
B. Aussilhou1, S. Dokmak1, F. S. Ftériche1, B. Blanc1, 
P. Lévy2, P. Ruszniewski2, J. Belghiti1 and A. Sauvanet1
1Department of Hepatobiliary and Pancreatic Surgery, 
Hospital Beaujon, Paris, France; 2Departement of 
Gastroenterology and Pancreatic Diseases, Hospital 
Beaujon, Paris, France
Introduction: Although the risk of diabetes is proportion-
ally related to the length of resected distal pancreas, the risk 
of pancreatic fi stula (PF) is not well know. Our aim was to 
compare the rate of pancreatic fi stulas according to the 
resected specimen length performed by laparoscopy.
Methods: From January 2008 to December 2011, 51 lapa-
roscopic distal pancreatectomies (LDP) were performed and 
studied from a unicentric prospective maintained database, 
including 28 (42.3%) distal pancreatectomies with section on 
the neck (Long Specimen: length of the resected specimen 
was ≥12 cm), including associated splenectomy in 22 
(78.6%) and 23 distal pancreatectomies with section on the 
body or tail (Short Specimen: length of the resected speci-
men was <12 cm). Section was done by stapler (Ethicon EC 
60®). The rate and gravity of PF were compared between the 
Long Specimen (LS) and Short Specimen (SS) groups.
Results: There was no difference regarding mean age (54.7 
and 51.3 years old), sex ratio (F/M = 43% vs 70%) and body 
mass index (25.6 kg/m² vs 25.9 kg/m²). The mean length of 
resected pancreas in the LS group was 12.8 cm versus 8 cm 
in the SS group (p < 0.001). Resection for cancer was more 
frequent in LS group (7 patients vs 0). The fi stula rate was 
signifi cantly higher (50% vs 78%; p = 0.038) in the SS group. 
There was no difference in the gravity of PF between the 
groups LS and SS: 9 (65%) and 13 (73%) patients with grade 
A, 3 (21%) and 4 (22%) patients with grade B, and 2 (14%) 
and 1 (5%) patients with grade C. The duration of PF was 
similar (26.6 vs 38.8 days; p = 0.16). The mean duration of 
hospital stay was 17.8 vs 19.33 days, respectively (p = 0.6).
Conclusion: Unlike diabetes, the rate of pancreatic fi stula 
is inversely proportional to the length of laparoscopic 
resected pancreas and is balanced with a low rate of diabetes, 
justifying a reappraisal of the section technique and not the 
section level. This information should be given to patients 
who will undergo small pancreatic resections for benign 
disease.
FOS284
EFFICACY OF MULTIMODAL PROGRAM 
“FAST TRACK SURGERY” IN THE 
SURGICAL TREATMENT FOR 
PANCREATIC CANCER PATIENTS
I. Shchepotin, A. Lukashenko, O. Kolesnik and M. Vovk
National Cancer Institute, Abdominal oncology, Kiev, 
Ukraine
Introduction: Recent developments in the pancreatic 
surgery are the introduction and implementation of multi-
modal fast track recovery programs. The aim of the study 
was to evaluate the results of a fast-track surgery (FTS) for 
pancreatic cancer patients.
Methods: The randomized controlled single center study 
was conceived to determine effi cacy of FTS and standard 
care (SC) in patients having pancretoduodenal resection for 
pancreatic cancer. The regimen FTS contained: no preoper-
ative bowel cleansing, transverse and small abdominal inci-
sions, no tubes, mobilization and consumption of clear 
carbohydrate rich fl uid until two hours before surgery, epi-
dural analgesia, oral laxatives. Intraoperative fl uid adminis-
tration was restricted, oral food intake started on the day of 
surgery with clear fl uids and was increased to a small 
amount of solid food on day 1 after surgery. Complete 
enteral nutrition was initiated on day 2 after surgery follow-
ing opaque media examination of the upper gastrointestinal 
tract.
Results: 21 patients with II-III stage of pancreatic cancer 
were included (11 FTS group vs. 10 SC group). The rates of 
pancreatic fi stula and other intra-abdominal complications 
were similar in the two groups. Delayed gastric emptying 
was signifi cantly reduced in the fast-track group (9 vs. 30 
per cent). We detected a signifi cantly faster return of fi rst 
bowel movement (median 12 h vs. 48 h). Length of stay 
was reduced with the fast-track protocol (median 10 vs. 16 
days).
Conclusion: Patients undergoing fast-track rehabilitation 
suffer from less pain and have a faster return of gastrointes-
tinal function in the postoperative course and recover faster. 
In addition, postoperative length of hospital stay was signifi -
cantly shorter in fast-track patients.
FOS285
THORACIC EPIDURAL ANAESTHESIA 
MODULATES INFLAMMATORY 
RESPONSE AND DECREASES THE 
SEVERITY OF ACUTE PANCREATITIS 
IN PIGS
J. Kral1, O. Winsö1, I. Kralova1, W. Wang2, 
P. Abrahamsson1, G. Johansson1 and P.-J. Blind3
1Department of Surgical and Perioperative Sciences, 
Anesthesiology and Intensive Care Medicine, Umeå 
University, 90185 Umeå, Sweden; 2Department of 
Pathology, Umeå University, 90185 Umeå, Sweden; 
3Department of Surgery, Skåne University Hospital, Lund, 
Sweden and Department of Clinical Sciences, Lund 
University, 22185 Lund, Sweden
Introduction: Sympathetic nervous system (SNS) is impor-
tant in the early neurogenic infl ammatory response. Severity 
of acute pancreatitis (AP) is determined by development of 
systemic infl ammatory response. In experimental settings, 
thoracic epidural anaesthesia (TEA) improved pancreatic 
and hepatic microcirculation during AP in rats. We investi-
gated whether TEA modulates infl ammatory response by 
SNS blockade, improves local metabolic parameters and 
decreases the severity of AP in pigs.
Methods: Anaesthetized normoventilated pigs were allo-
cated into three groups (G), eight in each one. G1 = AP, G2 
= AP + TEA, G3 = sham operation. AP was induced by 
infusion of sodium taurocholate (0.5 mL/kg under 20 min) 
into the pancreatic duct. An epidural catheter was inserted 
under radiographic control with the tip at T8 level and 
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continuous infusion of bupivacaine was started to block seg-
ments T5 to T12, simultaneously with AP induction. Six 
hours observation time ensued. Arterial blood was analyzed 
for lipase and insulin levels. Local metabolic changes in the 
pancreatic parenchyma were monitored by microdialysis 
(MD). Blood glucose levels were maintained stable using 
glucose infusion in all groups. Total glucose consumption 
was determined.
Results: All comparisons were made between baseline and 
end of observation time values, given as mean ± 95% confi -
dence interval. Increase in lipase levels was higher in G1 
than G2 (0.66 ± 0.25 vs. 0.33 ± 0.15 µKat/L, P = 0.017). 
Decrease in insulin levels was more pronounced in G2 than 
G1 (−25.6 ± 13.2 vs. −9 ± 8.5 ng/L, P = 0.025). MD-glucose 
levels in pancreatic parenchyma decreased in G1 by 2.47 ± 
1.02 and in G2 by 1.36 ± 1.16 mmol/L; there was no signifi -
cant difference between G1 and G2 values (P = 0.104). There 
were no signifi cant changes in lipase, insulin or MD-glucose 
levels in G3 during the observation time. Total glucose con-
sumption was 37.6 ± 8.0 g in G1, 13.5 ± 3.5 in G2, and 5.5 
± 2.2 in G3; G1 vs. G2 (P = 0.001), G2 vs. G3 (P = 0.001).
Conclusion: TEA attenuated increase in lipase levels caused 
by AP, thus suggesting alleviation of the course of the 
disease. Decrease in insulin levels was more pronounced in 
G2 than G1 despite that TEA could have stimulated insulin 
secretion through the SNS blockade. Contrary to a previous 
study in rats, our study showed decrease in MD-glucose 
levels in the pancreatic parenchyma in AP. These fi ndings 
raise a question whether TEA might be useful already at an 
early stage of the treatment of AP in man.
FOS286
PARENCHYMA-SPARING 
PANCREATECTOMY (PSP) FOR NON-
INVASIVE INTRADUCTAL PAPILLARY 
AND MUCINOUS NEOPLAMS (IPMN)
A. Sauvanet1, B. Blanc1, S. Dokmak1, S. Gaujoux1, 
B. Aussilhou1, A. Couvelard2, P. Levy3 and J. Belghiti1
1Department of HBP Surgery, Hopital Beaujon, University 
Paris VII, Clichy, France; 2Department of Pathology 
Hopital Beaujon, University Paris VII, Clichy, France; 
3Department of Gastroenterology-Pancreatology, Hopital 
Beaujon, University Paris VII, Clichy, France
Introduction: For non-invasive IPMN limited to a branch-
duct (BD) or to the central pancreas, standard resections such 
as pancreaticoduodenectomy (PD) or distal pancreatectomy 
(DP) can be considered as excessive due to their mortality, 
morbidity and functional consequences. PSP such as enucle-
ation (EN) or central pancreatectomy (CP) are alternative 
procedures. The aim of this study was to assess EN and CP 
for presumed non-invasive IPMN.
Methods: From 1997 to 2010, 379 patients had resection 
for presumed IPMN, with 83 (22%) PSP attempted including 
EN (n = 52) or CP (n = 31). Symptoms were present in 58 pts 
(70%). After preoperative work-up (CT, MRI and EUS), 
surgery was indicated for suspected main duct (MD) involve-
ment (n = 22), BD > 30 mm (n = 16) or with mural nodule 
(n = 11), otherwise for incapacitating symptoms. BD eligible 
for EN were localized on the uncus (n = 31), head (n = 9), 
neck/distal pancreas (n = 12). Intraoperative frozen section 
(FS) was routinely done and resection was converted to PD 
or DP if FS revealed MD involvement during CP, or at least 
moderate dysplasia on communicating duct during EN. 
Follow-up included clinical and biological assessment, with 
MRI on a yearly basis.
Results: Of 52 EN attempts, 7 (13%) were converted to PD 
due to infl ammation or FS fi ndings, and 2 were converted to 
CP. Of 31 CP attempts, 4 (13%) were converted to PD/DP. 
Overall, 72 (87%) pts had EN/CP with a 1.2% (n = 1) mortal-
ity rate and a 63% (n = 48) morbidity rate including 52% of 
pancreatic fi stula (19% being grade B + C). Accuracy of FS 
was 95%. Defi nitive pathologic examination after EN/CP 
revealed non-IPMN diagnosis (n = 3; 4%), non-invasive 
IPMN (n = 67; 93%), and minimally invasive IPMN (n = 2; 
3%). With a median follow-up of 41 mo. (12–156), 3 (4%) 
pts developed recurrent pancreatic symptoms, 2 (3%) devel-
oped de novo diabetes, and 2 (3%) de novo exocrine insuf-
fi ciency; 3 pts (4%) were reoperated for persistant (n = 1) or 
recurrent (n = 2) IPMN.
Conclusion: Parenchyma-sparing pancreatectomy for pre-
sumed non invasive IPMN have a high feasibility rate and 
avoid standard resection consequences, particularly for 
benign lesions mimicking IPMN. For IPMN, preoperative 
selection is accurate with very few missed invasive IPMN. 
Early morbidity is high but counterbalanced by a low rate of 
symptom recurrence, very rare pancreatic insuffi ciency and 
a tumor recurrence rate equivalent to the one commonly 
observed after standard resections.
FOS287
TEMPORARY MESENTERICO-CAVAL 
SHUNT IS A SAFE AND EFFECTIVE 
TECHNIQUE OF VENOUS RESECTION 
DURING A WHIPPLE PROCEDURE
V. Gushchin1, R. Rasulov2 and R. Khamatov2
1Mercy Medical Center, Balitmore, MD, USA; 2Irkutsk 
State Institute of Advanced Medical Training, Russia
Introduction: It is important to perform safe margin nega-
tive pancreatic head resection to improve outcomes in pan-
creatic malignancies. This study describes the technique and 
safety of extended Whipple procedure (WP) with venous 
resection using temporary redirection of the mesenteric 
venous drainage into the systemic circulation using a tempo-
rary mesenterico-caval shunt (TMCS).
Methods: One hundred and thirty two patients underwent 
surgery for periampular malignancies in 2005–2009: 67 men 
(50.8%) and 65 women (49.2%) at a mean age of 58.4 years. 
Eighty eight (66.7%) patients had exocrine adenocarcinoma 
of the pancreas and 44 (33.3%) patients had carcinoma of 
the ampula of Vater. Removal of the tumor with negative 
margins in some patients required resection of the porto-
mesenteric confl uence with diversion of the mesenteric 
venous fl ow after TMCS was created at an early stage of the 
resection. The mesenteric fl ow into the portal system was 
restored during the reconstruction stage of the procedure.
Results: Eighty four patients (64.4%) underwent WP with 
venous resection and TMCS, 44 patients (33.3%) had 
extended WP and 3 patients (2.3%) had standard WP. Mean 
length of WP with TMCS was 331.5 ± 6.2 min and the 
extended WP 293.5 ± 13 min (p = 0.01). Mean blood loss 
during extended WP with TMCS and extended WP were 
403.5 ± 40 ml and 721.4 ± 111.4 ml respectively (p = 0.01). 
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The mortality rates for these two groups of patients were 
2.3% and 2.2% (p = 0.5), major complication rates were 
28.2% and 25% (p = 0.9), and length of stay was 19.3 ± 1.3 
and 19.6 ± 2.4 days (p = 0.9). Margin negative resections 
were achieved in 118 (89.4%) patients. In 67 (50.7%) patients 
of the series there was histologically proven tumor invasion 
of the resected venous segment.
Conclusion: The diversion of the mesenteric venous fl ow 
into the systemic circulation prolonged the surgery but 
decreased the blood loss. A Whipple procedure with TMCS 
is a safe and feasible technique to perform margin negative 
resections in periampullary malignancies with venous tumor 
invasion.
FOS288
BEYOND THE LEARNING CURVE: 
ANALYSIS OF CONVERSION 
PREDICTORS IN ROBOTIC 
HEPATOBILIARY AND 
PANCREATIC SURGERY
E. Hanna1, K. Simo1, N. Rozario2, D. Sindram1, 
D. Iannitti1 and J. Martinie1
1Carolinas Medical Center, Department of General 
Surgery, Division of Hepatobiliary and Pancreatic Surgery, 
Charlotte, North Carolina, USA; 2R. Stuart Dixon Institute 
for Health Studies, Charlotte, North Carolina, USA
Introduction: Advanced robotic surgery has gained an 
increasing presence in the realm of minimally invasive hepa-
tobiliary and pancreatic (HPB) surgery. However, currently 
in the literature, only anecdotal evidence has been available 
for guiding patient selection for complex robotic procedures. 
In the following analysis, we review our experience to date 
and look for predictors of conversion in robotic assisted HPB 
surgery.
Methods: A retrospective review was performed of all 
patients who underwent robotic assisted hepatobiliary and 
pancreatic procedures at a single institution from October 
2008 through October 2011. Patient demographics, opera-
tive data, procedure type and conversion information were 
recorded. Trends were analyzed for indications for conver-
sion during the study time period. An additional subset 
analysis was performed for laparoscopic distal pancreatec-
tomy, with and without splenectomy. Statistical tests uti-
lized included t-tests or Wilcoxon rank sum tests as 
appropriate for data measured on the interval or ordinal 
scales; chi-square and Fisher’s exact tests were used for 
nominal data.
Results: 47 patients underwent robotic procedures by a 
single surgeon (JM) on a DaVinci Si robot. There were 22 
males (46.8%) and 25 females (53.2%) with median age 65. 
There were 13 conversions, decreasing in frequency from 
2009 (6) through 2011 (2). Conversions were associated with 
higher intraoperative blood loss (848.1 vs 156.3 ml, p < 
0.01), more frequent transfusion (30.8% vs 2.9%, p = 0.02) 
and longer operative time (291.3 vs 184.9 min, p < 0.01). 
BMI (29.6 vs 28.5 kg/m2, p = 0.43) and length of stay were 
not signifi cantly different (7.92 vs 7.24 days, p = 0.15). 23 
patients underwent distal pancreatectomy, 7 with splenec-
tomy. There were 8 conversions in this group which were 
younger (56.6 vs 61.1 years) with higher BMI (29.3 kg/m2 
vs 27.8, p = 0.50).
Conclusion: Robotic assistance can provide benefi cial 
advantages for complex, minimally invasive hepatobiliary 
and pancreatic surgical procedures. Factors prohibitive for 
successful completion of robotic assisted HPB surgeries 
include prolonged operating time and signifi cant intraopera-
tive blood loss. Careful patient selection and recognition of 
these conversion predictors will permit the maximal benefi t 
of robotic assisted HPB surgery to be realized.
FOS289
LOW CALORIC ORAL STIMULATION OF 
GUT IN NECROTIZING PANCREATITIS
G. Pupelis, H. Plaudis, K. Zeiza and N. Drozdova
Riga East Clinical University Hospital “Gailezers”, Latvia
Introduction: Early enteral nutrition facilitates recovery of 
the bowel function which is important precondition for suc-
cessful conservative management of necrotizing pancreatitis 
(NP). Tube feeding is recognized as safe mode of nutritional 
support. The aim of study was to demonstrate experience 
with alternative low caloric oral stimulation of gut (OSG) in 
necrotizing pancreatitis.
Methods: Low caloric OSG circa 280–427 kcal daily was 
provided in patients with NP admitted within 72-hour period 
from the onset of disease. OSG was achieved in formula 
group using standard feeding formula and in food group 
using low fat natural yoghurt/oatmeal soup. Primary end-
points of retrospective study were mortality and complica-
tion rate. Secondary endpoints were infection rate, incidence 
of surgical interventions, length of intensive care unit (ICU) 
and hospital stay. Main variables included mean caloric 
intake; dynamics of C-reactive protein (CRP) and lipase; 
incidence of organ dysfunction according to sequential organ 
failure assessment (SOFA) score. Statistical analysis was 
done on SPSS 17 statistical software.
Results: OSG have received 309 patients with NP, 103 
patients were admitted within 72-hour period. OSG was 
commenced 3–4 days after admission in 67 patients from 
formula group and in 36 patients from food group for 10 
days. Systemic infl ammation was observed in 92%–99% and 
MODS in 86%–93% of patients. Decrease of systemic 
infl ammation was observed in 7-day period. Peak CRP 
decreased from 299 mg/l on day 3 to 202.0 mg/l on day 7, 
activity of lipase from 2528 IU/L on day 1 to 63 IU/L on day 
7. Signifi cant prevalence of CNS dysfunction was observed 
in food group, p < 0.03. Infection rate reached 39% in both 
groups and 32% of patients were operated. Mean ICU stay 
was 16 days and mean hospital stay was 39 days. Overall 
mortality reached 14.6%.
Conclusion: Low caloric oral stimulation of gut as constitu-
ent of complex treatment protocol facilitates recovery of the 
bowel function in patients with necrotizing pancreatitis 
without application of generally recommended nutritional 
support. Overall treatment results are comparable with inter-
nationally reported data.
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RESECTION OF AN ISOLATED 
ARTERIAL SEGMENT DURING 
PANCREATECTOMY
N. De Lio1, F. Costa2, S. Signori1, V. G. Perrone1, 
F. Vistoli1, M. A. Belluomini2, F. Mosca2 and 
U. Boggi1
1Division of General and Transplant Surgery, University of 
Pisa, Pisa, Italy; 2First Division of General Surgery, 
University of Pisa, Pisa, Italy
Introduction: Isolated involvement of an arterial segment 
in pancreatic tumors occurs infrequently, and does not neces-
sarily mean tumor unresctability being possibly caused by 
tumor location rather than by excessive growth. By the UICC 
staging system all tumors involving a main peripancreatic 
artery are deemed unresectable by defi nition and staged T4. 
We report on the outcome of a highly selected group of 
patients undergoing pancreatectomy plus resection of an iso-
lated arterial segment at a single Institution.
Methods: From 01/1993 to 05/2011, resection of an isolated 
arterial segment was performed during 26 pancreatectomies. 
There were 12 males (46.1%) and 14 females (53.9%), with 
a mean age of 63.6 yrs. One patient (celiac trunk resection) 
was operated by robotic surgery. 2 patients underwent total 
pancreatectomy (7.7%), 5 pancreaticoduodenectomy (19.2%) 
and 19 distal splenopancreatectomy (73%). Resected arterial 
segments were celiac trunk (n = 14), hepatic artery (8), celiac 
trunk and hepatic artery (4). In 6 patients the hepatic arterial 
fl ow was reestablished by end-to-end anastomosis (n = 1), 
transposition of the left gastric artery (n = 1), and interposi-
tion of a saphenous vein jump graft (n = 4). Multivisceral 
resection was required in 9 patients.
Results: Final pathology disclosed ductal adenocarcinoma 
(DA) in 18 patients (69.2%), other pancreatic tumor types or 
periampullary carcinoma in 4 patients, mucinous cystic 
tumor in 1 patient, and metastatic tumor in 3 patients. 21 DA 
patients were node positive (85%). Post-operative morbidity 
and mortality were 55.5% and 3.8%, respectively. After a 
mean follow up period of 111 months (range 5–225), actual 
survival rate was 64% at 1 year and 20% at 3 years. Equivalent 
fi gures for DA were 30% and 15%, respectively. These data 
favorably compare with an historical cohort of patients with 
locally advanced DA undergoing palliation without resec-
tion. Noteworthy, no patient developed local recurrence, 
despite none received pre- or post-operative radiation.
Conclusion: In patients affected by DA, the resection 
remains key for cure and possibly provides the best palliative 
treatment. Our experience shows that highly selected patients 
with isolated involvement of celiac trunk and/or hepatic 
artery may undergo pancreatectomy with results similar to 
patients without vascular involvement and superior to those 
offered by palliation or medical therapy alone. The lack of 
local recurrence seems to be a relevant treatment endpoint, 
when cure cannot be achieved.
FOS291
STUDY OF THE PET WITH 18 
FLUORODEOXYGLUCOSE AS 
PARAMETER PROGNOSIS IN PATIENTS 
WITH NEUROENDOCRINE TUMOR 
OF PANCREAS
H. Duran1, B. Ielpo1, E. Diaz1, I. Fabra1, R. Puga1, 
J. C. Plaza2, Y. Quijano1 and E. Vicente
1General and Digestive General Service, Cirugia 
Sanchinarro, Madrid, Spain; 2Service of Pathology, 
Cirugia Sanchinarro, Madrid, Spain
Introduction: The rule of positron emission tomography 
(PET) in the diagnosis of pancreas cancer has been well 
established. But, it is still controversial its application on 
neuroendocrine tumor of pancreas (NETP).
Ki-67 proliferation index is a well known prognostic 
factor of pancreas NETP. Its lower value is related to poor 
prognosis and it is used for the prognostic classifi cation: 
Ki-67 < 2%: neuroendocrine tumor; Ki-67 range from 2% to 
20%: well differentiated neuroendocrine cancer; poor dif-
ferentiated neuroendocrine cancer.
Methods: The objective of this report is to assess the role 
of the PET as prognostic factor of NET.
We reviewed retrospectively 78 patients that underwent 
pancreas surgery form March 2009 to March 2011. NETP 
were 21 (26.9%): 11 male and 10 women. Median age was 
58 years (range: 35–73). NETP classifi cation was: 8 neuroen-
docrine tumor (38%); 9 well differentiated tumors (42%); 4 
poor differentiated tumors (19%).
Mean tumoral size: neuroendocrine tumor: 1.56 cm; neu-
roendocrine carcinoma: 5.05 (p < 0.05). The prognostic vali-
dation of PET is based upon a bivariant study: positive/
negative PET with Ki-67 index and tumoral size.
Results: All patients underwent PET tomography. Twelve 
positive (mean SUV of 6.34) and nine negative. The octreo-
tide scan of these 9 negative PET patients was positive in all.
Patients with positive PET tomography has a Ki-67 mean 
index of 22% and a mean tumoral size of 4.5 cm; patients 
with negative PET tomography and Octreotide positive scan 
has a Ki-67 mean index of 11.6% and a mean tumoral size 
of 3.5 cm (p < 0.05).
Conclusion: According to our results it seems that a positive 
PET tomography is related with a worse prognosis (higher 
size and Ki-67) than a positive octreotide scan. Further study 
is needed to prove the infl uence on survival rates.
FOS292
POST PANCREATECTOMY 
HAEMORRHAGE – A TEN 
YEAR EXPERIENCE
K. Dickinson, G. Marangoni, R. Storey, Z. Hamady, 
A. Aldouri, K. Menon and A. Smith
Department of HPB Surgery, St James University Hospital, 
Leeds, UK
Introduction: Post-pancreatectomy haemorrhage (PPH) is 
uncommon (1–8% pancreatic resections) but accounts for 
signifi cant mortality (11–38%). PPH can be defi ned as per 
the International Study Group of Pancreatic Surgery, ISGPS, 
criteria. Onset can be early (<24 hours) or late (>24 hours), 
bleeding can be intra- or extra-luminal and can be graded 
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(A-C) depending on severity, onset and clinical conse-
quences. Using these criteria to quantify PPH allows identi-
fi cation of risk factors and prognostic indicators.
Methods: All patients undergoing pancreatectomy 
(Whipples/PPPD/subtotal or total pancreatectomy) between 
1st January 2000 and 31st December 2010 were included. 
Our database included patient demographics, mode of pre-
sentation, type of surgery, characteristics of post-pancreatec-
tomy haemorrhage, management of haemorrhage and 
outcome of any intervention. Data regarding other post-
operative complications, histopathology, tumour staging, 
follow up and survival were also obtained. Correlation 
between patient outcome and potential risk factors was 
assessed using Chi squared, SPSS.
Results: 392 pts were included, 13 (3%) had PPH. Median 
age 67 yrs (IQR 61–77), M : F 9:4. 3 pts had early and 10 
late PPH. 3 had intraluminal bleeding, 8 extraluminal and 
2 pts both. 5 had pancreatic leak and sepsis and all these had 
late PPH. Bleeding source was unidentifi ed for 3, the gastro-
jejunal (GJ) anastamosis in 3, and arterial in 7 (gastroduodenal/
R,L hepatic/inf epigastric/Arc of Buhler). 8 had grade B PPH 
and 5 grade C. GJ bleeding was controlled surgically (2 pts) 
and endoscopically (1 pt). Vessel bleeding was controlled by 
embolisation/gluing. 3 pts had multiple angiographic proce-
dures and all these died. No signifi cant association existed 
between risk factors and survival (Chi squared). 8 pts died, 
median post-op survival 116 days (31–260).
Conclusion: Although uncommon, mortality following 
post-pancreatectomy haemorrhage remains high. Early 
haemorrhage can be controlled by surgical, endoscopic and 
angiographic manoeuvres. Late haemorrhage is associated 
with anastamotic leaks and sepsis. Repeated angiographic 
attempts at haemorrhage control is associated with 100% 
mortality, and probably refl ects the end stage of this systemic 
infl ammatory response process.
FOS293
SURROGATE ONCOLOGIC MARKERS 
FOR LONG TERM SURVIVAL ARE 
IMPROVED WITH THE USE OF 
MINIMAL ACCESS SURGERY FOR 
PANCREATIC CANCER
J. Stauffer, A. Rosales-Velderrain, R. Goldberg, T. Clarke, 
M. Buchanan, S. Bowers and H. Asbun
Department of Surgery, Mayo Clinic Florida, Jacksonville, 
Florida, USA
Introduction: Improved survival rates for pancreatic cancer 
are diffi cult to demonstrate with any alterations of surgical 
technique including laparoscopy. However, several variables 
have been shown to improve cancer outcomes for pancreas 
malignancies in patients undergoing open surgery. This study 
aims to specifi cally look at these parameters as surrogate 
markers for improved oncologic outcomes for those patients 
undergoing laparoscopic pancreatectomy versus open 
pancreatectomy.
Methods: A review of 5 year time period (July 2006–July 
2011) at our institution of open vs. totally laparoscopic pan-
creas resections was performed. Outcome comparisons were 
performed for those undergoing pancreaticoduodenectomy/
total pancreatectomy (PD/TP) and distal pancreatectomy 
(DP). Standard statistical analysis (t-test & two-tailed 
Fisher’s exact test) was performed. PD/TP was performed in 
139 and 40 patients undergoing open and laparoscopic 
surgery respectively, while DP was performed in 42 and 68 
patients undergoing open and laparoscopic surgery respec-
tively. Preoperative characteristics including demographics, 
comorbities, ASA status, and primary pathology were not 
statistically different for all groups.
Results: Pancreatic fi stula, complications, need for reopera-
tion, and 90 day mortality were not signifi cantly different for 
either the PD/TP or DP patient groups. Estimated blood loss, 
red blood cell transfusions, overall intensive care and hospi-
tal length of stay were signifi cantly lower in the laparoscopic 
patients compared to the open patients for both the PD/TP 
and DP groups. Tumor size, R0 resection rate, and node 
positivity were no different for either the PD/TP or DP 
groups. Overall number of lymph nodes was signifi cantly 
higher in the laparoscopic patients compared to the open 
patients for both the PD/TP and DP groups. Positive lymph 
node ratio was signifi cantly lower in the laparoscopic patients 
for PD/TP groups but not for the DP groups.
Conclusion: The use of minimal access surgery for pancre-
atic disease is increasing. Long term follow up for patients 
undergoing laparoscopic pancreas surgery with survival and 
oncologic outcome data are currently unavailable. This 
limited retrospective study appears to suggest that surrogate 
oncologic markers are improved with the use of laparoscopy 
and may suggest benefi t for a minimal access approach.
FOS294
DECREASING TRENDS IN SURGERY 
FOR PANCREATIC CANCER: A 21-YEAR 
POPULATION-BASED ANALYSIS
D. Hari1, A. Leung1, C. Chiu1, S. Stern1 and A. Bilchik2
1John Wayne Cancer Institute, Santa Monica, USA; 2John 
Wayne Cancer Institute and California Oncology Research 
Institute, Santa Monica, USA
Introduction: Resection is the only curative option for 
patients with pancreatic cancer. This population-based study 
examines trends in surgery offered and performed for patients 
with localized (Stage I) and regional (Stage II & III) pancreas 
cancer and the impact on survival over two decades.
Methods: The Surveillance, Epidemiology, and End Results 
(SEER) Database was queried to identify patients with local-
ized and regional pancreatic cancer (Stages I-III) that were 
diagnosed between 1988 and 2008. Interval trends in surgery 
offered and performed were evaluated over time (Year 
Stratums (YS): 1988–1993, 1994–1998, 1999–2003 and 
2004–2008) and correlated with survival.
Results: Patients with local (3,411) and regional (14,505) 
disease had an increasing trend in surgery offered from 
1988–2003, and then from 2004 to 2008, there was an 11% 
decrease in surgery offered (p < 0.0001). This decrease in 
surgery offered correlated with a 4% decrease in surgery 
performed (p < 0.0001). However, 3-yr survival for surgi-
cally treated patients increased over time for local (31% 
to 55%, p < 0.0001) and regional disease (11% to 24%, 
p < 0.0001). More importantly, 3-yr survival was more 
than 10-fold higher compared to unresected patients 
with local disease and 5–8-fold higher with regional disease 
(p < 0.0001).
Conclusion: In the largest temporal analysis of local and 
regional pancreatic cancer, we demonstrate a recent decrease 
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in surgical resections offered and performed. Furthermore, 
not only has survival continued to increase over time after 
surgical resection, it has remained signifi cantly higher com-
pared to unresected patients. Further studies are needed to 
determine why despite the seeming benefi t in pancreatic 
resection, surgical treatments are declining for pancreatic 
cancer.
FOS295
IMPACT OF HUMAN ADIPOSE TISSUE 
DERIVED REGENERATIVE CELL FOR 
CRYOPRESERVED PORCINE ISLETS
T. Ikemoto, M. Shimada, T. Utsunomiya, S. Imura, 
Y. Morine, J. Hanaoka, T. Miyatani and M. Kanamoto
Department of Digestive and Transplant Surgery, 
Tokushima University, Tokushima, Japan
Introduction: There were some urgent issues for islet trans-
plantation even though it represents promising future for the 
treatment of type 1 diabetes. For xenotransplantation, we 
have already reported that hADRCs (human-Adipose Tissue 
Derived Regenerative Cells) demonstrated the regenerative 
effects for injured pancreatic islets in vivo (IHPBA 2010), 
here we show our investigation whether hADRCs have pro-
tective effects to injured cryopreserved porcine pancreatic 
islets.
Methods: Step-wise cryopreserved 1.0 × 105 porcine islets 
(72 hours) were thewed and co-cultured with hADRCs 
without cell-to-cell contact (Co-culture group), 1.0 × 105 
islets were cultured alone (Control group) and hADRCs were 
cultured alone (ADRCs group). Recovery rate (%), viability 
of islets (%) and morphology score were evaluated after 48 
hours culture. Concentration of insulin and cytokines such 
as IL-1B, IL-6, IL-8, IL-10, TNF-α and VEGF in culture 
medium supernatants in all groups were measured.
Results: Islets in Co-culture group showed signifi cantly 
better recovery rate (67.3% vs 19.8%, P < 0.05) and con-
tained signifi cantly better viability (84.4% vs 63.5%, P < 
0.05). Morphology score of islets in Co-culture group tend 
to be higher in histological assessment. Insulin, IL-6, IL-8, 
VEGF in culture medium were higher signifi cantly (insulin; 
33690 µIU/ml vs 3147.8 µIU/ml vs 0 µIU/ml, IL-6; 3400 pg/
ml vs 0.2 pg/ml vs 0 pg/ml, IL-8; 25.2 pg/ml vs 2.0 pg/ml 
vs 0 pg/ml, VEGF; 892 pg/ml vs 20 pg/ml vs 10 pg/ml, 
Co-culture group vs Control group vs ADRCs group; P < 
0.01, respectively).
Conclusion: Cryopreserved porcine islets showed signifi -
cantly better recovery with co-culture of hADRCs. These 
supportive effects were strongly suggested due to the cyto-
kine network. These secretions required injured cells, 
however, did not require the direct cell-to-cell contact. This 
co-culture may be a new strategy for porcine islet xenotrans-
plantation from cryopreserved islet cell bank.
FOS296
CLINICAL EFFECTS OF NEOADJUVANT 
CHEMORADIATION THERAPY USING 
S-1 FOLLOWED BY SURGICAL 
RESECTION FOR PATIENTS WITH 
BORDERLINE RESECTABLE 
PANCREATIC CANCER
S. Satoi, T. Hideyoshi, Y. Hiroaki, Y. Tomohisa, 
H. Satoshi, I. Kentaro, M. Taku and A.-H. Kwon
Department of Surgery, Kansai Medical University, Osaka, 
Japan
Introduction: We have reported that surgical resection fol-
lowing neo-adjuvant chemoradiation therapy (NACRT) can 
be associated with improved prognosis of pancreatic cancer 
patients (Pancreas 2009 and 2011 in press). The aim of this 
study is to explore short-term results of the new regimen of 
NACRT using S-1 followed by surgical resection in patients 
with borderline resectable pancreatic cancer.
Methods: Between 2006 and 2010, 17 patients who under-
went surgical resection and adjuvant chemotherapy, were 
classifi ed as adjuvant group, and 23 patients who underwent 
NACRT followed by surgical resection and adjuvant che-
motherapy, were classifi ed as NACRT group. The regimen 
of NACRT was consisted of S-1 (orally twice daily, 5 days 
in a week, 80 mg/m2/day) and concurrent radiotherapy (a 
total of 50.4 Gy). The primary endpoint was the frequency 
of pathological curative resection (R0).
Results: There was no signifi cant difference in clinical back-
grounds between two groups. Other organ resection including 
vascular resection was done for 14 of 17 patients in adjuvant 
group and for 16 of 23 patients in NACRT group. The R0 rate 
in NACRT group was signifi cantly better than in adjuvant 
group (21/23 vs 7/17, p = 0.003). Although there was no 
signifi cant difference in retrieved number of lymph node, the 
number of metastatic lymph nodes in NACRT group (1 
(0–25)) was signifi cantly lower than in adjuvant group (2 
(0–19), p = 0.022). The frequency of local relapse in NACRT 
group was signifi cantly lower than in adjuvant group at 1 year 
after surgical resection (0% vs 35%, p = 0.022).
Conclusion: NACRT using S-1 can improve the R0 rate, 
and number of metastatic lymph nodes in patients with bor-
derline resectable pancreatic cancer, resulting in better local 
control.
FOS297
LONG TERM FOLLOW-UP AFTER 
PANCREATICO-JEJUNOSTOMY FOR 
CHRONIC PANCREATITIS IN 
180 PATIENTS
E. Lermite, A. Venara, S. Mucci, A. Roch, A. Hamy 
and J.-P. Arnaud
Digestive Surgery, CHU Angers, Angers, France
Introduction: Treatment of chronic pancreatitis is a chal-
lenging condition for surgeons: surgical techniques are based 
on decompression and/or resection techniques. The objective 
of this large retrospective series was to evaluate the immedi-
ate and long-term outcome of pancreaticojejunostomy (PJ) 
in the treatment of chronic pancreatitis.
Methods: From 1980 to 2002 all consecutive patients with 
chronic pancreatitis with dilated main pancreatic duct and 
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treated by PJ were included. Postoperative morbidity and 
mortality rates were reviewed. The resumption of work and 
physical activity, alcohol consumption, weight and the pres-
ence abdominal pain were assessed every 6 months. In all 
non diabetic patients an oral glucose tolerance test was per-
formed. Functional results were classed into three groups: 
good, mild or bad.
Results: There were 155 men and 25 women. Chronic pain 
was the indication for PJ in 126 patients (90%). Post-
operative mortality rate was 1.1% and postoperative morbid-
ity rate was 10%. The mean follow-up was 11.5 years (range: 
7–27 years). Functional results were good or mild in 91.5% 
of cases. A mean weight increase of 5.9 kg was observed in 
103 patients (79%). Fifteen patients developed de novo dia-
betes mellitus. In the 50 patients with preoperative diabetes, 
26 suffered deterioration of their status.
Conclusion: In case of dilated main pancreatic duct, PJ 
must be indicated because of its good effi ciency on pain 
relief with low mortality and morbidity rates.
FOS298
DOUBLE OMENTAL FLAP REDUCED 
PERI-ANASTOMOTIC COLLECTIONS 
AND RE-LAPAROTOMY RATES AFTER 
PANCREATICODUODENECTOMY WITH 
PANCREATICOGASTROSTOMY
E. Rosso, C. Nobili, E. Oussoultzoglou, P. Addeo 
and P. Bachellier
Hepato-Bilio-Pancreatic Surgery and Liver Transplantation 
Center, University of Strasbourg, France
Introduction: Omental fl ap has been proposed after pancre-
aticoduodenectomy (PD) to reduce perioperative morbidity. 
In view to verify such hypothesis we compared the results 
of double omental fl ap (DOF) after PD with pancreaticogas-
trostomy (PG) to a standard technique.
Methods: From January 2009 to December 2009, 61 patients 
underwent PD with PG for pancreatic adenocarcinoma in our 
department. Perioperative data were prospectively recorded, 
and postoperative outcome of patients who underwent or not 
a DOF (group DOF+ = 33 and group DOF− = 28, respec-
tively) was analyzed.
Results: The overall postoperative mortality was 1.6% (n = 
1). The overall postoperative morbidity rate was 27.8% (n = 
17). PF occurred in 8 (13.1%) patients and was of grade A 
in 6 (9.8%) patients. Clinically relevant PF (grade B and C) 
occurred in 2 (3.2%) patients. The univariate analysis showed 
that in the DOF+ groups there was a signifi cant reduction of 
peri-anastomotic collections (P = 0.034) and a signifi cant 
reduction of the re-laparotomy rate (P = 0.05).
Conclusion: The DOF contributed to reduce the rate of per-
anastomotic collections as well as the rate of re-laparotomy. 
A DOF should be considered a further step toward a reduc-
tion of surgical related complications after PD with PG.
FOS299
RANDOMIZED PROSPECTIVE STUDY 
ON THE OPTIMAL EXTENT OF 
RESECTION IN PANCREATIC 
HEAD CANCER
J.-Y. Jang1, S.-W. Kim1, D. W. Choi2, S. H. Choi2, 
S. J. Park3, D. S. Yoon4, B. H. Cho5 and K. J. Kang6
1Seoul National University, Seoul, Korea; 2Sungkyunkwan 
University, Seoul, South Korea; 3National Cancer Center, 
Goyang-si Gyeonggi-do, Korea; 4Yonsei University, Seoul, 
Korea; 5Chonbuk National University, Jeonju, Korea; 
6Keimyung University, Daegu, South Korea
Introduction: Although many surgeons have tried to 
improve survival outcome of pancreatic ductal adenocarci-
noma (PDAC) introducing aggressive resection of lymph 
node and nerve plexus along vessels, there was not enough 
evidence that extensive surgery could prolong survival. 
This study is designed to establish a surgical guideline for 
extent of surgery in the management of pancreatic head 
cancer.
Methods: Total of 253 patients was enrolled from 13 major 
hospitals in Korea. Web based randomization was completed 
in 200 patients; Participants were allocated to standard (SL) 
or extended lymphadenectomy group (EL). 167 patients 
from 7 centers who fulfi lled the inclusion criteria were fi nally 
included for further analysis. Surgical procedure was stan-
dardized through repeated consensus meetings and con-
fi rmed by operation photographs. All of the study subjects 
were followed up for at least 2 years after operation.
Results: There was no difference between two groups in 
terms of patient demographics or preoperative disease status. 
Operation time was longer and estimated blood loss was 
higher in EL than SL. R0 resection rate was comparable 
between 2 groups (85.5% (SL) vs. 90.7% (EL)). The retrieved 
lymph node number was higher in EL (33.7 (EL) vs. 17.3 
(SL)), but AJCC stage was comparable in each group (p = 
0.443). Morbidity rate was slightly higher in EL than SL 
(43.0% vs. 32.5%). There were 2 operative mortality in EL 
while no mortality in SL (p = 0.497). SL versus EL revealed 
comparable survival outcome after R0 resection (19 m vs. 
18 m, p = 0.239). There was no survival difference according 
to extent of lymphadenectomy regardless of lymph node 
metastasis.
Conclusion: This multicenter prospective randomized clini-
cal trial suggests that extended lymphadenectomy with nerve 
plexus excision has no signifi cant survival benefi t in patients 
with pancreatic head cancer when compared with standard 
lymphadenectomy. Keeping a balance between oncologic 
radicality and quality of life after pancreatectomy, standard 
resection is enough operation method for the management of 
pancreatic head cancer.
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FOS300
CHANGING TRENDS OF SURGICAL 
MANAGEMENT FOR PANCREATIC 
DISEASE AT A SINGLE HIGH 
VOLUME INSTITUTION
K. Soares1, M. Makary1, J. Cameron1, L. Zheng2, 
C. Nahime1, R. Schulick1, C. Wolfgang1 and B. Edil1
1Department of Surgery, Johns Hopkins Hospital, 
Baltimore, MD; 2Department of Oncology, Johns Hopkins 
Hospital, Baltimore, MD
Introduction: Laparoscopic pancreatic surgery (LPS) has 
been slow in gaining acceptance. Pancreatic resection is 
associated with 40% morbidity, the largest component being 
wound complications (18%) which can signifi cantly delay 
recovery. We examine the changing trend towards minimally 
invasive pancreas surgery at a high volume institution which 
has implications in the training of future pancreatic 
surgeons.
Methods: This is a single institution retrospective review 
from a prospectively collected database from June of 2006 
to December of 2011. Main outcome measures include oper-
ative time, length of hospital stay, lymph nodes resected, and 
tumor size.
Results: 113 laparoscopic pancreatic resections were per-
formed: 89 distal pancreatectomies (LDP), 20 whipples 
(LW), 3 enucleations, and 1 central pancreatectomy. LDP 
mean operative time was 258 minutes. Average length of stay 
(LOS) was 5.9 days, and 37% of the LDPs were spleen 
preserving. Mean tumor size was 2.3 cm and an average of 
11.4 lymph nodes were harvested. LW mean operative time 
was 454 minutes, average LOS was 11.7 days, and mean 
tumor size was 2.7 cm with an average of 19 lymph nodes 
harvested.
The number of laparoscopic pancreatic resections increased 
signifi cantly over this fi ve-year period (3 cases in 2006 to 43 
in 2011). The average wound infection rate of 18% seen with 
open resections drops down to 2% in LPS (p < 0.05).
Conclusion: Totally laparoscopic resections can be done 
safely while maintaining oncologic principals. Minimally 
invasive technique allows for an improvement in morbidity, 
primarily with wound infections. This has led to a shift at 
our institution with the progressive increase of laparoscopic 
resections from 2006–2011. Surgical training will need to 
evolve by making a concerted effort to emphasize advanced 
laparoscopic skills in the education of future pancreatic 
surgeons.
FOS301
INVESTIGATING NOTCH 2 IN 
PANCREATIC CANCER
M. Masood1, C. Neal1 and D. Berry2
1University Hospitals of Leicester NHS Trust, UK; 
2University Hospital of Wales, Wales, UK
Introduction: Pancreatic cancer is an aggressive malig-
nancy with low survival rates. Novel therapies are urgently 
required to improve patient survival. Abnormal Notch signal-
ling has been implicated in several malignancies including 
pancreatic ductal adenocarcinoma (PDAC). Down regulation 
of Notch signalling could be considered as a novel approach 
for pancreatic cancer therapy. Our aim is to investigate Notch 
2 expression in pancreatic cancer and to check its response 
to curcumin and Gamma Secretase Inhibitors.
Methods: A primary antibody for the active form of Notch 
2 was obtained and validated. Pancreatic cancer tissue slides 
were checked for the presence of Notch 2 using immunohis-
tochemistry. Pancreatic cancer cells were treated with 
increasing concentrations of Gamma Secretase Inhibitors 
(GSI) and curcumin, separately, for a period of 24 hours, 
using DMSO as control. The effect on Notch 2 signalling 
pathway was examined using western blot analysis.
Results: Notch 2 was present in the pancreatic cancer cells 
and was signifi cantly overexpressed in pancreatic cancer 
tissue. There was no decrease in Notch 2 levels when treated 
with increasing concentrations of GSIs and curcumin.
Conclusion: Notch 2 is overexpressed in pancreatic cancer 
tissue. Our results suggest curcumin does not utilize Notch 
2 signalling pathway when inhibiting nuclear factor-B 
(NF-B) pathway in causing cell growth inhibition and apop-
tosis in pancreatic cancer cells. Gamma secretase induced 
cleavage is one of the key steps in Notch activation and 
inhibition of GS activity has inhibited tumour progression in 
murine models of PDAC. The lack of activity of the GSI 
against Notch 2 requires further investigation.
FOS302
MATHEMATICAL MODELING REVEALS 
THE NUMBER OF BIOMARKERS 
REQUIRED FOR ACCURATE 
PANCREATIC ADENOCARCINOMA 
DETECTION
M. A. Firpo1, S. J. Mulvihill1 and K. M. Boucher2
1Department of Surgery and Huntsman Cancer Institute, 
Salt Lake City, UT, USA; 2Department of Oncological 
Sciences and Huntsman Cancer Institute, Salt Lake City, 
UT, USA
Introduction: Most patients with pancreatic adenocarci-
noma (PA) present after the disease has advanced to an 
incurable stage. Screening for PA would likely improve out-
comes through earlier detection, but could result in unaccept-
able levels of false-positive diagnoses using current 
biomarkers. We used characteristics of nine PA biomarkers 
measured in human sera to model the behavior of biomarker 
panels in order to delineate the number of biomarkers 
required for accurate detection of PA.
Methods: Levels of AXL, CA 19-9, haptoglobin, hyal-
uronic acid, MMP-7, MMP-11, osteopontin, serum amyloid 
A, and TIMP-1 were measured in sera from 117 healthy 
control subjects and 58 chronic pancreatitis patients, and 159 
PA patients prior to treatment.. Threshold indicators were 
constructed for individual biomarkers at the 95th percentile 
of the control value. We modeled the behavior of a biomarker 
panel consisting of a sum of indicator variables, then chose 
a cutoff for the sum to force specifi city to be high, and cal-
culated the sensitivity. To generate correlated biomarkers, we 
simulated correlated continuous biomarker data, made a 95th 
percentile cutoff for each biomarker, and then assessed per-
formance as above.
Results: Between 17% and 75% of the PA cases had values 
above the 95th percentile of control values with an average 
sensitivity for all biomarkers of 32%. The correlation 
between the indicator variables was near zero in controls and 
slightly positive in PA cases. None of the biomarkers were 
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highly correlated. The model shows that a panel consisting 
of 40 biomarkers characterized individually by 32% sensitiv-
ity at 95% specifi city would require any 7 biomarkers to be 
above the threshold and would result in an panel specifi city 
and sensitivity of 99% each. The addition of correlation 
assumptions reduced sensitivity for the 40 biomarker panel 
to 94% at an average correlation of 0.05 and 84% at an 
average correlation of 0.15.
Conclusion: Our modeling shows that a highly accurate, 
blood-based PA diagnostic panel can be developed from a 
reasonable number of individual serum biomarkers that are 
relatively weak classifi ers when used singly. The model pro-
vides a framework for maximizing biomarker sensitivities 
and minimizing biomarker correlation. A panel constructed 
as described is advantageous in that a high level of specifi city 
can be forced and allows for heterogeneity among patients 
and their tumor characteristics.
FOS303
PANCREATIC ENUCLEATIONS: 
PANCREATIC FISTULA RISK DEPENDS 
ON TUMOR LOCALIZATION
F. Faitot1, S. Gaujoux1, B. Blanc1, safi  Dokmak1, 
R. Cherif1, P. Ruszniewski2, J. Belghiti1 and A. Sauvanet1
1Department of HPB Surgery, PMAD, Beaujon Hospital, 
AP-HP; 2Department of Pancreatology, PMAD, Beaujon 
Hospital, AP-HP, France
Introduction: In selected patients with small and benign 
pancreatic neoplasms, enucleation is an alternative to stan-
dard resections. Enucleation is associated with a decreased 
incidence of long-term pancreatic insuffi ciency but its spe-
cifi c morbidity is little known. The aim of this study was to 
evaluate postoperative morbidity with a special attention to 
pancreatic fi stula risk following pancreatic enucleation.
Methods: From 1996 to 2010, 126 consecutive patients who 
underwent 129 pancreatic enucleations (3 multiple) were 
included. Patients who had resection of uncinate process 
or enucleation associated with standard resection were 
excluded. Enucleation was considered in benign or low-
grade neoplasms without any contact with the main pancre-
atic duct after intraoperative assessment by ultrasonography. 
Hemostasis and pancreatostasis were performed using 
stitches only, and peripancreatic drainage systematically 
used. Pancreatic fi stula was defi ned and graded according to 
the ISGPF defi nitions. Predictive risk factors of pancreatic 
fi stula were studied by uni- and multivariate analysis.
Results: Enucleation was indicated for branch-duct IPMN 
(n = 37, 29%), non functioning endocrine tumor (n = 35, 
28%), mucinous cystadenoma (n = 24, 19%) insulinoma (n 
= 11, 9%), and miscellaneous (n = 19, 15%). Mean tumor 
size was 21 mm (range: 6–60, median = 15). Tumor were 
localized in distal pancreas (n = 46, 37%), uncinate process 
(n = 33, 26%), head (n = 25, 20%) and neck (n = 22, 17%). 
Mortality was 0.8% (n = 1). Morbidity was 59% (n = 74), 
mainly represented by pancreatic fi stula (n = 72, 57%) 
including 52 (70%) graded B or C. In multivariate analysis, 
only uncinate localization was associated with an increased 
risk of pancreatic fi stula (p = 0.02; HR 1.7). With a 22 
months median follow-up, de novo diabetes and tumor recur-
rence occurred in 0.8% and 6.3%, respectively.
Conclusion: After pancreatic enucleation, pancreatic fi stula 
occurred in about two-thirds of patients, especially when 
tumor is located in the uncinate process. This increased mor-
bidity is justifi ed by excellent long-term outcome. It repre-
sents an excellent alternative to standard pancreatic 
resections, especially Whipple procedure, in highly selected 
patients with small benign lesions.
FOS304
INTRAPANCREATIC ACTIVATED GLIA 
IS A HALLMARK OF PANCREATIC 
NEUROPATHY IN PANCREATIC CANCER
E. Tieftrunk, I. E. Demir, T. Kehl, H. Friess 
and G. Ceyhan
Department of Surgery, Klinikum Rechts der ISAR, 
Technische Universitaet Muenchen, Munich, Germany
Introduction: Pancreatic neuropathy in pancreatic adeno-
carcinoma (PCa) is characterized by intrapancreatic neural 
hypertrophy, neural sprouting, pancreatic neuritis and neural 
invasion, resulting in abdominal neuropathic pain sensation. 
However, the role of glia cells as the key actor in peripheral 
neuropathies and pain has not yet been investigated in PCa. 
Therefore, our aim in this study was to elucidate the activa-
tion state of peripheral glia, i.e. Schwann cells, in pancreatic 
neuropathy in PCa.
Methods: To imitate the conditions in PCa microenviron-
ment, human Schwann cells (hSc) were cultivated under 
hypoxia and within PCa cell supernatants for varying time 
periods. To assess the activation state of hSc, the three car-
dinal features of reactive glia, i.e. enhanced proliferation, 
cellular hypertrophy and upregulation of the intermediate 
fi laments GFAP, nestin and vimentin were investigated 
via MTT proliferation assay, cell area measurement and 
immunoblotting.
Results: hSc demonstrate a prominent upregulation of 
GFAP, nestin and vimentin under hypoxia. When exposed to 
components of PCa microenvironment, hSc showed increased 
proliferation, enhanced GFAP expression and a star-like cel-
lular conformation (“stellation”). In contrast, these parame-
ters of glial activation were completely absent when hSc 
were exposed to colon cancer cell supernatants.
Conclusion: Intrapancreatic glia is specifi cally activated 
during PCa and bears all known major characteristics of 
reactive glia, as known from astrocytes of the central nervous 
system. This seminal demonstration of activated glia in a 
visceral neuropathy has profound implications for proper 
understanding of the neuropathic pain syndrome in PCa.
FOS305
REDO-OPERATIONS IN CHRONIC 
PANCREATITIS – A SUCCESSFUL 
OPTION FOR SELECTED PATIENTS
T. Hackert, C. Tjaden, S. Lutz, L. Schneider, 
O. Strobel, W. Hartwig, M. Büchler and J. Werner
Department of Surgery, University of Heidelberg, 
Heidelberg, Germany
Introduction: Surgery in chronic pancreatitis (CP) includes 
draining and resecting procedures. Besides chronic pain as 
the main indication, cholestasis and suspicion of malignancy 
are important indications for operations in CP. In a small 
number of CP patients a second operation is required due to 
recurrent CP symptoms. Aim of the study was to determine 
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frequency, indications, surgical procedures and outcome of 
redo-operations in CP patients.
Methods: During an observation period of 8 years, data of 
all CP patients undergoing surgery were analyzed with 
regard to recurrent operations. Indications and surgical 
procedures for the fi rst and second operation were analyzed 
as well as operative parameters, complications and outcome.
Results: During the observation period 665 operations were 
performed in CP patients: 233 Whipple operations, 207 duo-
denum-preserving pancreatic head resections (DPPHR), 48 
distal pancreatectomies and others. A second operation was 
necessary in only 34 patients (5.1%) due to recurrent pain 
(41%), pancreatic or bile duct obstruction (38%), symptom-
atic pseudocysts (18%) and suspected malignancy (3%). 
Secondary operations were Whipple operations (n = 18), 
DPPHR (n = 5), hepatico-jejunostomies (n = 5), total pan-
createctomies (n = 2) and drainage procedures (n = 4). 
Median time between primary and second operations was 
3.1 y. No perioperative deaths occurred, morbidity was 27%. 
Life quality improved signifi cantly and opioid pain medica-
tion was required in only 16.
Conclusion: Redo-operations in CP are rarely necessary 
(5%). Indications mainly include recurrent pain and cholesta-
sis. Surgery can be performed with low morbidity and mor-
tality and results are excellent in long-term outcome. The low 
need for surgical reinterventions supports the concept of 
organ and function preserving resections such as duodenum-
preserving pancreatic head resections.
FOS306
LAPAROSCOPIC DISTAL PANCREATIC 
RESECTION: IS THERE A LEARNING 
CURVE?
S. Dokmak1, B. Aussilhou1, F. S. Ftériche1, B. Blanc1, 
P. Lévy2, P. Ruszniewski2, J. Belghiti1 and A. Sauvanet1
1Department of Hepatobiliary and Pancreatic Surgery, 
Hospital Beaujon, Clichy, France; 2Departement of 
Gastroenterology and Pancreatic Diseases, Hospital 
Beaujon, Clichy, France
Introduction: laparoscopic distal pancreatic resections 
(LDPR) are more and more performed. The impact of the 
learning curve is not well known. Our aim was to study the 
results of LDPR during 2 consecutive periods.
Methods: From a prospective unicentric maintained data-
base, 55 patients who underwent LDPR between January 
2008 and December 2011 were included and divided in 2 
periods, including period 1 (January 2008-decembre 2009; n 
= 20) and period 2 (January 2010-decembre 2011; n = 35). 
Age, sex, body mass index (BMI), indication, operative 
(duration, blood loss, conversion, hand-assisted, necessity of 
sacrifi ce of the spleen or its vessels) and postoperative data 
(mortality, pancreatic fi stula [PF], re intervention, mean hos-
pital stay) were studied. No difference between periods 1 vs 
2 regarding age (51 vs 56; p = 0.12), sex (F/M = 14/6 vs 
17/18. p = 0.12), BMI (24.8 vs 26.3 kg/m², p = 0.48).
Results: Comparison of Periods 1 vs 2 showed less resec-
tions for adenocarcinoma (5% vs 20%; p = 0.129), more 
blood loss (256 ml vs 215 ml; p = 0.63), longer duration 
(254 mn vs 172 mn, p < 0.001), more conversion (15% vs 
8.6%; p = 0.46), less hand-assisted (0% vs 17.1%; p = 
0.021%) and re interventions (10% vs 0%; p = 0.05). In the 
subgroup of patients scheduled for pancreatectomy without 
splenectomy (n = 33), we note higher rate of splenectomy 
(21.4% vs 0%. p = 0.025) but no signifi cant difference 
regarding the sacrifi ce of splenic vessels (28.5% vs 47%; p 
= 0.53). No difference regarding mortality (0%), PF rate 
(70% vs 62.9%; p = 0.87) and the hospital stay (24 [8–70] 
vs 18 j [10–34], p = 0.11).
Conclusion: there is probably a learning curve allowing 
more rapid and safer resection with little impact on the post-
operative course. The lower conversion and unnecessary 
splenectomies rate can be explained by the learning curve, 
the hand assisted procedure and the sacrifi ce of the splenic 
vessels.
FOS307
PANCREATIC RESECTIONS FOR CYSTIC 
NEOPLASMS: FROM THE SURGEON’S 
PRESUMPTION TO THE 
PATHOLOGIST’S REALITY
G. Malleo, G. Marchegiani, S. Paiella, S. Pennacchio, 
M. Paini, A. Pea, C. Bassi and R. Salvia
General Surgery B, Pancreas Unit, G.B. Rossi Hospital, 
Department of Surgery, University of Verona, Italy
Introduction: Current guidelines for the management of 
pancreatic cystic neoplasms are based on the assumption that 
these lesions can be classifi ed correctly on the basis of fea-
tures of cross-sectional imaging. But a certain degree of 
overlap between different lesions exists, and little is known 
about the rate of inaccurate preoperative diagnoses. To 
address this issue, preoperative and fi nal pathologic diagno-
ses of patients resected for a presumed pancreatic cystic 
neoplasm were compared.
Methods: Retrospective analysis was undertaken of patients 
managed operatively between 2000 and 2010. Preoperative 
work-up was reviewed to identify diagnostic pitfalls and 
potential risk factors for incorrect preoperative characteriza-
tion of cystic lesions presumed to be neoplastic.
Results: 476 patients were analyzed. Final pathologic 
diagnosis matched the preoperative diagnosis in 78% of 
cases. The highest accuracy was reached for solid pseudo-
papillary neoplasms (95%) and for main duct/mixed duct 
IPMNs (81%). Surprisingly, 23 cysts (5%) were found to 
be ductal adenocarcinoma, while 45 patients (9%) under-
went a pancreatic resection for a non-neoplastic condition. 
The use of a routine radiologic work-up, including con-
trast-enhanced US and MRI, was associated with a favor-
ably correct characterization of the cystic lesion. EUS did 
not seem to improve diagnostic accuracy. Increased levels 
of serum CA19-9 resulted as risk factors for an incorrect 
diagnosis as well as for a fi nal diagnosis of ductal 
adenocarcinoma.
Conclusion: Overall rate of inaccurate preoperative diagno-
ses in a tertiary care center with a broad experience in pan-
creatology approached 22%. Serum Ca 19-9 is an important 
complementary tool within the context of preoperative inves-
tigation of cystic neoplasms of the pancreas.
 Free Orals Abstracts 237
© 2012 The Authors
HPB 2012, 14 (Suppl. 2), 107–287 HPB © 2012 Americas Hepato-Pancreato-Biliary Association
FOS308
NEUTROPHIL-LYMPOCYTE RATIO 
(NLR) AS A PREDICTOR OF POOR 
PROGNOSIS IN ACUTE PANCREATITIS: 
VALIDATION OF AN OPTIMAL NLR
A. Suppiah, D. J. Malde, T. Arab, A. M. Smith and 
G. Morris-Stiff
The HPB and Transplant Unit, St James University 
Hospital, Leeds, UK
Introduction: Current scoring systems in acute pancreatitis 
pancreatic (AP) are cumbersome and require multiple inves-
tigations and delay in scoring. Early deterioration in AP is 
associated with marked infl ammatory response.
Methods: Neutrophil to lymphocyte ratio (NLR) was calcu-
lated on Day 1, 2 and 3 of admission and correlated with 
outcome. Poor outcome was defi ned as intensive care admis-
sion, need for nutritional support, complications directly 
associated with pancreatitis, pancreatic necrosis or death.
Results: 146 consecutive patients (January-December 
2010) were included with 22 having poor outcome. NLR in 
the poor prognosis group was signifi cantly higher than in the 
favourable prognosis group on all 3 days (Day 1: 17.4 vs. 
13.3; Day 2: 16.2 vs. 10.2; Day 3: 14.6 vs. 7.2). The optimal 
cut-of calculated from a ROC curve was 10.6, 8.1 and 4.8 
on Day 1, 2 and 3 respectively giving a sensitivity (Sn) and 
Specifi city (Sp) of 63.6% and 56.7% (Day 1); 86.4% (Sn) 
and 50% (Sp) Day 2; 90.9% (Sn) and 53.5% (Sp) Day 3. The 
Positive and Negative values of poor outcome were 21.2% 
and 89.5% on Day 1, 31.1% and 93.3% on Day 2 and 29.9% 
and 96.4% on Day 3.
Conclusion: Admission and early NLR is signifi cantly 
higher in patients with poor outcome and is an independent 
predictor of poor prognosis.
FOS309
PORTAL VEIN STENOSIS: 
POSTOPERATIVE COMPLICATION OF 
PANCREATICODUODENECTOMY AND 
ITS MANAGEMENTS
A. Kenjo, T. Tsuchiya, T. Kimura, T. Anazawa, J. Haga, 
T. Sato, N. Sato and M. Gotoh
Department of Hepato-Biliary-Pancreatic Surgery, 
Fukushima Medical University, Fukushima, Japan
Introduction: Portal vein stenosis (PVS) after pancreatico-
duodenectomy (PD) is one of the notable complications 
which require adequate treatment. It may cause fatal gastro-
intestinal bleeding due to formation of gastrointestinal 
varices. We conducted retrospective study for portal vein 
stenosis after PD.
Methods: Among 98 patients undergoing PD in our institute 
from 2000 to 2010, 25 PVS were diagnosed by CT scan with 
typical collateral formation. Fifteen cases were due to local 
recurrence of tumor diagnosed with median postoperative 
time (MPT) of 14 months. Remaining no-malignant, benign 
PSV cases, diagnosed with MPT of 1 month (n = 10), were 
compared retrospectively with non-PSV cases (n = 73) on 
preoperative demographic, clinical data, surgical procedure, 
pathological diagnosis, and postoperative complications.
Results: There was no statistically signifi cant difference in 
parameters collected between the groups, however, the inci-
dence of postoperative pancreatic fi stula (PVS: 5/10, 50% / 
non-PVS: 21/73 28.8%) and perioperative irradiation (PVS: 
3/10, 30% / non-PVS: 14/73, 19.2%) tended to be higher in 
PVS than non-PVS. Periportal fl uid collections were usually 
found in most of the cases (8 of 10) within a week. PVS were 
found only in cases performing ante-colic reconstruction of 
pancreatico-intestinal anastomosis (10 of 55), but not in 
cases performing retro-colic approach (0 of 18). Two of 3 
PVS cases suffering from gastrointestinal bleeding from gas-
trointestinal varices were successfully treated with insertion 
of expandable metallic stent in portal vein.
Conclusion: Pancreatic fi stula, perioperative irradiation or/
and antecolic reconstruction of alimentary tract seemed to be 
risk factors for causing PVS and needs to be determined in 
the future prospective study.
FOS310
K-RAS MUTATION ANALYSIS IN 
ENDOSONOGRAPHY-GUIDED FINE 
NEEDLE ASPIRATION OF PANCREATIC 
SOLID LESIONS
G. Perrone1, M. L. Gaeta1, C. Brunelli1, 
M. Pandolfi 2, D. Borzomati3, F. M. Di Matteo2, 
R. Coppola3 and A. O. Muda1
1Department of Surgical Pathology, Università Campus 
Bio-Medico di Roma, Rome, Italy; 2Unit of Digestive 
Endoscopy, Università Campus Bio-Medico di Roma, 
Rome, Italy; 3Department of General Surgery, Università 
Campus Bio-Medico di Roma, Rome, Italy
Introduction: KRAS gene mutations (point mutations of 
codon 12) have been found in 75–90% of infi ltrating PADC 
and such a frequency seems suffi ciently high to deserve diag-
nostic application. Aim of the present study was to investigate 
the feasibility and reproducibility of combined cytopathologi-
cal examination and KRAS mutation analysis in improving 
the diagnostic accuracy on atypical/indefi nite pancreatic FNA 
samples obtained by endoscopic ultrasonography.
Methods: KRAS mutation analysis in codon 12 was per-
formed in 29 EUS-FNA specimens from patients with an 
atypical/indefi nite cytopathological diagnosis which were 
subsequently diagnosed as PADC (n = 23) or chronic pan-
creatitis (n = 6). As controls, KRAS mutation analysis was 
also performed in histological samples from patients with 
chronic pancreatitis (n = 10) and pancreatic adenocarcinoma 
(n = 10). In the latter group mutation analysis was performed 
also in areas of chronic pancreatitis collected at a distance 
from the tumour.
Results: In histological samples, signifi cant differences 
were found between carcinoma vs. non neoplastic tissue (p 
= 0.0001) in terms of KRAS mutation: all tumor samples 
were mutated, with an allele frequency of mutation ranging 
from 7% to 36%. Conversely, allele frequency of mutation 
in pancreatitis samples (associated or not with carcinoma) 
ranged from 0% to 5%. On this basis, 6% of allele frequency 
of KRAS mutation was defi ned as an adequate cut-off to 
distinguish neoplastic from non-neoplastic lesions.
In FNA specimens obtained at EUS-FNA, mutation rate 
was constantly <6% in all patients with a fi nal diagnosis of 
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chronic pancreatitis. In patients with fi nal diagnosis of PADC, 
the mutation rate of KRAS was >6% in 13/23 (56%) patients.
Conclusion: Our preliminary data suggest that in case of 
atypical/indefi nite diagnosis on FNA of pancreatic solid 
lesions, KRAS mutation analysis may be useful in strongly 
suggesting a diagnosis of PADC.
FOS311
DOES RADIOFREQUENCY ABLATION 
POSITIVELY IMPACT ON DISEASE 
PROGRESSION IN PATIENTS AFFECTED 
BY LOCALLY ADVANCED PANCREATIC 
CANCER? RESULTS FROM 134 
CONSECUTIVE CASES
P. Regi1, R. Girelli1, I. Frigerio1, A. Giardino1, 
R. Salvia2 and C. Bassi2
1Surgical Department, HPB Unit, CDC Dott. Pederzoli, 
Peschiera Del Garda, Verona, Italy; 2Surgical and 
Gastroenterological Department, Policlinico GB Rossi, 
University of Verona, Italy
Introduction: Around 80% of patients affected by pancre-
atic cancer are not eligible for radical surgery at time of 
presentation, due to the presence of local spread of disease 
or distant metastases. Radiofrequency ablation (RFA) repre-
sents a valid therapeutic option as part of the multidisci-
plinary management of locally advanced pancreatic cancer 
(LAPC). We investigated the patterns of disease-progression 
after RFA for LAPC in the largest single-center series avail-
able in literature.
Methods: A retrospective analysis of our Institution data-
base was performed between the date February 2007 and 
June 2011 searching for patients who underwent RFA for 
histologically proven LAPC (AJCC classifi cation stage III). 
Demographics, surgical and follow-up data were collected 
and statistically analyzed. Primary endpoint was progres-
sion-free survival (PFS) considered as time between diagno-
sis and imaging-based evidence of disease-progression. 
Survival estimations were reported as median and interquar-
tile (IQR) range based on Kaplan-Meier curves and com-
pared using the log-rank test at univariate analysis (a P-value 
<0.05 was considered signifi cant). Multivariate analysis was 
carried out using a backward stepwise Cox regression model.
Results: A total of 134 patients meeting the inclusion criteria 
were enrolled. Overall survival and PFS was 23 (IQR: 12–35; 
CI95%: 18.4–27.6) and 14 months (IQR: 24–8; CI95%: 12.1–
15.9), respectively. Factors associated with a worse PFS 
resulted: age >67 years (13 vs 20 months; P = 0.010), tumor 
size >35 mm (12 vs 18 months; P = 0.042), baseline CA 19-9 
level >80 U/mL (13 vs 20 months; P = 0.011), upfront-RFA 
(11 vs 15 months; P = 0.042) and a CA 19-9 level ratio (POD7/
baseline) >0.75 (11 vs 16 months; P = 0.039). Multivariate 
analysis indicated age (HR: 2; CI95%: 1.266–3.343; P = 
0.004), tumor size (HR: 1.7; CI95%: 1.038–2.863; P = 0.035) 
and upfront-RFA (HR: 2; CI95%: 1.228–3.239; P = 0.005) as 
independent predicting factors for early disease progression.
Conclusion: The prognosis of patients affected by LAPC 
still remains particularly poor even when chemoradiation 
alone is provided. However, this study shows that RFA com-
bined to standard palliative therapy may enhance the control 
of disease progression in selected patients and improve, as a 




PANCREATIC AND PERIAMPULLARY 
ADENOCARCINOMAS
Y-M. Shyr, S-E. Wang and C-H. Su
Taipei Veterans General Hospital, Taipei
Introduction: In this study, we investigated the role of a 
palliative pancreaticoduodenectomy in pancreatic and peri-
ampullary adenocarcinomas by evaluating the surgical risks 
and survival outcomes with different surgical approaches and 
resection margins. We provided the incidence of palliative 
pancreaticoduodenectomy and determined the predictors for 
resection margin status in periampullary adenocarcinomas.
Methods: Data on patients with periampullary adenocarci-
noma who underwent surgery were analyzed. Survival 
outcomes were compared between resections and bypass 
operations, and between curative (R0) and palliative resec-
tions, with a microscopically (R1) and a grossly (R2) positive 
resection margin.
Results: There were 595 surgical patients, including 47.4% 
curative resections (R0) and 17.8% palliative resections (R1 
+ R2). The positive margin rate after a pancreaticoduodenec-
tomy was 8.0% for a R1 and 19.3% for a R2. For periampul-
lary adenocarcinomas, there was a signifi cant survival 
difference between the R0, palliative, and no resection 
groups. However, there was no signifi cant survival differ-
ence between the R0 curative resections and the palliative 
pancreaticoduodenectomies for pancreatic head adenocarci-
noma. Note that the survival outcome after either a curative 
or a palliative pancreaticoduodenectomy was still better than 
the survival outcome of a bypass operation.
Conclusion: There was a survival benefi t after a pancreati-
coduodenectomy regardless of the resection margin or 
primary origin of the periampullary adenocarcinoma, as 
compared to a bypass operation. The resection margin after 
a pancreaticoduodenectomy did not play a role in the sur-
vival outcome in pancreatic head adenocarcinoma. Therefore, 
we recommend that pancreaticoduodenectomies should be 
attempted whenever possible.
FOS313
RADIOFREQUENCY ABLATION OF 
PANCREATIC CANCER – OVERVIEW
V. Shelat, J.K. Low and W. Woon
Department of General Surgery, Tan Tock Seng Hospital, 
Singapore
Introduction: Pancreatic ductal adenocarcinoma (PDAC) is 
one of the most aggressive cancers with less than a quarter 
patients being resectable at presentation. Overall 5-year-
survival is in single digits. Advances in surgical techniques, 
critical care, molecular diagnosis, diagnostic imaging, endo-
sonology and adjuvant therapy have been inadequate and 
there is an urgent need to discover other options that may 
impact survival. Radiofrequency ablation (RFA) is a thermal 
ablative therapy that is time tested.
Methods: A review of English literature in PubMed was 
done using the MESH terms for PDAC and RFA. All the 
articles were reviewed and core information was tabulated 
for reference. After a comprehensive review of all articles 
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the data was evaluated to discover the role of RFA in PDAC 
management.
Results: Indications, contraindications, feasibility, success 
rate, safety, complications and impact on survival were 
reviewed and are discussed further.
Conclusion: RFA appears to be an attractive option for non 
metastatic locally advanced PDAC. RFA is feasible but has 
a signifi cant morbidity and there is no evidence to suggest 
survival benefi t. The incorporation of RFA in the multimodal 
management of PDAC should be yet considered 
experimental.
FOS314
ANTIBIOTIC PROPHYLAXIS IN ACUTE 
PANCREATITIS: TO GIVE, OR NOT TO 
GIVE ...
Z. Dambrauskas1, P. Ignatavicius1, A. Vitkauskiene2, 
A. Gulbinas3, J. Pundzius1 and G. Barauskas1
1Department of Surgery, Lithuanian University of Health 
Sciences, Kaunas, Lithuania; 2Department of Laboratory 
Medicine, Lithuanian University of Health Sciences, 
Kaunas, Lithuania; 3Laboratory of Surgical 
Gastroenterology, Institute for Digestive System Research, 
Lithuanian University of Health Sciences, Kaunas, 
Lithuania
Introduction: The antibiotic prophylaxis during acute pan-
creatitis remains very contraversial topic, therefore the aim 
of this study was to assess the effects of prophylactic antibi-
otics and treatment on demand in prospective fashion.
Methods: The population of this study consisted of 210 
patients treated for severe acute pancreatitis. Group I (n = 
103) patients received prophylactic antibiotics (Ciprofl oxacin, 
Metronidazole). Group II (n = 107) patients were treated on 
demand according to the bacterial culture results (however, 
this was not done in randomized fashion but in different 
management schemes were applied in different cohorts of 
patients). When infected necrosis of pancreatic tissue was 
confi rmed, ultrasound-guided drainage or surgical debride-
ment of infected necrosis was performed. The primary end 
points were complication rate, the need and timing of surgi-
cal interventions, the incidence of nosocomial infections, and 
mortality rate.
Results: Ultrasound-guided fi ne needle aspiration (FNA), 
Ultrasound-guided drainage (UGD) and open surgical necro-
sectomy were performed more frequently (24 vs 13, 19 vs 6 
and 10 vs 5) and earlier (13.21 ± 8.97 vs 17.23 ± 6.68 and 
15.79 ± 10.91 vs 24.50 ± 14.18) in the course of the disease 
in Group II comparing to Group I (p < 0.05). There were no 
signifi cant (p > 0.05) differences between groups, when ana-
lyzing incidence of main outcomes and length of stay on 
surgical ward and intensive care unit.
Conclusion: Our data supports the recommendation to use 
prophylactic broad-spectrum antibiotics in CT-proven severe 
necrotizing pancreatitis, as this strategy results in decreased 
need for interventional and surgical management, decreased 
number of re-operations, although not affecting the rate of 
mortality.
FOS315
LONG TERM PANCREATIC FUNCTION 
AFTER PANCREATODUDENECTOMY 
WITH PANCREATOGASTROSTOMY AND 
PANCREATICOJEJUNOSTOMY
U. F. Wellner, M. Lunkiewicz, A. Lubitz U. T. Hopt and 
T. Keck
Department of General and Visceral Surgery, University of 
Freiburg, Germany
Introduction: Data concerning long-term pancreatic 
function after pancreatoduodenectomy (PD) is limited. 
Traditionally, it is supposed that pancreatogastrostomy 
leads to worse long-term pancreatic function than 
pancreaticojejunostomy.
Methods: Patients were seen during outpatient follow-up 
visits at least one year after operation. Exocrine and endo-
crine pancreatic function were assessed by anamnesis, fecal 
elastase measurements and oral glucose tolerance testing. 
Quality of Life and pancreatic morphology were assessed 
by EORTC QLQ-30/PAN26 and MRI or CT scan, 
respectively.
Results: Pancreatic function was assessed in 38 patients (26 
PG and 12 PJ, age 21–82) operated from 2001 to 2009 with 
a median follow-up of 3 years. Most frequent indications had 
been pancreatic ductal adenocarcinoma (32%) and chronic 
pancreatitis (18%). In total, a high rate of exocrine (90%) 
and endocrine pancreatic insuffi ciency (42%) was seen, the 
majority of which had developed de novo after operation 
(exocrine 79%, endocrine 29%). Comparing PG and PJ, rates 
of exocrine insuffi ciency were similar (PG vs PJ, 89% vs 
92%), but rates of de-novo diabetes were higher after PG 
(PG vs PJ, 35% vs 17%, p = not signifi cant). Quality of life 
could be considered equal in both groups.
Conclusion: Exocrine pancreatic function is impaired in the 
overwhelming majority of patients after PD. Endocrine func-
tion is less often impaired, but the rate of de-novo diabetes 
mellitus is still considerable. We found no signifi cant differ-
ence between PG and PJ with respect to long-term pancreatic 
function but higher case numbers are needed to confi rm these 
results. Regular surveillance of pancreatic function for 3 
years after operation is recommended.
FOS316
RESULTS AND COSTS ANALYSIS OF 
PANCREATICODUODENECTOMY IN 
ELDERLY PATIENTS
M. Del Chiaro, E. Rangelova, C. Ansorge, J. Blomberg, 
Åke Andrén-Sandberg and R. Segersvärd
Division of Surgery, Department of Clinical Science, 
Intervention and Technology (CLINTEC), Karolinska 
Institutet, Stockholm, Sweden
Introduction: It is today accepted that the bad prognosis of 
pancreatic cancer is life time limiting also in old patients. 
However, old age is sometimes considered a contraindication 
for PD due to increased risk of complications and peri-oper-
ative costs. The aim of this study is to analyze short and 
long-term outcome and peri-operative costs in elderly com-
pared to and younger individuals.
Methods: All patients who underwent PD between 2004 
and 2010 at Karolinska University Hospital were retrieved 
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from a prospective data registry and demographics, ASA 
score perioperative results, length of stay (LOS), costs and 
survival were analyzed. The cohort was divided by age into 
elderly (E ≥ 75 years) and younger individuals (Y < 75 
years). In total 367 consecutive PDs (201 males/166 females) 
were identifi ed (E: n = 65; Y: n = 302). The two groups were 
comparable regarding general characteristics except age 
(mean O 78.7 vs. 61.5 years) and pre-operative anesthesio-
logical risk (ASA1 + 2: E 49.0 vs. Y 65.2%; ASA 3 + 4: E 
51.0 vs. Y 34.8%; p = 0.02).
Results: Comparing E with Y there were no differences in 
LOS (E 16 vs. Y 16.7 days), overall post-operative complica-
tion rate (E 55 vs. Y 57%), severe (Clavien score ≥3b) com-
plications (E 16.9 vs. Y 16.5%), re-operation rate (E 6.1 vs. 
Y 7.9%), mortality (E: 1.5 vs Y 3.3%) or overall cost (E 
30570 vs. Y 32176 Euro). The 1, 3 and 5 year survival rates 
were comparable between the two groups in patients with 
pancreatic ductal adenocarcinoma (E: 64.7%, 34.4% and 
7.2% vs. Y 71.9%, 31.2% and 22%; p = 0.5). In contrast, a 
signifi cant difference in 1, 3 and 5 year survival rates was 
found in patients with other periampullary tumors (E: 81.8%, 
43% and 32.3% vs. Y: 87.9%, 69.5% and 62%; p = 0.01).
Conclusion: The current study shows no major differences 
in perioperative morbidity, mortality or costs between elderly 
and younger patients, thus PD can be considered safe in 
elderly patients. Old age is not “prognostic factor” in pan-
creatic ductal adenocarcinoma, but a negative one for patients 
suffering from less aggressive periampullary malignancies. 
On the basis of these results patients should never excluded 
from a PD based on age only.
FOS317
OUTCOME OF PANCREATIC 
RESECTION IN OCTOGENARIANS
C. Sperti, V. Beltrame, B. Bellamio, V. Lico and 
C. Pasquali
Pancreatic and Endocrine Digestive Surgical Unit, Clinica 
Chirurgica IV, University of Padua, Padua, Italy
Introduction: The increasing aging of the Western popula-
tion is obviously accomplished by an increasing number of 
older patients with cancer, including pancreatic cancer. Few 
Authors evaluated the outcome after resection in patients 
aged 80 years or older. Aim of this study was to evaluate a 
single-institution experience of pancreatic resection in 
patients older than 80 years of age.
Methods: Data were retrospectively collected on patients 
who underwent pancreatic resection in our Department from 
1998 to 2010, divided in two groups: group 1, patients under 
80 years of age, and group 2, patients with 80 years of age 
or older. The two groups were compared in term of demo-
graphic features, comorbidities, and surgical procedures. 
Operative morbidity, mortality, and long-term survival were 
analyzed. Prognostic variables were investigated, such as 
stage, grading, lymph node status, radicality of resection. 
Survival curves were constructed with the method of Kaplan–
Meier and compared with Log-rank test; independent prog-
nostic variables were examined with Cox regression analysis. 
Statistical signifi cance was considered as p < 0.05.
Results: There were 518 pancreatic resections: of there 31 
patients were 80 years or older (median 82, range 80–86) 
compared to 487 patients less than 80 (range 45–79). There 
was no signifi cant difference regarding gender, type of 
operation, and pathologic fi ndings between the two age 
groups. No difference was noted in complications rate for 
younger or older group (31 vs 32%) or mortality rate (2.0% 
vs 3.2%). In pancreatic cancer patients, overall median sur-
vival between the two groups was similar (median 19 vs 16 
months; p = 0.86). Tumor’s grading and radicality of resec-
tion were independent prognostic factors for disease-free 
survival, while grading and tumor’s stage were independent 
predictors for overall survival.
Conclusion: Pancreatic resection is a safe option for elderly 
patients. Patients older than 80 years have similar postopera-
tive results and long-term survival compared to younger 
patients. Age alone should not be considered a contraindica-




NEGATIVELY IMPACT ON LONG-TERM 
SURVIVAL IN PATIENTS AFTER 
INCOMPLETE RESECTION FOR 
PANCREATIC HEAD CANCER
D. Petermann, A. Tempia, N. Halkic, N. Demartines 
and M. Schafer
Department of Visceral Surgery, University Hospital 
CHUV, Lausanne, Switzerland
Introduction: Tumor biology, lymph node metastasis, and 
positive resection margins are known major factors that 
severely infl uence early tumor recurrence and survival after 
resection of pancreatic cancer. Since morbidity rates after 
pancreas resection are still increased, it remains to be 
elucidated whether postoperative complications and its 
severity also impact on the long-term survival after 
pancreaticoduodenectomy.
Methods: Out of 252 consecutive pancreatectomies per-
formed between 2000 and 2010, 120 pancreatic head resec-
tions for cancer were retrospectively analyzed. Postoperative 
complications were classifi ed on a 5-grades validated scale 
and were correlated to long-term survival. Grade III and IV 
complications were defi ned as severe complications.
Results: Postoperative overall morbidity and severe mor-
bidity were 55% and 28%, respectively. Median overall sur-
vival was 1.9 years (mean follow-up of 2.0 years). Signifi cant 
prognostic factors of survival were T- and N-stage of the 
tumor and R status of the resection (median survival of 2.4 
years for R0 vs. 1.0 year for R1, p = 0.0011). Median survival 
after severe postoperative complications was decreased from 
2.0 to 1.6 years (p = 0.8). Median survival for N0 or N1 
tumor, or after R0 resection was not infl uenced by the occur-
rence and severity of complications, but patients with a R1 
resection and severe complications showed a signifi cantly 
worsened median survival of 0.8 years vs. 1.8 years without 
severe complications (p = 0.029).
Conclusion: Long-term survival of patients with incom-
plete tumor resection is additionally decreased by the pres-
ence of severe postoperative complications. In all other 
patient groups, tumor-related factors such as T- and N-stage 
are more important risk factors that impact on long-term 
survival. Nevertheless, minimizing postoperative complica-
tions rates represents an important topic in modern pancre-
atic cancer surgery.
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FOS319
“DOUBLE HELIX” PARADIGM IN THE 
MANAGEMENT OF NECROTISING 
PANCREATITIS
S. Philip
Department of GastroIntestinal Surgery, Medical Trust 
Hospital, Kochi, Kerala, India
Introduction: The treatment of Necrotizing Pancreatitis 
(NP) has changed signifi cantly over the past few years in the 
light of new evidence which includes the multicentre Dutch 
and German studies.
The Aim of this study is to defi ne the current place of 
Minimally Invasive (MI) and Open Necrosectomy (ON) 
techniques vis-à-vis Step Up (SU) and Step Down (SD) 
approaches by analysis of published literature till date.
Methods: Multiple comparison of primary and secondary 
data obtained by searches of MEDLINE for the time period 
1996–November 2011 was done. Studies with original data 
and facts on outcome were included. Procedures were clas-
sifi ed as ON, Percutaneous drainage (PD), Percutaneous 
Necrosectomy (PN), Endoscopic Necrosectomy (EN), 
Laparoscopic Necrosectomy (LN) and Retroperitoneal 
Nephroscopic and Laparostomal (RNL) techniques. There 
were 57 studies reporting on 898 patients undergoing MI and 
1080 patients in major series of ON.
Results: In the PD group of 382 patients 44.4% (170) 
required another strategy for treatment. Within the EN group 
32.43% (63) needed additional intervention. The number of 
patients cured by endoscopy alone was 75%. Among the LN 
series of 67 patients 1.65% required reinterventions and 
93.5% were cured by it alone. Median number of patients in 
LN series was 7. PN group had 74 patients of which 72.9% 
did not require any other modality of management and the 
average number of reoperations was 3.1 per patient. In the 
RNL cohort of 240 patients 32.7% were cured by it alone 
and reoperations per patient was 1.2. In the major ON series, 
results differed signifi cantly depending on the type of ON. 
The reoperation range was 5.3–51% and mortality 3–27.3%.
Conclusion: Multidisciplinary management of NP is being 
practiced more commonly. Neither SU nor SD approaches 
can be used as a blanket strategy. A policy adapted to the 
patient’s specifi c needs, based on the anatomic location of 
the necrosis, clinical comorbidities, and operator experience 
decides the best approach. A Double Helix paradigm with 
MI techniques forming one arm, ON forming the other arm 
and the patients clinical and investigational status forming 
the bridge between the two arms will help to plan a more 
fl exible stratagem for management of NP.
FOS320
SURGICAL TECHNIQUES 
PANCREATICOJEJUNOSTOMY AND THE 
PREVENTION METHOD OF INTRA-
ABDOMINAL HEMORRHAGE RELATED 
TO ANASTOMOTIC LEAKAGE ~ 584 
EXPERIENCES IN OUR INSTITUTION
H. Ishikawa, H. Kinoshita, T. Hisaka, M. Yasunaga, 
H. Horiuchi and K. Shirouzu
Department of Surgery, Kurume University School of 
Medicine, Fukuoka prefecture, Japan
Introduction: Increased experience has led to a decline in 
mortality rate after panceraticoduodenectomy (PD), although 
morbidity rates remain high in experienced centers. 
Pancreaticojejunal anastomotic leakage (AL) and intra-
abdominal hemorrhage (AH) related to AL are the most 
common major complications. The aim of this study was to 
evaluate the results of pancreaticojejunostomy (PJ) and the 
prevention method of AH related to AL in our institution.
Methods: A total of 584 consecutive patients underwent PD 
between 1965 and 2010. Pancreas is sharply transected with 
a scalpel, because of intraoperative pathological fi ndings and 
the confi rmation of MPD. The remnant pancreatic stump is 
sealed by using the VIO soft coagulation system. PJ is under-
taken with an end-to-side anastomosis. A mucosal to duct 
anastomosis is performed between the pancreatic duct, as 
well as the pancreatic parenchyma and all layers of jejunal 
using 8 interrupted with 5-0 PDS-II. Single suture between 
the pancreatic parenchyma and jejunal serosa was performed 
using 2 interrupted suture with 4-0 prolen. The omental fl ap 
is set around the hepatic artery to prevent AH related to AL. 
Omental fl ap method was introduced from 2006.
Results: ISGPF grade B/C was identifi ed in 10.9% (64/584) 
of the patients. Soft pancreatic parenchyma and small pan-
creatic duct were risk factors of AL (p < 0.05). AH related 
to AL occurred in 2.2% (13/584) from 1965 to 2005. The 
bleeding source was GDA (45%), stump of pancreas (23%), 
SMV (8%), MCA (8%) and PHA (8%). All cases of AH were 
treated with TAE were controlled the bleeding, and liver 
dysfunction was not present after TAE. We did not experi-
ence AH since introduced the omental fl ap method (p < 
0.05).
Conclusion: The operative mortality rate after PD has sig-
nifi cantly declined due to the progression of surgical tech-
niques and interventional treatments. Pancreatic duct-to-all 
layer of the jejunal anastomosis was acceptable to prevent 
the pancreaticojejunal anastomotic leakage. The omental 
fl aps is useful for decreasing the risk of major vascular com-
plications related to pancreaticojejunal anastomotic leakage 
following PD.
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FOS321
A NEW TECHNIQUE FOR 
PANCREATICOGASTROSTOMY FOR 
THE SOFT PANCREAS: THE 
TRANSFIXING SUTURE METHOD
H. Shinchi, S. Takao, K. Maemura, Y. Mataki, 
H. Kurahara, M. Sakoda, S. Ueno and S. Natsugoe
Kagoshima University, Kagoshima, Japan
Introduction: Pancreatic anastomotic leak remains a persis-
tent problem after pancreaticoduodenectomy (PD). The pres-
ence of soft, nonfi brotic pancreatic tissue is one of the most 
important risk factors for pancreatic leak. Accordingly, we 
devised a pancreas-transfi xing suture method for pancreati-
cogastrostomies in patients with a soft, nonfi brotic pancreatic 
remnant.
Methods: As for the pancreaticogastrostomy technique, an 
ultrasonically activated scalpel was used for transecting the 
pancreas. The inner layer involves a duct-to-mucosa anasto-
mosis with an internal stent and the outer layer involves a 
single row pancreas-transfi xing sutures between the pancre-
atic remnant and the posterior gastric wall.
Results: A total of 205 consecutive patients underwent pan-
creaticoduodenectomy with pancreaticogastrostomy. Of the 
205 study patients, 137 patients (67%) had a soft pancreas. 
There were no operative or hospital death. Postoperative 
complications occurred in 38 patients (19%). Pancreatic leak 
(Grade B/C) occurred in 4 patients (2%) with a soft thin 
pancreas.
These pancreatic leaks were managed nonoperatively by 
maintaining the closed drains.
Conclusion: This technique is simple and appears to reduce 
the risk of pancreatic leakage possibly by decreasing the risk 
of suture injury of the pancreas and by embedding the tran-
sected stump into the wall of the stomach. This novel pan-
creaticogastrostomy is an effective reconstructive procedure, 
especially for patients with a soft, nonfi brotic pancreas.
FOS322
ARVS-ASSOCIATED ACUTE 
PANCREATITIS PRESENTING TO A 
REGIONAL HPB UNIT IN SOUTH AFRICA
J. Omoshoro-Jones, A. Sparaco and M. Smith
CHBAH/Fac Health Sci, University of the Witwatersrand; 
Johannesburg; South Africa
Introduction: The incidence of acute pancreatitis (AP) in 
HIV/AIDs is about 3.2% to 46%. Highly active anti-retrovi-
ral therapy (HAART), particularly combinations containing 
nucleoside analogues, protease-inhibitors, non-reverse tran-
scriptase, hydoxyureas, are the usual agents implicated. 
However, HI virus itself, other pancreotoxic agents like anti-
tuberculous drugs, opportunistic infections, chronic liver and 
biliary diseases, recreational drugs, hypertriglyceridemia of 
HAART may play varying roles.
Methods: Retrospective analysis of prospectively collected 
data of all HIV positive individuals presenting with acute 
pancreatitis to the HPB Unit at the Chris Hani-Baragwanath 
Academic Hospital (CHBAH), from January 2006 to 
December 2011. Stratifi cation of HIV status was according 
to CDC classifi cation, and the severity of pancreatitis was 
stratifi ed according to the current modifi ed Atlanta’s 
Classifi cation. Data analysed include demographic, clinical, 
investigational, management and outcome results.
Results: Twenty seven individuals (15 men, 12 women; 
median age 39 years, range 26–63 yrs) with HIV or HIV/
AIDs were managed for acute pancreatitis during the refer-
ence period. Mild AP occurred in 16 patients, whilst 11 
presented with severe AP. Generally, AP occurred following 
commencing stavudine-containing anti-retroviral combina-
tions in 18 individuals, protease inhibitors in combination 
with stavudine or didanosine in 9. Secondary possible 
agents found in 17 individuals include anti-tuberculous 
agents (5), ethanol use (5), gall stones (3), opportunistic 
infections (2), sulphonamide-trimethoprim (2). Acute pan-
creatitis occurred within two months of commencing ARVs 
in 10 individuals, within six months in 8, twelve months in 
5, more than twelve.
Conclusion: In this analysis, mild AP occurred in most of 
the patients. Stavudine, didanosine and pentamidine-contain-
ing combinations were the commonest pancreotoxic agent 
associated with AP in the cohort. Although severe pancreati-
tis remains highly fatal in HIV/AIDs individuals, local pan-
creatic complications can easily be managed by minimally 
invasive means. Nevertheless, acute pancreatitis in the HIV/
AIDs individual can be adequately managed as in the 
non-HIV positive population.
FOS323
EXTENDED RESECTION AND HIGHER 
AGE DO NOT INFLUENCE RESULTS OF 
PANCREATICODUODENECTOMY IN A 
DUTCH TERTIARY REFERRAL CENTER
K. P. Cieslak1, M. G. H. Besselink1, S. Fegrachi1, 
F. P. Vleggaar2, M. R. Vriens1, R. van Hillegersberg1, 
I. H. M. B. Rinkes1 and I. Q. Molenaar1
1Department of Surgery, University Medical Center 
Utrecht, The Netherlands; 2Department of 
Gastroenterology, University Medical Center Utrecht, The 
Netherlands
Introduction: Portal vein involvement and higher age are 
no longer absolute contra-indications for pancreaticoduode-
nectomy (PD) in patients with suspected malignancy of the 
pancreatic head and periampullary region. We aimed to eval-
uate the surgical and oncological outcome of PD for poten-
tially resectable pancreatic or periampullary tumors in a 
Dutch tertiary referral center and the impact of extended 
resections and high age on procedural morbidity, mortality 
and survival.
Methods: Retrospective, partly cross-sectional study in a 
Dutch tertiary referral center. Postoperative complications 
were graded according to the ISGPS defi nitions and Clavien-
Dindo classifi cation. General practitioners and oncologists 
were contacted to determine survival. Subgroup analysis was 
performed for patients who underwent an extended PD 
because of tumour involvement and patients >69 years. 
Between 2007 and 2010, 115 consecutive patients underwent 
an explorative laparotomy. In 101/115 patients (88%) the 
tumor could be resected by (extended) PD. An extended-PD 
was performed in 18/101 patients (vena portae, n = 11; 
total pancreatectomy, n = 5; splenectomy, n = 3; right 
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hemicolectomy, n = 3; left hemicolectomy, n = 1), 34/101 
patients were >69 years.
Results: A R0-resection was obtained in 73/90 patients 
(81%) with a histologically confi rmed malignancy. Pancreatic 
fi stulas (grade B/C) were observed in 8/101 patients. The 
30-days mortality was 4% and the in-hospital mortality 5%. 
45/101 patients were diagnosed with pancreatic adenocarci-
noma with 1- and 2-year survival rates of 67% and 37%. 
Mortality in patients with extended resection was 0% and the 
1-year and 2-year survival for pancreatic adenocarcinoma 
(76% en 38%) were comparable to patients with a standard 
resection. Mortality in patients older than 69 years was non-
signifi cantly increased (9% vs 3%; p = 0.33) but the 1-year 
and 2-year survival rates in patients with pancreatic adeno-
carcinoma (71% en 38%) were comparable to younger 
patients.
Conclusion: In the setting of a Dutch high-volume center, 
R0-resections can be achieved in over 80% of potentially 
resectable cases due to (extended) PD. Extended-PD can be 
performed with similar surgical and oncological outcomes 
as standard PD. In elderly patients postoperative mortality 




PRESENTATION OF A SERIES OF 
TWO SPANISH HOSPITALS, TREATMENT 
AND LONG-TERM RESULTS 
AFTER DIAGNOSIS
F. Borobia1, N. Garcia-Monforte1, A. Romaguera1, 
N. Bejarano1, R. Bella2, F. Estremiana3, J. Fabregat3 
and S. Navarro-Soto1
1Servicio de Cirugia General y Digestiva, Corporacio 
Sanitaria i Universitaria Parc Tauli, Sabadell, Barcelona; 
2Servicio de Anatomia Patologica, Corporacio Sanitaria i 
Universitaria Parc Tauli, Sabadell, Barcelona; 3Servicio de 
Cirugia General y Digestiva, Bellvitge Hospital, 
L’Hospitalet de Llobregat, Barcelona
Introduction: AIP is a rare disease that can mimic a pan-
creatic cancer (PC). Clinical picture is a painless obstructive 
jaundice. CT/MRCP shows typical images: global enlarge-
ment of the pancreas, irregular narrowing of the pancreatic 
duct and biliary duct dilatation. However “focal type” is dif-
fi cult to distinguish from PC. It is essential to consider this 
disease and only histology or response to steroids gives the 
clue. We present our experience in the diagnosis, treatment 
and follow-up.
Methods: From 1999 to 2011 we collected 15 patients (p) 
(10 M/5 F). Before 2003 4 p were detected with pathological 
review of pancreaticoduodenectomy (PD) without PC. Four 
were referred with biliary stents without pathological diag-
nosis. Another was sent after a bilio-entery bypass because 
was considered to have an advanced PC. One were consid-
ered advanced PC and treated with a stent. Steroids were 
given in 5 p but one did not respond and was resected. In 1 
p AIP was suspected intraoperatively and a core biopsy 
changed the strategy to a bypass procedure. Eight p were 
diagnosed after PD, 1 died in the postoperatory period. From 
2003 EUS/CT-biopsies were performed in all p to exclude 
PC and possibly to confi rm diagnosis before steroids 
treatment.
Results: Mean age was 50.9 y (24–75). Progressive or self-
limited obstructive jaundice was present in all p. CT and MR 
images showed diffusely enlarged gland (6 p) or pseudotu-
mour (9 p). We detected elevated IgG4 in 4 p. Only 1 p had 
a rheumatoid arthritis associated. Two p were diagnosed with 
biopsy, one by EUS and one intraoperatively. Three p were 
treated with steroids empirically and jaundice disappeared 
dramatically. Mean follow-up was 71.6 months. Only 1 p had 
recurrence of AIP associated with increased levels of IgG4 
and he responded to steroids. Another 2 p presented autoim-
mune cholangitis, 1 p was succesfully treated with steroids. 
De novo diabetes was detected in 6/14 p. Non resected p 
have a better quality of life.
Conclusion: AIP can be suspected in p with obstructive 
jaundice and typical images in TC/MR, in addition high 
levels of IgG4 and a positive biopsy. If only 1 criteria can be 
found, biopsies are mandatory to ruled out PC. In case of 
suspicion, a trial of steroids must be tried and resolution of 
jaundice is considered as a diagnostic test. Although pancre-
atic surgery is safe, must be indicated only in cases of doubt 
of PC. Long term follow-up is mandatory because the risk 
of recurrence (3/14).
FOS325
SURGICAL TREATMENT OF 
PANCREATIC INSULINOMA: 45 YEARS 
EXPERIENCE IN A SINGLE CENTER
L. Moletta, A. C. Milanetto, V. Liço, C. Sperti, 
S. Pedrazzoli and C. Pasquali
Clinica Chirurgica IV, Pancreatic and Digestive Endocrine 
Surgical Unit, Padova, Italy
Introduction: Insulinoma is the most common functioning 
neuroendocrine tumor of the pancreas. Over 90% of the 
insulinomas are benign and single. Depending on the loca-
tion within the gland, they can be enucleated, or treated with 
a partial or distal pancreatectomy or rarely with a pancreati-
coduodenectomy (PD).
Methods: We reviewed clinical data of patients observed in 
our Department for organic hyperinsulinism from January 
1966 to December 2010 (follow-up to June 2011). We 
observed 102 patients with organic hyperinsulinism, 60 F/42 
M, averaging 49.5 years. We observed 7 cases of hyperpla-
sia/nesidioblastosis. Among insulinomas, 7 had multiple 
tumors and 7 were malignant. The lesions were respectively 
located: 32 in the pancreatic head, 21 in the body, 33 in the 
tail, 8 in the isthmus, 5 lesions involved the whole pancreas, 
1 was located in the left ovary and in 2 cases the site was 
unknown (one lost in follow-up). 7 patients didn’t undergo 
surgery, 4 had previous surgery elsewhere and in 5 cases a 
second operation was needed.
Results: We performed 39 enucleations, 38 left pancreatec-
tomies (26 spleen preserving), 1 left pancreatectomy and 
enucleation of adenoma in the head, 6 middle pancreatecto-
mies, 3 duodenum preserving pancreatic head resections, 2 
PD, 2 near total pancreatectomies, 1 total pancreatectomy, 
1 left ovariectomy, 2 explorative surgery. Perioperative 
mortality was 5/95 (5%): there were 3 acute pancreatitis, 
1 stroke and 1 disseminated intravascular coagulation. 
Perioperative morbidity was 23/95 (24%): we observed 
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3 acute pancreatitis, 13 pancreatic fi stulas, 2 abdominal 
abscesses, 2 abdominal fl uid collections, 2 pseudocysts and 
1 biliary leakage. Excluding the malignant cases and the 
postoperative deaths, 85/87 patients were cured after surgery.
Conclusion: Surgical treatment of hyperinsulinism in our 
45 years-long experience resulted in high rate of cure; 
however morbidity and mortality related to treatment are still 
observed despite the progress in tumor detection and treat-
ment in the last 25 years.
FOS326
LEFT PANCREATECTOMY FOR 
NEUROENDOCRINE PANCREATIC 
TUMORS: RESULTS OF OPEN SURGERY 
IN 30 YEARS
A. C. Milanetto1, L. Moletta1, R. Alaggio2, 
C. Sperti1, S. Pedrazzoli1 and C. Pasquali1
1Clinica Chirurgica IV, Pancreatic and Digestive 
Endocrine Surgical Unit, University of Padova, Italy; 
2Pathology, University of Padova, Italy
Introduction: Neuroendocrine pancreatic tumors (NPT) are 
often localized in the body-tail of the pancreas. Left pancre-
atectomy (LP) is the procedure of choice and can be 
performed either with splenectomy (DP) or with a spleen-
preserving procedure (SPLP). The aim of this study was to 
retrospectively evaluate postoperative complications and 
clinical outcome of patients submitted to laparotomic left 
pancreatectomy for pNET in our Unit in the last 30 years.
Methods: We reviewed clinical data of patients who under-
went laparotomic LP for NTP from January 1981 to December 
2010, evaluating staging, type of surgery, early and late com-
plications, follow-up (FU) and disease free survival (DFS). 
We observed 216 patients affected by NPT: among them, 123 
tumors were localized in the body-tail of the pancreas and 
69 patients underwent laparotomic LP. We excluded 5 
patients who also underwent enucleation of a lesion in the 
head and 5 in whom the NPT was an incidental fi nding. We 
enrolled 59 patients (29 F/30 M; mean age 53.8 yrs). Patients 
were grouped according to the WHO 2000 and TNM 2010 
classifi cations. We had 33 benign tumors (55.9%), 5 uncer-
tain behaviour tumors (8.5%) and 21 malignant lesions 
(35.6%).
Results: We performed 29 DP (49.2%), 28 SPLP (47.4%, 
23 cases with splenic vessels preservation) and 2 left pancre-
atectomy in previous splenectomy (3.4%). DP was performed 
when a malignant tumor was evident (65.5% of cases). SPLP 
was performed for benign lesions in 93% of cases. Mortality 
was 3.9% and morbidity was 42.4%, equally distributed in 
DP and SPLP groups. We had 10 pancreatic fi stulas (16.9%, 
6 in DP and 4 in SPLP group), 8 abdominal fl uid collections, 
5 pseudocysts (8.5%, 4 in DP group) and 2 splenic infarc-
tions in SPLP with splenic vessels ligation (2/5 of Warshaw 
operation). Mean FU was 111.2 months (range 10–338), 
mean DFS was 120.7 months and in the 12 patients with 
metastatic disease mean time to progression was 30.7 
months.
Conclusion: Laparotomic left pancreatectomy in NPT can 
be performed with or without splenectomy. The complication 
rate is still high and it is comparable between the two surgical 
procedures.
FOS327
RESECTION OF THE HEAD OF THE 
PANCREAS: OF WHAT IMMEDIATE AND 
LONG TERM RISKS SHOULD PATIENTS 
BE INFORMED?
M. Tavernier1, J. Francoual1, L. Plard1, C. Bazille2, 
E. Salame1 and L. Chiche1
1Digestive Surgery Department, Centre Hospitalier 
Universitaire, Caen, France; 2Pathology Laboratory, 
Centre Hospitalier Universitaire, Caen, France
Introduction: Whipple Procedure (WP) is a quite frequent 
surgery, mainly performed to treat periampullar pathology. 
Although mortality has decreased in last years, morbidity 
remains high, and functional sequelae can be observed. The 
objective of this study was to analyse the mortality, morbid-
ity, and long-term consequences of WP, in order to better 
inform patients of the actual risk of this surgery.
Methods: Retrospective cohort study of 367 consecutive 
patients operated in a single specialized center (>25 WP/
year) between 1992 and 2011. The average age of patients 
was 61 years and 62% were men. Surgical procedure con-
sisted in a pancreatico-gastric anastomosis in 89.5% cases, a 
pylorus preserving in only 6.6% of cases. Histological exam-
ination showed that most frequent diseases were: pancreatic 
cancer (43.3%), ampulloma (15.8%), chronic pancreatitis 
(9.3%), distal common bile duct cancer (8.2%) and duodenal 
cancer (5.2%). Postoperative morbidity and mortality (during 
hospitalisation or within 30 days of operation), and long term 
follow-up data were collected and analyzed.
Results: 71% of WP were done for cancer, with 61% of 
positive lymphadenectomies. The average number of lymph 
nodes resected was 16. Venous resection was needed in 15% 
cases. The median length of stay was 15 days. Mortality rate 
was 1.4% and morbidity 64%. 10% patients required reop-
eration. Postoperative complications were pancreatic fi stula 
(19%), but 57% of them were grade A. Wound infection 
(19%), delayed gastric emptying (17%), and pulmonary mor-
bidity (13%) were frequent, while bleeding (8%), acute pan-
creatitis (5%) and bile duct leakage (3%) were rare but 
serious. When assessed by Clavien’s classifi cation, grades1 
and 2 were 75% of morbidity. Long-term follow-up of 146 
patients showed new onset of diabetes mellitus in 15% and 
71% experienced steatorrhea.
Conclusion: Whipple Procedure is a safe surgery, associ-
ated to less than 1.5% mortality when practiced in a special-
ized center. Moreover, even if postoperative morbidity 
remains high, it is benign in 75% of cases. During follow-up, 
most patients will be treated for exocrine insuffi ciency 
(>70%) but few will develop de novo diabetes (15%).
FOS328
SPLEEN PRESERVING DISTAL 
PANCREATECTOMY WITH AND 
WITHOUT SPLENIC VESSEL LIGATION: 
A SYSTEMATIC REVIEW
G. Jain, S. Chakravartty and A. G. Patel
Institute of Minimal Access Surgery, King’s College 
Hospital, London, UK
Introduction: Splenic preservation during distal pancre-
atectomy may be performed with splenic vein and artery 
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ligation, relying on short gastric blood fl ow (Warshaw’s 
Technique (WT) or by preserving the splenic artery and vein, 
and dividing small branches to the distal pancreas (Splenic 
vessel preservation (SVP). WT may allow for a faster and 
less technically challenging procedure than SVP, however it 
may be associated with more splenic complications. The 
consensus on which approach is best, is divided.
Methods: A systematic review of the evidence in the litera-
ture was undertaken with the aim of analysing the merits and 
disadvantages of both WT and SVP. A systematic search was 
undertaken of the medical literature using the electronic data-
bases Medline, Embase, Pubmed, and the Cochrane Library 
from 1985–2011. All comparative studies were included for 
analysis and case series of >5 reported cases. Non-English 
papers, individual case reports, case series <5, technical 
reports, reviews, animal and cadaveric papers were excluded. 
The remaining articles were reviewed by 2 reviewers con-
sidering study design, baseline characteristics, surgical tech-
nique undertaken, outcomes and complications.
Results: Of 547 articles identifi ed, 23 met the inclusion 
criteria. Of these, 2 papers were direct comparisons of WT 
and SVP. In total 335 patients underwent WT and 441 under-
went SVP. There was no signifi cant difference in the mean 
operating time between WT and SVP (188 mins vs 216 mins 
respectively) or in the mean estimated blood loss (330 ml vs 
259 ml). Splenic infarction was more common with the WT 
than SVP (n = 51 vs n = 2, p < 0.01), however intra-abdom-
inal abscess requiring intervention was similar in both groups 
(10 vs 11, ns). Splenic varices were signifi cantly higher in 
the WT group (8.3% vs 0% p < 0.0001). Post-operative 
splenectomy was required in 7 WT patients (2%) compared 
to 0 (0%) in the SVP group (p < 0.02).
Conclusion: Splenic preserving distal pancreatectomy can 
be performed with low complication rates. Whilst Warshaw’s 
Technique is thought to be technically less challenging, this 
was not demonstrated by a difference in either operating time 
or blood loss. Splenic complications, although low with 





M. A. Belluomini1, N. De Lio2, S. Signori2, 
V. G. Perrone2, F. Vistoli2, E. F. Kauffmann1, N. Napoli1 
and U. Boggi2
1First Division of General Surgery, University of Pisa, 
Pisa, Italy; 2Division of General and Transplant Surgery, 
University of Pisa, Pisa, Italy
Introduction: The daVinci surgical system reintroduces 
much of the operative dexterity lost during laparoscopic 
operations and offers the unique opportunity to verify if 
pancreaticoduodenectomy (PD) can be safely performed 
through a minimally invasive approach. We herein report our 
technique for total robotic PD employed in 29 consecutive 
patients. This experience was earned at a high-volume center 
of pancreatic surgery, having extensive experience in 
advanced laparoscopy and robotic surgery.
Methods: Our technique for total robotic PD is unique in 
several respects: (1) Pure laparoscopy is not used at any 
stage. (2) Only the right colonic fl exure is mobilized. (3) A 
total of fi ve ports are used. (4) The camera port is placed 
along the right pararectal line to allow optimal view of the 
uncinate process (UP). (5) The third robotic arm, driven by 
the surgeon’s right hand, is placed on the patient’s left side. 
It is used to “hang” the duodenum during dissection of the 
UP, and as the main operative arm. (6) The gallbladder is 
used to retract the liver. (7) In preparation for dissection of 
the UP, the fi rst jejunal loop is fully mobilized but it is not 
sectioned until the specimen is ready for removal, to facili-
tate jejunal rotation behind the mesenteric vessels.
Results: No PD was converted to open surgery or conven-
tional laparoscopy, despite 2 patients required segmental 
resection of the mesenteric vein and reconstruction by a jump 
graft. The entire stomach was preserved in 25 patients. Mean 
operative time was 568 minutes (420–960). Thirty-day oper-
ative mortality was nil. No pseudoaneurysm of the gastro-
duodenal artery was noted. Despite nearly all pancreas were 
soft and with small ducts (≤3 mm), only 3 patients developed 
grade B pancreatic fi stulas and none grade C fi stulas. Mean 
hospital-stay was 21.8 days (10–60). Fifty-one percent of the 
patients were diagnosed with malignant tumors. Overall, the 
mean number of lymph nodes retrieved was 29.8 ± 16.7. 
None of the margins was positive.
Conclusion: In selected patients total robotic PD is feasible. 
As compared to hybrid techniques, coupling laparoscopic 
dissection with robotic reconstruction, a total robotic proce-
dure spares unnecessary dissections and allows optimal 
control of large peripancreatic vessels permitting segmental 
vein resection and tailored reconstruction. Technology 
refi nements and improvement of surgical technique could 
make robotic PD an appealing alternative to open PD in 
selected patients.
FOS330
MINIMALLY INVASIVE PANCREATIC 
NECROSECTOMY IN THE 
ACUTE SETTING
C. Palanivelu, A. Vij, P. Senthilnathan, P. Palanivelu 
and C. Chandramaliteeswaran
GEM Hospital, Coimbatore, India
Introduction: Traditional surgical approaches to pancreatic 
necrosis are associated with signifi cant morbidity and mor-
tality and increased risk of major organ dysfunction. This has 
led to search for new, innovative and minimally invasive 
techniques for debridement. This study reports a series of 
patients undergoing pancreatic necrosectomy with the mini-
mally invasive approach.
Methods: A total of twenty patients (twelve males and four 
females; age group 19–69 years; mean age 41 years) with 
necrotizing pancreatitis (50–90% necrosis on CT) underwent 
minimally invasive necrosectomy between 2007 and 2010. 
Two to fi ve ports were used. Laparoscopic necrosectomy was 
performed by transperitoneal approach in fourteen patients 
and by retroperitoneoscopy in six patients. Transperitoneal 
access was through the gastrocolic ligament in all cases and 
through the left fl ank in cases of retroperitoneoscopy. Four 
patients had associated pancreatic abscess for which drain-
age was done. Necrosectomy was done by blunt dissection 
using suction-irrigator followed by thorough lavage. Two to 
four drainage tubes were kept as per requirement.
Results: There was evidence of preoperative organ dys-
function in six patients. All patients tolerated the procedure 
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well. There was no postoperative mortality or conversion to 
open necrosectomy. The mean operative time was 130 
minutes. There were no major postoperative complications 
attributed to the surgery. Two patients developed respiratory 
distress with ARDS causing prolonged stay in ICU and 
delay in discharge. One patient underwent relaparoscopy for 
persistent sepsis with intra abdominal collection while 
another was managed with percutaneous USG guided drain-
age. The mean stay in ICU was 3 days with postoperative 
hospital stay of 8 days. Most patients were discharged with 
drainage tube in situ which was removed after one week at 
follow up.
Conclusion: Minimally invasive approach to pancreatic 
necrosectomy is safe and feasible with good outcomes 
in centres of laparoscopic excellence. It requires careful 




RESECTIONS: ARE THEY WORTH 
THE RISK?
A. Siripong and M. Chung
Grand Rapids Medical Education Partners/MSU General 
Surgery Residency Program, Grand Rapids, MI, USA
Introduction: As mortality rates associated with pancreatic 
surgery decrease, there has been an increasing drive towards 
extended resections for locally invasive pancreatic disease; 
however, the impact of multivisceral resection on morbidity, 
mortality, and survival remains inconclusive.
Methods: An IRB-approved retrospective chart review was 
conducted on all patients who underwent a pancreatic resec-
tion by a single surgical oncologist at our institution between 
July 2004 to July 2011. Patients were grouped into 4 catego-
ries based on extent of resection: standard pancreaticoduo-
denectomy (SPD), multivisceral pancreaticoduodenectomy 
(MVPD), standard distal pancreatectomy (SDP), and multi-
visceral distal pancreatectomy (MVDP). Collected variables 
included demographics, length of stay, operating room (OR) 
time, postoperative morbidity and mortality, and median 
survival.
Results: 191 patients were included, with 143 undergoing 
standard resection and 48 multivisceral resection. No signifi -
cant difference was seen in demographics. MVPD vs. PD 
was associated with a longer OR time (361 vs. 299 min, p < 
0.0001) and a higher incidence of positive margins (47.8% 
vs. 25%, p = 0.03) without a signifi cant difference in morbid-
ity. MVDP vs. DP demonstrated a longer length of stay (13 
vs. 6 days, p < 0.0001) and OR time, with increased rates of 
abscess formation (24% vs. 5.4%, p = 0.03) and gastroparesis 
(36% vs. 5%, p = 0.002). No difference in 30-day or in-
hospital mortality was seen. However, Kaplan Meijer sur-
vival analysis demonstrated an inferior median and overall 
survival in the multivisceral group.
Conclusion: Our results demonstrate that although multi-
visceral pancreatic resections may be performed with accept-
able morbidity and mortality in the appropriate patient 
population with locally advanced disease, a survival benefi t 
has not been proven.
FOS332
BILIARY COMPLICATIONS AFTER 
PANCREATICODUODENECTOMY
P. Duconseil1, O. Turrini2, J. Ewald2, S. Berdah1, 
C. Brunet1, J.-R. Delpero2 and V. Moutardier1
1Digestive Surgery Department, North Hospital, Marseille; 
2Oncologic and Digestive Surgery Department, Paoli-
Calmettes Institute, Marseille, France
Introduction: The aim of the study was to determine the 
incidence of bile leak (BL) and biliary strictures (BS) after 
cephalic or total pancreaticoduodenectomy (PD), and to 
study the management of these complications.
Methods: Between April 2005 and September 2011, 397 
PD were performed (383 cephalic PD and 14 total PD) in 2 
centers. We reviewed the biliary complications from a pro-
spective database.
Results: A) Thirteen patients (3.3%) presented a BL. It was 
revealed by bile in the drain (54%), biloma (23%) or perito-
nitis (7%). In six patients (46%), BL dried out spontaneously; 
2 (15%) had a radiologic procedure, and 5 (38.5%) under-
went surgery. No patient having had a BL then developed a 
BS.
B) Seventeen patients (4.3%) developed a BS, 15 after 
cephalic PD (NS). Four patients (24%) had a malignant 
recurrence. Among the 13 other patients, 7 had a bile duct 
(BD) of 6 to 10 mm, and 6 had a thin BD (<5 mm). There 
was no infl ated BD (>10 mm). Fifteen BS were fi rst treated 
by endoscopic or radiologic procedures (ERP), and 2 BS had 
a medical treatment. Three patients had a redo of the anas-
tomosis 16 days, 5 and 9 months after respectively 2, 3 and 
2 ERP.
Conclusion: BL and BS were rare after PD. Directed low-
fl ow BF didn’t need any specifi c treatment. A BL wasn’t a 
promoting factor of BS. BS happened either in cases of 
malignant recurrence (24%) or when BD were normal or 
thin. 18% of the BS led to the redo of the anastomosis.
FOS333
DEVELOPMENT OF DIABETES 
AFTER PANCREATECTOMY: 
PROSPECTIVE ANALYSIS
J. W. Park, J.-Y. Jang, M. J. Kang, I. W. Han, 
S.-W. Kim and E.-J. Kim
Departments of Surgery, Seoul National University College 
of Medicine, Seoul, Korea
Introduction: Pancreatectomy is major treatment modality 
for various pancreas and periampullary diseases. But true 
development rate of DM after pancreatectomy is not estab-
lished, especially by prospective serial data and regular inter-
val follow up.
Methods: From 2007 to 2011, we analysed 120 pancreatec-
tomy patients with at least 1 year follow up, and the exclu-
sion of preoperative DM patients. Data collection was done 
fi ve times at preoperative, discharge, post-operative 3 
months, post-operative 6 months and post-operative 12 
months as scheduled. Fasting glucose sugar (FBS), oral 
glucose tolerance test (oGTT) and HbA1c were checked. 
And clinical and pathologic data were collected and analyzed 
to fi nd out infl uencing factor of development of diabetes after 
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pancreatectomy. Diabetes was diagnosed in this study by 
criteria of ADA with at least 2 times positive test result.
Results: Patients with DM by defi nition of WHO increase 
to post-operative 6 month follow up and decrease at post-
operative 12 month follow-up (18.8, 18.8, 23.9, 20.0; % of 
total numbers, respectively discharge, 3 month, 6 month, 12 
month). All clinical and pathologic demographics between 
post-pancreatectomy no DM group and post-pancreatectomy 
DM group. Post-pancreatectomy DM group were older (62.1 
± 8.8) than no DM group (58.4 ± 11.7). And it reveals that 
distal pancreatectomy increase post-pancreatectomy DM 
(odds ratio: 2.59). Adjuvant therapy, chronic pancreatitis and 
alcohol drinking history could not show signifi cant effect on 
post-pancreatic DM development.(p < 0.05).
Conclusion: Post operative DM developed in 20.0% of the 
patients (24/120). And distal pancreatectomy increase risk 




DISTAL PANCREATECTOMY: SPLENIC 
VESSELS PRESERVATION VERSUS 
WARSHAW’S TECHNIQUE
J.-P. Adam1, A. Jacquin2, C. Laurent1, B. Masson2, 
D. Collet2, L. Fernandez-Cruz3 and A. Sa-Cunha2
1Department of Surgery, Hôpital Saint-André, CHU de 
Bordeaux, University of Bordeaux Segalen, France; 
2Department of Surgery, Hôpital Haut-Lévèque, CHU de 
Bordeaux, University of Bordeaux Segalen, France; 
3Department of Surgery, Hospital Clinic I Provincial de 
Barcelona, University of Barcelona, Spain
Introduction: Laparoscopic spleen-preserving distal pan-
createctomy (LSPDP) is a safe, feasible and increasingly 
performed procedure.
The value of preservation compared to the sacrifi ce of the 
splenic vessels remains unclear.
The purpose of this study was to compare the preservation 
to the ligation of the splenic vessels as surgical management 
of laparoscopic spleen-preserving distal pancreatectomy.
Methods: From January 1997 to January 2011, a bi-centric 
retrospective study was performed from patients underwent 
laparoscopic distal pancreatectomy with spleen conservation 
for benign and low-grade malignant tumours in the body-tail 
of the pancreas. Patients treated with an intent-to-treat basis 
of splenic vessels preservation (group SVP) were compared 
to patients treated with an intent-to-treat basis of division of 
the splenic vessels (group WT). Clinicopathological features, 
operative and postoperative outcomes were assessed until 30 
days after surgery or during the hospital stay.
Results: Fifty-fi ve LSPDP were analysed in the group SVP 
and 85 in the group WT. The main fi nal histological diagno-
ses were cystic neoplasm (38%) and neuroendocrine tumour 
(31%). Clinical characteristics were similar in both groups 
except for tumour size, signifi cantly greater in the group WT 
(33.6 vs 42.5 mm, P < 0.001).
Operative time, blood loss and conversion to open rate did 
not differ between the 2 groups. The rate of spleen conserva-
tion was better with the splenic vessels preservation (96.4% 
vs 84.7%, P = 0.03). The preservation of the splenic vessels 
succeeded in 75%. Splenic related complications only 
occurred in the group WT (0 vs 19%, P < 0.001) and mean 
length of hospital stay was statistically shorter in the SVP 
group (8.2 vs 10.5, P = 0.01).
Conclusion: The preservation of the splenic vessels brought 
the best rate of spleen conservation without increased mor-
bidity. The short-term benefi ts associated with the preserva-
tion of the splenic vessels should lead to prefer this technique 
for laparoscopic spleen-preserving distal pancreatectomy in 
selected patients with benign or low-grade malignant tumours 
in the body-tail of the pancreas.
FOS335
HAS SURGICAL MANAGEMENT OF 
NEOPLASTIC CYST OF THE PANCREAS 
IMPROVED OVER TIME? TRENDS IN 
THE OUTCOME AND PATHOLOGY IN A 
SURGICAL SERIES
V. Kiswani, L. Manos, N. Rezaee, N. Ahuja, R. Hruban, 
B. Edil, A. M. Lennon and C. Wolfgang
Johns Hopkins Medical Institution, Baltimore, USA
Introduction: With the widespread use of cross-sectional 
imaging in the work-up of abdominal conditions the inciden-
tal fi nding of a pancreatic cyst has become commonplace. 
Indeed, the prevalence of pancreatic cysts identifi ed on 
imaging has increased over time from 0.21% with transab-
dominal ultrasound in 1994, to 2.6% with CT in 2006, and 
13.4% with MRI in 2010. The aim of this study was to 
determine if there has been a change in the surgical manage-
ment and pathological fi ndings of pancreatic cysts over time.
Methods: Patients who underwent resection of a pancreatic 
cyst were identifi ed from our prospectively maintained 
pancreatectomy database. For purposes of comparison of 
time-related trends, patients were divided into two groups 
– 1996–2001 (group 1) and 2006–2011 (group 2). Cysts were 
categorized as follows: pseudocyst (PS), serous cystadenoma 
(SCA), intraductal papillary mucinous neoplasm (IPMN), 
mucinous cystic neoplasm (MCN), solid psuedopapillary 
neoplasm (SPN), lymphoepithelial cyst (LEC) and neuroen-
docrine tumors (NET). General demographics, pathology 
and surgical procedure were documented and the prevalence 
of the resected cysts was compared between the two time 
periods using Fisher exact and chi-square tests.
Results: 576 patients underwent resection of a cystic lesion 
– 190 in group 1 and 386 in group 2. The pathological fi nd-
ings were: PS (n = 22), SCA (n = 87), IPMN (n = 309), MCN 
(n = 48), SPN (n = 34), LEC (n = 12) and NET (n = 6). There 
was a increase in the number of resections for IPMN from 
43.7% (n = 83) in group 1 to 223 (57.8%) in group 2 (p = 
0.001) and a decrease in the resection of benign cysts – 
30.5% to 22.5% (p = 0.04) for SCA and 6.8% to 2.3% for 
PS (p = 0.01). The proportion of resected IPMN with high 
grade dysplasia did not change over time (25.3% to 21.4%; 
p = 0.32), however, there was a signifi cant decrease in the 
proportion of IPMN with invasive adenocarcinoma (56.6% 
to 29.3%; p < 0.001) and an increase in low or moderate 
dysplasia (18.1% to 49.3%; p < 0.001).
Conclusion: The type of pancreatic cyst undergoing resec-
tion has changed signifi cantly over the past 15 years. The 
ability to identify benign cysts has improved with fewer 
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undergoing resection. The numbers of patients with IPMN 
undergoing surgical resection has increased, with lesions 
removed at an earlier stage of disease. These fi ndings suggest 
new tools and guidelines are required to identify those 
patients with low or moderate dysplasia who could undergo 
surveillance rather than surgical resection.
FOS336
EARLY TUMOR RECURRENCE 
FOLLOWING SUPERIOR MESENTERIC-
PORTAL VENOUS RESECTION (SMV-PV) 
IN PANCREATIC ADENOCARCINOMA IS 
ASSOCIATED WITH TRANSMURAL 
VENOUS TUMOR INVOLVEMENT AND A 
POSITIVE RESECTION MARGIN
D. Tran1, S. Roy-Chowdhury1, E. Chiorean2, H. Cardenes3, 
A. Nakeeb1 and T. Howard1
1Department of Surgery, Indiana University School of 
Medicine, Indianapolis, Indiana, USA; 2Division of 
Medical Oncology, Indiana University School of Medicine, 
Indianapolis, Indiana, USA; 3Department of Radiation 
Oncology, Indiana University School of Medicine, 
Indianapolis, Indiana, USA
Introduction: Long-term survival in patients with pancre-
atic adenocarcinoma requires compete tumor resection and 
timely adjuvant therapy. In certain situations, tumor resection 
requires en-bloc removal and reconstruction of the superior 
mesenteric portal venous (SMV-PV) confl uence. In this 
setting, patient selection is critical to maximize long-term 
disease free survival. This study examines variables associ-
ated with early tumor recurrence following en-bloc SMV-PV 
resection.
Methods: With IRB authorization, 52 consecutive patients 
over a 6 yr. period (2005–2011) with locally advanced pan-
creatic adenocarcinoma had en-bloc SMV-PV resection and 
reconstructions were retrospectively reviewed. There were 6 
(11.5%) perioperative deaths (90-day), 12 (23%) long-term 
(>2 yrs.) survivors, and 15 (29%) patients with early tumor 
recurrences. We compared the long-term survivors (N = 12) 
to the patients with early tumor recurrence (N = 15) for 
multiple preoperative, intraoperative, postoperative and his-
topathologic variables. Standard statistical tests were applied 
for nominal and ordinal variables.
Results: We identifi ed no differences between those with 
early tumor recurrence and long-term survivors in patient 
demographics, use of neoadjuvant chemoradiotherapy, pre-
operative EUS staging, operative time, estimated blood loss, 
histopathologic tumor grade, fi nal AJCC pathologic staging, 
postoperative complications, hospital length of stay, or use 
of adjuvant therapy. Patients with early tumor recurrence had 
a higher incidence of venous transmural tumor involvement 
[53% (8/15) vs. 0%, p-value = 0.003], poor differentiation 
on histological examination [67% (10/15) vs. 25% (3/12), 
p-value = 0.05], and/or a positive histologic resection margin 
(R1 resection) [33% (5/15) vs. 8% (1/12), p-value = 0.18].
Conclusion: Early tumor recurrence is associated with 
transmural venous tumor involvement, poor differentiation 
on histological examination, and/or a positive histologic 
resection margin. In pancreatic adenocarcinoma, en-bloc 
tumor resection with SMV-PV reconstruction has an 11.5% 
90-day perioperative mortality rate. Careful intraoperative 
assessment and judgment should be exercised to optimize 




AND COLECTOMY: A SAFE 
COMBINATION?
M. House, M. Kilbane, K. Lillemoe, A. Nakeeb, 
T. Howard, M. Schmidt, N. Zyromski and H. Pitt
Department of Surgery, Indiana University School of 
Medicine, Indiana, USA
Introduction: Postoperative complication rates following 
pancreatectomy remain high in the modern era. Substantial 
surgical procedures performed with pancreatectomy may 
result in additional postoperative morbidity and mortality. 
The aim of this study was to analyze the complications which 
occur after simultaneous pancreatectomy and colectomy.
Methods: All cases of regional pancreatectomy (P), seg-
mental colectomy (C), and simultaneous pancreatectomy and 
colectomy (P + C) were reviewed at a single high-volume 
institution between November 2006 and May 2011. All cases 
were monitored with complete 30-day outcomes through the 
American College of Surgeons-National Surgical Quality 
Improvement Program (ACS-NSQIP). Two and three-way 
statistical analyses were performed among the operation 
categories.
Results: The median age for patients undergoing P + C was 
54 yrs. Within the P + C group, pancreatoduodenectomy was 
performed in 9 patients, and distal pancreatectomy in 11. 
30-day mortality was 10% for the P + C group (9% distal 
pancreatectomy, 11% pancreatoduodenectomy, p = NS). 
Postoperative complications were recorded in 70% of patients 
undergoing P + C versus 33% in patients after pancreatectomy 
alone, p < 0.01. Deep organ space infection occurred in 45% 
of the P + C patients compared to 10% of the pancreatectomy 
patients, p < 0.01. Superfi cial surgical site infection occurred 
in 15% of the P + C patients versus 10% in the P and C groups, 
p = 0.31. The median postop hospital stay was 17 days (range, 
6–60 days) for P + C patients compared to 7 and 6 days for P 
and C patients, respectively (p = 0.01).
Conclusion: Extraordinarily high complication rates are 
observed after simultaneous regional pancreatectomy and 
colectomy which exceed the cumulative morbidities after 
each operation separately. Careful patient selection and strat-
egies to prevent and/or control anastomotic leaks are neces-
sary to improve outcomes in these patients.
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SARCOPENIA, A QUANTIFIABLE 
MEASURE OF FRAILTY, PREDICTS 
SHORT-TERM OUTCOMES IN 
PATIENTS UNDERGOING 
PANCREATICODUODENECTOMY
K. Idrees1, M. Mangano2, Y. Yan1, S. Strasberg1, 
W. Hawkins2, R. Fields1, C. Menias2 and D. Linehan1
1Hepatobiliary, Pancreatic and Gastrointestinal Surgery 
Section, Department of Surgery, Washington University in 
St. Louis, USA; 2Department of Radiology, Washington 
University in St. Louis, USA
Introduction: Sarcopenia, or loss of skeletal muscle mass, 
is one component of frailty and physiological reserve. 
Sarcopenia is objectively quantifi ed by morphometric mea-
surement of skeletal muscle on cross sectional imaging. The 
aim of the study is to evaluate the infl uence of sarcopenia on 
outcome of pancreaticoduodenectomy.
Methods: Sarcopenia was assessed by measuring psoas 
muscle density (PMD) and total psoas area (TPA) by pre-
operative abdominal computed tomography in 209 patients 
in a standardized fashion. Pre-operative factors evaluated 
were age, gender, race, pre-operative involuntary weight loss 
(categorized as <5% – pre-cachexia and >5% – cachexia), 
body mass index (BMI), Charlson comorbidity index (CCI), 
American Society of Anesthesiologist (ASA) status, and 
serum albumin. Outcome variables evaluated were post-
operative complications graded per Accordion classifi cation 
(major defi ned as >level 3), length of stay (LOS), 90-day 
readmission rate and overall survival. Logistic regression 
modeling was utilized to determine the effect of 
sarcopenia.
Results: Of 209 patients, 48% were males, median age was 
66 years and 43% were cachectic. Overall post-operative 
complication rate was 68%; 28.7% had major complications. 
90-day readmission rate was 35%. On multivariate analysis, 
mean PMD was a statistically signifi cant predictor of length 
of stay (p = 0.002). ASA, cachexia and CCI were not. 
Regarding readmission, age, ASA, BMI and mean PMD 
were statistically signifi cant factors on univariate analysis. 
However, after adjusting for other predictive indices, mean 
PMD was the only factor independently associated with 
90-day readmission (p = 0.03). Advance age was associated 
with higher morbidity (p = 0.02). Neither sarcopenia nor 
other predictive indices were statistically associated with 
overall survival.
Conclusion: Sarcopenia, an objective measure of frailty, 
correlates strongly with post-operative outcomes especially 
longer hospital stay and higher readmission rate after pan-
creaticoduodenectomy. However, sarcopenia does not infl u-
ence oncological outcome. Further studies are needed to 
evaluate the relationship between frailty utilizing sarcopenic 
measurements and post-operative outcomes in patients 
undergoing pancreaticoduodenectomy.
FOS339
IMPACT OF PERI-OPERATIVE 




R. Lochan, S. Robinson, R. Saif, D. Manas, J. French, 
R. Charnley, S. White and B. Jaques
Department of HPB and Transplantation Surgery, 
Newcastle upon Tyne, UK
Introduction: Complications after major pancreatic resec-
tion, particularly an anastomotic pancreatic leak, result in 
major morbidity and a prolonged hospital stay. The aim of 
this study was to determine whether peri-operative complica-
tions affect long-term survival after pancreaticoduodenec-
tomy (PD) for pancreatic ductal adenocarcinoma (PDCA).
Methods: Our unit is a tertiary referral centre for HPB 
surgery and performs over 100 elective pancreatic resections 
per annum. Patients presenting with ductal adenocarcinoma 
follow a standard management algorithm and all investiga-
tions, surgical procedures, pathology and complications are 
documented on a prospectively maintained database. All 
patients undergoing pancreaticoduodenectomy between 
2002–2009 were identifi ed. Post-operative complications 
and pancreatic leaks were graded according to the Clavien 
classifi cation and the International Study Group on Pancreatic 
Fistula (ISGPF) defi nition respectively.
Results: 486 PD were performed, 190 (39%) for PDCA. 
Complication rate for was 32.7% (159/486); Clavien grade 
1 = 16.4% (n = 26), grade 2 = 42.1% (n = 67), grade 3 = 
18.2% (n = 29), grade 4 = 17% (n = 27). There were 8 peri-op 
deaths 1.6%. Overall pancreatic fi stula rate was 17.5% 
(85/486); ISGPF Grade A = 23.5% (n = 20), Grade B = 
42.4% (n = 36) and Grade C = 34.1% (n = 29). Median (95% 
CI) survival for PDCA = 25.5 mo (20.3–30.7). Survival 
analysis didn’t reveal a signifi cant relationship between 
occurrence of pancreatic leak on long-term survival (p = 
0.199). However a serious complication (Clavien 4 and 5) 
resulted in signifi cantly (p = 0.03) reduced long-term [(med 
(95% CI)] survival [14.7 (1.7–27.6)] compared to those 
without [24.31 (20.8–27.7].
Conclusion: The mortality and postoperative complication 
rates in this 7-year cohort of pancreatico-duodenectomy 
patients are comparable to those reported by other large 
centres. A serious complication is associated with a reduction 
in long-term survival for patients with pancreatic ductal 
adenocarcinoma but this is not specifi c to an anastomotic 
pancreatic leak.
FOS340
SPLANCHNIC VENOUS THROMBOSIS IN 
ACUTE PANCREATITIS: IS THERE A 
ROLE FOR ROUTINE SYSTEMIC 
ANTICOAGULATION IN SEVERE 
ACUTE PANCREATITIS?
S. Vyas, J. Skipworth, F. Prete, Z. Amin, A. Shankar, 
S. Oldedamink, M. Malago and C. Imber
University College Hospital, London, UK
Introduction: Splanchnic Vein thrombosis involving the 
splenic vein and porto-mesenteric veins is a relatively 
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common observation in severe acute pancreatitis, associated 
with pancreatic necrosis and peri-pancreatic collections. The 
precise role of systemic anticoagulation to minimize the 
thrombosis and achieve recanalization is relatively unknown. 
We conducted a retrospective study to analyse natural history 
of splanchnic venous thrombosis in acute pancreatitis.
Methods: Complete data available for 87 patients with 
acute pancreatitis admitted or referred to a tertiary pancreatic 
unit was analysed for demographics, clinical data including 
severity and aetiology of pancreatitis. Imaging was reviewed 
to assess severity and extent of necrosis and collections, apart 
from establishing the presence /absence of splenic and/or 
porto-mesenteric thrombosis. Treatment data was looked at 
to assess anticoagulation and assess the effect of anticoagula-
tion in achieving recanalization.
Results: There were 52 males and 35 females. Gall stones 
were the commonest etiology (43.68%) followed by alcohol 
(28.74%). 29.88% patients had severe acute pancreatitis 
based on scoring criteria. 25.28% had splanchnic venous 
thrombosis (SVT) observed on CT scanning. Of all patients 
with SVT, 54.54% patients had splenic vein thrombosis, 
while 22.72% patients had porto-mesenteric thrombosis. 
Anticoagulation was not done in 17/22 patients, while 5/22 
patients with SVT were considered for anticoagulation. 
Anticoagulation was possible only in 2 patients while the 
remaining 3 patients were not anticoagulated due to contra-
indications. Of the group with did not receive anticoagula-
tion (n = 17); 76.47% patients had chronic occlusion of the 
splenic and/or porto-mesenteric venous system with resultant 
collateralization/portal hypertension.
Conclusion: The risk of developing SVT in patient with 
severe acute pancreatitis is signifi cant. Current protocols 
with respect to systemic anticoagulation (duration/methods) 
remain undefi ned. The effect of systemic anticoagulation in 
such high risk patients should be studied on a prospective 
basis and may be set the pathway for a randomised trial to 
assess the benefi ts/risks and long term outcomes following 
SVT in acute pancreatitis.
FOS341
CLINICAL, PATHOLOGIC, AND 
BIOLOGIC CHARACTERIZATION OF 
WHO GRADE 3, NON SMALL CELL AND 
NON LARGE CELL NEUROENDOCRINE 
CARCINOMA OF THE PANCREAS
C. Shi1, F. Revetta1, E. Liu2, A. Parikh2, 
M. K. Washington1 and N. Merchant2
1Department of Pathology, Vanderbilt University Medical 
Center, Nashville, TN, USA; 2Department of Surgery, 
Vanderbilt University Medical Center, Nashville, TN, USA
Introduction: WHO has classifi ed pancreatic neuroendo-
crine tumors (PanNETs) into 3 grades based on Ki-67 and 
mitosis: grade 1 (Ki-67 2% and mitosis < 2/10 HPF), grade 
2 (Ki-67 = 3–20% and/or mitosis = 2–20/10 HPF), and grade 
3 (Ki-67 > 20% and/or mitosis > 20/10 HPF). Little is known 
about a small percentage of grade 3 PanNETs that have a 
morphology indistinct from grade 1–2 PanNETs, but with a 
Ki-67 > 20% and/or mitosis > 20/10 HPF. This study explores 
their clinical, pathologic and biological features.
Methods: Review of 94 patients who had PanNET and also 
underwent resection/biopsy from 2002 to 2011 identifi ed 10 
WHO grade 3 PanNETs that were neither small cell carci-
noma nor large cell neuroendocrine tumor. These PanNETs 
had a morphology very similar to grade 1–2 PanNETs, 
however they had mitosis > 20/10 HPF (n = 5) and/or a Ki-67 
> 20% (n = 10). Clinical history and pathologic features were 
reviewed. Formalin-fi xed, paraffi n embedded surgical speci-
mens were obtained from these patients and were immuno-
histochemically labeled with Ki67, her2/neu, c-Met 
(hepatocyte growth factor receptor), and epidermal growth 
factor receptor (EGFR).
Results: Of the 10 cases, 60% were male and ages ranged 
from 38 to 78 years. The 3 youngest pts had a hereditary 
syndrome: 2 with MEN1 and 1 with Von Hippel–Lindau. 
Functional tumor was only seen in 1 pt with MEN1 syn-
drome. The 2 MEN1 pts had multiple PanNETs, all other 
cases had a single PanNET. Tumor size ranged from 2.4 to 
26.0 cm. 5 pts presented with stage IV disease, 4 with stage 
II and 1 with stage I. Overall survival for these pts was sig-
nifi cantly worse than that of grade 1 and 2 PanNET pts. Focal 
necrosis, lymphovascular invasion, and perineural invasion 
were observed in 50%, 70%, and 30% of cases, respectively. 
All cases were diffusely and strongly labeled with c-Met; 6 
had weak Her2/neu membranous labeling and 4 had expres-
sion of EGFR.
Conclusion: Grade 3 PanNETs account for ~10% of 
PanNETs and can occur in pts with or without a hereditary 
syndrome. Most pts present with advanced disease and 
have worse prognosis. The tumors are always associated 
with high risk pathologic features (necrosis, lymphovascu-
lar and perineural invasion and thickened fi brotic septa) and 
express other growth factor receptors such as c-Met, Her2/
neu or EGFR, which may provide a clue towards further 
understanding their biology to identify novel targeted 
therapies.
FOS342
THE ROLE OF CARCINOEMBRYONIC 
ANTIGEN-RELATED CELL ADHESION 
MOLECULE (CEACAM) 1, 5 AND 6 AS 
PROGNOSTIC FACTORS IN 
PANCREATIC ADENOCARCINOMA
F. Gebauer1, M. Tachezy1, D. Wicklein2, U. Schumacher2, 
W. Christoph3, I. Jakob1 and M. Bockhorn1
1Department of General, Visceral and Thoracic Surgery, 
University Medical-Center Hamburg Eppendorf, Hamburg, 
Germany; 2Institute of Anatomy and Experimental 
Morphology and University Cancer Center Hamburg 
(UCCH), University Medical-Center Hamburg Eppendorf, 
Germany; 3Institute of Clinical Chemistry, University 
Medical Center Hamburg-Eppendorf, Hamburg, Germany
Introduction: Members of the carcinoembryonic antigen-
related cell adhesion molecule (CEACAM) family have 
been implemented as tumor markers in the clinical routine 
workup (CEACAM 5 known as CEA). The aim of this 
study was to assess the role of carcinoembryonic antigen-
related cell adhesion molecule (CEACAM) 1, 5 and 6 and 
their combination as prognosticators in pancreatic adenocar-
cinoma (PAC).
Methods: All patients with PAC underwent surgery 
between 1994 and 2008 at the University Medical-Center 
Hamburg-Eppendorf.
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Expression of CEACAM1, 5 and 6 in specimens from 137 
patients with PAC were assessed by immunohistochemistry 
(IHC) on a tissue micro array and matched with clinico-
pathological data. Furthermore, serum analysis of CEACAM 
1, 5 and 6 were conducted by enzyme linked immunosorbent 
assays (ELISA) of 46 patients. Serum values of patients with 
PAC were compared to 43 patients with chronic pancreatitis 
(CP) and 40 serum probes of healthy blood donors (BD). 
Optimal cut-off values were calculated by receiver operating 
characteristic (ROC) and Youdens analysis.
Results: Immunohistochemical expression of CEACAM1 
was found in 86 patients (62.7%), CEACAM5 in 87 (63.5%) 
and CEACAM6 in 99 patients (72.3%). Patients with 
CEACAM5 and 6 expression showed a signifi cantly short-
ened overall-survival (OS) in the Kaplan-Meier survival 
analysis (CEACAM5 22.0 months (4.1–47.9 months) vs. 
16.0 months (12.8–19.2 months), log-rank test P = 0.025; 
CEACAM6 22.0 months (5.6–38.4 months) vs. 14.0 months 
(7.9–20.0 months), P = 0.010). Serum values for CEACAM1 
and 5 were signifi cantly increased compared to BD (P < 
0.001), whereas CEACAM6 serum values in PAC were 
higher than in CP and BD (P = 0.006 and P = 0.029). Survival 
analysis revealed a prolonged OS for patients with low serum 
CEACAM1 values (18.3 vs. 11.8 months, P = 0.02).
Conclusion: CEACAM5 (CEA) has become a widely 
accepted tumor marker in PAC, though its prognostic impact 
with respect to long-term survival lacks of precision. We 
were able to show, that the analysis of several CEACAM 
types can be helpful to stratify patients into different risk 
groups. We therefore conclude that not only CEA infl uences 
tumor progression but also CECAM1 and 6 are important 
factors in local and distant tumor growth.
FOS343
IS SPLEEN PRESERVING DISTAL 
PANCREATECTOMY ONCOLOGICALLY 
SAFE?
J. Onesti1, D. Jain1, M. Chung2, M. Staffod3 and 
P. Attawala3
1Grand Rapids Medical Education Partners, Grand 
Rapids, MI, USA; 2Spectrum Health Medical Partners, 
Grand Rapids, MI, USA; 3University of Michigan College 
of Human Medicine, Grand Rapids, MI, USA
Introduction: Spleen preserving distal pancreatectomy has 
been shown to be safe and effective in treating benign and 
low-grade malignant lesions of the pancreas. Preserving the 
spleen would preserve one’s immune function and avoid 
receiving regularly scheduled vaccinations and liberal use 
of antibiotics. However, despite standard practicing pat-
terns, little data exists to evaluate the oncologic impact of 
splenic preservation during resection of distal pancreatic 
malignancies.
Methods: We retrospectively reviewed 82 consecutive 
distal pancreatectomies performed for suspected or known 
pancreatic malignancies from June 1, 2005 to July 1, 2011 
by a single surgeon. Exclusion criteria included metastatic 
disease or planned en-bloc resection, leaving 46 cases 
for analysis. Data was reviewed for spleen or splenic 
vessel involvement according to the fi nal pathology report, 
relationship of the tumor to the splenic vessels and correla-
tion with preoperative fi ndings based on computed tomogra-
phy (CT) or other imaging.
Results: Of the 46 cases of distal pancreatectomy for sus-
pected cancer, the fi nal pathology showed adenocarcinoma 
or neuroendocrine tumor in 22 (48%), mucinous cysic neo-
plasm in 12 (26%) and benign in 12 (26%). In the 22 patients 
with malignant etiology, 2 had invasion of the spleen or 
splenic vessels on fi nal pathology. Both cases were consis-
tent with adenocarcinoma. The fi rst involved the splenic 
fl exure, necessitating en-bloc colon resection. The second 
had splenic artery involvement as identifi ed by CT, but no 
malignancy in the spleen itself. No positive splenic nodes 
were identifi ed. There were no infectious complications. 
Preoperative CT revealed 5 cases (10.9%) of splenic vessel 
encasement, 1 of which was malignant on fi nal pathology.
Conclusion: Splenic involvement in distal pancreatic 
tumors is rare. Our data demonstrate that splenectomy is not 
mandated for distal pancreatic tumors. The spleen could be 
preserved in a majority of cases. CT imaging conferred a 
high negative predictive value, suggesting accuracy when no 
vessel involvement was demonstrated. The combination of 
pre and intra-operative factors can adequately identify the 
necessity of splenectomy, allowing the approach to be tai-
lored as appropriate to individual patients.
FOS344
A NEW TRANSITORY MESENTERICO-
PORTAL SHUNT FOR PANCREATIC 
RESECTION IN CASE OF CHALLENGING 
VENOUS RESECTION
P. Bachellier, E. Rosso, P. David, E. Oussoultzoglou, 
P. Addeo and C. Nobili
Hepato-Bilio-Pancreatic Surgery and Liver Transplantation 
Center, University of Strasbourg, France
Introduction: To report a new type of transitory mesen-
terico-portal shunt (TMPS) which can be used during pan-
creaticoduodenectomy (PD) for adenocarcinoma of the 
pancreas in case of extensive portal vein (PV) or superior 
mesenteric vein (SMV) invasion with collateral circulation.
Methods: The resection was performed using a new TMPS. 
A TMPS is than performed by using a prosthesis of Gore-
Tex® (FEP*Ringed Gore-Tex®) of 20 cm of long (diameter 
14–20 mm, according to the diameter of the SMV axis) 
which is inserted between the distal stump of the PV and the 
proximal stump of the SMV by two termino-terminal anas-
tomosis with 5/0 non-absorbable monofi lament running 
sutures. The pancreaticoduodenectomy with lymphadenec-
tomy is completed and the specimen is removed en-bloc with 
the involved tract of the PV/SMV. Finally, the TMPS of 
Gore-Tex® is removed and a direct termino-terminal anasto-
mosis between the PV and SMV is performed with 6/0 non-
absorbable monofi lament running sutures. Fourteen patients 
with borderline or locally advanced “unresectable” adeno-
carcinoma of the pancreas underwent PD or total PD with 
venous resection after neoadjuvant chemotherapy.
Results: The postoperative mortality was nil, while the 
postoperative morbidity was 33%. In all patients the 
TMPS allowed to achieve curative intent resection avoiding 
massive bleeding or venous liver ischemia. Overall one-year 
survival was 97%, while one year disease-free survival 
was 36%.
Conclusion: The present new TMPS is feasible and safe and 
should be considered as an effective technical option for 
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patients with adenocarcinoma of the pancreas with extensive 
venous involvement and the concomitant presence of a col-
lateral circulation requiring PD.
FOS345
PANCREATIC CANCER CELLS SECRETE 
CXCL12 WHICH IS CHEMOATTRACTIVE 
UPON PERIPHERAL NEURAL GLIA: 
REVERSAL OF A PARADIGM
K. Kujundzic, I. E. Demir, T. Kehl, H. Friess and 
G. Ceyhan
Department of Surgery, Klinikum Rechts der Isar, 
Technische Universität München, Munich, Germany
Introduction: Neural invasion (NI) in pancreatic cancer 
(PCa) results from the biological affi nity of PCa cells (PCCs) 
to intrapancreatic nerves. However, the molecular mediators 
of NI, and particularly the role of chemokines in this che-
moattraction between nerves and PCCs, remain largely 
unknown. In this study, we sought to determine the role of 
the chemokine CXCL12 and its rececptor CXCR4 in NI in 
PCa.
Methods: Expression of CXCL12 and CXCR4 was studied 
in normal human pancreas (NP), PCa tissues, PCC lines, 
intrapancreatic nerves and human Schwann cells (hSC) via 
immunohistochemistry, immunoblotting and enzyme-linked-
immunosorbent-assay (ELISA). To identify the contribution 
of CXCL12/CXCR4 axis to NI, 3D-neural-migration and 
chemotaxis assays were performed under the infl uence of the 
CXCR4 chemical inhibitor AMD3100 and recombinant 
CXCL12.
Results: PCa tissues and PCCs demonstrated an upregula-
tion of CXCR4 and especially of CXCL12 when compared 
to NP. Interestingly, intrapancreatic nerves and within these 
especially hSC showed prominent levels of CXCR4. When 
co-cultivated, hSC migrated in a strictly targeted manner 
towards PCCs long before these even started with their 
migratory activity. Pre-treatment of hSC with AMD3100 sig-
nifi cantly reduced the cancer-targeted migration of hSC. 
Correspondingly, recombinant CXCL12 exerted a potent 
chemotactic effect upon hSC.
Conclusion: Chemokines like CXCL12 which are secreted 
by PCCs strongly attract glia cells that harbor the corre-
sponding chemokine receptors like CXCR4. Hence, in sharp 
contrast with the traditional assumption, NI results from the 
migration of peripheral glia (hSC) towards PCCs. This 
“chemokine-mediated migration of nerves towards cancer” 
urges for a reversal in our common understanding of NI in 
PCa.
FOS346
CONTEMPORARY OUTCOMES FROM 
SYNCHRONOUS PORTAL/SUPERIOR 




S. Jegatheeswaran and A. Siriwardena
Regional Hepatobiliary Surgery Unit, Manchester Royal 
Infi rmary, Manchester, UK
Introduction: Pancreaticoduodenectomy (PD) is the stan-
dard of care for localised cancer of the pancreas. Resectability 
can be improved by synchronous resection of the portal/SM 
vein. The procedure may add morbidity without benefi t. We 
previously reported outcome in PV/SMV resection from 
1966–2005 but included patients having arterial and venous 
resection and predated the era of high-volume centres. This 
study examines outcome from PV/SMV resection at PD in 
the 21st century.
Methods: Medline and Embase searches identifi ed 44 man-
uscripts giving data on 1905 patients undergoing PV/SMV 
resection reported during 2000–2010. Data were only 
included from original reports providing resection details 
and outcome data. Data were extracted to Cochrane criteria 
to populate a pre-determined database. Reporter variables 
included numbers of vein resections (total and proportion of 
all PD), outcome and survival. Data are presented as medians 
(range) of pooled data.
Results: Forty four centres report outcome after PD with 
vein resection to 2010. Of 1905 vein resections, 1638 were 
in centres which provided denominator data on PD without 
vein resection. PD with vein resection comprised 24% of 
6, 923 PD. Two centres used artifi cial grafts; all others used 
either partial circumference resections or autologous vein 
reconstruction. Median 30-day mortality ranged from 0–11%. 
The modal 30-day mortality was 0%. Median survival was 
15 (9–33) months.
Conclusion: This is thought to be the largest pooled report 
of portal/SMV resection at PD. The data show that vein 
resection is undertaken in up to a quarter undergoing PD with 
acceptable operative mortality. Median survival is 15 months. 
Vein resection has become an established option in the 




DOES AGGRESSIVE SURGICAL 
INTERVENTION IMPROVE OUTCOME?
M. White, L. Edwards, S. Cawich, M. Abu-Hilal, 
T. Armstrong and N. Pearce
University Hospitals Southampton, Department of Surgery, 
Southampton, UK
Introduction: Pancreatic neuroendocrine tumours (PNETS) 
often present late. At diagnosis 65% of patients have metas-
tases, with median survival of 24 months. The conventional 
approach is conservative management. Recent evidence has 
suggested that aggressive treatment leads to better outcomes. 
We have shown that in a cohort of patients with advanced 
PNETs aggressive resection prolongs survival.
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Methods: All patients with intra-abdominal neuroendocrine 
tumours (NETs) were assessed by the Hepato-pancreato-
biliary and NET Multidisciplinary Teams from January 
2002 to November 2011 were prospectively registered on a 
database. All patients with PNETs were identifi ed. 
Demographic, treatment, peri-operative morbidity and sur-
vival data were graded using the Clavien system and anal-
ysed using SPSS.
Results: 239 patients were assessed. 61 patients had PNETs 
(36 F : 25 M) with median age of 65. 55 patients underwent 
71 resections. 52 had primary tumours resected and 3 patients 
had the primary tumour left in situ. Resections included: 29 
conventional pancreatic; 17 extended (including vascular or 
multi-visceral resections); 9 pancreatic and liver resections 
(4 synchronous, 5 sequential); 16 had liver resections alone. 
27 patients had 48 additional medical and radiological 
interventions.
Peri-operative mortality 0%. 42% morbidity. 3 operated 
patients died from progressive disease. 2 non-surgical 
patients died. Overall survival for PNETs was 56/61 (92%) 
at a median follow up of 28 months. Survival for operated 
patients was 52/55 (95%) at 33 months.
Conclusion: An aggressive multi-modal approach with 
resection of advanced PNETs leads to excellent long term 
survival with acceptable patient morbidity.
FOS348
NEW PATHWAYS OF ENHANCED 
RECOVERY AFTER SURGERY IN 
PANCREATIC SURGERY: PRELIMINARY 
RESULTS FOR SAFETY AND 
ADHERENCE
N. Pecorelli, G. Capretti, G. Balzano, C. Martani, 
U. Casiraghi, R. Ariotti, L. Beretta and M. Braga
San Raffaele Scientifi c Institute, Milano, Italy
Introduction: Enhanced recovery after surgery (ERAS) 
programmes have been increasingly applied in different 
surgical specialties improving postoperative recovery and 
reducing morbidity. Its role on upper gastrointestinal major 
surgery, especially pancreatic surgery, is still controversial 
and data on its application are few. The objective of this 
study was to test safety and feasibility of an ERAS pathway 
for patients undergoing pancreaticoduodenectomy (PD) and 
left pancreasectomy (LP).
Methods: From October 2010 to November 2011, 103 con-
secutive patients undergoing PD (n = 60) and LP (n = 43, 
laparoscopic 53.4%) were treated with a multimodal, inter-
disciplinary perioperative ERAS pathway. The items imple-
mented were: preadmission counselling, no preoperative 
bowel preparation, carbohydrate loading, epidural analgesia 
avoiding the use of opioids, intraoperative iv fl uid restriction 
(4–5 ml/kg/hr), postoperative nausea and vomiting and 
hypothermia prophylaxis, removal NG tube at the end of 
surgery, POD 1 mobilization for at least 4 hrs, solid food diet 
on POD 1, early stop of iv infusions and removal of urinary 
catheter. Complications were classifi ed according to Clavien-
Dindo classifi cation (major complications grade III-V).
Results: Adherence to the pathway: Preadmission counsel-
ling 72%. Epidural analgesia 95% for PD and 83% for LP. 
64% of PD pts were successfully mobilized on POD1 for a 
median of 60 minutes, 95% on POD 2. Median day of solid 
diet intake was day 3[1] and iv infusions were stopped on 
day 5[2]; only 8% of pts needed the repositioning of a NGT. 
73% of LP pts were mobilized on POD1 with a median of 
53 minutes and 93% on POD 2. The median day of solid diet 
intake was day 2[1] and iv infusions were suspended on day 
4[1]. Surgical outcome: major complications 17% in PD and 
3% in LP, and mortality 4% and 0%. Delayed gastric empty-
ing occurred in 10% of PD pts. Readmission rate was 9% 
(PD) and 10% (LP). Postoperative LOS was 9.5[3] days for 
PD and 7[2] days for LP.
Conclusion: The application of an ERAS protocol proved 
to be safe with no increase in morbidity and readmission rate. 
Adherence to most items, especially preoperative and intra-
operative was high. Compliance with postoperative items 
such as early stop of iv infusions and early solid food diet 
had suboptimal results. Data on length of stay for both pro-
cedures are encouraging.
FOS349
RADIOLOGICAL INTERVENTION IN 
MANAGEMENT OF COMPLICATIONS 
AFTER PANCREATICODUODENECTOMY
J. A. M. G. Tol1, S. M. M. de Castro1, O. M. van Delden2, 
K. P. van Lienden2, T. M. van Gulik1, O. R. C. Busch1 and 
D. J. Gouma1
1Department of Surgery, Academic Medical Center, 
Amsterdam, The Netherlands; 2Department of Radiology, 
Academic Medical Center, Amsterdam, The Netherlands
Introduction: Pancreaticoduodenectomy is still associated 
with a high morbidity rate but mortality, overall relaparot-
omy rate and length of hospital stay have decreased substan-
tially. This might partly be due to improved non-surgical and 
radiological management of postoperative complications in 
particular in high-volume centres. The aim of the present 
study was to analyze the role of radiological intervention in 
management of postoperative complications in patients after 
pancreaticoduodenectomy.
Methods: This study included 909 consecutive patients 
who underwent pancreaticoduodenectomy between 1992 
and 2010. Patients were divided into 2 groups, patients 
treated from 1992–2002, group 1 and patients treated from 
2003–2010, group 2. Group 1 contained 454 patients, group 
2 contained 455 patients. These 2 cohorts were compared to 
analyze any changes in surgical outcomes and postoperative 
management over time. Data were obtained from a prospec-
tively collected database.
Results: In 464 patients (51%) 1 or more surgical complica-
tions were reported. Complications were treated conserva-
tively in 256 patients, required 1 or more radiological 
interventions in 157 patients and required a surgical interven-
tion in 86 patients. The amount of patients treated with radio-
logical interventions increased (group 1: 11%, group 2: 23%, 
P < 0.001). The total number of performed relaparotomies 
decreased (group 1: 92, group 2: 46, P = 0.03). Length of 
hospital stay shortened over the last decade (group 1: 15, 
group 2: 12 days, P < 0.001) and was shorter in patients who 
underwent radiological interventions compared with surgical 
interventions, 25 vs. 37 days resp. (P < 0.001). Overall mor-
tality was 2.3% and did not differ between groups.
Conclusion: There has been an increase in the use of radio-
logical interventions for surgical complications in patients 
after pancreaticoduodenectomy during the past decade. 
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Radiological interventions in patients with postoperative 
complications might lead to a shorter hospital stay compared 
to patients treated with surgical interventions.
FOS350
ROLE OF KRAS PATHWAY IN 
PROGRESSION OF PANCREATIC 
CANCER
M. Kocik1, M. Varga1, B. Mohelnikova-Duchonova3, 
V. Brynychova4, M. Oliverius1, E. Honsova2 and P. Soucek3
1Transplant Surgery Department, Institute for Clinical and 
Experimental Medicine, Prague, Czech Republic; 2Clinical 
and Transplant Pathology Department, Institute for 
Clinical and Experimental Medicine, Prague, Czech 
Republic; 3Department of Toxicogenomics, National 
Institute of Public Health, Prague, Czech Republic; 4Third 
Faculty of Medicine, Charles University in Prague, Czech 
Republic
Introduction: Pancreatic carcinoma (CaP) is an aggressive 
disease with extremely low sensitivity to anticancer agents. 
KRAS wildtype patients could potentially benefi t from anti-
EGFR therapy. In 90% of patients, with KRAS mutated, 
further targets downstream KRAS and along interacting sig-
naling pathways have to be identifi ed. The aim of this study 
was to analyze transcript levels of ten important genes along 
the KRAS signaling pathway in patients with CaP and evalu-
ate their importance for disease progression.
Methods: Transcript levels of SOS1, GRB2, SHC1, KRAS, 
RAF1, RAC1, MAP2K1, MAP2K2, MAPK1, and MAPK3 
in tumors and adjacent non-neoplastic control tissues from 
21 patients with CaP were determined by real-time PCR with 
relative quantifi cation. POP4 and ELF1 were used for nor-
malization of the results as reference genes. Differences in 
transcript levels in patients divided by TNM stage and grade 
were then analyzed by non-parametric tests (Kruskal-Wallis 
and Spearman tests, p < 0.05 considered as signifi cant).
Results: Levels of SHC1 (p = 0.025), KRAS (p = 0.032), 
RAC1 (p = 0.001), and MAPK3 (p < 0.001) were upregu-
lated whilst those of RAF1 (p < 0.001), MAP2K2 (p = 
0.007), and MAPK1 (p = 0.001) were downregulated in 
tumors compared to control tissues. MAPK1 level signifi -
cantly correlated with SOS1, GRB2, KRAS (p = 0.027) and 
MAP2K1 levels in tumors. Similarly, GRB2 level signifi -
cantly correlated with levels of KRAS, MAPK1, MAP2K1, 
and MAP2K2 in tumors. Except MAPK1 with KRAS (p = 
0.016), these correlations were not observed in control 
tissues. Levels of the followed genes did not signifi cantly 
associate with TNM stage or grade of carcinomas except the 
level of MAPK1 which was signifi cantly higher in grade 3 
in comparison to grade 2 tumors (n = 10 vs. n = 11, p = 
0.019).
Conclusion: Detailed analysis of correlations between 
levels of the analyzed genes in control and tumor tissues 
revealed massive deregulation of KRAS pathway in tumors. 
This study identifi ed several potential candidates for drug 
targets along the KRAS signaling pathway deregulated 
during pancreatic carcinogenesis. Namely MAPK1 (ERK2) 
whose level signifi cantly associated with the aggressiveness 
of pancreatic cancer shall be further explored. Study was 





COMPARATIVE PRE-CLINICAL STUDY 
TO ASSESS EFFICACY OF A 
RF-ASSISTED TRANSECTION DEVICE
D. Dorcaratto1, F. Burdio2, D. Fondevila3, A. Andaluz3, 
I. Poves2, R. Quesada4, E. Berjano5 and L. Grande2
1Department of Surgery, Universitat Autonoma de 
Barcelona, Barcelona, Spain; 2General Surgery 
Department, Hospital del Mar, Barcelona, Spain; 
3Department of Animal Medicine and Surgery, Facultat de 
Veterinària, Universitat Autònoma de Barcelona, 
Barcelona, Spain; 4Department of Biomedical Engineering, 
Universitat Politecnica de Catalunya, Barcelona, Spain; 
5Biomedical Synergy, Electronic Engineering Department, 
Universitat Politècnica de València, Valencia, Spain
Introduction: Several techniques have been described for 
pancreatic transection in laparoscopic distal pancreatectomy 
(LDP) and the best one remains to be elucidated. The inci-
dence of pancreatic fi stula (PF) after resection of distal pan-
creas persists high in most series. LDP is today the gold 
standard procedure for resection of benign and some malig-
nant neoplasms of left pancreas. Our goal was to compare 
safety and performance of a RF-assisted transection device 
versus stapler device in a porcine model of LDP.
Methods: LDP was performed in 29 swines. Pancreatic 
resection was performed by RF-assisted device (Coolinside®, 
Apeiron Medical, Valencia, Spain) in 15 swines (RF group), 
and by mechanical stapler in 14 swines (ST group). Animals 
were randomly assigned preoperatively either to RF or ST 
group, followed daily and necropsied at 4 weeks PO. Primary 
endpoints were the development of PF using the Pancreatic 
Anastomotic Leak Study Group defi nition (biochemical PF) 
and/or the presence of amylase-rich fl uid collections/
abscesses during necropsy and/or dye extravasation from the 
remnant duct. Secondary endpoints were postoperative plas-
matic amylase (PA) and glucose concentration (PG), intra/
post-operative complications/death, surgery and transection 
time.
Results: 1 biochemical PF without clinical consequences in 
RF and 2 clinical PF in ST group were diagnosed. Median 
peritoneal liquid amylase at 4PO day was 2330 UI/L in RF 
and 1328 in ST group (P > 0.05). No differences were found 
comparing postoperative PA/PG nor comparing median 
surgery/transection time (95/4 min in RF and 78/4 in ST). 
All RF animals showed at least a 10% increase of their initial 
weight at 4 weeks PO while two ST animals did not.
There was one postoperative wound infection in RF, two 
food intolerances and two surgery unrelated deaths in ST 
group. Transection surfaces showed a central area of necrosis 
surrounded by intense fi brosis and ductal obliteration in RF, 
and less fi brosis with increased limphocitic infi ltration in ST 
animals.
Conclusion: The RF-assisted device may be at least as safe 
and effi cacious as staplers to perform LDP in terms of PF 
prevention, surgical and transection time, postoperative com-
plications rate and postoperative pancreatic function. The 
results from this study are the fi rst step towards further clini-
cal trials using the Coolinside device.
 Free Orals Abstracts 255
© 2012 The Authors
HPB 2012, 14 (Suppl. 2), 107–287 HPB © 2012 Americas Hepato-Pancreato-Biliary Association
FOS352
SECOND SURGERY AFTER RESECTION 
FOR PANCREATIC CANCER
C. Sperti, V. Beltrame, B. Bellamio, A. C. Milanetto, 
L. Moletta and C. Pasquali
Pancreatic and Endocrine Digestive Surgical Unit, Clinica 
Chirurgica IV University of Padua, Italy
Introduction: The majority of the patients previously 
resected for pancreatic cancer develop tumor’s recurrence 
within 2 years of surgery, and recurrent cancer remains a 
signifi cant therapeutic challenge. Only few series have previ-
ously documented a second surgery after pancreatic resection 
in patients with pancreatic adenocarcinoma. The purpose of 
this study was to evaluate the effect of surgery in patients 
with recurrent pancreatic or second tumor after resection of 
primary cancer.
Methods: From January 1997 to December 2009, 226 
patients who underwent resection for pancreatic cancer were 
prospectively investigated with intensive follow-up includ-
ing tumor markers (CEA and CA 19-9), abdominal ultra-
sound and/or helical computer tomography, chest x-ray every 
3 months for the fi rst 2 years, and then every 6 months. 
Whole body PET scan (with CT acquisition) was performed 
within one year. Median follow-up time was 24 months 
(range 17–108 months).
Results: A total of 37 patients underwent reoperation: indi-
cation for surgery was recurrence of pancreatic cancer in 31, 
and a possible second cancer in 6 patients. Among 31 patients 
with recurrent pancreatic adenocarcinoma, 13 had radical 
resection, 7 had palliative resection, 11 had digestive and/or 
biliary bypass. There was no operative mortality. Median 
survival time after radical resection was 17.5 months, and 6 
months after palliative resection or bypass. Six patients had 
a second cancer detected by PET scan, and successfully 
resected: 4 colon cancer, 1 lung cancer, and 1 cancer for the 
larynx. Five patients are alive and disease-free, one patient 
died 15 months after reoperation for recurrence of pancreatic 
cancer.
Conclusion: Although rarely feasible, curative resection of 
recurrent tumor can be carried out safely in selected patients 
who had undergone pancreatectomy for pancreatic carci-
noma. Prolonged survival is possible in this subset of 
patients. Intensive and accurate follow-up is warranted for 
these patients in order to improve the management of recur-
rent disease. Surgery has to be considered in the multimodal-
ity treatment of relapsed pancreatic cancer.
FOS353
PERI-OPERATIVE OUTCOMES OF 500 
PANCREATODUODENECTOMIES AT 
TATA MEMORIAL CENTRE: TRENDS 
AND LESSONS LEARNT OVER 
2 DECADES
K. Suradkar1, S. G. Barreto2, B. A. Somashekar1, P. J. 
Shukla1, M. Goel1 and S. V. Shrikhande1
1Department of Gastrointestinal and Hepato, Pancreato, 
Biliary Surgical Oncology, Tata Memorial Centre, Parel, 
Mumbai; 2Department of Surgery, Modbury Hospital, 
South Australia
Introduction: The technique of pancreatoduodenectomy 
(PD) has steadily evolved over the last few decades. Evidence 
from literature suggests that technical refi nements, amongst 
other reasons, have helped improve peri-operative outcomes. 
Our aim was to analyze specifi c changes in technical aspects 
of PD over 2 decades at our centre and determine their effects 
on peri-operative outcomes.
Methods: The period from 1992 to date was divided into 
three specifi c time periods marking major shifts in practice 
and performance of PD, viz. period A – 1992 till 2001 (when 
pancreaticogastrostomy was predominantly performed), 
period B – 2003 – June 2009 (standardization of pancreati-
cojejunal anastomosis), and period C – July 2009 to date 
(introduction of neoadjuvant chemo-radiotherapy, vascular 
resections, and increasing surgical volume). Peri-operative 
outcomes in these three periods were compared.
Results: 500 PDs were performed in the study period. 
Morbidity and mortality rates were 34% and 5.4%, respec-
tively. Incidence of pancreatic anastomotic leaks (POPF), 
hemorrhage, delayed gastric emptying (DGE), and bile leaks 
were 10.8%, 6%, 3.9%, and 3.4%, respectively. On further 
comparison of the periods, POPF (16% vs 7% vs 10.7%) and 
DGE (6.9% vs 2.4% vs 2%) rates signifi cantly improved 
from period A to B (p < 0.02 and p < 0.01), with no differ-
ences between periods B and C. Hemorrhage (11.1% vs 5% 
vs 2%) and bile leak rates (6.3% vs 3.4% vs 0.7%) signifi -
cantly improved in period C as compared to A (p < 0.002 
and p < 0.01), although these were not different from period 
B. In period C, 17 patients underwent PD using the superior 
mesenteric artery-fi rst technique and 8 patients required vas-
cular resections in periods B and C.
Conclusion: Standardization of PD and the anastomotic 
technique not only improved peri-operative outcomes, but 
additionally helped sustain these improvements despite 
increasing surgical volume as well as the complexity of 
resections.
FOS354
QUALITY OF SURGERY IS A MAJOR 
PROGNOSTIC FACTOR IN 
PANCREATIC CANCER
M. Tavernier1, L. Plard1, J. Francoual1, C. Bazille2, 
E. Salame1 and L. Chiche1
1Digestive Surgery Department, Centre Hospitalier 
Universitaire de Caen, France; 2Pathology Laboratory, 
Centre Hospitalier Universitaire de Caen, France
Introduction: Recommendations for surgery of pancreatic 
head cancer are based on the resection of the retroportal 
pancreatic lamina into the sheath of the superior mesenteric 
artery in order to achieve a regional lymphadenectomy (RL) 
and increase R0 resection. The infl uence of surgical technical 
update (RL) on prognosis has not been studied to date.
Methods: Retrospective single-center study, including 119 
patients operated between 1992 and 2008: 71 patients under-
went standard pancreaticoduodenectomy (PD group) and 48 
patients had a complete cleaning of the retroportal lamina 
(PD + RL group). Morbidity, mortality and long term sur-
vival were compared.
Results: The 2 populations were comparable. Despite a high 
overall morbidity (52%), there was no mortality. There was 
no difference in morbidity between the two groups. In the 
PD + RL group, average hospital stay was reduced (19 vs 15 
days, p = 0.02) and more lymph nodes were resected (14 vs 
20, p < 0.001). There wasn’t any change neither in the rate 
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of R0 resection (61% vs 70%, p = 0.2) nor in involved lymph 
nodes rate (71 vs 72%, p = 0.5). The rate of patients treated 
by adjuvant therapy increased (49 vs 79%, p = 0.001) and 
median survival was improved in PD + LR group (15 [CI95% 
12–19] vs 32 months [CI95% 19–45], p = 0.02). In multivari-
ate analysis, R0 resection (p = 0.01), adjuvant therapy (p = 
0.02) and regional lymphadenectomy (p = 0.02) were inde-
pendent prognostic factors of survival.
Conclusion: Regional lymphadenectomy ie resection of the 
retroportal pancreatic lamina into the sheath of the superior 
mesenteric artery, without increasing morbidity, is an inde-
pendent prognostic factor in cases of pancreatic head cancer.
FOS355
ACUTE PANCREATITIS CONDITIONED 
MESENTERIC LYMPH CAN CAUSE 
CARDIAC DYSFUNCTION
S. Shanbhag, B. Choong, K. Askelund, R. Premkumar, 
L. Phang, S. Nachkebia, J. Windsor and A. Phillips
The Pancreas Research Group, Department of Surgery, 
Faculty of Medical and Health Sciences, School of 
Biological Sciences, University of Auckland, New Zealand
Introduction: Critical illness (CI) including acute pancre-
atitis (AP) is associated with multiple organ dysfunction 
syndrome (MODS) and death. Most common in MODS are 
cardiac and pulmonary dysfunction. The ‘gut-lymph hypoth-
esis’ states that MODS is due to the release of toxic factors 
from the intestine into mesenteric lymph (ML). Signifi cant 
composition changes to ML are associated with acute pan-
creatitis and other CI’s. ML is delivered to the systemic 
circulation via the thoracic duct and en route bypasses the 
liver avoiding potential detoxifi cation, before fi rst encounter-
ing the heart and then lungs. The aim of this study was to 
determine the effect of AP conditioned ML on cardiac func-
tion and the effect of external drainage of ML.
Methods: Groups (n = 8/group) of normal rats and those 
with taurocholate induced severe AP, a model of critical 
illness, had either no lymphatic intervention or thoracic duct 
(TD) ligation with external ML drainage (to protect the 
hearts from exposure to ML). After 6 hours the heart was 
removed from both groups for ex vivo functional measure-
ments, including cardiac output and ventricular contractility 
(+dP/dt), relaxation (−dP/dt). In a separate experiment ML 
was collected from normal rats and those with established 
taurocholate AP and infused into ex vivo perfused working 
hearts from donor normal rats to assess the impact on cardiac 
function.
Results: Signifi cant cardiac dysfunction was found in the 
hearts removed from rats with established AP alone (no lym-
phatic intervention) compared to the control group (p < 
0.05). Strikingly this dysfunction did not occur in rats with 
established AP and TD ligation with ML drainage. In the 
second experiment infusion of AP conditioned ML resulted 
in an immediate, similar and signifi cant reduction of cardiac 
output (p < 0.05) with corresponding signifi cant reductions 
in the measures of cardiac contractility and relaxation (p < 
0.05) compared with normal lymph. There was no change in 
the heart rate during these experiments, indicating that this 
was an inotropic and not a chronotropic effect.
Conclusion: AP conditioned ML causes signifi cant cardiac 
dysfunction which can be prevented by TD ligation and 
external ML drainage. This cardiodepressant effect is likely 
to be important in other CI’s. Further research is required to 
study the impact of conditioned ML in AP and other CI’s on 
the function of other vital organs in MODS.
FOS356
SURGICAL TREATMENT OF 
INSULINOMAS. A SINGLE-INSTITUTION 
EXPERIENCE OF 50 PATIENTS
N. Carrere1, D. Louis1, D. Vezzosi2, C. Voronca1, 
A. Bennet2, J. Selves3, P. Caron2 and B. Pradere1
1Digestive Surgery Department, Purpan University 
Hospital, Toulouse, France; 2Endocrinology Department, 
Larrey University Hospital, Toulouse, France; 3Pathology 
Department, Purpan University Hospital, Toulouse, France
Introduction: Insulinomas are rare pancreatic endocrine 
tumors. The aim of the study was to assess the results of the 
radiological and surgical procedures that had been employed 
in operated patients with insulinoma and to determine prog-
nostic factors regarding the recurrence risk.
Methods: This is a retrospective monocentric study on 50 
patients (mean age: 51 years) who underwent surgery for 
insulinoma between 1988 and 2010. Clinical, radiological, 
perioperative data and pathological fi ndings were analysed 
along with short- and long-term follow-up after surgical 
treatment. Kaplan Meier analysis was employed to study 
recurrence-free survival. Uni- and multi-variable analyses 
were performed to determine prognostic factors related to 
recurrence risk.
Results: Echoendoscopy and MRI-scan had a sensitivity of 
90% and 85%, respectively. In 3 patients (6%) per-operative 
examination failed to localize a tumor (nesioblastosis = 2, 
insulinoma = 1). During a median follow-up of 52 months, 
9 patients experienced a recurrence. In patients with insuli-
noma totally removed by surgery, the recurrence-free sur-
vival rate was 72% after 5 years. A uni-variable analysis 
revealed that the following factors were predictive of recur-
rence: pathological diagnosis of carcinoma (p < 0.001), 
lymph node invasion (p < 0.001), expression of Ki67 > 1% 
(p = 0.003), and presence of MEN1 mutation. Only endo-
crine carcinoma and MEN1 disease were identifi ed as sig-
nifi cant independent factors of recurrence.
Conclusion: In this series of operated patients with insuli-
noma, the high recurrence rate (28% after 5 years) is mainly 
related to endocrine carcinomas. This underlines the impor-
tance of histopathological criteria for the prognostic evalua-
tion, and of the long-term follow-up after surgical resection, 
even when the pancreatic endocrine tumor is diagnosed as 
benign.
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FOS357
ANTECOLIC VERSUS RETROCOLIC 




W. Eshuis1, C. Van Eijck2, P.-P. Coene3, I. De Hingh4, 
T. Karsten5, B. Bonsing6, J. Gerritsen7 and K. Bosscha8
1Academic Medical Center, Amsterdam, The Netherlands; 
2Erasmus Medical Center, Rotterdam, The Netherlands; 
3Maasstad Ziekenhuis, Rotterdam, The Netherlands; 
4Catharina Ziekenhuis, Eindhoven, The Netherlands; 
5Reinier de Graaf Gasthuis, Delft, The Netherlands; 
6Leiden University Medical Center, Leiden, The 
Netherlands; 7Medisch Spectrum Twente, JX Enschede, The 
Netherlands; 8Jeroen Bosch Ziekenhuis, The Netherlands
Introduction: Delayed gastric emptying (DGE) is one of 
the most prevalent complications after pancreatoduodenec-
tomy (PD). Some studies suggest that an antecolic route of 
the gastroenteric (GE) reconstruction leads to a lower inci-
dence of DGE, compared to a retrocolic route. In a consecu-
tive series from our hospital, we found no difference in DGE 
after antecolic or retrocolic GE reconstruction. The aim of 
the present trial was to investigate the relationship of the 
route of GE reconstruction after PD and DGE.
Methods: Ten middle to large volume centers contributed 
to the patient inclusion for this multicenter RCT. Patients 
who were older than 18 years, gave informed consent and 
underwent PD were included. Standard operation was a 
pylorus-preserving PD, while a ‘classic’ PD was reserved for 
cases of tumor ingrowth in the distal stomach, pylorus or 
proximal duodenum. Total pancreatectomies were excluded. 
Patients were randomized intraoperatively, when resection 
was achievable. Primary endpoint was DGE according to the 
ISGPS grading system described by Wente et al. in Surgery, 
2007. Secondary endpoints included other complications and 
length of hospital stay.
Results: There were 125 patients in the retrocolic (R-)
group, and 121 patients in the antecolic (A-)group. Baseline 
and treatment characteristics were similar. In the R-group, 
75 patients (60%) developed DGE of any grade, versus 73 
(60%) in the A-group (P-value 0.93). Clinically relevant 
DGE (grade B or C) was present in 44 (35%) and 41 (34%) 
patients, respectively. ‘Primary’ DGE (occurring in the 
absence of other intra-abdominal complications) occurred in 
38 (31%) and 30 (25%) patients, respectively (P 0.66). There 
were no differences other (non-)surgical complications, the 
need for (par)enteral nutritional support, and hospital mortal-
ity. Median length of stay was 12 days in both groups 
(P 0.24).
Conclusion: In PD, the route of GE reconstruction has no 
infl uence on postoperative incidence of DGE or other com-
plications. The etiology of DGE needs further investigation. 
The GE reconstruction in PD should be routed according to 
the surgeon’s preference.
FOS358
PANCREAS TEXTURE AND 
POSTOPERATIVE AMYLASE VALUE IN 
THE DRAINAGE FLUID AS BETTER 
PREDICTIVE FACTORS FOR POPF 
AFTER PD
T. Mimura, T. Niguma and T. Kojima
Department of Surgery, Saiseikai Okayama General 
Hospital, Japan
Introduction: Pancreaticoduodenectomy (PD) still has 
some controversies. The major complication is postoperative 
pancreatic fi stula (POPF) and following sepsis or homor-
rhage is the main cause of mortality. Although drain is 
usually placed to remove amylase-rich fl uid, it is also impor-
tant to pull it out as soon as possible to avoid infection and 
POPF. In this study, we reevaluated intraoperative fi ndings 
and analyzed amylase value in drains to determine the best 
timing of drain removal without causing POPF.
Methods: Patients who underwent PD from Jan 2003 to Oct 
2011 in our ward were analyzed. After PD, we usually 
perform panceaticojejunostomy (PJ) using an end-to-side 
two layer anastomosis technique including duct-to-mucosa 
and pancreatic parenchyma-to-jejunal seromuscular layer 
with externally stenting. To prevent abdominal abscess and 
vascular hemorrhage, omental fl ap was put under PJ and 
fi brin glue sealants were used around anastomosis. Low pres-
sure drainage was started soon after the operation at the 
upper portion of the PJ and was continued until removal. 
Amylase in the fl uid on POD1, 3, or 5 was evaluated to 
determine the best timing of the drain removal. Among 240 
patients, PJ cases were 235 (97.9%) including 1 death (0.4%) 
within 30-days.
Results: Patients were divided into two groups: #1/POPF(−) 
including non-fi stula (67.7%) & grade A (8.9%), and #2/
POPF(+) including grade B (20.4%) & grade C (3.0%), 
according to ISGPF defi nition. We fi rst reevaluated pancreas 
texture and the diameter of main pancreatic duct (MPD), 
empirically used predictors for POPF. The texture was quite 
predictive, because more than half (58.1%) of “soft” fell into 
#2 whereas only 7.6% of “hard” was found in #2. In contrast, 
MPD was less informative. We then analyzed relation 
between POPF and amylase in the drain by ROC curve. AUC 
for POD3 (0.86) or POD5 (0.86) was larger than that for 
POD1 (0.81). Cut off point of amylase on POD5 was 100 U/L 
and that on POD1 was 2000 U/L, whereas that on POD3 was 
hard to be determined.
Conclusion: We therefore conclude that pancreas texture 
and amylase value in drains after PD is quite predictive of 
POPF. Hard texture highly predicts postoperative course 
without POPF. Drainage tube can be most safely removed 
when the value of amylase in the drainage is within 100 U/L 
at POD 5.
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FOS359
A PHASE II STUDY OF ORAL S-1 WITH 
CONCURRENT RADIOTHERAPY FOR 
LOCALLY ADVANCED PANCREATIC 
CANCER
H. Shinchi, S. Takao, K. Maemura, Y. Mataki, 
H. Kurahara, M. Sakoda, S. Ueno and S. Natsugoe
Kagoshima University School of Medicine, Japan
Introduction: S-1 is a new oral fl uoropyrimidine anticancer 
agent shown to be effective for pancreatic cancer. In a previ-
ous phase I trial, we evaluated the safety of S-1 combined 
with radiotherapy to determine the MTD and DLT in patients 
with unresectable pancreatic cancer. This phase II study was 
conducted to further evaluate the effi cacy and toxicity of 
radiotherapy combined with S-1.
Methods: Eligible patients had locally advanced and unre-
sectable pancreatic cancer without distant metastases, an 
ECOG performance status of 0-1, adequate organ and 
marrow functions, and no prior anticancer therapy. Patients 
initially received 4 weeks of chemoradiotherapy. S-1 was 
given orally at a dose of 80 mg/m2/day twice daily on days 
1 to 21. Radiotherapy was delivered in fractions of 1.25 Gy 
twice daily, 5 days per week for 4 weeks (total dose: 50 Gy 
in 40 fractions). One month after the completion of chemo-
radiotherapy, S-1 was administered for 14 days followed by 
a 14-day rest period. This cycle was repeated as maintenance 
therapy until disease progression or unacceptable toxicity.
Results: Fifty patients were enrolled in this phase II study. 
Forty-three patients (86%) completed the scheduled course 
of chemoradiotherapy. There was no treatment-related death 
or grade 4 toxicity. The major toxic effects were leukopenia 
and nausea. The objective tumor responses by RECIST cri-
teria included 15 PR (30%), 23 SD (46%) and 12 PD (24%). 
Median PFS and median OS were 6.7 months and 14.3 
months, respectively. Survival rates at 1 and 2 years were 
62% and 27%, respectively.
Conclusion: Combination therapy with S-1 and radiation in 
patients with locally advanced and unresectable pancreatic 
cancer is considered a promising, well-tolerated regimen that 
can be recommended as an effective treatment for locally 
advanced pancreatic cancer.
FOS360
ADOPTING THE LEEDS 
PATHOLOGY PROTOCOL IN 
PANCREATICODUODENECTOMY – AN 
INDIAN EXPERIENCE
C. Tampi1, R. Shah2 and J. Palepu2
1Department of Histopathology, Lilavati Hospital and 
Research Centre, Mumbai, India; 2Department of Surgical 
Oncology, Lilavati Hospital and Research Centre, Mumbai, 
India
Introduction: R0 surgery in pancreatoduodenectomy offers 
the only opportunity for cure. However it is seen that recur-
rence rates after R0 and R1 are fairly similar, suggesting that 
positive margins are often under reported. While transection 
margins are routinely examined, it is the circumferential 
margin that defi nes the difference between R0 and R1 surger-
ies. This study assesses the impact of the Leeds protocol, on 
the R status in pancreatoduodenectomies done at our centre.
Methods: 40 consecutive cases of pancreatoduodenecto-
mies were analyzed, before and after adopting the Leeds’s 
Protocol. Only cases of ampullary and Pancreatic head ade-
nocarcinomas were included in the study. The circumferen-
tial margins were marked with differently colored inks, with 
special stress on the medial margin, ie SMV groove, and 
SMA surface. Serial axial slicing of the pancreatic head was 
done, with documentation of tumor distances from posterior, 
medial, and anterior surfaces. The differences in margin posi-
tivity before and after adopting the protocol were analyzed.
Results: On adopting the Leeds protocol, it is seen, that the 
incidence of Positive margins is more, the numbers with 
multiple positive margins also increased, and the medial 
margin positivity showed a marked increase. Small ampul-
lary tumors, hitherto thought to be completely resected, often 
showed retro duodenal margin positivity.
Conclusion: Lack of standardized protocols for margin 
examination, has led to imprecise reporting of margin status, 
and inconsistency in the rate of margin positivity. Accurate 
circumferential margin examination, reveals the true R0/R1 
status. This would result in better prognostication, and more 
reliable comparison of data. Coloring of margins, helps 3 
dimensional analysis and interpretation of the anatomic rela-
tion around the pancreatic head. It offers a better feedback 




PATIENTS WITH TUMOR OF THE HEAD 
OF THE PANCREAS AND 
PERIAMPULLARE AREA
I. Khatkov1, V. Tsvirkun2 and R. Izrailov1
1Moscow State University of Medicine and Dentistry, 
Moscow, Russia; 2Clinical Hospital 119 of the FMBA, 
Russia
Introduction: Aim to show our experience in treatment of 
33 patients with tumor of the head of the pancreas and peri-
ampullare area by using a total laparoscopic approach.
Methods: From January 2006 to June 2011 33 patients from 
39 underwent laparoscopic pancreaticoduodenectomy 
(LPDR) in our clinic. There were 20 females and 13 males, 
average age was 60.6 (range, 45–76) years. In retrospective 
study we analyzed the main outcome measures: conversion 
rate, blood loss, operative time, length of hospital stay, post-
operative morbidity and mortality.
Results: Conversions were needed in 6 cases. The average 
blood loss was 606 ml (range, 100–2100) and 250 ml in the 
5 last cases. The median operative time was 520 min, in the 
5 last cases – 360 min. The pathogistology diagnosis were: 
pancreatic adenocarcinoma (n-18), ampulloma (n-9), chronic 
pancreatatis (n-1), low bile duct carcinoma (n-3), synchro-
nous neuroendocrine tumor of the duodenum and multiple 
gastrointestinal stromal tumor (n-1), duodenal adenocarci-
noma (n-1). The complication rate was 19 (57.5%). This 
included delayed gastric empting (n-3), pancreatic fi stula 
(n-5), bile leak (n-1), bowel obstruction (n-1), bleeding (n-1), 
intraabdominal fl uid collection (n-3). There were two cases 
(6%) of postoperative mortality.
Conclusion: Laparoscopic resection for treating of the 
patients with cancer of biliopancreatoduodenal area is a 
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feasible and effective procedure. After passing the initial 
learning curve (about 25–30 cases), laparoscopic approach 
permits to make the blood loss signifi cantly lower and opera-
tive time comparable with traditional approach with the same 
early postoperative results.
FOS362
DOES MESENTERIC LYMPH INHIBIT 
OR PROMOTE GROWTH OF 
TRANSLOCATING BACTERIA?
B. Loveday1, S. Swift2, J. Windsor1 and A. Phillips1
1The Pancreas Research Group, Department of Surgery, 
University of Auckland, New Zealand; 2Molecular 
Medicine & Pathology, School of Medical Sciences, 
University of Auckland, New Zealand
Introduction: In severe acute pancreatitis the pancreas can 
become infected with a range of bacteria. Lymph can act as 
a conduit for bacteria from the intestine. The mesenteric 
lymph (ML) draining from the intestine changes dramati-
cally in composition during acute disease states. It is unknown 
whether these changes inhibit or promote bacterial growth in 
ML. The objective of this study was to determine the effect 
of acute and chronic disease-conditioned ML on the growth 
of commonly translocating bacteria.
Methods: Under sterile conditions the mesenteric duct was 
cannulated and disease-conditioned ML sourced from four 
animal models (n = 5 per group): i) Acute Pancreatitis [AP] 
(taurocholate ductal infusion model), ii) Hemorrhagic Shock 
[HS] (reversible 90 min hemorrhagic shock model), iii) 
Diabetes Mellitus [DM] (Streptozotocin Type I diabetes 
model of 5–8 weeks duration) and iv) Control [C] (normal 
lymph). Five bacterial species were studied: E. coli, S. aureus, 
K. pneumoniae, E. faecalis, and P. aeruginosa. Bacteria were 
seeded as low and high concentration inoculums into the 
disease-conditioned or control ML, and bacterial growth 
measured after incubation for 4 and 24 hours.
Results: In all ML groups, after a low concentration innocu-
lation, the concentration of S. aureus, E. faecalis, and 
P. aeruginosa increased, while E. coli and K. pneumoniae 
were inhibited by control lymph. After a high concentration 
inoculation, bacterial growth was promoted in all disease 
conditioned ML, except that DM- and AP-conditioned ML 
inhibited the growth of S. aureus and E. fecalis. HS condi-
tioned ML promoted the growth of all bacteria types at both 
low and high concentration inoculations.
Conclusion: There was a complex interaction between bac-
terial species, inoculum concentration, and disease state. 
Disease conditioned mesenterial lymph does not have a con-
sistently inhibit or promote the growth of translocating bac-
teria. Further research will be required to develop strategies 
to prevent or treat bacteria in ML during severe illness.
FOS363
COMPREHENSIVE 
CHARACTERIZATION AND THE TRUE 
IMPACT OF NEURAL INVASION 
SEVERITY IN GASTROINTESTINAL 
MALIGNANCIES – A 
PATHOMORPHOLOGICAL COMPARISON 
WITH PANCREATIC CANCER
G. Ceyhan1, F. Liebl1, I. E. Demir1, R. Rosenberg1, 
K. Becker2, A. Novotny1, T. Schuster3 and H. Friess1
1Department of Surgery, Klinikum Rechts der Isar, 
Technische Universität München, Munich, Germany; 
2Institute of Pathology, Klinikum Rechts der Isar, 
Technische Universität München, Munich, Germany; 
3Institute of Statistics and Epidemiology, Klinikum Rechts 
der Isar, Technische Universität München, Munich, 
Germany
Introduction: The UICC has recently added neural invasion 
(NI) as a novel parameter in the current TNM classifi cation. 
Since NI is not commonly characterized within the gastroin-
testinal malignancies (GIM) except pancreatic cancer and 
there are few studies existing with its only focus on NI, the 
aim of this study was to determine the exact prevalence and 
severity of NI in GIM and determine the true impact of NI 
on the clinical outcome and prognosis of GIM patients and 
compare them with pancreatic cancer.
Methods: NI was characterized in H&E-stained tissue sec-
tions of 2046 patients with adenocarcinoma of the esophago-
gastric junction (AEG) type I-III, squamous cell carcinoma 
of the esophagus (SCC), gastric cancer, colon cancer, rectal 
cancer, cholangiocellular cancer (CCC), hepatocellular 
cancer (HCC) and pancreatic cancer (PCa). NI severity score 
was determined and related to patient’s prognosis.
Results: Prevalence of NI in GIM showed an utmost high 
variability from 6% in HCC, 28% in colon and 34% in rectal 
cancer, 36% for AEG I and II, 37% for SCC, 38% for gastric 
cancer, 58% for CCC, 65% in AEG III and 100% in PCa. NI 
severity was detected to be a more powerful tool to then 
solely recording the presence of NI in patients with GIM. 
Increasing NI severity was associated with diminished sur-
vival only in gastric and pancreatic cancer after multivariate 
analysis including age, gender TNM and grading.
Conclusion: The prevalence and severity of NI strongly 
varies within gastrointestinal malignancies. NI severity has 
major impact on survival especially in pancreatic and gastric 
cancer. It seems obvious, that neural invasion is not a con-
comitant side feature in gastrointestinal malignancies and 
deserves special attention especially regarding better patient 




M. A. Belluomini1, N. De Lio2, S. Signori2, V. G. Perrone2, 
F. Vistoli2, E. F. Kauffmann1, N. Napoli1 and U. Boggi2
1First Division of General Surgery, University of Pisa, 
Pisa, Italy; 2Division of General and Transplant Surgery, 
University of Pisa, Pisa, Italy
Introduction: Laparoscopy has revolutionized abdominal 
surgery quickly becoming the standard approach for many 
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operations, especially when there is little need for fi ne intra-
corporeal suturing. The da Vinci surgical system overcomes 
most of the technical limitations of laparoscopy and provides 
the unique opportunity to test whether this approach can 
improve the outcome of pancreatic resections, which often 
require challenging dissection and complex digestive 
reconstructions.
Methods: 80 consecutive robotic pancreatic resections were 
performed between 10/2008 and 12/2011. There were 23 
males (28.7%) and 57 females (71.3%), with a mean age of 
58 yrs (range 24–80) and a mean body mass index of 
24.6 Kg/m2 (range 16.9–35.9). 30 patients underwent pan-
creaticoduodenectomy (PD) (38%), 36 distal pancreatec-
tomy (DP) (45%), 6 total pancreatectomy (7%), 5 tumor 
enucleation (6%), and 3 central pancreatectomy (4%). Since 
our activity spans over a 3-year period, data were analyzed 
according to the time of surgery, to verify progress in the 
learning curve: 17 patients were operated on between 
10/2008 and 09/2009, 22 patients between 10/2009 and 
09/2010, and 41 patients during the last 15 months 
(10/2010–12/2011)
Results: No patient was converted to laparoscopy or open 
surgery. Mean operative time (OT) was 437.8 minutes. In the 
fi rst period OT was 512 min for PD and 420 for DP. The 
mean number of lymph nodes examined (LN) was 16.8, 31.2 
for PD and 11.9 for DP. Pancreatic fi stula (PF) occurred in 
41% of the patients. In the second, OT was 596 min for PD 
and 402 for DP. The LN was 16.7, 27.2 for PD and 10.0 for 
DP. PF was amounted 36.3%. In the third, OT was 583 min 
for PD and 288 for DP. The LN was 28.7, 36.0 for PD and 
19.1 for DP. PF was amounted 36.6%. 44 patients were 
diagnosed with benign/low-grade tumors and 26 with cancer. 
Surgical margins were all negative. Post-operative mortality 
was nil, morbidity was 52%, mean hospital-stay was 16 days.
Conclusion: In selected patients laparoscopic robot-assisted 
pancreatic resections can be safely performed. Despite the 
existence of a learning curve, experienced pancreatic sur-
geons are not expected to pay to robotics the same price that 
they would have been asked for by laparoscopy.
FOS365
LONG-TERM OUTCOMES OF 
PANCREATIC INTERNAL SHORT 




K. Susumu, M. Fumihiko, A. Hodaka, T. Naoyuki, 
W. Keita, S. Makoto, M. Sawako, T. Tadahiro and S. Keiji
Teikyo University, Japan
Introduction: Effi cacy of internal drainage with pancreati-
cojejunostomy (PJ) has been recognized, however there have 
been few reports describing the long-term outcomes of an 
internal short stent placed across the PJ following pancreato-
duodenectomy (PD). The purpose of this study is to clarify 
the long-term outcomes the short internal stents.
Methods: Fifty-seven patients that had internal short stents 
placed across the PJ following PD were retrospectively ana-
lyzed. The cumulative defecation and deciduation rates of 
the stent, complications in relation to delayed defecation of 
the stents, and predictive factors infl uencing the delayed 
defecation, delayed deciduation, and the distal migration of 
the stents were analyzed.
Results: Defecation of the stent was confi rmed in 
35 patients. The median defecation time from PD and 
cumulative defecation rate at 1 year were 14.8 months and 
41%, respectively. The median deciduation time from PD 
and cumulative deciduation rate at 1 year were 13.1 months 
and 46%, respectively. Distal migration of the stent was 
observed in 7 patients: location of the migration was bile duct 
in 4 patients and afferent limb in 3 patients. Acute pancre-
atitis occurred in 2 patients with the stent remained in the 
remnant pancreatic duct. One patient encountered acute chol-
angitis due to stent migration to the bile duct and required 
percutaneous transhepatic cholangial drainage. A multivari-
ate analysis showed that stitches in the pancreatic duct and 
jejunal mucosa ≥5, stents ≥5 Fr, and pancreatic fi stula clas-
sifi ed as either Grade B or C were independent predictive 
factors for delayed defecation of the stent. Stitches in the 
duct-to-mucosa anastomosis ≥5 was independent predictive 
factor for delayed deciduation of the stent. Stent ≥5 Fr was 
predictive factor affecting the distal migration of stent.
Conclusions: In more than half of patients, internal short 
stents were not defecated within 1 year. Retrieval of the stent 
should be considered following the migration of an internal 
short stent. Stent ≥5 Fr was independent predictive factor 
affecting delayed defecation and the distal migration of stent. 
Stitches in the duct-to-mucosa anastomosis ≥5 was indepen-
dent predictive factor for delayed defecation and deciduation 
of stent.
FOS366
PROPOSAL OF NEW CLASSIFICATION 
OF INVASIVE INTRADUCTAL 
PAPILLARY MUCINOUS NEOPLASM 
OF THE PANCREAS
M. J. Kang1, J.-Y. Jang1, K. B. Lee2, I. W. Han1, 
W. Kwon1, J. W. Park1 and S.-W. Kim1
1Department of Surgery, Seoul National University College 
of Medicine, Seoul, Korea; 2Department of Pathology, 
Seoul National University College of Medicine, Seoul, 
Korea
Introduction: Current WHO classifi cation replaced inva-
sive intraductal papillary mucinous neoplasm (IPMN) with 
IPMN with an associated invasive carcinoma. However, the 
defi nition of invasive IPMN is not well established yet, espe-
cially in a viewpoint of its relationship with pancreatic ductal 
adenocarcinoma (DAC). The authors investigated the clini-
copathologic characteristics of IPMN with an associated 
invasive carcinoma according to tumor morphology and per-
centage of invasive component.
Methods: Data were collected from 45 patients who under-
went surgery at Seoul National University Hospital with 
diagnosis of IPMN with an associated invasive carcinoma 
from 1995 to 2009. IPMN associated with an invasive car-
cinoma was designated as intraductal papillary mucinous 
carcinoma (IPMC) and DAC associated IPMN according to 
cutoff value of 50% of its invasive component by a special-
ized pathologist. Radiologic image, clinicopathologic char-
acteristics including immunohistochemical staining for 
various oncogenesis markers, and survival outcomes were 
analyzed. Of 45 patients with IPMN associated with an 
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invasive carcinoma, 29 (64.4%) were classifi ed as IPMC and 
16 (35.6%) as DAC associated IPMN.
Results: IPMC revealed higher proportion of male patients 
(3.83 : 1 vs. 0.7 : 1, p = 0.015), main duct or mixed type 
IPMN (31.0% vs. 6.3%; p = 0.071), and higher grade of 
dysplasia in its intraductal portion (100% vs. 12.5%, p < 
0.001) than DAC associated IPMN. DAC associated IPMN 
had higher rate of T3 or T4 tumors (93.8% vs. 55.2%, p = 
0.008), lymph node metastasis (43.8% vs. 17.2%, p = 0.080), 
perineural invasion (75.0% vs. 27.6%; p = 0.002), and endo-
lymphatic invasion (43.8% vs. 3.4%; p = 0.002) than IPMC. 
With immunohistochemical staining, DAC associated IPMN 
had higher expression of S100A4 (75.0% vs. 39.3%, p = 
0.023), p53 (62.5% vs. 27.6%, p = 0.022) and lower expres-
sion of SMAD4 (18.8% vs. 82.8%, p < 0.001) and p16 
(18.8% vs. 44.8%, p = 0.080).
Conclusion: IPMN with an associated invasive carcinoma 
in current WHO classifi cation is composed of 2 distinct 
clinicopathologic subset which could be differentiated based 
on histologic morphology and percentage of invasive com-
ponent. Unlike IPMC, its irrelevance in oncogenesis marker 
expression between intraductal and invasive portion of 
DAC associated IPMN suggests its separate pathway of 
evolution of invasive carcinoma regardless from its back-
ground IPMN.
FOS367
P53 ANALYSIS IS A BETTER PREDICTOR 
OF PROGNOSIS THAN HISTOLOGY IN 
PANCREATIC IPMN
N. Nicholson, L. Yan, R. Sutton, S. Harrison, F. Campbell, 
J. Neoptolemos and W. Greenhalf
NIHR Pancreas Biomedical Research Unit, Liverpool, UK
Introduction: The role of p53 in the development and pro-
gression of IPMN is unclear. Currently, radiological size and 
location (side branch/main duct) are the most quoted pre-
operative predictors of malignancy in IPMNs.
Methods: We aimed to investigate whether p53 mutational 
status can predict malignancy and outcome in IPMNs. 29 
patients underwent resection for IPMN. p53 analysis was 
performed on intra-operatively collected pancreatic juice and 
frozen tissue samples taken from the resection specimens. 
p53 results were correlated with histological diagnosis and 
survival data.
Results: Histologically, there were 11 IPMNs, 7 IPMNs 
with invasive adenocarcinoma (IPMCs), 3 conventional 
PDACs and 8 other benign entities. Eight patients died 
(median follow-up: 730 days). Tissue sample p53 status cor-
related with histological malignancy (p = 0.0005). Tissue p53 
predicted survival in IPMN and IPMC (p = 0.0001) and was 
a better predictor of survival than conventional histology 
(p = 0.01).
Tissue p53 mutational status matched that in juice in all 
but 2 cases (where mutation site lay within the primers). 
There were no false positive p53 results in pancreatic juice.
Conclusion: p53 mutational status can predict poor outcome 
in IPMNs, regardless of histological grade. Pancreatic juice 
analysis could potentially be used to identify those patients 
with IPMN who should be considered for resection.
FOS368
THE POTENTIAL OF METASTATIC 
LYMPH NODES TO PREDICT POSITIVE 
RESECTION MARGINS IN PATIENTS 
WITH RESECTABLE PANCREATIC 
CANCER
D. Petermann, N. Demartines, N. Halkic and M. Schäfer
Department of Visceral Surgery, University Hospital 
CHUV, Lausanne, Switzerland
Introduction: Despite progress during recent decades, 
long-term outcome of patients with pancreatic cancer remains 
dismal. Since positive resection margins and metastatic 
lymph nodes are known risk factors for early tumor recur-
rence, patients at risk should be identifi ed and could poten-
tially benefi t from preoperative radio-chemotherapy. This 
study aimed to assess whether the presence of lymph node 
metastasis could be used to predict positive resection margins 
in patients with pancreatic cancer.
Methods: A series of 120 patients (68 male, 52 female, 
median age 67 years) underwent pancreatic head resection 
for various malignant diseases (pancreatic ductal adenocar-
cinoma, biliary cancer, periampullary cancer) at our institu-
tion from 2000 to 2010. Patients were identifi ed from our 
prospective database that collects more than 60 single items 
of all patients undergoing pancreatic resection. Lymph node 
metastasis and positive resection margins were all confi rmed 
by histological evaluation. Positive predictive value (PPV), 
negative predictive value (NPV), sensitivity and specifi city 
were calculated to assess the predictive value of metastatic 
lymph nodes regarding tumor-free (R0) and tumor-involved 
(R1) resection margins.
Results: There were 86 specimens (72%) with tumor-posi-
tive lymph nodes and 34 specimens with tumor-negative 
lymph nodes. Resection margins were positive in 34 speci-
mens (28%) and negative in 86 specimens. Sensitivity of 
tumor-positive lymph nodes to detect positive resection 
margins was 94%, and the NPV was also 94%. In contrast, 
specifi city and the PPV were both 37%, respectively.
Conclusion: Patients with resectable pancreatic cancer, who 
have no lymph node metastasis, are at very low risk to have 
positive resection margins (2 of 34 patients, NPV 94%). In 
contrast, more than one third of patients with metastatic 
lymph nodes are at increased risk for an incomplete tumor 
resection (sensitivity 94%). If lymph nodes metastases are 
highly suspected at preoperative staging, a neoadjuvant treat-
ment strategy should be considered to increase the R0 resec-
tion rate.
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THE UTILITY OF PANCREATIC 
PROTOCOL COMPUTERIZED 
TOMOGRAPHY SCANS FOR 
PREDICTING METASTATIC DISEASE OF 
PANCREATIC TUMORS: AN UPDATE 
USING CONTEMPORARY IMAGING 
TECHNOLOGY
A. Paniccia, S. Reddy, B. Edil, J. Cameron, R. Schulick, 
M. Makary, E. Fishman and C. Wolfgang
The Sol Goldman Pancreatic Cancer Research Center, The 
Johns Hopkins Medical Institutions, Baltimore, MD, USA
Introduction: Preoperative detection of metastatic disease, 
which precludes surgical resection, remains a limitation in 
the work up of pancreatic tumors. Technology in CT imaging 
has improved dramatically in the past decade. No recent 
study has assessed the ability of enhanced-resolution pancre-
atic protocol CT scans (PPCT) to detect metastatic disease. 
Therefore, the goal of the present study is to evaluate the 
accuracy of modern high quality PPCT in assessing pancre-
atic tumors for metastatic disease.
Methods: This is a single institution review of all patients 
who underwent PPCT and operative exploration for pancre-
atic adenocarcinoma and neuroendocrine tumors over a 5 
year period using 64-slice or higher PPCT with three-dimen-
sional reconstruction. PPCT results were correlated to opera-
tive fi ndings.
Results: 823 patients underwent operative exploration after 
PPCT. 671 patients had adenocarcinoma and 152 had neuro-
endocrine tumors. For patients with adenocarcinoma and 
neuroendocrine tumors, 410 (61.1%) and 51 (33.6%) under-
went pancreaticoduodenectomy, 101 (15.1%) and 82 (53.9%) 
distal pancreatectomy, 20 (3.0%) and 3 (2.0%) total pancre-
atectomy, 35 (5.2%) and 0 palliative bypass, and 105 (15.6%) 
and 16 (10.5%) underwent non-therapeutic laparotomy/lapa-
roscopy, respectively. The accuracy of PPCT in detecting 
metastatic disease for adenocarcinoma and neuroendocrine 
tumors was as follows: sensitivity 31.4% and 83.3%, speci-
fi city 99.0% and 97.5%, negative predictive value 87.5% and 
96.0%, and positive predictive value 86.1% and 89.3%, 
respectively.
Conclusion: Modern PPCT with 3-D reconstruction is a 
highly accurate method to identify metastatic disease in pan-
creatic tumors prior to planned surgical resection. All patients 
should undergo PPCT prior to operative exploration for pan-
creatic tumors. The sensitivity is lower for detecting meta-
static disease in patients with adenocarcinoma than in 
neuroendocrine neoplasms. Since the sensitivity remains 
relatively low, other modalities may be of benefi t in selected 
patients and should be further studied.
FOS370
POSTOPERATIVE PANCREATIC FISTULA 
RATE IS NOT HIGHER AFTER CENTRAL 
PANCREATECTOMY AS COMPARED TO 
SPLEEN PRESERVING DISTAL 
PANCREATECTOMY
T. Dumitrascu, A. Scarlat, M. Ionescu and I. Popescu
Fundeni Clinical Institute, Bucharest, Romania
Introduction: Central pancreatectomy is a pancreas-sparing 
alternative to distal pancreatectomy in selected cases (i.e. 
benign and low-malignant lesions of the pancreatic body). 
However, it is considered to have the highest postoperative 
fi stula rate of all pancreatic resections, making this procedure 
not widely used. The aim of the study is to assess the post-
operative outcome after central pancreatectomy, as compared 
to spleen preserving distal pancreatectomy, mainly in regard 
with pancreatic fi stula rates.
Methods: Twenty-two consecutives central pancreatecto-
mies (group 1) were compared to 24 consecutives spleen 
preserving distal pancreatectomies (group 2) performed 
between 2002 and 2011 at Fundeni Clinical Institute, 
Bucharest. Pre, intra and postoperative data were retrospec-
tively assessed for both groups from a prospective gathered 
electronic database. A detailed and comparative analysis of 
the postoperative outcomes was made between the two 
groups.
Results: There were no differences between the two groups 
in regard with age, sex, pancreas texture, pathology, tumor 
diameter and the mean follow-up time (49 months for group 
1 vs. 41 months for group 2, p = 0.3739). However, a sig-
nifi cant difference was found in regard with the length of the 
resected pancreas (5.5 ± 1.6 cm for group 1 vs. 9.3 ± 1.7 cm 
for group 2, p < 0.0001). No signifi cant differences were 
found in regard with overall or severe morbidity (50% vs. 
42% and 27% vs. 21%, respectively), overall or clinically 
signifi cant pancreatic fi stula rates (36% vs. 46% and 23% vs. 
21%, respectively). Re-laparotomy rate was higher in group 
1 (27%), as compared to group 2 (12.5%), but statistical 
signifi cance was not reached (p = 0.2757)
Conclusion: Postoperative overall and clinically signifi cant 
fi stula rates after central pancreatectomy are not higher, as 
compared to spleen preserving distal pancreatectomy. 
However, re-laparotomy rate seems to be higher after central 
pancreatectomy. Central pancreatectomy is a reasonable 
alternative procedure to distal pancreatectomy for benign 
and low-malignant tumors of the pancreatic body, in selected 
cases.
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FOS371
PREDICTIVE FACTORS OF LIVER 
HYPERTROPHY AFTER PERCUTANEOUS 
PORTAL VEIN EMBOLIZATION (PVE) 
BEFORE RIGHT HEPATIC RESECTION: 
A SINGLE EXPERIENCE OF 202 CASES
T. Aoyagi1, S. Dokmak1, B. Aussilhou1, F. Cauchy1, 
A. Sibert2, M. Zappa2, V. Vilgrain2 and J. Belghiti1
1Department of HPB and Transplantation Surgery, Beaujon 
Hospital, Paris, France; 2Department of Radiology, 
Beaujon Hospital, Paris, France
Introduction: Although PVE is accepted before major hep-
atectomy with small future remnant liver (FLR), predictive 
factors for hypertrophy of non-embolized FLR remains 
uncertain. We aimed to analyze factors of hypertrophy after 
PVE in a large homogeneous study in a single center.
Methods: From January 1999, 202 non jaundiced patients 
considered for right or extended right hepatectomy under-
went contra lateral percutaneous PVE with N-butyl cyano-
acrylate when FLR/total liver volume ratio (FLR%) was 
below 25% in normal liver or 40% in altered liver. Technical 
success of procedure, age, etiology of disease (liver metas-
tasis, n = 81, HCC, n = 79, cholangiocarcinoma, n = 25, and 
others, n = 17), type and duration of chemotherapy (n = 73), 
prior TACE (n = 59), characteristics of the liver parenchyma 
(F3-F4 n = 69; Steatosis > 30% n = 37), and biological data 
were restrospectively evaluated as predictive factors for 
hypertrophy of FLR.
Results: Technical failure was observed in 20 (10%), 
including portal vein thrombosis or material migration in 11. 
After PVE, FLR volume signifi cantly increased from 544 ± 
199 cm3 to 700 ± 238 cm3 with FLR% from 34.1% to 44.1%. 
Liver hypertrophy was decreased in patients with incomplete 
PVE (OR 17.4, p = 0.018) and in cirrhotic patients (OR 3.2, 
p = 0.002), except if prior TACE were performed (OR 0.33, 
p = 0.033). In non-cirrhotic patients, there was no infl uence 
of age, diabetes mellitus, etiology of disease, liver steatosis. 
Multiple logistic regression analyses revealed that biological 
cholestasis (GGT > 5N) (OR 2.5, p = 0.016), low platelet 
count (<100 000) (OR 2.5, p = 0.043), and platin-based che-
motherapy (OR 3.5, p = 0.021) were the signifi cant negative 
factors for liver hypertrophy.
Conclusion: This large series showed that thrombopenia, 
biological cholestasis, and preoperative chemotherapy with 
platin agents could impair hypertrophy after technically suc-
cessful PVE and confi rmed that prior TACE could overcome 
impaired hypertrophy in cirrhotic.
FOS372
COMPLICATIONS OF LIVER HYDATID 
CYST EPIDEMIOLOGICAL, 
CLINICAL, PARACLINICAL AND 
THERAPEUTIC PROFILE
Y. Narjis1, N. Ihfa1, K. Rabbani1, Z. Semlani2, A. Diffaa2, 
A. Louzi1, R. Benelkhaiat1 and B. Finech1
1Service de Chirurgie Viscérale, CHU Mohamed VI, 
Faculté de Médecine et de Pharmacie de Marrakech, 
Université Cadi Ayyad, Marrakech, Morocco; 2Service de 
Gastro-Entérologie, CHU Mohamed VI, Faculté de 
Médecine et de Pharmacie de Marrakech, Université Cadi 
Ayyad, Marrakech, Morocco
Introduction: The liver hydatid disease is a common 
disease in Morocco, where it is a public health problem. It 
is considered benign but can be serious because of its 
complications.
Methods: In order to study the liver hydatid cyst (LHC) in 
our context and its complications, we conducted a retrospec-
tive study on 75 cases among 201 patients operated for LHC, 
for a frequency of 37.3%. The series consisted of 43 women 
and 32 men with a mean age of 38.4 years (range 15 to 84 
years). Our patients were in 57.3% of cases from rural areas 
having contact with dogs in 82.7% and a history of hydatid 
disease in 9.33% of cases. Apart from a case of accidental 
discovery, the remaining patients had various clinical signs 
dominated by abdominal pain (94.67%). Radiological exam-
inations had an important role in the diagnosis, including 
ultrasound completed by CT in our serie, it showed LHC 
complicated in 65.33% of cases.
Results: Complications were dominated by cystobiliary 
fi stula (58.67%) and suppuration of the cyst contents (28%), 
followed by the rupture in the peritoneum (8%) and in the 
chest (5.33%). Treatment was surgical in all cases (100%) to 
eradicate the parasite and to treat the residual cavity and 
its complications. The surgical procedure was conservative 
(resection of the protruding dome) in the majority of cases 
(86.67%) whereas it was radical in 13.33% of cases (4 cys-
tectomy, 5 pericystectomy and 2 partial hepatectomy). The 
postoperative course was simple in 84% of cases, while 16% 
of patients had postoperative complications dominated by 
external biliary fi stula (58.33% of cases). The conservative 
techniques were complications with providers of posto.
Conclusion: Hydatid disease is often diagnosed at the stage 
of complications in our context, hence the importance of 
education as our outreach work.
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MECHANISM OF MELATONIN-
MEDIATED ATTENUATION OF 
TRAUMA-HEMORRHAGE-INDUCED 
LIVER INJURY
F.-J. Hsieh, J.-T. Hsu, T.-S. Yeh, T.-L. Hwang and Y.-Y. Jan
Department of Surgery, Chang Gung Memorial Hospital at 
Linkou, Chang Gung University College of Medicine, 
Taoyuan, Taiwan
Introduction: Although melatonin treatment following 
trauma-hemorrhage or ischemic reperfusion prevents organs 
from dysfunction and injury, the precise mechanism remains 
unknown. The aim of this study is to elucidate whether mel-
atonin-mediated attenuation of liver injury following trauma-
hemorrhage is via Akt-dependent HO-1 pathway.
Methods: After a 5-cm midline laparotomy, male rats 
underwent hemorrhagic shock (mean blood pressure 
~40 mmHg for 90 min) followed by fl uid resuscitation. At 
the onset of resuscitation, rats were treated with vehicle, 
melatonin (2 mg/kg), or melatonin plus phosphoinositide 
3-kinase (PI3K) inhibitor Wortmannin (1 g/kg). At 2 h after 
trauma-hemorrhage or sham operation, liver tissue myelo-
peroxidase (MPO) activity, alanine aminotransferase (ALT), 
asparate aminotransferase (AST), malondialdehyde (MDA) 
and adenosine triphosphate (ATP) were measured. Liver Akt, 
HO-1, and cleaved caspase-3 protein levels were also 
determined.
Results: Melatonin attenuated the trauma-hemorrhage-
induced increase in liver MPO activity, levels of ALT, AST, 
MDA and ATP, which was blocked by co-administration of 
Wortmannin. Administration of melatonin normalized liver 
Akt phosphorylation and further increased HO-1 expression 
and decreased cleaved caspase-3 levels following trauma-
hemorrhage. Co-administration of Wortmannin prevented 
the melatonin-mediated attenuation of shock-induced liver 
injury.
Conclusion: Our results collectively suggest that Akt-
dependent HO-1 upregulation may play a critical role 
in melatonin-meditated liver protection following 
trauma-hemorrhage.
FOS374
INCIDENCE AND PREDICTORS OF 
POSTHEPATECTOMY LIVER 
FAILURE FOLLOWING MAJOR 
LIVER RESECTIONS
E. L. Neo, G. Bonney, D. Bartlett, R. Marudanayagam 
and D. Mirza
HPB and Liver Transplantation Unit, Queen Elizabeth 
Hospital, Birmingham, UK
Introduction: Liver failure is a potentially fatal complica-
tion following major hepatic resection. This study evaluates 
the incidence and factors associated with posthepatectomy 
liver failure (PHLF), as well as the outcomes and survival of 
these patients.
Methods: All patients who underwent elective major 
hepatic resection (>3 liver segments) between January 2001 
and March 2011 from a single large UK centre were identi-
fi ed from a prospective database. PHLF was defi ned as 
bilirubin levels >100 micromol/L or INR >2 on 3 consecu-
tive days within the fi rst post-operative week. Patient demo-
graphics, comorbidities, clinical and pathological data were 
analysed. Outcome measures compared include ITU stay and 
survival.
Results: In this study 708 patients underwent major liver 
resections (PHLF = 54, control = 654). Compared to the 
control group, older patients, the presence of diabetes mel-
litus and preoperative portal vein embolization had a higher 
incidence of PHLF. There was no signifi cant difference in 
pre-operative chemotherapy, Pringle manoeuvre, steatosis 
of background liver, or blood transfusion. Post-operatively, 
patients with PHLF were more likely to require dialysis 
(13.2% vs 1.8%, p < 0.001) and had longer ITU stay (mean 
2.57 vs 0.84 days, p < 0.001). The PHLF group had higher 
30-day (22.6% vs 3.1%, p < 0.001) and 90-day mortality 
(41.5% vs 4.7%, p < 0.001). Median overall survival was 
9.86 months in the PHLF group and 49.77 months in the 
control group (p < 0.001).
Conclusion: This study over a 10-year period has shown a 
small risk of PHLF (7.6%) in patients undergoing major 
hepatic resection. Older patients, diabetes mellitus and pre-
operative PVE was associated with a signifi cantly higher 
incidence of PHLF. This resulted in a signifi cantly poorer 
30-day, 90-day and overall survival.
FOS375
MEASURED VERSUS ESTIMATED TOTAL 
LIVER VOLUME TO PREOPERATIVELY 
ASSESS THE ADEQUACY OF THE 
FUTURE REMNANT LIVER
D. Ribero, M. Amisano, F. Giraldi, S. Langella, 
R. L. Tesoriere, A. Ferrero and L. Capussotti
Department of Surgery, Ospedale Mauriziano “Umberto 
I”, Torino, Italy
Introduction: Systematic assessment of the future remnant 
liver (FLR) is essential before major or extended hepatec-
tomy to reduce the risk of postoperative hepatic insuffi -
ciency. The FLR volume is usually expressed as the ratio to 
nontumorous total liver volume (TLV) which can be directly 
measured on CT (mTLV) or estimated based on the correla-
tion existing with the body surface area (eTLV). Aim of the 
study was to determine which method of liver volumetry is 
more accurate in predicting a safe resection.
Methods: All consecutive, non-cirrhotic patients undergone 
major hepatectomy between April 2000 and December 2009 
for whom i) preoperative CT scan and ii) weight and height 
were available entered the study. The mTLV (calculated as: 
TLV-tumor volume), was compared to the eTLV (calculated 
as: −794.41 + 1267.28 × body surface area) using volumetric 
data (cc) and the following outcome measures: hepatic insuf-
fi ciency (HI) and 90-day mortality. Defi nition of HI was 
peakBil >7 mg/dL or, in patients with jaundice, an increasing 
bilirubin level on day 5 or thereafter.
Results: 199 patients underwent major (122) or extended 
(77) hepatectomies for biliary cancer (56), HCC (17), CRC 
mets (105), and other indications (21). 25 patients (12.5%) 
developed HI, while 7 (3.5%) died postoperatively. Compared 
to the eTLV, the mTLV underestimated the liver volume in 
65.4% of cases (P < 0.01). Based on mTLV and eTLV 39 and 
64 patients, respectively, would have needed a PVE which 
was used in 36 patients. In those 131 patients in whom both 
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methods did not evidence the need for PVE postoperative HI 
and mortality were 4.6% and 0.7%. In those 24 patients in 
whom the eTLV but not the mTLV predicted the need for 
PVE (and thus PVE was not performed) HI was signifi cantly 
higher (25%) (P = 0.004) as was the postoperative mortality 
rate (4.1%).
Conclusion: Use of eTLV selects a subset of patients 
(~12%) at higher risk of HI and mortality in whom volumet-
ric assessment with the mTLV do not reveal the need for a 
PVE.
FOS376
RATIONALE AND SURGICAL 
TECHNIQUE OF LAPAROSCOPIC LEFT 
LATERAL SECTIONECTOMY WITH 
ENDOSCOPIC STAPLE
S. S. Yun, D. H. Lee, D. S. Lee, I. S. Kwun and 
H. J. Kim
Deparment of Surgery, Division of HBP, Yeungnam 
University Hospital, Daegu, Korea
Introduction: Laparoscopic left lateral sectionectomy 
(LLLS) has been widely accepted due to benefi ts of mini-
mally invasive surgery. Some surgeons like to isolate glis-
sonian pedicles to segment 2 and 3 and control individual 
pedicles with surgical clips. But others like to control glis-
soinan pedicles to segment 2 and 3 at once with endoscopic 
stapling device without isolating each pedicles. The aim of 
this study is to fi nd rationale (safety, outcomes, learning 
curve) of LLLS with endoscopic staples.
Methods: We retrospectively analyzed and compared the 
clinical outcomes (operation time, blood loss, hospital stay, 
learning curve, complication rate, etc) in 33 patients who 
underwent LLLS between April 2004 and December, 2011. 
We divided our patients depending on surgical technique 
whether isolate each glissonian pedicles (individual group, n 
= 20) or not (batch group, n = 13). To see the learning curve, 
we arbitrarily divided fi rst and second half period (before and 
after December, 2009) depending on case number 17.
Results: There was one open conversion in individual 
group. Mean operative time was 265.3 ± 21.3 min (Mean ± 
SE) in the individual group and 170.0 ± 22.9 min in batch 
group. Operation time in batch group was signifi cantly 
shorter than individual group (p = 0.007). There was no 
blood transfusion in batch group, but 4 out of 20 patients in 
individual group needed blood transfusion during surgery. 
Mean post-operative hospital stay were 10.7 ± 1.1 and 9.4 ± 
0.8 days in individual and batch group (p = 0.46). Mean 
operative time in the fi rst and second half of individual and 
batch group were 271.9 ± 28.9/254.3 ± 32.2 min and 209.0 
± 29.1/142.1 ± 30.7 min (fi rst half/second half). In batch 
group, we could save operation time signifi cantly (p = 0.027) 
in second half period.
Conclusion: The LLLS with endoscopic staple (batch 
group) was easy and safe technique with short learning curve 
and better outcomes without morbidity and mortality. We 
will show schematic pictures and video to support rationale 
for LLLS with endoscopic staples (batch group).
FOS377
RATIO OF IL 10 OVER IL 12 IS A NOVEL 
SURROGATE TO EVALUATE THE 
SEVERITY OF NON ALCOHOLIC 
STEATOHAPATITIS (NASH) – A 
PROSPECTIVE CLINICAL PILOT STUDY
P. Basu1, T. Nair2, S. Farhat2, S. Foustin2, L. Ang2, 
M. Jafri3, N. J. Shah2 and K. Mittimani2
1Columbia University of Physicians and Surgeons, New 
York, USA; 2North Shore University Hospital, Forest Hills, 
New York, USA; 3NYMC Richmond University, Staten 
Island, New York, USA
Introduction: Non alcoholic steatohepatitis (NASH) is a 
growing global epidemic progressing to cirrhosis, liver 
failure, HCC, warrants liver transplant. The natural history 
is still not well defi ned, infl ammatory cytokines, intrahepatic 
immune traffi c, degree of apoptosis and path of fi brogenesis 
are the sequel of the disease process. This study evaluates a 
novel infl ammatory cytokines (IL 10 and IL 12) ratio to 
predict NAFLD to NASH and its severity index.
Methods: Ninety (n = 90) patients, mean age of 45 (28–54) 
were divided into Group A (n = 30) BMI (mean) <25% with 
normal lipids, healthy control. Group B NAFL D (n = 30) 
BMI > 29% with NAFLD (hepatic steatosis, Waist/Hip ratio 
>0.9, high lipids, HOMA > 1.8, mean normal ALT, AST, 
RBP4, 2.5, Leptin, Adiponectin, TNF alpha, serum NASH 
score <0.8, mean fi brotic score <0.1, mean IL 10/IL 12 ratio 
<0.9. NASH C (n = 30), BMI > 30, W/H ratio >1.1, high 
lipids, HOMA > 2.2, high AST, ALT, RBP > 4.5, high leptin, 
low adiponectin, high TNF alpha, IL10/IL12 ratio >2.5. 
Serums NASH score > 0.6, fi brotic score over 0.2. Liver 
biopsy in NASH group, macrovascular fat 18/30 (60%), bal-
looning 12/30 (40%), Mallory body 7/30 (23%), METAVIR 
score F2 12/30 (40%), F3 9/30 (30%), F4 3/30 (10%).
Results: IL 10/12 ratio correlated positively with the pro-
gression of NAFLD to NASH.
Conclusion: IL 10/12 ratio correlated positively with the 
progression of NAFLD to NASH. IL 10/12 ratio > 2.5 has 
NASH with high steatosis and fi brotic state and elevated 
infl ammatory cytokines. Larger study will establish the pre-
dictive index of IL10/IL 12 NASH severity and prognosis.
FOS378
QUALITY OF LIFE STUDY POST 
CYTOREDUCTIVE SURGERY AND 
INTRAPERITONEAL CHEMOTHERAPY 
FOR PSEUDOMYXOMA PERITONEII
R. Kirby, W. Liauw and D. Morris
UNSW Department of Surgery, St. George Hospital, 
Sydney, Australia
Introduction: Our aim in this study was to evaluate 
the quality of life in patients following cytoreductive sur-
gery and intraperitoneal chemotherapy for pseudomyxoma 
peritoneal.
Methods: We carried out telephone interviews with 51 
patients and sent postal questionnaires to the remaining 36 
patients that were uncontactable by telephone. The FACT C 
(version 4) quality of life questionnaire that included PWB 
(Physical Well-Being), SFWB (Social/Family Well-Being), 
EWB (Emotional Well Being), FWB (Functional Well Being) 
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and AC (Additional Concerns) was utilised. FACIT-TS-G 
(version 1) was also used.
In our institution 87 patients underwent cytoreductive 
surgery for pseudomyxoma peritoneii from 1997 to our most 
recent that were alive at the time of the study.
Results: A total of 63 patients (response rate 72%) were 
available for quality of life interview and analysis. 62% were 
female with an average age of 54 years. The median time 
since surgery was 31 months (range 6–161). 22% of patients 
had over one cytoreductive surgical procedure.
The median score on the PWB subscale was 2 (range 
0–11), SD 3 with a maximum score of 28 aiming for the 
lowest score 0.
The median score on the SFWB, EWB and FWB subscale 
was 21, 6 and 23 respectively.
The median score on the FACIT –TS-G questionnaire was 
21 (range 9–25), SD 4 with a maximum score of 25 aiming 
for the highest score 25.
25% of patients analysed had a stoma. The median score on 
FACT C AC subscale was 2 (range 0–4), SD 1 of maximum 
of 8 aiming for 0.
Conclusion: Our patients reported favourable outcomes 
from a physical, emotional, functional and social point of 
view. 79% of patients stated they would undergo further 
cytoreductive surgery if required. 13% were undecided at the 
time of the study.
FOS379
LONG-TERM RESULTS OF 
SPLENECTOMY WITH 
ESOPHAGOGASTRIC 
DEVASCULARIZATION IN PATIENTS 
WITH EXTRAHEPATIC PORTAL 
VENOUS OBSTRUCTION
V. Mangla1, S. Pal1, J. George1, N. R. Dash1, P. Sahni1, 
T. K. Chattopadhyay1, S. K. Acharya2 and S. Nundy3
1Department of GI Surgery and Liver Transplantation, All 
India Institute of Medical Sciences, New Delhi, Indial; 
2Department of Gastroenterology and Human Nutrition, All 
India Institute of Medical Sciences, New Delhi, India; 
3Department of Surgical Gastroenterology, Sir Ganga Ram 
Hospital, New Delhi, India
Introduction: Extrahepatic portal venous obstruction 
(EHO) is a common cause of portal hypertension in India. 
Esophagogastric devascularisation is the only surgical option 
in patients with variceal bleeding and no major shuntable 
vein. There is a paucity of data on the long-term results fol-
lowing these procedures. We analysed the short- and long-
term results of Modifi ed Hassab’s procedure in patients with 
EHO.
Methods: From 1976 to 2010, 103 (64 males) patients with 
EHO underwent splenectomy with esophagogastric devascu-
larization (Modifi ed Hassab’s procedure) if they had throm-
bosed splenic and superior mesenteric veins with recurrent 
bleeding despite endotherapy and/or symptomatic hyper-
splenism or when no shuntable vein was found during a 
planned shunt. Eleven (10.7%) of these had emergency pro-
cedures. The relevant data were extracted from a prospec-
tively maintained database. An attempt was made from 
January 2009 to June 2011 to obtain up-to-date follow up 
information on all these patients. Patient characteristics, 
short-term results (operative morbidity and mortality) and 
long-term complications and their management were 
analyzed.
Results: The mean age was 20.8 years. The mean number 
of episodes of variceal bleeding prior to surgery was 2.8 
(2.6). Fifty-fi ve (53.4%) patients had hypersplenism, of 
which 10 were symptomatic. Postoperative morbidity 
occurred in 24 (28.1%) patients (elective: 18.5%; emer-
gency: 63.6%). The operative mortality was 7.8% (elective: 
4.4%; emergency: 36.4%; p < 0.01). Four patients rebleed in 
the early postoperative period, two each after elective and 
emergency procedures. Sixty-nine (72.6%) patients were fol-
lowed up for a mean of 60 (range: 3–355) months. Rebleeding 
occurred in 14 (20.3%) patients and was managed with blood 
transfusion and endotherapy. Post splenectomy sepsis did not 
occur and no patient died of rebleeding during follow-up.
Conclusion: Splenectomy and esophagogastric devascular-
ization is a fairly effective surgical option for patients with 
EHO who cannot undergo surgical shunts. Patients undergo-




ASSESSMENT OF THE REMNANT LIVER 
AFTER A MAJOR HEPATECTOMY AND 
LIVER FUNCTION
S. De La Serna1, E. Vibert2, R. Memeo1, G. Pittau1, 
O. Ciacio1, L. Ricca1, R. Adam3 and D. Castaing1
1AP-HP Hôpital Paul Brousse, Centre Hépato-Biliaire, 
F-94800 Villejuif, France; 2Inserm, Unité 785, F-94800 
Villejuif, France; 3Univ Paris-Sud, Faculté de Médecine, 
F-94270 Le Kremlin-Bicêtre, France
Introduction: It is largely accepted that the liver function 
is correlated to the liver volume after an hepatectomy. 
Indeed, post-operative liver volume (POLV) and/or its varia-
tion (deltaLV) is used as “end-points” to assess methods to 
prevent post-operative (po.) liver failure. Aim of this study 
was to assess if this linear relation between liver function 
and liver volume is always true. For this, we have compared 
POLV and deltaLV of patients with or without po. liver 
failure in a case-match study.
Methods: Between 2006 and 2010, 11 non-cirrhotic patients 
have developed po. liver failure defi ned by a bilirubin 
>50 µmol/L and protrombin time <50% at 5th po. day. POVL 
and deltaLV of these patients have been compared to those 
of 11 patients without po. liver failure with volumetric 
CT-Scan at 7th po. day. A matching (1 to 1) between the 2 
groups of patients (liver failure, LF and non liver failure, 
NLF) was made for the gender, type of hepatectomy and the 
age.
Results: The 2-months po. mortality (LF vs NLF) was 7/11 
(63%) vs 2/11 (18%) (p = 0.08). The intra-operative blood 
transfusion (N. of red pack cell) and clamping duration (LF 
vs NLF) were respectively: 4.3 ± 3.1 vs 3.2 ± 2.8 (p = 0.4) 
and 53 ± 51 vs 44 ± 26 minutes (p = 0.6). Just after the hepa-
tectomy, the ratio of the remnant liver volume related to body 
weight (POLV/BW) (%) was 0.7 ± 0.3 in the LF group and 
0.9 ± 0.3 in the NLF group (p = 0.36). At 7th po. day, the 
POLV/BW (%) was 1.3 ± 0.3 in the LF group vs 1.4 ± 0.3 
in the NLF group (p = 0.5). At 7th po. day, the growth (%) 
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of remnant liver (deltaLV) was 190 ± 99 in the LF group and 
170 ± 62 in the NLF Group (p = 0.53).
Conclusion: As the post-operative liver volume and liver 
volume variation at 7th po. day were not signifi cantly differ-
ent between patients that developed or not a po. liver failure 
after major hepatectomy, these volumetric data could not be 
used as a method to assess the liver functional reserve 
post-operatively.
FOS381
PREOPERATIVE MEASURED BLOOD 
HGF MAY PREDICT THE 
POSTOPERATIVE COURSE OF 
LIVER REGENERATION
A. Schulz, M. Malinowski, J. Friso Lock, J. Aurich, F. 
Herrmann, T. Reese, P. Neuhaus and M. Stockmann
Department of General, Visceral and Transplantation 
Surgery, Charité, Universitätsmedizin Berlin, Campus 
Vichow Klinikum, Berlin, Germany
Introduction: Liver failure is a major cause of mortality 
after partial hepatectomy (PH). Resections up to 75% of the 
organ is possible, still the identifi cation of the patients with 
increased risk of postoperative liver failure and therefore 
development of complications is diffi cult. PH triggers the 
sequence of events which leads to proliferation of cells and 
restoration of liver volume. Hepatocyte growth factor (HGF) 
plays a key role in the regeneration of the liver. Therefore its 
course after PH was analyzed.
Methods: The postoperative course of patients who under-
went PH for different reasons has been analyzed in this 
prospective study.
Before the operation, as well as at 6 hours, and the post-
operative day 1, 2, 3, 5, 10, 14 and 85 the maximal liver 
function capacity using the new LiMAx test as well the 
serum levels of HGF and the routine liver blood values were 
analyzed. Also complications according to the classifi cation 
of surgical complications by Daniel Dindo were analysed.
HGF serum level was assessed by a commercial Quantikine 
Human HGF Immunoassay (R&D Systems, ELISA). Patients 
were divided in three groups according to the postoperative 
liver function regeneration at day 10 ((LiMAx (POD 0)/
(POD10)), group 1: 0–50%, 2: 50–100% and group 3: 
>100%).
Results: Till now 38 Patients were included into the study. 
The patients of group 1 had signifi cant higher HGF serum 
level preoperatively compared to group 3. This two groups 
differ in terms of severe postoperative complications (Dindo 
> II) too. The LiMAx value at 6 hours and 1 day correlates 
signifi cantly with the corresponding HGF serum level. The 
postoperative course of LiMAx values as well as in HGF 
serum level after PH depends on the extension of the liver 
resection.
Conclusion: HGF serum level correlates with the course of 
liver function regeneration after PH. Preoperative high HGF 
serum level might predict the occurrence of postoperative 
liver failure. Further analyses are needed to fully understand 
this aspect of the role of the HGF in liver regeneration.
FOS382
LONG-TERM RESULTS OF PROXIMAL 
SPLENORENAL SHUNT IN PATIENTS 
WITH EXTRAHEPATIC PORTAL 
VENOUS OBSTRUCTION
M. Vivek1, P. Sujoy1, J. George1, N. R. Dash1, 
S. Peush1, S. K. Acharya2, T. K. Chattopadhaya1 and 
S. Nundy3
1Department of GI Surgery and Liver Transplantation, All 
India Institute of Medical Sciences, New Delhi, India; 
2Department of Gastroenterology and Human Nutrition, All 
India Institute of Medical Sciences, New Delhi, India; 
3Department of Surgical Gastroenterology and Liver 
Transplantation, Sir Ganga Ram Hospital, New Delhi, 
India
Introduction: Extrahepatic portal venous obstruction 
(EHO) is a common cause of portal hypertension in India. 
Although this disease affects the young and does not cause 
liver dysfunction, death is usually due to variceal bleeding. 
We analysed the short- and long-term results of proximal 
splenorenal shunt (PSRS) in patients with EHO.
Methods: From 1976 to 2010, 832 (576 male; 69%) patients 
with EHO who either had a history of variceal bleeding or 
high risk varices, growth retardation and/or symptomatic 
hypersplenism underwent a proximal splenorenal shunt. 
Forty-one (5%) of these were emergency procedures. The 
relevant data was extracted from a prospectively maintained 
database. An attempt was made from January 2009 to 
November 2011 to obtain up-to-date follow up information 
on all these patients. Patient characteristics, postoperative 
outcome and long-term complications and their management 
were analyzed.
Results: The mean age, symptom duration and episodes of 
variceal bleeding were 18 years, 7 years and 3 respectively. 
The incidence of fundal varices was signifi cantly higher 
(p < 0.001) in patients who had prior endotherapy. Although 
57% patients had hypersplenism, only 8% were symptom-
atic. Postoperative morbidity and mortality were 10% and 
1.2% (elective – 0.9%; emergency – 7%) respectively. Mean 
hospital stay was 7.5 days. Among 73% patients followed up 
(mean: 69 months), hypersplenism was reversed in all, 
rebleeding occurred in 9.4% and further endotherapy was 
obviated in 93%. Liver function remained normal in all and 
none developed post-splenectomy infection or encephalopa-
thy. Both the 15-year overall and ‘bleed-free’ survival were 
≥96%.
Conclusion: In patients with EHO, proximal splenorenal 
shunt provides safe, effective and durable prophylaxis from 
variceal bleeding. In the long-term, PSRS obviates the need 
for further endotherapy or blood transfusions in >90% and 
ensures a 15-year overall survival of >95% in these patients.
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3D MICROSURGICAL ANANTOMY OF 
THE CAUDATE LOBE IN COLORED 
SILICONE-INJECTED 
LIVER SPECIMENS
A. C. de A. Martins1 and C. Martins2
1Instituto de Medicina Integral Prof. Fernando Figueira, 
IMIP, Brazil; 2University of Florida, FL, USA
Introduction: Modern hepatobiliary surgery is challenged 
by the complex anatomy of the caudate lobe. With the advent 
of major hepatic surgery, leading to safe hepatectomies and 
transplantation procedures, the caudate is a crucial structure 
during hilar colangiocarcinoma resection and living-related 
transplantation.
The inferior margin of the hilar fi ssure is the location of 
many microantomical structures as the caudate portal vessels, 
caudate arterial supply and caudate biliary ducts.
Methods: To highlight this microanatomy, isolated cadav-
eric livers injected with colored with silicone (blue – vena 
cava, red – hepatic artery and green – bile ducts) were used. 
The dissection was performed under microscopic vision 
(Karl Zeiss, Germany) of 10X, using microsurgical instru-
ments (Codman, USA). 3D images have been produced with 
a W 3D Fuji camera (Japan) and A Nikon D 5100 (12.4 
Mpixels) with a 100 mm micro lenses (Nikon Corp., Japan). 
StereoPhoto Maker, Version 4.3 was used to produce ana-
glyphic 3D images for projecting or printing. Our focus was 
the microsurgical anatomy of the caudate portal/arterial 
vessels and the caudate biliary duct.
Results: Normally the main portal branch for the caudate 
arises from the beginning of the left portal vein. Accessory 
portal branches were seen arising from the portal bifurcation 
and from the proximal right portal vein. A dominant arterial 
vessel was observed entering the Spiegel lobe together with 
the dominant portal vessel forming a Glissonian pedicle for 
the caudate. The caudate duct can drain to the left or right 
hepatic duct, crossing the inferior lip of the hilar fi ssure.
Conclusion: Colored-silicone injected cadaveric speci-
mens, dissected under microscopic guidance, are an auxiliary 
anatomical model to study the microsurgical anatomy of the 
caudate lobe and its vessels and ducts.
FOS384
EFFECT OF PERIOPERATIVE STEROIDS 
ON ISCHEMIA-REPERFUSION INJURY 
AND SURGICAL STRESS RESPONSE FOR 
PATIENTS UNDERGOING LIVER 
SURGERY: A SYSTEMATIC REVIEW 
AND META-ANALYSIS
L. A. Orci, C. Toso, G. Mentha, P. M. and P. E. Majno
Visceral and Transplantation Surgery Unit, Department of 
Surgery, Geneva University Hospitals, Geneva, Switzerland
Introduction: Because of their association with morbidity, 
hepatic ischemia-reperfusion and surgical stress response 
have been addressed through several therapeutic strategies, 
such as ischemic preconditioning and pharmacological inter-
ventions. The role of steroids in this setting remains contro-
versial. Accordingly, we conducted a systematic review and 
meta-analysis of the literature investigating the impact of 
perioperative administration of steroids to patients undergo-
ing liver surgery.
Methods: We conducted a comprehensive literature search 
in highly solicited databases, identifying studies comparing 
perioperative steroids to standard care or placebo. We 
included randomized controlled trials (RCTs), quasi- and 
non-RCTs. Critical appraisal and meta-analysis were carried 
out according to the in the Preferred Reporting Items for 
Systematic reviews and Meta-analyses (PRISMA) statement. 
Pooled risk ratios (RR) and weighted mean differences 
(WMD) were calculated for dichotomous and continuous 
outcomes, respectively. Fixed or random effect models were 
applied, depending on heterogeneity between studies.
Results: Eight articles were retained. Seven were RCTs. 
Pooling the results revealed that patients receiving glucocor-
ticosteroids were 30% less likely to suffer postoperative 
morbidity compared to controls (RR = 0.7, 95% confi dence 
interval (CI): 0.54–0.93, p = 0.01). In addition, steroids sig-
nifi cantly reduced postoperative blood levels of total biliru-
bin (WMD = −10 micromoles/l 95%CI: −19 to −1.0, p = 
0.03), and of interleukin-6 (IL-6) (WMD = −81.8 pg/ml 
95%CI: −112 to −51.5, p < 0.001). Lastly, there was no 
evidence supporting a risk difference in infectious complica-
tions, wound healing, and length of hospital stay between 
study groups.
Conclusion: This meta-analysis shows that perioperative 
steroids favorably impact on postoperative outcomes after 
liver surgery, both on a clinical and biochemical standpoint. 
Further studies are warranted, in order to confi rm our fi nd-
ings and defi ne subgroups more likely to benefi t from the 
intervention.
FOS385
FUNCTIONAL AND MORPHOLOGICAL 
INVESTIGATION OF LIVER 
HYPERTROPHY AFTER PORTAL 
VEIN EMBOLISATION
A. A. Roeth1, P. H. Alizai1, T. M. Lodewick2, 
A. H. Mahnken3, R. M. van Dam2, C. H. C. Dejong2, 
M. Schmeding1 and U. P. Neumann1
1Department of General, Visceral and Transplantation 
Surgery, University Hospital Aachen, Aachen, Germany; 
2Department of Surgery, Maastricht University Medical 
Center, Maastricht, The Netherlands; 3Department of 
Diagnostic and Interventional Radiology, University 
Hospital Aachen, Aachen, Germany
Introduction: Portal vein embolisations are more and more 
often performed prior to major liver resections to induce 
hypertrophy of the remnant liver. The success of a portal vein 
embolisation can only be investigated by imaging techniques 
such as CT-volumetry. This study explores the pertinence of 
the LiMAx-test, a metabolic 13C-Methacetin respiratory 
test, to functionally examine the induced hypertrophy over 
time.
Methods: 18 patients with portal vein embolisation of the 
right portal vein prior to major liver resections were included. 
Indications for the right hemihepatectomies included colorec-
tal metastases (n = 9), Klatskin tumors (n = 5), HCC (n = 1), 
CCC (n = 2) and liver metastases of other cancers (n = 2). 
The function of the liver was investigated with the LiMAx 
test prior to the embolisation, 24 hours after embolisation 
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and directly prior to the resection. The CT-volumetry of the 
right and left liver was performed prior to the embolisation 
and prior to the resection. Volumetry was performed using 
OsiriX® software.
Results: The average LiMAx-value prior to the portal vein 
embolisation was 399 µg/h/kg, postinterventionally 309 µg/h/
kg and directly preoperatively 372 µg/h/kg (p < 0.05). The 
average time between embolisation and resection was 32 
days (SD 11 days). In this time, the remanent left liver 
volume signifi cantly increased from 486 ml to 700 ml in 
average (p < 0.001), whereas the right liver volume signifi -
cantly decreased (mean 1163 ml to 977 ml, p < 0.01). The 
postinterventional smaller LiMAx-value can be explained by 
the loss in function of the right liver which is also represented 
in the decrease in volume after some time. The increase of 
the LiMAx-value after regeneration proofs the hypertrophy 
of the remanent liver which is also shown by the CT-volumetry.
Conclusion: In comparison to imaging techniques such as 
CT-volumetries the LiMAx-test has the major advantage of 
monitoring the progress in hypertrophy not only in size but 
also in function. This may help fi nd the optimal time point 
for the postinterventional resection.
FOS386
LIVER FAILURE AFTER MAJOR LIVER 
RESECTION: BILIRUBIN VALUES EARLY 
PREDICT MORTALITY
L. Viganò, S. Langella, A. Ferrero, N. Russolillo and 
L. Capussotti
Department of HPB and Digestive Surgery, Ospedale 
Mauriziano Umberto I, Torino, Italy
Introduction: Liver failure (LF) is the fi rst cause of death 
after liver resection (LR). Liver function test’s values have 
been analyzed to early predict lethal LF, but there is no 
consensus about their interpretation. To assess the reliability 
of total bilirubin (TB) and prothrombin time (PT) values 
during the fi rst postoperative week in predicting LF-related 
mortality.
Methods: 278 consecutive patients undergoing major LR 
(>3 Couinaud segments) between January 2005 and August 
2011 were considered. Patients with preoperative TB >3 mg/
dl (n = 25), no LF-related death (n = 3) and LF secondary to 
vascular thrombosis (n = 2) were excluded. The remaining 
248 patients were included.
Predictive factors of 90-day mortality were analyzed, 
including TB and PT values on postoperative day (POD) 1, 
3, 5 and 7 and the ratio of their values between different 
POD. ROC curve analyses were performed to defi ne the 
optimal cut-off value of any signifi cant variable. The 50–50 
criteria (TB > 50 µmol/L and PT < 50%) on POD 5 (50–50) 
and the TB peak >7 mg/dL within POD 7 (PeakTB7) were 
also considered.
Results: Mortality rate was 2% (5 patients). TB on POD 3, 
5, 7 were associated with mortality (p = 0.001, p < 0.001, p 
< 0.001). ROC analyses showed higher AUC for TB POD5 
vs. POD3 (0.954 vs. 0.896), but cut-offs (3 mg/dL for both) 
had similar sensitivity (Se) and specifi city (Sp) (80% and 
89.3% vs. 80% and 88.4%). For TB POD7 (AUC 0.981) 
cut-off 4.5 mg/dL had 80% Se and 96.7% Sp. The ratio TB 
POD7/POD3 predicted mortality (p < 0.001, AUC 0.948); its 
cut-off 1.25 had 80% Se and 92.9% Sp. PT on POD 3, 5, 7 
predicted mortality (p < 0.05) but no adequate cut-offs were 
identifi ed. 50–50 and PeakTB7 had low Se (40%). At multi-
variate analysis TB POD7 > 4.5 mg/dL and TB POD7/POD3 
> 1.25 were independent predictors of mortality (OR 40.24, 
p = 0.004 and OR 15.26, p = 0.035).
Conclusion: Early prediction of LF-related mortality after 
major LR should rely on TB values more than on PT ones. 
TB > 3 mg/dL on POD 3 allows a preliminary evaluation 
with good Se and Sp, similar to those of TB values on POD 
5. Anyway, the optimal risk assessment should be performed 
on POD 7: TB values >4.5 mg/dL and ratio TB POD 7/ 
POD3 > 1.25 are the strongest predictors of LF-related 
mortality.
FOS387
SURGICAL TECHNIQUES FOR 
COMPLETING ANATOMICALLY 
ACCURATE LAPAROSCOPIC 
SEGMENTECTOMY OF THE LIVER
T. Ishizawa1, N. Kokudo2 and B. Gayet1
1Department of Digestive Disease, Institut Mutualiste 
Montsouris, Paris, France; 2Hepato-Biliary-Pancreatic 
Surgery Division, Department of Surgery, Graduate School 
of Medicine, University of Tokyo, Tokyo, Japan
Introduction: Hepatic segmentectomy has played an 
important role in maximizing the post-operative functional 
hepatic reserve without reducing the curability. However, 
laparoscopic surgical techniques to complete anatomically 
accurate segmentectomy have not yet been well 
established.
Methods: Data of 62 patients who had undergone laparo-
scopic segmentectomy (LS) were reviewed. LS was defi ned 
as complete removal of the Couinaud’s segment, in which 
the corresponding hepatic veins are exposed on the raw 
surface. The laparoscopic approach was facilitated by using 
intraoperative ultrasonography for each segment and by 
placing intercostal trocars to expose the root of the right 
hepatic vein for segmentectomy VII and VIII (the lateral 
approach). Recently, fl uorescent imaging technique was used 
to identify hepatic segment by injecting indocyanine green 
(ICG, 0.25 mg) into a segmental portal branch (positive 
staining) or by administering ICG (2.5 mg) intravenously 
after clamping a segmental portal pedicle (negative 
staining).
Results: Surgical procedures of the 62 LS included 36 seg-
mentectomies (from segment I to VIII), 16 bisegmentecto-
mies of the right lobe, and 10 subsegmentectomies. 
Conversion to open surgery was required in 3 patients (seg-
mentectomy IVa, VI, and VII). When 26 LS of the superior/
posterior hepatic (sub)segments (I, IVa, VII, and VIII) were 
compared to the remaining 36 LS, the former group required 
a longer operation time (240 [132–390] in. vs. 155 [90–
360]) in, P < 0.01) and showed an increased amount of blood 
loss (350 [20–1500] L vs. 100 [10–1100] L, P = 0.02). 
Positive and negative staining techniques with ICG-
fl uorescent imaging clearly delineated hepatic segments 
during laparoscopic procedures.
Conclusion: LS is feasible and safe, although diffi cult pro-
cedures such as resection of superior/posterior hepatic 
segment should be left to surgeons with advanced techniques 
both in open and minimally invasive surgery. The lateral 
approach for segmentectomy VII and VIII and fl uorescent 
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imaging technique may further enhance the safety and accu-
racy of LS.
FOS388
OMENTAL FLAP WRAPPING OF THE 
CUT SURFACE OF THE LIVER IS 
EFFECTIVE IN REDUCING DELAYED 
GASTRIC EMPTYING AFTER LEFT-
SIDED HEPATECTOMY
K. Okano, J. Uemura, MInoru Oshima, N. Yamamoto 
and Y. Suzuki
Department of Gastroenterological Surgery, Kagawa 
University, Japan
Introduction: Delayed gastric emptying (DGE) is a 
common complication following left-sided hepatectomy. 
Adhesion between the stomach and the cut surface of the 
liver is considered to be the cause of the disruption of normal 
gastrointestinal movement. In this report, we analyzed the 
feasibility and safety of our procedure using omental fl ap 
wrapping with fi xation to the cut surface of the liver, in order 
to ameliorate DGE after left-sided hepatectomy.
Methods: Between January 2000 and December 2010, 24 
of 49 patients undergoing left-sided hepatectomy were 
treated with omental fl ap wrapping with fi xation to the cut 
surface of the liver, to prevent its adhesion to the stomach 
and duodenum. Clinicopathologic risk factors for DGE after 
left-sided hepatectomy were identifi ed using univariate and 
multivariate models, and compared to 25 patients without an 
omental fl ap retrospectively.
The greater omental fl ap, based on the right gastroepiploic 
vessels, was made by dividing the left side of the greater 
omentum from the transverse colon and the stomach by using 
ultrasonic coagulation shears. The cut surface of the liver 
was wrapped with the greater omental fl ap, using 8–10 
sutures.
Results: There was a signifi cant difference in the incidence 
of DGE between the patients with (4.1%) and without an 
omental fl ap (36%). The incidences of gastric distension and 
use of prokinetic drugs were also signifi cantly lower in 
patients with an omental fl ap as compared to the patients 
without. Patients with an omental fl ap resumed a solid diet 
signifi cantly earlier than those without. Univariate analysis 
revealed no omental fl ap, lymph node clearance, and left 
hemihepatectomy to be associated with postoperative DGE. 
Multivariate analysis showed the no omental fl ap to be 
the only independent signifi cant factor (odds ratio, 21.23; 
p = 0.0002).
Conclusion: To conclude, omental fl ap wrapping with fi xa-
tion to the cut surface of the liver is safe procedure and an 
independent signifi cant factor associated with DGE. It seems 
that omental fl ap wrapping with fi xation reduce the incidence 
of DGE after left-sided hepatectomy; however, further inves-
tigations, including a prospective randomized controlled 
trial, are needed to verify these conclusions.
FOS389
VASCULAR OCCLUSION VERSUS 
NO VASCULAR OCCLUSION FOR 
LIVER RESECTIONS
J. Vaughan, K. Gurusamy, R. Ramamoorthy, 
D. Sharma and B. Davidson
Department of Surgery, Royal Free Campus, UCL Medical 
School, 9th Floor, Royal Free Hospital, London, UK
Introduction: There is considerable controversy regarding 
whether vascular occlusion should be used during elective 
liver resections because of concerns about the safety and 
effi cacy of the procedure. The aim of this review was to 
assess vascular occlusion during elective liver resections.
Methods: The Cochrane Hepato-Biliary Group Controlled 
Trials Register, the Cochrane Central Register of Controlled 
Trials (CENTRAL) in The Cochrane Library, MEDLINE, 
EMBASE, mRCT and Science Citation Index Expanded 
were searched until September 2011. Only randomised 
clinical trials were included. Two authors independently 
assessed trials for inclusion and independently extracted 
the data. Data was analysed with both the fi xed-effect and 
the random-effects models using RevMan Analysis. Risk 
ratio (RR), mean difference (MD), or standardised mean 
difference (SMD) was calculated with 95% confi dence 
intervals (CI) based on intention-to-treat or available case 
analysis.
Results: A total of six trials (of high bias-risk) were identi-
fi ed involving 356 participants undergoing liver resection 
comparing vascular occlusion (n = 180) versus no vascular 
occlusion (n = 176). With regards to primary outcomes, there 
was no signifi cant difference in short-term mortality (RR 
0.56; 95% CI 0.12 to 2.55), long-term mortality (HR 0.99; 
95% CI 0.68 to 1.44) or in the difference in the number 
serious adverse events (rate ratio 0.77; 95% CI 0.37 to 1.59). 
Quality of life was not reported in any of the trials. With 
regards to secondary outcomes, there was no signifi cant dif-
ference between the two groups with regards to the number 
of people requiring transfusions (RR 0.75; 95% CI 0.56 to 
1.00) but the blood transfusion volume requirements were 
signifi cantly lower in the vascular occlusion group when 
compared to the control group (SMD −0.44; 95% CI −0.81 
to −0.07). There was no signifi cant difference in blood loss 
between the two groups (MD −0.04 litre; 95% CI −0.11 to 
0.04), nor was there any difference in hospital stay (MD 0.23 
days; 95% CI −1.13 to 1.60) or operating time (MD −45.86 
minutes; 95% CI −95.60 to 3.88). Return to work was not 
reported in any of the studies.
Conclusion: Intermittent vascular occlusion seems safe in 
liver resection and appears to reduce transfusion require-
ments. However, it does not seem to decrease morbidity. 
More randomised trials are needed to assess the impact of 
vascular occlusion on the mortality, morbidity, and quality 
of life.
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FOS390
PROSPECTIVE ASSESSMENT OF THE 
INDOCYANINE GREEN’S CAMERA FOR 
THE INTRAOPERATIVE DETECTION OF 
SUBCAPSULAR PRIMITIVE AND 
SECONDARY LIVER TUMOR
E. Vibert1, G. Mendes1, M. Sebagh2, R. Adam1, 
C. Salloum1, D. Azoulay1, C. Guettier3 and D. Castaing1
1AP-HP Hopital Paul Brousse, Centre Hépato-Biliaire, 
F-94800 Villejuif, France; 2Univ Paris-Sud, UMR-S785, 
F-94800 Villejuif, France; 3Inserm, Unite 785, F-94800, 
Villejuif, France
Introduction: Indocyanine green (ICG) is a vital dye 
excreted in bile that could be trapped around or into liver 
tumor. The presence of the dye at the surface of the liver can 
be detected using an infrared ICG camera. The aim of this 
prospective study was to evaluate the usefulness of this 
camera for the intraoperative detection of superfi cial and/or 
subcapsular hepatocellular carcinoma (HCC) or liver metas-
tasis (LM).
Methods: Between November 2010 and June 2011, 39 
patients underwent a hepatectomy with diagnosis of HCC 
(n = 8) or LM (n = 31). After the mobilization of the liver, 
intraoperative ultrasound and palpation were routinely per-
formed before an exploration of the liver surface with the 
ICG camera. The surgical strategy impact of this method and 
histological analysis of resected areas were assessed.
Results: Among patients with LM (n = 31), the camera had 
identifi ed additional superfi cial “spot” in 4 patients (13%). 
Resection of these “spots” had changed surgical strategy in 
all cases and histological analysis diagnosed LM in 3/4 cases. 
Among patients with HCC (n = 8), additional spots have 
been demonstrated in 5 patients (62%). Resection of these 
spots had changed surgical strategy in 4/5 patients and malig-
nancy were found in 2/5 cases at histological analysis.
Conclusion: The indocyanine green fl uorescent imaging is 
a technological innovation that increases the sensitivity of 
the exploration of the liver surface. The diminution of the 
size of this camera will create new perspectives in the evalu-
ation of liver surface by laparoscopy.
FOS391
POST-HEPATECTOMY LIVER FAILURE: 
IS THE RELATIONSHIP BETWEEN 
LIVER FUNCTION AND LIVER VOLUME 
STILL THE SAME BEFORE AND AFTER 
HEPATECTOMY?
N. Golse1, E. Vibert2, L. Schwarz1, S. Hamdani2, 
C. Brechot1, D. Castaing3 and J. Faivre1
1Inserm, Unite 785, F-94800 Villejuif, France; 2Univ 
Paris-Sud, UMR-S785, F-94800 Villejuif, France; 3AP-HP 
Hopital Paul Brousse, Centre Hepato-Biliaire, F-94800 
Villejuif, France
Introduction: The risk of posthepatectomy liver failure is 
related to the volume of the remaining liver. This work aims 
to establish a quantitative relationship between the early liver 
function of the remaining liver, estimated from the elimina-
tion of indocyanine green (IG), and the liver mass removed.
Methods: In 32 rats (Wistar – 260 g), a laparotomy or a 
hepatectomy with removal of 30, 70, 85% of the liver mass 
or a 85% hepatectomy + splenectomy were performed. The 
liver function was evaluated at H24 after hepatectomy by 
two different methods: measurement of the overall hepatic 
metabolism through the retention rate of plasmatic IG at 
15 min (IG15); measurement of the hepatocyte function 
independently of the remaining liver volume by quantifi ca-
tion of the residual infrared fl uorescence intensity (Fluo) of 
a pre-operatively injected IG. These data were correlated 
with the hepatocyte proliferation index (BrdU) at H24 after 
0, 30 and 70% hepatectomy.
Results: The postoperative mortality was zero. At H24 after 
0, 30, 70, 85 or 85% hepatectomy + splenectomy, IG15 (in 
%) was of 6 ± 2, 26 ± 3, 43 ± 7, 49 ± 1 and 54 ± 4 (p = 0.01) 
and FLUO (expressed in arbitrary units) was of 16 ± 1, 32 
± 10, 76 ± 15 and 35 ± 7 (p < 0.0001), respectively. Hepatocyte 
proliferation index at H24 was of 0, 222 ± 30 and 1641 ± 
169. Thus, from 30% hepatectomy on, the overall hepatic 
metabolism decreased in the remaining volume and splenec-
tomy degraded the liver function. Above 30% of mass 
removed, the hepatocyte function declined with the impor-
tance of the hepatectomy and was improved by the splenec-
tomy. The splenectomy, however, decreased the IG uptake 
by reducing the portal fl ow and altered the measurement of 
the function.
Conclusion: When this hemodynamic bias was bypassed by 
a preoperative IG injection, the Fluo measurements demon-
strated a benefi cial effect of splenectomy on the hepatocyte 
function.
After major hepatectomy, the decline in liver function is 
due to the decrease in liver volume and an impairment of the 
hepatocyte function, a parameter improved by splenectomy. 
This drop in liver function could be due to a cell division 
process unfavorable to an effi cient metabolism.
FOS392
EVALUATION OF STRESS RESPONSE 
IN LAPAROSCOPIC LIVER SURGERY: 
A PROSPECTIVE STUDY OF 
INFLAMMATORY PROFILE, 
COAGULATION HOMEOSTASIS AND 
CLINICAL OUTCOME
F. Cipriani, F. Ratti, M. Paganelli, M. Catena and 
L. Aldrighetti
Hepatobiliary Surgery Unit, General Surgery Department, 
IRCCS H San Raffaele, Vita-Salute San Raffaele 
University, Via Olgettina 60, Milan, Italy
Introduction: An infl ammatory and hypercoagulability 
state develop after surgery, and their biological mediators are 
cytokines. Laparoscopy has been introduced in clinical prac-
tice, showing advantages over the open technique. However, 
benefi ts of the laparoscopic approach for liver resections 
remain to be demonstrated. This is a case-matched analysis 
concerning the short term outcome of laparoscopic and open 
liver resections in terms of clinical outcome, infl ammatory 
profi le and coagulation homeostasis.
Methods: 68 liver resections have been enrolled. 34 were 
assigned to the laparoscopic approach (LLR). The further 34 
to the open procedure (OLR). The 2 groups were matched 
for: extent of resection, liver function, tumour histology and 
size. Outcome measures were: operating time, intraoperative 
blood losses and transfusions, tumour exposure at the tran-
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section surface, surgical margin, hospital stay, morbidity 
rate, analgesic therapy, time of mobilization, fasting duration 
and time of fi rst fl atus. Plasma samples were collected pre 
and postoperatively for the assessment of liver function (bili-
rubin, transaminase), infl ammatory (IL6, TNF, WBC, CRP) 
and coagulation impairment (platelets, D-dimer, fi brinogen, 
antithrombin III, prothrombin time).
Results: Postoperative plasma levels of transaminase, white 
blood cells count, C-reactive protein, Interleukin 6, pro-
thrombin time and fi brin D-dimer showed a lower rise in 
LLR group compared to OLR group. Intraoperative blood 
losses, blood transfusions rate, analgesic therapy amount, 
time of mobilization, fasting duration, time of fi rst fl atus and 
overall morbidity resulted lower in LLR group. The decrease 
of platelets count, antithrombin III and fi brinogen levels was 
lower in LLR group than in OLR group. Postoperative 
plasma levels of total bilirubin and Tumour Necrosis Factor, 
along with operating time, tumour exposure at the transec-
tion surface and minimal surgical margins resulted compa-
rable between the two groups.
Conclusion: The laparoscopic approach for liver resections 
seems to result in improved clinical outcome, lower infl am-
matory stress response and lower coagulation alterations. 
Thus, in the near future, laparoscopy may become the gold-
standard approach for selected liver resections.
FOS393
COMBINED MAJOR HEPATECTOMY 
WITH NEPHRECTOMY. INDICATIONS 
AND POSTOPERATIVE OUTCOME
R. Alikhanov1, D. Panchenkov2, A. Bistrov3 and 
A. Baranov4
1M.V.Lomonosov Moscow State University, Russia; 
2Research Clinical Laboratory of Minimally Invasive 
Surgery, MGMSU, Russia; 3Moscow Oncology Hospital, 
Russia; 4Moscow State University of Medicine and 
Dentistry, Russia
Introduction: Combined major hepatectomy with nephrec-
tomy (MHN) is uncommon. Aim of the study was review of 
our experience with combined major hepatectomy and 
nephrectomy in patients with simultaneous liver and kidney 
malignances. Recent postoperative outcome and long term 
survival were assessed.
Methods: Records of patients who underwent MHN at our 
clinics between January 2008 and May 2011 were examined. 
Nine patients underwent MHN. Mean (±SD) age was 54.9 ± 
12.8 years, 5 were women, and 4 presented with comorbidi-
ties. Most kidney neoplasms were renal cell carcinomas of 
the right kidney (n = 8) with a mean diameter of 15.0 ± 
5.1 cm. The most common indications for hepatectomy were 
direct liver invasion in eight patients and distant hepatic 
metastases in 1 patient; liver tumors were 6.5 ± 3.4 cm (mean 
± SD) in diameter. One patient underwent combined left 
nephrectomy with distal pancreatectomy and splenectomy 
and resection of colon with right hepatectomy.
Results: Mean (±SD) operative time was 8.4 ± 2.5 hours. 
All liver resections included were right hepatectomies. In all 
cases, tumor negative hepatic margins were achieved. 
Median operative blood loss was 1,500 mL (range 200 to 
3,000 mL). There was no perioperative death. In 4 patients 
developed reactive pleuritis, in one patient – wound infec-
tion, in 2 patients was lymph leak from the kidney bed, 1 
patient suffered severe small for size syndrome. All compli-
cations were managed conservatively. Mean hospital stay 
was 13 ± 8.8 days. All patients are still alive.
Conclusion: In specialized centers combined MHN may be 
considered as acceptable and safe procedure in properly 
selected patients for combined resection for synchronous 
neoplasms of the kidney and liver.
FOS394
DEVELOPMENT AND VALIDATION 




P. Pessaux1, M. van den Broek2, E. Marzano1, 
R. van Dam2, T. Piardi1, C. Dejong2, D. Ntourakis1 
and S. O. Damink2
1Department of Hepato-Biliary Surgery and Liver 
Transplantation; 2Department of Surgery, Maastricht 
University Medical Centre, Maastricht, The Netherlands
Introduction: Postoperative infectious complications 
(PICs) following surgery are associated with signifi cant mor-
bidity, increase the length of hospital stays, and have a nega-
tive impact on long-term oncological outcome. The aim of 
this study was to determine the risk factors for PICs follow-
ing hepatectomy, and to develop and validate with an 
external database an applicable score based on simple 
parameters.
Methods: Between January 2006 and December 2009, 555 
patients underwent elective hepatectomy. We prospectively 
collected and retrospectively analyzed demographic data, 
pathological variables, associated pathological conditions, 
and preoperative, intraoperative, and postoperative variables. 
The dependent variables studied were the occurrence of 
PICs, defi ned as development of one or more of the follow-
ing conditions: pneumonia, septicemia, venous catheter 
infection, urinary tract infection, wound infection, and 
intraabdominal collection. PICs were devised in medical 
(PIMCs) and surgical (PISCs) complications. The incidence 
of PICs and validation of the predictive score were deter-
mined using an external prospective database of 342 patients.
Results: The multivariate analysis identifi ed 3 independent 
risk factors for PICs: the presence of a nasogastric tube (OR 
= 1.8), blood transfusion (OR = 1.9), and diabetes (OR = 
2.4). The multivariate analysis identifi ed only one indepen-
dent risk factor for PISCs: an associated portal venous resec-
tion (OR = 5.5). The multivariate analysis identifi ed 4 
independent risk factors for PIMCs: presence of a biliary 
drainage (OR = 1.9), blood transfusion (OR = 2.1), diabetes 
(OR = 2.9), and presence of atrial fi brillation (OR = 3.6). 
According to the 3 predictive factors, the observed rates of 
PICs ranged from 18.8% to 77.8% and ranged from 24.2% 
to 100% in the external database. Predicted and observed 
risks of PICs were very similar.
Conclusion: The correction of modifi able risk factors 
among the identifi ed factors could reduce the incidence of 
PICs and, as a consequence, improve patient outcomes and 
reduce the length of hospital stays.
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COMBINED MAJOR HEPATIC 
RESECTION AND MAJOR VASCULAR 
RESECTION USING IN-SITU COLD 
PERFUSION OF THE LIVER
D. Cavallucci, P. Kim, L. Hawryluck, S. McCluskey, 
C. Swallow, S. Gallinger and I. McGilvray
University Health Network, Toronto General Hospital, 
Canada
Introduction: In situ hypothermic liver perfusion is useful 
for the resection of tumours involving the hepatic venous 
outfl ow, retrohepatic vena cava or porta hepatis where total 
hepatic vascular isolation is required. Having previously 
described the technique in detail, we now present our results 
from 17 patients over a 6 year period.
Methods: A prospectively-collected database of all patients 
undergoing hepatic vein or caval resection between October 
2005 and October 2011 (n = 26) at Toronto General Hospital 
identifi ed 17 patients who underwent in situ hypothermic 
liver perfusion. Primary end-point analysis was 30-day or 
in-hospital mortality. Secondary endpoints included morbid-
ity, vascular graft complications, length of stay (LOS), post-
hepatectomy liver failure (PHLF-as defi ned by the ISGLS) 
and renal failure, disease recurrence and overall survival 
(OS).
Results: Median follow-up was 13.8 months. 14 patients 
had major hepatectomies and 3 had primary caval resection. 
Four patients have died: two in-hospital (at 66 and 120 days), 
one of recurrent disease at 14 months and one of an unrelated 
new primary at 29 months. 4 patients experienced major 
complications, 3 required re-operation. 10 patients devel-
oped PHLF (grade A = 7, grade C = 3). PHLF was predictive 
of increased LOS (median 7 vs 22 days) and morbidity. 
Median OS for the cohort was 19.8 months. 7 patients pro-
gressed during the follow-up period, 5 patients with recurrent 
disease and 2 patients whilst awaiting a planned second stage 
procedure. Of the 3 patients with cholangiocarcinoma, two 
recurred within 8 months and one died in hospital.
Conclusion: In-situ cold perfusion is a safe technical tool for 
the resection of otherwise unresectable tumours. PHLF is a 
signifi cant concern that predicts both morbidity and mortality 
in this patient group; patient selection is critical. Oncologic 
outcomes are acceptable especially considering the advanced 
nature of these patients underlying malignancies.
FOS396
IS CLOSE MONITORING IN THE 
INTENSIVE CARE UNIT NECESSARY 
AFTER ELECTIVE LIVER RESECTION
S. H. Kim1, J. G. Lee1, S. Y. Kwon2, J. H. Lim1, 
W. O. Kim2 and K. S. Kim1
1Department of Surgery, Yonsei University College of 
Medicine, Seoul, Korea; 2Department of Anesthesiology 
and Pain Medicine , Catholic University of Korea College 
of Medicine, Seoul, Korea
Introduction: Many surgical patients are admitted to the 
intensive care unit (ICU), resulting in an increased demand, 
and possible waste, of resources. Patients who undergo liver 
resection are also transferred postoperatively to the ICU. 
However, this may not be necessary in all cases. This study 
was designed to assess the necessity of ICU admission.
Methods: Medical records of 313 patients who underwent 
liver resections, as performed by a single surgeon from 
March 2000 to December 2010 at Yonsei University Health 
System were retrospectively reviewed.
Results: Among 313 patients, 168 (53.7%) patients were 
treated in the ICU. 148 (88.1%) patients received only obser-
vation during the ICU care. The ICU re-admission and inten-
sive medical treatment signifi cantly correlated with major 
liver resection (odd ratio [OR], 6.481; p = 0.011), intraopera-
tive transfusions (OR, 7.108; p = 0.016). Patients who under-
went major liver resection and intraoperative transfusion, 
were signifi cantly associated with needs of mechanical ven-
tilator care, longer postoperative stays in the ICU and the 
hospital and the hospital mortality.
Conclusion: Most patients admitted to the ICU after major 
liver resection just received close monitoring. Even though 
patients underwent major liver resection, patients without 
receipt of intraoperative transfusion might send to the general 
ward. Duration of ICU/hospital stay, ventilator care and mor-
tality signifi cantly correlated with major liver resection and 
intraoperative transfusion. Major liver resection and receipt 
of intraoperative transfusions should be considered indica-
tors for ICU admission.
FOS397
PREDICTIVE FACTORS OF MORBIDITY 
AND MORTALITY IN THE SURGICAL 
MANAGEMENT OF HYDATID CYST OF 
THE LIVER; RETROSPECTIVE 
MULTICENTRIC STUDY
M. Soufi 1, S. Benamer2, M. Bouziane1, R. Mssrouri2, 
A. Essadel2, A. Taghy2, A. Settaf2 and B. Chad2
1Oujda Department of Surgery, Faculty of Medicine, 
University Mohammed First Morocco; 2Rabat Surgery B 
Department Avicenne Hospital Morocco
Introduction: Cystic echinococcosis is endemic in certain 
parts of the world, surgery remains the treatment of choice, 
but surgical management of hydatid cyst of the liver is still 
associated with high mortality and morbidity; The aim of this 
study is to fi nd out possible predictors for this high mortality 
and morbidity.
Methods: The medical records of 426 patients who under-
went surgery for hydatid cyst of the liver were retrospec-
tively reviewed. The mortality and the morbidity rates were 
assessed as well as the following eight potential predictors 
of mortality and morbidity: age of the patients, size of 
the cyst, and number of cysts, other organs involved by the 
disease, the presence of preoperative complications, and the 
type of surgery performed (radical or conservative). Cross-
tabulation and logistic regression between mortality and 
morbidity (dependent variable) and the above-mentioned 
eight potential predictors (independent variables) were 
carried out.
Results: Results of the 426 patients, 68% were female sub-
jects and 32% male subjects, (mean = 34 years), the mortality 
rate was 4% (n = 4), and the overall morbidity rate was 26% 
(n = 112), while specifi c complications of liver hydatid cyst 
surgery were seen in 19% (n = 80). Patients of age >40 years, 
with a cyst diameter of >10 cm, right cyst of liver, 
who presented with pre-operative complications, who had 
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conservative surgery, were having a signifi cantly higher mor-
tality and morbidity rate.
Conclusion: Age, size of the cyst, the presence of preopera-
tive complications particularly cyst-biliary communication, 
and type of surgical procedure performed (conservative or 
radical) represent as signifi cant predictors of mortality and 
morbidity of surgery for liver hydatid cyst.
FOS398
AN OPEN-SOURCE WEB-BASED LIVER 
AUDIT DATABASE
R. Bryant and N. ORourke
Royal Brisbane and Womens Hospital, QLD, Australia
Introduction: Prospective data collection in liver surgery is 
a vital part of both clinical research and ongoing perfor-
mance audit. Meaningful analysis of this data requires group-
ing of results according to complex criteria and the 
computation of multiple clinical scores. Ideally these results 
are available in real time, which requires that the database is 
readily available in different clinical settings and that the 
various computations and compilations are performed 
automatically.
Methods: A database was constructed using Microsoft SQL 
Server 2008 R2. The database stores the entered raw data, 
and automatically performs multiple compilations (e.g. strat-
ifying according to type of surgery, major versus minor 
resection, anatomic versus non-anatomic resection) and com-
putations (e.g. Childs score, MELD score, liver volume, 
tumour volume, Basingstoke Prognostic Index, Clinical Risk 
Score, overall survival, primary and secondary disease-free 
survival). CUSUM data for mortality, margin positivity and 
bleeding based on published risk factors for these outcomes 
are calculated automatically. A web-based front end to the 
database was constructed using ASP. NET MVC 3 and the 
Microsoft Internet Information Services web server.
Results: The web-based database is currently fully func-
tional and in use within the unit of the presenting authors. It 
has been constructed using Microsoft technology to facilitate 
compatibility with hospital IT services. The software required 
to run the database on a Windows system is available as an 
offi cial free download from Microsoft. It is designed to be 
able to run either on a stand-alone computer, on a local 
network, over the Internet or be hosted in the Cloud. The 
script to construct the database is contained within a single 
text fi le written in T-SQL, which enables the accuracy of the 
calculations to be independently tested and verifi ed.
Conclusion: A comprehensive web-based liver audit data-
base is presented. A demonstration of the database is hosted 
at http://www.liverdb.com. It is proposed to make the data-
base freely available to any units that may wish to implement 
it at their institution, as it is recognised that a common data 
set would facilitate sharing of data for collaborative studies. 
Interested parties are invited to join a committee to continue 
development of this database as an open source project.
FOS399
UNPLANNED HOSPITAL READMISSIONS 
WITHIN 30 DAYS AFTER LIVER AND 
PANCREATIC RESECTIONS
E. L. Neo, S. Bramhall, J. Isaac, R. Marudanayagam, 
D. Mayer, D. Mirza, P. Muiesan and R. Sutcliffe
Liver Unit, Queen Elizabeth Hospital, Birmingham, UK
Introduction: Due to limited resources within the NHS, 
clinicians in the UK are under constant pressure to dis-
charge patients rapidly, even after major surgery. There is a 
concern that premature discharge may lead to high readmis-
sion rates and worsen clinical outcomes. The aim of this 
study was to evaluate the incidence and outcome of 
unplanned hospital readmission after liver and pancreatic 
resection.
Methods: Patients who underwent liver or pancreatic 
resection between January and December 2010 were 
identifi ed from a prospective database. Potential risk 
factors for unplanned readmission within 30 days of dis-
charge from hospital were evaluated. Reasons for readmis-
sion were categorized as minor (Clavien grade 1–2) or major 
complications (grade 3–4), and mortality after readmission 
was also assessed.
Results: Median hospital stay after liver and pancreatic 
resections were 6 (range 4–66) and 9 days (5–225). 14/174 
(8%) patients were readmitted after liver resection. The type 
of liver resection was associated with readmission (major 
12.5% v minor 3%; p = 0.03). Of the readmitted patients, 7 
(50%) had major complications, including 4 who had an 
uncomplicated index admission and 2 patients died. 10/100 
(10%) patients were readmitted after pancreatic resection. 
Readmission was more likely in patients with pancreatic 
fi stula (30% v 8%; p = 0.06) or white cell count >15 × 109/L 
at the time of discharge (38% v 6%; p = 0.003). Of the read-
mitted patients, 4 (40%) had major complications, including 
3 who needed urgent embolization. Two patients in this 
group died.
Conclusion: Hospital readmission rates after liver and pan-
creatic resection are acceptable. However, readmitted 
patients have a very high morbidity, often requiring urgent 
intervention only available at a specialist centre. Effi cient 
communication and rapid transfer of patients to a centre with 
the available expertise is vitally important to prevent delayed 
deaths after major liver or pancreatic resections.
FOS400
LONG TERM RESULTS WITH MAJOR 
HEPATECTOMY AND BILIARY 
RECONSTRUCTION FOR HEPATIC 
ALVEOLAR ECHINOCOCCOSIS
J. Lubrano1, S. Bresson-Hadni1, N. Halkic2, B. Heyd1, 
N. Demartines2 and G. Mantion1
1Digestive Surgery and Liver Transplantation Unit, 
Besançon University Hospital, France; 2Digestive Surgery 
and Transplantation Unit, Lausanne University Hospital, 
Lausanne, Switzerland
Introduction: Hepatic alveolar echinococcosis (HAE) is a 
parasitic disease due to the hepatic involvement by the larva 
of Echinococcus multilocularis. Natural history of the 
disease leads to pseudo-tumoral involvement of the liver and 
the hepatic veins and even to a metastatic disease to the lungs 
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and the brain. Without treatment, up to 80% of patients may 
die within ten years of diagnosis. Surgical treatment is still 
controversial especially in case of involvement of the biliary 
convergence.
Methods: For the last 30 years, 115 patients have undergone 
liver resection in our surgical unit for HAE. Among them, 
28 patients had enlarged hepatectomy with biliary recon-
struction due to involvement of the biliary convergence.
Results: Patient’s median age was 55 years old. Main 
symptom was jaundice with cholangitis in 57% of the cases. 
Major hepatectomy with biliary reconstruction was per-
formed in all cases (right lobectomy in 75%) and vascular 
reconstruction in 46% of the cases. Mortality and morbidity 
rates were 3.5 (1/28) and 10% respectively. There was no 
post operative liver failure. Median follow-up was 11 years, 
with a 10-years overall and disease free survivals of 82% and 
78% respectively.
Conclusion: Enlarged hepatectomy with biliary reconstruc-
tion in front of biliary convergence’s involvement due to 
hepatic alveolar echinococcosis are possible and lead to long 
term survival.
FOS401
MICROWAVE ABLATION FOR THE 
TREATMENT OF LIVER TUMORS: A 
SINGLE-INSTITUTION EXPERIENCE OF 
92 CASES
R. Groeschl, S. Pappas, K. Christians, E. Hohenwalter, 
E. Quebbeman, S. Tutton, W. Rilling and T. Gamblin
Medical College of Wisconsin, Milwaukee, WI, USA
Introduction: When liver tumors are unresectable, micro-
wave ablation (MWA) is an available technique used to 
achieve local control. Few studies have reported the effi cacy 
of MWA for treating hepatic malignancies. We sought to 
examine our institutional experience using MWA to treat 
liver tumors, with particular emphasis on disease-free sur-
vival and prognostic factors for recurrence of metastatic 
disease.
Methods: A single-institution retrospective review was con-
ducted of all patients with liver tumors treated by MWA. 
Patients were grouped by primary tumor type: hepatocellular 
carcinoma (HCC), colorectal liver metastases (CLM), meta-
static carcinoid (MC), and other tumors. Survival was ana-
lyzed with Kaplan-Meier curves. Overall survival (OS) and 
disease-free survival (DFS) analysis included only those 
patients whose malignancies were completely ablated on 
postoperative imaging. Cox proportional hazards models 
assessed independent signifi cance of prognostic variables 
with hazard ratios (HR) and 95% confi dence intervals (CI).
Results: Eighty-one patients (43 female) underwent 92 
MWA operations (72 open, 13 laparoscopic, 7 percutaneous). 
Ten operations were for HCC, 39 for CLM, 20 for MC, and 
23 for other tumors. Median tumor size was 2 cm (range 
0.9–5.5). Concomitant liver resection was performed in 56 
cases (61%). Overall 90-day morbidity and mortality rates 
were 16% and 1%. On postoperative imaging, 84 cases 
(91%) demonstrated complete ablation. At a median follow 
up of 16 months, there were 11 local recurrences (14%). 
Median OS and DFS were 36 and 18 months. Use of 
neoadjuvant chemotherapy independently predicted earlier 
recurrence (HR: 2.1, CI: 1.0–4.4, p = 0.05). Tumor size and 
number of tumors ablated did not correlate with DFS 
(p > 0.6).
Conclusion: MWA can be used to treat liver tumors with an 
acceptably low morbidity and mortality. The effi cacy of 
MWA to provide local control for liver malignancies may 
depend on preoperative factors such as the use of neoadju-
vant chemotherapy, but larger comparative studies are 
needed to substantiate and expound upon these fi ndings.
FOS402
EVALUATION OF THE RISK FACTORS 
FOR BLEEDING IN MAJOR LIVER 
RESECTION
V. Vishnevsky, V. Subbotin, M. Efanov, R. Ikramov 
and I. Kozyrin
Vishnevsky Institute of Surgery, Moscow, Russia
Introduction: Major liver resections are still associated 
with high risk of massive blood loss. Up to now the exact 
defi nition of massive blood loss is not defi ned. The aim was 
to evaluate the prognostic factors for intraoperative bleeding 
signifi cant for morbidity and mortality after major liver 
resections.
Methods: Design – a single-center retrospective cohort 
study. The results of major liver resections (removing 3 or 
more segments) in 230 patients with solid malignant and 
benign liver tumors and Klatskin’s tumor were evaluated. 
The blood loss was calculated in percentage of blood volume 
(BV). The complications rate was evaluated according 
to Dindo-Clavien. The variables were compared by the 
chi-square test or odds ratio (OR) and 95% confi dence 
interval.
Results: The mean blood loss (BL) was 33% of blood 
volume (BV) (23; 54%). The rate of the moderate and severe 
complications was 43%, the mortality rate was 7.4%. BL > 
30% of BV increased the risk of liver insuffi ciency, OR 2.54 
(1.1, 5.6). BL > 40% of BV increased the major complica-
tions rate, OR 2 (1.2; 3.4). BL > 70% of BV impacted on 
mortality, OR 4.53 (1.5; 12.1). The signifi cant prognostic 
factors for blood loss were: liver cirrhosis (p = 0.04); preop-
erative chemotherapy, OR 3.1 (1.23, 3.94); prothrombin 
index <45% (p = 0.002); tumor size >7 cm, OR 5 (2, 12); 
the tumor involvement >3 liver segments, OR = 2.2 (1.3, 
3.9); the right lobe tumor location, OR, 2.7 (1.3, 5.8); tumor 
invasion into the main branches of the portal vein, OR = 4.4 
(1.1, 16.8) and into inferior vena cava (IVC), OR = 6 (1.2, 
29); the impairment of blood fl ow in IVC, right and middle 
hepatic veins, OR = 5.2 (1.8, 14.7).
Conclusion: Estimation of prognostic factors could help to 
calculate the risk of massive blood loss. It allows decreasing 
intraoperative bleeding, postoperative morbidity and mortal-
ity after major liver resections.
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FOS403
MANAGEMENT OF SPONTANEOUS 
LIVER HEMORRHAGE
A. Rosales-Velderrain, M. Kendrick and F. Que
Mayo Clinic, Rochester, Minnesota, USA
Introduction: Spontaneous hemorrhage from liver tumors 
is an uncommon but serious complication. Recently inter-
ventional radiologic techniques are being utilized increas-
ingly in management of these patients. We report our 16-year 
experience in managing spontaneous hemorrhage from liver 
tumors.
Methods: 26 consecutive patients were diagnosed with non-
traumatic spontaneous liver hemorrhage between 1995 and 
2011.
Results: Initial management was operative in 7, interven-
tional radiology (IR) in 10 and supportive in 9. Of those 
managed operatively, 4 were segmentectomies, 1 hemihepa-
tectomy, 1 wedge resection, 1 packing who later died from 
coagulopathy. In the IR patients, 10 underwent angiography 
with 7 having simultaneous angiographic embolization (AE); 
2 required re-embolization; 1 underwent resection of a 
hepatic adenoma (HA) 21 days after AE. The malignant 
lesions included hepatocellular carcinoma (n = 3), angiosar-
coma (AS, n = 1), metastatic squamous cell carcinoma (SCC, 
n = 1), metastatic leiomyosarcoma (n = 1), non-SCC (n = 1) 
or metastatic AS (n = 1). Benign diseases included HA 
(n = 6), end-stage liver disease (n = 1), or polycystic liver 
(n = 1). Ten were unknown.
Conclusion: Spontaneous hemorrhage from the liver occurs 
evenly from benign or malignant causes, 1/3 of which are 
primary liver disease. If the patients presents emergently, 
angiographic embolization may control the bleeding and 
allow for elective resection once the sequelae of bleeding 
have resolved.
FOS404
CHANGING TRENDS IN HEPATIC 
ARTERY ANEURYSMS – A SINGLE 
CENTRE EXPERIENCE
R. Nagaraja1, V. Varma1, A. Gupta2, N. Mehta1, 
V. Kumaran1 and S. Nundy1
1Department of Surgical Gastroenterology and Liver 
Transplantation, Sir Ganga Ram Hospital, Rajinder Nagar, 
New Delhi 110060, India; 2Department of Interventional 
Radiology, Sir Ganga Ram Hospital, Rajinder Nagar, New 
Delhi 110060, India
Introduction: There have been changes, over time, in the 
type, cause and presentation of hepatic artery aneurysms 
(HAA) as well as their management. Although there are 
many case reports, few are from developing countries and 
few comparing patient outcomes after angioembolisation and 
surgery.
Methods: We retrospectively analysed patients admitted 
with HAAs between February 1999 and July 2011. We 
divided them into two groups, those who presented before 
2007 (Surgery group) and after 2007 (Embolisation group). 
We studied their demographic characteristics, presentation, 
investigations, technical/ clinical success of treatment and in 
hospital mortality. Technical success was defi ned as 
non-visualisation of the pseudoaneurysm after the procedure 
and clinical success as cessation of further bleeding (includes 
absence of bleeding from same site on re-embolisation or 
surgery), non requirement of further blood transfusions, 
stable hemoglobin level and improvement of hemodynamic 
parameters.
Results: There were 30 patients with a median age of 42 
years and 17 were males. Nine patients underwent surgery 
and 21 had embolisation (24 procedures). Iatrogenic causes 
(14; 47%) and trauma accounted for the majority (12; 40%). 
Only one patient had true aneurysm. The predominant symp-
toms were gastrointestinal bleeding (17; 57%) or abdominal 
pain (13; 43%). There was no mortality in the surgery group, 
in hospital stay was longer and transfusion requirement 
higher. In the embolisation group, technical success was 
100% and clinical success 83%. Clinical failure (2; 67%) and 
complications (1; 33%) were seen in common hepatic aneu-
rysms after embolisation. The mortality in this group was 
14% (3).
Conclusion: Hepatic artery pseudoaneurysms are much 
commoner than true aneurysms, and occur more commonly 
on the right side, in an intrahepatic location. The majority 
are due to an iatrogenic cause or trauma. Both surgery and 
angioembolisation are equally effective but the latter has 
advantages because of the rapidity of the bleeding control, 
shorter hospital stay and lower transfusion requirement. 
Clinical failure and complications were higher when aneu-
rysms of common hepatic were embolised.
FOS405
CONSERVATIVE SURGERY SHOULD BE 
THE FIRST LINE TREATEMENT FOR 
LIVER HYDATID CYST SURGERY: 
RESULTS OF COMPARATIVE 
RANDOMISED STUDY
H. O. El Malki1, A. Souadka2, A. Benkabbou2, 
R. Mohsine2, L. Ifrine2, R. Abouqal3 and A. Belkouchi2
1Medical Center of Clinical Trials and Epidemiological 
Study (CRECET), Biostatical, clinical research and 
epidemiological laboratory (LBRCE), Surgery Department 
“A” Ibn Sina Hospital, Rabat Morocco; 2Surgery 
Departement “A” Ibn Sina Hospital, Rabat Morocco; 
3Medical Center of Clinical Trials and Epidemiological 
Study (CRECET), Biostatical, clinical research and 
epidemiological laboratory (LBRCE), Medical School, 
University Mohammed Vth Souissi, Rabat, Morocco
Introduction: To date, management of liver hydatid cyst 
(LHC) is still subject of controversy. However, surgery is the 
basic treatment. It can be divided into two opposite 
approaches radical (R) and conservative (C). The purpose of 
this study was to demonstrate that R surgery of LHC is not 
the best attitude.
Methods: A retrospective study, from January 1990 to 
December 2010, of 792 patients with liver hydatid cyst were 
treated in experienced unit in hepatobiliary surgery. 
Propensity-score computer matching was performed, based 
on 17 variables representing patients characteristics and 
reoperative risk factors to correct for and minimise selection 
bias (Hosmer-Lemeshow goodness of fi t, p = 0.9). A total of 
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170 patients were successfully matched and consisted of 85 
pairs either undergoing C or R approaches.
Results: With median follow-up of 87 months (IQR 25, 75: 
45 months; 126 months) recurrence rate was equal, 3.5% in 
each groups C and R odds ration (OR) 1 (95% IC, 0.2 to 5.1). 
There were also no statistically signifi cant differences 
between C surgery and R surgery in terms of operative mor-
tality 1.2% vs 0% (p = 0.99), deep abdominal complications 
11.9% vs 16.5% OR 1.46 (95% IC, 0.6 to 3.5), global post-
operative complications 15.3% vs 18.8% OR 1.3 (95% IC, 
0.6 to 2.9), re interventions 0% vs 3.5% (p = 0.99), median 
hospital stay 7 d (IQR 5 d; 1 d) vs 7 d (IQR 5 d; 1 d) 
(p = 0.22).
Conclusion: Radical surgical resection does not prevent 
recurrences of LHC when compared to conservative 
approaches. As benign disease, we suggest that conservative 
approaches should be the preferred treatment especially in 
endemic countries. Radical surgery may keep some indica-
tions in specifi c cases and selected patients.
FOS406
SURGICAL PROCEDURES IN ADULT 
EXTRA-HEPATIC PORTAL VEIN 
OBSTRUCTION
G. Nagarajan, K. Adayanthaya and D. Amarapurkar
Bombay Hospital and Medical Research Centre, Mumbai
Introduction: Extrahepatic portal vein obstruction 
(EHPVO) is a relatively uncommon cause of portal hyperten-
sion in the adult population. Unlike portal hypertension for 
cirrhosis where surgery has almost become obsolete, many 
patients with EHPVO end up requiring surgical interventions 
for varied clinical issues related to the venous obstruction. 
We present our experience as regards surgical interventions 
in adult patients with EHPVO.
Methods: We analyzed a prospectively maintained database 
of 121 adult patients of EHPVO maintained by one of the 
authors (DA) from 1995 to 2011. We studied the 26 patients 
who underwent surgical procedures for various conditions 
resulting due to the EHPVO. We analyzed their demographic 
data, type of surgery, indications, immediate and late post 
operative complications and outcomes of these patients. Of 
the 121 patients with EHPVO, 26 (21%) adult patients 
required surgery. The age group ranged from 16 to 53 years 
(mean age 23 years), 16 male and 10 female.
Results: Surgical interventions were splenectomy with 
proximal splenorenal shunt (11), DSRS (1), splenectomy 
with devascularization (4), splenectomy alone (4), devascu-
larization (2), side-side mesocavalshunt (1), small bowel 
resection (3). Of 19 patients who had shunt/devascularization 
surgery, 14 were for bleed, 5 were for hypersplenism. Of 
those who had splenectomy alone, 2 were for splenic abscess. 
Of the devascularizations, 2 patients had failure of earlier 
shunt surgery. Small bowel resection was performed in 2 
patients for ischemic strictures and 1 gangrene.
Post operatively, 1 patient had thrombosis of the shunt on 
day 3. There were no mortalities. Long term, 4 patients had 
a blocked shunt, 5 patients had varices requiring banding. No 
encephalopathy.
Conclusion: Adult EHPVO is an uncommon condition and 
often requires a surgical intervention. Appropriate selection 
of the procedure can yield gratifying results in these patients. 
Shunt and devascularization surgery are yet in vogue for 
select patients.
FOS407
OUTCOMES OF LIVER RESECTION FOR 
HEPATOCELLULAR ADENOMA AND 
FOCAL NODULAR HYPERPLASIA; 
RESULTS OF A PROSPECTIVE TRIAL
M. Bieze1, S. Phoa2, O. Busch1, J. Verheij3, D. Gouma1 
and T. van Gulik1
1Department of Surgery, Academic Medical Center 
Amsterdam; 2Department of Radiology, Academic Medical 
Center Amsterdam; 3Department of Pathology, Academic 
Medical Center Amsterdam
Introduction: HCA and FNH are rare, benign liver lesions 
of which diagnosis and management generate confusion. 
Resection for HCA > 5 cm is recommended because of risk 
of bleeding and malignant transformation, whereas FNH is 
only resected because of symptoms. The aim of the study 
was to prospectively assess the outcomes of resection of 
hepatocellular adenoma (HCA) or focal nodular hyperplasia 
(FNH).
Methods: Between January2008 and July2011, 111 con-
secutive patients with suspicion on FNH or HCA > 2 cm 
based on imaging studies were included. All patients under-
went pre-operative Gd-EOB-DTPA magnetic resonance 
(MR) imaging. Liver resections were classifi ed as major: >3 
segments, or minor: <3 segments, including laparoscopic and 
local excisions. Histological diagnosis was used as standard 
of reference. Abdominal symptoms, postoperative morbidity 
(Dindo/Clavien classifi cation), mortality, and relief of symp-
toms were scored.
Results: 111 patients (4 m; 107 f; mean age 38 yr) were 
included. Preoperative diagnoses based on MR imaging: 
HCA (44), FNH (59), HCA + FNH (4), and other (4). 46 
patients were selected for resection because of HCA > 5 cm 
(29), symptomatic FNH (2) or strong wish of the patient (15). 
Mean lesion size was 7.9 cm (SD 2.5). 28/46 patients pre-
sented with complaints. Types of resection included 36 
(78%) minor (9 laparoscopic resections), 10 major resec-
tions. Postoperative complications were: Grade I: 7, Grade 
II: 4, Grade IIIa: 2, Grade IIIb: 1, Grade IVa: 1, no mortality. 
Preoperative diagnosis was confi rmed in 28/29 patients with 
HCA (1 hemangioma), and 15/15 patients with FNH. 26/28 
patients showed improved complaint scores 3 months 
postoperatively.
Conclusion: Patients with suspicion on HCA or FNH were 
accurately diagnosed and selected for resection on the basis 
of MR imaging and symptoms. Most lesions (78%) required 
minor resection with relief of complaints in most patients 
(90%) with symptoms.
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FOS408
GAMMA-GLUTAMYLTRANSPEPTIDASE-
SPECIFIC FLUORESCENT PROBE FOR 
THE REAL-TIME IDENTIFICATION OF 
LIVER CANCERS
Y. Miyata1, T. Ishizawa1, Y. Sugawara1, K. Hasegawa1, 
A. Shinozaki2, M. Sakabe3, Y. Urano3 and N. Kokudo1
1Hepato-Biliary-Pancreatic Surgery Division, Artifi cial 
Organ and Transplantation Division, Department of 
Surgery, Graduate School of Medicine, The University 
of Tokyo; 2Department of Pathology, Graduate School 
of Medicine, The University of Tokyo; 3Graduate School of 
Medicine, The University of Tokyo
Introduction: It has been reported that gamma-glutamyl-
transpeptidase (GGT), which is an enzyme of cell surface, is 
overexpressed in human cancer tissues. The aim of this study 
was to evaluate the ability of a novel fl uorescent probe 
(gGlu-HMRG) to visualize liver cancer tissues on cut sur-
faces of resected specimens.
Methods: gGlu-HMRG was sprayed on the cut surface of 
surgical specimens of 43 hepatocellular carcinomas (HCC), 
6 intrahepatic cholangiocarcinomas (ICC), and 35 colorectal 
liver metastases (CRLM). Gross appearance of the fl uores-
cence and fl uorescent intensities of cancerous tissues and 
non-cancerous tissues were evaluated.
Results: Fluorescence of gGlu-HMRG was grossly identi-
fi able in 20 nodules of HCC (47%), 6 nodules of ICC 
(100%), and 34 nodules of CRLM (97%), from 5 minutes 
after spraying gGlu-HMRG. Among 29 nodules of HCC 
with quantitative analysis, fl uorescent intensity was signifi -
cantly higher in 8 nodules with gross identifi cation of the 
fl uorescence than remaining 21 nodules without gross iden-
tifi cation (1.549 vs. 0.062, P < 0.001). Immunohistostaining 
of GGT revealed that the proportion of nodules positive for 
GGT was higher in HCCs with gross identifi cation of the 
fl uorescence (4 out of 5) than grossly unidentifi able HCCs 
(1 out of 7).
Conclusion: gGlu-HMRG enabled real-time identifi cation 
of HCC and adenocarcinoma of the liver. Since fl uores-
cence of gGlu-HMRG is visible to the naked eyes, fl uores-
cent imaging technique using this probe may be useful to 
identify liver cancers during hepatectomy and cancerous 
tissues remaining on the raw surface of the liver after 
resection.
FOS409
MAJOR LIVER RESECTION FOR 
PATIENTS WITH LIVER TRAUMA
O. Hegazy, H. Soliman, H. Shoreem, S. Saleh, T. Yaseen, 
N. Abdelmoez, K. Aboelela and T. Ibrahim
National Liver Institute, Menoufi ya University, HPB & 
Liver Transplantation Surgery, Giza, Egypt
Introduction: The liver is the second most commonly 
injured organ in abdominal trauma, but liver damage is the 
most common cause of death after abdominal injury. In spite 
of there has been a paradigm shift in the management of 
patients who have stable hemodynamic with marked change 
toward a more conservative approach in the treatment of 
abdominal trauma has been noted during the last decades, 
urgent surgery continues to be the standard for hemodynami-
cally compromised patients with hepatic trauma.
Methods: this study included sixty fi ve patients referred to 
the National Liver Institute (NLI), university of Menoufi ya 
as a tertiary center during the last fi ve years. The manage-
ment option was based on hemodynamic status, radiological 
(ultrasound and CT) staging criteria.
Results: The age of 65 patients ranged from 4–38 years 
Twenty seven (41.5%) patients were not previously explored 
and 5 (7.6%) were explored in NLI due to biliary peritonitis. 
Thirty eight (58.5%) were referred after primary exploration. 
Fourteen (21.5%) were managed conservatively and only 5 
(7.6%) were opened for removal of packs after 48 hours. 
Twenty four (36.9%) were reexplored due to hemodynamic 
instability and CT criteria, 4 (6.1%) were managed by con-
servative surgery (repair of lacerations). Twenty (30.7%) 
patients needed major liver resection, 3 (4.6%) patients by 
left lateral segmentectomy, 2 (3%) patients by right posterior 
sector resection, and 15 (23%) patients underwent right 
hepatectomy with one mortality, one PVT, biliary 
complications.
Conclusion: hemodynamic stable patients can be managed 
safely non-operatively, while urgent surgery continues to be 
the standard for hemodynamic compromised patients with 
hepatic trauma. NOP management doesn’t lead to longer 
hospital stay. Low grade injuries can be managed non-
operatively with excellent results.
FOS410
211 CASES OF GENERAL SURGERIES 
UNDER DA VINCI SYSTEM IN A SINGLE 
INSTITUTE IN CHINA
N. Zhou
Institute of Hepatobiliary and Gastrointestinal Disease of 
PLA Second Artillery
Introduction: To summarize the clinical experience of 211 
general surgeries under da Vinci S system.
Methods: From January 2009 to August 2011, 211 patients 
with hepato-pancreatico-biliary (HPB) and gastrointestinal 
disease underwent robotic surgeries by using da Vinci S 
system. The clinical data of 211 patients were analyzed.
Results: 202 patients had undergone total robotic surgeries. 
9 patients converted to hand-assisted procedure and the con-
version rate was 4.2% (9/211). 85 cases of bile duct surgery, 
including 45 cases of hilar cholangiocarcinoma, bile duct 
carcinoma in the middle in 1 case, bile duct carcinoma under 
section in 2 cases, gallbladder in 13 cases, complex intrahe-
patic bile duct in 18 cases and iatrogenic biliary injury in 6 
cases; Pancreatic surgery in 48 patients, including pancreti-
coduedenectomy, 19 cases of pancreatic resection of the 
body, the 7 cases in the middle, and pancreatic resection in 
1, and pancreatic pseudocyst in 1 and palliative surgery in 
20 cases; Hepatic surgery in 22; Gastrointestinal surgery 
in 13 cases; Other procedures, including 45 cases bravery 
manager stone arts, a probe take retroperitoneal lymph node 
dissection and spleen resection and etc. 13 cases of obstruc-
tive suppurative cholangitis patients were all performed 
under the robotic system in the emergency operation. The 
postoperative infection symptoms were controlled and the 
shock was soon rectifi ed, no perioperative deaths. 13 cases 
occurred postoperative complications, the overall complica-
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tion rate was 6.2% (13/211); 2 patients died, and mortality 
was 0.9% (2/211). There were no device-related complica-
tions. Recovery was accelerated and blood loss was less.
Conclusion: Almost all operations in hepatobiliary pancre-
atic surgery could be performed successfully with da Vinci 
S system. Robotic surgery will improve the development of 
minimally invasive surgery.
FOS411
EFFECT OF MAJOR HEPATECTOMY IN 
RATS ON TUMORAL GROWTH IN THE 
REMNANT LIVER
L. Schwarz1, E. Vibert2, F. Faitot1, R. Adam3, D. Castaing3 
and J. Faivre1
1Inserm, Unité 785, F-94800 Villejuif, France; 2Univ 
Paris-Sud, UMR-S785, F-94800 Villejuif, France; 3AP-HP 
Hôpital Paul Brousse, Centre Hépato-Biliaire, F-94800 
Villejuif, France
Introduction: Portal vein occlusion modifi es the natural 
history of macroscopic colorectal liver metastases (CLM) by 
inducing their growth (Pamecha, Br J Cancer 2009). The 
effect of an hepatectomy on growth of macroscopic CLM in 
the remnant liver was poorly studied. Aim of this experimen-
tal study in rats was to assess, comparatively to a laparotomy 
(LAP), the growth of macroscopic CLM in the remnant liver 
after a major (H70%) hepatectomy.
Methods: Bilobar macroscopic bilobar CLM were obtained 
at day 7 after a portal injection of a suspension of 15.10^6 
colorectal malignant cells (DHDK12) in 26 males rats 
(BD-IX) (Mean age: 6 weeks; Mean weight: 170 g). At this 
date, 25 rats underwent an H70% (n = 13) or a LAP (n = 12). 
Two weeks later, at sacrifi ce, a morphometric analysis 
(weight of rats and liver) and a numerical analysis (by cal-
culating on numeric picture with Adobe Photoshop the ratio 
of the CLM on heathly liver of embedded specimen) were 
performed.
Results: Post-operative mortality was nil. At morphometric 
analysis (H70% vs LAP), body weights of rat were similar 
(p = 0.6), and liver weights were of 9.1 g ± 0.9 versus12.6 g 
± 2.8 respectively (p = 0.0004). At numerical analysis, the 
ratio of CLM on heathly liver was estimated at 9.4% ± 5.4 
in the group H70% vs 20% ± 8.8 in group LAP (p = 0.0014), 
indicating a lower growth of CLM after major hepatectomy 
than after laparotomy.
Conclusion: Contrary to portal vein occlusion, a major 
hepatectomy decreases the growth of macroscopic CLM in 
the remnant liver as compared to a laparotomy. This experi-
mental data must be confi rmed in patients that required two-
steps hepatectomy in bilobar CLM.
FOS412
DEEP SEGMENTS ARE MORE RISKY 
THAN PERIPHERAL SEGMENTS FOR 
MINOR LIVER RESECTION: ANALYSIS 
ON 2012 LIVER RESECTIONS
S. Dokmak, F. S. Ftériche, B. Aussilhou, O. Farges, 
A. Sauvanet and J. Belghiti
Department of Hepatobiliary and Pancreatic Surgery, 
Hospital Beaujon, Clichy, France
Introduction: Our aim was to evaluate the risk of minor 
liver resection in the deep posterior (DP) and superfi cial 
peripheral (SP) liver segments.
Methods: From January 2000 to December 2009, 2012 con-
secutive liver resections were studied from a unicentric pro-
spectively maintained database. Resections including <1 
segment (n = 439) or associated with procedures (n = 367; 
biliary, vascular or extrahepatic) were excluded. Patients 
were classifi ed in two groups and include 104 resections in 
the deep posterior segments (I, VII, VIII) and 560 resections 
in the superfi cial peripheral segments (II, III, IV, V and VI, 
including left hepatectomy). ASA score was similar between 
groups. Ninety days mortality, major morbidity (Clavien > 
III), liver specifi c complications and the hospital stay were 
studied.
Results: There were older patients (59 vs 54, p = 0.003), 
more male (68% vs 55%; p = 0.013), more malignancy (87% 
vs 65%, p < 0.001) in the DP group but similar rate of cir-
rhosis (30.8% vs 22.7%, p = 0.10). DP vs SP showed higher 
mortality (5.8% vs 1.4%; p = 0.005), morbidity (30.8% vs 
14.8%, p < 0.001), more transfusion (22.1% vs 12.7%, p = 
0.011) and bleeding (20% vs 10.5%, p = 0.007). There were 
more pulmonary complications (25% vs 13.2%, p = 0.02), 
bile leakage (11.5% vs 6.1%; p = 0.04), ascitis (18.3% vs 
9.6%; p = 0.01), drained pleural effusion (4% vs 1.3%, p = 
0.05), relaparotomy (6.7% vs 2.5%; p = 0.024), liver insuf-
fi ciency (1.9% vs 0%, p = 0.001) and more drained collec-
tions (10.6% vs 5.9%, p = 0.078). The mean hospital stay 
was longer (12.3 vs 10.29, p = 0.026).
Conclusion: Minor resections of the posterior segments are 
more risky than minor superfi cial peripheral segments and 
should be classifi ed among major and not minor resections 
groups.
FOS413
MANAGEMENT OF GRADE III-IV 
(AAOST-OIS) BLUNT LIVER TRAUMAS: 
A COMPARISON STUDY WITH AND 
WITHOUT ANGIOGRAPHIC 
EMBOLIZATION
L. Bonariol, M. Massani, E. Caratozzolo, C. Ruffolo, 
R. Bonariol, B. Pauletti and N.’ Bassi
IV Dpt Surgery, Regional Center for HPS Surgery, 
Regional Hospital Treviso Italy
Introduction: Liver lesions consequent to open or close 
abdominal trauma are a life threatening situation and their 
management, thanks to the extensive use of interventional 
radiology, progressively changed during last 30 years. 
Treatment choice is affected by associated lesions, but gold 
standard is avoiding any surgical procedure.
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Methods: We review our experience in the treatment of 
adult blunt liver traumas in attempt to assess the impact of 
angiographic embolization in expanding indications for con-
servative treatment of grade III-IV liver injuries comparing 
two time windows 1993 to 2005, and 2005 to 2010.
Results: Seventy patients, with grade III-VI liver lesion, 
admitted to the hospital ward between January 1993 and June 
2010 were recruited; those with Grade III-IV (AAST-Grading 
system) lesions (n 50) were selected for our study.
They were predominantly male, had a median age of 29 
years (range: 16 to 91), and majority of them were hemody-
namic stable (75% = 38/50)). The trauma was more fre-
quently as a result of a road accident (78% = 39/50); type III 
lesions were more frequent than type IV (64% vs 36%); most 
of the patients had grade III hemoperitoneum (70% = 35/50) 
and the percentage of those non operatively treated was 62% 
( = 31/50).
At multivariable analysis patients treated before 2005 were 
more likely to be older than 39 years (OR = 8.75; CI: 2.)
Conclusion: Indications for conservative treatment of liver 
traumas cannot be solely based on to the relief of hemody-
namic stability. The new multi-slice high-speed CT scanners 
are very sensitive and assist in ruling out associated intra-
abdominal injuries, and allow one to quantify the presence 
of blood in the peritoneal cavity and especially to identify 
those patients in whom conservative treatment might fail due 
to hepatic arterial hemorrhage that could be stopped by angi-
ographic embolization.
FOS414
CLINICAL COURSE OF RUPTURE TO A 
LIVER HYDATID CYST IN TO 
PERITONEAL CAVITY. ANALYSIS OF 
PROGNOSTIC FACTOR IN A COHORT 
OF PATIENTS
C. Muñoz1, H. Losada2 and N. Jarufe1
1Gastrointestinal Surgery Department, Pontifi cia 
Universidad Católica de Chile, Santiago, Chile; 
2Hepatopancreatobiliary Unit, Surgery Department, 
Universidad de La Frontera, Temuco, Chile
Introduction: The hydatid disease is endemic in some 
regions of Asia, Mediterranean and South America. The liver 
is the primary site of localization in human and the rupture 
of liver hydatid cyst to peritoneal cavity is infrequent and 
poor prognosis complication of this disease. Our aim is to 
present the results of a cohort patients operated for a rupture 
of liver hydatid cyst to peritoneal cavity and analysed some 
prognostic factor for peritoneal recurrence.
Methods: A historical cohort study was conduced in 2 
Universitary Hospital from Chile between January 2000 to 
December 2010. All patients with a rupture of liver hydatid 
cyst operated was included. Clinical variables was measured: 
biodemograhics, liver hydatid disease history and surgery, 
abdominal trauma history, cystobiliar communication, 
hydatid cyst characteristics, hydatid cyst size. The results 
variables measured: type of surgery, morbidity, inhospital 
mortality, peritoneal recurrence. The statistical analysis was 
done with use of descriptive and analytical statistics in soft-
ware Stata 10.0.
Results: Twenty nine patients are the cohort. The median 
age was 40.7 ± 21.6 (12–82) years and 69% male. The 65.5% 
don’t have hydatid disease history. A 19.9% have history of 
abdominal blunt trauma. The 69% was localized in right 
hepatic lobe. The 37.9% have between 10–15 cms. size. The 
48.8% have a cystobiliary communication. The 72.4% was 
a multivesicular cyst. The 44.8% was a subtotal cystectomy. 
A 48% have a sometype morbidity. In a 13.8% received 
albendazole in a postoperative period. Five patients (17.25%) 
have a diffuse peritoneal recurrence during a 12 months 
median follow-up. The variables measured: size, cystobiliary 
communication and hydatid cyst characteristics didn’t asso-
ciate with peritoneal recurrence.
Conclusion: The peritoneal rupture of liver hydatid cyst 
is associated with a high rate morbidity and high rate of 
peritoneal recurrence. We don’t found an association between 
size, cystobiliary communication and hydatid cyst character-
istics with more probability of peritoneal recurrence.
FOS415
THE PLACE OF THE “DA VINCI” 
ROBOTIC SURGICAL COMPLEX IN 
PANCREATIC AND LIVER SURGERY
S. Berelavichus, A. Kriger, A. Fedorov, M. Efanov 
and D. Gorin
Vishnevsky A.V. Institute of Surgery, Moscow, Russia
Introduction: Nowadays the robotic technics actively pen-
etrates in routine surgical practice. While developing this 
direction the great advantages of robotic operations in com-
parison with both traditional and laparoscopic ones were 
found.
Methods: Since 2009 in abdominal department of Surgery 
Institution named by Vishnevsky 79 robot-assisted opera-
tions were provided. There is a quite broad range of the 
interventions: 37 liver resections, 8 pancreatic resections, 1 
pancreato-duodenic resection, 33 operations on the other 
abdominal and extra abdominal organs.
The pathology selection for robot-assisted surgery directly 
depended on the experience of laparoscopic treatment of this 
pathology.
The preoperational procedure included computer mode-
ling of the coming surgery. The patients underwent computer 
tomography followed by the 3D reconstruction.
Results: The ideal points of application of robototechnics in 
liver surgery are so-called posterior liver segments (VII, 
VIII). In this particular hard-to-reach for traditional laparo-
scopic technics segments the robot-assisted atypical resec-
tions are approved.
As far as pancreas is concerned the most advanced robotic 
interventions could be the distal resections (especially in case 
of saving the organ) and median pancreas resection.
Due to the great manipulation advantages of the robotic 
instruments and the 3D image opportunities the interventions 
on these areas can be carried out more precisely and safely 
in comparison with traditional laparoscopic technic.
There were no complications noted in the early post opera-
tion period.
Conclusion: Operating with the help of the robotic complex 
allows high quality volumetric vision, precise mobilization, 
decrease of the intra operational injury and blood loss. It also 
provides comfortable position of the surgeon in the course 
of the complicated pancreatic and liver interventions.
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REVERSIBLE PORTAL VEIN 
EMBOLIZATION INDUCES LIVER 
REGENERATION DESPITE 
RECANALIZATION
E. Melloul1, D. A. Raptis1, T. Pfammatter2, R. Graf1, 
P.-A. Clavien1 and M. Lesurtel1
1Department of Surgery and Transplantation, Swiss HPB 
Center, University Hospital Zürich, Switzerland; 
2Department of Interventional Radiology, University 
Hospital Zürich, Switzerland
Introduction: Preoperative permanent portal vein emboli-
zation (PVE) is widely used before major hepatectomy to 
induce hypertrophy of the remnant liver. Reversible PVE 
with absorbable agents would be safer in clinical situations 
where the embolized liver is not resected. Study aims: (1) To 
determine the recanalization time course following revers-
ible PVE; (2) to confi rm the effi cacy of reversible PVE on 
hypertrophy of the non-embolized liver lobes; (3) to observe 
the impact of reversible PVE on embolized lobes.
Methods: Thirty BL6/male mice underwent 70% PVE 
using powdered absorbable material. Repeated portographies 
and angiographic MRI were carried out until complete recan-
alization of the embolized lobes. Liver regeneration was 
assessed by immunohistochemistry (BrdU, Ki-67, Ph-Histone 
3 stainings). Liver lobe volumes were determined by small 
animal MRI volumetry.
Results: Proximal and complete recanalization of the embo-
lized portal tributaries occurred 10 and 14 days after PVE, 
respectively. The hypertrophy ratio of the non-embolized 
lobes was 52 ± 5.9% at day 10 (i.e. 67% of total liver 
volume) and 75 ± 19% at day 14 (i.e. 63% of total liver 
volume). The atrophy ratio of the embolized lobes was 55 ± 
1.4% at day 10 (i.e. 33% of total liver volume) and 33 ± 11% 
at day 14 (i.e. 37% of total liver volume). Reversible PVE 
induced signifi cant hepatocyte proliferation in the non-
embolized lobes.
Conclusion: Despite recanalization of portal tributaries, 
reversible PVE effi ciently induces liver regeneration and 
volume hypertrophy in the non-embolized lobes. The next 
step will be to assess the functional and morphological 
recovery of the embolized liver lobes after recanalization.
FOS417
100 LAPAROSCOPIC LIVER 
RESECTIONS IN A SINGLE CENTER: 
UNDERLYING LIVER DESASE (ULD) 
VS. NO UNDERLYING LIVER 
DISEASE (NULD)
G. M. Ettorre, R. Santoro, M. Colasanti, P. Lepiane, 
E. Moroni, L. Colace, A. Laurenzi and G. Vennarecci
General Surgery and Transplantation Unit, S. Camillo 
Hospital, Rome, Italy
Introduction: The advantages of the laparoscopic approach 
in abdominal surgery have been shown in various abdominal 
procedures. Laparoscopic Liver Resection (LLR) has 
recently been developed and could reduce postoperative 
morbidity. The aim of this study was to evaluate retrospec-
tively our results of LLR in underlying liver disease (ULD) 
patients and no underlying liver disease patients (NULD).
Methods: Between 2004 January and 2011 November 100 
consecutive laparoscopic hepatic resections were performed 
in our center. Surgical results and postoperative course were 
evaluated in two groups according to the ULD/NULD. The 
criteria for patient’s selection were not modifi ed by the use 
of laparoscopy. ULD was present in 38/100 (38%) patients 
and NULD in 62/100 (62%). Median (IQR) age and sex was 
respectively 64 years old (54–73), (22 m: 9 f) and 53 years 
old (44–62), (22 m: 40 f). In the ULD group, indication for 
liver resection was: HCC 36 (95%), Cholangiocarcinoma 1 
(2.5%), benign pathology 1 (2.5%); in NULD: MENCR 20 
(32.3%), benign pathology 20 (32.3%), MECCR 17 (27.4%) 
and cholangiocarcinoma 4 (6.5%).
Results: The type of resection was respectively: wedge 
resection (28 vs. 41) (73.7% vs. 66.1%), left lobectomy (9 
vs. 16) (23.7% vs. 25.8%), right hepatectomy (0 vs. 2) (0 vs. 
3.2%) and left hepatectomy (1 vs. 3) (2.6% vs. 4.8%). 
Median operating time was: 120 minutes (110–80) vs. 140 
(75–180) (p: 0.970). Median blood loss (ml) was: 100 (38–
200) vs. 50 (10–100) (p: 0.004). Blood transfusion was 
required in 1 patient in ULD group (2.6%, p: 0.004). 
Conversion to laparotomy occurred in 3 patients (7.9%) in 
ULD group and in 1 patient (1.6%) in NULD to achieve an 
adequate hemostasis (p: 0.152). Morbidity rate was 2.9% in 
ULD group and 6.9% in NULD. Median hospital stay (IQR) 
was 6 (4–7) vs. 5 (3–7) days (p: 0.098).
Conclusion: Left lobectomy and wedge resection of the 
anterior hepatic segments remain the gold standard for LLR, 
but major hepatectomies are feasible in “experienced hands”. 
In our experience no signifi cantly different results were 
reported for LLR in ULD vs. NULD patients. However, the 
median blood loss is greater in ULD group even if minor 
resections are associated. In conclusion LLR is a feasible and 
safe procedure in ULD/ NULD selected patients.
FOS418
IS LAPAROSCOPIC LIVER SURGERY 
COST-EFFECTIVE FOR BOTH MINOR 
AND MAJOR HEPATECTOMY?
M. Abu Hilal, F. Di Fabio, S. Syed, E. Dimovska, 
J. N. Primrose and N. W. Pearce
Hepatobiliary and Pancreatic Surgical Unit, Southampton 
University Hospitals NHS Foundation Trust, Southampton, 
UK
Introduction: Laparoscopic liver surgery is progressively 
gaining popularity. However, it is still unclear whether the 
laparoscopic approach is cost-effective for both minor and 
major hepatectomy compared to the open approach. In this 
study we analysed the cost-effectiveness of the laparo-
scopic approach for standardized minor hepatectomy, as 
left lateral sectionectomy, and major hepatectomy, as right 
hemi-hepatectomy.
Methods: A retrospective clinical and cost comparison 
analysis for patients undergoing laparoscopic right hepatec-
tomy (LRH) and laparoscopic left lateral sectionectomy 
(LLLS) versus the open counterparts (ORH and OLLS) was 
performed. Data considered for the comparison analysis 
were: operative costs (surgical procedure, operative time, 
blood transfusions), postoperative costs (hospital stay, com-
plication management, readmissions) and overall costs.
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Results: A total of 149 patients were included: 38 patients 
underwent LRH and 46 ORH; 46 patients underwent LLLS 
and 19 OLLS. For LRH the average operative, postoperative 
and overall costs were: £10181, £4037 and £14218; for ORH 
the average operative, postoperative and overall costs were: 
£6483 (p < 0.0001), £10304 (p ≤ 0.0001), and £16787 (p = 
0.886, Mann-Whitney test). Regarding LLLS, the average 
operative, postoperative and overall costs were: £5460, 
£2587, and £8047; for OLLS the average operative, postop-
erative and overall costs were: £5841 (p = 0.873), £5687 
(p < 0.0001), and £11528 (p = 0.0001, Mann-Whitney test).
Conclusion: Our data support the cost-effectiveness of 
laparoscopic left lateral sectionectomy and the cost-neutral-
ity of laparoscopic right hepatectomy compared to the open 
approach. The benefi ts of the minimally-invasive approach 
can be extended to major hepatectomy without cost 
disadvantage.
FOS419
COMPARISON OF LAPAROSCOPIC AND 
ROBOTIC LIVER RESECTION
K.-H. Kim, J.-M. Namkoong, S.-Y. Yoon, S.-W. Jung, 
S.-K. Lee and S.-G. Lee
Asan Medical Center, Ulsan University, South Korea
Introduction: The minimal invasive surgical procedures 
have developed more and more in the fi eld of HBP surgery. 
One of them, a robotic surgery can be applicable to the liver 
resection. Here, the author report the comparison of laparo-
scopic (LLR) and robotic liver resection (RLR).
Methods: Between May 2010 and June 2011, there were 13 
robotic hepatectomies including 10 left lateral sectionecto-
mies and 3 left hepatectomies and 17 laparoscopic hepatec-
tomies including 11 left hepatectomies and 6 left lateral 
sectionectomies. The left hepatectomy and left lateral sectio-
nectomy in laparoscopic liver resection were selected to 
compare with robotic liver resection under same condition. 
On the other hand, 177 laparoscopic hepatectomies were 
performed from July 2007 to June 2011. The da Vinci® 
Robotic Surgical System (Intuitive Surgical, Sunnyvale, CA) 
was used with 4 robotic arms during liver resection.
Results: There were no signifi cant differences in preopera-
tive characteristics between the two groups. The mean opera-
tive time (240.9 ± 68.6 vs. 291.5 ± 85.1 mins; p = 0.082) and 
blood loss (342.6 ± 84.7 vs. 388.5 ± 65.0 ml; p = 0.114) were 
similar between the LLR group and the RLR group. There 
were no signifi cant differences in postoperative characteris-
tics except the mean medical cost (7,628,639 ± 1,620,475 vs. 
12,943,898 ± 2,452,476 won; p = 0.001) between the LLR 
and RLR groups.
Conclusion: The robotic surgical system has sophisticated 
advantages such as 3-dimensional image that provides a 
advanced vision for surgeon and 360° rotating endowrist that 
is very comfortable for suture. RLR seems to be a safe and 
feasible procedure in selected patients, which is same with 
LLR. However, RLR needs to have a liver transaction tool 




A CONSIDERATION FOR ACCEPTANCE 
AS STANDARD OF CARE
G. Belli1, B. Gayet2, H. S. Han3, G. Wakabayashi4, 
H. Kaneko5, C. Gamblin6, I. Dagher7 and J. F. Buell8
1Department of General and Hepato-Pancreato-Biliary 
Surgery S.M. Loreto Nuovo Hospital, Naples, Italy; 
2Department of Digestive Diseases, Institut Mutualiste 
Montsouris, University Paris V, Paris, France; 
3Department of Surgery, Seoul National University 
Bundang Hospital, Seongnam City, Korea; 4Department of 
Surgery, Iwate Medical University School of Medicine, 
Japan; 5Department of Surgery, Omori Hospital, Toho 
University School of Medicine, Tokyo, Japan; 6Department 
of Surgery, Medical College of Wisconsin Division of 
Surgical Oncology, Milwaukee, USA; 7Department of 
Surgery, Antoine Béclère Hospital, Clamart, France; 
8Department of Surgery, Director of Transplantation, 
Jewish Hospital Transplant Center, Louisville, USA
Introduction: Since the inception of laparoscopic liver 
resection, the left lateral resection has become standard of 
care for lesions located in segment II and III. However, few 
centers have evaluated hemi-hepatectomy as standard of 
care. This study evaluates the potential for laparoscopic left 
hemi-hepatectomy to be evaluated as standard of care.
Methods: An international database of 1620 laparoscopic 
liver resections was established and patient outcomes were 
analyzed using univariate, and multivariate analysis.
Results: 222 laparoscopic left lateral sectionectomy (L lat) 
and 82 laparoscopic left hemi-hepatecomy (LH) were per-
formed. The L Lat group compared to LH group had diag-
nosed a higher rate of cirrhosis (27% vs. 21%; P = 0.003) 
and cancer (48% vs. 35% P = 0.04). Tumours in the LH group 
were larger than those removed in Llat group (7.09 vs. 
4.89 cm; P = 0.0006) The mean operating time for LH was 
longer than Llat (3.9 vs. 2.9 hours; P < 0.0001, as well as 
whereas blood loss was higher in the LH group (306 vs. 198 
P = 0.003). Morbidity (24% vs. 12%; P = 0.008) and length 
of hospital stay (7.1 vs. 2.5 days; P ≤ 0.0001) higher in the 
Lh group than Llat group. Mortality and recurrence did not 
differ between the 2 groups.
Conclusion: Laparoscopic L lat should be considered as a 
standard of care as confi rmed by the analysis of this multi-
centric database. Laparoscopic LH is a more complex and 
time consuming procedure than L lat but has the potential to 
be investigated in comparative prospective studies as a new 
standard of care. Intra-operative d blood loss, complications 
and conversions are more than acceptable in experts hands. 
Postoperative morbidity and mortality rates together with 
safe surgical margins.
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LAPAROSCOPIC HEPATECTOMY FOR 
BENIGN TUMOUR, LOCALIZATION IS 
NOT A LIMITED FACTOR
G. Luc1, C. Laurent2 and A. Sa-Cunha1
1Department of Digestive, Endocrine and Laparoscopic 
Surgery, University Hospital of Bordeaux, Maison du 
Haut-Lévèque, Avenue de Magellan, 33604 Pessac Cedex; 
2Department of Digestive Surgery, University Hospital of 
Bordeaux, Hospital Saint-André, Cours d’Albret 33000 
Bordeaux
Introduction: Laparoscopic hepatectomy (LH) is a 
growing surgical operation with over 3000 published cases. 
Amongst those 3000 LH, 44.7% have been performed on 
benign tumors. The laparoscopic approach is appropriate 
when dealing with this indication, but it has limitations 
regarding the size and localization of tumors. The aims of 
this study are to give an account of the surgical results of 
the LH performed at our centre and to verify the choice 
of this method as a prime approach regardless of the local-
ization of lesions.
Methods: Retrospective analysis and prospective data gath-
ering examining the surgical results of laparoscopic hepatec-
tomies of benign hepatic tumors carried out at the University 
Hospital of BORDEAUX. The patients were all histologi-
cally diagnosed with benign hepatic tumor. The Focal 
Nodular Hyperplasia, the hepatic hemangioma and the 
hepatic cysts were all symptomatic in pre-operative. Their 
localization and size were taken into account in pre-operative 
but were not a limiting factor to the laparoscopic approach. 
Two groups are compared according to localization of tumor. 
The patients who had an inferior or anterior hepatic tumor 
(group I) are compared to the patients with diffi cult localiza-
tion (posterior and superior; group II).
Results: Between January 2000 and December 2008, 94 
patients received Laparoscopic Hepatectomies. Sixty four 
patients have had a benign tumor. Forty seven patients had 
an easy localization and seventeen had a diffi cult localiza-
tion. The operating time was similar into the two groups 
(median group I 150 minutes, groups II 150 minutes, p 
0.953). The blood lost was similar into the groups (median, 
group I 100 ml, group II 100 ml, p 0.800). There was one 
complication into the group II and one laparotomy conver-
sion (2 complications in the group I, p 1.000). In multivari-
able analysis the tumor localization was not an independent 
risk factor of morbidity.
Conclusion: LH is a reliable operation and should become 
the technique of choice when dealing with benign hepatic 
lesions of surgical order. Their localization should not be 
contra-indicative to laparoscopy.
FOS422
CLINICAL FEATURES AND 
MANAGEMENT OF HEPATIC 
CYSTADENOMAS AND 
CYSTADENOCARCINOMAS
G. Martel, J. Al-Sharif, J. Rekman, J.-M. Aubin, 
R. Fairfull-Smith, R. Mimeault and F. Balaa
Liver and Pancreas Surgery Unit, Division of General 
Surgery, The Ottawa Hospital, University of Ottawa, 
Ottawa, ON, Canada
Introduction: Liver cystadenomas and cystadenocarcino-
mas comprise approximately 5% of hepatic cysts. Neoplastic 
cysts are often incorrectly diagnosed and incompletely 
managed. The objective of this work was to describe a single 
tertiary care center’s experience with these lesions over 15 
years.
Methods: A retrospective chart review was carried out. 
Consecutive patients undergoing surgery for liver cystadeno-
mas or cystadenocarcinomas from 1997–2011 were included. 
Clinical, operative, postoperative, and pathological data 
were collected and summarized.
Results: A total of 13 patients with cysts 6–18 cm were 
identifi ed. Most were females (92%). The commonest pre-
senting symptom was abdominal discomfort (62%). Most 
cysts were located in the left lobe/centrally (77%) and had 
septations (62%). Mural nodularity was infrequent (23%). 
Nine patients had liver resection/enucleation, while 4 had 
unroofi ng/fenestration. In 3 patients with unroofi ng, a frozen 
section was falsely negative. Pathology showed mucinous 
cystadenoma in 11 patients. Two patients had foci of cystad-
enocarcinoma within mural nodules. There was no 90-day 
mortality. All but one patient (myocardial infarction) were 
alive at a median follow-up of 10 months (1–158). Two 
patients with cystadenomas developed recurrence after 
unroofi ng.
Conclusion: Hepatic cystadenomas were most commonly 
found in women, with a predilection for the left lobe or 
central liver. Malignant transformation was identifi ed in 15% 
and was associated with nodularity. Enucleation or formal 
resection is indicated to avoid cyst recurrence. Intraoperative 
frozen section analysis was ineffective at ruling out 
cystadenomas.
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EUROPEAN EXPERIENCE FOR 
LAPAROSCOPIC MAJOR 
HEPATECTOMY
D. Tzanis1, B. Gayet2, M. Abu Hilal3, A. Laurent4, 
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Introduction: Laparoscopic liver resections have seen an 
important proliferation worldwide, but this regards mostly 
minor hepatectomies. Major anatomic resections were 
initially considered unsuitable for a minimally invasive 
approach. Nowadays, major hepatectomies are still confi ned 
to few expert centers worldwide. Our aim is to report the 
experience of European expert centers and discuss the 
current trends in the application of laparoscopy in major 
hepatectomies with the different techniques and approaches.
Methods: The prospective databases of 4 French, 2 Italian, 
1 English, 1 Dutch, 1 Spanish and 1 Norwegian centers were 
combined to provide answers to a questionnaire that had 
been addressed to all European centers known to perform 
laparoscopic liver surgery. Between 1996 and 2011 a total of 
389 laparoscopic major liver resections were performed: 
right and left hepatectomies in their vast majority. The selec-
tion criteria, indications and important technical points are 
discussed.
Results: Major liver resections represented 19.4% of all 
laparoscopic hepatectomies. 5% to 31% of right and left 
hepatectomies were performed by laparoscopy. Benign, 
primary malignant and metastatic lesions were respectively 
25.6%, 18.1% and 56.3% of all indications. Hand assistance 
was selectively used in 9 centers and systematically in one. 
Portal triad clamping was applied routinely in 2 centers and 
infl ow was controlled extraparenchymally by 9 groups. 
Different approaches were found regarding liver mobiliza-
tion and hepatic vein control prior to parenchyma transec-
tion. Overall conversion rate was 14%. Operative times for 
right and left hepatectomies were 319 min and 268 min, 
respectively, while blood loss was 409 ml and 278 ml, 
respectively.
Conclusion: To date, an important experience has been 
accumulated in Europe for laparoscopic liver resections and 
experience for major hepatectomies is constantly increasing 
with more centers being involved. Whatsoever, they still 
remain technically very demanding procedures that should 
be confi ned to expert surgeons having already acquired 
considerable experience with simpler laparoscopic liver 
resections.
FOS424
CAUSES, PREDICTIVE FACTORS AND 
MANAGEMENT OF CONVERSIONS IN 
223 CONSECUTIVE LAPAROSCOPIC 
LIVER RESECTIONS
R. Montalti, J. Van Limmen, D. Cavaniglia, 
K. Reyntjens, X. Rogiers and R. I. Troisi
Department of General & Hepato-Biliary Surgery, Liver 
Transplantation Service, Ghent University Hospital and 
Medical School, De Pintelaan 185, 9000 Ghent, Belgium
Introduction: As a consequence of continuous technical 
developments in liver surgery, laparoscopic liver resection 
(LLR) is increasingly performed worldwide, especially for 
malignancies. We report herein a single institution 7-year 
experience in LLR, focusing on causes of conversion, techni-
cal issues and outcomes.
Methods: Between January 2004 and December 2010, 223 
LLR were performed in 200 patients for benign, live dona-
tion, primary and metastatic liver disease. Repeat LLR and 
two-stage hepatectomy were performed in 19 (8.5%) and 3 
(1.3%) cases, respectively. Simultaneous resection of colo-
rectal primary cancer and synchronous liver metastases was 
done in 6 (2.7%) patients.
Results: Overall conversion rate was 17/223 (7.6%), mainly 
due to bleeding episodes (52.9%). Conversions were equally 
distributed over time and statistically signifi cant factors for 
conversion were found to be LLR of P-S segments in the 
converted vs. the non-converted group (14.5% vs. 4.1%, p = 
0.012 respectively) and major vs. minor hepatectomy (17.5% 
vs. 5.5%, p = 0.017). In malignancy, R0 resection was 
obtained in 91% of cases. Complication rates were scored 
as: n = 15 grade I; n = 9 grade II; n = 7 grade III and n = 1 
grade IV. Multivariate analysis revealed resections involving 
P-S segments as an independent risk factor for conversion (p 
= 0.036, OR = 3.2, CI = 1.1–9.4).
Conclusion: LLR can be safely performed accounting for 
low overall morbidity and a favourable outcome. LLR in P-S 
segments most likely lead to conversion to open approach 
irrespective from the learning curve, needing careful intra-
operative management.
FOS425
LAPAROSCOPIC ASSISTED MAJOR 
LIVER RESECTION 
H. Nitta, A. Sasaki, T. Fujita, Y. Hasegawa, N. Ito, 
T. Takahara, M. Takahashi and G. Wakabayashi
Department of Surgery, Iwate Medical University School of 
Medicine
Introduction: The number of reports of laparoscopic major 
hepatectomies has gradually been increasing and living 
donor hepatectomies for liver transplant have also recently 
been performed. However, because of the high degree of 
profi ciency required, major hepatectomies have not been 
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widespread. We have developed an original procedure in 
which the liver is mobilized laparoscopically and resected by 
a hanging technique through a small incision.
Methods: Between November 2002 and December 2010, 
75 patients underwent laparoscopy-assisted major liver 
resections (LAMLRs) in our institution for hepatocellular 
carcinoma (HCC), metastatic liver cancer, benign diseases, 
and living donor. LAMLRs were completed for 74 patients 
(98.7%). The median age of was 57 years (range: 20–83 
years). Preoperative diagnoses were malignant diseases (n = 
42), benign disease (n = 8), and living donor (n = 24). The 
types of liver resection consisted of the following: right tri-
sectionectomy (n = 2), right hepatectomy (n = 34), left hepa-
tectomy (n = 22), trisegmentectomy 4, 5, 8 (n = 3), right 
anterior sectionectomy (n = 5), and right posterior sectionec-
tomy (n = 8).
Results: The median operating time was 355 minutes 
(range: 192–542 minutes), and median blood loss was 416 ml 
(range: 52–2785 ml). Eight patients (10.8%) experienced 
postoperative complications, 4 patients (5.4%) showed bile 
leakage, and 4 patients (5.4%) developed wound infections. 
The median postoperative hospital stay was 10 days (range: 
6–154 days).
Conclusion: LAMLR with the hanging technique can be 
completed safely. The procedure can be performed by open 
liver surgeons; and thus may be widely performed in the 
future.
FOS426
A SUSCEPTIBILITY MODEL FOR 
VENOUS THROMBOEMBOLISM AFTER 
MAJOR HEPATIC RESECTION
J. Schwartz1, A. Redd2, H. Thiesset3, J. Sorensen3, 
A. Yopp4, J. Arenas1 and R. Schwarz4
1Division of Transplantation, Department of Surgery, 
University of Texas, Southwestern; 2Department of 
Epidemiology, University of Utah; 3Section of 
Transplantation, Department of General Surgery, School of 
Medicine, University of Utah; 4Division of Surgical 
Oncology, Department of Surgery, University of Texas, 
Southwestern
Introduction: Despite an international normalized ratio that 
is frequently elevated, patients with advanced chronic liver 
disease were recently found to have an elevated risk of 
venous thromboembolism (VTE). With the decision to pro-
phylax against VTE frequently predicated on assessment of 
individualized patient risk, the aim of this study was to 
develop a predictive model to assess the risk of VTE after 
major hepatic resection (MHR).
Methods: For the multivariate regression model, variables 
at a signifi cance level of p < 0.05 were chosen from univari-
ate analysis of the National Surgical Quality Improvement 
Program (NSQIP) database for the years 2006–2008; which 
included operating time, red blood cells (RBC), height, age, 
return to OR, pneumonia, organ/space SSI, sepsis, unplanned 
intubation, on a ventilator, progressive renal failure, and 
cardiac arrest requiring CPR. The model was then calibrated 
by adjusting the relative weight of the cases using the LASSO 
procedure. Sensitivity and specifi city were calculated on the 
basis of 3-fold cross-validated prediction.
Results: The model reported is the fi rst one to exceed 80% 
cross-validated sensitivity of the ROC Curve and is described 
by the following equation: *logit(score) = (−7.763 for CPT 
47120 or 47122) (−8.121 for CPT 47125) (−7.595 for CPT 
47130). For the years studied, the incidence of pulmonary 
embolus ranged form 1.11%–1.68%; deep vein thrombosis 
ranged from 1.56%–2.85% amongst 268 NSQUIP institu-
tions. The model depicted demonstrates 83% sensitivity, 
56% specifi city, and 6% PPV, with increased risk for age, 
height, and operating time.
Conclusion: Despite the potential for many false positive 
results, a sensitivity of 83% indicates that 1) this method may 
be useful in screening patients for VTE risk after MHR, and 
2) helping to assess the need for VTE prophylaxis after major 
liver surgery.
*The inverse of the logit function is logit − 1(x) = 1/(1 + 
exp(−x)).
FOS427
A STANDARDIZED PREOPERATIVE 
CARE PLAN DECREASES MORBIDITY 
AND LENGTH OF STAY IN PATIENTS 
UNDERGOING 
PANCREATODUODENECTOMY
A. Cocieru and R. White
Duke University Medical Center, Department of Surgical 
Oncology, Durham, USA
Introduction: Our hypothesis was that institution of a stan-
dardized postoperative care plan would decrease length of 
stay in ptss undergoing pancreaticoduodenectomy (PD).
Methods: We retrospectively reviewed a prospectively 
maintained database of 182 pts who underwent pancreato-
duodencetomy between January of 2008 and August 2011 at 
a tertiary referral center. A standardized postoperative care 
plan was instituted in January of 2011. Mortality, morbidity 
and length of stay where compared between 141 pts treated 
prior to (Group 1) and 41 pts treated after institution of the 
care plan (Group 2). Fisher’s exact, student’s t-test, and 
Mann-Whitney U test were used to determine statistical dif-
ferences in group characteristics and outcomes.
Results: The two groups were comparable in terms of age, 
pancreatic cancer as diagnosis, neoadjuvant therapy and rate 
of vascular resection. Length of stay was shorter in Group 2 
(median 10) than Group 1 (median 12). Postoperative com-
plications occurred in 63.8% pts in Group 1 and 43.9% pts 
in Group 2 (p = 0.029). Pancreas-specifi c complications 
(pancreatic leak) developed in 13.4% and 14.6% (p = 0.8).
Conclusion: Standardized postoperative care plan decreases 
morbidity and length of stay in patients undergoing 
pancreatoduodenectomy.
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FOS428
THE ACCURACY OF MDCT IN 
PREDICTING PANCREATIC CANCER 
RESECTABILITY: IS ARTERY 
ENCASEMENT ALWAYS A SIGN 
OF INVASION?
O. Zakharova, V. Egorov and G. Karmazanovsky
Vishnevsky Institute of Surgery, Moscow, Russia
Introduction: Pancreatic cancer is often a late diagnosis, 
with the signs of extrapancreatic spread already present. 
Assessment of vascular invasion is an important parameter 
for determining resectability for PC. A frequent error is to 
misdiagnose an involved major vessel. Accurate preopera-
tive staging of PC is essential not to deny the opportunity for 
cure in patients with resectable disease. Our aim was to 
evaluate the ability of MDCT to assess vascular involvement 
in patients with PC.
Methods: Our study encompasses 20 cases, selected 
according to the following criteria: tumoral lesions without 
a perspective of radical surgery due to invasion of a major 
arterial vessel, judged by MDCT, in which the preoperative 
determination of unresectability was not confi rmed during 
surgery. MDCT fi ndings were compared to surgical and 
pathology gold standards. We defi ned “vascular invasion” 
as histological invasion of vessel wall by tumor, “vascular 
encasement” as radiological circumferential involvement of 
more than 180 degrees of the artery, and “vascular abut-
ment” as tumor adjacency requiring vascular resection 
during surgery.
Results: Among these 20 patients, six (30%) had free of 
tumor vessels, with the possibility of artery skeletonization, 
including patients with MDCT signs of invasion (radiologi-
cal absence of a fat plane between tumor and vessel, wall 
irregularity, vascular encasement); vascular abutment requir-
ing vascular resection during surgery was present in 10 
(50%) cases (celiac axis resection was completed in 3 cases); 
4 (20%) patients had amenable for R0 resection tumor to 
vessel adjacency, but were found inoperable because of small 
liver metastasis, missed during MDCT. Considering our cri-
teria for patient selection, no cases of histologically proven 
vascular invasion were found in our study.
Conclusion: MDCT has become an important method for 
preoperative staging, however, alone, it has been shown too 
inaccurate for the evaluation of resectability, particularly in 
defi ning artery invasion. Apparently, surgical exploration 
with pathological examination remains the “gold standard” 
from the standpoint of vascular involvement for patients with 
pancreatic cancer.
FOS429
CAN MDCT PREDICT THE 
RESECTION STATUS AFTER 
PANCREATICODUODENECTOMY FOR 
PANCREATIC ADENOCARCINOMA?
O. Zakharova, V. Egorov and G. Karmazanovsky
Vishnevsky Institute of Surgery, Moscow, Russia
Introduction: The completeness of resection resulting from 
pancreaticoduodenectomy for pancreatic cancer has a power-
ful prognostic signifi cance for recurrence and survival. The 
superior mesenteric artery (SMA) margin is the most com-
monly positive following PD, and one that cannot be rere-
sected if the intraoperative frozen section analysis determines 
that it is positive. 3D-CT is an accurate predictor of resect-
ability for PC. The aim is to fi gure out whether it can prevent 
a margin positive resection.
Methods: Retrospective analysis of CT scans and pathohis-
tological reports of 89 cases (62 men and 27 women; mean 
age 59.6 ± 2) of pancreatic ductal adenocarcinoma after 
Whipple procedures (2006–2011). We conducted a compara-
tive analysis of demographic, clinical, intraoperative and 
pathologic characteristics of the two groups of patients: with 
R0 and R1 resections following PD. The tested specifi cations 
included: sex, age, size of tumor (CT and morphology), 
TNM stage, evaluation of vessel involvement (using 3D 
reconstructions) and tumor grade. Based on the radiological 
data, cases of resectable and borderline-resectable tumors 
were analyzed. Only patients with clear, unequivocal CT 
evidence of tumor unresectability were excluded from our 
study.
Results: No gross or microscopic residual disease (R0) was 
found in 76 (85.4%) patients, which formed the fi rst group 
(A). Microscopically positive surgical margins (R1) with no 
gross residual disease was detected in 13 (14.6%) cases 
(group B). There were no resections with grossly evident 
residual disease in our study. The accuracy of 3D-CT in 
determining a margin negative resection was 85%. Patients 
who underwent vascular resections and reconstructions were 
more likely to have had an R1 resection. In group B: the 
average size of tumor was 30.4 ± 3.7 mm (p < 0.05); 4 
(30.8%) patients had circumferential involvement of a major 
vessel of more than 180 degrees (p < 0.05).
Conclusion: Margin negative resection remains the only 
potentially curative therapy, prolonging survival and improv-
ing the quality of life. MDCT is the most reliable and com-
monly used method for pancreatic cancer staging, however, 
in up to 15% irresectability is only seen during operation. 
3D-CT imaging increases the diagnostic accuracy of vascular 
invasion. To avoid unnecessary laparotomies it is important 
to properly interpret CT data.
FOS430
LAPAROSCOPIC APPROACH IS GOLD 
STANDARD FOR LEFT LATERAL 
RESECTION FOR BENIGN 
LIVER LESION
S. Dokmak, V. Raut, S. Fteriche, B. Aussilhou, 
O. Farges, A. Sauvanet and J. Belghiti
Department of Hepato-Pancreato-Biliary Surgery, Beaujon 
Hospital, Clichy, France
Introduction: The left lateral segment of the liver is the fi rst 
choice for a laparoscopic anatomic resection because of its 
peripheral location, minimal dissection. In this controlled 
matched study, we analyzed effi cacy of open and laparo-
scopic left lateral resection for benign lesion.
Methods: 31 laparoscopic left lateral resections were 
control matched with 31 open left lateral resections by strict 
selection based on pathology of lesion, size of lesion, ASA 
grade, BMI, age and sex of the patient.
Results: Despite strict matching of age and sex in both 
groups, females constitute 80.6% of study population with a 
mean age of 38.9 years as compared to 19.4% males with a 
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mean age of 57.9 years. Duration of operation in open group 
was 243.9 ± 104.6 minutes as compared to 181.7 ± 71.5 
minutes in laparoscopic group (p = 0.048). Blood loss was 
signifi cantly lower in laparoscopic group (455.8 ± 593.1 ml 
vs. 223.0 ± 281.2 ml; p = 0.035). Duration of hospital stay 
was signifi cantly lower in laparoscopic group (8.06 ± 4.4 
days vs. 4.1 ± 1.7 days; p ≤ 0.001). Total cost of hospitaliza-
tion for left lateral resection in open group was 11504 ± 7776 
Euros whereas for laparoscopic group it 7475 ± 2679 Euros 
(p ≤ 0.001).
Conclusion: Our strictly control matched study demon-
strated operative safety, excellent post-operative outcomes, 
economic benefi ts of the laparoscopic liver resection. 
Moreover postoperative quality of life was higher in the 
young females after laparoscopic liver resections. Results of 
the liver surgery are improved, when the benefi ts of the lapa-
roscopic surgery combined to it, we recommend the laparo-
scopic left lateral liver resection as a gold standard procedure 
for benign liver lesions.
